Clustering O 0 0.44382721185684204
of O 0 0.03401753306388855
missense O 1 0.9533254504203796
mutations O 1 0.9664841890335083
in O 0 0.0331035852432251
the O 0 0.14281421899795532
ataxia B-Disease 1 0.9947592616081238
- I-Disease 1 0.9701231122016907
telangiectasia I-Disease 1 0.9921672940254211
gene O 1 0.9658944606781006
in O 0 0.023091113194823265
a O 0 0.06780955940485
sporadic B-Disease 1 0.9083598852157593
T I-Disease 1 0.9803260564804077
- I-Disease 1 0.9381507039070129
cell I-Disease 1 0.97303706407547
leukaemia I-Disease 1 0.981986403465271
. O 0 0.07946350425481796

Ataxia B-Disease 1 0.9836450815200806
- I-Disease 1 0.9392117261886597
telangiectasia I-Disease 1 0.9815462231636047
( O 0 0.17386041581630707
A B-Disease 0 0.13193298876285553
- I-Disease 1 0.6941896677017212
T I-Disease 1 0.9344570636749268
) O 0 0.03703110292553902
is O 0 0.012139344587922096
a O 0 0.12468969076871872
recessive B-Disease 1 0.9968357682228088
multi I-Disease 1 0.9644554853439331
- I-Disease 1 0.9485871195793152
system I-Disease 1 0.8770398497581482
disorder I-Disease 1 0.9966657757759094
caused O 1 0.8526474237442017
by O 0 0.049148041754961014
mutations O 1 0.9700263142585754
in O 0 0.00867125391960144
the O 0 0.009553170762956142
ATM O 1 0.5761168599128723
gene O 1 0.9325879216194153
at O 0 0.02664925344288349
11q22 O 1 0.7694487571716309
- O 1 0.5835391283035278
q23 O 1 0.783816933631897
( O 0 0.09887407720088959
ref O 0 0.40125495195388794
. O 0 0.010257902555167675
3 O 0 0.016364334151148796
) O 0 0.01629715785384178
. O 0 0.016856873407959938

The O 0 0.03162593021988869
risk O 1 0.7617722749710083
of O 0 0.03171519935131073
cancer B-Disease 1 0.9897108674049377
, O 0 0.014767796732485294
especially O 0 0.1712656468153
lymphoid B-Disease 1 0.9743843078613281
neoplasias I-Disease 1 0.595572829246521
, O 0 0.00825943797826767
is O 0 0.007134336978197098
substantially O 0 0.17659775912761688
elevated O 0 0.462927907705307
in O 0 0.016530951485037804
A B-Disease 0 0.16465598344802856
- I-Disease 1 0.8793715238571167
T I-Disease 1 0.9832956194877625
patients O 1 0.9570855498313904
and O 0 0.006930097006261349
has O 0 0.006808530539274216
long O 0 0.026029912754893303
been O 0 0.007917091250419617
associated O 0 0.15152518451213837
with O 0 0.08961977064609528
chromosomal O 1 0.9905762672424316
instability O 1 0.9459342956542969
. O 0 0.055204667150974274

By O 0 0.06433472037315369
analysing O 1 0.8120531439781189
tumour B-Disease 1 0.9857913255691528
DNA O 1 0.846849799156189
from O 0 0.062189921736717224
patients O 1 0.9606004953384399
with O 0 0.06718891859054565
sporadic B-Disease 1 0.9244793057441711
T I-Disease 1 0.9825881123542786
- I-Disease 1 0.950373113155365
cell I-Disease 1 0.9864121675491333
prolymphocytic I-Disease 1 0.9860201478004456
leukaemia I-Disease 1 0.9946318864822388
( O 1 0.6207235455513
T B-Disease 1 0.972788393497467
- I-Disease 1 0.7300238013267517
PLL I-Disease 1 0.9517053365707397
) O 0 0.01943814381957054
, O 0 0.006362928543239832
a O 0 0.010677434504032135
rare O 0 0.37142905592918396
clonal B-Disease 1 0.9621671438217163
malignancy I-Disease 1 0.9781680703163147
with O 0 0.01071828231215477
similarities O 0 0.031169453635811806
to O 0 0.00582169508561492
a O 0 0.029093900695443153
mature B-Disease 1 0.917773425579071
T I-Disease 1 0.9813458323478699
- I-Disease 1 0.933448314666748
cell I-Disease 1 0.9807093143463135
leukaemia I-Disease 1 0.9896386861801147
seen O 0 0.025179345160722733
in O 0 0.009939617477357388
A B-Disease 0 0.04360819235444069
- I-Disease 0 0.31994396448135376
T I-Disease 1 0.6601659059524536
, O 0 0.0044104731641709805
we O 0 0.002688391599804163
demonstrate O 0 0.005890336818993092
a O 0 0.0043561109341681
high O 0 0.006671581882983446
frequency O 0 0.03497840464115143
of O 0 0.009872077964246273
ATM O 1 0.7654934525489807
mutations O 1 0.9798756837844849
in O 0 0.06294107437133789
T B-Disease 1 0.9406775832176208
- I-Disease 1 0.6881155967712402
PLL I-Disease 1 0.9257370829582214
. O 0 0.04776071757078171

In O 0 0.017178881913423538
marked O 0 0.017276844009757042
contrast O 0 0.016120431944727898
to O 0 0.005915312096476555
the O 0 0.008086571469902992
ATM O 1 0.787219762802124
mutation O 1 0.9854544401168823
pattern O 0 0.4580535888671875
in O 0 0.009780523367226124
A B-Disease 0 0.04460696130990982
- I-Disease 0 0.3780565857887268
T I-Disease 1 0.7406051754951477
, O 0 0.004015116952359676
the O 0 0.0030775871127843857
most O 0 0.00543564697727561
frequent O 0 0.09291612356901169
nucleotide O 0 0.4526329040527344
changes O 0 0.022013582289218903
in O 0 0.007003400474786758
this O 0 0.016178572550415993
leukaemia B-Disease 1 0.9845603704452515
were O 0 0.0318484902381897
missense O 1 0.9726300239562988
mutations O 1 0.9764451384544373
. O 0 0.07008695602416992

These O 0 0.01577991060912609
clustered O 0 0.022185541689395905
in O 0 0.006869985722005367
the O 0 0.0045831045135855675
region O 0 0.006633460056036711
corresponding O 0 0.006546436809003353
to O 0 0.002853698330000043
the O 0 0.003819690551608801
kinase O 1 0.7053556442260742
domain O 0 0.01732539013028145
, O 0 0.0028183236718177795
which O 0 0.002337656682357192
is O 0 0.003076842287555337
highly O 0 0.012035973370075226
conserved O 0 0.10397829860448837
in O 0 0.008991782553493977
ATM O 1 0.6181915402412415
- O 0 0.4758317470550537
related O 0 0.4790749251842499
proteins O 1 0.722123384475708
in O 0 0.022501381114125252
mouse O 1 0.8271178603172302
, O 0 0.017460128292441368
yeast O 1 0.8329368829727173
and O 0 0.01681750826537609
Drosophila O 1 0.5422998070716858
. O 0 0.03265702724456787

The O 0 0.024602826684713364
resulting O 0 0.22710348665714264
amino O 1 0.512208104133606
- O 0 0.2995051145553589
acid O 1 0.6467969417572021
substitutions O 0 0.02574773132801056
are O 0 0.004493428394198418
predicted O 0 0.011699446476995945
to O 0 0.004285325296223164
interfere O 0 0.05147470533847809
with O 0 0.008421645499765873
ATP O 0 0.34391283988952637
binding O 0 0.13265810906887054
or O 0 0.021023504436016083
substrate O 0 0.33647143840789795
recognition O 0 0.05982189625501633
. O 0 0.026406222954392433

Two O 0 0.02201365865767002
of O 0 0.015801912173628807
seventeen O 0 0.08911854773759842
mutated O 1 0.9764891266822815
T B-Disease 1 0.9598090052604675
- I-Disease 1 0.5959941744804382
PLL I-Disease 1 0.8845424652099609
samples O 0 0.050832681357860565
had O 0 0.007862324826419353
a O 0 0.008439694531261921
previously O 0 0.013104566372931004
reported O 0 0.04872387275099754
A B-Disease 0 0.07643985748291016
- I-Disease 1 0.6809805631637573
T I-Disease 1 0.9577749967575073
allele O 1 0.942449688911438
. O 0 0.05091375112533569

In O 0 0.020317815244197845
contrast O 0 0.022200794890522957
, O 0 0.008363352157175541
no O 0 0.00951078999787569
mutations O 1 0.8787597417831421
were O 0 0.0050786202773451805
detected O 0 0.18814429640769958
in O 0 0.005617249757051468
the O 0 0.009675816632807255
p53 O 1 0.9857618808746338
gene O 1 0.9642581343650818
, O 0 0.008371178060770035
suggesting O 0 0.05104230344295502
that O 0 0.006530126091092825
this O 0 0.03328350558876991
tumour B-Disease 1 0.9938801527023315
suppressor O 1 0.9652630686759949
is O 0 0.008270209655165672
not O 0 0.005789321381598711
frequently O 0 0.015706464648246765
altered O 0 0.15307392179965973
in O 0 0.013656617142260075
this O 0 0.022416625171899796
leukaemia B-Disease 1 0.974767804145813
. O 0 0.05100741609930992

Occasional O 0 0.4515814781188965
missense O 1 0.9296219348907471
mutations O 1 0.9136430025100708
in O 0 0.013985452242195606
ATM O 0 0.0335787832736969
were O 0 0.004814141895622015
also O 0 0.004866696894168854
found O 0 0.015020516701042652
in O 0 0.03952252119779587
tumour B-Disease 1 0.9952693581581116
DNA O 1 0.9430578351020813
from O 0 0.08736559748649597
patients O 1 0.9799771308898926
with O 0 0.07535337656736374
B B-Disease 1 0.905049204826355
- I-Disease 1 0.9013713598251343
cell I-Disease 1 0.9793522953987122
non I-Disease 1 0.8994278907775879
- I-Disease 1 0.9833657145500183
Hodgkins I-Disease 1 0.9974034428596497
lymphomas I-Disease 1 0.9950968623161316
( O 0 0.426718145608902
B B-Disease 1 0.6136929988861084
- I-Disease 0 0.1730525642633438
NHL I-Disease 0 0.05696069076657295
) O 0 0.009341356344521046
and O 0 0.005073069129139185
a O 0 0.010210764594376087
B B-Disease 0 0.23833990097045898
- I-Disease 0 0.14914606511592865
NHL I-Disease 0 0.14702194929122925
cell O 0 0.4868888854980469
line O 0 0.026105016469955444
. O 0 0.021695777773857117

The O 0 0.011990618892014027
evidence O 0 0.008098708465695381
of O 0 0.0047491081058979034
a O 0 0.005350417457520962
significant O 0 0.0074203540571033955
proportion O 0 0.015035820193588734
of O 0 0.0044069718569517136
loss O 0 0.15851520001888275
- O 0 0.12256406992673874
of O 0 0.006793044973164797
- O 0 0.33345580101013184
function O 0 0.41247743368148804
mutations O 1 0.955799400806427
and O 0 0.003892525564879179
a O 0 0.003990116994827986
complete O 0 0.00684317434206605
absence O 0 0.007461967412382364
of O 0 0.0023267949000000954
the O 0 0.0025585771072655916
normal O 0 0.029333166778087616
copy O 0 0.011983542703092098
of O 0 0.0029232550878077745
ATM O 0 0.031014785170555115
in O 0 0.0031374862883239985
the O 0 0.0033490483183413744
majority O 0 0.0162042248994112
of O 0 0.02199452929198742
mutated O 1 0.9918963313102722
tumours B-Disease 1 0.9958263039588928
establishes O 1 0.9427922368049622
somatic O 1 0.97098708152771
inactivation O 1 0.6906911134719849
of O 0 0.0064618573524057865
this O 0 0.007409435696899891
gene O 1 0.7494490742683411
in O 0 0.006425694562494755
the O 0 0.009118844754993916
pathogenesis O 1 0.9610224366188049
of O 0 0.021487465128302574
sporadic B-Disease 1 0.8453994393348694
T I-Disease 1 0.9573249816894531
- I-Disease 1 0.6293853521347046
PLL I-Disease 1 0.9072032570838928
and O 0 0.007222297135740519
suggests O 0 0.033125340938568115
that O 0 0.005296511109918356
ATM O 0 0.13705837726593018
acts O 0 0.017300421372056007
as O 0 0.009648886509239674
a O 0 0.09189007431268692
tumour B-Disease 1 0.9873788952827454
suppressor O 1 0.9660821557044983
. O 0 0.062475141137838364

As O 0 0.01644536852836609
constitutional O 0 0.021458908915519714
DNA O 0 0.08495508134365082
was O 0 0.005483225919306278
not O 0 0.004078320227563381
available O 0 0.004473083186894655
, O 0 0.004546400625258684
a O 0 0.013494853861629963
putative O 1 0.904164731502533
hereditary O 1 0.9788163900375366
predisposition O 1 0.9798316359519958
to O 0 0.025394795462489128
T B-Disease 1 0.9393453001976013
- I-Disease 1 0.5498971343040466
PLL I-Disease 1 0.8475407361984253
will O 0 0.0075192940421402454
require O 0 0.019309476017951965
further O 0 0.009955689311027527
investigation O 0 0.01748129539191723
. O 0 0.010392398573458195
. O 0 0.016682317480444908

Myotonic B-Disease 1 0.9818665385246277
dystrophy I-Disease 1 0.9885056018829346
protein O 1 0.9394855499267578
kinase O 1 0.8656474947929382
is O 0 0.012989886105060577
involved O 0 0.012198981828987598
in O 0 0.005499925930052996
the O 0 0.004805274773389101
modulation O 0 0.20747631788253784
of O 0 0.005896388087421656
the O 0 0.015578607097268105
Ca2 O 1 0.9826055765151978
+ O 1 0.9487819075584412
homeostasis O 1 0.9751958250999451
in O 0 0.13612166047096252
skeletal O 1 0.9846599102020264
muscle O 1 0.9830363392829895
cells O 1 0.9609901309013367
. O 0 0.06181156262755394

Myotonic B-Disease 1 0.9860430955886841
dystrophy I-Disease 1 0.991650402545929
( O 1 0.6639971733093262
DM B-Disease 1 0.9754788279533386
) O 0 0.02784755825996399
, O 0 0.0070595345459878445
the O 0 0.006130478344857693
most O 0 0.029383065178990364
prevalent O 1 0.976055920124054
muscular B-Disease 1 0.9957946538925171
disorder I-Disease 1 0.996670663356781
in O 0 0.048609357327222824
adults O 1 0.6212624907493591
, O 0 0.007848035544157028
is O 0 0.009160502813756466
caused O 0 0.3363739848136902
by O 0 0.010241049341857433
( O 0 0.06446032226085663
CTG O 1 0.8191507458686829
) O 0 0.027310144156217575
n O 0 0.08720196038484573
- O 0 0.07471968978643417
repeat O 0 0.10157965123653412
expansion O 0 0.012111181393265724
in O 0 0.005124460440129042
a O 0 0.01613212190568447
gene O 1 0.9358331561088562
encoding O 1 0.6309741139411926
a O 0 0.09356513619422913
protein O 1 0.9597281217575073
kinase O 1 0.9826311469078064
( O 1 0.6215402483940125
DM B-Disease 1 0.9921197891235352
protein O 1 0.9785740971565247
kinase O 1 0.972758948802948
; O 0 0.056121841073036194
DMPK O 1 0.5268006920814514
) O 0 0.01072255615144968
and O 0 0.0052272845059633255
involves O 0 0.0338747501373291
changes O 0 0.01625479944050312
in O 0 0.009347934275865555
cytoarchitecture O 0 0.37504518032073975
and O 0 0.015237384475767612
ion O 1 0.6062122583389282
homeostasis O 1 0.9359056949615479
. O 0 0.04458491876721382

To O 0 0.015661831945180893
obtain O 0 0.015741150826215744
clues O 0 0.016406364738941193
to O 0 0.0047875456511974335
the O 0 0.004576757550239563
normal O 0 0.06072872132062912
biological O 0 0.04502788558602333
role O 0 0.009098667651414871
of O 0 0.004549980163574219
DMPK O 0 0.4746816158294678
in O 0 0.014139492996037006
cellular O 1 0.8547856211662292
ion O 1 0.7399215698242188
homeostasis O 1 0.8969945907592773
, O 0 0.004989815875887871
we O 0 0.002677150769159198
have O 0 0.002716852817684412
compared O 0 0.0073956213891506195
the O 0 0.004550839774310589
resting O 0 0.26355689764022827
[ O 0 0.4507068693637848
Ca2 O 1 0.9758483171463013
+ O 1 0.562430202960968
] O 0 0.042015425860881805
i O 0 0.004066712688654661
, O 0 0.0028721755370497704
the O 0 0.0030144075863063335
amplitude O 0 0.06083989888429642
and O 0 0.004221196286380291
shape O 0 0.09054624289274216
of O 0 0.020571142435073853
depolarization O 1 0.9884338974952698
- O 1 0.9575973153114319
induced O 1 0.9938463568687439
Ca2 O 1 0.9903370141983032
+ O 1 0.879929780960083
transients O 1 0.5259968042373657
, O 0 0.005059177055954933
and O 0 0.0027994888368993998
the O 0 0.003250859444960952
content O 0 0.006614684592932463
of O 0 0.0050971596501767635
ATP O 0 0.38759830594062805
- O 0 0.14564482867717743
driven O 0 0.06315737962722778
ion O 0 0.4937400221824646
pumps O 0 0.33613845705986023
in O 0 0.042082279920578
cultured O 1 0.9605980515480042
skeletal O 1 0.9914402961730957
muscle O 1 0.9906071424484253
cells O 1 0.9544249773025513
of O 0 0.010635648854076862
wild O 0 0.24994175136089325
- O 0 0.4223179519176483
type O 0 0.30783581733703613
and O 0 0.013442931696772575
DMPK O 1 0.8432919383049011
[ O 1 0.5110687017440796
- O 1 0.7337533235549927
/ O 1 0.8102034330368042
- O 1 0.5763963460922241
] O 1 0.5147265791893005
knockout O 1 0.8960334658622742
mice O 1 0.959394097328186
. O 0 0.04725392162799835

In O 0 0.05285024642944336
vitro O 1 0.8686769008636475
- O 1 0.5978251099586487
differentiated O 1 0.8821560740470886
DMPK O 1 0.923689067363739
[ O 1 0.5225344896316528
- O 1 0.5771726369857788
/ O 1 0.6352340579032898
- O 0 0.266369491815567
] O 0 0.16644972562789917
myotubes O 0 0.27597853541374207
exhibit O 0 0.023384667932987213
a O 0 0.00907918717712164
higher O 0 0.01827298291027546
resting O 0 0.24228234589099884
[ O 0 0.3474885821342468
Ca2 O 1 0.9537853598594666
+ O 0 0.46089479327201843
] O 0 0.030118761584162712
i O 0 0.004253229591995478
than O 0 0.0038706776686012745
do O 0 0.004541815258562565
wild O 0 0.06386527419090271
- O 0 0.2524093687534332
type O 0 0.2311406135559082
myotubes O 0 0.24791987240314484
because O 0 0.005900824908167124
of O 0 0.0031185687985271215
an O 0 0.004054195713251829
altered O 0 0.060696832835674286
open O 0 0.009075851179659367
probability O 0 0.030759992077946663
of O 0 0.006021392531692982
voltage O 0 0.4550907611846924
- O 1 0.5476145148277283
dependent O 1 0.6325119733810425
l O 1 0.9152650237083435
- O 1 0.7468940615653992
type O 1 0.8214490413665771
Ca2 O 1 0.9689493179321289
+ O 1 0.5828332304954529
and O 0 0.014588329941034317
Na O 1 0.7479376196861267
+ O 0 0.47972697019577026
channels O 0 0.0610605850815773
. O 0 0.027669288218021393

The O 0 0.029480965808033943
mutant O 1 0.6496327519416809
myotubes O 0 0.28726083040237427
exhibit O 0 0.03613562136888504
smaller O 0 0.019280698150396347
and O 0 0.010019301436841488
slower O 0 0.30257079005241394
Ca2 O 1 0.9689245820045471
+ O 1 0.6096609830856323
responses O 0 0.16449353098869324
upon O 0 0.012193077243864536
triggering O 0 0.37283456325531006
by O 0 0.017422912642359734
acetylcholine O 1 0.8231109976768494
or O 0 0.025250403210520744
high O 0 0.026032278314232826
external O 0 0.0870218276977539
K O 0 0.39415332674980164
+ O 0 0.43047717213630676
. O 0 0.028928369283676147

In O 0 0.01616832986474037
addition O 0 0.0116126649081707
, O 0 0.005286820232868195
we O 0 0.003941270988434553
observed O 0 0.00817094650119543
that O 0 0.003994254395365715
these O 0 0.01030623260885477
Ca2 O 1 0.9706267714500427
+ O 1 0.8283602595329285
transients O 1 0.7883031368255615
partially O 0 0.1298750340938568
result O 0 0.01888919621706009
from O 0 0.004916367121040821
an O 0 0.004888999741524458
influx O 0 0.10210750252008438
of O 0 0.008069610223174095
extracellular O 1 0.8434333205223083
Ca2 O 1 0.9672002196311951
+ O 0 0.49356722831726074
through O 0 0.012384461238980293
the O 0 0.012385767884552479
l O 1 0.8287118673324585
- O 1 0.669704794883728
type O 1 0.771763801574707
Ca2 O 1 0.9636031985282898
+ O 1 0.5675187706947327
channel O 0 0.04691886529326439
. O 0 0.026889199391007423

Neither O 0 0.024826286360621452
the O 0 0.009579361416399479
content O 0 0.013137693516910076
nor O 0 0.01035970076918602
the O 0 0.005649966187775135
activity O 0 0.014292222447693348
of O 0 0.01075897365808487
Na O 1 0.8942345976829529
+ O 1 0.8695446848869324
/ O 1 0.7831257581710815
K O 1 0.6913255453109741
+ O 1 0.8260908126831055
ATPase O 1 0.9183120727539062
and O 0 0.05800963565707207
sarcoplasmic O 1 0.9820114374160767
reticulum O 1 0.9839261770248413
Ca2 O 1 0.9804396033287048
+ O 1 0.9002251625061035
- O 1 0.6528188586235046
ATPase O 1 0.8655073642730713
are O 0 0.011704586446285248
affected O 0 0.08499852567911148
by O 0 0.0183701328933239
DMPK O 1 0.525112509727478
absence O 0 0.13409481942653656
. O 0 0.028739362955093384

In O 0 0.014529850333929062
conclusion O 0 0.012854963541030884
, O 0 0.005066327750682831
our O 0 0.004336806945502758
data O 0 0.005124944262206554
suggest O 0 0.009605472907423973
that O 0 0.004472972359508276
DMPK O 0 0.2511986196041107
is O 0 0.004906464833766222
involved O 0 0.007955759763717651
in O 0 0.004989665001630783
modulating O 0 0.30896830558776855
the O 0 0.00482589565217495
initial O 0 0.01055618654936552
events O 0 0.009729955345392227
of O 0 0.007495609577745199
excitation O 1 0.8409271836280823
- O 1 0.6384180784225464
contraction O 1 0.9360878467559814
coupling O 1 0.9252583980560303
in O 0 0.13396967947483063
skeletal O 1 0.9843562245368958
muscle O 1 0.9771843552589417
. O 0 0.031606703996658325
. O 0 0.02531425654888153

Constitutional O 1 0.5708423852920532
RB1 O 1 0.9658693075180054
- O 1 0.9421627521514893
gene O 1 0.9857330322265625
mutations O 1 0.9859868884086609
in O 0 0.11431639641523361
patients O 1 0.9680513143539429
with O 0 0.05639450252056122
isolated O 1 0.7098396420478821
unilateral B-Disease 1 0.7501430511474609
retinoblastoma I-Disease 1 0.9643228650093079
. O 0 0.054239846765995026

In O 0 0.02915089577436447
most O 0 0.027661029249429703
patients O 1 0.9215606451034546
with O 0 0.030021853744983673
isolated O 1 0.7035912871360779
unilateral B-Disease 1 0.8155267834663391
retinoblastoma I-Disease 1 0.9835910201072693
, O 0 0.05085470527410507
tumor B-Disease 1 0.9862966537475586
development O 0 0.03666288033127785
is O 0 0.006815786939114332
initiated O 0 0.0537465363740921
by O 0 0.011723289266228676
somatic O 1 0.8869476318359375
inactivation O 1 0.5254534482955933
of O 0 0.006353294476866722
both O 0 0.0089436499401927
alleles O 1 0.8799197673797607
of O 0 0.011772028170526028
the O 0 0.029708946123719215
RB1 O 1 0.9706774353981018
gene O 1 0.9417503476142883
. O 0 0.039205681532621384

However O 0 0.018189888447523117
, O 0 0.007961602881550789
some O 0 0.0050671640783548355
of O 0 0.005586681421846151
these O 0 0.018103890120983124
patients O 1 0.9643798470497131
can O 0 0.10629460215568542
transmit O 1 0.875245988368988
retinoblastoma B-Disease 1 0.9845036268234253
predisposition O 1 0.949183464050293
to O 0 0.011729401536285877
their O 0 0.014945890754461288
offspring O 1 0.6512224674224854
. O 0 0.03261648118495941

To O 0 0.013890440575778484
determine O 0 0.013925531879067421
the O 0 0.007196836173534393
frequency O 0 0.014082244597375393
and O 0 0.004315707832574844
nature O 0 0.010705254971981049
of O 0 0.007329793646931648
constitutional O 0 0.20990271866321564
RB1 O 1 0.9906743168830872
- O 1 0.9609859585762024
gene O 1 0.9937965869903564
mutations O 1 0.993615984916687
in O 0 0.0997176468372345
patients O 1 0.9703531861305237
with O 0 0.03686423972249031
isolated O 1 0.68780517578125
unilateral B-Disease 1 0.7240055799484253
retinoblastoma I-Disease 1 0.9635775089263916
, O 0 0.007006322033703327
we O 0 0.005022267811000347
analyzed O 0 0.11729466170072556
DNA O 1 0.6455746293067932
from O 0 0.029396386817097664
peripheral O 1 0.961959719657898
blood O 1 0.9441621899604797
and O 0 0.029380226507782936
from O 0 0.22332364320755005
tumor B-Disease 1 0.9941257238388062
tissue O 1 0.9765526652336121
. O 0 0.06254144012928009

The O 0 0.021208524703979492
analysis O 0 0.0257259551435709
of O 0 0.01115485467016697
tumors B-Disease 1 0.9733937382698059
from O 0 0.011942183598876
54 O 0 0.03314976766705513
( O 0 0.01622215285897255
71 O 0 0.028392724692821503
% O 0 0.012415281496942043
) O 0 0.00622231001034379
of O 0 0.004038825165480375
76 O 0 0.05849548429250717
informative O 0 0.22950780391693115
patients O 1 0.9074817299842834
showed O 0 0.020119555294513702
loss O 0 0.06183074414730072
of O 0 0.007530418690294027
constitutional O 0 0.09136020392179489
heterozygosity O 1 0.9664774537086487
( O 0 0.29664888978004456
LOH O 1 0.9528124928474426
) O 0 0.03171788528561592
at O 0 0.01758447475731373
intragenic O 1 0.6235517263412476
loci O 1 0.8911015391349792
. O 0 0.039179861545562744

Three O 0 0.026818720623850822
of O 0 0.019060613587498665
13 O 0 0.041712310165166855
uninformative O 1 0.8224390149116516
patients O 1 0.9123719930648804
had O 0 0.018206344917416573
constitutional O 0 0.043198712170124054
deletions O 1 0.5722067952156067
. O 0 0.03164549916982651

For O 0 0.02185274101793766
39 O 0 0.02664448693394661
randomly O 0 0.03345801681280136
selected O 0 0.028200499713420868
tumors B-Disease 1 0.9834209084510803
, O 0 0.015160494484007359
SSCP O 1 0.6278321743011475
, O 0 0.021860936656594276
hetero O 1 0.9673964381217957
- O 1 0.6217387318611145
duplex O 1 0.8479189276695251
analysis O 0 0.051962580531835556
, O 0 0.006587537005543709
sequencing O 0 0.11309126019477844
, O 0 0.0042837271466851234
and O 0 0.003203520318493247
Southern O 0 0.007470982149243355
blot O 0 0.11556988954544067
analysis O 0 0.009511850774288177
were O 0 0.0032094514463096857
used O 0 0.005808614194393158
to O 0 0.006489351391792297
identify O 0 0.12195183336734772
mutations O 1 0.9581667184829712
. O 0 0.027293598279356956

Mutations O 1 0.8599629998207092
were O 0 0.017575014382600784
detected O 0 0.08958268165588379
in O 0 0.011897637508809566
21 O 0 0.014234042726457119
( O 0 0.01512084063142538
91 O 0 0.021808762103319168
% O 0 0.015017850324511528
) O 0 0.01030316948890686
of O 0 0.00843880232423544
23 O 0 0.08392113447189331
tumors B-Disease 1 0.9879292249679565
with O 0 0.07408647239208221
LOH O 1 0.9270408153533936
. O 0 0.03603648766875267

In O 0 0.021571969613432884
6 O 0 0.019557802006602287
( O 0 0.014732268638908863
38 O 0 0.012844108045101166
% O 0 0.011008985340595245
) O 0 0.006741613149642944
of O 0 0.004326074384152889
16 O 0 0.041162315756082535
tumors B-Disease 1 0.9920834302902222
without O 0 0.06040480360388756
LOH O 1 0.9069477319717407
, O 0 0.005851530935615301
one O 0 0.007323416415601969
mutation O 1 0.9487423300743103
was O 0 0.005372443236410618
detected O 0 0.1050436794757843
, O 0 0.002844827249646187
and O 0 0.0020846384577453136
in O 0 0.0026332226116210222
9 O 0 0.006208993494510651
( O 0 0.011470051482319832
56 O 0 0.009348561987280846
% O 0 0.010130594484508038
) O 0 0.004368881229311228
of O 0 0.0028296057134866714
the O 0 0.00838386919349432
tumors B-Disease 1 0.9911934733390808
without O 0 0.05287144333124161
LOH O 1 0.9217550754547119
, O 0 0.007516629062592983
both O 0 0.010939694941043854
mutations O 1 0.9305895566940308
were O 0 0.006337233353406191
found O 0 0.017246443778276443
. O 0 0.01683935523033142

Thus O 0 0.02159610018134117
, O 0 0.008775523863732815
a O 0 0.005917365662753582
total O 0 0.004796660039573908
of O 0 0.004127632360905409
45 O 0 0.017673365771770477
mutations O 1 0.9284045100212097
were O 0 0.004954203963279724
identified O 0 0.03718513622879982
in O 0 0.021817389875650406
tumors B-Disease 1 0.9878666400909424
of O 0 0.019596301019191742
36 O 0 0.20073434710502625
patients O 1 0.9664847254753113
. O 0 0.034465640783309937

Thirty O 0 0.035193976014852524
- O 0 0.026908963918685913
nine O 0 0.01063879020512104
of O 0 0.005680345464497805
the O 0 0.00865115225315094
mutations O 1 0.9694756269454956
- O 0 0.11979559808969498
including O 0 0.008264033123850822
34 O 0 0.022954467684030533
small O 0 0.04111698642373085
mutations O 1 0.9589352011680603
, O 0 0.005955236963927746
2 O 0 0.007141462992876768
large O 0 0.007750192191451788
structural O 0 0.2217324823141098
alterations O 0 0.1483028531074524
, O 0 0.004981170874089003
and O 0 0.005876543466001749
hypermethylation O 1 0.8767365217208862
in O 0 0.01572497934103012
3 O 0 0.1530468463897705
tumors O 1 0.9923761487007141
- O 0 0.12488211691379547
were O 0 0.00383990490809083
not O 0 0.004444181453436613
detected O 0 0.09679465740919113
in O 0 0.0045211357064545155
the O 0 0.006395295262336731
corresponding O 0 0.26810967922210693
peripheral O 1 0.971135675907135
blood O 1 0.9660508632659912
DNA O 1 0.8738207817077637
. O 0 0.04134513437747955

In O 0 0.020661603659391403
6 O 0 0.018078938126564026
( O 0 0.013313566334545612
17 O 0 0.008830085396766663
% O 0 0.0075117540545761585
) O 0 0.004633121192455292
of O 0 0.002742492128163576
the O 0 0.004208147991448641
36 O 0 0.04660613834857941
patients O 1 0.9269126653671265
, O 0 0.005543882958590984
a O 0 0.013576764613389969
mutation O 1 0.9605931043624878
was O 0 0.006980028003454208
detected O 0 0.17727147042751312
in O 0 0.00454911170527339
constitutional O 0 0.014443506486713886
DNA O 0 0.1914225071668625
, O 0 0.0034207948483526707
and O 0 0.002174331108108163
1 O 0 0.00346865295432508
of O 0 0.0025178887881338596
these O 0 0.006080474704504013
mutations O 1 0.9486040472984314
is O 0 0.004506957251578569
known O 0 0.005486757960170507
to O 0 0.0030160690657794476
be O 0 0.0035637079272419214
associated O 0 0.02137177251279354
with O 0 0.0086717139929533
reduced O 0 0.19271525740623474
expressivity O 1 0.922514021396637
. O 0 0.035628125071525574

The O 0 0.016244754195213318
presence O 0 0.014983023516833782
of O 0 0.0062558092176914215
a O 0 0.008015556260943413
constitutional O 0 0.024701399728655815
mutation O 1 0.907082200050354
was O 0 0.004155377857387066
not O 0 0.003208024427294731
associated O 0 0.010280942544341087
with O 0 0.003098432905972004
an O 0 0.0037606980185955763
early O 0 0.008363534696400166
age O 0 0.04164355248212814
at O 0 0.017391137778759003
treatment O 1 0.7832161784172058
. O 0 0.035622671246528625

In O 0 0.030500134453177452
1 O 0 0.03340497612953186
patient O 1 0.7000411152839661
, O 0 0.017050080001354218
somatic O 1 0.8741183876991272
mosaicism O 1 0.8575975894927979
was O 0 0.008799339644610882
demonstrated O 0 0.019427118822932243
by O 0 0.007684777956455946
molecular O 0 0.28589388728141785
analysis O 0 0.02027849853038788
of O 0 0.0067875138483941555
DNA O 0 0.3572365641593933
and O 0 0.009694019332528114
RNA O 1 0.7186193466186523
from O 0 0.04481006786227226
peripheral O 1 0.9578681588172913
blood O 1 0.9242775440216064
. O 0 0.0486142635345459

In O 0 0.029227230697870255
2 O 0 0.040437694638967514
patients O 1 0.8935654163360596
without O 0 0.021221069619059563
a O 0 0.03010701760649681
detectable O 1 0.9559423327445984
mutation O 1 0.9878439903259277
in O 0 0.06389392167329788
peripheral O 1 0.9728829264640808
blood O 1 0.9177738428115845
, O 0 0.01682743802666664
mosaicism O 1 0.8906764388084412
was O 0 0.005666500423103571
suggested O 0 0.009867398999631405
because O 0 0.005461507011204958
1 O 0 0.0052042086608707905
of O 0 0.0044379387982189655
the O 0 0.016704203560948372
patients O 1 0.9856746792793274
showed O 1 0.6811904311180115
multifocal O 1 0.9961040019989014
tumors B-Disease 1 0.9918070435523987
and O 0 0.007250878028571606
the O 0 0.005165071692317724
other O 0 0.005781915038824081
later O 0 0.01016787625849247
developed O 0 0.20981861650943756
bilateral B-Disease 0 0.22928185760974884
retinoblastoma I-Disease 1 0.9478691816329956
. O 0 0.04063804820179939

In O 0 0.015187964774668217
conclusion O 0 0.012526462785899639
, O 0 0.005225184839218855
our O 0 0.004019584972411394
results O 0 0.006366505287587643
emphasize O 0 0.008877393789589405
that O 0 0.002466538455337286
the O 0 0.0032836413010954857
manifestation O 0 0.11100687831640244
and O 0 0.005509166978299618
transmissibility O 1 0.8012194037437439
of O 0 0.007419514004141092
retinoblastoma B-Disease 1 0.8630148768424988
depend O 0 0.008097004145383835
on O 0 0.002564630936831236
the O 0 0.0024406241718679667
nature O 0 0.0043513053096830845
of O 0 0.001833741320297122
the O 0 0.002260868903249502
first O 0 0.0041103605180978775
mutation O 1 0.9203715920448303
, O 0 0.0025504922959953547
its O 0 0.0021283177193254232
time O 0 0.0021598704624921083
in O 0 0.0019203337142243981
development O 0 0.0031250775791704655
, O 0 0.0015843110159039497
and O 0 0.0012150364927947521
the O 0 0.0013328983914107084
number O 0 0.0019390822853893042
and O 0 0.002170158550143242
types O 0 0.03009605035185814
of O 0 0.004312439355999231
cells O 1 0.706512451171875
that O 0 0.0045457337982952595
are O 0 0.0055375006049871445
affected O 0 0.12250328063964844
. O 0 0.010748771950602531
. O 0 0.017000507563352585

Hereditary B-Disease 1 0.9539146423339844
deficiency I-Disease 1 0.9730396866798401
of I-Disease 0 0.012235107831656933
the I-Disease 0 0.007310598157346249
fifth I-Disease 0 0.01056097261607647
component I-Disease 0 0.019635342061519623
of I-Disease 0 0.006185877602547407
complement I-Disease 0 0.029126480221748352
in O 0 0.009180629625916481
man O 0 0.0228385329246521
. O 0 0.02238638885319233

I O 0 0.07546330243349075
. O 0 0.06137043610215187

Clinical O 1 0.8080757260322571
, O 0 0.019684813916683197
immunochemical O 0 0.20078998804092407
, O 0 0.01016814075410366
and O 0 0.00955046433955431
family O 0 0.03773711621761322
studies O 0 0.07376816868782043
. O 0 0.023822519928216934

The O 0 0.01805972307920456
first O 0 0.01358623243868351
recognized O 0 0.03676271066069603
human O 0 0.1952459216117859
kindred O 1 0.8897889256477356
with O 0 0.14517620205879211
hereditary B-Disease 1 0.9864200949668884
deficiency I-Disease 1 0.9933575987815857
of I-Disease 0 0.005912484601140022
the I-Disease 0 0.004583182744681835
fifth I-Disease 0 0.010445116087794304
component I-Disease 0 0.04069647192955017
of I-Disease 0 0.006412987597286701
complement I-Disease 0 0.1966104954481125
( O 0 0.08097207546234131
C5 O 1 0.7183046936988831
) O 0 0.014893477782607079
is O 0 0.009415573440492153
described O 0 0.024743100628256798
. O 0 0.019910350441932678

The O 0 0.024608289822936058
proband O 0 0.0967027097940445
, O 0 0.010111804120242596
a O 0 0.009249581024050713
20 O 0 0.010511782951653004
- O 0 0.05608473718166351
year O 0 0.013981166295707226
- O 0 0.1901877373456955
old O 0 0.0810016617178917
black O 0 0.38915231823921204
female O 1 0.854377031326294
with O 1 0.87061607837677
systemic B-Disease 1 0.9985643029212952
lupus I-Disease 1 0.9989868998527527
erythematosus I-Disease 1 0.9966390132904053
since O 0 0.19098611176013947
age O 0 0.11624331027269363
11 O 0 0.0267462357878685
, O 0 0.013301525264978409
lacked O 0 0.40135782957077026
serum O 1 0.9852818846702576
hemolytic O 1 0.994866132736206
complement O 0 0.36644446849823
activity O 0 0.06969510763883591
, O 0 0.01001254003494978
even O 0 0.01239701360464096
during O 0 0.025958247482776642
remission O 1 0.8962824940681458
. O 0 0.03853028267621994

C5 O 1 0.6188165545463562
was O 0 0.026525378227233887
undetectable O 1 0.6369374990463257
in O 0 0.013885295018553734
her O 0 0.020789412781596184
serum O 1 0.7532433271408081
by O 0 0.01406814344227314
both O 0 0.015180121175944805
immunodiffusion O 1 0.7164479494094849
and O 0 0.07096303999423981
hemolytic O 1 0.9912334084510803
assays O 1 0.8132304549217224
. O 0 0.050786927342414856

Other O 0 0.017283525317907333
complement O 0 0.027265219017863274
components O 0 0.014943251386284828
were O 0 0.006098631303757429
normal O 0 0.10102888941764832
during O 0 0.043467868119478226
remission O 1 0.9645431637763977
of O 0 0.04711466282606125
lupus O 1 0.9956823587417603
, O 0 0.013288897462189198
but O 0 0.011020227335393429
C1 O 1 0.8735053539276123
, O 0 0.011697076261043549
C4 O 1 0.5333156585693359
, O 0 0.0129482327029109
C2 O 1 0.7795857191085815
, O 0 0.008016989566385746
and O 0 0.008369792252779007
C3 O 1 0.683620274066925
levels O 0 0.1206062063574791
fell O 0 0.04700750485062599
during O 0 0.0649522915482521
exacerbations O 1 0.9585501551628113
. O 0 0.043886229395866394

A O 0 0.03195391595363617
younger O 0 0.057898834347724915
half O 0 0.018598271533846855
- O 0 0.15196765959262848
sister O 0 0.041935086250305176
, O 0 0.004893802106380463
who O 0 0.003973905462771654
had O 0 0.005495705641806126
no O 0 0.016490502282977104
underlying O 1 0.8210508823394775
disease O 1 0.9924300312995911
, O 0 0.0049105058424174786
was O 0 0.0031305369921028614
also O 0 0.0032777758315205574
found O 0 0.006075719371438026
to O 0 0.005696335807442665
lack O 0 0.07914219051599503
immunochemically O 1 0.8190684914588928
detectable O 1 0.9215202331542969
C5 O 1 0.8223222494125366
. O 0 0.03917599469423294

By O 0 0.14273376762866974
hemolytic O 1 0.9873281121253967
assay O 0 0.32386621832847595
, O 0 0.010133386589586735
she O 0 0.006886633113026619
exhibited O 0 0.013225994072854519
1 O 0 0.007082062773406506
- O 0 0.024138715118169785
2 O 0 0.004769614432007074
% O 0 0.0043091238476336
of O 0 0.0025450566317886114
the O 0 0.003753102384507656
normal O 0 0.23027877509593964
serum O 1 0.9153114557266235
C5 O 1 0.6765443682670593
level O 0 0.011619114316999912
and O 0 0.004214721266180277
normal O 0 0.03980983793735504
concentrations O 0 0.07161381095647812
of O 0 0.004840455017983913
other O 0 0.0069253104738891125
complement O 0 0.04298192635178566
components O 0 0.04010462760925293
. O 0 0.02230606973171234

C5 O 0 0.2924503982067108
levels O 0 0.027604229748249054
of O 0 0.007072251755744219
other O 0 0.004870560020208359
family O 0 0.00680660642683506
members O 0 0.0038804453797638416
were O 0 0.002824747236445546
either O 0 0.004965273663401604
normal O 0 0.025514323264360428
or O 0 0.005953156389296055
approximately O 0 0.006885909009724855
half O 0 0.012418936006724834
- O 0 0.23011097311973572
normal O 0 0.1303255259990692
, O 0 0.006624618079513311
consistent O 0 0.07173150032758713
with O 0 0.07570753991603851
autosomal O 1 0.9956478476524353
codominant O 1 0.824968159198761
inheritance O 1 0.632888913154602
of O 0 0.009773981757462025
the O 0 0.031282223761081696
gene O 1 0.9800606966018677
determining O 1 0.8784364461898804
C5 B-Disease 1 0.9812843203544617
deficiency I-Disease 1 0.9919195175170898
. O 0 0.10909256339073181

Normal O 1 0.8818969130516052
hemolytic O 1 0.9836099147796631
titers O 1 0.6583327651023865
were O 0 0.012616179883480072
restored O 0 0.019321259111166
to O 0 0.008695249445736408
both O 0 0.01882334239780903
homozygous O 1 0.9745713472366333
C5 B-Disease 1 0.9784162044525146
- I-Disease 1 0.8869025111198425
deficient I-Disease 1 0.9800035357475281
( O 0 0.19010530412197113
C5D B-Disease 1 0.8577784299850464
) O 0 0.025975922122597694
sera O 0 0.06208224222064018
by O 0 0.0065918355248868465
addition O 0 0.007215585559606552
of O 0 0.005856442265212536
highly O 0 0.06399067491292953
purified O 1 0.5311697721481323
human O 0 0.46271517872810364
C5 O 1 0.8464148640632629
. O 0 0.03359546139836311

In O 0 0.03023732639849186
specific O 0 0.0519922599196434
C5 O 1 0.755020022392273
titrations O 1 0.701264500617981
, O 0 0.007769361604005098
however O 0 0.004940940532833338
, O 0 0.0028354646638035774
it O 0 0.0022782147862017155
was O 0 0.0022449924144893885
noted O 0 0.002933439565822482
that O 0 0.0020124604925513268
when O 0 0.0027521555311977863
limited O 0 0.004152812995016575
amounts O 0 0.007548126857727766
of O 0 0.0037295243237167597
C5 O 0 0.25696316361427307
were O 0 0.0027100241277366877
assayed O 0 0.026643645018339157
in O 0 0.0030522022861987352
the O 0 0.002813498256728053
presence O 0 0.008419969119131565
of O 0 0.004544429015368223
low O 0 0.05601659044623375
dilutions O 1 0.7003173828125
of O 0 0.006879944819957018
either O 0 0.03539937362074852
C5D B-Disease 1 0.9020018577575684
serum O 1 0.8758386969566345
, O 0 0.009090322069823742
curving O 0 0.12605708837509155
rather O 0 0.011078918352723122
than O 0 0.013767987489700317
linear O 1 0.804869532585144
dose O 1 0.9179437756538391
- O 0 0.26439419388771057
response O 0 0.05242624506354332
plots O 0 0.01616065762937069
were O 0 0.003518778830766678
consistently O 0 0.007461377419531345
obtained O 0 0.007938865572214127
, O 0 0.005512786563485861
suggesting O 0 0.01876753196120262
some O 0 0.008877630345523357
inhibitory O 1 0.653537929058075
effect O 0 0.14133048057556152
. O 0 0.0262235626578331

Further O 0 0.025039883330464363
studies O 0 0.024703284725546837
suggested O 0 0.015650980174541473
that O 0 0.007020981516689062
low O 0 0.03344156593084335
dilutions O 1 0.7579664587974548
of O 0 0.013172581791877747
C5D B-Disease 1 0.9147133231163025
serum O 1 0.9232125878334045
contain O 0 0.1278921365737915
a O 0 0.0296014416962862
factor O 0 0.4007372260093689
( O 0 0.04214591532945633
or O 0 0.020040594041347504
factors O 0 0.16519999504089355
) O 0 0.011371429078280926
interfering O 0 0.016188671812415123
at O 0 0.003504136111587286
some O 0 0.0031430015806108713
step O 0 0.006979796569794416
in O 0 0.005312058608978987
the O 0 0.015665346756577492
hemolytic O 1 0.996311604976654
assay O 1 0.6011892557144165
of O 0 0.009262069128453732
C5 O 1 0.6681727170944214
, O 0 0.005126750562340021
rather O 0 0.005848207976669073
than O 0 0.005389741621911526
a O 0 0.009206143207848072
true O 0 0.0797872394323349
C5 O 1 0.9256551265716553
inhibitor O 1 0.9550455212593079
or O 0 0.06528371572494507
inactivator O 1 0.6614220142364502
. O 0 0.02953452058136463

Of O 0 0.019521450623869896
clinical O 0 0.3575758635997772
interest O 0 0.009362570941448212
are O 0 0.004563037306070328
( O 0 0.007376955356448889
a O 0 0.004081303719431162
) O 0 0.00449173990637064
the O 0 0.0033157551661133766
documentation O 0 0.01780676655471325
of O 0 0.014076048508286476
membranous O 1 0.9858477115631104
glomerulonephritis B-Disease 1 0.9946889877319336
, O 0 0.19621317088603973
vasculitis B-Disease 1 0.9936743974685669
, O 0 0.03131566196680069
and O 0 0.026971518993377686
arthritis B-Disease 1 0.9956167936325073
in O 0 0.00775672122836113
an O 0 0.0065239486284554005
individual O 0 0.05780664458870888
lacking O 0 0.24706576764583588
C5 O 1 0.8077040910720825
( O 0 0.01142862904816866
and O 0 0.0034920619800686836
its O 0 0.004851837642490864
biologic O 1 0.7281731367111206
functions O 0 0.019102299585938454
) O 0 0.006387784611433744
, O 0 0.0028750214260071516
and O 0 0.003035160480067134
( O 0 0.0121559277176857
b O 0 0.09709081053733826
) O 0 0.008234073407948017
a O 0 0.006676551420241594
remarkable O 0 0.07839872688055038
propensity O 1 0.8904991745948792
to O 0 0.11702962964773178
bacterial B-Disease 1 0.9975912570953369
infections I-Disease 1 0.9949967861175537
in O 0 0.008246809244155884
the O 0 0.006498673465102911
proband O 0 0.33692532777786255
, O 0 0.003955771680921316
even O 0 0.004481150768697262
during O 0 0.00601815665140748
periods O 0 0.019610583782196045
of O 0 0.005809614434838295
low O 0 0.23800979554653168
- O 0 0.49912726879119873
dose O 1 0.8844167590141296
or O 0 0.03211474046111107
alternate O 0 0.07349167764186859
- O 0 0.40249207615852356
day O 0 0.08067232370376587
corticosteroid O 1 0.9719676971435547
therapy O 1 0.9626758098602295
. O 0 0.05677611008286476

Other O 0 0.014641938731074333
observations O 0 0.014681724831461906
indicate O 0 0.010446278378367424
that O 0 0.004080939572304487
the O 0 0.004728542175143957
C5D B-Disease 0 0.23484304547309875
state O 0 0.0057352338917553425
is O 0 0.004499994684010744
compatible O 0 0.045904774218797684
with O 0 0.009862472303211689
normal O 0 0.4024271070957184
coagulation O 1 0.9702252149581909
function O 0 0.03701120615005493
and O 0 0.0031296026427298784
the O 0 0.003331212094053626
capacity O 0 0.006040460895746946
to O 0 0.005038871429860592
mount O 0 0.03560243174433708
a O 0 0.08419840037822723
neutrophilic O 1 0.9779852628707886
leukocytosis O 1 0.9778714776039124
during O 1 0.5167422294616699
pyogenic B-Disease 1 0.9828835129737854
infection I-Disease 1 0.9876509308815002
. O 0 0.03769472986459732
. O 0 0.03323638439178467

Susceptibility O 1 0.9545128345489502
to O 0 0.10789301991462708
ankylosing B-Disease 1 0.9858840107917786
spondylitis I-Disease 1 0.9803317785263062
in O 0 0.02816961333155632
twins O 0 0.3982817232608795
: O 0 0.010138102807104588
the O 0 0.005194163415580988
role O 0 0.01147797517478466
of O 0 0.0075979153625667095
genes O 1 0.9476096034049988
, O 0 0.023991137742996216
HLA O 1 0.9295308589935303
, O 0 0.005819095764309168
and O 0 0.004485168494284153
the O 0 0.006978838238865137
environment O 0 0.0362224280834198
. O 0 0.01939963735640049

OBJECTIVE O 0 0.02495742030441761
To O 0 0.007321292068809271
determine O 0 0.00856954138725996
the O 0 0.004470060113817453
relative O 0 0.03433401137590408
effects O 0 0.4884783625602722
of O 0 0.012408442795276642
genetic O 1 0.9561840891838074
and O 0 0.010638879612088203
environmental O 0 0.17714226245880127
factors O 0 0.4717278778553009
in O 0 0.07650711387395859
susceptibility O 1 0.9889740943908691
to O 0 0.26484012603759766
ankylosing B-Disease 1 0.9939457774162292
spondylitis I-Disease 1 0.9896078705787659
( O 0 0.1243218258023262
AS B-Disease 0 0.02262980118393898
) O 0 0.03109307959675789
. O 0 0.021407781168818474

METHODS O 0 0.05946962162852287
Twins O 0 0.15896271169185638
with O 0 0.008980411104857922
AS B-Disease 0 0.005954347550868988
were O 0 0.003573046298697591
identified O 0 0.006710411049425602
from O 0 0.004567511845380068
the O 0 0.0048330966383218765
Royal O 0 0.0393378883600235
National O 0 0.10045275837182999
Hospital O 1 0.9521926641464233
for O 1 0.520461916923523
Rheumatic B-Disease 1 0.9977192282676697
Diseases I-Disease 1 0.995311439037323
database O 1 0.727875292301178
. O 0 0.05789612978696823

Clinical O 1 0.6129561066627502
and O 0 0.018981309607625008
radiographic O 0 0.48025140166282654
examinations O 0 0.03139985725283623
were O 0 0.005879379343241453
performed O 0 0.010210028849542141
to O 0 0.005753167439252138
establish O 0 0.16443556547164917
diagnoses O 1 0.9800962805747986
, O 0 0.023424603044986725
and O 0 0.06942813098430634
disease O 1 0.9965986609458923
severity O 1 0.9026445746421814
was O 0 0.007607391569763422
assessed O 0 0.01683979667723179
using O 0 0.0071707856841385365
a O 0 0.006834604777395725
combination O 0 0.04302540421485901
of O 0 0.005956543609499931
validated O 0 0.03735640272498131
scoring O 0 0.020181892439723015
systems O 0 0.10692823678255081
. O 0 0.02038838155567646

HLA O 1 0.9398967027664185
typing O 1 0.6522735357284546
for O 0 0.05666622519493103
HLA O 1 0.9676730632781982
- O 1 0.6804618835449219
B27 O 1 0.7895881533622742
, O 0 0.05920899286866188
HLA O 1 0.9745210409164429
- O 1 0.5448964834213257
B60 O 1 0.5550571084022522
, O 0 0.01276329718530178
and O 0 0.012772672809660435
HLA O 1 0.9647796154022217
- O 0 0.4216141104698181
DR1 O 1 0.7539480924606323
was O 0 0.008774188347160816
performed O 0 0.014281141571700573
by O 0 0.012941049411892891
polymerase O 1 0.7560380697250366
chain O 0 0.23081561923027039
reaction O 0 0.08530832827091217
with O 0 0.008115129545331001
sequence O 0 0.1800638884305954
- O 0 0.17623476684093475
specific O 0 0.03772016242146492
primers O 0 0.27029937505722046
, O 0 0.005595403723418713
and O 0 0.005516645964235067
zygosity O 0 0.17261675000190735
was O 0 0.00847134180366993
assessed O 0 0.03195609897375107
using O 0 0.025492331013083458
microsatellite O 1 0.8706415891647339
markers O 0 0.4490351378917694
. O 0 0.03561785817146301

Genetic O 1 0.7466651201248169
and O 0 0.01401189062744379
environmental O 0 0.02576884999871254
variance O 0 0.03258628770709038
components O 0 0.010783834382891655
were O 0 0.0034707318991422653
assessed O 0 0.008365733548998833
with O 0 0.0034216386266052723
the O 0 0.0033224073704332113
program O 0 0.013853468932211399
Mx O 0 0.36006492376327515
, O 0 0.003056347370147705
using O 0 0.003697248175740242
data O 0 0.003569932421669364
from O 0 0.0023861241061240435
this O 0 0.002024575602263212
and O 0 0.0021392765920609236
previous O 0 0.005249617621302605
studies O 0 0.013297328725457191
of O 0 0.005071045830845833
twins O 0 0.20416009426116943
with O 0 0.009617465548217297
AS B-Disease 0 0.01579604111611843
. O 0 0.02018779329955578

RESULTS O 0 0.03591257333755493
Six O 0 0.01928623951971531
of O 0 0.014241390861570835
8 O 0 0.052847970277071
monozygotic O 1 0.9660428762435913
( O 0 0.2806312143802643
MZ O 1 0.9787154197692871
) O 0 0.06294993311166763
twin O 0 0.47814998030662537
pairs O 0 0.33481210470199585
were O 0 0.017684228718280792
disease O 1 0.9938434362411499
concordant O 1 0.7995821237564087
, O 0 0.005899656098335981
compared O 0 0.009320683777332306
with O 0 0.00397677393630147
4 O 0 0.006213160697370768
of O 0 0.004302356392145157
15 O 0 0.014329141937196255
B27 O 1 0.506159782409668
- O 0 0.3681906461715698
positive O 1 0.5435556173324585
dizygotic O 1 0.9687929749488831
( O 0 0.22146646678447723
DZ O 1 0.9405240416526794
) O 0 0.03509275242686272
twin O 0 0.3123311400413513
pairs O 0 0.20863866806030273
( O 0 0.02358841896057129
27 O 0 0.009704984724521637
% O 0 0.009137640707194805
) O 0 0.004882469307631254
and O 0 0.0030017958488315344
4 O 0 0.004439637530595064
of O 0 0.0038191790226846933
32 O 0 0.01813371665775776
DZ O 1 0.8497125506401062
twin O 0 0.4163849353790283
pairs O 0 0.1976410299539566
overall O 0 0.07010690867900848
( O 0 0.01606246829032898
12 O 0 0.007917948067188263
. O 0 0.005254201591014862
5 O 0 0.009978517889976501
% O 0 0.018834292888641357
) O 0 0.015218734741210938
. O 0 0.014815110713243484

Nonsignificant O 0 0.3126554489135742
increases O 0 0.04481496661901474
in O 0 0.011356664821505547
similarity O 0 0.04324290156364441
with O 0 0.006405356340110302
regard O 0 0.010048984549939632
to O 0 0.005046525038778782
age O 0 0.14539436995983124
at O 0 0.17233319580554962
disease O 1 0.997803270816803
onset O 1 0.9856087565422058
and O 0 0.005417836830019951
all O 0 0.0031180705409497023
of O 0 0.005503972992300987
the O 0 0.07630758732557297
disease O 1 0.9972150325775146
severity O 1 0.9600573778152466
scores O 0 0.14818157255649567
assessed O 0 0.11004199087619781
were O 0 0.006390875671058893
noted O 0 0.05425862595438957
in O 0 0.16821278631687164
disease O 1 0.9964736104011536
- O 1 0.9361401796340942
concordant O 1 0.974617600440979
MZ O 1 0.9822549819946289
twins O 1 0.8468559384346008
compared O 0 0.16670797765254974
with O 0 0.06261119246482849
concordant O 1 0.9292725324630737
DZ O 1 0.9521380066871643
twins O 1 0.7746438980102539
. O 0 0.04775915667414665

HLA O 1 0.9518754482269287
- O 0 0.3842841684818268
B27 O 0 0.306877464056015
and O 0 0.009117836132645607
B60 O 0 0.11065102368593216
were O 0 0.0055046831257641315
associated O 0 0.02213994786143303
with O 0 0.006411735434085131
the O 0 0.014169474132359028
disease O 1 0.9924505352973938
in O 0 0.011236495338380337
probands O 0 0.38825592398643494
, O 0 0.003596954047679901
and O 0 0.0024808410089462996
the O 0 0.0035433433949947357
rate O 0 0.0787409320473671
of O 0 0.032191574573516846
disease O 1 0.9954924583435059
concordance O 1 0.6656550765037537
was O 0 0.007765708491206169
significantly O 0 0.14121054112911224
increased O 0 0.0427781380712986
among O 0 0.023398207500576973
DZ O 1 0.8939792513847351
twin O 0 0.2858048677444458
pairs O 0 0.08567584306001663
in O 0 0.004545080009847879
which O 0 0.0035392462741583586
the O 0 0.004432492423802614
co O 0 0.17153911292552948
- O 0 0.14033646881580353
twin O 0 0.21390940248966217
was O 0 0.00495144072920084
positive O 0 0.019914884120225906
for O 0 0.005741112865507603
both O 0 0.008889519609510899
B27 O 0 0.3718022406101227
and O 0 0.01807990111410618
DR1 O 1 0.8181683421134949
. O 0 0.03613266721367836

Additive O 1 0.8898749947547913
genetic O 1 0.9241237640380859
effects O 0 0.14912956953048706
were O 0 0.007174408994615078
estimated O 0 0.010412332601845264
to O 0 0.004897942300885916
contribute O 0 0.012140466831624508
97 O 0 0.01050577312707901
% O 0 0.006754675880074501
of O 0 0.004191132262349129
the O 0 0.005664692260324955
population O 0 0.021361161023378372
variance O 0 0.11187411844730377
. O 0 0.019921887665987015

CONCLUSION O 0 0.06662028282880783
Susceptibility O 1 0.6851576566696167
to O 0 0.007806945592164993
AS B-Disease 0 0.006835611537098885
is O 0 0.004697767551988363
largely O 0 0.011066251434385777
genetically O 0 0.4517524540424347
determined O 0 0.009720146656036377
, O 0 0.003198763821274042
and O 0 0.002413098933175206
the O 0 0.0032601309940218925
environmental O 0 0.03684370964765549
trigger O 0 0.49701768159866333
for O 0 0.007676518056541681
the O 0 0.022524964064359665
disease O 1 0.9908125996589661
is O 0 0.01718841679394245
probably O 0 0.04101615026593208
ubiquitous O 0 0.3892996609210968
. O 0 0.031472887843847275

HLA O 1 0.9543362259864807
- O 0 0.22281360626220703
B27 O 0 0.13206355273723602
accounts O 0 0.013748079538345337
for O 0 0.00571671687066555
a O 0 0.005701645743101835
minority O 0 0.013634809292852879
of O 0 0.003827029373496771
the O 0 0.0057594431564211845
overall O 0 0.1997143030166626
genetic O 1 0.9781842827796936
susceptibility O 1 0.9463861584663391
to O 0 0.011220845393836498
AS B-Disease 0 0.01784326322376728
. O 0 0.020967289805412292

Cell O 1 0.8200037479400635
cycle O 1 0.5611488223075867
- O 0 0.2667410969734192
dependent O 0 0.19628815352916718
colocalization O 0 0.3977038562297821
of O 0 0.012319785542786121
BARD1 O 1 0.720763623714447
and O 0 0.02701038122177124
BRCA1 O 1 0.9846158623695374
proteins O 1 0.5815684199333191
in O 0 0.014777512289583683
discrete O 0 0.1493506133556366
nuclear O 0 0.0487695150077343
domains O 0 0.1937086433172226
. O 0 0.027419958263635635

Germ O 1 0.8793671131134033
- O 0 0.2685490548610687
line O 0 0.056717343628406525
mutations O 1 0.9310826659202576
of O 0 0.013958670198917389
the O 0 0.09366080164909363
BRCA1 O 1 0.9955371618270874
gene O 1 0.9894812107086182
predispose O 1 0.9771522879600525
women O 0 0.20029734075069427
to O 0 0.026605837047100067
early O 1 0.5555235743522644
- O 1 0.9848061203956604
onset O 1 0.9983915686607361
breast B-Disease 1 0.9987227320671082
and I-Disease 1 0.8768969178199768
ovarian I-Disease 1 0.9990897178649902
cancer I-Disease 1 0.9971541166305542
by O 0 0.05361754074692726
compromising O 1 0.5179978609085083
the O 0 0.028276631608605385
genes O 1 0.9768219590187073
presumptive O 1 0.9339863657951355
function O 0 0.3594101667404175
as O 0 0.023847311735153198
a O 0 0.15813575685024261
tumor B-Disease 1 0.9899556636810303
suppressor O 1 0.9636752605438232
. O 0 0.07381070405244827

Although O 0 0.020768726244568825
the O 0 0.012700656428933144
biochemical O 0 0.3326700031757355
properties O 0 0.038676101714372635
of O 0 0.011184326373040676
BRCA1 O 1 0.9804453253746033
polypeptides O 0 0.4028627872467041
are O 0 0.00499519519507885
not O 0 0.0033155507408082485
understood O 0 0.007981717586517334
, O 0 0.0030025795567780733
their O 0 0.0035401226487010717
expression O 0 0.07737050950527191
pattern O 0 0.1426888406276703
and O 0 0.006244569551199675
subcellular O 0 0.4214276373386383
localization O 0 0.2458275854587555
suggest O 0 0.01873059943318367
a O 0 0.00787333957850933
role O 0 0.022829808294773102
in O 0 0.01508522592484951
cell O 1 0.8411672711372375
- O 1 0.5839264392852783
cycle O 1 0.720961332321167
regulation O 0 0.3640459477901459
. O 0 0.031495142728090286

When O 0 0.03781809285283089
resting O 0 0.39358076453208923
cells O 1 0.796161413192749
are O 0 0.00946783646941185
induced O 1 0.8028602004051208
to O 0 0.006237078923732042
proliferate O 0 0.18927498161792755
, O 0 0.004278969950973988
the O 0 0.0036261826753616333
steady O 0 0.015688739717006683
- O 0 0.027422843500971794
state O 0 0.005478573031723499
levels O 0 0.04434581100940704
of O 0 0.008440157398581505
BRCA1 O 1 0.9837759137153625
increase O 0 0.027284344658255577
in O 0 0.005999078042805195
late O 0 0.012087252922356129
G1 O 1 0.5719497203826904
and O 0 0.005737551022320986
reach O 0 0.007986877113580704
a O 0 0.007027935702353716
maximum O 0 0.011095890775322914
during O 0 0.012429073452949524
S O 0 0.1587669998407364
phase O 0 0.17971274256706238
. O 0 0.027138130739331245

Moreover O 0 0.047147832810878754
, O 0 0.01457386463880539
in O 0 0.012131970375776291
S O 0 0.35475969314575195
phase O 1 0.5749828219413757
cells O 1 0.936369001865387
, O 0 0.028857558965682983
BRCA1 O 1 0.9827441573143005
polypeptides O 1 0.5643039345741272
are O 0 0.009766806848347187
hyperphosphorylated O 0 0.33716121315956116
and O 0 0.007782374043017626
accumulate O 0 0.2205951064825058
into O 0 0.012682102620601654
discrete O 0 0.29982849955558777
subnuclear O 1 0.7515644431114197
foci O 1 0.877091646194458
termed O 1 0.5944514870643616
" O 0 0.07768172025680542
BRCA1 O 1 0.9773139357566833
nuclear O 0 0.15441498160362244
dots O 1 0.5929086804389954
. O 0 0.03333894535899162

" O 0 0.07247213274240494
BRCA1 O 1 0.9693649411201477
associates O 0 0.21288107335567474
in O 0 0.016043730080127716
vivo O 0 0.4960848391056061
with O 0 0.013407928869128227
a O 0 0.023807143792510033
structurally O 1 0.7447911500930786
related O 0 0.43267327547073364
protein O 1 0.848419189453125
termed O 1 0.5599210858345032
BARD1 O 1 0.7150439620018005
. O 0 0.03802797570824623

Here O 0 0.013551883399486542
we O 0 0.005812040995806456
show O 0 0.006249024532735348
that O 0 0.003038522321730852
the O 0 0.0034269203897565603
steady O 0 0.012580943293869495
- O 0 0.02040768601000309
state O 0 0.004336955025792122
levels O 0 0.016763178631663322
of O 0 0.004414641764014959
BARD1 O 0 0.376085102558136
, O 0 0.004741656593978405
unlike O 0 0.010181049816310406
those O 0 0.004315964411944151
of O 0 0.008750883862376213
BRCA1 O 1 0.9893609881401062
, O 0 0.00807912740856409
remain O 0 0.010225285775959492
relatively O 0 0.031602662056684494
constant O 0 0.05511977896094322
during O 0 0.03446679189801216
cell O 1 0.8749450445175171
cycle O 1 0.855771541595459
progression O 1 0.9608391523361206
. O 0 0.05103740468621254

However O 0 0.02424057200551033
, O 0 0.013699674978852272
immunostaining O 0 0.1414911150932312
revealed O 0 0.02008695900440216
that O 0 0.008635657839477062
BARD1 O 0 0.4792097806930542
resides O 0 0.11356917768716812
within O 0 0.036985501646995544
BRCA1 O 1 0.9837677478790283
nuclear O 0 0.07008487731218338
dots O 0 0.3644641935825348
during O 0 0.012152062729001045
S O 0 0.08154868334531784
phase O 0 0.03944491967558861
of O 0 0.004078000783920288
the O 0 0.00545139703899622
cell O 1 0.6506197452545166
cycle O 0 0.2286592423915863
, O 0 0.00411916384473443
but O 0 0.0031915197614580393
not O 0 0.0030027462635189295
during O 0 0.005823088809847832
the O 0 0.007371796760708094
G1 O 1 0.8263732194900513
phase O 0 0.26252689957618713
. O 0 0.028667205944657326

Nevertheless O 0 0.043900731950998306
, O 0 0.017007185146212578
BARD1 O 0 0.24817083775997162
polypeptides O 0 0.10206584632396698
are O 0 0.005258524790406227
found O 0 0.00567870307713747
exclusively O 0 0.005610089749097824
in O 0 0.00325564481317997
the O 0 0.00289000547491014
nuclear O 0 0.005827308166772127
fractions O 0 0.009847810491919518
of O 0 0.004271905869245529
both O 0 0.009473123587667942
G1 O 1 0.9539806842803955
- O 0 0.31162676215171814
and O 0 0.012154782190918922
S O 0 0.34533393383026123
- O 0 0.4540502429008484
phase O 1 0.5119518041610718
cells O 1 0.9227288365364075
. O 0 0.03810623288154602

Therefore O 0 0.02838595025241375
, O 0 0.014101468957960606
progression O 1 0.5573436617851257
to O 0 0.006851135287433863
S O 0 0.06722960621118546
phase O 0 0.04213012009859085
is O 0 0.005272305104881525
accompanied O 0 0.007046321406960487
by O 0 0.004069121088832617
the O 0 0.004082757513970137
aggregation O 0 0.11174257099628448
of O 0 0.006330037489533424
nuclear O 0 0.04644985496997833
BARD1 O 1 0.6139149069786072
polypeptides O 1 0.6647886633872986
into O 0 0.052042387425899506
BRCA1 O 1 0.981566309928894
nuclear O 0 0.17533279955387115
dots O 1 0.5422361493110657
. O 0 0.03353628143668175

This O 0 0.030163992196321487
cell O 1 0.565342366695404
cycle O 0 0.42044058442115784
- O 0 0.2109709084033966
dependent O 0 0.1920170933008194
colocalization O 0 0.3740423321723938
of O 0 0.012086701579391956
BARD1 O 1 0.6572639346122742
and O 0 0.019714925438165665
BRCA1 O 1 0.9805650115013123
indicates O 0 0.09885711967945099
a O 0 0.012599890120327473
role O 0 0.020886274054646492
for O 0 0.01290083397179842
BARD1 O 1 0.8214229941368103
in O 0 0.20150873064994812
BRCA1 O 1 0.9948176741600037
- O 1 0.967427134513855
mediated O 1 0.9860299229621887
tumor B-Disease 1 0.9922129511833191
suppression O 1 0.8701505661010742
. O 0 0.06105678528547287

Ethnic O 0 0.04502764344215393
differences O 0 0.036733727902173996
in O 0 0.015233833342790604
the O 0 0.017914853990077972
HFE O 1 0.9241334795951843
codon O 1 0.801371693611145
282 O 1 0.6240158081054688
( O 0 0.36077645421028137
Cys O 1 0.9580119848251343
/ O 1 0.8045094013214111
Tyr O 1 0.899833619594574
) O 0 0.07537402957677841
polymorphism O 1 0.6177901029586792
. O 0 0.031047074124217033

Recent O 0 0.03777434676885605
studies O 0 0.030941570177674294
have O 0 0.010645010508596897
shown O 0 0.024443166330456734
that O 0 0.03631172701716423
hereditary B-Disease 1 0.990829586982727
hemochromatosis I-Disease 1 0.9957569241523743
( O 1 0.5850545167922974
HH B-Disease 1 0.9669520854949951
) O 0 0.01641303487122059
is O 0 0.005141693167388439
likely O 0 0.006595511455088854
to O 0 0.0032271824311465025
be O 0 0.003122354159131646
caused O 0 0.096766896545887
by O 0 0.006043627858161926
homozygosity O 0 0.23686350882053375
for O 0 0.006348010618239641
a O 0 0.015755629166960716
Cys282Tyr O 1 0.7618152499198914
mutation O 1 0.9598905444145203
in O 0 0.012437699362635612
the O 0 0.016054119914770126
HFE O 1 0.9663781523704529
gene O 1 0.8921105861663818
located O 0 0.02108648419380188
4 O 0 0.024356327950954437
. O 0 0.02135554701089859

5 O 0 0.0761052817106247
Mb O 1 0.5491383075714111
telomeric O 1 0.8233906626701355
to O 0 0.028263242915272713
HLA O 1 0.9424019455909729
- O 0 0.20520852506160736
A O 0 0.033780209720134735
. O 0 0.031288594007492065

Population O 0 0.02925947494804859
studies O 0 0.019796796143054962
of O 0 0.005805552937090397
this O 0 0.005600446369498968
polymorphism O 0 0.23140566051006317
are O 0 0.0043250261805951595
facilitated O 0 0.020400358363986015
by O 0 0.00319162430241704
the O 0 0.002834978047758341
fact O 0 0.0036179462913423777
that O 0 0.003103655995801091
the O 0 0.006146300118416548
Cys282Tyr O 1 0.844179630279541
mutation O 1 0.9804173707962036
creates O 0 0.29078051447868347
a O 0 0.021453214809298515
Rsal O 0 0.4359811842441559
restriction O 0 0.07513213902711868
site O 0 0.02830805815756321
. O 0 0.02581457793712616

We O 0 0.015234900638461113
have O 0 0.010021126829087734
studied O 0 0.015767546370625496
the O 0 0.010893518105149269
codon O 0 0.44727250933647156
282 O 1 0.5275269746780396
( O 0 0.286964476108551
Cys O 1 0.9754129648208618
/ O 1 0.8722623586654663
Tyr O 1 0.8623121380805969
) O 0 0.03469744324684143
polymorphism O 0 0.2867293953895569
in O 0 0.007633383851498365
different O 0 0.009372965432703495
ethnic O 0 0.02012820541858673
groups O 0 0.02404862642288208
. O 0 0.021921446546912193

In O 0 0.015455307438969612
agreement O 0 0.011883211322128773
with O 0 0.006271504331380129
previous O 0 0.006943154148757458
observations O 0 0.010294449515640736
the O 0 0.007406820077449083
Tyr O 1 0.867332398891449
allele O 1 0.8538612723350525
appeared O 0 0.009903313592076302
to O 0 0.0034455503337085247
be O 0 0.003626809688284993
rare O 0 0.039294466376304626
or O 0 0.007155284751206636
absent O 0 0.0643678531050682
in O 0 0.007595352828502655
Asiatic O 0 0.3434653878211975
( O 0 0.024897674098610878
Indian O 0 0.009119912981987
, O 0 0.005596303381025791
Chinese O 0 0.010831990279257298
) O 0 0.022465266287326813
populations O 0 0.28515130281448364
. O 0 0.02360098622739315

The O 0 0.021221337839961052
highest O 0 0.03410374000668526
allele O 1 0.8740485906600952
frequency O 0 0.09410139173269272
( O 0 0.011680473573505878
7 O 0 0.007204700727015734
. O 0 0.0038016652688384056
5 O 0 0.005621317774057388
% O 0 0.007161919958889484
) O 0 0.004457194358110428
was O 0 0.0029035427141934633
found O 0 0.0053521934896707535
in O 0 0.006456668023020029
Swedes O 0 0.03880678117275238
. O 0 0.01663120836019516

Saamis O 1 0.5003752708435059
( O 0 0.03334084898233414
2 O 0 0.016396649181842804
% O 0 0.014966468326747417
) O 0 0.009604334831237793
and O 0 0.004656351637095213
Mordvinians O 0 0.2658798098564148
( O 0 0.010091962292790413
1 O 0 0.00528345862403512
. O 0 0.003539858153089881
8 O 0 0.004998120944947004
% O 0 0.006044461391866207
) O 0 0.00488577876240015
had O 0 0.0035282650496810675
significantly O 0 0.020437993109226227
lower O 0 0.0105948681011796
frequencies O 0 0.014035950414836407
of O 0 0.006723848171532154
the O 0 0.013031763955950737
Tyr O 1 0.886631429195404
allele O 1 0.9361640810966492
. O 0 0.04557035490870476

Comparisons O 0 0.05481236055493355
with O 0 0.024065857753157616
allele O 1 0.7820428609848022
frequencies O 0 0.03072739765048027
based O 0 0.009978517889976501
on O 0 0.006290939636528492
prevalence O 1 0.8264434933662415
estimates O 0 0.023107800632715225
of O 0 0.006877667270600796
HH B-Disease 1 0.819675624370575
showed O 0 0.008836118504405022
some O 0 0.004387084860354662
disagreements O 0 0.012925246730446815
with O 0 0.00427004462108016
the O 0 0.004890589043498039
RFLP O 1 0.6471621990203857
data O 0 0.010520679876208305
, O 0 0.0058785597793757915
particularly O 0 0.01162214856594801
in O 0 0.009172661229968071
Finns O 0 0.081946961581707
. O 0 0.023612724617123604

The O 0 0.025884883478283882
newly O 0 0.03055504523217678
described O 0 0.04455513879656792
HFE O 1 0.866991400718689
marker O 0 0.06501506268978119
provides O 0 0.011830940842628479
a O 0 0.005468097515404224
new O 0 0.0038588258903473616
approach O 0 0.005195188336074352
to O 0 0.0022027012892067432
the O 0 0.003287200117483735
screening O 0 0.10130716860294342
of O 0 0.005058262497186661
HH B-Disease 1 0.8511301875114441
as O 0 0.0034565511159598827
well O 0 0.0026421828661113977
as O 0 0.0024591542314738035
studies O 0 0.007128590252250433
of O 0 0.002582055749371648
the O 0 0.003198174061253667
relationship O 0 0.08654505759477615
between O 0 0.016065800562500954
the O 0 0.02728496678173542
HFE O 1 0.9868505001068115
Tyr O 1 0.9780529737472534
allele O 1 0.9704756140708923
and O 0 0.036579031497240067
different O 0 0.2365841269493103
disorders O 1 0.9925078749656677
including O 0 0.4437214136123657
cancer B-Disease 1 0.9877024292945862

Autosomal B-Disease 1 0.98431396484375
dominant I-Disease 1 0.9344611167907715
neurohypophyseal I-Disease 1 0.9747933149337769
diabetes I-Disease 1 0.9950167536735535
insipidus I-Disease 1 0.9814152717590332
associated O 0 0.22888022661209106
with O 0 0.025527894496917725
a O 0 0.07337789982557297
missense O 1 0.9766125679016113
mutation O 1 0.9868239164352417
encoding O 1 0.9078845381736755
Gly23 O 1 0.9287396669387817
- O 1 0.7207163572311401
- O 1 0.7245950102806091
> O 1 0.8719683885574341
Val O 1 0.8208707571029663
in O 0 0.027979262173175812
neurophysin O 1 0.6009929180145264
II O 0 0.14462755620479584
. O 0 0.03291017934679985

Autosomal B-Disease 1 0.9840782880783081
dominant I-Disease 1 0.9539673328399658
neurohypophyseal I-Disease 1 0.9785667657852173
diabetes I-Disease 1 0.9965009689331055
insipidus I-Disease 1 0.9878701567649841
( O 1 0.53266841173172
ADNDI B-Disease 1 0.8990810513496399
) O 0 0.07048618048429489
is O 0 0.026294786483049393
an O 0 0.11526110023260117
inherited B-Disease 1 0.9945790767669678
disease I-Disease 1 0.9980327486991882
caused O 1 0.8710973262786865
by O 0 0.05737192928791046
progressive O 1 0.8584267497062683
degeneration O 1 0.9829266667366028
of O 0 0.008807161822915077
the O 0 0.012221221812069416
magnocellular O 1 0.9411230683326721
neurons O 1 0.6977341175079346
of O 0 0.005886367056518793
the O 0 0.006917471531778574
hypothalamus O 1 0.7011539936065674
leading O 0 0.013635911047458649
to O 0 0.00544008519500494
decreased O 0 0.16480541229248047
ability O 0 0.018916964530944824
to O 0 0.0051679713651537895
produce O 0 0.03882058709859848
the O 0 0.01635478250682354
hormone O 1 0.9816708564758301
arginine O 1 0.9450016021728516
vasopressin O 1 0.9515346884727478
( O 0 0.19608886539936066
AVP O 1 0.7575879693031311
) O 0 0.04485663026571274
. O 0 0.026494909077882767

Affected O 0 0.17887286841869354
individuals O 0 0.02417518012225628
are O 0 0.006994015537202358
not O 0 0.007643646094948053
symptomatic O 1 0.8736687302589417
at O 0 0.010333987884223461
birth O 0 0.3665773570537567
, O 0 0.007352790329605341
but O 0 0.008950512856245041
usually O 0 0.24061916768550873
develop O 1 0.9657348990440369
diabetes B-Disease 1 0.9979469180107117
insipidus I-Disease 1 0.9874690771102905
at O 0 0.01912616193294525
1 O 0 0.03306741639971733
- O 0 0.20926305651664734
6 O 0 0.03606092557311058
yr O 1 0.6808369159698486
of O 0 0.011450749821960926
age O 0 0.050742581486701965
. O 0 0.021431367844343185

The O 0 0.03496260568499565
genetic O 1 0.9223642945289612
locus O 1 0.624518096446991
of O 0 0.009959354996681213
the O 0 0.02229185961186886
disease O 1 0.9870868921279907
is O 0 0.00775953708216548
the O 0 0.007604595273733139
AVP O 1 0.8578888773918152
- O 1 0.6043702363967896
neurophysin O 1 0.8548821210861206
II O 0 0.37884363532066345
( O 0 0.1346050351858139
NPII O 1 0.8916549682617188
) O 0 0.1261817067861557
gene O 1 0.9066723585128784
, O 0 0.007034990470856428
and O 0 0.006198181305080652
mutations O 1 0.9675878286361694
that O 0 0.007288335356861353
cause O 1 0.5075092315673828
ADNDI B-Disease 0 0.2988449037075043
have O 0 0.003419283777475357
been O 0 0.0026748322416096926
found O 0 0.003375055966898799
in O 0 0.002269806805998087
both O 0 0.002269719261676073
the O 0 0.0028529639821499586
signal O 0 0.020932020619511604
peptide O 0 0.2910008430480957
of O 0 0.0039013137575238943
the O 0 0.007206644397228956
prepro O 1 0.7886858582496643
- O 1 0.650192379951477
AVP O 1 0.9348828196525574
- O 1 0.6620181202888489
NPII O 1 0.7837721705436707
precursor O 0 0.42991647124290466
and O 0 0.011267539113759995
within O 0 0.01658729650080204
NPII O 0 0.378641277551651
itself O 0 0.03948687016963959
. O 0 0.026058673858642578

An O 0 0.0214652381837368
affected O 0 0.07590201497077942
girl O 0 0.032106976956129074
who O 0 0.007018996402621269
presented O 0 0.00675704050809145
at O 0 0.004731199238449335
9 O 0 0.006054060533642769
months O 0 0.004996445029973984
of O 0 0.002816405612975359
age O 0 0.009456662461161613
and O 0 0.0030445288866758347
her O 0 0.013298047706484795
similarly O 0 0.17032046616077423
affected O 0 0.36007454991340637
younger O 0 0.17858579754829407
brother O 0 0.021675333380699158
and O 0 0.002918324200436473
father O 0 0.004582935478538275
were O 0 0.0016857882728800178
all O 0 0.001911485567688942
found O 0 0.0028363652527332306
to O 0 0.002420946955680847
have O 0 0.0032587319146841764
a O 0 0.009600303135812283
novel O 0 0.4758811593055725
missense O 1 0.988034188747406
mutation O 1 0.9924348592758179
( O 0 0.3599165380001068
G1758 O 1 0.9093324542045593
- O 1 0.7206807136535645
- O 1 0.7279613018035889
> O 1 0.9036923050880432
T O 1 0.7814888954162598
) O 0 0.020418765023350716
encoding O 0 0.1015922948718071
the O 0 0.010062974877655506
amino O 1 0.5901352763175964
acid O 1 0.8804466724395752
substitution O 1 0.6293354630470276
Gly23 O 1 0.9139477014541626
- O 1 0.7335805296897888
- O 1 0.6905941367149353
> O 1 0.8421686887741089
Val O 1 0.7589938640594482
within O 0 0.046286121010780334
NPII O 1 0.5327023267745972
. O 0 0.040367502719163895

The O 0 0.03869149833917618
mutation O 1 0.8528692722320557
was O 0 0.01675654575228691
confirmed O 0 0.02079932391643524
by O 0 0.016210239380598068
restriction O 0 0.16944430768489838
endonuclease O 1 0.7464607357978821
analysis O 0 0.07440607994794846
. O 0 0.029902499169111252

A O 0 0.05763500928878784
T1 O 1 0.6097123622894287
- O 0 0.09377921372652054
weighted O 0 0.03351648151874542
magnetic O 0 0.05615248158574104
resonance O 0 0.24295616149902344
imaging O 0 0.22999344766139984
of O 0 0.007331188768148422
the O 0 0.010256178677082062
fathers O 1 0.7215272188186646
pituitary O 1 0.9902142286300659
gland O 1 0.9860608577728271
demonstrates O 1 0.6345162391662598
an O 0 0.13394716382026672
attenuated O 1 0.9833083152770996
posterior O 1 0.9827477335929871
pituitary O 1 0.9735556244850159
bright O 0 0.29818859696388245
spot O 0 0.06002546846866608
. O 0 0.029516933485865593

This O 0 0.030207183212041855
mutation O 1 0.89375239610672
may O 0 0.015616935677826405
be O 0 0.004966777749359608
valuable O 0 0.005773396696895361
for O 0 0.00387985585257411
developing O 0 0.030798273161053658
models O 0 0.020708564668893814
of O 0 0.009268161840736866
dominantly B-Disease 1 0.9370814561843872
inherited I-Disease 1 0.9822145104408264
neurodegeneration I-Disease 1 0.9862489104270935
, O 0 0.005582357291132212
as O 0 0.0034576188772916794
the O 0 0.003438468324020505
early O 0 0.00759844807907939
age O 0 0.03769250214099884
of O 0 0.017672289162874222
onset O 1 0.9898843765258789
of O 0 0.04739423468708992
symptoms O 1 0.9923878908157349
suggests O 0 0.18846753239631653
that O 0 0.005693845916539431
this O 0 0.013066467829048634
mutation O 1 0.9775810241699219
may O 0 0.03356437757611275
be O 0 0.005154910963028669
particularly O 0 0.028959481045603752
deleterious O 1 0.7438052296638489
to O 0 0.007288649212568998
the O 0 0.012701715342700481
magnocellular O 1 0.9273611903190613
neuron O 1 0.900048017501831
. O 0 0.024243036285042763
. O 0 0.025250934064388275

Frequent O 0 0.3371864855289459
inactivation O 1 0.6503989696502686
of O 0 0.05365413799881935
PTEN O 1 0.9641072154045105
/ O 1 0.8694359660148621
MMAC1 O 1 0.8772189617156982
in O 0 0.1344095915555954
primary O 1 0.8839545845985413
prostate B-Disease 1 0.9948970675468445
cancer I-Disease 1 0.9895403981208801
. O 0 0.1389320343732834

Sporadic B-Disease 1 0.9566941261291504
prostate I-Disease 1 0.9941602945327759
carcinoma I-Disease 1 0.9914537668228149
is O 0 0.012888353317975998
the O 0 0.006533288396894932
most O 0 0.01151076890528202
common O 0 0.37296563386917114
male B-Disease 1 0.881291389465332
cancer I-Disease 1 0.9899455904960632
in O 0 0.0040350379422307014
the O 0 0.0027042825240641832
Western O 0 0.004507014993578196
world O 0 0.0035350515972822905
, O 0 0.002098418539389968
yet O 0 0.0024429685436189175
many O 0 0.0018878631526604295
of O 0 0.0018462559673935175
the O 0 0.0025461451150476933
major O 0 0.03410280868411064
genetic O 1 0.8345405459403992
events O 0 0.013161052018404007
involved O 0 0.009599079377949238
in O 0 0.0030662345234304667
the O 0 0.004080243408679962
progression O 1 0.8171218633651733
of O 0 0.005688325501978397
this O 0 0.013549631461501122
often O 0 0.33730635046958923
fatal O 1 0.9949259757995605
cancer B-Disease 1 0.9946605563163757
remain O 0 0.018039604648947716
to O 0 0.00646775308996439
be O 0 0.009359528310596943
elucidated O 0 0.44556865096092224
. O 0 0.02563084103167057

Numerous O 0 0.06241818517446518
cytogenetic O 1 0.8170685172080994
and O 0 0.0186842679977417
allelotype O 0 0.42513924837112427
studies O 0 0.056852374225854874
have O 0 0.008066927082836628
reported O 0 0.01899833232164383
frequent O 0 0.0581628791987896
loss O 0 0.05810907110571861
of O 0 0.009346803650259972
heterozygosity O 1 0.8692329525947571
on O 0 0.024431174620985985
chromosomal O 1 0.9862735867500305
arm O 1 0.8326010704040527
10q O 1 0.8828164935112
in O 0 0.24931737780570984
sporadic B-Disease 1 0.9712584614753723
prostate I-Disease 1 0.9963033199310303
cancer I-Disease 1 0.9922277331352234
. O 0 0.17697608470916748

Deletion O 1 0.7625989317893982
mapping O 0 0.07857336103916168
studies O 0 0.02946275658905506
have O 0 0.009181859903037548
unambiguously O 0 0.03654399886727333
identified O 0 0.013412573374807835
a O 0 0.0072445920668542385
region O 0 0.01043134368956089
of O 0 0.00680386321619153
chromosome O 1 0.9265590310096741
10q23 O 0 0.1386355310678482
to O 0 0.0035377515014261007
be O 0 0.0028951503336429596
the O 0 0.0033166406210511923
minimal O 0 0.019192565232515335
area O 0 0.006419273093342781
of O 0 0.005961470305919647
loss O 0 0.09519083797931671
. O 0 0.02236730046570301

A O 0 0.07176434248685837
new O 0 0.26879167556762695
tumor B-Disease 1 0.9885843992233276
suppressor O 1 0.9844605326652527
gene O 1 0.9780906438827515
, O 0 0.1205376386642456
PTEN O 1 0.9793418049812317
/ O 1 0.7752242684364319
MMAC1 O 1 0.5058431029319763
, O 0 0.006637150421738625
was O 0 0.005650038365274668
isolated O 0 0.0390712171792984
recently O 0 0.00628637382760644
at O 0 0.00327957677654922
this O 0 0.0028092991560697556
region O 0 0.006826563272625208
of O 0 0.005868879146873951
chromosome O 1 0.9578627943992615
10q23 O 0 0.3318026065826416
and O 0 0.003769510192796588
found O 0 0.003856245893985033
to O 0 0.0030865769367665052
be O 0 0.004173667635768652
inactivated O 0 0.337802916765213
by O 0 0.030291330069303513
mutation O 1 0.9871909618377686
in O 0 0.05755019932985306
three O 1 0.5861037969589233
prostate B-Disease 1 0.9985272884368896
cancer I-Disease 1 0.9973704814910889
cell O 1 0.9474994540214539
lines O 0 0.26697593927383423
. O 0 0.04443875700235367

We O 0 0.02972721867263317
screened O 0 0.28925490379333496
80 O 1 0.5181465744972229
prostate B-Disease 1 0.995171844959259
tumors I-Disease 1 0.991855263710022
by O 0 0.05206845700740814
microsatellite O 1 0.9349651336669922
analysis O 0 0.049307990819215775
and O 0 0.007392352446913719
found O 0 0.03722163662314415
chromosome O 1 0.9385303854942322
10q23 O 0 0.17623858153820038
to O 0 0.005755834747105837
be O 0 0.005087233614176512
deleted O 0 0.029065273702144623
in O 0 0.007667982019484043
23 O 0 0.018007025122642517
cases O 0 0.08233374357223511
. O 0 0.02207840234041214

We O 0 0.012138692662119865
then O 0 0.007775097619742155
proceeded O 0 0.008899346925318241
with O 0 0.0058094821870327
sequence O 0 0.01763363927602768
analysis O 0 0.007911460474133492
of O 0 0.003686001058667898
the O 0 0.004675399046391249
entire O 0 0.08950060606002808
PTEN O 1 0.9826853275299072
/ O 1 0.8372751474380493
MMAC1 O 1 0.827712893486023
coding O 1 0.7061143517494202
region O 0 0.022529589012265205
and O 0 0.005987224634736776
tested O 0 0.1345379650592804
for O 0 0.010328308679163456
homozygous O 1 0.9369984865188599
deletion O 1 0.8671503067016602
with O 0 0.008713336661458015
new O 0 0.007938392460346222
intragenic O 0 0.3673490583896637
markers O 0 0.10032898932695389
in O 0 0.0049484530463814735
these O 0 0.00465980963781476
23 O 0 0.013085407204926014
cases O 0 0.05765106901526451
with O 0 0.009991326369345188
10q23 O 0 0.3940628468990326
loss O 0 0.13687419891357422
of O 0 0.0159464031457901
heterozygosity O 1 0.8754369020462036
. O 0 0.037317968904972076

The O 0 0.013791629113256931
identification O 0 0.014258177019655704
of O 0 0.005699623841792345
the O 0 0.005689628422260284
second O 0 0.008986982516944408
mutational O 1 0.7161460518836975
event O 0 0.01609613560140133
in O 0 0.006063131615519524
10 O 0 0.00864916481077671
( O 0 0.019614866003394127
43 O 0 0.0380830354988575
% O 0 0.13857883214950562
) O 0 0.24537433683872223
tumors B-Disease 1 0.9938223361968994
establishes O 1 0.914667010307312
PTEN O 1 0.9796981811523438
/ O 0 0.4730789363384247
MMAC1 O 0 0.16342490911483765
as O 0 0.006657774094492197
a O 0 0.007097966969013214
main O 0 0.01027322094887495
inactivation O 0 0.38004711270332336
target O 0 0.013772808015346527
of O 0 0.008716339245438576
10q O 1 0.6584001779556274
loss O 0 0.42544934153556824
in O 0 0.14456771314144135
sporadic B-Disease 1 0.973443329334259
prostate I-Disease 1 0.997351884841919
cancer I-Disease 1 0.9945216178894043
. O 0 0.05319121852517128
. O 0 0.0319642573595047

Risk O 1 0.856296956539154
reversals O 1 0.5426387786865234
in O 0 0.037365175783634186
predictive O 1 0.8994126915931702
testing O 1 0.6825922727584839
for O 0 0.19742517173290253
Huntington B-Disease 1 0.9849202632904053
disease I-Disease 1 0.990584135055542
. O 0 0.09430214762687683

The O 0 0.020454853773117065
first O 0 0.017492150887846947
predictive O 1 0.8535780310630798
testing O 1 0.6533147096633911
for O 0 0.24025768041610718
Huntington B-Disease 1 0.9953225255012512
disease I-Disease 1 0.9977200627326965
( O 0 0.1620246171951294
HD B-Disease 0 0.3947810232639313
) O 0 0.006704390514642
was O 0 0.002752125496044755
based O 0 0.00325903226621449
on O 0 0.002437278861179948
analysis O 0 0.00965083297342062
of O 0 0.005449298303574324
linked O 1 0.7694053649902344
polymorphic O 1 0.9795645475387573
DNA O 1 0.7339489459991455
markers O 0 0.14731177687644958
to O 0 0.004107907880097628
estimate O 0 0.009367379359900951
the O 0 0.004012187477201223
likelihood O 0 0.055469878017902374
of O 0 0.0063918414525687695
inheriting O 1 0.5751384496688843
the O 0 0.0168780330568552
mutation O 1 0.966076672077179
for O 0 0.018741348758339882
HD B-Disease 0 0.4055421054363251
. O 0 0.025175997987389565

Limits O 0 0.027821268886327744
to O 0 0.009358715265989304
accuracy O 0 0.015214704908430576
included O 0 0.009752069599926472
recombination O 0 0.36224663257598877
between O 0 0.00652663828805089
the O 0 0.005195042584091425
DNA O 0 0.3193392753601074
markers O 0 0.10007025301456451
and O 0 0.004199928138405085
the O 0 0.006267027463763952
mutation O 1 0.9686426520347595
, O 0 0.007834981195628643
pedigree O 0 0.3034974932670593
structure O 0 0.015168235637247562
, O 0 0.0031268158927559853
and O 0 0.002460185205563903
whether O 0 0.004917351063340902
DNA O 0 0.15173247456550598
samples O 0 0.012249482795596123
were O 0 0.003138321451842785
available O 0 0.004333680495619774
from O 0 0.005318245850503445
family O 0 0.014932278543710709
members O 0 0.010803475975990295
. O 0 0.015525978989899158

With O 0 0.019483091309666634
direct O 0 0.01804060861468315
tests O 0 0.016663797199726105
for O 0 0.005606741178780794
the O 0 0.006801441311836243
HD B-Disease 1 0.5400596261024475
mutation O 1 0.8784900307655334
, O 0 0.004668642301112413
we O 0 0.0024302720557898283
have O 0 0.0022677246015518904
assessed O 0 0.004553801845759153
the O 0 0.0021187621168792248
accuracy O 0 0.004218903835862875
of O 0 0.0025326982140541077
results O 0 0.009996454231441021
obtained O 0 0.005919340066611767
by O 0 0.005103080999106169
linkage O 0 0.3008255362510681
approaches O 0 0.02179735153913498
when O 0 0.004487421829253435
requested O 0 0.0045133973471820354
to O 0 0.0023829657584428787
do O 0 0.003024504752829671
so O 0 0.003449740819633007
by O 0 0.0037929187528789043
the O 0 0.004913778509944677
test O 0 0.022130277007818222
individuals O 0 0.04547059163451195
. O 0 0.018652917817234993

For O 0 0.013165821321308613
six O 0 0.008202610537409782
such O 0 0.005415571387857199
individuals O 0 0.008611349388957024
, O 0 0.0031867842189967632
there O 0 0.002758207032456994
was O 0 0.0032358767930418253
significant O 0 0.008962673135101795
disparity O 0 0.11913429945707321
between O 0 0.009353446774184704
the O 0 0.008272204548120499
tests O 0 0.12994790077209473
. O 0 0.02426445484161377

Three O 0 0.01771024987101555
went O 0 0.011693978682160378
from O 0 0.008291903883218765
a O 0 0.010715036652982235
decreased O 0 0.3807557225227356
risk O 0 0.43709635734558105
to O 0 0.004442759323865175
an O 0 0.00509094912558794
increased O 0 0.06087613105773926
risk O 0 0.3885873556137085
, O 0 0.0032707618083804846
while O 0 0.0026564830914139748
in O 0 0.002637748373672366
another O 0 0.004164171405136585
three O 0 0.003657393855974078
the O 0 0.005530830472707748
risk O 0 0.4933193624019623
was O 0 0.009607265703380108
decreased O 0 0.26047664880752563
. O 0 0.026829570531845093

Knowledge O 0 0.021596835926175117
of O 0 0.007361391559243202
the O 0 0.00526910275220871
potential O 0 0.010102339088916779
reasons O 0 0.005235231947153807
for O 0 0.0028737669344991446
these O 0 0.00276480452157557
changes O 0 0.006737664807587862
in O 0 0.0024921742733567953
results O 0 0.007478032726794481
and O 0 0.0021866823080927134
impact O 0 0.011652423068881035
of O 0 0.002815605839714408
these O 0 0.007106124889105558
risk O 1 0.6793397665023804
reversals O 0 0.24571973085403442
on O 0 0.0034363153390586376
both O 0 0.006315501406788826
patients O 1 0.7729431390762329
and O 0 0.002914259908720851
the O 0 0.003766343928873539
counseling O 0 0.1803930401802063
team O 0 0.0036507376935333014
can O 0 0.0034323313739150763
assist O 0 0.004835751373320818
in O 0 0.002021349733695388
the O 0 0.002015882171690464
development O 0 0.004361365456134081
of O 0 0.0025616136845201254
strategies O 0 0.03914583474397659
for O 0 0.0030898787081241608
the O 0 0.003306427039206028
prevention O 1 0.5754140019416809
and O 0 0.00261093582957983
, O 0 0.0023354648146778345
where O 0 0.002182684140279889
necessary O 0 0.003544887760654092
, O 0 0.0025647515431046486
management O 0 0.007897482253611088
of O 0 0.002909807488322258
a O 0 0.009420773014426231
risk O 1 0.645812451839447
reversal O 0 0.12894855439662933
in O 0 0.0052388692274689674
any O 0 0.00808775331825018
predictive O 1 0.6593684554100037
testing O 0 0.1440345048904419
program O 0 0.02737618423998356
. O 0 0.014490111730992794
. O 0 0.019182119518518448

A O 0 0.04462805390357971
novel O 0 0.14279258251190186
common O 0 0.3706390857696533
missense O 1 0.9635336995124817
mutation O 1 0.9701154828071594
G301C O 0 0.3601026237010956
in O 0 0.012079454958438873
the O 0 0.009342044591903687
N O 0 0.2190835326910019
- O 0 0.39924436807632446
acetylgalactosamine O 1 0.8453277945518494
- O 1 0.5593870282173157
6 O 0 0.19199353456497192
- O 1 0.854844331741333
sulfate O 1 0.9852594137191772
sulfatase O 1 0.9850412011146545
gene O 1 0.9724391102790833
in O 0 0.0679108053445816
mucopolysaccharidosis B-Disease 1 0.8628873825073242
IVA I-Disease 1 0.92112135887146
. O 0 0.05000665783882141

Mucopolysaccharidosis B-Disease 1 0.86822110414505
IVA I-Disease 1 0.9104064702987671
( O 0 0.11504130065441132
MPS B-Disease 0 0.31872472167015076
IVA I-Disease 1 0.954590380191803
) O 0 0.0875246599316597
is O 0 0.05044781416654587
an O 0 0.44874244928359985
autosomal B-Disease 1 0.9980165958404541
recessive I-Disease 1 0.9974011182785034
lysosomal I-Disease 1 0.9923835396766663
storage I-Disease 1 0.8816664218902588
disorder I-Disease 1 0.994886577129364
caused O 1 0.7549630999565125
by O 0 0.032389868050813675
a O 0 0.15656964480876923
genetic B-Disease 1 0.9921234250068665
defect I-Disease 1 0.9754366874694824
in O 0 0.027743369340896606
N O 0 0.4369247853755951
- O 1 0.5723590850830078
acetylgalactosamine O 1 0.8208060264587402
- O 1 0.5210705995559692
6 O 0 0.15120674669742584
- O 1 0.8036831617355347
sulfate O 1 0.9795096516609192
sulfatase O 1 0.9759268164634705
( O 0 0.24410346150398254
GALNS O 1 0.7458412647247314
) O 0 0.03957566246390343
. O 0 0.023870710283517838

In O 0 0.016402723267674446
previous O 0 0.013125075958669186
studies O 0 0.014964254572987556
, O 0 0.00351917021907866
we O 0 0.002169323153793812
have O 0 0.0024364511482417583
found O 0 0.0041891844011843204
two O 0 0.004974612034857273
common O 0 0.2875514328479767
mutations O 1 0.9749325513839722
in O 0 0.010373858734965324
Caucasians O 0 0.487983375787735
and O 0 0.005551306530833244
Japanese O 0 0.010040000081062317
, O 0 0.007405001204460859
respectively O 0 0.016244959086179733
. O 0 0.017144137993454933

To O 0 0.021274637430906296
characterize O 0 0.055309053510427475
the O 0 0.014580043032765388
mutational O 1 0.6409688591957092
spectrum O 0 0.03856900334358215
in O 0 0.005714557133615017
various O 0 0.005546055268496275
ethnic O 0 0.01256139948964119
groups O 0 0.011760606430470943
, O 0 0.007846294902265072
mutations O 1 0.9387262463569641
in O 0 0.006995830684900284
the O 0 0.01033345703035593
GALNS O 1 0.9163721203804016
gene O 1 0.9488006234169006
in O 0 0.01336829923093319
Colombian O 0 0.23228819668293
MPS B-Disease 1 0.6461657881736755
IVA I-Disease 1 0.9906982779502869
patients O 1 0.9594951272010803
were O 0 0.004681391641497612
investigated O 0 0.03149844706058502
, O 0 0.00418660556897521
and O 0 0.00437973253428936
genetic O 1 0.6879458427429199
backgrounds O 0 0.016315575689077377
were O 0 0.0033008549362421036
extensively O 0 0.008362719789147377
analyzed O 0 0.011598384007811546
to O 0 0.0031537169124931097
identify O 0 0.01602376438677311
racial O 0 0.02402692846953869
origin O 0 0.010771227069199085
, O 0 0.004130757879465818
based O 0 0.006137454882264137
on O 0 0.006335780490189791
mitochondrial O 1 0.9381168484687805
DNA O 1 0.8793132305145264
( O 0 0.1316574662923813
mtDNA O 1 0.9228348135948181
) O 0 0.08199208229780197
lineages O 1 0.7277339696884155
. O 0 0.032418832182884216

Three O 0 0.04086914658546448
novel O 0 0.3575974702835083
missense O 1 0.9602282643318176
mutations O 1 0.9645175933837891
never O 0 0.014859180897474289
identified O 0 0.013897384516894817
previously O 0 0.006261755246669054
in O 0 0.0036708605475723743
other O 0 0.003178300568833947
populations O 0 0.06084774434566498
and O 0 0.00268560484983027
found O 0 0.0036633708514273167
in O 0 0.002885442692786455
16 O 0 0.004007656592875719
out O 0 0.0030953132081776857
of O 0 0.004058633930981159
19 O 0 0.011568416841328144
Colombian O 0 0.08992177248001099
MPS B-Disease 0 0.4309958517551422
IVA I-Disease 1 0.9794551134109497
unrelated O 1 0.8325861096382141
alleles O 1 0.9287745356559753
account O 0 0.021663667634129524
for O 0 0.01437266543507576
84 O 0 0.04546169191598892
. O 0 0.02518201246857643

2 O 0 0.025539547204971313
% O 0 0.014595129527151585
of O 0 0.006520194932818413
the O 0 0.007677425164729357
alleles O 1 0.7800142168998718
in O 0 0.009209469892084599
this O 0 0.008011030964553356
study O 0 0.04132985696196556
. O 0 0.019480012357234955

The O 0 0.030295100063085556
G301C O 0 0.20137767493724823
and O 0 0.023079445585608482
S162F O 1 0.6683791875839233
mutations O 1 0.9321995973587036
account O 0 0.024710362777113914
for O 0 0.01610407419502735
68 O 0 0.036666154861450195
. O 0 0.024282563477754593

4 O 0 0.03822978958487511
% O 0 0.024414435029029846
and O 0 0.012227238155901432
10 O 0 0.019042205065488815
. O 0 0.021598108112812042

5 O 0 0.030016062781214714
% O 0 0.02073143795132637
of O 0 0.009548885747790337
mutations O 1 0.8935496211051941
, O 0 0.005408185068517923
respectively O 0 0.006163799203932285
, O 0 0.0034470832906663418
whereas O 0 0.007445827592164278
the O 0 0.0032788754906505346
remaining O 0 0.00544707803055644
F69V O 0 0.12659291923046112
is O 0 0.003983210306614637
limited O 0 0.005377794615924358
to O 0 0.004112528171390295
a O 0 0.007643547840416431
single O 0 0.029850760474801064
allele O 1 0.8550384044647217
. O 0 0.02903813123703003

The O 0 0.021920766681432724
skewed O 0 0.3134373128414154
prevalence O 1 0.7574217319488525
of O 0 0.010289233177900314
G301C O 0 0.21099530160427094
in O 0 0.007678569760173559
only O 0 0.007470373995602131
Colombian O 0 0.18387044966220856
patients O 1 0.9615248441696167
and O 0 0.013732758350670338
haplotype O 1 0.9438392519950867
analysis O 0 0.038116179406642914
by O 0 0.008769819512963295
restriction O 0 0.11087049543857574
fragment O 0 0.26854315400123596
length O 0 0.1269829422235489
polymorphisms O 1 0.8989149928092957
in O 0 0.009038549847900867
the O 0 0.01027989387512207
GALNS O 1 0.885314404964447
gene O 1 0.926659345626831
suggest O 0 0.05357559025287628
that O 0 0.007969626225531101
G301C O 0 0.2395402193069458
originated O 0 0.03474162891507149
from O 0 0.009567673318088055
a O 0 0.012669344432651997
common O 0 0.08785735815763474
ancestor O 0 0.3699236214160919
. O 0 0.031732771545648575

Investigation O 0 0.03123999945819378
of O 0 0.009095710702240467
the O 0 0.008368853479623795
genetic O 1 0.7182302474975586
background O 0 0.015940479934215546
by O 0 0.005191519856452942
means O 0 0.006454676389694214
of O 0 0.0050002820789813995
mtDNA O 1 0.821498453617096
lineages O 1 0.7158839106559753
indicate O 0 0.021798795089125633
that O 0 0.0030035478994250298
all O 0 0.002791951410472393
our O 0 0.0056146131828427315
patients O 1 0.773594856262207
are O 0 0.00358125870116055
probably O 0 0.006868641823530197
of O 0 0.0044993446208536625
native O 0 0.015332349576056004
American O 0 0.021483834832906723
descent O 0 0.24796514213085175

Low O 0 0.1561288982629776
frequency O 0 0.16755682229995728
of O 0 0.06628648936748505
BRCA1 O 1 0.9898950457572937
germline O 1 0.9864734411239624
mutations O 1 0.9768859148025513
in O 0 0.031948987394571304
45 O 0 0.17320947349071503
German O 1 0.7995331883430481
breast B-Disease 1 0.9966508746147156
/ I-Disease 1 0.9914515614509583
ovarian I-Disease 1 0.9974365830421448
cancer I-Disease 1 0.9948949217796326
families O 0 0.4147396981716156
. O 0 0.06258067488670349

In O 0 0.017138153314590454
this O 0 0.008973564952611923
study O 0 0.014555475674569607
we O 0 0.006824675481766462
investigated O 0 0.04703756794333458
45 O 0 0.07365672290325165
German O 1 0.7840345501899719
breast B-Disease 1 0.998119056224823
/ I-Disease 1 0.9948404431343079
ovarian I-Disease 1 0.9988640546798706
cancer I-Disease 1 0.9974293112754822
families O 0 0.49112316966056824
for O 0 0.14362134039402008
germline O 1 0.9909145832061768
mutations O 1 0.986884593963623
in O 0 0.03591214120388031
the O 0 0.0772983655333519
BRCA1 O 1 0.9888228178024292
gene O 1 0.9587241411209106
. O 0 0.06756927818059921

We O 0 0.02010592445731163
identified O 0 0.03665195032954216
four O 0 0.03513569384813309
germline O 1 0.9856786131858826
mutations O 1 0.9879406690597534
in O 0 0.08050107210874557
three O 0 0.29607030749320984
breast B-Disease 1 0.9978951215744019
cancer I-Disease 1 0.9959263801574707
families O 0 0.1023334413766861
and O 0 0.00784364901483059
in O 0 0.030301041901111603
one O 0 0.3430589735507965
breast B-Disease 1 0.9984979629516602
- I-Disease 1 0.9948996901512146
ovarian I-Disease 1 0.9992727637290955
cancer I-Disease 1 0.9981960654258728
family O 0 0.17522534728050232
. O 0 0.005388565827161074
among O 0 0.0042326184920966625
these O 0 0.0029807162936776876
were O 0 0.003039776813238859
one O 0 0.008814358152449131
frameshift O 1 0.9816378951072693
mutation O 1 0.9783222079277039
, O 0 0.007007258478552103
one O 0 0.00659521110355854
nonsense O 0 0.28649529814720154
mutation O 1 0.9605602025985718
, O 0 0.006792794447392225
one O 0 0.005919677205383778
novel O 0 0.09187089651823044
splice O 1 0.7971757650375366
site O 0 0.04960176721215248
mutation O 1 0.9527249336242676
, O 0 0.007339000701904297
and O 0 0.0063735004514455795
one O 0 0.014641424641013145
missense O 1 0.9614408612251282
mutation O 1 0.9757437705993652
. O 0 0.047777220606803894

The O 0 0.03783941641449928
missense O 1 0.9167205095291138
mutation O 1 0.9033277630805969
was O 0 0.01254605408757925
also O 0 0.007897892966866493
found O 0 0.010157013311982155
in O 0 0.009160247631371021
2 O 0 0.017610475420951843
. O 0 0.0183518435806036

8 O 0 0.02122611179947853
% O 0 0.010348144918680191
of O 0 0.004172143992036581
the O 0 0.00368816452100873
general O 0 0.004058271646499634
population O 0 0.006948820780962706
, O 0 0.0030468597542494535
suggesting O 0 0.013299987651407719
that O 0 0.0027657956816256046
it O 0 0.0037097246386110783
is O 0 0.007857457734644413
not O 0 0.019966604188084602
disease O 1 0.990078330039978
associated O 0 0.2336658388376236
. O 0 0.02543424628674984

The O 0 0.02170644886791706
average O 0 0.04500817134976387
age O 0 0.12499623000621796
of O 0 0.09948016703128815
disease O 1 0.9967569708824158
onset O 1 0.9868906736373901
in O 0 0.014520669355988503
those O 0 0.017402993515133858
families O 0 0.304736852645874
harbouring O 1 0.9481632709503174
causative O 1 0.9772740602493286
mutations O 1 0.9728714227676392
was O 0 0.011495327576994896
between O 0 0.016586314886808395
32 O 0 0.02923882193863392
. O 0 0.022292159497737885

3 O 0 0.04650961607694626
and O 0 0.020474396646022797
37 O 0 0.03843333199620247
. O 0 0.030011452734470367

4 O 0 0.026675337925553322
years O 0 0.01327468641102314
, O 0 0.006971552036702633
whereas O 0 0.012837228365242481
the O 0 0.00527956523001194
family O 0 0.03842762112617493
harbouring O 0 0.4136194586753845
the O 0 0.014611170627176762
missense O 1 0.9656985402107239
mutation O 1 0.9611534476280212
had O 0 0.008742444217205048
an O 0 0.005679510533809662
average O 0 0.01379616279155016
age O 0 0.02690950594842434
of O 0 0.009368167258799076
onset O 1 0.9555599689483643
of O 0 0.012157759629189968
51 O 0 0.05574023723602295
. O 0 0.024774761870503426

2 O 0 0.05498233810067177
years O 0 0.043702494353055954
. O 0 0.033176880329847336

These O 0 0.020658796653151512
findings O 0 0.02911481447517872
show O 0 0.014891931787133217
that O 0 0.010210838168859482
BRCA1 O 1 0.9758511781692505
is O 0 0.01099687535315752
implicated O 0 0.15101192891597748
in O 0 0.005689545068889856
a O 0 0.007328538224101067
small O 0 0.016136785969138145
fraction O 0 0.2704510986804962
of O 0 0.30303555727005005
breast B-Disease 1 0.9983586668968201
/ I-Disease 1 0.9954555034637451
ovarian I-Disease 1 0.9990761280059814
cancer I-Disease 1 0.9977384805679321
families O 0 0.26363521814346313
suggesting O 0 0.08839128911495209
the O 0 0.0069519514217972755
involvement O 0 0.07529307901859283
of O 0 0.010308339260518551
another O 0 0.18328659236431122
susceptibility O 1 0.9901586174964905
gene O 1 0.9773030281066895
( O 0 0.22595316171646118
s O 0 0.3916705548763275
) O 0 0.08174397051334381

Paternal O 1 0.8937490582466125
transmission O 1 0.9154826998710632
of O 1 0.5474483370780945
congenital B-Disease 1 0.9935264587402344
myotonic I-Disease 1 0.9843897223472595
dystrophy I-Disease 1 0.9793736934661865
. O 0 0.1968594789505005

We O 0 0.015801580622792244
report O 0 0.015725407749414444
a O 0 0.01393358875066042
rare O 0 0.09104301035404205
case O 0 0.03540017828345299
of O 0 0.059273045510053635
paternally O 1 0.9854108095169067
transmitted O 1 0.9932875037193298
congenital B-Disease 1 0.9979448914527893
myotonic I-Disease 1 0.9962443113327026
dystrophy I-Disease 1 0.9957520961761475
( O 1 0.8658231496810913
DM B-Disease 1 0.9758922457695007
) O 0 0.1039641872048378
. O 0 0.037609998136758804

The O 0 0.02153659239411354
proband O 0 0.1338779479265213
is O 0 0.009883364662528038
a O 0 0.009967153891921043
23 O 0 0.011834759265184402
year O 0 0.009376338683068752
old O 0 0.042505595833063126
, O 0 0.03666714206337929
mentally B-Disease 1 0.9512593150138855
retarded I-Disease 1 0.9688451290130615
male O 1 0.852035641670227
who O 0 0.3205007314682007
suffers O 1 0.9863344430923462
severe O 1 0.9852139353752136
muscular B-Disease 1 0.9824464321136475
weakness I-Disease 1 0.9103068709373474
. O 0 0.10130780190229416

He O 0 0.024764707311987877
presented O 0 0.030551113188266754
with O 0 0.07811396569013596
respiratory O 1 0.9873413443565369
and O 0 0.014613775536417961
feeding O 1 0.5356650352478027
difficulties O 0 0.2036423683166504
at O 0 0.01987501233816147
birth O 1 0.5495622754096985
. O 0 0.03060600534081459

His O 0 0.038096606731414795
two O 0 0.035935647785663605
sibs O 1 0.9511582255363464
suffer O 1 0.9025177955627441
from O 0 0.14877396821975708
childhood O 1 0.9665964245796204
onset O 1 0.9856947064399719
DM B-Disease 1 0.9715022444725037
. O 0 0.14438198506832123

Their O 0 0.018176879733800888
late O 0 0.0168966855853796
father O 0 0.012092726305127144
had O 0 0.006349706556648016
the O 0 0.006168746389448643
adult O 0 0.23173649609088898
type O 0 0.21929796040058136
of O 0 0.01218142919242382
DM B-Disease 1 0.9749050140380859
, O 0 0.011335916817188263
with O 0 0.01803504303097725
onset O 1 0.9479554891586304
around O 0 0.010850750841200352
30 O 0 0.0127429673448205
years O 0 0.014178377576172352
. O 0 0.01999686099588871

Only O 0 0.013855905272066593
six O 0 0.01068371906876564
other O 0 0.00676064845174551
cases O 0 0.04456644132733345
of O 0 0.008092899806797504
paternal O 1 0.8808813095092773
transmission O 1 0.9347237348556519
of O 0 0.18406841158866882
congenital B-Disease 1 0.9976047277450562
DM I-Disease 1 0.9855729937553406
have O 0 0.015425408259034157
been O 0 0.011034026741981506
reported O 0 0.027710413560271263
recently O 0 0.02917966991662979
. O 0 0.02237926609814167

We O 0 0.015724919736385345
review O 0 0.014911910519003868
the O 0 0.009052978828549385
sex O 0 0.1432090848684311
related O 0 0.22435148060321808
effects O 1 0.5384948253631592
on O 0 0.013364776037633419
transmission O 1 0.9104743599891663
of O 0 0.2098407745361328
congenital B-Disease 1 0.9956830739974976
DM I-Disease 1 0.9794641733169556
. O 0 0.10317745059728622

Decreased O 1 0.654784619808197
fertility O 1 0.8028159141540527
of O 0 0.0184931643307209
males O 1 0.5153805017471313
with O 0 0.0695495456457138
adult O 1 0.9174448847770691
onset O 1 0.9938207268714905
DM B-Disease 1 0.9824404716491699
and O 0 0.008592411875724792
contraction O 0 0.2842823266983032
of O 0 0.004672428127378225
the O 0 0.004964619409292936
repeat O 0 0.20871636271476746
upon O 0 0.011599384248256683
male O 0 0.3906972408294678
transmission O 1 0.6593924760818481
contribute O 0 0.027791356667876244
to O 0 0.0031054543796926737
the O 0 0.003307226812466979
almost O 0 0.00807801540941
absent O 0 0.19728760421276093
occurrence O 1 0.5066547989845276
of O 0 0.015485631301999092
paternal O 1 0.9418209195137024
transmission O 1 0.962434709072113
of O 0 0.32897812128067017
congenital B-Disease 1 0.9960046410560608
DM I-Disease 1 0.9767036437988281
. O 0 0.11462754756212234

Also O 0 0.013539088889956474
the O 0 0.008297800086438656
fathers O 0 0.015442224219441414
of O 0 0.005056865978986025
the O 0 0.006105658132582903
reported O 0 0.10463368892669678
congenitally O 1 0.8924564719200134
affected O 0 0.24899183213710785
children O 0 0.03094598650932312
showed O 0 0.008082807995378971
, O 0 0.003757005324587226
on O 0 0.0027299176435917616
average O 0 0.008125401102006435
, O 0 0.0064852554351091385
shorter O 0 0.17147080600261688
CTG O 1 0.7957808971405029
repeat O 0 0.33515819907188416
lengths O 0 0.09074941277503967
and O 0 0.009196169674396515
hence O 0 0.18407131731510162
less O 0 0.296356737613678
severe O 1 0.9914326667785645
clinical O 1 0.9916752576828003
symptoms O 1 0.9905292391777039
than O 0 0.011364515870809555
the O 0 0.008628183044493198
mothers O 1 0.6111422777175903
of O 0 0.013065556064248085
children O 0 0.453086793422699
with O 0 0.3957553505897522
congenital B-Disease 1 0.9964145421981812
DM I-Disease 1 0.9846144318580627
. O 0 0.12885016202926636

We O 0 0.01774631254374981
conclude O 0 0.03226225823163986
that O 0 0.014015430584549904
paternal O 1 0.8423961400985718
transmission O 1 0.9383065700531006
of O 0 0.20206084847450256
congenital B-Disease 1 0.9975640773773193
DM I-Disease 1 0.9869088530540466
is O 0 0.03205768018960953
rare O 0 0.15633903443813324
and O 0 0.009772153571248055
preferentially O 1 0.6125444173812866
occurs O 0 0.48042869567871094
with O 0 0.03496210649609566
onset O 1 0.9794385433197021
of O 0 0.016678212210536003
DM B-Disease 1 0.9668526649475098
past O 0 0.011966440826654434
30 O 0 0.00863676331937313
years O 0 0.005396063439548016
in O 0 0.00449804263189435
the O 0 0.005018242169171572
father O 0 0.014755929820239544
. O 0 0.010103173553943634
. O 0 0.01718306913971901

The O 0 0.128147691488266
RB1 O 1 0.9730125665664673
gene O 1 0.9732400178909302
mutation O 1 0.9613271355628967
in O 0 0.01896301843225956
a O 0 0.025424329563975334
child O 1 0.5709623098373413
with O 0 0.3192114531993866
ectopic B-Disease 1 0.9907399415969849
intracranial I-Disease 1 0.987130343914032
retinoblastoma I-Disease 1 0.9714888334274292
. O 0 0.10325074195861816

The O 0 0.11473432928323746
RB1 O 1 0.9729672074317932
gene O 1 0.9703145623207092
mutation O 1 0.9537346959114075
was O 0 0.011159409768879414
investigated O 0 0.020400594919919968
in O 0 0.007237939164042473
a O 0 0.013827343471348286
child O 0 0.47398340702056885
with O 0 0.21113114058971405
ectopic B-Disease 1 0.9953795671463013
intracranial I-Disease 1 0.9949544072151184
retinoblastoma I-Disease 1 0.9848715662956238
using O 0 0.04585247114300728
DNA O 0 0.4486788213253021
obtained O 0 0.00853169709444046
from O 0 0.005038909614086151
both O 0 0.005242214538156986
the O 0 0.008686121553182602
pineal B-Disease 1 0.9576459527015686
and I-Disease 0 0.07847543805837631
retinal I-Disease 1 0.990627646446228
tumours I-Disease 1 0.9838117957115173
of O 0 0.01570875011384487
the O 0 0.025925949215888977
patient O 1 0.8759822845458984
. O 0 0.03565477207303047

A O 0 0.049227580428123474
nonsense O 0 0.2851678729057312
mutation O 1 0.9343324899673462
in O 0 0.019247455522418022
exon O 0 0.4831182062625885
17 O 0 0.025862393900752068
( O 0 0.03372484818100929
codon O 0 0.48864683508872986
556 O 0 0.14925751090049744
) O 0 0.008880646899342537
of O 0 0.0049997055903077126
the O 0 0.009270167909562588
RB1 O 1 0.9724448919296265
gene O 1 0.8253470063209534
was O 0 0.004894852172583342
found O 0 0.004593961872160435
to O 0 0.0024036578834056854
be O 0 0.002297781640663743
present O 0 0.004617499653249979
homozygously O 0 0.06651286780834198
in O 0 0.003947067074477673
both O 0 0.004933570511639118
the O 0 0.008153625763952732
retinal B-Disease 1 0.9553405046463013
and I-Disease 0 0.009955180808901787
the I-Disease 0 0.029041679576039314
pineal I-Disease 1 0.9776048064231873
tumours I-Disease 1 0.984377920627594
. O 0 0.08265897631645203

The O 0 0.020579703152179718
same O 0 0.020930983126163483
mutation O 1 0.8878530859947205
was O 0 0.007529788184911013
present O 0 0.008571425452828407
heterozygously O 0 0.10398867726325989
in O 0 0.00415035430341959
the O 0 0.003988207783550024
DNA O 0 0.12289676070213318
from O 0 0.003879131516441703
the O 0 0.0036152247339487076
constitutional O 0 0.017303388565778732
cells O 1 0.5828520059585571
of O 0 0.00363369844853878
the O 0 0.005924730561673641
patient O 1 0.7161794900894165
, O 0 0.004316673148423433
proving O 0 0.010308830067515373
it O 0 0.002693201880902052
to O 0 0.0027785776183009148
be O 0 0.003215234028175473
of O 0 0.006252575665712357
germline O 1 0.9268728494644165
origin O 0 0.0852881595492363
. O 0 0.02432929538190365

The O 0 0.023672517389059067
initial O 0 0.07034948468208313
mutation O 1 0.8473577499389648
was O 0 0.007649170700460672
shown O 0 0.007902923040091991
to O 0 0.0036639729514718056
have O 0 0.004138308577239513
occurred O 0 0.01072952151298523
in O 0 0.006053730379790068
the O 0 0.009427807293832302
paternally O 1 0.8517668843269348
derived O 1 0.7059184312820435
RB1 O 1 0.9704952836036682
allele O 1 0.9409298896789551
. O 0 0.051134996116161346

The O 0 0.020501188933849335
mutation O 1 0.7769302725791931
is O 0 0.007626563776284456
in O 0 0.004186937585473061
an O 0 0.003059898968786001
area O 0 0.003483768552541733
of O 0 0.0027433347422629595
the O 0 0.0036352716851979494
gene O 1 0.7201911807060242
that O 0 0.005027891602367163
encodes O 0 0.24857302010059357
the O 0 0.007150834426283836
protein O 1 0.7174128293991089
- O 0 0.19861570000648499
binding O 0 0.08831755816936493
region O 0 0.012411517091095448
known O 0 0.00653128931298852
as O 0 0.002939383964985609
the O 0 0.0031511217821389437
pocket O 0 0.047107573598623276
region O 0 0.006476228125393391
and O 0 0.0024352874606847763
has O 0 0.0026452394668012857
been O 0 0.003354234155267477
detected O 0 0.12239871919155121
in O 0 0.003955963533371687
other O 0 0.004773346241563559
cases O 0 0.07506422698497772
of O 0 0.011422979645431042
retinoblastoma B-Disease 1 0.9540246725082397
. O 0 0.018339263275265694
. O 0 0.021839218214154243

Low O 0 0.057531509548425674
levels O 0 0.03906983882188797
of O 0 0.014469296671450138
beta O 0 0.3746527135372162
hexosaminidase O 0 0.3567553460597992
A O 0 0.017069844529032707
in O 0 0.013128052465617657
healthy O 1 0.6388769745826721
individuals O 0 0.1016392856836319
with O 0 0.03929793834686279
apparent O 1 0.8188499212265015
deficiency O 1 0.9924106597900391
of O 0 0.011263890191912651
this O 0 0.017600126564502716
enzyme O 1 0.871467113494873
. O 0 0.03537655994296074

Appreciable O 1 0.5146608352661133
beta O 0 0.3137992024421692
hexosaminidase O 0 0.24968676269054413
A O 0 0.018209779635071754
( O 0 0.014642750844359398
hex O 0 0.036302175372838974
A O 0 0.009914418682456017
) O 0 0.008650771342217922
activity O 0 0.012583396397531033
has O 0 0.00464812945574522
been O 0 0.005867996718734503
detected O 1 0.5646218061447144
in O 0 0.05708836391568184
cultured O 1 0.9853056073188782
skin O 1 0.9966590404510498
fibroblasts O 1 0.9928629994392395
and O 1 0.515394389629364
melanoma B-Disease 1 0.9980888962745667
tissue O 1 0.98894202709198
from O 0 0.06248387321829796
healthy O 1 0.7939320802688599
individuals O 0 0.055477410554885864
previously O 0 0.0120918620377779
reported O 0 0.017327819019556046
as O 0 0.005412146914750338
having O 0 0.053299423307180405
deficiency B-Disease 1 0.9912256598472595
of I-Disease 0 0.005102499853819609
hex I-Disease 0 0.05658481642603874
A I-Disease 0 0.010353635996580124
activity O 0 0.039565570652484894
indistinguishable O 0 0.14631597697734833
from O 0 0.005448729265481234
that O 0 0.005891911685466766
of O 0 0.01713481917977333
patients O 1 0.9871150255203247
with O 1 0.5525954961776733
Tay B-Disease 1 0.9948441982269287
- I-Disease 1 0.9848428964614868
Sachs I-Disease 1 0.9901530146598816
disease I-Disease 1 0.995394766330719
( O 1 0.5713003277778625
TSD B-Disease 1 0.9606776833534241
) O 0 0.06528609991073608
. O 0 0.026308443397283554

Identification O 0 0.047751110047101974
and O 0 0.014761712402105331
quantitation O 0 0.13898086547851562
of O 0 0.0100184865295887
hex O 0 0.029191695153713226
A O 0 0.01248678844422102
, O 0 0.008215920068323612
amounting O 0 0.018987268209457397
to O 0 0.00921108853071928
3 O 0 0.019361447542905807
. O 0 0.017562873661518097

5 O 0 0.050028685480356216
% O 0 0.04077927768230438
- O 0 0.07408244162797928
6 O 0 0.03651372343301773
. O 0 0.02841043286025524

9 O 0 0.024899017065763474
% O 0 0.013076605275273323
of O 0 0.006509359460324049
total O 0 0.007875938899815083
beta O 0 0.20590966939926147
hexosaminidase O 0 0.26014918088912964
activity O 0 0.014284000732004642
, O 0 0.004045609850436449
has O 0 0.003309146733954549
been O 0 0.0036793898325413465
obtained O 0 0.0075030638836324215
by O 0 0.010649294592440128
cellulose O 1 0.8498037457466125
acetate O 1 0.9418582916259766
gel O 1 0.9672632813453674
electrophoresis O 1 0.9550608396530151
, O 0 0.031136469915509224
DEAE O 1 0.8162619471549988
- O 1 0.508773684501648
cellulose O 1 0.8622309565544128
ion O 1 0.7074989676475525
- O 0 0.3544011116027832
exchange O 0 0.04230315983295441
chromatography O 1 0.7182852029800415
, O 0 0.01304593775421381
radial O 1 0.6975151896476746
immunodiffusion O 0 0.44187119603157043
, O 0 0.010684851557016373
and O 0 0.01070556789636612
radioimmunoassay O 0 0.34852415323257446
. O 0 0.026387637481093407

Previous O 0 0.036127589643001556
family O 0 0.032259538769721985
studies O 0 0.021978193894028664
suggested O 0 0.009107081219553947
that O 0 0.0035304150078445673
these O 0 0.0038788621313869953
individuals O 0 0.01161116547882557
may O 0 0.0068936580792069435
be O 0 0.0034006580244749784
compound O 0 0.03693550452589989
heterozygotes O 1 0.5047632455825806
for O 0 0.005131785292178392
the O 0 0.007122524082660675
common O 0 0.37113529443740845
mutant O 1 0.9811831712722778
TSD B-Disease 1 0.9912347793579102
gene O 1 0.9574322700500488
and O 0 0.008416470140218735
a O 0 0.018000200390815735
rare O 0 0.36697888374328613
( O 0 0.1309633105993271
allelic O 1 0.954621434211731
) O 0 0.16455891728401184
mutant O 1 0.9284394383430481
gene O 1 0.9410430192947388
. O 0 0.0424710288643837

Thus O 0 0.027541162446141243
, O 0 0.011387081816792488
the O 0 0.008954552933573723
postulated O 0 0.35371658205986023
rate O 0 0.22593306005001068
mutant O 1 0.8892297744750977
gene O 1 0.8992806673049927
appears O 0 0.01621720753610134
to O 0 0.0034717184025794268
code O 0 0.006044928915798664
for O 0 0.002667588647454977
the O 0 0.0027687170077115297
expression O 0 0.010557380504906178
of O 0 0.003743273438885808
low O 0 0.015589125454425812
amounts O 0 0.013316422700881958
of O 0 0.006956356577575207
hex O 0 0.056513648480176926
A O 0 0.01991172879934311
. O 0 0.022299081087112427

Heterozygotes O 1 0.5325719714164734
for O 0 0.01704278402030468
the O 0 0.012230347841978073
rare O 0 0.1469547301530838
mutant O 1 0.5933182239532471
may O 0 0.019339311867952347
be O 0 0.00612085172906518
indistinguishable O 0 0.13377518951892853
from O 0 0.01032914686948061
heterozygotes O 1 0.6891494393348694
for O 0 0.007605718448758125
the O 0 0.010575731284916401
common O 0 0.3336057662963867
TSD B-Disease 1 0.9688668251037598
mutant O 1 0.9049696326255798
. O 0 0.051396045833826065

However O 0 0.020252665504813194
, O 0 0.009908096864819527
direct O 0 0.012422029860317707
visualization O 0 0.04513932019472122
and O 0 0.006000560708343983
quantitation O 0 0.18694618344306946
of O 0 0.005053082015365362
hex O 0 0.018771575763821602
A O 0 0.0059218378737568855
by O 0 0.0040113371796905994
the O 0 0.0033880923874676228
methods O 0 0.0162025298923254
described O 0 0.03372085466980934
may O 0 0.04515523090958595
prevent O 0 0.3853052854537964
false O 0 0.15138064324855804
- O 1 0.6153730750083923
positive O 1 0.772987425327301
prenatal O 1 0.9919520020484924
diagnosis O 1 0.9853489995002747
of O 0 0.02297680452466011
TSD B-Disease 1 0.9672210812568665
in O 0 0.015995385125279427
fetuses O 1 0.7977334856987
having O 0 0.010862154886126518
the O 0 0.005538566969335079
incomplete O 0 0.087888702750206
hex B-Disease 0 0.23232802748680115
A I-Disease 0 0.09377314895391464
deficiency I-Disease 1 0.9898926615715027
of O 0 0.005505515728145838
the O 0 0.005273453891277313
type O 0 0.10156946629285812
described O 0 0.010828188620507717
in O 0 0.004389794543385506
the O 0 0.005255704279989004
four O 0 0.013024718500673771
healthy O 1 0.7450575828552246
individuals O 0 0.294554740190506

The O 0 0.21553808450698853
tumor B-Disease 1 0.9859134554862976
suppressor O 1 0.98093181848526
gene O 1 0.9765839576721191
Smad4 O 1 0.9046912789344788
/ O 1 0.6297677755355835
Dpc4 O 0 0.2936745285987854
is O 0 0.0065260534174740314
required O 0 0.006544533185660839
for O 0 0.004838157910853624
gastrulation O 1 0.5193232297897339
and O 0 0.00410507433116436
later O 0 0.004868683405220509
for O 0 0.0046347351744771
anterior O 1 0.5920918583869934
development O 0 0.016596509143710136
of O 0 0.006270939484238625
the O 0 0.014740131795406342
mouse O 1 0.9173059463500977
embryo O 1 0.9271972179412842
. O 0 0.047752369195222855

Mutations O 1 0.8930848836898804
in O 0 0.0283824373036623
the O 0 0.030137736350297928
SMAD4 O 1 0.948061466217041
/ O 1 0.962090790271759
DPC4 O 1 0.9778964519500732
tumor B-Disease 1 0.994981586933136
suppressor O 1 0.9842437505722046
gene O 1 0.9027515053749084
, O 0 0.009058104828000069
a O 0 0.00759325735270977
key O 0 0.011315599083900452
signal O 0 0.03427616506814957
transducer O 0 0.28043752908706665
in O 0 0.006379543337970972
most O 0 0.008990134112536907
TGFbeta O 1 0.7423554062843323
- O 0 0.34116098284721375
related O 0 0.22012180089950562
pathways O 1 0.708393931388855
, O 0 0.004342888947576284
are O 0 0.002943967003375292
involved O 0 0.0058341436088085175
in O 0 0.004214175045490265
50 O 0 0.009842803701758385
% O 0 0.05094150826334953
of O 0 0.06472918391227722
pancreatic B-Disease 1 0.9927434921264648
cancers I-Disease 1 0.9916998744010925
. O 0 0.09184981137514114

Homozygous O 1 0.9246959090232849
Smad4 O 1 0.9020609259605408
mutant O 1 0.9516372084617615
mice O 1 0.9615737795829773
die O 0 0.3656071424484253
before O 0 0.022045506164431572
day O 0 0.018939130008220673
7 O 0 0.029313046485185623
. O 0 0.024879910051822662

5 O 0 0.05752287805080414
of O 0 0.031773895025253296
embryogenesis O 1 0.5193858742713928
. O 0 0.04669089987874031

Mutant O 1 0.6474159955978394
embryos O 0 0.2628360390663147
have O 0 0.01251665223389864
reduced O 0 0.027228934690356255
size O 0 0.012469648383557796
, O 0 0.005921670235693455
fail O 0 0.02825162746012211
to O 0 0.004567854106426239
gastrulate O 0 0.2520025372505188
or O 0 0.009658441878855228
express O 0 0.014643233269453049
a O 0 0.012814552523195744
mesodermal O 1 0.8631086349487305
marker O 0 0.18612954020500183
, O 0 0.0071720522828400135
and O 0 0.006602863315492868
show O 0 0.023216359317302704
abnormal O 1 0.9574987292289734
visceral O 1 0.8811724185943604
endoderm O 1 0.9104039072990417
development O 0 0.09957212954759598
. O 0 0.03256916254758835

Growth B-Disease 1 0.6659384965896606
retardation I-Disease 1 0.9082564115524292
of O 0 0.011937419883906841
the O 0 0.014438397251069546
Smad4 O 1 0.8638133406639099
- O 1 0.7025086283683777
deficient O 1 0.9511675238609314
embryos O 1 0.6448203921318054
results O 0 0.0752192810177803
from O 0 0.018076693639159203
reduced O 0 0.4229235053062439
cell O 1 0.8974145650863647
proliferation O 0 0.4547102749347687
rather O 0 0.01236367505043745
than O 0 0.011800641193985939
increased O 0 0.102938711643219
apoptosis O 1 0.9180053472518921
. O 0 0.03217082843184471

Aggregation O 0 0.38736000657081604
of O 0 0.0264783576130867
mutant O 1 0.9030126333236694
Smad4 O 1 0.9087742567062378
ES O 1 0.8550840616226196
cells O 1 0.887567400932312
with O 0 0.0199113842099905
wild O 0 0.18104170262813568
- O 0 0.48467332124710083
type O 1 0.6290668249130249
tetraploid O 1 0.9375430941581726
morulae O 1 0.8544347286224365
rescues O 1 0.5723536014556885
the O 0 0.04125872254371643
gastrulation B-Disease 1 0.9473072290420532
defect I-Disease 1 0.9353563785552979
. O 0 0.04996822401881218

These O 0 0.01846175268292427
results O 0 0.01745089516043663
indicate O 0 0.014216309413313866
that O 0 0.006271836813539267
Smad4 O 0 0.08369304239749908
is O 0 0.004418736789375544
initially O 0 0.004202501382678747
required O 0 0.003820474725216627
for O 0 0.0023008391726762056
the O 0 0.0029749039094895124
differentiation O 0 0.1960487961769104
of O 0 0.003654654836282134
the O 0 0.005485241767019033
visceral O 1 0.604249894618988
endoderm O 1 0.6098772883415222
and O 0 0.004486710298806429
that O 0 0.004135729279369116
the O 0 0.006304973736405373
gastrulation B-Disease 1 0.9260588884353638
defect I-Disease 1 0.8888955116271973
in O 0 0.00706714391708374
the O 0 0.006550270598381758
epiblast O 1 0.8426638245582581
is O 0 0.007576129864901304
secondary O 0 0.04856240376830101
and O 0 0.006273091305047274
non O 0 0.07078099995851517
- O 0 0.3979458212852478
cell O 1 0.6634417772293091
autonomous O 0 0.08520587533712387
. O 0 0.028965657576918602

Rescued O 0 0.1752328723669052
embryos O 1 0.6800227761268616
show O 0 0.13154704868793488
severe O 1 0.9464050531387329
anterior O 1 0.9266784191131592
truncations O 1 0.5225738286972046
, O 0 0.008201307617127895
indicating O 0 0.014117221347987652
a O 0 0.006136568263173103
second O 0 0.005404090508818626
important O 0 0.005811106879264116
role O 0 0.012290679849684238
for O 0 0.007850482128560543
Smad4 O 0 0.4931870400905609
in O 0 0.023531047627329826
anterior O 1 0.9566487669944763
patterning O 1 0.9386194348335266
during O 0 0.12608221173286438
embryogenesis O 1 0.868413507938385
. O 0 0.0537198930978775

Prevalence O 1 0.8843445777893066
of O 0 0.028291255235671997
p16 O 1 0.9179840683937073
and O 0 0.04148527979850769
CDK4 O 1 0.9521569013595581
germline O 1 0.9870936274528503
mutations O 1 0.9855734705924988
in O 0 0.11318986862897873
48 O 1 0.6885077357292175
melanoma B-Disease 1 0.9943894743919373
- O 1 0.7868923544883728
prone O 1 0.7678207159042358
families O 0 0.051865674555301666
in O 0 0.014657489024102688
France O 0 0.048217277973890305
. O 0 0.024175653234124184

The O 0 0.04997892677783966
French O 1 0.630344033241272
Familial B-Disease 1 0.9887804985046387
Melanoma I-Disease 1 0.9904728531837463
Study O 0 0.33898112177848816
Group O 0 0.06252024322748184
. O 0 0.03212028369307518

Germline O 1 0.9512980580329895
mutations O 1 0.9151263236999512
in O 0 0.015343289822340012
the O 0 0.012804049998521805
p16 O 1 0.8481115102767944
and O 0 0.012777809984982014
CDK4 O 1 0.743155837059021
genes O 1 0.7554535865783691
have O 0 0.004928690381348133
been O 0 0.004084788262844086
reported O 0 0.007719184271991253
in O 0 0.0035139736719429493
a O 0 0.006884670350700617
subset O 0 0.2828861474990845
of O 0 0.026399176567792892
melanoma B-Disease 1 0.9959618449211121
pedigrees O 1 0.6933428645133972
, O 0 0.006032933481037617
but O 0 0.004746569320559502
their O 0 0.005571919027715921
prevalence O 1 0.879397988319397
is O 0 0.005156429950147867
not O 0 0.004252603277564049
well O 0 0.006311720237135887
known O 0 0.01701088435947895
. O 0 0.016809208318591118

We O 0 0.016426220536231995
searched O 0 0.02296370267868042
for O 0 0.01094573363661766
such O 0 0.022470811381936073
germline O 1 0.9827949404716492
mutations O 1 0.9796218872070312
in O 0 0.018792320042848587
48 O 0 0.14516477286815643
French O 1 0.6852768659591675
melanoma B-Disease 1 0.9971423745155334
- O 1 0.7038773894309998
prone O 1 0.6577868461608887
families O 0 0.015273874625563622
selected O 0 0.005555604584515095
according O 0 0.00397832877933979
to O 0 0.002536957850679755
two O 0 0.0029142475686967373
major O 0 0.005686478223651648
criteria O 0 0.0090688681229949
families O 0 0.0054959505796432495
with O 0 0.002705733524635434
at O 0 0.00267142616212368
least O 0 0.003254834096878767
three O 0 0.0034950680565088987
affected O 0 0.07568583637475967
members O 0 0.005090662278234959
( O 0 0.017992476001381874
n O 0 0.06976550072431564
= O 0 0.13534441590309143
20 O 0 0.006420088466256857
) O 0 0.005151904188096523
or O 0 0.0035746507346630096
families O 0 0.0049131629057228565
with O 0 0.0024297935888171196
two O 0 0.0022205105051398277
affected O 0 0.01932157576084137
members O 0 0.002351896371692419
, O 0 0.0018649173434823751
one O 0 0.0015082389581948519
of O 0 0.0016995773185044527
them O 0 0.0018973768455907702
affected O 0 0.010741930454969406
before O 0 0.0024066681507974863
the O 0 0.0019424814963713288
age O 0 0.005465496797114611
of O 0 0.0027434141375124454
50 O 0 0.008172922767698765
( O 0 0.020589588209986687
n O 0 0.07440456748008728
= O 0 0.14443014562129974
28 O 0 0.008302858099341393
) O 0 0.004850392695516348
, O 0 0.002479775808751583
and O 0 0.002315026940777898
one O 0 0.003602036740630865
additional O 0 0.00994968879967928
minor O 0 0.14687557518482208
criterion O 0 0.19270718097686768
. O 0 0.023354150354862213

Sixteen O 0 0.0582144632935524
different O 0 0.06992744654417038
p16 O 1 0.9702448844909668
germline O 1 0.9760740995407104
mutations O 1 0.947704017162323
were O 0 0.006806402932852507
found O 0 0.007441192399710417
in O 0 0.004582924302667379
21 O 0 0.006634893827140331
families O 0 0.00876519363373518
, O 0 0.003910118248313665
while O 0 0.0052084363996982574
one O 0 0.015314649790525436
germline O 1 0.9892237186431885
mutation O 1 0.9881773591041565
, O 0 0.01272972859442234
Arg24His O 0 0.3289021849632263
, O 0 0.005238563288003206
was O 0 0.005082833115011454
detected O 0 0.10597538948059082
in O 0 0.00701842550188303
the O 0 0.011028138920664787
CDK4 O 1 0.8231207728385925
gene O 1 0.9290375709533691
. O 0 0.03414655104279518

The O 0 0.021722180768847466
frequency O 0 0.0426158644258976
of O 0 0.017952704802155495
p16 O 1 0.9720311164855957
gene O 1 0.9727705717086792
mutation O 1 0.9458081722259521
in O 0 0.00690460903570056
our O 0 0.005402747076004744
sample O 0 0.018127834424376488
( O 0 0.008333657868206501
44 O 0 0.009272660128772259
% O 0 0.009933444671332836
) O 0 0.004725096747279167
is O 0 0.0021852704230695963
among O 0 0.00283953920006752
the O 0 0.0022789444774389267
highest O 0 0.00545140728354454
rates O 0 0.023889340460300446
yet O 0 0.004993524868041277
reported O 0 0.008715127594769001
and O 0 0.0028166293632239103
the O 0 0.005775835830718279
CDK4 O 1 0.8691464066505432
mutation O 1 0.9731950759887695
is O 0 0.005919612478464842
the O 0 0.004486250225454569
second O 0 0.034261614084243774
mutation O 1 0.9884665012359619
detected O 1 0.5846062898635864
in O 0 0.010111584328114986
this O 0 0.01332771871238947
gene O 1 0.9271517992019653
worldwide O 0 0.21281054615974426
. O 0 0.02704920433461666

In O 0 0.018119120970368385
summary O 0 0.020605117082595825
, O 0 0.00608860095962882
our O 0 0.005211802199482918
results O 0 0.00846678577363491
show O 0 0.007197061087936163
frequent O 0 0.03301847353577614
involvement O 0 0.019962236285209656
of O 0 0.005696537904441357
the O 0 0.019422510638833046
p16 O 1 0.986339807510376
gene O 1 0.9855031967163086
in O 0 0.2521880269050598
familial B-Disease 1 0.9960248470306396
melanoma I-Disease 1 0.9946171641349792
and O 0 0.006623595021665096
confirm O 0 0.009426728822290897
the O 0 0.003930266480892897
role O 0 0.0074067991226911545
of O 0 0.004085416905581951
the O 0 0.009240242652595043
CDK4 O 1 0.9400017857551575
gene O 1 0.9764882326126099
as O 0 0.03875909000635147
a O 0 0.45763570070266724
melanoma B-Disease 1 0.9973451495170593
- O 1 0.9697502255439758
predisposing O 1 0.9863986372947693
gene O 1 0.9696214199066162
. O 0 0.02615591511130333
. O 0 0.02515254355967045

Progression O 1 0.7934874296188354
of O 0 0.03203098475933075
somatic O 1 0.9130303859710693
CTG O 1 0.8487885594367981
repeat O 0 0.3641737997531891
length O 0 0.10403959453105927
heterogeneity O 1 0.6115814447402954
in O 0 0.014520957134664059
the O 0 0.027115007862448692
blood O 1 0.9786821603775024
cells O 1 0.9859265089035034
of O 0 0.4822435677051544
myotonic B-Disease 1 0.9944450259208679
dystrophy I-Disease 1 0.9957380294799805
patients O 1 0.979129433631897
. O 0 0.1591615229845047

The O 0 0.035643596202135086
genetic O 1 0.8080773949623108
basis O 0 0.03633400425314903
of O 0 0.11163276433944702
myotonic B-Disease 1 0.9931020736694336
dystrophy I-Disease 1 0.996209979057312
( O 1 0.6535085439682007
DM B-Disease 1 0.9780929088592529
) O 0 0.016914229840040207
is O 0 0.004666305612772703
the O 0 0.0038487145211547613
expansion O 0 0.007588239852339029
of O 0 0.004003716632723808
an O 0 0.008276312611997128
unstable O 1 0.779762327671051
CTG O 1 0.7797415256500244
repeat O 0 0.1518394649028778
in O 0 0.005853960290551186
the O 0 0.005754418671131134
34 O 0 0.014322374016046524
UTR O 0 0.3104352653026581
of O 0 0.00967747438699007
the O 0 0.023629076778888702
DM B-Disease 1 0.9835525751113892
protein O 1 0.9647573828697205
kinase O 1 0.9714798331260681
gene O 1 0.9337648153305054
on O 0 0.022977551445364952
chromosome O 1 0.9355354905128479
19 O 0 0.04772772267460823
. O 0 0.030200794339179993

One O 0 0.01287437230348587
of O 0 0.006274119950830936
the O 0 0.004887144546955824
principal O 0 0.00784823577851057
features O 0 0.006864424329251051
of O 0 0.0038986706640571356
the O 0 0.012707378715276718
DM B-Disease 1 0.9914546012878418
mutation O 1 0.9825300574302673
is O 0 0.007760059554129839
an O 0 0.004982855636626482
extraordinarily O 0 0.05506833642721176
high O 0 0.007332042790949345
level O 0 0.0069643789902329445
of O 0 0.006904341746121645
somatic O 1 0.9493082761764526
mosaicism O 1 0.9501513838768005
, O 0 0.00613629724830389
due O 0 0.007040138356387615
to O 0 0.002562084002420306
an O 0 0.0035611398052424192
extremely O 0 0.014242173172533512
high O 0 0.007196212653070688
degree O 0 0.011590317822992802
of O 0 0.005105359014123678
somatic O 1 0.9183444380760193
instability O 0 0.4857419431209564
both O 0 0.004451793618500233
within O 0 0.004745920188724995
and O 0 0.004048183094710112
between O 0 0.008224593475461006
different O 0 0.015716878697276115
tissues O 1 0.8580811023712158
. O 0 0.03549500182271004

This O 0 0.02187628671526909
instability O 0 0.2395867556333542
appears O 0 0.014166531153023243
to O 0 0.00393384275957942
be O 0 0.0033270353451371193
biased O 0 0.007602519355714321
towards O 0 0.004397253971546888
further O 0 0.003757197642698884
expansion O 0 0.005132036749273539
and O 0 0.0023734562564641237
continuous O 0 0.006846847478300333
throughout O 0 0.003121527610346675
the O 0 0.0019013615092262626
life O 0 0.0032742007169872522
of O 0 0.001982558285817504
an O 0 0.002426622901111841
individual O 0 0.007107840385288
, O 0 0.0022529831621795893
features O 0 0.003886019578203559
that O 0 0.0017809835262596607
could O 0 0.002002021064981818
be O 0 0.0016246295999735594
associated O 0 0.006170210894197226
with O 0 0.002682653721421957
the O 0 0.0032715999986976385
progressive O 0 0.17405682802200317
nature O 0 0.027880625799298286
of O 0 0.008173719048500061
the O 0 0.04590393230319023
disease O 1 0.9904605746269226
. O 0 0.05551113560795784

Although O 0 0.03409026190638542
increasing O 0 0.04161817580461502
measured O 0 0.10779434442520142
allele O 1 0.899092435836792
size O 0 0.044036053121089935
between O 0 0.048580463975667953
patients O 1 0.919750452041626
clearly O 0 0.024731876328587532
correlates O 0 0.34094345569610596
with O 0 0.007917138747870922
an O 0 0.007837946526706219
increased O 0 0.1568746119737625
severity O 1 0.8586286902427673
of O 0 0.026852216571569443
symptoms O 1 0.9894875288009644
and O 0 0.004278413951396942
an O 0 0.004028144292533398
earlier O 0 0.007204393856227398
age O 0 0.030819691717624664
of O 0 0.008694230578839779
onset O 1 0.9778157472610474
, O 0 0.005074727814644575
this O 0 0.003832794725894928
correlation O 0 0.1275484412908554
is O 0 0.0030345371924340725
not O 0 0.00252797594293952
precise O 0 0.009092960506677628
and O 0 0.0029820306226611137
measured O 0 0.02887694537639618
allele O 1 0.8242671489715576
length O 0 0.017105700448155403
cannot O 0 0.004964830819517374
be O 0 0.0022921229247003794
used O 0 0.003036902518942952
as O 0 0.0027687158435583115
an O 0 0.003292556619271636
accurate O 0 0.01299299206584692
predictor O 0 0.3570159077644348
of O 0 0.005854036193341017
age O 0 0.033719416707754135
of O 0 0.017412835732102394
onset O 1 0.9676652550697327
. O 0 0.05683792382478714

In O 0 0.014358582906425
order O 0 0.009283469058573246
to O 0 0.004926594905555248
further O 0 0.007038585841655731
characterize O 0 0.05770281329751015
the O 0 0.007376906927675009
dynamics O 0 0.23621468245983124
of O 0 0.028819480910897255
DM B-Disease 1 0.9884853363037109
CTG O 1 0.9647179841995239
repeat O 1 0.8398091793060303
somatic O 1 0.9565358757972717
instability O 1 0.5147423148155212
, O 0 0.004807837773114443
we O 0 0.002960775513201952
have O 0 0.0029233479872345924
studied O 0 0.006435619667172432
repeat O 0 0.05535636097192764
length O 0 0.010792383924126625
changes O 0 0.010613814927637577
over O 0 0.005348083563148975
time O 0 0.008932997472584248
in O 0 0.04403799772262573
111 O 1 0.9345991611480713
myotonic B-Disease 1 0.9976546168327332
dystrophy I-Disease 1 0.9987395405769348
patients O 1 0.9919208288192749
with O 0 0.1257568895816803
varying O 1 0.6951566338539124
clinical O 1 0.9787034392356873
severity O 1 0.9303869605064392
and O 0 0.016267217695713043
CTG O 1 0.7147935032844543
repeat O 0 0.16637541353702545
size O 0 0.010786257684230804
over O 0 0.004830869846045971
time O 0 0.004534314386546612
intervals O 0 0.011473307386040688
of O 0 0.00465404475107789
1 O 0 0.010666499845683575
- O 0 0.06254293024539948
7 O 0 0.016454849392175674
years O 0 0.014772201888263226
. O 0 0.01836617849767208

We O 0 0.011386577039957047
have O 0 0.006332064978778362
found O 0 0.005692531354725361
a O 0 0.0058801122941076756
direct O 0 0.010139357298612595
progression O 0 0.41736745834350586
of O 0 0.0031902152113616467
the O 0 0.003420629072934389
size O 0 0.012534422799944878
heterogeneity O 0 0.23177842795848846
over O 0 0.004150707274675369
time O 0 0.004290594719350338
related O 0 0.02118554152548313
to O 0 0.003740262473002076
initial O 0 0.03054705820977688
CTG O 1 0.6497045755386353
repeat O 0 0.14799804985523224
size O 0 0.008756299503147602
and O 0 0.003195686498656869
the O 0 0.0033347064163535833
time O 0 0.004219957627356052
interval O 0 0.014774201437830925
and O 0 0.003265219973400235
always O 0 0.0047469837591052055
biased O 0 0.011005175299942493
towards O 0 0.008058286271989346
further O 0 0.01113985851407051
expansion O 0 0.030989358201622963
. O 0 0.019594451412558556

Attempts O 0 0.031463220715522766
to O 0 0.01089908741414547
mathematically O 0 0.019350966438651085
model O 0 0.010802601464092731
the O 0 0.004416908137500286
dynamics O 0 0.026096459478139877
have O 0 0.003141593188047409
proved O 0 0.006341348402202129
only O 0 0.002776459092274308
partially O 0 0.044031575322151184
successful O 0 0.011932403780519962
suggesting O 0 0.017835445702075958
that O 0 0.0034194865729659796
individual O 0 0.019626205787062645
specific O 0 0.08680082857608795
genetic O 1 0.945328950881958
and O 0 0.008517053909599781
/ O 0 0.34598517417907715
or O 0 0.013251996599137783
environmental O 0 0.03182780742645264
factors O 0 0.0348280631005764
also O 0 0.002981119090691209
play O 0 0.003982238005846739
a O 0 0.0053761061280965805
role O 0 0.013778177089989185
in O 0 0.014612785540521145
somatic O 1 0.9408747553825378
mosaicism O 1 0.9534756541252136
. O 0 0.0189791452139616
. O 0 0.02289997972548008

Aspartylglucosaminuria B-Disease 0 0.4207229018211365
among O 0 0.038577739149332047
Palestinian O 0 0.04332204535603523
Arabs O 0 0.0551026277244091
. O 0 0.030280008912086487

Aspartylglucosaminuria B-Disease 1 0.8466413617134094
( O 0 0.3114827275276184
AGU B-Disease 1 0.9533103704452515
) O 0 0.026291999965906143
is O 0 0.010621964000165462
a O 0 0.02042263001203537
rare O 1 0.6262039542198181
disorder B-Disease 1 0.9915253520011902
of I-Disease 0 0.03932613506913185
glycoprotein I-Disease 1 0.9671693444252014
metabolism I-Disease 1 0.9689554572105408
caused O 1 0.511724591255188
by O 0 0.011969971470534801
the O 0 0.01631537824869156
deficiency B-Disease 1 0.9931055903434753
of I-Disease 0 0.010808390565216541
the I-Disease 0 0.04356526955962181
lysosomal I-Disease 1 0.9851014614105225
enzyme I-Disease 1 0.9744176864624023
aspartylglucosaminidase I-Disease 1 0.8774139285087585
( O 0 0.11938802897930145
AGA O 1 0.5603657364845276
) O 0 0.03388826549053192
. O 0 0.023622123524546623

AGU B-Disease 1 0.9368577003479004
is O 0 0.046015314757823944
inherited O 1 0.8019865155220032
as O 0 0.02951442264020443
an O 0 0.32254666090011597
autosomal O 1 0.9977565407752991
recessive O 1 0.9968517422676086
trait O 1 0.9458765983581543
and O 0 0.010272858664393425
occurs O 0 0.16103295981884003
with O 0 0.00450047105550766
a O 0 0.0051713259890675545
high O 0 0.007598929572850466
frequency O 0 0.021973704919219017
in O 0 0.0036220881156623363
Finland O 0 0.007555749733000994
because O 0 0.004889247938990593
of O 0 0.0036558026913553476
a O 0 0.010038868524134159
founder O 0 0.04628835245966911
effect O 0 0.12245898693799973
. O 0 0.023251552134752274

While O 0 0.021201645955443382
very O 0 0.014600953087210655
few O 0 0.02044081874191761
patients O 1 0.8942800760269165
with O 0 0.01775551773607731
AGU B-Disease 1 0.9149655103683472
have O 0 0.004471796564757824
been O 0 0.003561659250408411
reported O 0 0.0064963772892951965
from O 0 0.004508307669311762
non O 0 0.032088737934827805
- O 0 0.09957996755838394
Finnish O 0 0.05394827201962471
origin O 0 0.04126390069723129
, O 0 0.007649597711861134
we O 0 0.015708794817328453
diagnosed O 1 0.9952064156532288
the O 0 0.06819196790456772
disorder O 1 0.9958546161651611
in O 0 0.03255234658718109
8 O 0 0.14818908274173737
patients O 1 0.9640668630599976
originating O 0 0.1735297441482544
from O 0 0.0075586107559502125
3 O 0 0.014815242029726505
unrelated O 0 0.17462894320487976
families O 0 0.010063031688332558
, O 0 0.002764307428151369
all O 0 0.002339305356144905
Palestinian O 0 0.006784047000110149
Arabs O 0 0.007130449637770653
from O 0 0.00410288805142045
the O 0 0.003752489108592272
region O 0 0.00724386889487505
of O 0 0.005522315390408039
Jerusalem O 0 0.018405674025416374
. O 0 0.017860310152173042

The O 0 0.0526956208050251
clinical O 1 0.9618763327598572
diagnosis O 1 0.9630098938941956
of O 0 0.01827743649482727
AGU B-Disease 1 0.9554318189620972
is O 0 0.008784766308963299
often O 0 0.006989575456827879
difficult O 0 0.008212694898247719
, O 0 0.002558686537668109
in O 0 0.002318404149264097
particular O 0 0.0035419331397861242
early O 0 0.003288448555395007
in O 0 0.0021715746261179447
the O 0 0.0021787506993860006
course O 0 0.007034134119749069
of O 0 0.003055401612073183
the O 0 0.010111726820468903
disease O 1 0.9918038845062256
, O 0 0.003925522789359093
and O 0 0.0019087056862190366
most O 0 0.002405717968940735
of O 0 0.0031066094525158405
the O 0 0.018818534910678864
patients O 1 0.9817549586296082
are O 0 0.034160252660512924
diagnosed O 1 0.9897316098213196
after O 0 0.008422238752245903
the O 0 0.003974359016865492
age O 0 0.012402035295963287
of O 0 0.005119516048580408
5 O 0 0.01192973367869854
years O 0 0.012222366407513618
. O 0 0.0171928983181715

However O 0 0.02098441682755947
, O 0 0.010186764411628246
since O 0 0.010888664051890373
these O 0 0.009964024648070335
patients O 1 0.9066385626792908
excrete O 1 0.5142198801040649
early O 0 0.010323561728000641
large O 0 0.008197968825697899
amounts O 0 0.014766998589038849
of O 0 0.005087054334580898
aspartylglucosamine O 0 0.3268911838531494
in O 0 0.01023910753428936
urine O 1 0.6820164918899536
, O 0 0.011378753930330276
biochemical O 1 0.732472836971283
screening O 0 0.19867783784866333
is O 0 0.006057456135749817
easy O 0 0.011732464656233788
by O 0 0.009998275898396969
urine O 1 0.7051675319671631
chromatography O 1 0.6406378149986267
. O 0 0.01654723845422268
. O 0 0.019575849175453186

Detection O 0 0.18674738705158234
of O 0 0.025183692574501038
heterozygous O 1 0.7684208750724792
carriers O 0 0.20641204714775085
of O 0 0.014195788651704788
the O 0 0.08601656556129456
ataxia B-Disease 1 0.9947770833969116
- I-Disease 1 0.9641745686531067
telangiectasia I-Disease 1 0.9915879368782043
( O 0 0.33484524488449097
ATM O 1 0.7160194516181946
) O 0 0.14579595625400543
gene O 1 0.9375694394111633
by O 0 0.04609105736017227
G2 O 1 0.9787160754203796
phase O 1 0.9064027667045593
chromosomal O 1 0.9878067374229431
radiosensitivity O 1 0.894015371799469
of O 0 0.057413410395383835
peripheral O 1 0.9765076637268066
blood O 1 0.9781644344329834
lymphocytes O 1 0.9743105173110962
. O 0 0.08784335106611252

In O 0 0.36804094910621643
ataxia B-Disease 1 0.9914903044700623
- I-Disease 1 0.954963207244873
telangiectasia I-Disease 1 0.9901555776596069
( O 0 0.31449562311172485
A B-Disease 0 0.31674978137016296
- I-Disease 1 0.9153934717178345
T I-Disease 1 0.9840929508209229
) O 0 0.2975216209888458
patients O 1 0.967241644859314
, O 0 0.017873087897896767
mutations O 1 0.9585734009742737
in O 0 0.005785792600363493
a O 0 0.008336606435477734
single O 0 0.05588649585843086
gene O 1 0.9150421023368835
, O 0 0.008175303228199482
ATM O 0 0.27792882919311523
, O 0 0.006839797832071781
result O 0 0.09433631598949432
in O 0 0.04281068593263626
an O 1 0.5889701843261719
autosomal B-Disease 1 0.9992461204528809
recessive I-Disease 1 0.9991263747215271
syndrome I-Disease 1 0.9982489347457886
that O 0 0.015542641282081604
embraces O 0 0.11207476258277893
a O 0 0.008572718128561974
variety O 0 0.011734852567315102
of O 0 0.005596231669187546
clinical O 1 0.684235692024231
features O 0 0.015061723068356514
and O 0 0.005641747731715441
manifests O 0 0.23232302069664001
extreme O 0 0.08033832907676697
radiosensitivity O 0 0.28874653577804565
and O 0 0.005421201698482037
a O 0 0.007229354232549667
strong O 0 0.018065601587295532
pre O 0 0.2003851979970932
- O 0 0.31922200322151184
disposition O 0 0.31414228677749634
to O 0 0.02093212492763996
malignancy B-Disease 1 0.9643787145614624
. O 0 0.04434465989470482

Heterozygotes O 1 0.5123051404953003
for O 0 0.015231117606163025
the O 0 0.011547025293111801
ATM O 0 0.4785035252571106
gene O 1 0.7645391225814819
have O 0 0.007400505244731903
no O 0 0.009302104823291302
clinical O 1 0.681126058101654
expression O 0 0.08212863653898239
of O 0 0.005339856259524822
A B-Disease 0 0.07822217047214508
- I-Disease 1 0.5915383100509644
T I-Disease 1 0.9435250759124756
but O 0 0.010799960233271122
may O 0 0.07625278830528259
be O 0 0.03549684211611748
cancer B-Disease 1 0.9950382113456726
prone O 1 0.6654609441757202
with O 0 0.00767141580581665
a O 0 0.008307996205985546
moderate O 0 0.07908409088850021
increase O 0 0.02757921814918518
in O 0 0.008493924513459206
in O 0 0.013692541979253292
vitro O 1 0.824891984462738
radiosensitivity O 1 0.6534753441810608
. O 0 0.038291849195957184

We O 0 0.017826566472649574
performed O 0 0.022012053057551384
a O 0 0.01839199662208557
blind O 1 0.539921224117279
chromosomal O 1 0.9655035734176636
analysis O 0 0.08267787843942642
on O 0 0.013996819965541363
G2 O 1 0.9749852418899536
- O 1 0.7016838192939758
phase O 1 0.6961187124252319
lymphocytes O 1 0.975915789604187
from O 0 0.016547951847314835
7 O 0 0.05297878384590149
unrelated O 1 0.6367388963699341
A B-Disease 0 0.18400585651397705
- I-Disease 1 0.8693886995315552
T I-Disease 1 0.9849705696105957
patients O 1 0.9727345705032349
, O 0 0.011026370339095592
13 O 0 0.026622740551829338
obligate O 1 0.5893755555152893
A B-Disease 0 0.1536082923412323
- I-Disease 1 0.7572199702262878
T I-Disease 1 0.9697893261909485
heterozygotes O 1 0.953831672668457
( O 0 0.028840580955147743
parents O 0 0.013077047653496265
of O 0 0.003712519071996212
the O 0 0.0071214656345546246
patients O 1 0.9238300919532776
) O 0 0.008852499537169933
, O 0 0.0025648006703704596
and O 0 0.0023803848307579756
14 O 0 0.005334557965397835
normal O 0 0.04742124304175377
controls O 0 0.029266566038131714
following O 0 0.01480446569621563
X O 0 0.25380998849868774
- O 0 0.18073733150959015
irradiation O 0 0.3078659176826477
with O 0 0.006929998751729727
1 O 0 0.009457363747060299
Gy O 1 0.5090139508247375
in O 0 0.004345178138464689
order O 0 0.004290273413062096
to O 0 0.0029925426933914423
evaluate O 0 0.014166837558150291
this O 0 0.004534157458692789
cytogenetic O 1 0.5700048804283142
method O 0 0.011223099194467068
as O 0 0.003864703234285116
a O 0 0.005942894145846367
tool O 0 0.01447996310889721
for O 0 0.007173128426074982
detection O 0 0.18508979678153992
of O 0 0.011884738691151142
ATM O 0 0.40094810724258423
carriers O 0 0.4234262704849243
. O 0 0.028511548414826393

Both O 0 0.03354280814528465
A B-Disease 0 0.08029785007238388
- I-Disease 1 0.6577614545822144
T I-Disease 1 0.95023113489151
homozygotes O 1 0.8987944722175598
and O 0 0.013621815480291843
heterozygotes O 1 0.8086483478546143
showed O 0 0.038498654961586
significantly O 0 0.21994267404079437
increased O 0 0.057826749980449677
levels O 0 0.14217491447925568
of O 0 0.02161688543856144
radiation O 1 0.9785027503967285
- O 1 0.9229729175567627
induced O 1 0.9911336302757263
chromatid O 1 0.9825527667999268
damage O 1 0.533929169178009
relative O 0 0.018790435045957565
to O 0 0.005175868980586529
that O 0 0.00443662004545331
of O 0 0.006601256784051657
normal O 0 0.07760987430810928
controls O 0 0.06381374597549438
. O 0 0.024159887805581093

These O 0 0.01539834588766098
results O 0 0.0150376558303833
show O 0 0.008725049905478954
that O 0 0.005319199524819851
the O 0 0.008076136000454426
G2 O 1 0.9593529105186462
- O 1 0.6212424039840698
phase O 1 0.8048616647720337
chromosomal O 1 0.9887493848800659
radiosensitivity O 1 0.8323280215263367
assay O 0 0.3092801868915558
can O 0 0.0052230386063456535
be O 0 0.0023890824522823095
used O 0 0.002651424612849951
for O 0 0.0024796121288090944
the O 0 0.00386320729739964
detection O 0 0.13443627953529358
of O 0 0.007381720002740622
A B-Disease 0 0.07628292590379715
- I-Disease 1 0.6631788015365601
T I-Disease 1 0.9540379643440247
heterozygotes O 1 0.9373087882995605
. O 0 0.04199245944619179

In O 0 0.024541059508919716
combination O 0 0.16684803366661072
with O 0 0.01985935866832733
molecular O 1 0.8013243079185486
genetic O 1 0.9289617538452148
analyses O 0 0.07931336760520935
, O 0 0.004196501336991787
this O 0 0.003033751156181097
test O 0 0.006546666380017996
may O 0 0.004317766055464745
be O 0 0.0018830756889656186
of O 0 0.0019277454121038318
value O 0 0.002954434137791395
in O 0 0.0031046858057379723
studies O 0 0.02076941542327404
of O 0 0.00756258238106966
familial B-Disease 1 0.9819840788841248
and I-Disease 0 0.01972624845802784
sporadic I-Disease 1 0.8488023281097412
cancers I-Disease 1 0.9917237162590027
aimed O 0 0.030910899862647057
at O 0 0.005179090891033411
determination O 0 0.007151084952056408
of O 0 0.0029300800524652004
the O 0 0.0033668475225567818
potential O 0 0.05347055569291115
involvement O 0 0.10579922795295715
of O 0 0.020352261140942574
ATM O 1 0.94611656665802
mutations O 1 0.9945217370986938
in O 0 0.2952992916107178
tumor B-Disease 1 0.9959558844566345
risk O 1 0.9284800291061401
or O 0 0.034482140094041824
development O 0 0.02580913156270981
. O 0 0.011035775765776634
. O 0 0.016416147351264954

Ataxia B-Disease 1 0.9824256896972656
- I-Disease 1 0.8503945469856262
telangiectasia I-Disease 1 0.9612733721733093
: O 0 0.025730501860380173
identification O 0 0.024572718888521194
and O 0 0.006428769789636135
detection O 0 0.104645274579525
of O 0 0.006716820411384106
founder O 0 0.1576111614704132
- O 0 0.3893904685974121
effect O 0 0.4748017191886902
mutations O 1 0.9678859114646912
in O 0 0.008322041481733322
the O 0 0.009320726618170738
ATM O 1 0.5793323516845703
gene O 1 0.8969330191612244
in O 0 0.01212264783680439
ethnic O 0 0.06415156275033951
populations O 1 0.5139870047569275
. O 0 0.028849469497799873

To O 0 0.015272541902959347
facilitate O 0 0.020466044545173645
the O 0 0.007415915839374065
evaluation O 0 0.02672513946890831
of O 0 0.00714125344529748
ATM O 1 0.5582811832427979
heterozygotes O 1 0.9036051034927368
for O 0 0.02114538475871086
susceptibility O 1 0.9556688666343689
to O 0 0.00801986176520586
other O 0 0.03164321184158325
diseases O 1 0.9928345680236816
, O 0 0.007360176183283329
such O 0 0.018480686470866203
as O 0 0.0968998596072197
breast B-Disease 1 0.9977656602859497
cancer I-Disease 1 0.9930711388587952
, O 0 0.004747988656163216
we O 0 0.002459851559251547
have O 0 0.0022235943470150232
attempted O 0 0.004817039240151644
to O 0 0.002292195800691843
define O 0 0.007961610332131386
the O 0 0.002974981674924493
most O 0 0.006487325765192509
common O 0 0.2832976281642914
mutations O 1 0.9572069048881531
and O 0 0.00408276729285717
their O 0 0.005910110659897327
frequencies O 0 0.16833242774009705
in O 0 0.1280527412891388
ataxia B-Disease 1 0.9962738752365112
- I-Disease 1 0.9648680090904236
telangiectasia I-Disease 1 0.992085874080658
( O 0 0.25041869282722473
A B-Disease 0 0.18250544369220734
- I-Disease 1 0.7567079067230225
T I-Disease 1 0.9525676369667053
) O 0 0.07641566544771194
homozygotes O 1 0.7399094700813293
from O 0 0.011773336678743362
10 O 0 0.01432043593376875
ethnic O 0 0.04271828010678291
populations O 0 0.3742499053478241
. O 0 0.026583926752209663

Both O 0 0.04682279750704765
genomic O 1 0.9150043725967407
mutations O 1 0.8971390128135681
and O 0 0.00988216046243906
their O 0 0.008435681462287903
effects O 0 0.13009214401245117
on O 0 0.008237460628151894
cDNA O 0 0.17635613679885864
were O 0 0.01301344484090805
characterized O 0 0.38604047894477844
. O 0 0.030288081616163254

Protein O 1 0.6755173802375793
- O 0 0.18092580139636993
truncation O 0 0.24364104866981506
testing O 0 0.026165857911109924
of O 0 0.006960186176002026
the O 0 0.006035876460373402
entire O 0 0.016555577516555786
ATM O 0 0.2658850848674774
cDNA O 1 0.5812436938285828
detected O 0 0.37305745482444763
92 O 0 0.04545765742659569
( O 0 0.01985195465385914
66 O 0 0.024834878742694855
% O 0 0.025498738512396812
) O 0 0.030895229429006577
truncating O 1 0.8581165075302124
mutations O 1 0.9666479825973511
in O 0 0.01748388446867466
140 O 0 0.11376190930604935
mutant O 1 0.9165274500846863
alleles O 1 0.9590975642204285
screened O 0 0.29451224207878113
. O 0 0.03865288570523262

The O 0 0.025331616401672363
haplotyping O 0 0.21253974735736847
of O 0 0.015607430599629879
patients O 1 0.9122003316879272
with O 0 0.014243760146200657
identical O 0 0.33638450503349304
mutations O 1 0.9680629372596741
indicates O 0 0.03135174140334129
that O 0 0.0027166681829839945
almost O 0 0.0026288554072380066
all O 0 0.0014202893944457173
of O 0 0.0017443416872993112
these O 0 0.0021385725121945143
represent O 0 0.004971988033503294
common O 0 0.05169254168868065
ancestry O 0 0.07486698031425476
and O 0 0.0029137430246919394
that O 0 0.0029840071219950914
very O 0 0.006446813233196735
few O 0 0.013833094388246536
spontaneously O 1 0.8055264949798584
recurring O 1 0.9109636545181274
ATM O 1 0.8895121216773987
mutations O 1 0.9764893651008606
exist O 0 0.07802215963602066
. O 0 0.02696974389255047

Assays O 0 0.3192361295223236
requiring O 0 0.06192801147699356
minimal O 0 0.03921952843666077
amounts O 0 0.019095120951533318
of O 0 0.007347425911575556
genomic O 1 0.7391214370727539
DNA O 0 0.1336791217327118
were O 0 0.003771164920181036
designed O 0 0.006085753906518221
to O 0 0.0035282161552459
allow O 0 0.008096207864582539
rapid O 0 0.13717682659626007
screening O 0 0.1550832986831665
for O 0 0.007205209229141474
common O 0 0.1161767765879631
ethnic O 0 0.19051431119441986
mutations O 1 0.9734869599342346
. O 0 0.04659569635987282

These O 0 0.029099924489855766
rapid O 0 0.3075807988643646
assays O 1 0.6391133666038513
detected O 1 0.6148616671562195
mutations O 1 0.9126836657524109
in O 0 0.0095562394708395
76 O 0 0.021603131666779518
% O 0 0.010956940241158009
of O 0 0.006550624500960112
Costa O 0 0.09027750790119171
Rican O 0 0.28272074460983276
patients O 1 0.9558259844779968
( O 0 0.03193787857890129
3 O 0 0.008826522156596184
) O 0 0.004232871346175671
, O 0 0.00209413911215961
50 O 0 0.003065090626478195
% O 0 0.0046657053753733635
of O 0 0.003236449556425214
Norwegian O 0 0.07677137106657028
patients O 1 0.9559921026229858
( O 0 0.017704635858535767
1 O 0 0.005867267958819866
) O 0 0.004137328360229731
, O 0 0.0021526969503611326
25 O 0 0.0032580222468823195
% O 0 0.005170756950974464
of O 0 0.0031676709186285734
Polish O 0 0.10471517592668533
patients O 1 0.9318200945854187
( O 0 0.021388063207268715
4 O 0 0.006476173177361488
) O 0 0.004151555243879557
, O 0 0.0018944352632388473
and O 0 0.0018976450664922595
14 O 0 0.0036062165163457394
% O 0 0.005392441526055336
of O 0 0.003710609395056963
Italian O 0 0.1531858593225479
patients O 1 0.967102587223053
( O 0 0.025802727788686752
1 O 0 0.006360564846545458
) O 0 0.0038294591940939426
, O 0 0.0017932900227606297
as O 0 0.0017607631161808968
well O 0 0.002068169880658388
as O 0 0.0022378158755600452
in O 0 0.005228135269135237
patients O 1 0.8153097629547119
of O 0 0.006490578409284353
Amish O 0 0.29520726203918457
/ O 0 0.3587890565395355
Mennonite O 0 0.07718675583600998
and O 0 0.0070245759561657906
Irish O 0 0.04324320703744888
English O 0 0.01868465542793274
backgrounds O 0 0.051179517060518265
. O 0 0.02325318567454815

Additional O 0 0.049950458109378815
mutations O 1 0.7304157018661499
were O 0 0.009133271872997284
observed O 0 0.014238646253943443
in O 0 0.005360892508178949
Japanese O 0 0.006912468001246452
, O 0 0.00455789640545845
Utah O 0 0.009797115810215473
Mormon O 0 0.016868384554982185
, O 0 0.005166309420019388
and O 0 0.005287747830152512
African O 0 0.09631260484457016
American O 0 0.10495287925004959
patients O 1 0.9525195360183716
. O 0 0.038540564477443695

These O 0 0.021689169108867645
assays O 0 0.08694108575582504
should O 0 0.010577143169939518
facilitate O 0 0.038406044244766235
screening O 0 0.1011175662279129
for O 0 0.006452258676290512
A B-Disease 0 0.0521659217774868
- I-Disease 1 0.6135428547859192
T I-Disease 1 0.9613238573074341
heterozygotes O 1 0.8525263667106628
in O 0 0.008686495944857597
the O 0 0.008467253297567368
populations O 0 0.3229704797267914
studied O 0 0.02492736652493477
. O 0 0.011807188391685486
. O 0 0.01872354745864868

The O 0 0.06577006727457047
von B-Disease 1 0.9127274751663208
Hippel I-Disease 1 0.9704080820083618
- I-Disease 1 0.969348132610321
Lindau I-Disease 1 0.9902321696281433
tumor I-Disease 1 0.9947852492332458
suppressor O 1 0.9851545691490173
gene O 1 0.9522088766098022
is O 0 0.01084094401448965
required O 0 0.011439969763159752
for O 0 0.008869683369994164
cell O 1 0.5293540954589844
cycle O 0 0.30664968490600586
exit O 0 0.0714605525135994
upon O 0 0.019010717049241066
serum O 1 0.8051437735557556
withdrawal O 0 0.23317745327949524
. O 0 0.030859677121043205

The O 0 0.028929267078638077
inactivation O 0 0.1906914860010147
of O 0 0.015930384397506714
the O 0 0.020312756299972534
von B-Disease 1 0.917610228061676
Hippel I-Disease 1 0.9814572334289551
- I-Disease 1 0.9578622579574585
Lindau I-Disease 1 0.9871640205383301
( I-Disease 1 0.8373268842697144
VHL I-Disease 1 0.9920050501823425
) I-Disease 1 0.8892655372619629
tumor I-Disease 1 0.9962053894996643
suppressor O 1 0.9935989379882812
gene O 1 0.9916362762451172
predisposes O 1 0.9839422106742859
affected O 1 0.55226731300354
individuals O 0 0.05846468359231949
to O 0 0.007883737795054913
the O 0 0.03272524103522301
human O 1 0.9722984433174133
VHL B-Disease 1 0.9981426000595093
cancer I-Disease 1 0.9989218711853027
syndrome I-Disease 1 0.9981632828712463
and O 0 0.029946500435471535
is O 0 0.027431519702076912
associated O 0 0.26622235774993896
with O 0 0.15348052978515625
sporadic B-Disease 1 0.9815877676010132
renal I-Disease 1 0.9981337189674377
cell I-Disease 1 0.9925940632820129
carcinomas I-Disease 1 0.9948188662528992
( O 1 0.5968419909477234
RCC B-Disease 1 0.9569269418716431
) O 0 0.07651462405920029
and O 0 0.025774279609322548
brain B-Disease 1 0.9639704823493958
hemangioblastomas I-Disease 1 0.7662451863288879
. O 0 0.04063776135444641

VHL O 1 0.9354929327964783
- O 1 0.5900974869728088
negative O 1 0.5238114595413208
786 O 1 0.8482053875923157
- O 1 0.5121093392372131
0 O 0 0.24775254726409912
RCC B-Disease 1 0.9302771091461182
cells O 1 0.8554137349128723
are O 0 0.009360168129205704
tumorigenic O 0 0.2513667345046997
in O 0 0.01107866782695055
nude O 1 0.6088630557060242
mice O 1 0.9430438280105591
which O 0 0.007469858042895794
is O 0 0.006316315848380327
suppressed O 0 0.055170368403196335
by O 0 0.006856048945337534
the O 0 0.00792874675244093
reintroduction O 0 0.32184675335884094
of O 0 0.024957964196801186
VHL B-Disease 1 0.9614943861961365
. O 0 0.052180107682943344

Remarkably O 0 0.10996251553297043
, O 0 0.01218383852392435
this O 0 0.008389397524297237
occurs O 0 0.07068286836147308
without O 0 0.0076322536915540695
affecting O 0 0.06807196140289307
the O 0 0.0047256434336304665
growth O 0 0.09717459976673126
rate O 0 0.06313174217939377
and O 0 0.00731391366571188
cell O 1 0.6419469118118286
cycle O 0 0.4812674820423126
profile O 0 0.12588229775428772
of O 0 0.005000158678740263
these O 0 0.009984456934034824
cells O 1 0.7391685247421265
in O 0 0.010487517341971397
culture O 0 0.029478643089532852
. O 0 0.020442498847842216

The O 0 0.032504014670848846
786 O 1 0.6748028993606567
- O 0 0.26780885457992554
0 O 0 0.09725446999073029
cell O 0 0.3809690475463867
line O 0 0.011770281009376049
, O 0 0.005941386800259352
like O 0 0.016581682488322258
many O 0 0.06652872264385223
cancer B-Disease 1 0.9961723685264587
cells O 1 0.952083945274353
, O 0 0.006879227701574564
fails O 0 0.03572497516870499
to O 0 0.003858214244246483
exit O 0 0.015974069014191628
the O 0 0.0067499177530407906
cell O 1 0.6322816014289856
cycle O 0 0.3513518273830414
upon O 0 0.02313803881406784
serum O 1 0.890571117401123
withdrawal O 0 0.3005214035511017
. O 0 0.0354321226477623

Here O 0 0.016136368736624718
, O 0 0.008060824126005173
it O 0 0.003996314946562052
is O 0 0.0035686178598552942
shown O 0 0.0048628924414515495
that O 0 0.0032299337908625603
reintroduction O 0 0.04810802638530731
of O 0 0.003915705252438784
the O 0 0.006261823698878288
wild O 0 0.2783670425415039
- O 1 0.7751026153564453
type O 1 0.879806399345398
VHL B-Disease 1 0.9913115501403809
gene O 1 0.9731306433677673
restores O 0 0.40581491589546204
the O 0 0.008871212601661682
ability O 0 0.06891275942325592
of O 0 0.03180847689509392
VHL O 1 0.9923309087753296
- O 1 0.9529861211776733
negative O 1 0.9712312817573547
RCC B-Disease 1 0.9939385652542114
cancer I-Disease 1 0.9967165589332581
cells O 1 0.9012143015861511
to O 0 0.006792476400732994
exit O 0 0.030847342684864998
the O 0 0.007789873983711004
cell O 1 0.5552915930747986
cycle O 0 0.2520889937877655
and O 0 0.00908423401415348
enter O 0 0.10612696409225464
G0 O 1 0.9759237170219421
/ O 1 0.7665191888809204
quiescence O 1 0.8239299654960632
in O 0 0.019495349377393723
low O 0 0.1701471507549286
serum O 1 0.8600566983222961
. O 0 0.04339321330189705

Both O 0 0.06991314142942429
VHL O 1 0.9643473625183105
- O 0 0.4450719654560089
positive O 0 0.24506641924381256
and O 0 0.0470905676484108
VHL O 1 0.9854394197463989
- O 1 0.7891761064529419
negative O 1 0.8222156763076782
RCC B-Disease 1 0.9758106470108032
cells O 1 0.9425094127655029
exit O 0 0.11868928372859955
the O 0 0.015416240319609642
cell O 1 0.7973738312721252
cycle O 1 0.5460473299026489
by O 0 0.029692895710468292
contact O 0 0.40783926844596863
inhibition O 1 0.8842180967330933
. O 0 0.035601355135440826

The O 0 0.06380698084831238
cyclin O 1 0.9521308541297913
- O 1 0.6829533576965332
dependent O 1 0.7510882019996643
kinase O 1 0.9712920188903809
inhibitor O 1 0.9650843739509583
, O 0 0.021752702072262764
p27 O 1 0.9172219038009644
, O 0 0.010792918503284454
accumulates O 0 0.24503643810749054
upon O 0 0.010510968044400215
serum O 1 0.7239639163017273
withdrawal O 0 0.0662650614976883
, O 0 0.0035436751786619425
only O 0 0.00244833342730999
in O 0 0.0025815265253186226
the O 0 0.0026838735211640596
presence O 0 0.00948399305343628
of O 0 0.004481750074774027
VHL B-Disease 1 0.9319379925727844
, O 0 0.003815951058641076
as O 0 0.0027858733665198088
a O 0 0.0035517949145287275
result O 0 0.0061197844333946705
of O 0 0.0026792671997100115
the O 0 0.0034808132331818342
stabilization O 0 0.04011940956115723
of O 0 0.004910096060484648
the O 0 0.00817654188722372
protein O 1 0.5620784759521484
. O 0 0.026324057951569557

We O 0 0.014321782626211643
propose O 0 0.021295547485351562
that O 0 0.005879278760403395
the O 0 0.005559446290135384
loss O 0 0.02070147916674614
of O 0 0.006620991509407759
wild O 0 0.23846694827079773
- O 1 0.793940544128418
type O 1 0.9275201559066772
VHL B-Disease 1 0.9924079179763794
gene O 1 0.9657883644104004
results O 0 0.04598645493388176
in O 0 0.006001143250614405
a O 0 0.01050893496721983
specific O 0 0.1303911805152893
cellular O 1 0.9117587208747864
defect O 1 0.9641437530517578
in O 0 0.04117204248905182
serum O 1 0.9534435272216797
- O 0 0.47636282444000244
dependent O 0 0.2687303125858307
growth O 0 0.14567409455776215
control O 0 0.03786212205886841
, O 0 0.007174951955676079
which O 0 0.007722950540482998
may O 0 0.06241855025291443
initiate O 1 0.6328713893890381
tumor B-Disease 1 0.9854647517204285
formation O 1 0.543951153755188
. O 0 0.03517328202724457

This O 0 0.015803832560777664
is O 0 0.011093592271208763
corrected O 0 0.03640299662947655
by O 0 0.006145942490547895
the O 0 0.005512256175279617
reintroduction O 0 0.20068930089473724
of O 0 0.008396160788834095
wild O 0 0.3235924243927002
- O 1 0.7122290134429932
type O 1 0.8207080364227295
VHL B-Disease 1 0.981189489364624
, O 0 0.02567371167242527
implicating O 1 0.691832959651947
VHL B-Disease 1 0.9515278935432434
as O 0 0.007760859560221434
the O 0 0.00704694539308548
first O 0 0.045997146517038345
tumor B-Disease 1 0.9940144419670105
suppressor O 1 0.9615196585655212
involved O 0 0.019068706780672073
in O 0 0.004456405062228441
the O 0 0.003820579731836915
regulation O 0 0.0420483723282814
of O 0 0.005745524074882269
cell O 1 0.6654562950134277
cycle O 0 0.2854349911212921
exit O 0 0.0233828816562891
, O 0 0.0029682288877665997
which O 0 0.0023908312432467937
is O 0 0.0025530699640512466
consistent O 0 0.005815023556351662
with O 0 0.0033380964305251837
its O 0 0.005136121064424515
gatekeeper O 1 0.5461181998252869
function O 0 0.08000845462083817
in O 0 0.0072916727513074875
the O 0 0.015018980018794537
kidney O 1 0.9852509498596191
. O 0 0.018606169149279594
. O 0 0.021301144734025

Piebaldism B-Disease 1 0.8497843742370605
with O 0 0.11056169122457504
deafness B-Disease 1 0.9808177947998047
: O 0 0.031214941293001175
molecular O 0 0.2995167374610901
evidence O 0 0.01218260545283556
for O 0 0.008779283612966537
an O 0 0.0159015990793705
expanded O 0 0.24226900935173035
syndrome O 1 0.9907859563827515
. O 0 0.06336427479982376

In O 0 0.018424363806843758
a O 0 0.016085589304566383
South O 0 0.012925192713737488
African O 0 0.02604597806930542
girl O 0 0.0548718199133873
of O 0 0.010900943540036678
Xhosa O 1 0.7888859510421753
stock O 0 0.16248802840709686
with O 0 0.08536326885223389
severe O 1 0.9723547101020813
piebaldism B-Disease 1 0.9187758564949036
and O 0 0.1289038062095642
profound O 1 0.9760644435882568
congenital O 1 0.9982465505599976
sensorineural B-Disease 1 0.9931389689445496
deafness I-Disease 1 0.9898028373718262
we O 0 0.012351872399449348
identified O 0 0.03559986874461174
a O 0 0.012373827397823334
novel O 0 0.1428646445274353
missense O 1 0.7980705499649048
substitution O 0 0.0838778167963028
at O 0 0.0072896433994174
a O 0 0.007826357148587704
highly O 0 0.02066514454782009
conserved O 0 0.08840039372444153
residue O 0 0.07445555925369263
in O 0 0.006383105181157589
the O 0 0.007636137306690216
intracellular O 1 0.9177456498146057
kinase O 1 0.8809987902641296
domain O 0 0.02720308117568493
of O 0 0.0062029617838561535
the O 0 0.01028717402368784
KIT O 1 0.5958737134933472
proto O 1 0.9132160544395447
- O 1 0.7397393584251404
oncogene O 1 0.9525835514068604
, O 0 0.026620185002684593
R796G O 0 0.4231339991092682
. O 0 0.03876224905252457

Though O 0 0.05031301826238632
auditory B-Disease 1 0.6768317818641663
anomalies I-Disease 0 0.3080877661705017
have O 0 0.008162979036569595
been O 0 0.006723147816956043
observed O 0 0.02504650503396988
in O 0 0.011941098608076572
mice O 1 0.9591726064682007
with O 0 0.0230390802025795
dominant O 1 0.6197438836097717
white O 1 0.511358380317688
spotting O 1 0.9098299145698547
( O 0 0.26676473021507263
W O 1 0.8891347050666809
) O 0 0.025250129401683807
due O 0 0.025693537667393684
to O 0 0.01058983150869608
KIT O 1 0.8943141102790833
mutations O 1 0.9919418096542358
, O 0 0.0647183507680893
deafness B-Disease 1 0.9891465902328491
is O 0 0.007231222465634346
not O 0 0.004572974052280188
typical O 0 0.02594025246798992
in O 0 0.009129294194281101
human O 0 0.15516334772109985
piebaldism B-Disease 1 0.579960286617279
. O 0 0.02835221029818058

Thus O 0 0.030916020274162292
, O 0 0.011999586597084999
the O 0 0.00937309768050909
occurrence O 1 0.5014131665229797
of O 0 0.03764059394598007
sensorineural B-Disease 1 0.9879712462425232
deafness I-Disease 1 0.9903202652931213
in O 0 0.014343701303005219
this O 0 0.010361583903431892
patient O 1 0.6678605675697327
extends O 0 0.03984080255031586
considerably O 0 0.030590152367949486
the O 0 0.005422255955636501
phenotypic O 0 0.4188997447490692
range O 0 0.010506040416657925
of O 0 0.00568349426612258
piebaldism B-Disease 0 0.4944993853569031
due O 0 0.04177527129650116
to O 0 0.011440595611929893
KIT O 1 0.9153753519058228
gene O 1 0.9898059964179993
mutation O 1 0.9843605160713196
in O 0 0.02492538094520569
humans O 1 0.5424391627311707
and O 0 0.008817441761493683
tightens O 1 0.6220679879188538
the O 0 0.010141109116375446
clinical O 1 0.8093904256820679
similarity O 0 0.14346955716609955
between O 0 0.011927872896194458
piebaldism B-Disease 0 0.13964195549488068
and O 0 0.00399680295959115
the O 0 0.004094100557267666
various O 0 0.007368238642811775
forms O 0 0.13561712205410004
of O 0 0.13732832670211792
Waardenburg B-Disease 1 0.9931394457817078
syndrome I-Disease 1 0.9956144094467163
. O 0 0.06870640069246292
. O 0 0.033196017146110535

Cycloheximide O 0 0.3555980622768402
facilitates O 0 0.07715654373168945
the O 0 0.012967992573976517
identification O 0 0.017106248065829277
of O 0 0.00754552660509944
aberrant O 1 0.5484930872917175
transcripts O 0 0.05057527869939804
resulting O 0 0.06082121282815933
from O 0 0.007155677303671837
a O 0 0.008738145232200623
novel O 0 0.1345750242471695
splice O 1 0.8703456521034241
- O 0 0.4266912043094635
site O 0 0.056745726615190506
mutation O 1 0.9657427072525024
in O 0 0.01394952367991209
COL17A1 O 1 0.6020191311836243
in O 0 0.013259517028927803
a O 0 0.057628560811281204
patient O 1 0.9537709355354309
with O 0 0.2884470522403717
generalized O 1 0.9840742349624634
atrophic B-Disease 1 0.9898382425308228
benign I-Disease 1 0.9874060750007629
epidermolysis I-Disease 1 0.9785088896751404
bullosa I-Disease 1 0.9496761560440063
. O 0 0.15397746860980988

Patients O 1 0.9569993019104004
with O 0 0.21837462484836578
generalized O 1 0.9711479544639587
atrophic B-Disease 1 0.9854828119277954
benign I-Disease 1 0.9849255681037903
epidermolysis I-Disease 1 0.9866530299186707
bullosa I-Disease 1 0.9749666452407837
often O 0 0.05035229027271271
show O 0 0.023485109210014343
decreased O 0 0.23627504706382751
expression O 0 0.10462356358766556
of O 0 0.012831779196858406
type O 1 0.7054613828659058
XVII O 1 0.9531180262565613
collagen O 1 0.9669848680496216
, O 0 0.013219300657510757
a O 0 0.021884972229599953
transmembrane O 1 0.7213783860206604
hemidesmosomal O 1 0.6679865717887878
protein O 1 0.702861487865448
encoded O 0 0.10562843084335327
by O 0 0.023337289690971375
COL17A1 O 0 0.3653789460659027
. O 0 0.029224345460534096

This O 0 0.016782743856310844
report O 0 0.013868493027985096
documents O 0 0.012319332920014858
a O 0 0.011568307876586914
novel O 0 0.07921689003705978
splice O 1 0.7744114995002747
- O 0 0.28901711106300354
site O 0 0.05560243874788284
mutation O 1 0.9725841283798218
in O 0 0.014369288459420204
COL17A1 O 1 0.5397606492042542
in O 0 0.011777026578783989
a O 0 0.058699190616607666
patient O 1 0.9585494995117188
with O 0 0.2151375263929367
generalized O 1 0.989124059677124
atrophic B-Disease 1 0.9950383305549622
benign I-Disease 1 0.9938795566558838
epidermolysis I-Disease 1 0.9928112626075745
bullosa I-Disease 1 0.9781931638717651
, O 0 0.011874927207827568
and O 0 0.0055513037368655205
applies O 0 0.01122784148901701
a O 0 0.0056984806433320045
new O 0 0.004253411199897528
methodology O 0 0.01047421433031559
to O 0 0.00350925512611866
define O 0 0.010179195553064346
and O 0 0.004566323943436146
characterize O 0 0.06489778310060501
the O 0 0.008454544469714165
resulting O 0 0.36147087812423706
mRNA O 1 0.7502076625823975
splice O 1 0.8785337805747986
variants O 1 0.6793960332870483
. O 0 0.03844892233610153

Mutational O 1 0.7394389510154724
analysis O 0 0.04584100842475891
of O 0 0.018485065549612045
COL17A1 O 0 0.4965861439704895
identified O 0 0.05006520450115204
a O 0 0.03273463249206543
maternally O 1 0.9432550072669983
inherited O 1 0.9549175500869751
G O 1 0.7153434157371521
- O 0 0.21677471697330475
to O 0 0.011153681203722954
- O 0 0.37824705243110657
T O 1 0.8154945373535156
transversion O 0 0.27460572123527527
at O 0 0.007926587015390396
the O 0 0.005412508267909288
- O 0 0.02244878187775612
1 O 0 0.00705366488546133
position O 0 0.006498682778328657
of O 0 0.0077819982543587685
exon O 0 0.35130298137664795
32 O 0 0.029864249750971794
. O 0 0.023777499794960022

This O 0 0.02991827204823494
acceptor O 1 0.6514068841934204
splice O 1 0.7410640120506287
- O 0 0.2215208262205124
site O 0 0.025525717064738274
mutation O 1 0.8418569564819336
led O 0 0.008863028138875961
to O 0 0.0040620723739266396
the O 0 0.004480763338506222
formation O 0 0.0315927155315876
of O 0 0.005753783043473959
aberrant O 1 0.6408686637878418
transcripts O 0 0.045798782259225845
present O 0 0.010605505667626858
at O 0 0.00886537041515112
extremely O 0 0.03585081920027733
low O 0 0.05638860911130905
levels O 0 0.14907413721084595
. O 0 0.02910219319164753

Based O 0 0.01780058816075325
on O 0 0.007820231840014458
our O 0 0.007557984907180071
recent O 0 0.010267367586493492
finding O 0 0.012468504719436169
that O 0 0.007512279320508242
cycloheximide O 1 0.5205561518669128
stabilized O 1 0.7814275622367859
mutant O 1 0.9173868298530579
COL17A1 O 1 0.7560583353042603
transcripts O 0 0.10325241833925247
in O 0 0.014430514536798
keratinocytes O 1 0.8624745011329651
homozygous O 1 0.8344832062721252
for O 0 0.009587631560862064
a O 0 0.039034586399793625
frameshift O 1 0.9775190353393555
mutation O 1 0.9638846516609192
, O 0 0.00544779421761632
the O 0 0.004555162508040667
effects O 0 0.07195385545492172
of O 0 0.004081960767507553
the O 0 0.006064522545784712
splice O 1 0.7870944738388062
- O 0 0.3009611666202545
site O 0 0.02834245003759861
mutation O 1 0.9102413058280945
on O 0 0.00679504731670022
splicing O 0 0.3933565616607666
of O 0 0.00664646178483963
COL17A1 O 0 0.30939409136772156
transcripts O 0 0.018196675926446915
were O 0 0.004747889470309019
determined O 0 0.011668974533677101
using O 0 0.014412683434784412
reverse O 0 0.4982423186302185
transcriptase O 1 0.9776655435562134
polymerase O 1 0.8591176867485046
chain O 0 0.16428710520267487
reaction O 0 0.03403347358107567
of O 0 0.00584379630163312
total O 0 0.0104127312079072
RNA O 1 0.7107774615287781
from O 0 0.015755843371152878
keratinocytes O 1 0.8285415768623352
incubated O 0 0.28409436345100403
for O 0 0.01127362996339798
2 O 0 0.020748792216181755
. O 0 0.020860986784100533

5 O 0 0.0328843891620636
h O 0 0.04639061167836189
in O 0 0.007200560998171568
the O 0 0.00519584072753787
presence O 0 0.012993262149393559
or O 0 0.007048981264233589
absence O 0 0.018727721646428108
of O 0 0.0053336042910814285
10 O 0 0.014706267043948174
microg O 0 0.47863954305648804
cycloheximide O 1 0.5127414464950562
per O 0 0.034064196050167084
ml O 1 0.6662853956222534
. O 0 0.03425079211592674

Using O 0 0.02272794209420681
this O 0 0.00926260743290186
approach O 0 0.012988314032554626
, O 0 0.005829751491546631
an O 0 0.008841616101562977
abnormally O 1 0.8431553244590759
spliced O 1 0.77544105052948
transcript O 0 0.11440058797597885
was O 0 0.00553900608792901
identified O 0 0.006676418241113424
that O 0 0.0030141237657517195
contains O 0 0.004402275662869215
an O 0 0.003053652122616768
extra O 0 0.0061899032443761826
264 O 0 0.015581438317894936
bases O 0 0.007839789614081383
upstream O 0 0.030209975317120552
from O 0 0.006367769092321396
exon O 0 0.3639044165611267
32 O 0 0.012277976609766483
, O 0 0.005915472283959389
resulting O 0 0.05661991611123085
in O 0 0.006331480108201504
a O 0 0.01513361930847168
premature O 1 0.8989713191986084
termination O 1 0.7695659399032593
codon O 0 0.45960432291030884
27 O 0 0.023375194519758224
bp O 0 0.05057741701602936
downstream O 0 0.05820474028587341
from O 0 0.011359094642102718
the O 0 0.01102053839713335
cryptic O 0 0.3692314326763153
splice O 1 0.5812739729881287
site O 0 0.03271489590406418
. O 0 0.02693757973611355

Three O 0 0.02110009640455246
other O 0 0.01358021516352892
splice O 1 0.5440104603767395
variants O 0 0.1956169307231903
, O 0 0.00516953831538558
including O 0 0.004288460593670607
one O 0 0.0031252719927579165
derived O 0 0.009692247956991196
from O 0 0.0033811565954238176
the O 0 0.003017173381522298
skipping O 0 0.033230364322662354
of O 0 0.004753733053803444
exon O 0 0.23036299645900726
32 O 0 0.009278631769120693
, O 0 0.004243404604494572
were O 0 0.003926469944417477
also O 0 0.005776709411293268
identified O 0 0.020396500825881958
. O 0 0.017078367993235588

These O 0 0.016953613609075546
results O 0 0.015408976003527641
indicate O 0 0.012034228071570396
the O 0 0.006243129260838032
usefulness O 0 0.06490454822778702
of O 0 0.008264523930847645
cycloheximide O 1 0.6858071684837341
treatment O 1 0.5616123080253601
in O 0 0.005872839130461216
evaluating O 0 0.04634065926074982
the O 0 0.005703338421881199
abnormal O 1 0.8392441868782043
processing O 0 0.023835916072130203
of O 0 0.004910217132419348
mRNA O 0 0.24618864059448242
due O 0 0.01700885407626629
to O 0 0.0064735072664916515
splice O 1 0.8846933245658875
- O 0 0.41267967224121094
site O 0 0.050945937633514404
mutations O 1 0.970604658126831
, O 0 0.006715794093906879
because O 0 0.009222248569130898
( O 0 0.010158800520002842
i O 0 0.00570466835051775
) O 0 0.016742685809731483
aberrant O 1 0.6639430522918701
splicing O 1 0.7110500931739807
often O 0 0.020126087591052055
generates O 0 0.10106358677148819
a O 0 0.03688265010714531
premature O 1 0.9361794590950012
termination O 1 0.8633982539176941
codon O 1 0.5837227702140808
, O 0 0.009259496815502644
( O 0 0.021184129640460014
ii O 0 0.031558871269226074
) O 0 0.011541985906660557
transcripts O 0 0.05237323045730591
with O 0 0.01804357022047043
premature O 1 0.9185344576835632
termination O 1 0.8382360339164734
codons O 1 0.6237804293632507
can O 0 0.0169156976044178
occur O 0 0.159684419631958
at O 0 0.00660909665748477
low O 0 0.07168366760015488
or O 0 0.058094561100006104
undetectable O 1 0.937498927116394
levels O 0 0.1451740711927414
due O 0 0.02199586294591427
to O 0 0.006092696916311979
nonsense O 0 0.16087965667247772
- O 0 0.4101939797401428
mediated O 1 0.9030912518501282
mRNA O 1 0.6704132556915283
decay O 0 0.43103212118148804
, O 0 0.004996814765036106
and O 0 0.0035868885461241007
( O 0 0.013439124450087547
iii O 0 0.04253743588924408
) O 0 0.004175112582743168
the O 0 0.0022319601848721504
levels O 0 0.006742163095623255
of O 0 0.0024405107833445072
these O 0 0.003189502516761422
transcripts O 0 0.012260143645107746
can O 0 0.004390072543174028
be O 0 0.0032968127634376287
increased O 0 0.010829481296241283
by O 0 0.009900596924126148
cycloheximide O 0 0.34017229080200195
. O 0 0.025544017553329468

A O 0 0.07514527440071106
deletion O 1 0.9191074371337891
mutation O 1 0.9441730976104736
in O 0 0.016372572630643845
COL17A1 O 0 0.23334234952926636
in O 0 0.0086327800527215
five O 0 0.012253452092409134
Austrian O 0 0.12732072174549103
families O 0 0.10488879680633545
with O 0 0.12616591155529022
generalized O 1 0.9844614863395691
atrophic B-Disease 1 0.9918420314788818
benign I-Disease 1 0.9896484017372131
epidermolysis I-Disease 1 0.9861651659011841
bullosa I-Disease 1 0.9747432470321655
represents O 0 0.15103238821029663
propagation O 0 0.19229307770729065
of O 0 0.01372015755623579
an O 0 0.01880009099841118
ancestral O 0 0.4932717978954315
allele O 1 0.9160902500152588
. O 0 0.0359315425157547

Patients O 1 0.9583678245544434
with O 0 0.3644893765449524
generalized O 1 0.9762305021286011
atrophic B-Disease 1 0.9878135919570923
benign I-Disease 1 0.9879165887832642
epidermolysis I-Disease 1 0.9861156940460205
bullosa I-Disease 1 0.9685639142990112
, O 0 0.018769076094031334
a O 0 0.014401349239051342
usually O 0 0.018565785139799118
nonlethal O 0 0.24012792110443115
form O 0 0.09617677330970764
of O 0 0.04124514013528824
junctional B-Disease 1 0.9864939451217651
epidermolysis I-Disease 1 0.990885317325592
bullosa I-Disease 1 0.9846071600914001
, O 0 0.021557746455073357
have O 0 0.016882482916116714
generalized O 1 0.8878642320632935
blistering B-Disease 1 0.8349483013153076
, O 0 0.12581901252269745
nail B-Disease 1 0.9806883335113525
dystrophy I-Disease 1 0.9955542683601379
, O 0 0.24106639623641968
patchy B-Disease 1 0.975501537322998
alopecia I-Disease 1 0.9903883337974548
, O 0 0.06469127535820007
and O 0 0.061001647263765335
dental B-Disease 1 0.9765510559082031
abnormalities I-Disease 1 0.9844993948936462
. O 0 0.08546554297208786

Skin B-Disease 1 0.9667962789535522
fragility I-Disease 1 0.6710218787193298
in O 0 0.012285223230719566
most O 0 0.010286776348948479
cases O 0 0.05744097754359245
is O 0 0.005371482577174902
due O 0 0.014545970596373081
to O 0 0.006013141479343176
mutations O 1 0.9453886151313782
in O 0 0.008447427302598953
the O 0 0.021325061097741127
gene O 1 0.9805247783660889
encoding O 1 0.9407973289489746
type O 1 0.9257493019104004
XVII O 1 0.9691482186317444
collagen O 1 0.9794089198112488
( O 0 0.22565120458602905
COL17A1 O 1 0.6639713644981384
) O 0 0.041303131729364395
. O 0 0.027801457792520523

Recently O 0 0.035004012286663055
, O 0 0.011820776388049126
we O 0 0.006732828449457884
reported O 0 0.013038492761552334
five O 0 0.010399183258414268
Austrian O 0 0.08683798462152481
families O 0 0.08692363649606705
with O 0 0.11575374752283096
generalized O 1 0.9790651798248291
atrophic B-Disease 1 0.9912946820259094
benign I-Disease 1 0.9901911020278931
epidermolysis I-Disease 1 0.9872503280639648
bullosa I-Disease 1 0.9642431735992432
who O 0 0.01941382884979248
share O 0 0.01840001344680786
the O 0 0.01175724808126688
same O 0 0.02975938282907009
COL17A1 O 1 0.8640428185462952
mutation O 1 0.9662103056907654
. O 0 0.04807039350271225

Affected O 0 0.12472804635763168
individuals O 0 0.021106461063027382
in O 0 0.007345833349972963
three O 0 0.006091684103012085
families O 0 0.010643377900123596
are O 0 0.005483725108206272
homozygous O 1 0.6181442141532898
for O 0 0.007857364602386951
4003delTC O 0 0.304686576128006
, O 0 0.004676581360399723
whereas O 0 0.009474268183112144
those O 0 0.00411579804494977
in O 0 0.0033766990527510643
two O 0 0.003893282264471054
others O 0 0.0065414272248744965
are O 0 0.006362491752952337
compound O 0 0.12220274657011032
heterozygotes O 1 0.8507966995239258
. O 0 0.0331241674721241

To O 0 0.013868095353245735
determine O 0 0.013322409242391586
if O 0 0.006672836374491453
the O 0 0.004680552054196596
occurrence O 0 0.08876240253448486
of O 0 0.004767963197082281
4003delTC O 0 0.19909869134426117
in O 0 0.00508314510807395
these O 0 0.005683508235961199
unrelated O 0 0.22629253566265106
families O 0 0.025595270097255707
signifies O 0 0.12536631524562836
propagation O 0 0.10362062603235245
of O 0 0.004491106141358614
an O 0 0.007794947363436222
ancestral O 0 0.4489893317222595
allele O 1 0.9275223016738892
or O 0 0.02209409885108471
a O 0 0.012808196246623993
mutational O 1 0.8544785976409912
hot O 0 0.028558554127812386
spot O 0 0.013800840824842453
, O 0 0.006397189572453499
haplotypes O 1 0.6545616388320923
were O 0 0.0037403441965579987
determined O 0 0.009735111147165298
for O 0 0.004881192930042744
polymorphisms O 1 0.617978036403656
both O 0 0.006784271914511919
within O 0 0.008625222370028496
and O 0 0.008670918643474579
flanking O 0 0.29535621404647827
COL17A1 O 1 0.6797533631324768
. O 0 0.03511958196759224

Five O 0 0.037937965244054794
intragenic O 0 0.441793829202652
polymorphisms O 1 0.5473498106002808
were O 0 0.008725374937057495
chosen O 0 0.008902313187718391
based O 0 0.006974725052714348
on O 0 0.00522784935310483
their O 0 0.008760567754507065
informativeness O 0 0.33601319789886475
. O 0 0.025026414543390274

One O 0 0.01235214527696371
of O 0 0.005712850950658321
these O 0 0.004067712929099798
, O 0 0.0029410277493298054
not O 0 0.002390493405982852
previously O 0 0.003599757794290781
reported O 0 0.005509193520992994
, O 0 0.0027976364362984896
was O 0 0.0032089208252727985
2988 O 0 0.10799132287502289
A O 0 0.006639027502387762
or O 0 0.007541578263044357
C O 0 0.03262916952371597
that O 0 0.0032110109459608793
introduces O 0 0.014071562327444553
a O 0 0.004888119176030159
new O 0 0.004909730516374111
restriction O 0 0.01638336479663849
site O 0 0.007630739826709032
for O 0 0.007369389291852713
Eco0109 O 0 0.23709513247013092
I O 0 0.015843061730265617
. O 0 0.016951965168118477

All O 0 0.0153242452070117
the O 0 0.013994516804814339
4003delTC O 0 0.47569146752357483
alleles O 1 0.7598211169242859
showed O 0 0.012428333051502705
the O 0 0.005777583457529545
same O 0 0.009647305123507977
haplotype O 1 0.7790917754173279
for O 0 0.006095123942941427
these O 0 0.0072054509073495865
five O 0 0.016894785687327385
polymorphic O 1 0.9391499161720276
markers O 1 0.5800567865371704
. O 0 0.039781685918569565

Fourteen O 0 0.0671239122748375
microsatellite O 1 0.8394431471824646
polymorphisms O 1 0.5236830115318298
were O 0 0.007731370162218809
selected O 0 0.007424615789204836
based O 0 0.005213642492890358
on O 0 0.0029042745009064674
their O 0 0.003707760013639927
high O 0 0.0077031697146594524
heterozygosity O 0 0.3231835663318634
and O 0 0.0040782755240798
their O 0 0.004748987499624491
location O 0 0.00892671849578619
within O 0 0.013012152165174484
10q23 O 1 0.5138826966285706
- O 0 0.29995855689048767
q25 O 1 0.5330241918563843
near O 0 0.05905168876051903
COL17A1 O 1 0.5733550786972046
. O 0 0.039559900760650635

Three O 0 0.026700587943196297
families O 0 0.03152880817651749
shared O 0 0.051667470484972
microsatellite O 1 0.9452223181724548
polymorphisms O 1 0.9083026051521301
covering O 0 0.02217681147158146
at O 0 0.0066516525112092495
most O 0 0.005294029600918293
19 O 0 0.011294307187199593
cM O 0 0.07241324335336685
, O 0 0.0032156112138181925
whereas O 0 0.006008816882967949
the O 0 0.0025578446220606565
others O 0 0.004351082257926464
shared O 0 0.007045514415949583
smaller O 0 0.012697737663984299
regions O 0 0.02961995080113411
consistent O 0 0.014076492749154568
with O 0 0.0046957978047430515
cross O 0 0.012416824698448181
- O 0 0.013962549157440662
over O 0 0.003466532099992037
events O 0 0.005355088505893946
during O 0 0.004800112452358007
passage O 0 0.007931245490908623
of O 0 0.004212690517306328
this O 0 0.0065798466093838215
mutation O 1 0.9096054434776306
through O 0 0.011432746425271034
several O 0 0.011127447709441185
generations O 0 0.08726125210523605
. O 0 0.023180387914180756

These O 0 0.01627298630774021
results O 0 0.01752960868179798
indicate O 0 0.017192041501402855
that O 0 0.007265153340995312
4003delTC O 0 0.250736266374588
occurs O 0 0.04342217370867729
on O 0 0.004077951889485121
a O 0 0.007277204189449549
single O 0 0.019692301750183105
ancestral O 0 0.4936262369155884
allele O 1 0.9144131541252136
. O 0 0.016829142346978188
. O 0 0.02304973639547825

The O 0 0.0465800017118454
haptoglobin O 1 0.9203084707260132
- O 1 0.784115195274353
gene O 1 0.9658655524253845
deletion O 1 0.8931431770324707
responsible O 0 0.05224975198507309
for O 0 0.019344555214047432
anhaptoglobinemia B-Disease 0 0.4125822186470032
. O 0 0.0308785829693079

We O 0 0.012412937358021736
have O 0 0.007597318850457668
found O 0 0.008695701137185097
an O 0 0.00821706559509039
allelic O 1 0.7421030402183533
deletion O 1 0.6202682256698608
of O 0 0.006732446141541004
the O 0 0.012600132264196873
haptoglobin O 1 0.9427214860916138
( O 0 0.12345941364765167
Hp O 0 0.4870412051677704
) O 0 0.04268250986933708
gene O 1 0.6345531940460205
from O 0 0.006494793109595776
an O 0 0.005656557157635689
individual O 0 0.01358701940625906
with O 0 0.013626390136778355
anhaptoglobinemia B-Disease 0 0.4601591229438782
. O 0 0.030364729464054108

The O 0 0.02817029505968094
Hp O 0 0.3966452479362488
gene O 1 0.8285617828369141
cluster O 0 0.11753256618976593
consists O 0 0.011985952965915203
of O 0 0.006000124849379063
coding O 0 0.3019016683101654
regions O 0 0.012093762867152691
of O 0 0.0036019699182361364
the O 0 0.00416517211124301
alpha O 0 0.05724235624074936
chain O 0 0.08040494471788406
and O 0 0.005662871990352869
beta O 0 0.2023153454065323
chain O 0 0.08478371053934097
of O 0 0.005274244584143162
the O 0 0.01221443060785532
haptoglobin O 1 0.9678753018379211
gene O 1 0.9801846146583557
( O 0 0.10037301480770111
Hp O 0 0.16173967719078064
) O 0 0.005406553857028484
and O 0 0.0022790853399783373
of O 0 0.0022353960666805506
the O 0 0.0032554466743022203
alpha O 0 0.03574487566947937
chain O 0 0.059966277331113815
and O 0 0.004429814405739307
beta O 0 0.09034804254770279
chain O 0 0.04619931802153587
of O 0 0.004466418642550707
the O 0 0.009045855142176151
haptoglobin O 1 0.9568526148796082
- O 1 0.7793797254562378
related O 1 0.7965660691261292
gene O 1 0.9802950024604797
( O 0 0.18057703971862793
Hpr O 1 0.9014637470245361
) O 0 0.014052418060600758
, O 0 0.004014138597995043
in O 0 0.003822138998657465
tandem O 0 0.031611621379852295
from O 0 0.005651756189763546
the O 0 0.005784928798675537
5 O 0 0.01061982847750187
side O 0 0.014497999101877213
. O 0 0.01865721307694912

Southern O 0 0.04126449674367905
blot O 0 0.15902723371982574
and O 0 0.012493381276726723
PCR O 0 0.25554153323173523
analyses O 0 0.01794065162539482
have O 0 0.0038681598380208015
indicated O 0 0.005143906455487013
that O 0 0.002289914758875966
the O 0 0.002648598048835993
individual O 0 0.006028437055647373
with O 0 0.004616258665919304
anhaptoglobinemia B-Disease 0 0.2919448912143707
was O 0 0.004862278699874878
homozygous O 1 0.6388276219367981
for O 0 0.005223747342824936
the O 0 0.008066106587648392
gene O 1 0.9560222625732422
deletion O 1 0.7661446928977966
and O 0 0.00365191581659019
that O 0 0.003082927083596587
the O 0 0.005402898415923119
gene O 1 0.8934944272041321
deletion O 1 0.5333186984062195
was O 0 0.003738929983228445
included O 0 0.0032789050601422787
at O 0 0.002756734611466527
least O 0 0.003318056697025895
from O 0 0.0030894188676029444
the O 0 0.003707640105858445
promoter O 0 0.11422671377658844
region O 0 0.008603171445429325
of O 0 0.004923162516206503
Hp O 0 0.1419379711151123
to O 0 0.007040617987513542
Hpr O 1 0.7534540891647339
alpha O 0 0.03507811576128006
but O 0 0.005488829221576452
not O 0 0.005228854715824127
to O 0 0.008098551072180271
Hpr O 1 0.8748792409896851
beta O 1 0.5734405517578125
( O 0 0.07624471187591553
Hpdel O 1 0.5490333437919617
) O 0 0.02864621765911579
. O 0 0.02253047004342079

In O 0 0.014505814760923386
addition O 0 0.0111150611191988
, O 0 0.004530616104602814
we O 0 0.0026459929067641497
found O 0 0.00393332913517952
seven O 0 0.003735757665708661
individuals O 0 0.008074761368334293
with O 0 0.003966713789850473
hypohaptoglobinemia B-Disease 0 0.07691461592912674
in O 0 0.0029054482001811266
three O 0 0.002863518428057432
families O 0 0.00536845438182354
, O 0 0.0020562447607517242
and O 0 0.0017018811777234077
the O 0 0.0021837821695953608
genotypes O 0 0.3623570203781128
of O 0 0.0026294258423149586
six O 0 0.0024411471094936132
of O 0 0.0018422200810164213
the O 0 0.00198766659013927
seven O 0 0.0031722031999379396
individuals O 0 0.006169345695525408
were O 0 0.002128921216353774
found O 0 0.004386895336210728
to O 0 0.003861848032101989
be O 0 0.007062457036226988
Hp2 O 1 0.635138988494873
/ O 1 0.5985823273658752
Hpdel O 1 0.5889315009117126
. O 0 0.03306186944246292

The O 0 0.02558021806180477
phenotypes O 1 0.7990314960479736
and O 0 0.010707341134548187
genotypes O 1 0.5620771646499634
in O 0 0.004727087914943695
one O 0 0.003101278329268098
of O 0 0.002208972116932273
these O 0 0.002407281892374158
three O 0 0.002644726075232029
families O 0 0.005289270542562008
showed O 0 0.004200242925435305
the O 0 0.0028226503636687994
father O 0 0.005650585051625967
to O 0 0.0030723304953426123
be O 0 0.004495570901781321
hypohaptoglobinemic B-Disease 0 0.4631919264793396
( O 0 0.04810984805226326
Hp2 O 1 0.500622570514679
) O 0 0.013433245010674
and O 0 0.005833422765135765
Hp2 O 1 0.5941632986068726
/ O 0 0.39737454056739807
Hpdel O 0 0.2558654248714447
, O 0 0.003926279488950968
the O 0 0.003566705621778965
mother O 0 0.010748548433184624
to O 0 0.003107718424871564
be O 0 0.003908510319888592
Hp2 O 0 0.48521915078163147
- O 0 0.13775290548801422
1 O 0 0.011634161695837975
and O 0 0.006048659794032574
Hp1 O 1 0.763128399848938
/ O 0 0.44525861740112305
Hp2 O 0 0.20115824043750763
, O 0 0.002618007129058242
one O 0 0.002048197202384472
of O 0 0.0016642672708258033
the O 0 0.00191825395449996
two O 0 0.002631884068250656
children O 0 0.007721452042460442
to O 0 0.0025699620600789785
be O 0 0.0037006717175245285
hypohaptoglobinemic B-Disease 1 0.543465256690979
( O 0 0.09029646217823029
Hp2 O 1 0.6514883041381836
) O 0 0.019916603341698647
and O 0 0.006797866430133581
Hp2 O 1 0.7643458247184753
/ O 0 0.4831954538822174
Hpdel O 0 0.23662148416042328
, O 0 0.0032209318596869707
and O 0 0.0020273071713745594
the O 0 0.002178430324420333
other O 0 0.002660926431417465
child O 0 0.020226484164595604
to O 0 0.0029301177710294724
be O 0 0.003997658845037222
Hp1 O 0 0.326214075088501
and O 0 0.009813097305595875
Hp1 O 1 0.8469237685203552
/ O 1 0.6753484606742859
Hpdel O 1 0.5331360697746277
, O 0 0.0058081019669771194
showing O 0 0.011834966018795967
an O 0 0.007360663264989853
anomalous O 1 0.5056578516960144
inheritance O 1 0.6032615900039673
of O 0 0.011820186860859394
Hp O 1 0.5686836242675781
phenotypes O 1 0.9166632294654846
in O 0 0.008959085680544376
the O 0 0.008226186968386173
child O 0 0.14520399272441864
with O 0 0.02160664089024067
Hp1 O 1 0.657920777797699
. O 0 0.029099073261022568

The O 0 0.03453337773680687
Hp2 O 1 0.7546375393867493
/ O 0 0.4774945378303528
Hpdel O 0 0.3617025315761566
individuals O 0 0.018533816561102867
had O 0 0.006032255943864584
an O 0 0.004539444111287594
extremely O 0 0.0117083340883255
low O 0 0.01251179724931717
level O 0 0.0069738226011395454
of O 0 0.005254044197499752
Hp O 0 0.30098390579223633
( O 0 0.04609479010105133
mean O 0 0.11564958095550537
+ O 1 0.7738308310508728
/ O 1 0.6579920649528503
- O 0 0.3376125395298004
SD O 1 0.6239274144172668
= O 0 0.3146577477455139
0 O 0 0.04167803376913071
. O 0 0.020965300500392914
049 O 1 0.9618782997131348
+ O 1 0.8375850915908813
/ O 1 0.5736083388328552
- O 0 0.1569070816040039
0 O 0 0.04317961633205414
. O 0 0.016083117574453354
043 O 1 0.8964102268218994
mg O 1 0.9297793507575989
/ O 1 0.7680651545524597
ml O 1 0.7951087951660156
; O 0 0.03112504445016384
n O 0 0.07512366026639938
= O 0 0.11159718781709671
6 O 0 0.008802342228591442
) O 0 0.004616048187017441
, O 0 0.0024559348821640015
compared O 0 0.003920647781342268
with O 0 0.0023689214140176773
the O 0 0.0024139899760484695
level O 0 0.0051428694278001785
( O 0 0.006876950617879629
1 O 0 0.005290432833135128
. O 0 0.00416009034961462
64 O 0 0.015138034708797932
+ O 0 0.48961958289146423
/ O 0 0.25733453035354614
- O 0 0.0661911740899086
1 O 0 0.010316538624465466
. O 0 0.00911296159029007
07 O 0 0.361168771982193
mg O 1 0.8989866375923157
/ O 1 0.8224043250083923
ml O 1 0.7503693103790283
) O 0 0.011208700016140938
obtained O 0 0.00794043205678463
from O 0 0.005838407203555107
52 O 0 0.025128189474344254
healthy O 1 0.5527867674827576
volunteers O 0 0.0677262395620346
having O 0 0.06638575345277786
phenotype O 1 0.9865148663520813
Hp2 O 1 0.6598924398422241
, O 0 0.006944021675735712
whereas O 0 0.015235158614814281
the O 0 0.006135561503469944
serum O 1 0.7567803859710693
Hp O 0 0.10097432881593704
level O 0 0.007413788698613644
of O 0 0.004075326956808567
an O 0 0.004950839094817638
individual O 0 0.014537971466779709
with O 0 0.016008011996746063
Hp1 O 1 0.8127006888389587
/ O 1 0.6194167733192444
Hpdel O 0 0.43897268176078796
was O 0 0.01153453066945076
0 O 0 0.02808411978185177
. O 0 0.021406123414635658

50 O 0 0.060629550367593765
mg O 1 0.8172934055328369
/ O 1 0.5024181604385376
ml O 0 0.38056036829948425
, O 0 0.005950487684458494
which O 0 0.003326870733872056
was O 0 0.002712537534534931
approximately O 0 0.003641887102276087
half O 0 0.003089096862822771
the O 0 0.0026392340660095215
level O 0 0.004120474681258202
of O 0 0.003043938660994172
Hp O 0 0.06891857832670212
in O 0 0.004681169055402279
control O 0 0.023010745644569397
sera O 0 0.08779803663492203
from O 0 0.006196456961333752
the O 0 0.008570753037929535
Hp1 O 1 0.9163208603858948
phenotype O 1 0.9853072166442871
( O 0 0.03476368635892868
1 O 0 0.008757293224334717
. O 0 0.006431563291698694
26 O 0 0.030451809987425804
+ O 1 0.6461362838745117
/ O 0 0.4121758043766022
- O 0 0.09915778040885925
0 O 0 0.01991664059460163
. O 0 0.007620730437338352
33 O 0 0.04323603957891464
mg O 1 0.8753130435943604
/ O 1 0.7118649482727051
ml O 1 0.8315608501434326
; O 0 0.03266427665948868
n O 0 0.08489122986793518
= O 0 0.13853290677070618
9 O 0 0.010968510992825031
) O 0 0.0078527070581913
, O 0 0.004042645916342735
showing O 0 0.010957146994769573
a O 0 0.02464628405869007
gene O 1 0.96825110912323
- O 1 0.6259650588035583
dosage O 1 0.9281505346298218
effect O 0 0.29434412717819214
. O 0 0.03483450785279274

The O 0 0.024602826684713364
other O 0 0.01948729157447815
allele O 1 0.9219352602958679
( O 0 0.03986776992678642
Hp2 O 0 0.30093643069267273
) O 0 0.008374175056815147
of O 0 0.004458903800696135
individuals O 0 0.024242732673883438
with O 0 0.010675632394850254
Hp2 O 1 0.7941799163818359
/ O 0 0.486330509185791
Hpdel O 0 0.25369784235954285
was O 0 0.0038871881552040577
found O 0 0.003477019490674138
to O 0 0.002156301401555538
have O 0 0.001923993811942637
, O 0 0.001819174038246274
in O 0 0.0023570095654577017
all O 0 0.0029735248535871506
exons O 0 0.2964308261871338
, O 0 0.00554322637617588
no O 0 0.00729761878028512
mutation O 1 0.918932318687439
, O 0 0.007707989774644375
by O 0 0.011908993124961853
DNA O 1 0.5673279762268066
sequencing O 0 0.4269633889198303
. O 0 0.0279972106218338

On O 0 0.010171486996114254
the O 0 0.005742146633565426
basis O 0 0.004557677078992128
of O 0 0.00244658044539392
the O 0 0.0025382975582033396
present O 0 0.003523394698277116
study O 0 0.006176430266350508
, O 0 0.0027666010428220034
the O 0 0.0027756262570619583
mechanism O 0 0.034541431814432144
of O 0 0.003138998756185174
anhaptoglobinemia B-Disease 0 0.13444320857524872
and O 0 0.0032058062497526407
the O 0 0.003859964432194829
mechanism O 0 0.09052639454603195
of O 0 0.0059937299229204655
anomalous O 1 0.7120633721351624
inheritance O 1 0.6217326521873474
of O 0 0.01278493832796812
Hp O 1 0.5143978595733643
phenotypes O 1 0.8247095942497253
were O 0 0.008269521407783031
well O 0 0.010780487209558487
explained O 0 0.028606070205569267
. O 0 0.020524701103568077

However O 0 0.024401137605309486
, O 0 0.011147167533636093
the O 0 0.008531780913472176
mechanism O 0 0.04413239285349846
of O 0 0.009316660463809967
hypohaptoglobinemia B-Disease 0 0.39203253388404846
remains O 0 0.04848629981279373
unknown O 0 0.1411365270614624

ATM O 1 0.7818081974983215
mutations O 1 0.9612346291542053
and O 0 0.04158863052725792
phenotypes O 1 0.9722299575805664
in O 0 0.2888891100883484
ataxia B-Disease 1 0.9947648048400879
- I-Disease 1 0.9179090261459351
telangiectasia I-Disease 1 0.9821165204048157
families O 0 0.028279047459363937
in O 0 0.005616157781332731
the O 0 0.004408637527376413
British O 0 0.010153071954846382
Isles O 0 0.07723943144083023
: O 0 0.008428003638982773
expression O 0 0.042578838765621185
of O 0 0.006096706259995699
mutant O 1 0.8652331829071045
ATM O 0 0.3308972716331482
and O 0 0.0063766902312636375
the O 0 0.013089755550026894
risk O 1 0.9410480856895447
of O 0 0.2561438977718353
leukemia B-Disease 1 0.9981318116188049
, O 1 0.598856508731842
lymphoma B-Disease 1 0.9978070855140686
, O 0 0.13394106924533844
and O 0 0.2339155673980713
breast B-Disease 1 0.9954054355621338
cancer I-Disease 1 0.9913279414176941
. O 0 0.13030943274497986

We O 0 0.01261467020958662
report O 0 0.011249799281358719
the O 0 0.00716750742867589
spectrum O 0 0.021672144532203674
of O 0 0.008160284720361233
59 O 0 0.13090066611766815
ATM O 1 0.867507815361023
mutations O 1 0.9899071455001831
observed O 1 0.5577972531318665
in O 0 0.33891549706459045
ataxia B-Disease 1 0.9967578053474426
- I-Disease 1 0.9762078523635864
telangiectasia I-Disease 1 0.9934091567993164
( O 0 0.36347222328186035
A B-Disease 0 0.2787933945655823
- I-Disease 1 0.8862088322639465
T I-Disease 1 0.9807212352752686
) O 0 0.16777396202087402
patients O 1 0.8670777678489685
in O 0 0.006276814267039299
the O 0 0.007424144074320793
British O 0 0.02171713300049305
Isles O 0 0.19559231400489807
. O 0 0.02450408972799778

Of O 0 0.024867039173841476
51 O 0 0.09899025410413742
ATM O 1 0.665057361125946
mutations O 1 0.9559419751167297
identified O 0 0.02117457054555416
in O 0 0.004860959015786648
families O 0 0.007140567991882563
native O 0 0.00442630797624588
to O 0 0.0022885454818606377
the O 0 0.0030271068681031466
British O 0 0.006030043121427298
Isles O 0 0.02787364087998867
, O 0 0.0037089125253260136
11 O 0 0.005089618731290102
were O 0 0.002985971746966243
founder O 0 0.07642138749361038
mutations O 1 0.8699464201927185
, O 0 0.0030766273848712444
and O 0 0.0022109036799520254
2 O 0 0.0030575969722121954
of O 0 0.002362145110964775
these O 0 0.0032017361372709274
11 O 0 0.008167234249413013
conferred O 0 0.07707851380109787
a O 0 0.06072162464261055
milder O 1 0.9749549627304077
clinical O 1 0.9822412133216858
phenotype O 1 0.9850364923477173
with O 0 0.010965119116008282
respect O 0 0.0077387308701872826
to O 0 0.006059224717319012
both O 0 0.041965458542108536
cerebellar B-Disease 1 0.9918535351753235
degeneration I-Disease 1 0.9925621151924133
and O 0 0.025604527443647385
cellular O 1 0.6915881037712097
features O 0 0.05657593533396721
. O 0 0.027770210057497025

We O 0 0.013616696000099182
report O 0 0.009485076181590557
, O 0 0.0045896004885435104
in O 0 0.004144403617829084
two O 0 0.004500383045524359
A B-Disease 0 0.027702702209353447
- I-Disease 0 0.46451428532600403
T I-Disease 1 0.8649489283561707
families O 0 0.02629806287586689
, O 0 0.005699015688151121
an O 0 0.010578789748251438
ATM O 1 0.8019764423370361
mutation O 1 0.9889910221099854
( O 0 0.18000933527946472
7271T O 1 0.8783264756202698
- O 1 0.6990036368370056
- O 1 0.7603560090065002
> O 1 0.9325857758522034
G O 1 0.5929476618766785
) O 0 0.0099042858928442
that O 0 0.002571296179667115
may O 0 0.0040968325920403
be O 0 0.0021284339018166065
associated O 0 0.00836868491023779
with O 0 0.0032489437144249678
an O 0 0.005992252379655838
increased O 0 0.15814870595932007
risk O 1 0.907116711139679
of O 0 0.1329406052827835
breast B-Disease 1 0.9982771873474121
cancer I-Disease 1 0.9945148229598999
in O 0 0.013177765533328056
both O 0 0.02099282667040825
homozygotes O 1 0.941490113735199
and O 0 0.017662836238741875
heterozygotes O 1 0.9496023058891296
( O 0 0.09282051026821136
relative O 0 0.13771428167819977
risk O 1 0.6098964214324951
12 O 0 0.010305630043148994
. O 0 0.005101791117340326
7 O 0 0.012773605063557625
; O 0 0.018963677808642387
P O 0 0.2901434004306793
= O 0 0.30932509899139404
. O 0 0.011986427940428257
0025 O 1 0.8299515843391418
) O 0 0.008871074765920639
, O 0 0.0029729173984378576
although O 0 0.0030677157919853926
there O 0 0.002296227030456066
is O 0 0.002744840458035469
a O 0 0.005858966615051031
less O 0 0.05016916245222092
severe O 1 0.9439342617988586
A B-Disease 0 0.2657405436038971
- I-Disease 1 0.887848436832428
T I-Disease 1 0.9848891496658325
phenotype O 1 0.9729191064834595
in O 0 0.005459023639559746
terms O 0 0.005487710237503052
of O 0 0.0037160112988203764
the O 0 0.005325664300471544
degree O 0 0.03632177785038948
of O 0 0.02804131619632244
cerebellar B-Disease 1 0.9882416129112244
degeneration I-Disease 1 0.9869274497032166
. O 0 0.1516597419977188

This O 0 0.05101204290986061
mutation O 1 0.9649068713188171
( O 0 0.1714121550321579
7271T O 1 0.7821869254112244
- O 1 0.6160339117050171
- O 1 0.6243882775306702
> O 1 0.8278697729110718
G O 0 0.3840271830558777
) O 0 0.008665005676448345
also O 0 0.0038764735218137503
allows O 0 0.006808334030210972
expression O 0 0.010435626842081547
of O 0 0.0032791418489068747
full O 0 0.0062364633195102215
- O 0 0.1084604486823082
length O 0 0.044851407408714294
ATM O 0 0.23283590376377106
protein O 0 0.1964360624551773
at O 0 0.005138251464813948
a O 0 0.004804232623428106
level O 0 0.0063006822019815445
comparable O 0 0.01510858815163374
with O 0 0.005143782123923302
that O 0 0.0047632018104195595
in O 0 0.008756166324019432
unaffected O 1 0.5109184384346008
individuals O 0 0.08899703621864319
. O 0 0.023863745853304863

In O 0 0.014333141036331654
addition O 0 0.01051238738000393
, O 0 0.0044340770691633224
we O 0 0.002744323806837201
have O 0 0.003058644011616707
studied O 0 0.00793234072625637
18 O 0 0.012738758698105812
A B-Disease 0 0.07404189556837082
- I-Disease 1 0.7445060014724731
T I-Disease 1 0.9837452173233032
patients O 1 0.9648584723472595
, O 0 0.006014680955559015
in O 0 0.004765881225466728
15 O 0 0.008790760301053524
families O 0 0.027091529220342636
, O 0 0.007393070496618748
who O 0 0.03009025938808918
developed O 1 0.9282193779945374
leukemia B-Disease 1 0.9984157085418701
, O 1 0.5050890445709229
lymphoma B-Disease 1 0.9977325201034546
, O 0 0.18362800776958466
preleukemic O 1 0.972708523273468
T O 1 0.9854310750961304
- O 1 0.9355255961418152
cell O 1 0.9780634641647339
proliferation O 1 0.9573789238929749
, O 0 0.1218893975019455
or O 1 0.6936327219009399
Hodgkin B-Disease 1 0.9979141354560852
lymphoma I-Disease 1 0.9970357418060303
, O 0 0.017936568707227707
mostly O 0 0.016210215166211128
in O 0 0.014525269158184528
childhood O 1 0.6206785440444946
. O 0 0.03452315926551819

A O 0 0.025586554780602455
wide O 0 0.02088550291955471
variety O 0 0.016119694337248802
of O 0 0.010560284368693829
ATM O 1 0.7768468260765076
mutation O 1 0.9830978512763977
types O 0 0.20379765331745148
, O 0 0.0078980578109622
including O 0 0.025053171440958977
missense O 1 0.9735569953918457
mutations O 1 0.9816328287124634
and O 0 0.0063267843797802925
in O 0 0.00719305919483304
- O 0 0.10414110124111176
frame O 0 0.05872458219528198
deletions O 0 0.29064542055130005
, O 0 0.003995305858552456
were O 0 0.0028933342546224594
seen O 0 0.00695332046598196
in O 0 0.006561041343957186
these O 0 0.014369815587997437
patients O 1 0.8974344730377197
. O 0 0.02442295476794243

We O 0 0.010216597467660904
also O 0 0.005752705968916416
show O 0 0.005475367419421673
that O 0 0.002942244755104184
25 O 0 0.004198546055704355
% O 0 0.004081158433109522
of O 0 0.0024884450249373913
all O 0 0.0031046560034155846
A B-Disease 0 0.045441605150699615
- I-Disease 1 0.6826648116111755
T I-Disease 1 0.9753722548484802
patients O 1 0.9272724986076355
carried O 0 0.012464958243072033
in O 0 0.0077592553570866585
- O 0 0.25130704045295715
frame O 0 0.26478293538093567
deletions O 1 0.8606089949607849
or O 0 0.12904991209506989
missense O 1 0.9762631058692932
mutations O 1 0.9444429874420166
, O 0 0.0039709643460810184
many O 0 0.00255509908311069
of O 0 0.0018543475307524204
which O 0 0.0020317789167165756
were O 0 0.001895784749649465
also O 0 0.0027509243227541447
associated O 0 0.00934172235429287
with O 0 0.004145487677305937
expression O 0 0.05630193278193474
of O 0 0.00824031326919794
mutant O 1 0.8703094124794006
ATM O 1 0.6651331186294556
protein O 1 0.7672389149665833
. O 0 0.02875140868127346

The O 0 0.047279324382543564
DMPK O 1 0.8425751328468323
gene O 1 0.942139208316803
of O 0 0.08727093040943146
severely O 1 0.9675871133804321
affected O 1 0.9789849519729614
myotonic B-Disease 1 0.9957648515701294
dystrophy I-Disease 1 0.997776448726654
patients O 1 0.9877365827560425
is O 0 0.058583274483680725
hypermethylated O 1 0.7236380577087402
proximal O 1 0.6775797605514526
to O 0 0.009783460758626461
the O 0 0.008979612961411476
largely O 0 0.018430257216095924
expanded O 0 0.029617153108119965
CTG O 1 0.616468071937561
repeat O 0 0.3029874861240387
. O 0 0.03423396870493889

Using O 0 0.05515152961015701
methylation O 1 0.6612140536308289
- O 0 0.20830480754375458
sensitive O 0 0.08629478514194489
restriction O 0 0.12712423503398895
enzymes O 0 0.36098533868789673
, O 0 0.005578481126576662
we O 0 0.0041045211255550385
characterized O 0 0.06368578970432281
the O 0 0.004867176990956068
methylation O 0 0.44161102175712585
pattern O 0 0.06814390420913696
on O 0 0.0030412462074309587
the O 0 0.0026507109869271517
5 O 0 0.003926219884306192
side O 0 0.003277616808190942
of O 0 0.0024604296777397394
the O 0 0.003795166267082095
CTG O 1 0.5806258320808411
repeat O 0 0.16782057285308838
in O 0 0.005474693141877651
the O 0 0.007302211131900549
DMPK O 1 0.8213700652122498
gene O 1 0.8679679036140442
of O 0 0.006952178198844194
normal O 0 0.1412559449672699
individuals O 0 0.05652576684951782
and O 0 0.006419830489903688
of O 0 0.025029022246599197
patients O 1 0.9913888573646545
affected O 1 0.8975709080696106
with O 0 0.4660007953643799
myotonic B-Disease 1 0.996709942817688
dystrophy I-Disease 1 0.9962043166160583
, O 0 0.013990337960422039
showing O 0 0.021257907152175903
expansions O 0 0.04736598581075668
of O 0 0.006697341334074736
the O 0 0.01057798694819212
repetitive O 1 0.8507218956947327
sequence O 0 0.2506350874900818
. O 0 0.030162710696458817

The O 0 0.03459237515926361
gene O 1 0.7503336071968079
segment O 0 0.043205976486206055
analyzed O 0 0.0255594402551651
corresponds O 0 0.01949097402393818
to O 0 0.007401948794722557
the O 0 0.01081247441470623
genomic O 1 0.8733198046684265
SacI O 1 0.824515700340271
- O 0 0.27683529257774353
HindIII O 0 0.4832518994808197
fragment O 0 0.19597411155700684
carrying O 0 0.024514053016901016
exons O 1 0.5919004678726196
11 O 0 0.028475185856223106
- O 0 0.12393522262573242
15 O 0 0.02494893968105316
. O 0 0.02266307920217514

There O 0 0.01835859939455986
is O 0 0.014955934137105942
constitutive O 0 0.24499428272247314
methylation O 0 0.3467853367328644
in O 0 0.011415648274123669
intron O 1 0.6241298317909241
12 O 0 0.009803159162402153
at O 0 0.005406625103205442
restriction O 0 0.014111070893704891
sites O 0 0.005830182693898678
of O 0 0.004186579491943121
SacII O 0 0.2277265191078186
and O 0 0.005279405042529106
HhaI O 0 0.3171095848083496
, O 0 0.0075244056060910225
localized O 1 0.517488420009613
1 O 0 0.008416367694735527
, O 0 0.005161728244274855
159 O 0 0.031135354191064835
- O 0 0.03755898028612137
1 O 0 0.005964780226349831
, O 0 0.0038129466120153666
232 O 0 0.015780672430992126
bp O 0 0.01788783259689808
upstream O 0 0.013073330745100975
of O 0 0.0036315929610282183
the O 0 0.004588062409311533
CTG O 1 0.6571820378303528
repeat O 0 0.21288390457630157
, O 0 0.004315842874348164
whereas O 0 0.010983710177242756
most O 0 0.002858661813661456
, O 0 0.0019193306798115373
if O 0 0.0018200029153376818
not O 0 0.0012166068190708756
all O 0 0.0011919826501980424
, O 0 0.0012569352984428406
of O 0 0.0012760680401697755
the O 0 0.0015888384077697992
other O 0 0.0017645192565396428
sites O 0 0.0036150820087641478
of O 0 0.003252465045079589
SacII O 0 0.3688184916973114
, O 0 0.005050278268754482
HhaI O 0 0.28468161821365356
, O 0 0.0039442358538508415
and O 0 0.0031126770190894604
HpaII O 0 0.09718260169029236
in O 0 0.0036700288765132427
this O 0 0.0028057924937456846
region O 0 0.005976141896098852
are O 0 0.003342975163832307
unmethylated O 0 0.3483034372329712
, O 0 0.0036736505571752787
in O 0 0.003727841656655073
normal O 0 0.05636337026953697
individuals O 0 0.010510810650885105
and O 0 0.0027520430739969015
most O 0 0.003398112254217267
of O 0 0.004320776090025902
the O 0 0.010929092764854431
patients O 1 0.9444459080696106
. O 0 0.0382508859038353

In O 0 0.015435301698744297
a O 0 0.009831150993704796
number O 0 0.006416594609618187
of O 0 0.00499039376154542
young O 0 0.03608408942818642
and O 0 0.015675077214837074
severely O 1 0.8920882940292358
affected O 1 0.8122511506080627
patients O 1 0.9409145712852478
, O 0 0.005159921478480101
however O 0 0.004027631599456072
, O 0 0.003014405956491828
complete O 0 0.00770746823400259
methylation O 0 0.12272288650274277
of O 0 0.0026995695661753416
these O 0 0.003397369524464011
restriction O 0 0.013568446040153503
sites O 0 0.005518990568816662
was O 0 0.00413808086887002
found O 0 0.005918451119214296
in O 0 0.006552614271640778
the O 0 0.014967628754675388
mutated O 1 0.9727527499198914
allele O 1 0.9569756984710693
. O 0 0.054920703172683716

In O 0 0.01590265892446041
most O 0 0.007640691474080086
of O 0 0.005615550093352795
these O 0 0.009357821196317673
patients O 1 0.847891092300415
, O 0 0.006238018628209829
the O 0 0.008838769979774952
onset O 1 0.9721234440803528
of O 0 0.016242697834968567
the O 0 0.14969436824321747
disease O 1 0.9948628544807434
was O 0 0.2660800516605377
congenital O 1 0.9933187961578369
. O 0 0.09936036169528961

Preliminary O 0 0.049559906125068665
in O 0 0.023417653515934944
vivo O 1 0.7690041661262512
footprinting O 1 0.8091952800750732
data O 0 0.01391502097249031
gave O 0 0.01043477188795805
evidence O 0 0.008878229185938835
for O 0 0.009408125653862953
protein O 1 0.8950618505477905
- O 1 0.6100855469703674
DNA O 1 0.7713183164596558
contact O 0 0.09488426148891449
in O 0 0.007059758994728327
normal O 0 0.21675816178321838
genes O 1 0.780474066734314
at O 0 0.0073355198837816715
an O 0 0.008212621323764324
Sp1 O 1 0.7958358526229858
consensus O 0 0.012980597093701363
binding O 0 0.02456795424222946
site O 0 0.006293396465480328
upstream O 0 0.0111488476395607
of O 0 0.0034756301902234554
the O 0 0.004196571186184883
CTG O 0 0.34999313950538635
repeat O 0 0.04451939836144447
and O 0 0.0028869034722447395
for O 0 0.0027317488566040993
a O 0 0.0036860627587884665
significant O 0 0.006695216055959463
reduction O 0 0.021037757396697998
of O 0 0.0032294916454702616
this O 0 0.0035415207967162132
interaction O 0 0.051156241446733475
in O 0 0.0071577103808522224
cells O 1 0.7208573222160339
with O 0 0.009426186792552471
a O 0 0.028983836993575096
hypermethylated O 1 0.8556879162788391
DMPK O 1 0.9117938280105591
gene O 1 0.9421001672744751
. O 0 0.02241084724664688
. O 0 0.024201268330216408

The O 0 0.07133776694536209
hemochromatosis B-Disease 1 0.978476345539093
gene O 1 0.9192392826080322
product O 0 0.07038462162017822
complexes O 0 0.10123136639595032
with O 0 0.009242042899131775
the O 0 0.009908867999911308
transferrin O 1 0.819028913974762
receptor O 1 0.8049237728118896
and O 0 0.00960497371852398
lowers O 0 0.41094234585762024
its O 0 0.009770811535418034
affinity O 0 0.14309073984622955
for O 0 0.012472139671444893
ligand O 0 0.32465556263923645
binding O 0 0.14209192991256714
. O 0 0.025203265249729156

We O 0 0.017494814470410347
recently O 0 0.0188071820884943
reported O 0 0.014033455401659012
the O 0 0.007705350406467915
positional O 0 0.10333031415939331
cloning O 0 0.20056910812854767
of O 0 0.006764568388462067
a O 0 0.01058958563953638
candidate O 0 0.10097809880971909
gene O 1 0.9592876434326172
for O 0 0.08149013668298721
hereditary B-Disease 1 0.9869747161865234
hemochromatosis I-Disease 1 0.9900310039520264
called O 0 0.4589747488498688
HFE O 1 0.9503759145736694
. O 0 0.06521864980459213

The O 0 0.025754760950803757
gene O 1 0.5723589658737183
product O 0 0.018834689632058144
, O 0 0.0069352807477116585
a O 0 0.005670050624758005
member O 0 0.0046936809085309505
of O 0 0.0030415342189371586
the O 0 0.004300531465560198
major O 0 0.024447431787848473
histocompatibility O 1 0.9547678828239441
complex O 0 0.07214716076850891
class O 0 0.031063038855791092
I O 0 0.008169515058398247
- O 0 0.04342670738697052
like O 0 0.007652769330888987
family O 0 0.012914344668388367
, O 0 0.0029478254728019238
was O 0 0.0023066436406224966
found O 0 0.003220059210434556
to O 0 0.0023308207746595144
have O 0 0.003342404728755355
a O 0 0.012239983305335045
mutation O 1 0.9852008819580078
, O 0 0.02494126372039318
Cys O 1 0.9533923864364624
- O 1 0.5745545029640198
282 O 1 0.6837348937988281
- O 1 0.7531533241271973
- O 1 0.8425002098083496
> O 1 0.9568920731544495
Tyr O 1 0.9500216841697693
( O 0 0.11497694253921509
C282Y O 1 0.5119814872741699
) O 0 0.011130271479487419
, O 0 0.004102295730262995
in O 0 0.004305103328078985
85 O 0 0.014081205241382122
% O 0 0.016776520758867264
of O 0 0.014140729792416096
patient O 1 0.9301486611366272
chromosomes O 1 0.8265508413314819
. O 0 0.032779760658741

This O 0 0.026202328503131866
mutation O 1 0.9219314455986023
eliminates O 0 0.13359619677066803
the O 0 0.008367358706891537
ability O 0 0.016363443806767464
of O 0 0.007044320460408926
HFE O 1 0.8503825664520264
to O 0 0.006792678497731686
associate O 0 0.02506255730986595
with O 0 0.013463259674608707
beta2 O 1 0.6973438262939453
- O 1 0.5227530002593994
microglobulin O 1 0.8306581377983093
( O 0 0.12213888764381409
beta2m O 1 0.5984175801277161
) O 0 0.027943046763539314
and O 0 0.011290435679256916
prevents O 1 0.7934622168540955
cell O 1 0.7834408283233643
- O 0 0.2713150978088379
surface O 0 0.09147681295871735
expression O 0 0.2853466272354126
. O 0 0.027180777862668037

A O 0 0.027611667290329933
second O 0 0.019716989248991013
mutation O 1 0.8161287307739258
that O 0 0.004695211071521044
has O 0 0.004088933579623699
no O 0 0.004056589212268591
effect O 0 0.011536607518792152
on O 0 0.003937561064958572
beta2m O 0 0.3420524597167969
association O 0 0.02213495597243309
, O 0 0.004131615161895752
H63D O 0 0.13067814707756042
, O 0 0.0031085603404790163
was O 0 0.0024477317929267883
found O 0 0.0029822150245308876
in O 0 0.0021140079479664564
eight O 0 0.0030927923507988453
out O 0 0.0027324450202286243
of O 0 0.003324095392599702
nine O 0 0.021490205079317093
patients O 1 0.9627151489257812
heterozygous O 1 0.8198185563087463
for O 0 0.00897680502384901
the O 0 0.011290756054222584
C282Y O 1 0.5811141133308411
mutant O 1 0.8245623111724854
. O 0 0.04156799241900444

In O 0 0.015782058238983154
this O 0 0.006541830021888018
report O 0 0.007089074235409498
, O 0 0.0037996377795934677
we O 0 0.003607510356232524
demonstrate O 0 0.008979643695056438
in O 0 0.007966078817844391
cultured O 1 0.671114444732666
293 O 1 0.8285854458808899
cells O 1 0.9801160097122192
overexpressing O 1 0.9770228862762451
wild O 1 0.5791083574295044
- O 1 0.6213899850845337
type O 1 0.5593241453170776
or O 0 0.08259148895740509
mutant O 1 0.9522342681884766
HFE O 1 0.9752495288848877
proteins O 0 0.44489574432373047
that O 0 0.005002716090530157
both O 0 0.004883319605141878
the O 0 0.004652389325201511
wild O 0 0.13358162343502045
- O 0 0.3390498459339142
type O 0 0.35347485542297363
and O 0 0.01423129253089428
H63D O 1 0.9345831274986267
HFE O 1 0.9808470606803894
proteins O 1 0.8599650263786316
form O 0 0.20634254813194275
stable O 0 0.3191507160663605
complexes O 0 0.22062234580516815
with O 0 0.009273018687963486
the O 0 0.014868642203509808
transferrin O 1 0.9485674500465393
receptor O 1 0.9706118702888489
( O 0 0.25958505272865295
TfR O 1 0.9456285834312439
) O 0 0.04321518540382385
. O 0 0.025235924869775772

The O 0 0.034210171550512314
C282Y O 1 0.6339561343193054
mutation O 1 0.914008378982544
nearly O 0 0.022067347541451454
completely O 0 0.022687718272209167
prevents O 0 0.10837395489215851
the O 0 0.005409952253103256
association O 0 0.009591580368578434
of O 0 0.005253346636891365
the O 0 0.00877742376178503
mutant O 1 0.8658658862113953
HFE O 1 0.9615732431411743
protein O 1 0.6303337812423706
with O 0 0.016972733661532402
the O 0 0.01642659865319729
TfR O 1 0.8801398873329163
. O 0 0.03617558628320694

Studies O 0 0.05156490579247475
on O 0 0.01654365286231041
cell O 1 0.5327877402305603
- O 0 0.20346111059188843
associated O 0 0.07527873665094376
transferrin O 0 0.38426801562309265
at O 0 0.009523745626211166
37 O 0 0.015343230217695236
degrees O 0 0.016648443415760994
C O 0 0.09289645403623581
suggest O 0 0.011863889172673225
that O 0 0.004623429384082556
the O 0 0.007848920300602913
overexpressed O 1 0.92171710729599
wild O 0 0.3826771080493927
- O 1 0.6853281855583191
type O 1 0.7895312309265137
HFE O 1 0.9800170660018921
protein O 1 0.8018873929977417
decreases O 0 0.1912774294614792
the O 0 0.007791196461766958
affinity O 0 0.0651155561208725
of O 0 0.007630971726030111
the O 0 0.01008841022849083
TfR O 1 0.7983618974685669
for O 0 0.019821137189865112
transferrin O 1 0.690742015838623
. O 0 0.034810375422239304

The O 0 0.03720344975590706
overexpressed O 1 0.9046139121055603
H63D O 1 0.688653826713562
protein O 0 0.3169788718223572
does O 0 0.008210818283259869
not O 0 0.0031535474117845297
have O 0 0.0026326405350118876
this O 0 0.0025382903404533863
effect O 0 0.008487578481435776
, O 0 0.0021169986575841904
providing O 0 0.003629086771979928
the O 0 0.001715981401503086
first O 0 0.002217691158875823
direct O 0 0.004920669831335545
evidence O 0 0.00400901585817337
for O 0 0.0028432297986000776
a O 0 0.005367189180105925
functional O 0 0.09184599667787552
consequence O 0 0.04988187924027443
of O 0 0.006117134355008602
the O 0 0.012838087975978851
H63D O 1 0.8983578681945801
mutation O 1 0.9761739373207092
. O 0 0.04713677242398262

Addition O 0 0.03620767220854759
of O 0 0.020338451489806175
soluble O 1 0.7508764266967773
wild O 0 0.3536492884159088
- O 1 0.6970922350883484
type O 1 0.8339307904243469
HFE O 1 0.9790946841239929
/ O 1 0.8666253685951233
beta2m O 1 0.8375381827354431
heterodimers O 1 0.8737053871154785
to O 0 0.01334605272859335
cultured O 1 0.7570520639419556
cells O 1 0.8054097294807434
also O 0 0.005807378329336643
decreased O 0 0.06637564301490784
the O 0 0.004797072149813175
apparent O 0 0.054582126438617706
affinity O 0 0.05749896541237831
of O 0 0.0038409270346164703
the O 0 0.00478246109560132
TfR O 1 0.6167294383049011
for O 0 0.004144652746617794
its O 0 0.004512306302785873
ligand O 0 0.15066257119178772
under O 0 0.005227941088378429
steady O 0 0.04098697379231453
- O 0 0.06165384501218796
state O 0 0.004680180922150612
conditions O 0 0.017316510900855064
, O 0 0.004017058294266462
both O 0 0.004559709224849939
in O 0 0.006484375800937414
293 O 0 0.47311103343963623
cells O 1 0.8824387788772583
and O 0 0.010475024580955505
in O 0 0.02447212114930153
HeLa O 1 0.9602357745170593
cells O 1 0.9329186081886292
. O 0 0.049240753054618835

Furthermore O 0 0.045438580214977264
, O 0 0.012374077923595905
at O 0 0.008326775394380093
4 O 0 0.009231364354491234
degrees O 0 0.011380878277122974
C O 0 0.02567669376730919
, O 0 0.003957162145525217
the O 0 0.0035665598697960377
added O 0 0.007727187126874924
soluble O 0 0.3524414896965027
complex O 0 0.028262222185730934
of O 0 0.015651963651180267
HFE O 1 0.9762726426124573
/ O 1 0.789236843585968
beta2m O 1 0.7644913792610168
inhibited O 1 0.6505209803581238
binding O 0 0.054836455732584
of O 0 0.01011949684470892
transferrin O 1 0.6672137975692749
to O 0 0.018469175323843956
HeLa O 1 0.9692642688751221
cell O 1 0.894341230392456
TfR O 1 0.8035301566123962
in O 0 0.009533483535051346
a O 0 0.013705351389944553
concentration O 0 0.19495917856693268
- O 0 0.2350936084985733
dependent O 0 0.17852015793323517
manner O 0 0.0654766634106636
. O 0 0.024765998125076294

Scatchard O 0 0.10384416580200195
plots O 0 0.027599060907959938
of O 0 0.006796211935579777
these O 0 0.005555071868002415
data O 0 0.00516005652025342
indicate O 0 0.00609037047252059
that O 0 0.0026950647588819265
the O 0 0.003778609214350581
added O 0 0.006907696835696697
heterodimer O 1 0.5396899580955505
substantially O 0 0.07569868862628937
reduced O 0 0.020074985921382904
the O 0 0.005332425702363253
affinity O 0 0.09907352179288864
of O 0 0.010174501687288284
TfR O 1 0.8644086718559265
for O 0 0.020624777302145958
transferrin O 1 0.7611932158470154
. O 0 0.03415435180068016

These O 0 0.016358964145183563
results O 0 0.018847743049263954
establish O 0 0.016417978331446648
a O 0 0.011820336803793907
molecular O 0 0.43048012256622314
link O 0 0.1234365925192833
between O 0 0.016500119119882584
HFE O 1 0.79495769739151
and O 0 0.0046709077432751656
a O 0 0.005937356036156416
key O 0 0.011586194857954979
protein O 0 0.36527448892593384
involved O 0 0.009778693318367004
in O 0 0.003901857417076826
iron O 0 0.025644320994615555
transport O 0 0.008737926371395588
, O 0 0.002972860587760806
the O 0 0.00347427767701447
TfR O 1 0.568111002445221
, O 0 0.0031247560400515795
and O 0 0.0022068405523896217
raise O 0 0.0053040580824017525
the O 0 0.002624145243316889
possibility O 0 0.009618395939469337
that O 0 0.0027770567685365677
alterations O 0 0.05487198755145073
in O 0 0.0029818094335496426
this O 0 0.003366140415892005
regulatory O 0 0.20658352971076965
mechanism O 0 0.1347641497850418
may O 0 0.00743399653583765
play O 0 0.003576956456527114
a O 0 0.004006659146398306
role O 0 0.007333493325859308
in O 0 0.00444154255092144
the O 0 0.008510855957865715
pathogenesis O 1 0.9722210168838501
of O 0 0.07700177282094955
hereditary B-Disease 1 0.9893201589584351
hemochromatosis I-Disease 1 0.990715742111206
. O 0 0.04690360277891159
. O 0 0.03393147513270378

Genomic O 1 0.5552012324333191
organization O 0 0.03333413228392601
of O 0 0.014330131001770496
the O 0 0.019459174945950508
UBE3A O 1 0.9606618881225586
/ O 1 0.883438766002655
E6 O 1 0.8855164647102356
- O 1 0.6598972082138062
AP O 0 0.4281198978424072
gene O 1 0.8804500699043274
and O 0 0.016016075387597084
related O 0 0.2089971899986267
pseudogenes O 1 0.7906396985054016
. O 0 0.03260723128914833

The O 0 0.04406604915857315
UBE3A O 1 0.909182608127594
gene O 1 0.8877049684524536
encodes O 0 0.2950271666049957
the O 0 0.017284659668803215
E6 O 1 0.6977584362030029
- O 1 0.5588750839233398
AP O 0 0.39053159952163696
ubiquitin O 1 0.7996364235877991
- O 0 0.45848360657691956
protein O 1 0.7395807504653931
ligase O 0 0.12257250398397446
and O 0 0.004276362247765064
has O 0 0.003998585976660252
recently O 0 0.006530668120831251
been O 0 0.0037724501453340054
shown O 0 0.006366270128637552
to O 0 0.004722616635262966
be O 0 0.01996552385389805
mutated O 1 0.9913961291313171
in O 1 0.8265776634216309
Angelman B-Disease 1 0.9985639452934265
syndrome I-Disease 1 0.9991382360458374
patients O 1 0.9905531406402588
who O 0 0.06336076557636261
lack O 0 0.38372352719306946
15q11 O 1 0.8613584637641907
- O 1 0.6568778157234192
q13 O 1 0.8577142953872681
deletions O 1 0.9051299691200256
or O 0 0.23666717112064362
chromosome O 1 0.9702126383781433
15 O 0 0.09640559554100037
paternal O 1 0.8367855548858643
uniparental B-Disease 1 0.9437084197998047
disomy I-Disease 1 0.695450484752655
. O 0 0.05501198023557663

Previous O 0 0.06440941989421844
UBE3A O 1 0.7818575501441956
cDNA O 0 0.21163053810596466
analysis O 0 0.030291428789496422
has O 0 0.011015222407877445
shown O 0 0.011292901821434498
a O 0 0.009160628542304039
coding O 0 0.27063608169555664
region O 0 0.011378335766494274
of O 0 0.00557680381461978
approximately O 0 0.012206891551613808
2 O 0 0.016340434551239014
. O 0 0.01965351402759552

6 O 0 0.04559015482664108
kb O 0 0.05755138024687767
and O 0 0.011939449235796928
a O 0 0.013014866039156914
3 O 0 0.018260294571518898
- O 0 0.19583408534526825
untranslated O 1 0.5756099820137024
region O 0 0.04065973684191704
( O 0 0.026654189452528954
UTR O 0 0.42965373396873474
) O 0 0.009693222120404243
of O 0 0.00543553801253438
< O 0 0.17665031552314758
50 O 0 0.0077075413428246975
bp O 0 0.02191568724811077
, O 0 0.004268977791070938
whereas O 0 0.011302175000309944
Northern O 0 0.005996799096465111
analysis O 0 0.008560762740671635
has O 0 0.003855237504467368
indicated O 0 0.009879239834845066
mRNA O 0 0.07651650160551071
sizes O 0 0.012432598508894444
of O 0 0.005321369040757418
5 O 0 0.011382830329239368
- O 0 0.06557537615299225
8 O 0 0.020068159326910973
kb O 0 0.2994641661643982
. O 0 0.02330038696527481

We O 0 0.014964381232857704
have O 0 0.009620903991162777
analyzed O 0 0.019624486565589905
additional O 0 0.011597848497331142
cDNA O 0 0.2388303577899933
clones O 0 0.2700129449367523
and O 0 0.005138986743986607
provide O 0 0.005880909971892834
evidence O 0 0.004937118384987116
for O 0 0.00400967663154006
an O 0 0.00539158983156085
additional O 0 0.011956804431974888
0 O 0 0.023503048345446587
. O 0 0.018036799505352974

5 O 0 0.04408740624785423
kb O 0 0.06580760329961777
of O 0 0.013483273796737194
5 O 0 0.022419221699237823
- O 0 0.14376674592494965
UTR O 1 0.5423324108123779
and O 0 0.0101541168987751
> O 0 0.28663602471351624
2 O 0 0.011316859163343906
kb O 0 0.04715201258659363
of O 0 0.009884082712233067
3 O 0 0.02174726314842701
- O 0 0.1562858670949936
UTR O 1 0.5521769523620605
. O 0 0.03640952333807945

We O 0 0.01392380241304636
have O 0 0.00667143939062953
established O 0 0.007577137090265751
the O 0 0.006477480288594961
genomic O 0 0.46138790249824524
organization O 0 0.010309112258255482
of O 0 0.00574469892308116
UBE3A O 1 0.5421465039253235
and O 0 0.004833165556192398
the O 0 0.005680229514837265
sequence O 0 0.04965760186314583
of O 0 0.012099319137632847
intron O 1 0.952267587184906
- O 0 0.4753991365432739
exon O 1 0.7155433297157288
borders O 0 0.09817516058683395
. O 0 0.03352605178952217

We O 0 0.011793315410614014
have O 0 0.00615371810272336
also O 0 0.005034818779677153
mapped O 0 0.010032241232693195
two O 0 0.005261031910777092
highly O 0 0.03883356228470802
homologous O 1 0.8369504809379578
processed O 0 0.12133393436670303
pseudogenes O 1 0.803997278213501
, O 0 0.007625889033079147
UBE3AP1 O 0 0.24644921720027924
and O 0 0.005474973004311323
UBE3AP2 O 0 0.22019468247890472
, O 0 0.003919877111911774
to O 0 0.003496661316603422
chromosomes O 0 0.3242388069629669
2 O 0 0.005716890562325716
and O 0 0.0027280827052891254
21 O 0 0.004327571485191584
, O 0 0.0024015195667743683
respectively O 0 0.0038890959694981575
, O 0 0.0024469434283673763
and O 0 0.0026771696284413338
determined O 0 0.007546877022832632
their O 0 0.0067494637332856655
genomic O 1 0.7481482028961182
organization O 0 0.028640873730182648
. O 0 0.018413782119750977

These O 0 0.013552570715546608
results O 0 0.01325184665620327
will O 0 0.0049423943273723125
form O 0 0.006117418874055147
the O 0 0.0029404181987047195
basis O 0 0.004462120588868856
for O 0 0.004223546478897333
studies O 0 0.032104384154081345
of O 0 0.008105951361358166
mutation O 1 0.9585040807723999
and O 0 0.013042962178587914
imprinting O 1 0.8439021110534668
of O 0 0.022855354472994804
UBE3A O 1 0.9238731861114502
. O 0 0.04063740745186806

Mutation O 1 0.9466149210929871
spectrum O 0 0.3284776508808136
and O 0 0.05298403277993202
genotype O 1 0.9735706448554993
- O 1 0.8983445167541504
phenotype O 1 0.9864153265953064
analyses O 1 0.6665636897087097
in O 0 0.3076827824115753
Cowden B-Disease 1 0.9915054440498352
disease I-Disease 1 0.9946739673614502
and O 0 0.14219707250595093
Bannayan B-Disease 1 0.9719522595405579
- I-Disease 1 0.9764407277107239
Zonana I-Disease 1 0.9887486696243286
syndrome I-Disease 1 0.9945507645606995
, O 0 0.06608496606349945
two O 0 0.18074800074100494
hamartoma B-Disease 1 0.9874881505966187
syndromes I-Disease 1 0.9915959239006042
with O 1 0.5296544432640076
germline O 1 0.9850385785102844
PTEN O 1 0.9791749119758606
mutation O 1 0.9757561683654785
. O 0 0.09121950715780258

The O 0 0.2681976556777954
tumour B-Disease 1 0.9882622361183167
suppressor O 1 0.98263019323349
gene O 1 0.981408417224884
PTEN O 1 0.9366353154182434
, O 0 0.013056379742920399
which O 0 0.008358540013432503
maps O 0 0.013402455486357212
to O 0 0.011529888026416302
10q23 O 0 0.17723920941352844
. O 0 0.027059193700551987

3 O 0 0.03330574184656143
and O 0 0.01212900411337614
encodes O 0 0.059261005371809006
a O 0 0.01522535365074873
403 O 0 0.14377133548259735
amino O 1 0.5600353479385376
acid O 1 0.8503031730651855
dual O 0 0.3894864618778229
specificity O 1 0.831678569316864
phosphatase O 1 0.9777082800865173
( O 0 0.32465860247612
protein O 1 0.9488722085952759
tyrosine O 1 0.9534772634506226
phosphatase O 1 0.9701674580574036
; O 0 0.07250130921602249
PTPase O 0 0.4259447157382965
) O 0 0.009111463092267513
, O 0 0.0037122543435543776
was O 0 0.003587334882467985
shown O 0 0.005495887249708176
recently O 0 0.005140542518347502
to O 0 0.002969923662021756
play O 0 0.004177656956017017
a O 0 0.005780569277703762
broad O 0 0.028451133519411087
role O 0 0.02168477512896061
in O 0 0.013040376827120781
human O 0 0.36148321628570557
malignancy B-Disease 1 0.974532961845398
. O 0 0.05594896152615547

Somatic O 1 0.9345431327819824
PTEN O 1 0.9441589713096619
deletions O 1 0.7384685277938843
and O 0 0.02388584241271019
mutations O 1 0.9076940417289734
were O 0 0.010217557661235332
observed O 0 0.14290985465049744
in O 0 0.050036750733852386
sporadic B-Disease 1 0.9541121125221252
breast I-Disease 1 0.9963556528091431
, I-Disease 0 0.351004958152771
brain I-Disease 1 0.9945830702781677
, I-Disease 1 0.5984565019607544
prostate I-Disease 1 0.9982648491859436
and I-Disease 1 0.7349188923835754
kidney I-Disease 1 0.9987905621528625
cancer I-Disease 1 0.9980406165122986
cell O 1 0.9273974895477295
lines O 0 0.05893945321440697
and O 0 0.005443865898996592
in O 0 0.005787410773336887
several O 0 0.009967694990336895
primary O 0 0.3433307111263275
tumours B-Disease 1 0.9906408190727234
such O 0 0.17515482008457184
as O 0 0.41396626830101013
endometrial B-Disease 1 0.9970736503601074
carcinomas I-Disease 1 0.9966944456100464
, O 1 0.8905835747718811
malignant B-Disease 1 0.9978334307670593
melanoma I-Disease 1 0.9972937703132629
and O 1 0.7426092624664307
thyroid B-Disease 1 0.9947130084037781
tumours I-Disease 1 0.9835494756698608
. O 0 0.159925177693367

In O 0 0.020221760496497154
addition O 0 0.019043631851673126
, O 0 0.011027025058865547
PTEN O 1 0.6897793412208557
was O 0 0.007399406284093857
identified O 0 0.014718280173838139
as O 0 0.005780040752142668
the O 0 0.015143650583922863
susceptibility O 1 0.9869948029518127
gene O 1 0.9718985557556152
for O 0 0.04073631763458252
two O 0 0.39779239892959595
hamartoma B-Disease 1 0.9961562752723694
syndromes I-Disease 1 0.9984694123268127
Cowden B-Disease 1 0.9962530136108398
disease I-Disease 1 0.9959506988525391
( O 0 0.3266206979751587
CD B-Disease 0 0.19858725368976593
; O 0 0.10343636572360992
MIM O 1 0.8909255862236023
158350 O 1 0.635421097278595
) O 0 0.021468250080943108
and O 0 0.010814417153596878
Bannayan B-Disease 1 0.7904996871948242
- I-Disease 1 0.6763409376144409
Zonana I-Disease 1 0.9613284468650818
( I-Disease 0 0.2231452763080597
BZS I-Disease 1 0.9340333938598633
) I-Disease 0 0.08626881241798401
or I-Disease 0 0.11721009761095047
Ruvalcaba I-Disease 1 0.9707185626029968
- I-Disease 1 0.8355962038040161
Riley I-Disease 1 0.8774511218070984
- I-Disease 1 0.9410319328308105
Smith I-Disease 1 0.9250869750976562
syndrome I-Disease 1 0.9964883327484131
( O 0 0.48163092136383057
MIM O 1 0.9455098509788513
153480 O 1 0.7275211215019226
) O 0 0.03974118083715439
. O 0 0.023585179820656776

Constitutive O 0 0.42839470505714417
DNA O 0 0.15534380078315735
from O 0 0.01599782519042492
37 O 0 0.017862318083643913
CD B-Disease 0 0.01609785109758377
families O 0 0.010429552756249905
and O 0 0.004795180633664131
seven O 0 0.008510526269674301
BZS B-Disease 1 0.5266528725624084
families O 0 0.020289484411478043
was O 0 0.008643490262329578
screened O 0 0.08760254085063934
for O 0 0.03599357232451439
germline O 1 0.9786534309387207
PTEN O 1 0.9770673513412476
mutations O 1 0.9716988205909729
. O 0 0.06303498148918152

PTEN O 1 0.9329138398170471
mutations O 1 0.8358412384986877
were O 0 0.012109486386179924
identified O 0 0.014773991890251637
in O 0 0.0051645985804498196
30 O 0 0.005715072154998779
of O 0 0.0034851424861699343
37 O 0 0.010248474776744843
( O 0 0.010163180530071259
81 O 0 0.019767504185438156
% O 0 0.01393206138163805
) O 0 0.007920343428850174
CD B-Disease 0 0.01051140483468771
families O 0 0.008143140003085136
, O 0 0.0033577459398657084
including O 0 0.006341828964650631
missense O 1 0.7482261061668396
and O 0 0.00528174452483654
nonsense O 0 0.07113240659236908
point O 0 0.016134625300765038
mutations O 1 0.9776565432548523
, O 0 0.01059726346284151
deletions O 1 0.5480592250823975
, O 0 0.0065063899382948875
insertions O 0 0.32599204778671265
, O 0 0.007209914270788431
a O 0 0.014612717553973198
deletion O 1 0.9306604266166687
/ O 1 0.6923718452453613
insertion O 1 0.5422899127006531
and O 0 0.013710289262235165
splice O 1 0.785874605178833
site O 0 0.08727336674928665
mutations O 1 0.9482187628746033
. O 0 0.03876020759344101

These O 0 0.021186817437410355
mutations O 0 0.4983066916465759
were O 0 0.006587898824363947
scattered O 0 0.008274633437395096
over O 0 0.003771149320527911
the O 0 0.0034437335561960936
entire O 0 0.0068565295077860355
length O 0 0.016527850180864334
of O 0 0.005406299605965614
PTEN O 1 0.8970884084701538
, O 0 0.0036974770482629538
with O 0 0.0025007924996316433
the O 0 0.002071461407467723
exception O 0 0.0034693635534495115
of O 0 0.001986387185752392
the O 0 0.002134738489985466
first O 0 0.002784654963761568
, O 0 0.0030524444300681353
fourth O 0 0.005731354933232069
and O 0 0.004542431328445673
last O 0 0.012213578447699547
exons O 1 0.5302468538284302
. O 0 0.0274962205439806

A O 0 0.028338931500911713
hot O 0 0.030103106051683426
spot O 0 0.021749475970864296
for O 0 0.01604294776916504
PTEN O 1 0.970454752445221
mutation O 1 0.9619961380958557
in O 0 0.00923985056579113
CD B-Disease 0 0.01576836034655571
was O 0 0.0046341149136424065
identified O 0 0.007276087533682585
in O 0 0.004885368049144745
exon O 0 0.1370653361082077
5 O 0 0.005684626288712025
that O 0 0.0030130224768072367
contains O 0 0.0038672336377203465
the O 0 0.003154952544718981
PTPase O 0 0.15322376787662506
core O 0 0.01784469187259674
motif O 0 0.1472073197364807
, O 0 0.003218117170035839
with O 0 0.003076285356655717
13 O 0 0.003980523440986872
of O 0 0.002806388773024082
30 O 0 0.007367613725364208
( O 0 0.009342874400317669
43 O 0 0.012219236232340336
% O 0 0.02320558950304985
) O 0 0.016835154965519905
CD B-Disease 0 0.08856198936700821
mutations O 1 0.9659621119499207
identified O 0 0.025275850668549538
in O 0 0.0064584300853312016
this O 0 0.009083797223865986
exon O 0 0.3883458375930786
. O 0 0.025227094069123268

Seven O 0 0.017369655892252922
of O 0 0.007939849980175495
30 O 0 0.009986860677599907
( O 0 0.009347621351480484
23 O 0 0.0064779529348015785
% O 0 0.00589295057579875
) O 0 0.0035553814377635717
were O 0 0.001492391573265195
within O 0 0.0022441211622208357
the O 0 0.001996442908421159
core O 0 0.00619436614215374
motif O 0 0.08228051662445068
, O 0 0.0023689845111221075
the O 0 0.002092209178954363
majority O 0 0.005424586124718189
( O 0 0.003671462181955576
five O 0 0.002363040577620268
of O 0 0.0019085040548816323
seven O 0 0.0026557608507573605
) O 0 0.0032001552172005177
of O 0 0.0021817570086568594
which O 0 0.002642047358676791
were O 0 0.00392098119482398
missense O 1 0.9331679940223694
mutations O 1 0.9727888107299805
, O 0 0.004659340716898441
possibly O 0 0.010015962645411491
pointing O 0 0.0060003637336194515
to O 0 0.002332105301320553
the O 0 0.0031329947523772717
functional O 0 0.02175319753587246
significance O 0 0.008202149532735348
of O 0 0.004948671441525221
this O 0 0.006245264783501625
region O 0 0.019293053075671196
. O 0 0.016321774572134018

Germline O 1 0.963912308216095
PTEN O 1 0.9536184668540955
mutations O 1 0.8311117887496948
were O 0 0.009419768117368221
identified O 0 0.010919684544205666
in O 0 0.003941831178963184
four O 0 0.0034333416260778904
of O 0 0.0030126397032290697
seven O 0 0.006837521679699421
( O 0 0.014490887522697449
57 O 0 0.021764423698186874
% O 0 0.026844816282391548
) O 0 0.01891464553773403
BZS B-Disease 0 0.41709640622138977
families O 0 0.03651532158255577
studied O 0 0.033685870468616486
. O 0 0.024335520341992378

Interestingly O 0 0.06330572068691254
, O 0 0.011813349090516567
none O 0 0.010332618840038776
of O 0 0.005465751048177481
these O 0 0.00771115580573678
mutations O 1 0.9214903712272644
was O 0 0.005839354358613491
observed O 0 0.01368488185107708
in O 0 0.0050882636569440365
the O 0 0.007955729961395264
PTPase O 0 0.38889992237091064
core O 0 0.0759648010134697
motif O 0 0.44670653343200684
. O 0 0.030596710741519928

It O 0 0.012644579634070396
is O 0 0.007132292725145817
also O 0 0.004839563742280006
worthy O 0 0.008426740765571594
of O 0 0.003307613544166088
note O 0 0.005896784830838442
that O 0 0.0026315038558095694
a O 0 0.004308534786105156
single O 0 0.00892434362322092
nonsense O 0 0.06702382117509842
point O 0 0.015293975360691547
mutation O 1 0.9758018851280212
, O 0 0.007525606080889702
R233X O 0 0.22286510467529297
, O 0 0.0046488442458212376
was O 0 0.003680763766169548
observed O 0 0.007871566340327263
in O 0 0.00370337488129735
the O 0 0.005857235752046108
germline O 1 0.9688133597373962
DNA O 0 0.3992207646369934
from O 0 0.005848160479217768
two O 0 0.00540875643491745
unrelated O 0 0.1979931741952896
CD B-Disease 0 0.02195712924003601
families O 0 0.011191663332283497
and O 0 0.005218591075390577
one O 0 0.009847237728536129
BZS B-Disease 1 0.7010942697525024
family O 0 0.06066719815135002
. O 0 0.024275487288832664

Genotype O 1 0.9596477150917053
- O 1 0.8141148090362549
phenotype O 1 0.9613146185874939
studies O 0 0.022399257868528366
were O 0 0.004136921837925911
not O 0 0.0032629785127937794
performed O 0 0.00452388497069478
on O 0 0.0026506201829761267
this O 0 0.0032370768021792173
small O 0 0.005952022969722748
group O 0 0.009270325303077698
of O 0 0.01049731858074665
BZS B-Disease 1 0.7270923852920532
families O 0 0.06332781165838242
. O 0 0.0262419655919075

However O 0 0.03725098446011543
, O 0 0.030106239020824432
genotype O 1 0.9537451267242432
- O 1 0.7232632040977478
phenotype O 1 0.9808592200279236
analysis O 0 0.10824426263570786
inthe O 0 0.4152258634567261
group O 0 0.009946444071829319
of O 0 0.004527390003204346
CD B-Disease 0 0.016044272109866142
families O 0 0.009924369864165783
revealed O 0 0.00899094995111227
two O 0 0.0036600343883037567
possible O 0 0.006954190321266651
associations O 0 0.010693032294511795
worthy O 0 0.011040033772587776
of O 0 0.0037094370927661657
follow O 0 0.007983907125890255
- O 0 0.023691296577453613
up O 0 0.005944379139691591
in O 0 0.006455807946622372
independent O 0 0.011571448296308517
analyses O 0 0.06030351668596268
. O 0 0.019275397062301636

The O 0 0.011491280980408192
first O 0 0.007469490170478821
was O 0 0.005046500358730555
an O 0 0.004346255213022232
association O 0 0.007150212302803993
noted O 0 0.004475923255085945
in O 0 0.002782768802717328
the O 0 0.0026109146419912577
group O 0 0.006228427868336439
of O 0 0.004840729758143425
CD B-Disease 0 0.09596586227416992
families O 0 0.19353319704532623
with O 0 0.32073020935058594
breast B-Disease 1 0.996141254901886
disease I-Disease 1 0.9933539628982544
. O 0 0.11380861699581146

A O 0 0.03007560782134533
correlation O 0 0.06792815029621124
was O 0 0.008580592460930347
observed O 0 0.012584746815264225
between O 0 0.0059911226853728294
the O 0 0.004658564459532499
presence O 0 0.05634397640824318
/ O 0 0.23406490683555603
absence O 0 0.025054505094885826
of O 0 0.005813022144138813
a O 0 0.06507965922355652
PTEN O 1 0.9869677424430847
mutation O 1 0.9702479839324951
and O 0 0.005946157034486532
the O 0 0.006109639070928097
type O 0 0.396112322807312
of O 0 0.041214536875486374
breast O 1 0.9950790405273438
involvement O 1 0.7477870583534241
( O 0 0.31569525599479675
unaffected O 1 0.9317163228988647
versus O 1 0.8772081136703491
benign O 1 0.9861958026885986
versus O 1 0.9224818348884583
malignant O 1 0.9875991344451904
) O 0 0.13747236132621765
. O 0 0.03254124894738197

Specifically O 0 0.025981761515140533
and O 0 0.006707016844302416
more O 0 0.005151375662535429
directly O 0 0.005029255989938974
, O 0 0.003000488970428705
an O 0 0.0028266150038689375
association O 0 0.005840757861733437
was O 0 0.002801746129989624
also O 0 0.0027724585961550474
observed O 0 0.006787566002458334
between O 0 0.003909648396074772
the O 0 0.0034531098790466785
presence O 0 0.014526299200952053
of O 0 0.006436442956328392
a O 0 0.17053024470806122
PTEN O 1 0.9925284385681152
mutation O 1 0.9950540065765381
and O 1 0.7722946405410767
malignant B-Disease 1 0.9975219368934631
breast I-Disease 1 0.9972266554832458
disease I-Disease 1 0.9947237968444824
. O 0 0.2159753292798996

Secondly O 0 0.051245566457509995
, O 0 0.009781409986317158
there O 0 0.005212781950831413
appeared O 0 0.005828145891427994
to O 0 0.0030128760263323784
be O 0 0.002668502042070031
an O 0 0.004346878733485937
interdependent O 0 0.34027108550071716
association O 0 0.03496711701154709
between O 0 0.025252610445022583
mutations O 1 0.9628300666809082
upstream O 0 0.04463038221001625
and O 0 0.00368671421892941
within O 0 0.004466965328902006
the O 0 0.0036041252315044403
PTPase O 0 0.19009269773960114
core O 0 0.014995359815657139
motif O 0 0.11347535252571106
, O 0 0.003110222052782774
the O 0 0.0028305063024163246
core O 0 0.008257361128926277
motif O 0 0.09558924287557602
containing O 0 0.007396068423986435
the O 0 0.0033536076080054045
majority O 0 0.009439450688660145
of O 0 0.0067366380244493484
missense O 1 0.9688816070556641
mutations O 1 0.9641744494438171
, O 0 0.003347510937601328
and O 0 0.0019762441515922546
the O 0 0.002159968251362443
involvement O 0 0.007007606793195009
of O 0 0.0023121763952076435
all O 0 0.0028317051474004984
major O 0 0.035022325813770294
organ O 1 0.8130603432655334
systems O 0 0.43084466457366943
( O 0 0.07374044507741928
central O 0 0.0360201932489872
nervous O 1 0.9533798098564148
system O 0 0.4506152868270874
, O 0 0.2175450474023819
thyroid O 1 0.9977666139602661
, O 0 0.49452733993530273
breast O 1 0.9972971081733704
, O 0 0.36936789751052856
skin O 1 0.9935230016708374
and O 0 0.3336874842643738
gastrointestinal O 1 0.9950876832008362
tract O 1 0.9831400513648987
) O 0 0.13517755270004272
. O 0 0.035618290305137634

However O 0 0.015469267033040524
, O 0 0.006774205714464188
these O 0 0.004104602616280317
observations O 0 0.005676419474184513
would O 0 0.002539945999160409
need O 0 0.0032332236878573895
to O 0 0.0020263080950826406
be O 0 0.001971815712749958
confirmed O 0 0.0036239607725292444
by O 0 0.0027715677861124277
studying O 0 0.0038715640548616648
a O 0 0.003553707618266344
larger O 0 0.005243256688117981
number O 0 0.0038219571579247713
of O 0 0.004410370718687773
CD B-Disease 0 0.02100299671292305
families O 0 0.03209042549133301
. O 0 0.021157458424568176

Molecular O 1 0.865645706653595
defects O 1 0.9298990368843079
leading O 0 0.029877180233597755
to O 0 0.011466596275568008
human O 0 0.15605780482292175
complement B-Disease 1 0.5070560574531555
component I-Disease 1 0.8546480536460876
C6 I-Disease 1 0.9903643727302551
deficiency I-Disease 1 0.9955961108207703
in O 0 0.018326181918382645
an O 0 0.01202823594212532
African O 0 0.11137016862630844
- O 0 0.24403265118598938
American O 0 0.028712701052427292
family O 0 0.06183088570833206
. O 0 0.025072405114769936

Complement B-Disease 1 0.7061998844146729
component I-Disease 1 0.9193903803825378
C6 I-Disease 1 0.9853538274765015
deficiency I-Disease 1 0.995145857334137
( O 0 0.2979852855205536
C6D B-Disease 1 0.8470646142959595
) O 0 0.05333380773663521
was O 0 0.01383974403142929
diagnosed O 1 0.972107470035553
in O 0 0.005810900591313839
a O 0 0.007582610473036766
16 O 0 0.014038312248885632
- O 0 0.13641364872455597
year O 0 0.01741114817559719
- O 0 0.22102472186088562
old O 0 0.051855359226465225
African O 0 0.17877891659736633
- O 0 0.41750040650367737
American O 0 0.10568591952323914
male O 1 0.8468565940856934
with O 1 0.6517996191978455
meningococcal B-Disease 1 0.995169460773468
meningitis I-Disease 1 0.9935638308525085
. O 0 0.20827437937259674

The O 0 0.030577102676033974
patients O 1 0.8162621855735779
father O 0 0.013949661515653133
and O 0 0.0044898297637701035
two O 0 0.004434062168002129
brothers O 0 0.018584778532385826
also O 0 0.0034075945150107145
had O 0 0.004258398432284594
C6D B-Disease 0 0.15861915051937103
, O 0 0.003223201259970665
but O 0 0.002679491648450494
gave O 0 0.004316355567425489
no O 0 0.003838504897430539
history O 0 0.007254325319081545
of O 0 0.022294742986559868
meningitis B-Disease 1 0.9954046010971069
or O 0 0.11047406494617462
other O 0 0.05890752747654915
neisserial B-Disease 1 0.9556329250335693
infection I-Disease 1 0.9902029037475586
. O 0 0.07603989541530609

By O 0 0.03224064037203789
using O 0 0.03288525342941284
exon O 1 0.6032965779304504
- O 0 0.26379984617233276
specific O 0 0.11232727020978928
polymerase O 1 0.8797774910926819
chain O 1 0.5316041707992554
reaction O 0 0.43075478076934814
( O 0 0.08230692893266678
PCR O 1 0.757614254951477
) O 0 0.04931659623980522
/ O 0 0.28444668650627136
single O 0 0.02802620455622673
- O 0 0.255687415599823
strand O 1 0.5630251169204712
conformation O 1 0.566058337688446
polymorphism O 0 0.4574715495109558
as O 0 0.0057970378547906876
a O 0 0.006358721759170294
screening O 0 0.04012667387723923
step O 0 0.009758693166077137
and O 0 0.004707306623458862
nucleotide O 0 0.2668609619140625
sequencing O 0 0.05953775346279144
of O 0 0.00456281378865242
target O 0 0.010680261068046093
exons O 0 0.19867415726184845
, O 0 0.0036918639671057463
we O 0 0.002265132497996092
determined O 0 0.004477361682802439
that O 0 0.002595953643321991
the O 0 0.0030778604559600353
proband O 0 0.07509760558605194
was O 0 0.0037701535038650036
a O 0 0.006952010095119476
compound O 0 0.10282717645168304
heterozygote O 1 0.7272707223892212
for O 0 0.01068981271237135
two O 0 0.03885811194777489
C6 O 1 0.9720525145530701
gene O 1 0.9797486662864685
mutations O 1 0.9768850803375244
. O 0 0.05724511295557022

The O 0 0.01606300286948681
first O 0 0.009976823814213276
, O 0 0.008228424936532974
1195delC O 0 0.10651035606861115
located O 0 0.0071881976909935474
in O 0 0.0059056356549263
exon O 0 0.34335240721702576
7 O 0 0.009548289701342583
, O 0 0.0036883396096527576
is O 0 0.0035238054115325212
a O 0 0.005789439659565687
novel O 0 0.1813240647315979
mutation O 1 0.8893226385116577
, O 0 0.0032870047725737095
while O 0 0.0026506755966693163
the O 0 0.002291651675477624
second O 0 0.0034939392935484648
, O 0 0.003321983851492405
1936delG O 0 0.16181667149066925
in O 0 0.0046484023332595825
exon O 0 0.3119876980781555
12 O 0 0.006150886882096529
, O 0 0.002768182661384344
has O 0 0.0022827705834060907
been O 0 0.0026379001792520285
described O 0 0.004923003725707531
before O 0 0.0032464696560055017
to O 0 0.004141639452427626
cause O 1 0.5050209760665894
C6D B-Disease 0 0.4776104688644409
in O 0 0.0063820164650678635
an O 0 0.007711444981396198
unrelated O 0 0.47914233803749084
African O 0 0.1645565778017044
- O 0 0.22366295754909515
American O 0 0.02281041443347931
individual O 0 0.046869371086359024
. O 0 0.022218884900212288

Both O 0 0.05244790390133858
mutations O 1 0.9471047520637512
result O 0 0.10891833156347275
in O 0 0.030614608898758888
premature O 1 0.9441619515419006
termination O 1 0.893522322177887
codons O 1 0.7856401205062866
and O 0 0.03235815465450287
C6 O 1 0.9258419871330261
null O 1 0.7535660862922668
alleles O 1 0.9431102275848389
. O 0 0.050828855484724045

Allele O 1 0.8898154497146606
- O 0 0.15638452768325806
specific O 0 0.03646639361977577
PCR O 0 0.29234424233436584
indicated O 0 0.013597804121673107
that O 0 0.0049712806940078735
the O 0 0.004825799725949764
probands O 0 0.14857707917690277
two O 0 0.005923890974372625
brothers O 0 0.044121235609054565
also O 0 0.006908894516527653
inherited O 1 0.657766580581665
the O 0 0.011350937187671661
1195delC O 1 0.8320980668067932
mutation O 1 0.9695248007774353
from O 0 0.009214242920279503
their O 0 0.009007986634969711
heterozygous O 1 0.8610857725143433
mother O 0 0.054524119943380356
and O 0 0.0050868322141468525
the O 0 0.008721289224922657
1936delG O 1 0.7924011945724487
mutation O 1 0.9758077263832092
from O 0 0.012837911956012249
their O 0 0.011709988117218018
homozygous O 1 0.8878271579742432
father O 0 0.05058350786566734
. O 0 0.014890365302562714
. O 0 0.020776841789484024

PAX6 O 1 0.8994542360305786
mutations O 1 0.9023775458335876
reviewed O 0 0.1098160520195961
. O 0 0.05840853601694107

Mutations O 1 0.9450495839118958
in O 0 0.02237781137228012
PAX6 O 1 0.7340653538703918
are O 0 0.007282841484993696
responsible O 0 0.01334705762565136
for O 0 0.005123811773955822
human O 0 0.05102218687534332
aniridia B-Disease 0 0.2924652397632599
and O 0 0.0033163700718432665
have O 0 0.002777996240183711
also O 0 0.0027312161400914192
been O 0 0.003285427112132311
found O 0 0.010289646685123444
in O 0 0.016261884942650795
patients O 1 0.9699780941009521
with O 0 0.09343860298395157
Peters B-Disease 1 0.9258193969726562
anomaly I-Disease 1 0.9797230362892151
, O 0 0.10285229980945587
with O 1 0.5900210738182068
congenital B-Disease 1 0.998941957950592
cataracts I-Disease 1 0.9974682331085205
, O 0 0.1657809168100357
with O 0 0.47550079226493835
autosomal B-Disease 1 0.9975099563598633
dominant I-Disease 1 0.9524309635162354
keratitis I-Disease 1 0.9868049621582031
, O 0 0.013227339833974838
and O 0 0.008587360382080078
with O 0 0.019799096509814262
isolated B-Disease 1 0.7045320272445679
foveal I-Disease 1 0.9476602673530579
hypoplasia I-Disease 1 0.9771221280097961
. O 0 0.080583356320858

No O 0 0.03115386888384819
locus O 0 0.28113794326782227
other O 0 0.012723421677947044
than O 0 0.015182316303253174
chromosome O 1 0.9425204396247864
11p13 O 0 0.2247418612241745
has O 0 0.007694034371525049
been O 0 0.006667038891464472
implicated O 0 0.19937735795974731
in O 0 0.00694347033277154
aniridia B-Disease 0 0.4020686447620392
, O 0 0.005833732429891825
and O 0 0.004982572514563799
PAX6 O 1 0.742219865322113
is O 0 0.0042064860463142395
clearly O 0 0.004702628590166569
the O 0 0.002472227904945612
major O 0 0.005204351153224707
, O 0 0.0024968204088509083
if O 0 0.0028244226705282927
not O 0 0.002528189914301038
only O 0 0.003628976410254836
, O 0 0.006975042168051004
gene O 1 0.7202557325363159
responsible O 0 0.041618090122938156
. O 0 0.024169255048036575

Twenty O 0 0.045563552528619766
- O 0 0.03523610532283783
eight O 0 0.014955083839595318
percent O 0 0.01398404035717249
of O 0 0.010074799880385399
identified O 0 0.16752059757709503
PAX6 O 1 0.9708958268165588
mutations O 1 0.9748541116714478
are O 0 0.01525085512548685
C O 0 0.4774063527584076
- O 0 0.3602680265903473
T O 1 0.6776890754699707
changes O 0 0.027293892577290535
at O 0 0.009112152270972729
CpG O 1 0.7103883028030396
dinucleotides O 0 0.2672463655471802
, O 0 0.004425717052072287
20 O 0 0.004729693289846182
% O 0 0.00527593307197094
are O 0 0.0033436757512390614
splicing O 0 0.42027488350868225
errors O 0 0.021470246836543083
, O 0 0.0025378039572387934
and O 0 0.001908484031446278
more O 0 0.0023187173064798117
than O 0 0.002914654789492488
30 O 0 0.005121310707181692
% O 0 0.011330787092447281
are O 0 0.005647724494338036
deletion O 1 0.7425097823143005
or O 0 0.01993054710328579
insertion O 0 0.3500683605670929
events O 0 0.034628212451934814
. O 0 0.025383001193404198

There O 0 0.01419671531766653
is O 0 0.008271558210253716
a O 0 0.009625538252294064
noticeably O 0 0.09729760885238647
elevated O 0 0.11693155765533447
level O 0 0.009549111127853394
of O 0 0.005711601581424475
mutation O 1 0.9161619544029236
in O 0 0.004862500354647636
the O 0 0.00466777803376317
paired O 0 0.11990515887737274
domain O 0 0.03020704910159111
compared O 0 0.009131115861237049
with O 0 0.0035838664043694735
the O 0 0.003041375195607543
rest O 0 0.005528194829821587
of O 0 0.004815987776964903
the O 0 0.010025261901319027
gene O 1 0.8652496933937073
. O 0 0.027475137263536453

Increased O 0 0.15091389417648315
mutation O 1 0.8383342623710632
in O 0 0.012691408395767212
the O 0 0.008848991245031357
homeodomain O 0 0.43306276202201843
is O 0 0.006113079842180014
accounted O 0 0.009604919701814651
for O 0 0.004344976507127285
by O 0 0.005911777261644602
the O 0 0.00752932857722044
hypermutable O 1 0.5959296822547913
CpG O 1 0.8496205806732178
dinucleotide O 1 0.6503145694732666
in O 0 0.02018854022026062
codon O 0 0.3920341730117798
240 O 0 0.054886460304260254
. O 0 0.0253511443734169

Very O 0 0.02187204174697399
nearly O 0 0.01694922335445881
all O 0 0.00955753494054079
mutations O 1 0.9419028162956238
appear O 0 0.025049546733498573
to O 0 0.005339030642062426
cause O 0 0.3523823320865631
loss O 0 0.03028964251279831
of O 0 0.0033044947776943445
function O 0 0.01651712693274021
of O 0 0.0030321446247398853
the O 0 0.004704577382653952
mutant O 1 0.8450368642807007
allele O 1 0.8860270380973816
, O 0 0.004222671501338482
and O 0 0.0024197520688176155
more O 0 0.002406946150586009
than O 0 0.0031153210438787937
80 O 0 0.005739778745919466
% O 0 0.006698315497487783
of O 0 0.004751365166157484
exonic O 0 0.24339616298675537
substitutions O 0 0.06932134181261063
result O 0 0.037067074328660965
in O 0 0.013524549081921577
nonsense O 0 0.2553652822971344
codons O 1 0.7137870192527771
. O 0 0.03823242336511612

In O 0 0.02347206510603428
a O 0 0.019297262653708458
gene O 1 0.6525636911392212
with O 0 0.008288716897368431
such O 0 0.0065827989019453526
extraordinarily O 0 0.0426674485206604
high O 0 0.008984969928860664
sequence O 0 0.033956799656152725
conservation O 0 0.013367380946874619
throughout O 0 0.005748030263930559
evolution O 0 0.014513573609292507
, O 0 0.003631009953096509
there O 0 0.002995145972818136
are O 0 0.0037353402003645897
presumed O 0 0.1642875224351883
undiscovered O 1 0.7558460235595703
missense O 1 0.9751162528991699
mutations O 1 0.9673681259155273
, O 0 0.004705825820565224
these O 0 0.00329024950042367
are O 0 0.0029619778506457806
hypothesized O 0 0.08928295969963074
to O 0 0.0027221005875617266
exist O 0 0.005664450582116842
in O 0 0.003419320797547698
as O 0 0.004069370683282614
- O 0 0.08082994073629379
yet O 0 0.019959554076194763
unidentified O 0 0.19178588688373566
phenotypes O 1 0.9226749539375305
. O 0 0.019026342779397964
. O 0 0.023947905749082565

Genetic O 1 0.9259103536605835
heterogeneity O 1 0.5699521899223328
and O 0 0.019172029569745064
penetrance O 1 0.7870973348617554
analysis O 0 0.02629687823355198
of O 0 0.00848347507417202
the O 0 0.020165029913187027
BRCA1 O 1 0.9916818737983704
and O 0 0.23704932630062103
BRCA2 O 1 0.9962916374206543
genes O 1 0.9903534650802612
in O 1 0.7655325531959534
breast B-Disease 1 0.9970239996910095
cancer I-Disease 1 0.9941918253898621
families O 0 0.4094235897064209
. O 0 0.056236110627651215

The O 0 0.39025285840034485
Breast B-Disease 1 0.9894161820411682
Cancer I-Disease 1 0.9858257174491882
Linkage O 1 0.9077273607254028
Consortium O 0 0.45442911982536316
. O 0 0.04681913182139397

The O 0 0.019408129155635834
contribution O 0 0.031008707359433174
of O 0 0.024106718599796295
BRCA1 O 1 0.9878446459770203
and O 0 0.11530160903930664
BRCA2 O 1 0.9946869611740112
to O 0 0.4271165430545807
inherited B-Disease 1 0.9959596991539001
breast I-Disease 1 0.9981947541236877
cancer I-Disease 1 0.9961289167404175
was O 0 0.017180008813738823
assessed O 0 0.08466191589832306
by O 0 0.011693405918776989
linkage O 1 0.6596635580062866
and O 0 0.011881900951266289
mutation O 1 0.9757768511772156
analysis O 0 0.0375804677605629
in O 0 0.004664845764636993
237 O 0 0.03619636967778206
families O 0 0.008079945109784603
, O 0 0.002762499265372753
each O 0 0.0025647564325481653
with O 0 0.002638846402987838
at O 0 0.0028951296117156744
least O 0 0.004077694844454527
four O 0 0.006609729491174221
cases O 0 0.35739564895629883
of O 0 0.13276956975460052
breast B-Disease 1 0.9981953501701355
cancer I-Disease 1 0.9956554174423218
, O 0 0.01305485051125288
collected O 0 0.013371129520237446
by O 0 0.027248099446296692
the O 0 0.20495186746120453
Breast B-Disease 1 0.9975208640098572
Cancer I-Disease 1 0.996243953704834
Linkage O 1 0.9656787514686584
Consortium O 1 0.6295593976974487
. O 0 0.04781205207109451

Families O 0 0.028638428077101707
were O 0 0.008239936083555222
included O 0 0.0075100623071193695
without O 0 0.006484415847808123
regard O 0 0.006712949834764004
to O 0 0.003987249452620745
the O 0 0.006035695318132639
occurrence O 1 0.5158248543739319
of O 0 0.053146861493587494
ovarian B-Disease 1 0.9945230484008789
or I-Disease 0 0.18313543498516083
other I-Disease 0 0.0903896614909172
cancers I-Disease 1 0.9894840121269226
. O 0 0.08207546919584274

Overall O 0 0.18458431959152222
, O 0 0.06454689800739288
disease O 1 0.9865273833274841
was O 0 0.011955109424889088
linked O 0 0.29692497849464417
to O 0 0.0081287557259202
BRCA1 O 1 0.9700656533241272
in O 0 0.004836335778236389
an O 0 0.0035195965319871902
estimated O 0 0.006878416519612074
52 O 0 0.007112560328096151
% O 0 0.005484177265316248
of O 0 0.002780115930363536
families O 0 0.007400295697152615
, O 0 0.002961420454084873
to O 0 0.0033112294040620327
BRCA2 O 1 0.978150486946106
in O 0 0.00409842049703002
32 O 0 0.0069802794605493546
% O 0 0.005462711676955223
of O 0 0.002167673548683524
families O 0 0.005036120768636465
, O 0 0.0022653003688901663
and O 0 0.0018085523042827845
to O 0 0.002258150139823556
neither O 0 0.015071708709001541
gene O 1 0.6487939953804016
in O 0 0.0046521942131221294
16 O 0 0.00783272460103035
% O 0 0.012615256942808628
( O 0 0.007763036992400885
95 O 0 0.008224615827202797
% O 0 0.010622159577906132
confidence O 0 0.014044862240552902
interval O 0 0.18811658024787903
[ O 0 0.17959962785243988
CI O 1 0.6959248781204224
] O 0 0.06830862164497375
6 O 0 0.012735016644001007
% O 0 0.019933830946683884
- O 0 0.05039177089929581
28 O 0 0.010832787491381168
% O 0 0.016618601977825165
) O 0 0.009542401880025864
, O 0 0.00554759381338954
suggesting O 0 0.03182877600193024
other O 0 0.01689910888671875
predisposition O 1 0.9709152579307556
genes O 1 0.9464377164840698
. O 0 0.05110587552189827

The O 0 0.021797331050038338
majority O 0 0.022397108376026154
( O 0 0.017428124323487282
81 O 0 0.026319559663534164
% O 0 0.019811440259218216
) O 0 0.010586818680167198
of O 0 0.0077093616127967834
the O 0 0.19134578108787537
breast B-Disease 1 0.9986209869384766
- I-Disease 1 0.9942785501480103
ovarian I-Disease 1 0.9992617964744568
cancer I-Disease 1 0.9978741407394409
families O 0 0.09269234538078308
were O 0 0.004611557349562645
due O 0 0.02381082996726036
to O 0 0.007912822999060154
BRCA1 O 1 0.9869565963745117
, O 0 0.005321977194398642
with O 0 0.004012625198811293
most O 0 0.003756291465833783
others O 0 0.006579534616321325
( O 0 0.009431958198547363
14 O 0 0.00794075895100832
% O 0 0.021755613386631012
) O 0 0.011372791603207588
due O 0 0.014521229080855846
to O 0 0.013111581094563007
BRCA2 O 1 0.9779606461524963
. O 0 0.03666410222649574

Conversely O 0 0.054609254002571106
, O 0 0.009097662754356861
the O 0 0.005655793007463217
majority O 0 0.0068861800245940685
of O 0 0.003970747347921133
families O 0 0.011541534215211868
with O 0 0.009045428596436977
male B-Disease 0 0.44579052925109863
and I-Disease 0 0.04436175897717476
female I-Disease 1 0.9240975975990295
breast I-Disease 1 0.998104453086853
cancer I-Disease 1 0.9952290058135986
were O 0 0.008959582075476646
due O 0 0.051692359149456024
to O 0 0.02072908729314804
BRCA2 O 1 0.9877482652664185
( O 0 0.07989196479320526
76 O 0 0.0814308226108551
% O 0 0.040643077343702316
) O 0 0.02470569685101509
. O 0 0.019054552540183067

The O 0 0.015628617256879807
largest O 0 0.017693551257252693
proportion O 0 0.038606151938438416
( O 0 0.015589961782097816
67 O 0 0.015637336298823357
% O 0 0.009741798043251038
) O 0 0.004689743742346764
of O 0 0.002530362457036972
families O 0 0.00642565730959177
due O 0 0.004699792712926865
to O 0 0.0022483745124191046
other O 0 0.003126704366877675
genes O 0 0.4616384506225586
was O 0 0.0031636895146220922
found O 0 0.003347864141687751
in O 0 0.002647396642714739
families O 0 0.0060976832173764706
with O 0 0.0033831880427896976
four O 0 0.003455844707787037
or O 0 0.006148564163595438
five O 0 0.007152595091611147
cases O 0 0.16318534314632416
of O 0 0.02835722826421261
female O 1 0.9316578507423401
breast B-Disease 1 0.9970417618751526
cancer I-Disease 1 0.9939078092575073
only O 0 0.03257175162434578
. O 0 0.034365441650152206

These O 0 0.015611798502504826
estimates O 0 0.01564159244298935
were O 0 0.005240780767053366
not O 0 0.0047444747760891914
substantially O 0 0.03955058380961418
affected O 0 0.023670619353652
either O 0 0.005319107789546251
by O 0 0.0044112252071499825
changing O 0 0.012542215175926685
the O 0 0.004546702839434147
assumed O 0 0.05719723924994469
penetrance O 1 0.8969798684120178
model O 0 0.058788664638996124
for O 0 0.012967394664883614
BRCA1 O 1 0.9859282970428467
or O 0 0.014534501358866692
by O 0 0.006973594892770052
including O 0 0.008991587907075882
or O 0 0.02724655531346798
excluding O 0 0.3668667674064636
BRCA1 O 1 0.9913520812988281
mutation O 1 0.9800273776054382
data O 0 0.05407778173685074
. O 0 0.02803668938577175

Among O 0 0.02241520769894123
those O 0 0.012724906206130981
families O 0 0.055384907871484756
with O 0 0.06421505659818649
disease O 1 0.9927424192428589
due O 0 0.058612268418073654
to O 0 0.009405265562236309
BRCA1 O 1 0.9812563061714172
that O 0 0.004094024654477835
were O 0 0.00250294990837574
tested O 0 0.017925940454006195
by O 0 0.0026276258286088705
one O 0 0.0019068795954808593
of O 0 0.0018989632371813059
the O 0 0.002620888873934746
standard O 0 0.03208038583397865
screening O 0 0.25443828105926514
methods O 0 0.03571470454335213
, O 0 0.007542131468653679
mutations O 1 0.9253462553024292
were O 0 0.0036943741142749786
detected O 0 0.08877221494913101
in O 0 0.004456716123968363
the O 0 0.005102199502289295
coding O 0 0.43790096044540405
sequence O 0 0.06882381439208984
or O 0 0.011195859871804714
splice O 0 0.408006489276886
sites O 0 0.007371692452579737
in O 0 0.004140541888773441
an O 0 0.004043998196721077
estimated O 0 0.009539851918816566
63 O 0 0.016319386661052704
% O 0 0.011612644419074059
( O 0 0.010521145537495613
95 O 0 0.012684300541877747
% O 0 0.02236526645720005
CI O 0 0.44345080852508545
51 O 0 0.02375432848930359
% O 0 0.021658005192875862
- O 0 0.09924538433551788
77 O 0 0.031055396422743797
% O 0 0.022740453481674194
) O 0 0.017320705577731133
. O 0 0.016407782211899757

The O 0 0.02071656659245491
estimated O 0 0.02631933055818081
sensitivity O 0 0.05081593617796898
was O 0 0.006592047866433859
identical O 0 0.013028157874941826
for O 0 0.005055148620158434
direct O 0 0.009572853334248066
sequencing O 0 0.05764777958393097
and O 0 0.005694909952580929
other O 0 0.007711181882768869
techniques O 0 0.02892460860311985
. O 0 0.018105441704392433

The O 0 0.02949226275086403
penetrance O 1 0.7452876567840576
of O 0 0.014791210182011127
BRCA2 O 1 0.962562620639801
was O 0 0.009053702466189861
estimated O 0 0.011376908048987389
by O 0 0.00742121459916234
maximizing O 0 0.03522109240293503
the O 0 0.006736432667821646
LOD O 0 0.3405010998249054
score O 0 0.013511528261005878
in O 0 0.057567764073610306
BRCA2 O 1 0.9947212934494019
- O 1 0.8815287947654724
mutation O 1 0.9793528914451599
families O 0 0.028334520757198334
, O 0 0.005111153703182936
over O 0 0.005051723215728998
all O 0 0.0054438477382063866
possible O 0 0.03767288848757744
penetrance O 1 0.8632199168205261
functions O 0 0.04988975450396538
. O 0 0.022698771208524704

The O 0 0.023588847368955612
estimated O 0 0.06788157671689987
cumulative O 1 0.7807796001434326
risk O 1 0.9005559086799622
of O 0 0.11695773154497147
breast B-Disease 1 0.9959278702735901
cancer I-Disease 1 0.9916895627975464
reached O 0 0.02080078050494194
28 O 0 0.019950315356254578
% O 0 0.020170964300632477
( O 0 0.012586650438606739
95 O 0 0.012229875661432743
% O 0 0.027112673968076706
CI O 0 0.4588966369628906
9 O 0 0.010525718331336975
% O 0 0.014016654342412949
- O 0 0.03467250242829323
44 O 0 0.00934185553342104
% O 0 0.009183665737509727
) O 0 0.005054402630776167
by O 0 0.0032932767644524574
age O 0 0.005815541371703148
50 O 0 0.004031500779092312
years O 0 0.0034511922858655453
and O 0 0.0027663351502269506
84 O 0 0.011647756211459637
% O 0 0.010222526267170906
( O 0 0.008819508366286755
95 O 0 0.00967126153409481
% O 0 0.018776293843984604
CI O 0 0.36474132537841797
43 O 0 0.015874594449996948
% O 0 0.0196125078946352
- O 0 0.047450676560401917
95 O 0 0.011189636774361134
% O 0 0.011262726970016956
) O 0 0.006846652366220951
by O 0 0.005182752851396799
age O 0 0.011612949892878532
70 O 0 0.013373671099543571
years O 0 0.013613872230052948
. O 0 0.01685941033065319

The O 0 0.07332462817430496
corresponding O 1 0.9110866189002991
ovarian B-Disease 1 0.996155321598053
cancer I-Disease 1 0.994750440120697
risks O 1 0.7797116637229919
were O 0 0.017040221020579338
0 O 0 0.048672065138816833
. O 0 0.027858495712280273

4 O 0 0.03018886037170887
% O 0 0.022567681968212128
( O 0 0.01592923142015934
95 O 0 0.014957479201257229
% O 0 0.02359137497842312
CI O 0 0.4799332618713379
0 O 0 0.025908321142196655
% O 0 0.01987389288842678
- O 0 0.03565492853522301
1 O 0 0.0059510632418096066
% O 0 0.007212105207145214
) O 0 0.004555814899504185
by O 0 0.0031446367502212524
age O 0 0.005256372038275003
50 O 0 0.004110794514417648
years O 0 0.0035371684934943914
and O 0 0.00223166705109179
27 O 0 0.005634957924485207
% O 0 0.009093459695577621
( O 0 0.007222834508866072
95 O 0 0.009922964498400688
% O 0 0.04163963720202446
CI O 1 0.6571572422981262
0 O 0 0.028261100873351097
% O 0 0.026067759841680527
- O 0 0.07072259485721588
47 O 0 0.012911730445921421
% O 0 0.014262298122048378
) O 0 0.006143493112176657
by O 0 0.004689122550189495
age O 0 0.010055681690573692
70 O 0 0.012852955609560013
years O 0 0.013707928359508514
. O 0 0.01637336239218712

The O 0 0.032453861087560654
lifetime O 1 0.5597596168518066
risk O 1 0.8940077424049377
of O 0 0.21102111041545868
breast B-Disease 1 0.9976372718811035
cancer I-Disease 1 0.9951989054679871
appears O 0 0.1508323848247528
similar O 0 0.020520111545920372
to O 0 0.004109726753085852
the O 0 0.008658774197101593
risk O 1 0.8620328307151794
in O 0 0.07094482332468033
BRCA1 O 1 0.9945399165153503
carriers O 0 0.37607207894325256
, O 0 0.0039050958584994078
but O 0 0.0024817122612148523
there O 0 0.0019782406743615866
was O 0 0.001713841105811298
some O 0 0.0018764757551252842
suggestion O 0 0.004910487215965986
of O 0 0.0028345438186079264
a O 0 0.008774996735155582
lower O 0 0.14023298025131226
risk O 1 0.8956873416900635
in O 0 0.0808376595377922
BRCA2 O 1 0.9941269159317017
carriers O 1 0.8496173620223999
< O 1 0.6091151833534241
50 O 0 0.010358507744967937
years O 0 0.008398117497563362
of O 0 0.0069249700754880905
age O 0 0.03296151012182236
. O 0 0.01931031607091427

Eye B-Disease 1 0.8677974343299866
movement I-Disease 0 0.46202749013900757
abnormalities I-Disease 1 0.9812088012695312
correlate O 1 0.8846085071563721
with O 0 0.22770053148269653
genotype O 1 0.9791287183761597
in O 1 0.524904727935791
autosomal O 1 0.9964621663093567
dominant O 1 0.9756718277931213
cerebellar B-Disease 1 0.9911956787109375
ataxia I-Disease 1 0.9898449182510376
type I-Disease 1 0.7400118708610535
I I-Disease 0 0.035233642905950546
. O 0 0.030262302607297897

We O 0 0.023255828768014908
compared O 0 0.04633161798119545
horizontal O 0 0.3812759518623352
eye O 1 0.7184525728225708
movements O 0 0.09913058578968048
( O 0 0.04207032918930054
visually O 0 0.17556017637252808
guided O 0 0.041768405586481094
saccades O 1 0.9004127383232117
, O 0 0.010258803144097328
antisaccades O 0 0.25289079546928406
, O 0 0.005369040183722973
and O 0 0.0037992531433701515
smooth O 0 0.0643480122089386
pursuit O 0 0.05871390923857689
) O 0 0.007464465219527483
in O 0 0.0040006088092923164
control O 0 0.02929404377937317
subjects O 0 0.0470469705760479
( O 0 0.03210369125008583
n O 0 0.11504294723272324
= O 0 0.21310117840766907
14 O 0 0.0127527741715312
) O 0 0.008171225897967815
and O 0 0.0041846055537462234
patients O 1 0.7880904674530029
with O 0 0.0043883598409593105
three O 0 0.005492557771503925
forms O 0 0.11968942731618881
of O 0 0.06158827990293503
autosomal O 1 0.9972038269042969
dominant O 1 0.95820152759552
cerebellar B-Disease 1 0.9921320080757141
ataxias I-Disease 1 0.9608151316642761
type I-Disease 1 0.8302508592605591
I I-Disease 0 0.08351888507604599
spinocerebellar B-Disease 1 0.985325276851654
ataxias I-Disease 1 0.6364794969558716
1 I-Disease 0 0.0124006737023592
and I-Disease 0 0.0051291766576468945
2 I-Disease 0 0.010528220795094967
( O 0 0.02110162004828453
SCA1 B-Disease 0 0.35779038071632385
, O 0 0.007826915942132473
n O 0 0.05414239317178726
= O 0 0.09952516853809357
11 O 0 0.013018173165619373
; O 0 0.013458839617669582
SCA2 B-Disease 0 0.2885293960571289
, O 0 0.006822462193667889
n O 0 0.04194090515375137
= O 0 0.10429482161998749
10 O 0 0.009172139689326286
) O 0 0.012507108971476555
and O 0 0.009731507860124111
SCA3 B-Disease 1 0.9221259951591492
/ O 1 0.8730859160423279
Machado B-Disease 1 0.9186810255050659
- I-Disease 1 0.8972439169883728
Joseph I-Disease 1 0.8654037117958069
disease I-Disease 1 0.9960911870002747
( O 0 0.3485288619995117
MJD B-Disease 1 0.9478840827941895
) O 0 0.05711015313863754
( O 0 0.028117839246988297
n O 0 0.08325472474098206
= O 0 0.18430298566818237
16 O 0 0.01923341676592827
) O 0 0.017748018726706505
. O 0 0.01772512122988701

In O 0 0.035512372851371765
SCA1 B-Disease 0 0.4111192524433136
, O 0 0.019774680957198143
saccade O 1 0.6013737916946411
amplitude O 0 0.12740890681743622
was O 0 0.009438830427825451
significantly O 0 0.07646749913692474
increased O 0 0.023628082126379013
, O 0 0.007938895374536514
resulting O 0 0.09051384776830673
in O 0 0.013858542777597904
hypermetria B-Disease 0 0.3885163962841034
. O 0 0.026672814041376114

The O 0 0.03062472678720951
smooth O 0 0.08094257116317749
pursuit O 0 0.05003140866756439
gain O 0 0.025118719786405563
was O 0 0.015313176438212395
decreased O 0 0.20805098116397858
. O 0 0.026964399963617325

In O 0 0.04240791127085686
SCA2 B-Disease 0 0.35077130794525146
, O 0 0.025533942505717278
saccade O 1 0.6340277791023254
velocity O 0 0.05931137502193451
was O 0 0.020413415506482124
markedly O 1 0.5253000259399414
decreased O 0 0.3373890221118927
. O 0 0.03221651166677475

The O 0 0.017342975363135338
percentage O 0 0.017208823934197426
of O 0 0.007164806593209505
errors O 0 0.022012237459421158
in O 0 0.0066760266199707985
antisaccades O 0 0.13694007694721222
was O 0 0.005414867773652077
greatly O 0 0.01659254916012287
increased O 0 0.009750458411872387
and O 0 0.003636848647147417
was O 0 0.0049105240032076836
significantly O 0 0.1870778203010559
correlated O 1 0.640038788318634
with O 0 0.028738977387547493
age O 0 0.37310370802879333
at O 0 0.3463190495967865
disease O 1 0.9958421587944031
onset O 1 0.9892451763153076
. O 0 0.16108690202236176

In O 0 0.01810585707426071
addition O 0 0.012804591096937656
, O 0 0.006122926250100136
a O 0 0.006968901492655277
correlation O 0 0.06883076578378677
between O 0 0.007876133546233177
smooth O 0 0.0730699971318245
pursuit O 0 0.023378176614642143
gain O 0 0.007186908274888992
and O 0 0.00297932093963027
the O 0 0.002944478066638112
number O 0 0.004176540765911341
of O 0 0.006164240185171366
trinucleotide O 1 0.8599572777748108
repeats O 0 0.17577359080314636
was O 0 0.00933436956256628
found O 0 0.016019854694604874
. O 0 0.018130483105778694

In O 0 0.032075412571430206
SCA3 B-Disease 1 0.6082526445388794
, O 0 0.017246300354599953
gaze B-Disease 0 0.27732011675834656
- I-Disease 0 0.30748602747917175
evoked I-Disease 1 0.5170918703079224
nystagmus I-Disease 1 0.9147020578384399
was O 0 0.00760028138756752
often O 0 0.007087855599820614
present O 0 0.005045650526881218
as O 0 0.00416602473706007
was O 0 0.006468961015343666
saccade O 1 0.657855749130249
hypometria O 0 0.34199848771095276
and O 0 0.0075984192080795765
smooth O 0 0.07782064378261566
pursuit O 0 0.05160102620720863
gain O 0 0.02255939319729805
was O 0 0.012585227377712727
markedly O 0 0.396940141916275
decreased O 0 0.3198069930076599
. O 0 0.02990727126598358

Three O 0 0.02368365041911602
major O 0 0.01946234330534935
criteria O 0 0.023009859025478363
, O 0 0.012067357078194618
saccade O 1 0.6692764759063721
amplitude O 0 0.20753087103366852
, O 0 0.010752160102128983
saccade O 0 0.43906038999557495
velocity O 0 0.023317353799939156
, O 0 0.004829666577279568
and O 0 0.003390404861420393
presence O 0 0.007998891174793243
of O 0 0.004495792556554079
gaze B-Disease 0 0.23342140018939972
- I-Disease 0 0.4249574840068817
evoked I-Disease 1 0.6884265542030334
nystagmus I-Disease 1 0.9608739018440247
, O 0 0.00539830606430769
permitted O 0 0.005651203915476799
the O 0 0.0035768982488662004
correct O 0 0.02303343266248703
assignment O 0 0.007844561710953712
of O 0 0.002396493451669812
90 O 0 0.004461720585823059
% O 0 0.004009941127151251
of O 0 0.0023541331756860018
the O 0 0.002859830856323242
SCA1 B-Disease 0 0.1304236352443695
, O 0 0.0031423205509781837
90 O 0 0.004667038097977638
% O 0 0.004257034044712782
of O 0 0.002001261804252863
the O 0 0.002920278115198016
SCA2 B-Disease 0 0.1251894235610962
, O 0 0.0029251386877149343
and O 0 0.0021711220033466816
93 O 0 0.006828273646533489
% O 0 0.00497583020478487
of O 0 0.0027057465631514788
the O 0 0.004495393950492144
patients O 1 0.8749690055847168
with O 0 0.01059680338948965
SCA3 B-Disease 1 0.5982155799865723
to O 0 0.004381441976875067
their O 0 0.009581312537193298
genetically O 1 0.9316686987876892
confirmed O 0 0.34338274598121643
patient O 1 0.8429720401763916
group O 0 0.010041669011116028
and O 0 0.002814766950905323
, O 0 0.0026822108775377274
therefore O 0 0.004078657366335392
, O 0 0.0031524612568318844
may O 0 0.008748489432036877
help O 0 0.011771352030336857
orient O 0 0.07861439883708954
diagnoses O 1 0.9157699942588806
of O 0 0.007903597317636013
SCA1 B-Disease 1 0.5861250162124634
, O 0 0.007044103462249041
SCA2 B-Disease 0 0.3049167990684509
, O 0 0.00452430872246623
and O 0 0.004229237325489521
SCA3 B-Disease 0 0.41686245799064636
at O 0 0.007584156934171915
early O 0 0.030862608924508095
clinical O 1 0.8489391803741455
stages O 0 0.19961947202682495
of O 0 0.008083740249276161
the O 0 0.03819487988948822
diseases O 1 0.9906439781188965
. O 0 0.021466920152306557
. O 0 0.023421917110681534

Genetic O 1 0.7164226770401001
basis O 0 0.029057037085294724
and O 0 0.01960686966776848
molecular O 1 0.7183911800384521
mechanism O 1 0.7791863679885864
for O 0 0.25163477659225464
idiopathic B-Disease 1 0.9924236536026001
ventricular I-Disease 1 0.9872503280639648
fibrillation I-Disease 1 0.9837146401405334
. O 0 0.12390561401844025

Ventricular B-Disease 1 0.9746734499931335
fibrillation I-Disease 1 0.9786726236343384
causes O 1 0.6262866258621216
more O 0 0.012067596428096294
than O 0 0.008553440682590008
300 O 0 0.01009984128177166
, O 0 0.006435637827962637
000 O 0 0.04796648398041725
sudden O 0 0.4507686197757721
deaths O 0 0.16607722640037537
each O 0 0.005536338314414024
year O 0 0.006115876603871584
in O 0 0.004638694226741791
the O 0 0.005878016352653503
USA O 0 0.024555616080760956
alone O 0 0.020603319630026817
. O 0 0.016775695607066154

In O 0 0.017514480277895927
approximately O 0 0.014196883887052536
5 O 0 0.012344422750175
- O 0 0.023387201130390167
12 O 0 0.006160332355648279
% O 0 0.005314795766025782
of O 0 0.0024986809585243464
these O 0 0.0032935647759586573
cases O 0 0.01304525788873434
, O 0 0.0023629709612578154
there O 0 0.0021257842890918255
are O 0 0.002724924124777317
no O 0 0.016787514090538025
demonstrable O 1 0.9719085693359375
cardiac O 1 0.9955646991729736
or O 0 0.29023170471191406
non O 1 0.730279266834259
- O 1 0.9426743984222412
cardiac O 1 0.9954743981361389
causes O 1 0.7855024933815002
to O 0 0.004325174726545811
account O 0 0.0056260512210428715
for O 0 0.002772797364741564
the O 0 0.0027492607478052378
episode O 0 0.008736911229789257
, O 0 0.003277973271906376
which O 0 0.002956463024020195
is O 0 0.004117988515645266
therefore O 0 0.01865381747484207
classified O 0 0.275518000125885
as O 0 0.1886131465435028
idiopathic B-Disease 1 0.9965676069259644
ventricular I-Disease 1 0.9950725436210632
fibrillation I-Disease 1 0.9959970712661743
( O 1 0.7831327319145203
IVF B-Disease 1 0.9812241792678833
) O 0 0.09670945256948471
. O 0 0.028702424839138985

A O 0 0.03464515134692192
distinct O 0 0.0781606137752533
group O 0 0.025142157450318336
of O 0 0.018414421007037163
IVF B-Disease 1 0.9867794513702393
patients O 1 0.9282135963439941
has O 0 0.0064342692494392395
been O 0 0.004236122593283653
found O 0 0.004204933065921068
to O 0 0.0027677747420966625
present O 0 0.0042931134812533855
with O 0 0.004664795007556677
a O 0 0.01068065408617258
characteristic O 0 0.48414522409439087
electrocardiographic O 1 0.7688941955566406
pattern O 1 0.5167368650436401
. O 0 0.030506065115332603

Because O 0 0.016193639487028122
of O 0 0.006768267136067152
the O 0 0.004247631411999464
small O 0 0.004742189776152372
size O 0 0.004561166279017925
of O 0 0.0027316163759678602
most O 0 0.0037427684292197227
pedigrees O 0 0.17718125879764557
and O 0 0.002699372125789523
the O 0 0.0037417251151055098
high O 0 0.0413106270134449
incidence O 1 0.9387406706809998
of O 0 0.007576283533126116
sudden B-Disease 1 0.6866204142570496
death I-Disease 0 0.11658837646245956
, O 0 0.005940944887697697
however O 0 0.006252644117921591
, O 0 0.009173993952572346
molecular O 1 0.8522260189056396
genetic O 1 0.9579441547393799
studies O 0 0.10959392040967941
of O 0 0.007566175889223814
IVF B-Disease 1 0.9364683032035828
have O 0 0.005113314371556044
not O 0 0.003805549582466483
yet O 0 0.0059276847168803215
been O 0 0.006979035679250956
done O 0 0.01282294001430273
. O 0 0.016259130090475082

Because O 1 0.7095216512680054
IVF B-Disease 1 0.9804702401161194
causes O 1 0.9810922145843506
cardiac O 1 0.9904922842979431
rhythm O 1 0.8536993861198425
disturbance O 1 0.635246992111206
, O 0 0.008609538897871971
we O 0 0.005049865692853928
investigated O 0 0.01677614264190197
whether O 0 0.008669712580740452
malfunction O 0 0.46588394045829773
of O 0 0.005993641912937164
ion O 0 0.37779977917671204
channels O 0 0.074407197535038
could O 0 0.019637489691376686
cause O 1 0.645895779132843
the O 0 0.03365622088313103
disorder O 1 0.9928299784660339
by O 0 0.021759692579507828
studying O 0 0.14459441602230072
mutations O 1 0.9722718596458435
in O 0 0.012538885697722435
the O 0 0.030220914632081985
cardiac O 1 0.9872158169746399
sodium O 1 0.929937481880188
channel O 0 0.3872973620891571
gene O 1 0.9560145735740662
SCN5A O 1 0.7969463467597961
. O 0 0.045454077422618866

We O 0 0.013315333984792233
have O 0 0.008698373101651669
now O 0 0.00780066940933466
identified O 0 0.017013318836688995
a O 0 0.017215510830283165
missense O 1 0.9655394554138184
mutation O 1 0.9771661758422852
, O 0 0.01195566076785326
a O 0 0.03316112607717514
splice O 1 0.9634494781494141
- O 1 0.8436792492866516
donor O 1 0.9566548466682434
mutation O 1 0.9778048396110535
, O 0 0.0076805828139185905
and O 0 0.005724422633647919
a O 0 0.018629340454936028
frameshift O 1 0.9787437319755554
mutation O 1 0.9686545133590698
in O 0 0.006800210569053888
the O 0 0.006240224000066519
coding O 1 0.588134765625
region O 0 0.013807643204927444
of O 0 0.006055744830518961
SCN5A O 0 0.3494461178779602
in O 0 0.009472408331930637
three O 0 0.018417170271277428
IVF B-Disease 1 0.9589682221412659
families O 0 0.10398180782794952
. O 0 0.030319077894091606

We O 0 0.013702603988349438
show O 0 0.011998088099062443
that O 0 0.006994763854891062
sodium O 0 0.10158982872962952
channels O 0 0.01482064463198185
with O 0 0.0069198631681501865
the O 0 0.01120706181973219
missense O 1 0.9720787405967712
mutation O 1 0.9869488477706909
recover O 0 0.36782175302505493
from O 0 0.0120401531457901
inactivation O 0 0.45623892545700073
more O 0 0.005784953478723764
rapidly O 0 0.03904210031032562
than O 0 0.004731518682092428
normal O 0 0.024052487686276436
and O 0 0.0033291957806795835
that O 0 0.004172482527792454
the O 0 0.011338566429913044
frameshift O 1 0.9886090755462646
mutation O 1 0.9922961592674255
causes O 1 0.8249634504318237
the O 0 0.008502374403178692
sodium O 0 0.3647947609424591
channel O 0 0.013294488191604614
to O 0 0.004405649844557047
be O 0 0.005575868301093578
non O 0 0.03650462254881859
- O 0 0.18024781346321106
functional O 0 0.30313560366630554
. O 0 0.029833117499947548

Our O 0 0.02642180398106575
results O 0 0.03123321756720543
indicate O 0 0.040444787591695786
that O 0 0.01911148615181446
mutations O 1 0.979470431804657
in O 0 0.0965270847082138
cardiac O 1 0.992172360420227
ion O 1 0.7980899214744568
- O 0 0.4250648319721222
channel O 0 0.09319815039634705
genes O 1 0.8351089954376221
contribute O 0 0.039743199944496155
to O 0 0.004834162537008524
the O 0 0.005719303153455257
risk O 0 0.49294817447662354
of O 0 0.010823235847055912
developing O 1 0.6202039122581482
IVF B-Disease 1 0.9651161432266235
. O 0 0.024040773510932922
. O 0 0.023315932601690292

Molecular O 1 0.7188963890075684
heterogeneity O 1 0.5940419435501099
in O 0 0.02044094167649746
mucopolysaccharidosis B-Disease 1 0.631447970867157
IVA I-Disease 1 0.6406998634338379
in O 0 0.007949245162308216
Australia O 0 0.006598995998501778
and O 0 0.0035588108003139496
Northern O 0 0.0058382912538945675
Ireland O 0 0.008896169252693653
: O 0 0.006736933719366789
nine O 0 0.008967497386038303
novel O 0 0.28201186656951904
mutations O 1 0.972000002861023
including O 0 0.014275558292865753
T312S O 0 0.3904017210006714
, O 0 0.006668810732662678
a O 0 0.011374924331903458
common O 0 0.24740858376026154
allele O 1 0.9460774660110474
that O 0 0.020116694271564484
confers O 1 0.7102130651473999
a O 0 0.11342169344425201
mild O 1 0.9689902663230896
phenotype O 1 0.9780087471008301
. O 0 0.07795290648937225

Mucopolysaccharidosis B-Disease 1 0.8623064160346985
IVA I-Disease 1 0.8843984007835388
( O 0 0.13850688934326172
MPS B-Disease 0 0.3664943277835846
IVA I-Disease 1 0.9531769156455994
) O 0 0.08088196069002151
is O 0 0.045714013278484344
an O 0 0.4001851975917816
autosomal B-Disease 1 0.9979817867279053
recessive I-Disease 1 0.9975351095199585
lysosomal I-Disease 1 0.9922892451286316
storage I-Disease 1 0.9161093235015869
disorder I-Disease 1 0.9932384490966797
caused O 1 0.6558364033699036
by O 0 0.02454715594649315
a O 0 0.10368324816226959
genetic B-Disease 1 0.985765814781189
defect I-Disease 1 0.9660409688949585
in O 0 0.0229154285043478
N O 0 0.4019830524921417
- O 1 0.6369529366493225
acetylgalactosamine O 1 0.8752933144569397
- O 1 0.632088303565979
6 O 0 0.17086249589920044
- O 1 0.8450403213500977
sulfate O 1 0.9804437160491943
sulfatase O 1 0.9745247960090637
( O 0 0.2548096179962158
GALNS O 1 0.7198763489723206
) O 0 0.03885442391037941
. O 0 0.029250439256429672

Previous O 0 0.03239350765943527
studies O 0 0.029886871576309204
of O 0 0.01007892470806837
patients O 1 0.6122108697891235
from O 0 0.00712323235347867
a O 0 0.007864749990403652
British O 0 0.012501673772931099
- O 0 0.06669237464666367
Irish O 0 0.04156055673956871
population O 0 0.0091954180970788
showed O 0 0.005810365546494722
that O 0 0.003076673950999975
the O 0 0.00396724883466959
I113F O 1 0.568366527557373
mutation O 1 0.9470393061637878
is O 0 0.004642751533538103
the O 0 0.0032322925981134176
most O 0 0.005502574145793915
common O 0 0.12650881707668304
single O 0 0.17438815534114838
mutation O 1 0.9875800013542175
among O 0 0.16299240291118622
MPS B-Disease 1 0.8613325953483582
IVA I-Disease 1 0.9916063547134399
patients O 1 0.9890543222427368
and O 0 0.03602631762623787
produces O 1 0.6852716207504272
a O 0 0.2516409158706665
severe O 1 0.9850791692733765
clinical O 1 0.9804328680038452
phenotype O 1 0.9818461537361145
. O 0 0.11165177077054977

We O 0 0.019814152270555496
studied O 0 0.04147138446569443
mutations O 1 0.8905901312828064
in O 0 0.009093321859836578
the O 0 0.008461862802505493
GALNS O 1 0.7543060779571533
gene O 1 0.8777986168861389
from O 0 0.011033627204596996
23 O 0 0.018132248893380165
additional O 0 0.027277367189526558
MPS B-Disease 0 0.43566563725471497
IVA I-Disease 1 0.9834161996841431
patients O 1 0.9477993249893188
( O 0 0.01655142940580845
15 O 0 0.005835092626512051
from O 0 0.0035909705329686403
Australia O 0 0.003567455103620887
, O 0 0.0027730439323931932
8 O 0 0.0037507086526602507
from O 0 0.002928311238065362
Northern O 0 0.00515141524374485
Ireland O 0 0.008817708119750023
) O 0 0.0057531618513166904
, O 0 0.003047781065106392
with O 0 0.005718229338526726
various O 0 0.03578455001115799
clinical O 1 0.9861837029457092
phenotypes O 1 0.9936996698379517
( O 1 0.5021572113037109
severe O 1 0.9676799178123474
, O 0 0.008791291154921055
16 O 0 0.01784367300570011
cases O 0 0.13693904876708984
; O 0 0.012710782699286938
intermediate O 0 0.08978170156478882
, O 0 0.006050871219485998
4 O 0 0.028245123103260994
cases O 0 0.31977608799934387
; O 0 0.06553933024406433
mild O 1 0.7891272306442261
, O 0 0.006723823491483927
3 O 0 0.018882285803556442
cases O 0 0.10673291236162186
) O 0 0.021387482061982155
. O 0 0.01687013916671276

We O 0 0.012369790114462376
found O 0 0.0111711286008358
two O 0 0.007316863629966974
common O 0 0.077363021671772
mutations O 1 0.8511645793914795
that O 0 0.00338345835916698
together O 0 0.004206574521958828
accounted O 0 0.007531128358095884
for O 0 0.0030505063477903605
32 O 0 0.004769304301589727
% O 0 0.004219196271151304
of O 0 0.0025588166899979115
the O 0 0.004226077813655138
44 O 0 0.02582637593150139
unrelated O 1 0.6696377992630005
alleles O 1 0.9645712375640869
in O 0 0.020457442849874496
these O 0 0.03253188356757164
patients O 1 0.9499898552894592
. O 0 0.03735126182436943

One O 0 0.018372435122728348
is O 0 0.010312294587492943
the O 0 0.010004262439906597
T312S O 1 0.7069929242134094
mutation O 1 0.9650417566299438
, O 0 0.008305615745484829
a O 0 0.012405533343553543
novel O 0 0.25909939408302307
mutation O 1 0.972989559173584
found O 0 0.03440581634640694
exclusively O 0 0.035029925405979156
in O 0 0.026646098122000694
milder O 1 0.9505558609962463
patients O 1 0.9636502265930176
. O 0 0.048419609665870667

The O 0 0.013316197320818901
other O 0 0.007952106185257435
is O 0 0.005876799114048481
the O 0 0.00508620822802186
previously O 0 0.00799529068171978
described O 0 0.018154870718717575
I113F O 0 0.2942346930503845
that O 0 0.010516942478716373
produces O 0 0.3027660548686981
a O 0 0.0818718746304512
severe O 1 0.9753888845443726
phenotype O 1 0.9787110686302185
. O 0 0.06543264538049698

The O 0 0.025967130437493324
I113F O 0 0.15993332862854004
and O 0 0.016882970929145813
T312S O 1 0.6469405293464661
mutations O 1 0.9476243853569031
accounted O 0 0.031898003071546555
for O 0 0.006624097470194101
8 O 0 0.00884972233325243
( O 0 0.008848167024552822
18 O 0 0.006597879808396101
% O 0 0.007373995613306761
) O 0 0.004634121432900429
and O 0 0.0023330370895564556
6 O 0 0.0056715370155870914
( O 0 0.00652703084051609
14 O 0 0.005497368052601814
% O 0 0.007816310971975327
) O 0 0.004833743441849947
of O 0 0.0037781207356601954
44 O 0 0.018961023539304733
unrelated O 1 0.5013304948806763
alleles O 1 0.9373464584350586
, O 0 0.01189615111798048
respectively O 0 0.018351919949054718
. O 0 0.016329852864146233

The O 0 0.02160142920911312
relatively O 0 0.030758727341890335
high O 0 0.02057627961039543
residual O 0 0.3247196674346924
GALNS O 0 0.4648585915565491
activity O 0 0.02602705918252468
seen O 0 0.008795443922281265
when O 0 0.006535388063639402
the O 0 0.006438517477363348
T312S O 1 0.5438464283943176
mutant O 1 0.8670296669006348
cDNA O 1 0.751644492149353
is O 0 0.029330329969525337
overexpressed O 1 0.9080779552459717
in O 0 0.023819444701075554
mutant O 1 0.9412257075309753
cells O 1 0.8728119730949402
provides O 0 0.020499523729085922
an O 0 0.005520844366401434
explanation O 0 0.022979039698839188
for O 0 0.005795670207589865
the O 0 0.02137763984501362
mild O 1 0.9853954911231995
phenotype O 1 0.99480801820755
in O 0 0.11150014400482178
patients O 1 0.9696244597434998
with O 0 0.02850501425564289
this O 0 0.033708833158016205
mutation O 1 0.9757163524627686
. O 0 0.037380144000053406

The O 0 0.016472013667225838
distribution O 0 0.01719532161951065
and O 0 0.005406409502029419
relative O 0 0.009051840752363205
frequencies O 0 0.01023060455918312
of O 0 0.0035202805884182453
the O 0 0.004003902897238731
I113F O 0 0.15490585565567017
and O 0 0.006941559724509716
T312S O 1 0.6375812292098999
mutations O 1 0.9365819096565247
in O 0 0.0054931361228227615
Australia O 0 0.005291415844112635
corresponded O 0 0.00972976628690958
to O 0 0.0027870407793670893
those O 0 0.0029406922403723
observed O 0 0.006968775764107704
in O 0 0.0026430850848555565
Northern O 0 0.003997497726231813
Ireland O 0 0.00410390505567193
and O 0 0.0018136192811653018
are O 0 0.0016286139143630862
unique O 0 0.0031482288613915443
to O 0 0.0016380129382014275
these O 0 0.0020057980436831713
two O 0 0.002748368075117469
populations O 0 0.08378750085830688
, O 0 0.002593528712168336
suggesting O 0 0.008684972301125526
that O 0 0.0023710974492132664
both O 0 0.0039712307043373585
mutations O 1 0.8643338680267334
were O 0 0.002686842577531934
probably O 0 0.003958411980420351
introduced O 0 0.004085822496563196
to O 0 0.0023690296802669764
Australia O 0 0.0032142638228833675
by O 0 0.003754414850845933
Irish O 0 0.012369679287075996
migrants O 0 0.008790601044893265
during O 0 0.006507428362965584
the O 0 0.0056604347191751
19th O 0 0.014495033770799637
century O 0 0.01762336492538452
. O 0 0.01978112757205963

Haplotype O 1 0.8196327686309814
analysis O 0 0.039366986602544785
using O 0 0.01920362561941147
6 O 0 0.015941636636853218
RFLPs O 0 0.11467394977807999
provides O 0 0.00998462550342083
additional O 0 0.006255182903259993
data O 0 0.005079593509435654
that O 0 0.003485536901280284
the O 0 0.005336397793143988
I113F O 1 0.6665027141571045
mutation O 1 0.9627900719642639
originated O 0 0.04342164099216461
from O 0 0.0074507808312773705
a O 0 0.011574000120162964
common O 0 0.0821562185883522
ancestor O 0 0.40445488691329956
. O 0 0.029007062315940857

The O 0 0.016649262979626656
other O 0 0.01208481565117836
9 O 0 0.019501516595482826
novel O 0 0.3084222078323364
mutations O 1 0.9667292237281799
identified O 0 0.028185125440359116
in O 0 0.005337470676749945
these O 0 0.004315544385462999
23 O 0 0.01347877737134695
patients O 0 0.4839246869087219
were O 0 0.002648351015523076
each O 0 0.003256950993090868
limited O 0 0.00489446148276329
to O 0 0.0035585740115493536
a O 0 0.006007492076605558
single O 0 0.01439021248370409
family O 0 0.03913545235991478
. O 0 0.020358746871352196

These O 0 0.013946802355349064
data O 0 0.01055877935141325
provide O 0 0.007847754284739494
further O 0 0.006269115023314953
evidence O 0 0.006088598165661097
for O 0 0.0060117170214653015
extensive O 0 0.03436361253261566
allelic O 1 0.8552913665771484
heterogeneity O 1 0.6256289482116699
in O 0 0.012302031740546227
MPS B-Disease 0 0.19005748629570007
IVA I-Disease 1 0.9404138326644897
in O 0 0.015676062554121017
British O 0 0.07832633703947067
- O 0 0.42584511637687683
Irish O 0 0.3966769576072693
patients O 1 0.8698710799217224
and O 0 0.0031930962577462196
provide O 0 0.004677811171859503
evidence O 0 0.004092850256711245
for O 0 0.0027088415808975697
their O 0 0.0030369036830961704
transmission O 0 0.16634656488895416
to O 0 0.003325661411508918
Australia O 0 0.004931055009365082
by O 0 0.004980653058737516
British O 0 0.01147305779159069
- O 0 0.08513621240854263
Irish O 0 0.055540669709444046
migrants O 0 0.029877083376049995
. O 0 0.01212697196751833
. O 0 0.017789218574762344

Identification O 0 0.049050576984882355
of O 0 0.018572920933365822
constitutional O 0 0.13662759959697723
WT1 O 1 0.9792975783348083
mutations O 1 0.981745183467865
, O 0 0.027274731546640396
in O 0 0.05569764971733093
patients O 1 0.9794647097587585
with O 0 0.1753530204296112
isolated O 1 0.9740773439407349
diffuse B-Disease 1 0.994206428527832
mesangial I-Disease 1 0.9964009523391724
sclerosis I-Disease 1 0.9967851638793945
, O 0 0.01835002936422825
and O 0 0.008352871052920818
analysis O 0 0.04567878693342209
of O 0 0.021698299795389175
genotype O 1 0.9876036643981934
/ O 1 0.9382731914520264
phenotype O 1 0.9861549735069275
correlations O 1 0.5299871563911438
by O 0 0.007522038649767637
use O 0 0.007087657693773508
of O 0 0.006098446436226368
a O 0 0.019002333283424377
computerized O 1 0.7564532160758972
mutation O 1 0.9669017791748047
database O 0 0.2366867959499359
. O 0 0.03274117037653923

Constitutional O 0 0.07094573974609375
mutations O 1 0.7506155371665955
of O 0 0.012345184572041035
the O 0 0.016148289665579796
WT1 O 1 0.9684204459190369
gene O 1 0.922636866569519
, O 0 0.011535818688571453
encoding O 0 0.28185591101646423
a O 0 0.03651174530386925
zinc O 1 0.9129573106765747
- O 1 0.7431953549385071
finger O 1 0.8657602071762085
transcription O 1 0.9616289734840393
factor O 1 0.6063421368598938
involved O 0 0.12018513679504395
in O 0 0.06588691473007202
renal O 1 0.9960108995437622
and O 0 0.030602650716900826
gonadal O 1 0.9716697931289673
development O 0 0.02192729152739048
, O 0 0.00387555081397295
are O 0 0.0025467905215919018
found O 0 0.0048016817308962345
in O 0 0.004620458465069532
most O 0 0.021624108776450157
patients O 1 0.9827172160148621
with O 0 0.32091954350471497
Denys B-Disease 1 0.9918609261512756
- I-Disease 1 0.9854015111923218
Drash I-Disease 1 0.9928881525993347
syndrome I-Disease 1 0.9984277486801147
( O 1 0.7828786969184875
DDS B-Disease 1 0.9772863984107971
) O 0 0.08807577192783356
, O 0 0.02230769395828247
or O 0 0.369078129529953
diffuse B-Disease 1 0.9917553663253784
mesangial I-Disease 1 0.9955440163612366
sclerosis I-Disease 1 0.9978770017623901
( O 1 0.7977024912834167
DMS B-Disease 1 0.976527988910675
) O 0 0.07059147953987122
associated O 0 0.057298656553030014
with O 0 0.014029081910848618
pseudohermaphroditism B-Disease 1 0.7553437948226929
and O 0 0.02704656310379505
/ O 1 0.8507013916969299
or O 0 0.47624731063842773
Wilms B-Disease 1 0.992255687713623
tumor I-Disease 1 0.9914968609809875
( O 0 0.35768967866897583
WT B-Disease 1 0.9434101581573486
) O 0 0.04549112170934677
. O 0 0.02521575801074505

Most O 0 0.07524695992469788
mutations O 1 0.9712409377098083
in O 0 0.08285040408372879
DDS B-Disease 1 0.9760313630104065
patients O 1 0.9490334391593933
lie O 0 0.026156935840845108
in O 0 0.008797036483883858
exon O 0 0.3226776719093323
8 O 0 0.01639990322291851
or O 0 0.01284322515130043
exon O 0 0.42582112550735474
9 O 0 0.014014284126460552
, O 0 0.0070755877532064915
encoding O 0 0.4250386953353882
zinc O 1 0.6720947623252869
finger O 0 0.358206570148468
2 O 0 0.018988683819770813
or O 0 0.02690645307302475
zinc O 1 0.5811964273452759
finger O 0 0.1793600469827652
3 O 0 0.007827168330550194
, O 0 0.0038283076137304306
respectively O 0 0.004543001297861338
, O 0 0.0029335732106119394
with O 0 0.0033125546760857105
a O 0 0.005317872390151024
hot O 0 0.017991896718740463
spot O 0 0.023099727928638458
( O 0 0.03274819627404213
R394W O 0 0.3391406834125519
) O 0 0.014299914240837097
in O 0 0.010061131790280342
exon O 0 0.36036446690559387
9 O 0 0.025862500071525574
. O 0 0.021908767521381378

We O 0 0.013846369460225105
analyzed O 0 0.020443221554160118
a O 0 0.008865813724696636
series O 0 0.009431921876966953
of O 0 0.004980209283530712
24 O 0 0.0242383424192667
patients O 1 0.8518380522727966
, O 0 0.005354227963835001
10 O 0 0.007801758591085672
with O 0 0.013160151429474354
isolated B-Disease 1 0.7328466176986694
DMS I-Disease 1 0.981929361820221
( O 0 0.2421797811985016
IDMS B-Disease 1 0.9778152704238892
) O 0 0.01228251587599516
, O 0 0.004375906195491552
10 O 0 0.0059556118212640285
with O 0 0.008540971204638481
DDS B-Disease 1 0.7648638486862183
, O 0 0.004457653500139713
and O 0 0.003684938419610262
4 O 0 0.010717220604419708
with O 0 0.03081207536160946
urogenital B-Disease 1 0.9846996665000916
abnormalities I-Disease 1 0.9909152388572693
and O 0 0.029378622770309448
/ O 1 0.6838988065719604
or O 0 0.07782173901796341
WT B-Disease 1 0.9130728840827942
. O 0 0.038014769554138184

We O 0 0.033645953983068466
report O 0 0.09955761581659317
WT1 O 1 0.9663856029510498
heterozygous O 1 0.9690507054328918
mutations O 1 0.9755268692970276
in O 0 0.016309361904859543
16 O 0 0.038654930889606476
patients O 1 0.8323008418083191
, O 0 0.006083017680794001
4 O 0 0.007318949326872826
of O 0 0.005143328569829464
whom O 0 0.01096431165933609
presented O 0 0.012523666955530643
with O 0 0.019823499023914337
IDMS B-Disease 1 0.9426258206367493
. O 0 0.033829715102910995

One O 0 0.02034677006304264
male O 0 0.051441241055727005
and O 0 0.010103282518684864
two O 0 0.014863754622638226
female O 1 0.8278404474258423
IDMS B-Disease 1 0.9896112680435181
patients O 1 0.9885462522506714
with O 0 0.4933095872402191
WT1 O 1 0.9875645041465759
mutations O 1 0.9916485548019409
underwent O 1 0.9674493074417114
normal O 1 0.7988158464431763
puberty O 1 0.9468556642532349
. O 0 0.05494077876210213

Two O 0 0.04263801500201225
mutations O 1 0.9618257880210876
associated O 0 0.13998271524906158
with O 0 0.016745008528232574
IDMS B-Disease 1 0.8802047371864319
are O 0 0.00542644876986742
different O 0 0.006251835264265537
from O 0 0.005359296686947346
those O 0 0.007527743931859732
described O 0 0.06563445925712585
in O 0 0.05865219235420227
DDS B-Disease 1 0.978354811668396
patients O 1 0.9734223484992981
. O 0 0.05178877338767052

No O 0 0.08670982718467712
WT1 O 1 0.9566587805747986
mutations O 1 0.921151876449585
were O 0 0.008908675983548164
detected O 0 0.09997811168432236
in O 0 0.004835454281419516
the O 0 0.004505829885601997
six O 0 0.01010570116341114
other O 0 0.0450248196721077
IDMS B-Disease 1 0.9916505217552185
patients O 1 0.9855555295944214
, O 0 0.031379710882902145
suggesting O 0 0.4717823266983032
genetic O 1 0.9769636988639832
heterogeneity O 1 0.7435927391052246
of O 0 0.013710036873817444
this O 0 0.0557713657617569
disease O 1 0.9898781776428223
. O 0 0.06077568605542183

We O 0 0.03122517094016075
analyzed O 0 0.4295012652873993
genotype O 1 0.9752115607261658
/ O 1 0.898144543170929
phenotype O 1 0.9733805060386658
correlations O 0 0.23677243292331696
, O 0 0.004129085224121809
on O 0 0.002302558161318302
the O 0 0.0019568458665162325
basis O 0 0.002534559229388833
of O 0 0.001812224742025137
the O 0 0.0023585183080285788
constitution O 0 0.005114508327096701
of O 0 0.003505155211314559
a O 0 0.024344434961676598
WT1 O 1 0.9855263233184814
mutation O 1 0.9844324588775635
database O 0 0.10373084992170334
of O 0 0.006796121597290039
84 O 0 0.16622164845466614
germ O 1 0.9494206309318542
- O 0 0.32233601808547974
line O 0 0.04810313507914543
mutations O 1 0.9445338249206543
, O 0 0.0035803024657070637
to O 0 0.002419583033770323
compare O 0 0.014196702279150486
the O 0 0.0029099304229021072
distribution O 0 0.017366532236337662
and O 0 0.0033077315893024206
type O 0 0.126412495970726
of O 0 0.005547638051211834
mutations O 1 0.9591459631919861
, O 0 0.004080309998244047
according O 0 0.004956529941409826
to O 0 0.0036901505663990974
the O 0 0.006163971498608589
different O 0 0.05630859360098839
symptoms O 1 0.98375004529953
. O 0 0.05191708728671074

This O 0 0.018845083191990852
demonstrated O 0 0.028822187334299088
( O 0 0.013727978803217411
1 O 0 0.008203103207051754
) O 0 0.005919199902564287
the O 0 0.003622733522206545
association O 0 0.013971368782222271
between O 0 0.015531109645962715
mutations O 1 0.9448123574256897
in O 0 0.009152301587164402
exons O 0 0.4837894141674042
8 O 0 0.008726723492145538
and O 0 0.0037663078401237726
9 O 0 0.008481905795633793
and O 0 0.00601661391556263
DMS B-Disease 1 0.9070596098899841
; O 0 0.01595567725598812
( O 0 0.014480269514024258
2 O 0 0.010908087715506554
) O 0 0.01468190923333168
among O 0 0.021138908341526985
patients O 1 0.9324824810028076
with O 0 0.01442761905491352
DMS B-Disease 1 0.810809850692749
, O 0 0.004198731388896704
a O 0 0.0051110731437802315
higher O 0 0.009349063970148563
frequency O 0 0.025013312697410583
of O 0 0.006246448960155249
exon O 1 0.605067789554596
8 O 0 0.0796782448887825
mutations O 1 0.9647727012634277
among O 0 0.0203276127576828
46 O 0 0.0820959210395813
, O 0 0.04492056742310524
XY O 1 0.9753890037536621
patients O 1 0.9604176878929138
with O 0 0.025870544835925102
female O 0 0.45762917399406433
phenotype O 1 0.9781768321990967
than O 0 0.010858011431992054
among O 0 0.017883487045764923
46 O 0 0.08114911615848541
, O 0 0.046166568994522095
XY O 1 0.9862825274467468
patients O 1 0.9777827858924866
with O 0 0.029770363122224808
sexual O 0 0.4840381145477295
ambiguity O 0 0.39328819513320923
or O 0 0.11642926931381226
male O 1 0.8670841455459595
phenotype O 1 0.9918226599693298
; O 0 0.020690886303782463
and O 0 0.004411262925714254
( O 0 0.009978345595300198
3 O 0 0.007744950242340565
) O 0 0.005622576456516981
statistically O 0 0.017099529504776
significant O 0 0.007411031983792782
evidence O 0 0.006120475009083748
that O 0 0.0048408592119812965
mutations O 1 0.8815916180610657
in O 0 0.006523638963699341
exons O 0 0.408699095249176
8 O 0 0.00924896914511919
and O 0 0.004208164289593697
9 O 0 0.01025384571403265
preferentially O 0 0.23441539704799652
affect O 0 0.21778462827205658
amino O 0 0.4880819618701935
acids O 0 0.4033513069152832
with O 0 0.006897374521940947
different O 0 0.0077105797827243805
functions O 0 0.015210247598588467
. O 0 0.00990232266485691
. O 0 0.01636878028512001

The O 0 0.0515022911131382
185delAG O 1 0.914542555809021
BRCA1 O 1 0.9864311814308167
mutation O 1 0.9611278176307678
originated O 0 0.04384142905473709
before O 0 0.006869725417345762
the O 0 0.004747722297906876
dispersion O 0 0.04051143303513527
of O 0 0.003780016442760825
Jews O 0 0.005076664034277201
in O 0 0.0029490715824067593
the O 0 0.003087869845330715
diaspora O 0 0.015132490545511246
and O 0 0.0032978628296405077
is O 0 0.003077759640291333
not O 0 0.003534459974616766
limited O 0 0.008415189571678638
to O 0 0.007644986733794212
Ashkenazim O 0 0.397095650434494
. O 0 0.0211930088698864

The O 0 0.041008759289979935
185delAG O 1 0.8858950734138489
mutation O 1 0.9776318073272705
in O 0 0.07800885289907455
BRCA1 O 1 0.9866394400596619
is O 0 0.0246854517608881
detected O 0 0.38511744141578674
in O 0 0.009863370098173618
Ashkenazi O 0 0.40928664803504944
Jews O 0 0.02004740945994854
both O 0 0.020269492641091347
in O 0 0.20078541338443756
familial B-Disease 1 0.9969893097877502
breast I-Disease 1 0.9979438185691833
and I-Disease 1 0.7745220065116882
ovarian I-Disease 1 0.9990310668945312
cancer I-Disease 1 0.9960657954216003
and O 0 0.008386930450797081
in O 0 0.005898540373891592
the O 0 0.006410882342606783
general O 0 0.010427752509713173
population O 0 0.029139388352632523
. O 0 0.0195845365524292

All O 0 0.03028113767504692
tested O 1 0.6089125275611877
Ashkenazi O 1 0.9212213158607483
mutation O 1 0.9767034649848938
carriers O 0 0.29469215869903564
share O 0 0.012282544746994972
the O 0 0.007152233738452196
same O 0 0.012854820117354393
allelic O 1 0.8034852743148804
pattern O 0 0.278226763010025
at O 0 0.015647387132048607
the O 0 0.026709958910942078
BRCA1 O 1 0.986647367477417
locus O 1 0.9285457730293274
. O 0 0.053280748426914215

Our O 0 0.0163290873169899
previous O 0 0.014087785966694355
study O 0 0.012361201457679272
showed O 0 0.009027989581227303
that O 0 0.0048513817600905895
this O 0 0.007451257202774286
Ashkenazi O 1 0.8082228302955627
mutation O 1 0.9766586422920227
also O 0 0.00754602300003171
occurs O 0 0.11219417303800583
in O 0 0.00433124927803874
Iraqi O 0 0.006493398454040289
Jews O 0 0.005895781330764294
with O 0 0.005217707250267267
a O 0 0.008372959680855274
similar O 0 0.04314444959163666
allelic O 1 0.896081805229187
pattern O 1 0.5581047534942627
. O 0 0.03781025484204292

We O 0 0.01239650510251522
extended O 0 0.012718193233013153
our O 0 0.006603830028325319
analysis O 0 0.0077324314042925835
to O 0 0.00380618404597044
other O 0 0.004106478299945593
non O 0 0.0309011060744524
- O 0 0.14085394144058228
Ashkenazi O 0 0.38523995876312256
subsets O 0 0.11012277752161026
354 O 0 0.04241717979311943
of O 0 0.005812520161271095
Moroccan O 0 0.022793179377913475
origin O 0 0.01260549109429121
, O 0 0.005108913406729698
200 O 0 0.009486138820648193
Yemenites O 0 0.11334791779518127
and O 0 0.0070916758850216866
150 O 0 0.012894949875772
Iranian O 0 0.01580657623708248
Jews O 0 0.022294873371720314
. O 0 0.019937148317694664

Heteroduplex O 0 0.3004099428653717
analysis O 0 0.038660045713186264
complemented O 0 0.03457854315638542
by O 0 0.011429695412516594
direct O 0 0.025117089971899986
DNA O 0 0.46765878796577454
sequencing O 0 0.24598945677280426
of O 0 0.010850531049072742
abnormally O 1 0.8525019288063049
migrating O 0 0.20028556883335114
bands O 0 0.019942909479141235
were O 0 0.009540779516100883
employed O 0 0.026105308905243874
. O 0 0.02122086100280285

Four O 0 0.016603242605924606
of O 0 0.009851917624473572
Moroccan O 0 0.032266829162836075
origin O 0 0.015421411022543907
( O 0 0.01093837060034275
1 O 0 0.006096053868532181
. O 0 0.003463576314970851
1 O 0 0.004474765155464411
% O 0 0.005884096492081881
) O 0 0.003502702573314309
and O 0 0.0018195923184975982
none O 0 0.0028158004861325026
of O 0 0.001962984912097454
the O 0 0.0029065648559480906
Yemenites O 0 0.21441589295864105
or O 0 0.004747438710182905
Iranians O 0 0.005565418396145105
was O 0 0.0035306091886013746
a O 0 0.005065135657787323
carrier O 0 0.024687113240361214
of O 0 0.005280667450278997
the O 0 0.0105295330286026
185delAG O 1 0.7751621603965759
mutation O 1 0.9668739438056946
. O 0 0.043474290519952774

BRCA1 O 1 0.9610481858253479
allelic O 1 0.7764561176300049
patterns O 0 0.06114054098725319
were O 0 0.005967211443930864
determined O 0 0.006523250136524439
for O 0 0.003080470021814108
four O 0 0.002855701372027397
of O 0 0.0020470013841986656
these O 0 0.002348728943616152
individuals O 0 0.006036299746483564
and O 0 0.0024878366384655237
for O 0 0.0028256394434720278
12 O 0 0.005957786459475756
additional O 0 0.015552201308310032
non O 0 0.16772891581058502
- O 1 0.7404433488845825
Ashkenazi O 1 0.9724351763725281
185delAG O 1 0.9764361381530762
mutation O 1 0.9923535585403442
carriers O 1 0.8452670574188232
who O 0 0.09167250990867615
had O 0 0.49388840794563293
breast B-Disease 1 0.9969364404678345
/ I-Disease 1 0.9907752871513367
ovarian I-Disease 1 0.9977678060531616
cancer I-Disease 1 0.994037389755249
. O 0 0.2003808319568634

Six O 0 0.0375639982521534
non O 0 0.11059268563985825
- O 0 0.2649644911289215
Ashkenazi O 0 0.4473583996295929
individuals O 0 0.024909164756536484
shared O 0 0.01260792464017868
the O 0 0.007837406359612942
common O 0 0.2319832593202591
Ashkenazi O 1 0.7725529670715332
haplotype O 1 0.9266821146011353
, O 0 0.005026231519877911
four O 0 0.0038770996034145355
had O 0 0.0038770365063101053
a O 0 0.005751208867877722
closely O 0 0.020903101190924644
related O 0 0.09264341741800308
pattern O 0 0.10263769328594208
, O 0 0.003106171963736415
and O 0 0.002120478544384241
the O 0 0.002873029327020049
rest O 0 0.0069684823974967
( O 0 0.017274998128414154
n O 0 0.07707223296165466
= O 0 0.1522151380777359
6 O 0 0.011101930402219296
) O 0 0.008093880489468575
displayed O 0 0.009177054278552532
a O 0 0.015115642920136452
distinct O 1 0.5627298355102539
BRCA1 O 1 0.9902957081794739
allelic O 1 0.9597589373588562
pattern O 1 0.7907795906066895
. O 0 0.045748766511678696

We O 0 0.017247987911105156
conclude O 0 0.023556701838970184
that O 0 0.007948807440698147
the O 0 0.012658420950174332
185delAG O 1 0.9500055313110352
BRCA1 O 1 0.9940178394317627
mutation O 1 0.9892420172691345
occurs O 0 0.3843270540237427
in O 0 0.0068597933277487755
some O 0 0.007058809511363506
non O 0 0.13438533246517181
- O 0 0.48769310116767883
Ashkenazi O 1 0.7615067362785339
populations O 0 0.2704494595527649
at O 0 0.008581873960793018
rates O 0 0.04751770943403244
comparable O 0 0.023961305618286133
with O 0 0.005961348302662373
that O 0 0.005515090189874172
of O 0 0.009700140915811062
Ashkenazim O 1 0.5359410047531128
. O 0 0.02867012843489647

The O 0 0.016754699870944023
majority O 0 0.016574809327721596
of O 0 0.009201202541589737
Jewish O 0 0.06806155294179916
185delAG O 1 0.8955771923065186
mutation O 1 0.9835692048072815
carriers O 0 0.2803557217121124
have O 0 0.005093986168503761
a O 0 0.007679045666009188
common O 0 0.16961370408535004
allelic O 1 0.9133345484733582
pattern O 0 0.33817946910858154
, O 0 0.004178397357463837
supporting O 0 0.007557831238955259
the O 0 0.0037680640816688538
founder O 0 0.026967063546180725
effect O 0 0.03324885666370392
notion O 0 0.014053125865757465
, O 0 0.003220022190362215
but O 0 0.0030017332173883915
dating O 0 0.017622748389840126
the O 0 0.005006719846278429
mutations O 1 0.938471257686615
origin O 0 0.009692252613604069
to O 0 0.0029871829319745302
an O 0 0.002874018158763647
earlier O 0 0.005061219912022352
date O 0 0.005418808665126562
than O 0 0.004984201397746801
currently O 0 0.006710829678922892
estimated O 0 0.018104899674654007
. O 0 0.015631113201379776

However O 0 0.019116235896945
, O 0 0.008447411470115185
the O 0 0.006731390953063965
different O 0 0.010722914710640907
allelic O 1 0.771593451499939
pattern O 0 0.21849708259105682
at O 0 0.008903032168745995
the O 0 0.01346199307590723
BRCA1 O 1 0.9924970865249634
locus O 1 0.8176475763320923
even O 0 0.008158313110470772
in O 0 0.00451920460909605
some O 0 0.005461758002638817
Jewish O 0 0.12133962661027908
mutation O 1 0.9879240393638611
carriers O 1 0.5215423703193665
, O 0 0.0049202218651771545
might O 0 0.006319817621260881
suggest O 0 0.008642351254820824
that O 0 0.004156600683927536
the O 0 0.00879223458468914
mutation O 1 0.972722053527832
arose O 0 0.14959825575351715
independently O 0 0.023019282147288322
. O 0 0.011958759278059006
. O 0 0.017349354922771454

Crystal O 0 0.07995801419019699
structure O 0 0.02583579532802105
of O 0 0.011491237208247185
the O 0 0.02153504639863968
hemochromatosis B-Disease 1 0.9887672066688538
protein O 1 0.9157363176345825
HFE O 1 0.9230014085769653
and O 0 0.009286700747907162
characterization O 0 0.03618993982672691
of O 0 0.006495450157672167
its O 0 0.008456172421574593
interaction O 0 0.11735302209854126
with O 0 0.025089062750339508
transferrin O 1 0.8920877575874329
receptor O 1 0.9124854207038879
. O 0 0.03624856472015381

HFE O 1 0.8836057186126709
is O 0 0.024738118052482605
an O 0 0.02385416254401207
MHC O 1 0.9568440914154053
- O 1 0.5264301300048828
related O 0 0.3325606882572174
protein O 0 0.42188331484794617
that O 0 0.005782551132142544
is O 0 0.007742451969534159
mutated O 1 0.8407057523727417
in O 0 0.011080433614552021
the O 0 0.0157721359282732
iron B-Disease 1 0.7264564633369446
- I-Disease 1 0.9697422385215759
overload I-Disease 1 0.9903981685638428
disease I-Disease 1 0.9968798160552979
hereditary B-Disease 1 0.9904961585998535
hemochromatosis I-Disease 1 0.9883779883384705
. O 0 0.2219763994216919

HFE O 1 0.8726398944854736
binds O 0 0.4496248662471771
to O 0 0.03101498633623123
transferrin O 1 0.9008327126502991
receptor O 1 0.9529220461845398
( O 0 0.15099366009235382
TfR O 1 0.9046460390090942
) O 0 0.015386262908577919
and O 0 0.005341005977243185
reduces O 0 0.1139998510479927
its O 0 0.005752991884946823
affinity O 0 0.091014564037323
for O 0 0.006043439265340567
iron O 0 0.09915327280759811
- O 0 0.15730240941047668
loaded O 0 0.027928484603762627
transferrin O 1 0.7127308249473572
, O 0 0.018466653302311897
implicating O 1 0.6914266347885132
HFE O 1 0.9394673109054565
in O 0 0.020341500639915466
iron O 0 0.3437056541442871
metabolism O 1 0.9321699142456055
. O 0 0.04250301793217659

The O 0 0.04346657916903496
2 O 0 0.04978960007429123
. O 0 0.04106495529413223

6 O 0 0.03624660521745682
A O 0 0.02126902900636196
crystal O 0 0.04540532827377319
structure O 0 0.01804226078093052
of O 0 0.007628942374140024
HFE O 1 0.8362215161323547
reveals O 0 0.03885965049266815
the O 0 0.006354877725243568
locations O 0 0.015354892238974571
of O 0 0.023214586079120636
hemochromatosis B-Disease 1 0.9949643611907959
mutations O 1 0.9784650802612305
and O 0 0.00706354109570384
a O 0 0.010291973128914833
patch O 1 0.5271885395050049
of O 0 0.005107433069497347
histidines O 0 0.19022490084171295
that O 0 0.004129589069634676
could O 0 0.004279168788343668
be O 0 0.003493658499792218
involved O 0 0.012320457957684994
in O 0 0.012791319750249386
pH O 1 0.942488431930542
- O 0 0.4105949401855469
dependent O 0 0.3047078251838684
interactions O 0 0.48728692531585693
. O 0 0.028725337237119675

We O 0 0.013510027900338173
also O 0 0.009247509762644768
demonstrate O 0 0.012492628768086433
that O 0 0.00824500247836113
soluble O 1 0.7675908207893372
TfR O 1 0.8853200674057007
and O 0 0.013337730430066586
HFE O 1 0.957342267036438
bind O 0 0.38662272691726685
tightly O 0 0.02564052678644657
at O 0 0.00472388556227088
the O 0 0.003605365287512541
basic O 0 0.012130769900977612
pH O 1 0.5342465043067932
of O 0 0.00382847897708416
the O 0 0.004942666739225388
cell O 0 0.4682091176509857
surface O 0 0.021271301433444023
, O 0 0.0030966363847255707
but O 0 0.002315118443220854
not O 0 0.0022507368121296167
at O 0 0.0031076937448233366
the O 0 0.004856319632381201
acidic O 1 0.7993320226669312
pH O 1 0.8928107619285583
of O 0 0.016405703499913216
intracellular O 1 0.9160696268081665
vesicles O 1 0.8611912131309509
. O 0 0.037205249071121216

TfR O 1 0.9102611541748047
HFE O 1 0.9262799620628357
stoichiometry O 1 0.6110453605651855
( O 0 0.032676130533218384
2 O 0 0.017231889069080353
1 O 0 0.012741155922412872
) O 0 0.011034464463591576
differs O 0 0.04211317002773285
from O 0 0.013725210912525654
TfR O 1 0.908385157585144
transferrin O 1 0.8818376660346985
stoichiometry O 1 0.746079683303833
( O 0 0.020975865423679352
2 O 0 0.00785342138260603
2 O 0 0.006167156156152487
) O 0 0.0049935393035411835
, O 0 0.0029473043978214264
implying O 0 0.009858616627752781
a O 0 0.0036063026636838913
different O 0 0.0034099435433745384
mode O 0 0.012568511068820953
of O 0 0.0034588249400258064
binding O 0 0.04836074262857437
for O 0 0.007330554071813822
HFE O 1 0.8814866542816162
and O 0 0.006475074682384729
transferrin O 1 0.5007993578910828
to O 0 0.007640944793820381
TfR O 1 0.6935033798217773
, O 0 0.0045763966627418995
consistent O 0 0.006819725502282381
with O 0 0.003388916840776801
our O 0 0.0035913598258048296
demonstration O 0 0.01031698752194643
that O 0 0.006625747308135033
HFE O 1 0.9113222360610962
, O 0 0.007853885181248188
transferrin O 0 0.36765000224113464
, O 0 0.006113998591899872
and O 0 0.0061733173206448555
TfR O 1 0.6918330788612366
form O 0 0.03656166419386864
a O 0 0.017004581168293953
ternary O 0 0.4414830505847931
complex O 0 0.0853012204170227
. O 0 0.02490193396806717

Identification O 0 0.030798297375440598
of O 0 0.011436826549470425
three O 0 0.009928250685334206
novel O 0 0.12260457128286362
mutations O 1 0.8780517578125
and O 0 0.005216897930949926
a O 0 0.0056344070471823215
high O 0 0.006680767983198166
frequency O 0 0.014770536683499813
of O 0 0.004144536796957254
the O 0 0.009704608470201492
Arg778Leu O 1 0.9180309772491455
mutation O 1 0.9872720837593079
in O 0 0.05722738429903984
Korean O 1 0.7102863192558289
patients O 1 0.9859811067581177
with O 0 0.2602407932281494
Wilson B-Disease 1 0.9044324159622192
disease I-Disease 1 0.9910769462585449
. O 0 0.08734599500894547

Four O 0 0.07224344462156296
mutations O 1 0.9769530296325684
- O 0 0.493090957403183
- O 0 0.3146975040435791
R778L O 0 0.38020840287208557
, O 0 0.009846402332186699
A874V O 0 0.24577035009860992
, O 0 0.006992959883064032
L1083F O 0 0.1741929054260254
, O 0 0.005230664741247892
and O 0 0.005525123327970505
2304delC O 1 0.5787509083747864
- O 0 0.11826347559690475
- O 0 0.04568780958652496
in O 0 0.004550001583993435
the O 0 0.004304572008550167
copper O 0 0.08092042803764343
- O 0 0.24425886571407318
transporting O 0 0.17914573848247528
enzyme O 1 0.9106339812278748
, O 0 0.021490199491381645
P O 1 0.6491310000419617
- O 1 0.6724265813827515
type O 1 0.7904461622238159
ATPase O 1 0.964992880821228
( O 0 0.10113590210676193
ATP7B O 0 0.465116947889328
) O 0 0.009832445532083511
, O 0 0.003628771286457777
were O 0 0.0033509298227727413
identified O 0 0.014659824781119823
in O 0 0.008981871418654919
Korean O 0 0.3433312475681305
Patients O 1 0.9794832468032837
with O 0 0.15425188839435577
Wilson B-Disease 1 0.900663435459137
disease I-Disease 1 0.9921940565109253
. O 0 0.09304650127887726

Arg778Leu O 0 0.17588935792446136
, O 0 0.010974607430398464
the O 0 0.005680752452462912
most O 0 0.005895582959055901
frequently O 0 0.018512262031435966
reported O 0 0.04712971672415733
mutation O 1 0.8784623146057129
of O 0 0.0038966326974332333
this O 0 0.004677855875343084
enzyme O 1 0.5321401953697205
, O 0 0.0031692266929894686
was O 0 0.0022889396641403437
found O 0 0.003103596856817603
in O 0 0.0025702372658997774
six O 0 0.0038086571730673313
of O 0 0.003531106049194932
eight O 0 0.02573372982442379
unrelated O 1 0.8531954884529114
patients O 1 0.9656197428703308
studied O 0 0.02816789038479328
, O 0 0.006618771236389875
an O 0 0.009153161197900772
allele O 1 0.8195638656616211
frequency O 0 0.047451943159103394
of O 0 0.010348018258810043
37 O 0 0.029308093711733818
. O 0 0.021266475319862366

5 O 0 0.024293620139360428
% O 0 0.013232381083071232
, O 0 0.004943491891026497
which O 0 0.003235790878534317
is O 0 0.003430343931540847
considerably O 0 0.010359998792409897
higher O 0 0.004747623577713966
than O 0 0.0036149669904261827
those O 0 0.003735189326107502
in O 0 0.004345941357314587
other O 0 0.006975151132792234
Asian O 0 0.14186808466911316
populations O 1 0.5400312542915344
. O 0 0.027942469343543053

The O 0 0.022272193804383278
novel O 0 0.04665765166282654
single O 0 0.03240124136209488
nucleotide O 1 0.6961797475814819
deletion O 1 0.8302141427993774
, O 0 0.009668558835983276
2304delC O 0 0.16711534559726715
, O 0 0.005737015511840582
was O 0 0.004659533035010099
found O 0 0.006445024162530899
in O 0 0.00587758794426918
one O 0 0.009493145160377026
patient O 1 0.6813287734985352
. O 0 0.02547414042055607

Since O 0 0.04113292694091797
a O 0 0.03184381499886513
mutation O 1 0.9038141369819641
at O 0 0.02333160676062107
cDNA O 1 0.7502389550209045
nucleotide O 1 0.9307410717010498
2302 O 1 0.9604659676551819
( O 0 0.06128813698887825
2302insC O 0 0.30268219113349915
) O 0 0.008067179471254349
had O 0 0.004235559143126011
been O 0 0.003127808915451169
previously O 0 0.004135578405112028
described O 0 0.006046547554433346
, O 0 0.002575594699010253
this O 0 0.0023257886059582233
region O 0 0.004607826936990023
of O 0 0.0031726888846606016
the O 0 0.0075652520172297955
ATP7B O 1 0.9100111126899719
gene O 1 0.9746882915496826
may O 0 0.08142302930355072
be O 0 0.013946035876870155
susceptible O 1 0.9268618822097778
to O 0 0.043285634368658066
gene O 1 0.9846550226211548
rearrangements O 1 0.9764936566352844
causing O 1 0.9703328609466553
Wilson B-Disease 1 0.9281367063522339
disease I-Disease 1 0.9895831346511841
. O 0 0.07855957001447678

Disruption O 0 0.15888023376464844
of O 0 0.023794399574398994
splicing O 1 0.5806170701980591
regulated O 0 0.07944463193416595
by O 0 0.016880525276064873
a O 0 0.022590262815356255
CUG O 1 0.7398055791854858
- O 1 0.5584391951560974
binding O 1 0.6952164173126221
protein O 1 0.94386225938797
in O 0 0.279072642326355
myotonic B-Disease 1 0.9876030087471008
dystrophy I-Disease 1 0.9894904494285583
. O 0 0.13602100312709808

Myotonic B-Disease 1 0.9837350845336914
dystrophy I-Disease 1 0.9919791221618652
( O 1 0.702303409576416
DM B-Disease 1 0.9781372547149658
) O 0 0.04115183651447296
is O 0 0.009238754399120808
caused O 0 0.07391241192817688
by O 0 0.00679708132520318
a O 0 0.008074535988271236
CTG O 0 0.20794570446014404
expansion O 0 0.01104023214429617
in O 0 0.0044234213419258595
the O 0 0.004967095796018839
3 O 0 0.01026766188442707
untranslated O 0 0.3112311065196991
region O 0 0.013841664418578148
of O 0 0.008169695734977722
the O 0 0.019970180466771126
DM B-Disease 1 0.9804421067237854
gene O 1 0.9521340131759644
. O 0 0.044363923370838165

One O 0 0.02407834306359291
model O 0 0.033919863402843475
of O 0 0.023181796073913574
DM B-Disease 1 0.9842080473899841
pathogenesis O 1 0.9768575429916382
suggests O 0 0.0914139524102211
that O 0 0.006842691916972399
RNAs O 0 0.09908390045166016
from O 0 0.005095399916172028
the O 0 0.003976226318627596
expanded O 0 0.011217194609344006
allele O 1 0.7227964401245117
create O 0 0.0216030515730381
a O 0 0.006029802840203047
gain O 0 0.0177613478153944
- O 0 0.08669468760490417
of O 0 0.006699028890579939
- O 0 0.4752097427845001
function O 1 0.5079605579376221
mutation O 1 0.9594005346298218
by O 0 0.006615648977458477
the O 0 0.004655216354876757
inappropriate O 0 0.04427078738808632
binding O 0 0.026540623977780342
of O 0 0.004567542113363743
proteins O 0 0.11328339576721191
to O 0 0.005681355483829975
the O 0 0.00836385041475296
CUG O 1 0.5562664866447449
repeats O 0 0.30702221393585205
. O 0 0.027194274589419365

Data O 0 0.022440092638134956
presented O 0 0.012577377259731293
here O 0 0.006699362304061651
indicate O 0 0.008111891336739063
that O 0 0.0037402037996798754
the O 0 0.004639810882508755
conserved O 0 0.18228884041309357
heterogeneous O 1 0.7303232550621033
nuclear O 0 0.09854099154472351
ribonucleoprotein O 1 0.8671823740005493
, O 0 0.013255618512630463
CUG O 1 0.6940473914146423
- O 0 0.4376489818096161
binding O 0 0.44985637068748474
protein O 1 0.8377676010131836
( O 0 0.08933936059474945
CUG O 1 0.6903573274612427
- O 0 0.28752443194389343
BP O 0 0.19494560360908508
) O 0 0.011508452706038952
, O 0 0.00485538924112916
may O 0 0.009735695086419582
mediate O 0 0.11494803428649902
the O 0 0.006762898992747068
trans O 1 0.7166589498519897
- O 0 0.26683691143989563
dominant O 0 0.20032009482383728
effect O 0 0.03799716383218765
of O 0 0.006181832868605852
the O 0 0.010268166661262512
RNA O 1 0.5726467967033386
. O 0 0.02163386344909668

CUG O 1 0.531102180480957
- O 0 0.09129700809717178
BP O 0 0.04681500419974327
was O 0 0.010411664843559265
found O 0 0.007927820086479187
to O 0 0.005101942457258701
bind O 0 0.09514796733856201
to O 0 0.006047387141734362
the O 0 0.012524953112006187
human O 1 0.779046893119812
cardiac O 1 0.9950205087661743
troponin O 1 0.9876505732536316
T O 1 0.966907799243927
( O 0 0.17374619841575623
cTNT O 1 0.7100557088851929
) O 0 0.03223796933889389
pre O 0 0.20451457798480988
- O 0 0.2958192825317383
messenger O 0 0.4875567555427551
RNA O 1 0.632472813129425
and O 0 0.008713854476809502
regulate O 0 0.10103777796030045
its O 0 0.010995660908520222
alternative O 0 0.06076044589281082
splicing O 1 0.6629105806350708
. O 0 0.03602001070976257

Splicing O 0 0.3158111870288849
of O 0 0.02269580215215683
cTNT O 0 0.3021363317966461
was O 0 0.016866296529769897
disrupted O 0 0.45812857151031494
in O 0 0.11732161790132523
DM B-Disease 1 0.9910596013069153
striated O 1 0.9874840378761292
muscle O 1 0.9637062549591064
and O 0 0.009368454106152058
in O 0 0.01546541228890419
normal O 0 0.41030314564704895
cells O 1 0.891045331954956
expressing O 0 0.08780434727668762
transcripts O 0 0.03699726611375809
that O 0 0.010423767380416393
contain O 0 0.05581039562821388
CUG O 1 0.5549262762069702
repeats O 0 0.369373619556427
. O 0 0.0322735458612442

Altered O 0 0.17395417392253876
expression O 0 0.0530366376042366
of O 0 0.018818296492099762
genes O 1 0.8747979998588562
regulated O 0 0.31120723485946655
posttranscriptionally O 0 0.4799785614013672
by O 0 0.023908304050564766
CUG O 1 0.7111319303512573
- O 0 0.2794175446033478
BP O 0 0.13749070465564728
therefore O 0 0.018418259918689728
may O 0 0.02438858523964882
contribute O 0 0.07291342318058014
to O 0 0.020874060690402985
DM B-Disease 1 0.9813350439071655
pathogenesis O 1 0.9706051349639893
. O 0 0.027773180976510048
. O 0 0.026788122951984406

Identification O 0 0.03556890785694122
of O 0 0.01199645921587944
a O 0 0.013995866291224957
novel O 0 0.09046625345945358
nonsense O 0 0.35667258501052856
mutation O 1 0.9326589703559875
and O 0 0.007107113488018513
a O 0 0.011210687458515167
missense O 1 0.7343207001686096
substitution O 0 0.08900631964206696
in O 0 0.007461170200258493
the O 0 0.009174298495054245
vasopressin O 1 0.9120340347290039
- O 1 0.561487078666687
neurophysin O 1 0.8132296204566956
II O 0 0.316201776266098
gene O 1 0.8251055479049683
in O 0 0.008946551010012627
two O 0 0.010449365712702274
Spanish O 0 0.07099191844463348
kindreds O 1 0.9154567718505859
with O 0 0.3176819980144501
familial B-Disease 1 0.9896988272666931
neurohypophyseal I-Disease 1 0.980160653591156
diabetes I-Disease 1 0.9944228529930115
insipidus I-Disease 1 0.9687226414680481
. O 0 0.1419246941804886

Familial B-Disease 1 0.9742797613143921
neurohypophyseal I-Disease 1 0.9653756022453308
diabetes I-Disease 1 0.9939126372337341
insipidus I-Disease 1 0.9825063943862915
( O 1 0.5154340863227844
FNDI B-Disease 1 0.9223340749740601
) O 0 0.0669722780585289
is O 0 0.030568396672606468
an O 0 0.21426159143447876
autosomal B-Disease 1 0.9973125457763672
dominant I-Disease 1 0.9850050210952759
disease I-Disease 1 0.9976280331611633
caused O 1 0.9340099096298218
by O 0 0.2638440728187561
deficiency O 1 0.9948381781578064
in O 0 0.024519963189959526
the O 0 0.04316757246851921
antidiuretic O 1 0.9853242039680481
hormone O 1 0.9888486862182617
arginine O 1 0.9572021961212158
vasopressin O 1 0.9537832736968994
( O 0 0.13348373770713806
AVP O 1 0.7077018022537231
) O 0 0.019177695736289024
encoded O 0 0.02986503764986992
by O 0 0.008930684998631477
the O 0 0.009153983555734158
AVP O 1 0.7521662712097168
- O 0 0.4394335150718689
neurophysin O 1 0.7798515558242798
II O 0 0.33755019307136536
( O 0 0.18419818580150604
AVP O 1 0.9347208142280579
- O 1 0.7736523747444153
NPII O 1 0.9120860695838928
) O 0 0.1460791528224945
gene O 1 0.9201687574386597
on O 0 0.020992955192923546
chromosome O 1 0.952412486076355
20p13 O 1 0.6683033108711243
. O 0 0.040921758860349655

In O 0 0.015729879960417747
this O 0 0.007727757096290588
study O 0 0.00923214852809906
, O 0 0.0038458872586488724
we O 0 0.002575044520199299
analyzed O 0 0.0076768663711845875
two O 0 0.0036747921258211136
families O 0 0.007428474724292755
with O 0 0.00516091613098979
FNDI B-Disease 0 0.29630976915359497
using O 0 0.008425282314419746
direct O 0 0.013066621497273445
automated O 0 0.046003010123968124
fluorescent O 0 0.2519369125366211
, O 0 0.004908765200525522
solid O 0 0.011287818662822247
phase O 0 0.040149882435798645
, O 0 0.005941593088209629
single O 0 0.015461571514606476
- O 0 0.17692427337169647
stranded O 0 0.32081538438796997
DNA O 1 0.6455527544021606
sequencing O 0 0.3427208960056305
of O 0 0.01416805014014244
PCR O 1 0.8737869262695312
- O 1 0.5665339231491089
amplified O 1 0.7406362295150757
AVP O 1 0.9222907423973083
- O 1 0.7025413513183594
NPII O 1 0.8825368285179138
DNA O 1 0.7871512770652771
. O 0 0.041512079536914825

In O 0 0.013668928295373917
one O 0 0.006876124069094658
of O 0 0.004781026858836412
the O 0 0.004759842064231634
families O 0 0.01260565035045147
, O 0 0.004638458602130413
affected O 0 0.046506430953741074
individuals O 0 0.0140923373401165
presented O 0 0.006241897586733103
a O 0 0.007336735725402832
novel O 0 0.12793031334877014
nonsense O 1 0.5082088708877563
mutation O 1 0.9732851982116699
in O 0 0.009009510278701782
exon O 0 0.35730329155921936
3 O 0 0.006815760862082243
of O 0 0.0030754520557820797
the O 0 0.004012633115053177
gene O 1 0.6638422012329102
, O 0 0.003529981942847371
consisting O 0 0.004802297335118055
in O 0 0.003163205459713936
a O 0 0.006435254588723183
G O 0 0.19367921352386475
to O 0 0.005186848342418671
T O 1 0.5443122982978821
transition O 0 0.045942604541778564
at O 0 0.007312231697142124
nucleotide O 1 0.6503564119338989
2101 O 1 0.6340253353118896
, O 0 0.004810046870261431
which O 0 0.003503926331177354
produces O 0 0.017811579629778862
a O 0 0.005230251234024763
stop O 0 0.008341239765286446
signal O 0 0.01667841523885727
in O 0 0.007678780239075422
codon O 1 0.5885159969329834
82 O 0 0.10639618337154388
( O 0 0.09457488358020782
Glu O 1 0.9258564114570618
) O 0 0.015546930953860283
of O 0 0.011096685193479061
NPII O 0 0.4207852780818939
. O 0 0.028135376051068306

The O 0 0.028176356106996536
premature O 1 0.8419146537780762
termination O 1 0.5342327952384949
eliminates O 0 0.12096939980983734
part O 0 0.009276497177779675
of O 0 0.004806560464203358
the O 0 0.00619974359869957
C O 0 0.25410112738609314
- O 0 0.2280874401330948
terminal O 0 0.15740333497524261
domain O 0 0.029275795444846153
of O 0 0.004729477688670158
NPII O 0 0.18789610266685486
, O 0 0.0037761377170681953
including O 0 0.0044072275049984455
a O 0 0.006224551238119602
cysteine O 0 0.14900003373622894
residue O 0 0.06340545415878296
in O 0 0.0038769205566495657
position O 0 0.003997100982815027
85 O 0 0.009558080695569515
, O 0 0.002762896241620183
which O 0 0.0021378612145781517
could O 0 0.002407131716609001
be O 0 0.0018481083679944277
involved O 0 0.004050669725984335
in O 0 0.002893957309424877
the O 0 0.0037436040583997965
correct O 0 0.03177801892161369
folding O 0 0.06193416565656662
of O 0 0.007666780613362789
the O 0 0.013253754004836082
prohormone O 1 0.8593055605888367
. O 0 0.032016485929489136

In O 0 0.012067766860127449
the O 0 0.006662600673735142
second O 0 0.007443541660904884
family O 0 0.010570148937404156
, O 0 0.004580906126648188
a O 0 0.005514582619071007
G279A O 0 0.12379138171672821
substitution O 0 0.042342495173215866
at O 0 0.004282963927835226
position O 0 0.0043402547016739845
- O 0 0.01766626536846161
1 O 0 0.004193722270429134
of O 0 0.0024029661435633898
the O 0 0.0031811133958399296
signal O 0 0.02850344404578209
peptide O 0 0.436987042427063
was O 0 0.004380248486995697
observed O 0 0.009595357812941074
in O 0 0.0046259574592113495
all O 0 0.00511762872338295
affected O 0 0.129344180226326
individuals O 0 0.060706205666065216
. O 0 0.021572092548012733

This O 0 0.04106362909078598
missense O 1 0.9401599168777466
mutation O 1 0.9408839344978333
, O 0 0.012091529555618763
which O 0 0.008351943455636501
replaces O 0 0.25266924500465393
Ala O 1 0.5276087522506714
with O 0 0.018850499764084816
Thr O 1 0.9375249743461609
, O 0 0.007544801104813814
is O 0 0.006864290684461594
frequent O 0 0.08645632117986679
among O 0 0.05059851333498955
FNDI B-Disease 1 0.9552745819091797
patients O 1 0.927707850933075
and O 0 0.003676433116197586
is O 0 0.0032498689834028482
thought O 0 0.004551602527499199
to O 0 0.0026379090268164873
reduce O 0 0.011319526471197605
the O 0 0.003362164366990328
efficiency O 0 0.0153180668130517
of O 0 0.0058512696996331215
cleavage O 1 0.7884405851364136
by O 0 0.012694695964455605
signal O 0 0.09621585160493851
peptidases O 1 0.5639727115631104
. O 0 0.015145741403102875
. O 0 0.019982360303401947

Genetic O 1 0.924545168876648
heterogeneity O 1 0.672572672367096
of O 0 0.04614996165037155
Saethre B-Disease 1 0.9522864818572998
- I-Disease 1 0.9506828784942627
Chotzen I-Disease 1 0.983482837677002
syndrome I-Disease 1 0.995768666267395
, O 0 0.012784114107489586
due O 0 0.014773541130125523
to O 0 0.007484359201043844
TWIST O 0 0.17594300210475922
and O 0 0.015324979089200497
FGFR O 1 0.8939787745475769
mutations O 1 0.9758434891700745
. O 0 0.06004291772842407

Thirty O 0 0.06065545976161957
- O 0 0.16582493484020233
two O 0 0.018758704885840416
unrelated O 1 0.677273690700531
patients O 1 0.8754987716674805
with O 0 0.009878614917397499
features O 0 0.02215029112994671
of O 0 0.016079168766736984
Saethre B-Disease 1 0.9569664597511292
- I-Disease 1 0.9530307650566101
Chotzen I-Disease 1 0.9897778630256653
syndrome I-Disease 1 0.9976096153259277
, O 0 0.03776787966489792
a O 0 0.08167959749698639
common O 1 0.8569880723953247
autosomal B-Disease 1 0.9973198771476746
dominant I-Disease 1 0.9107141494750977
condition I-Disease 1 0.870153546333313
of O 0 0.04670684039592743
craniosynostosis B-Disease 1 0.9909232258796692
and O 0 0.05272359028458595
limb B-Disease 1 0.9829578995704651
anomalies I-Disease 1 0.771329939365387
, O 0 0.006342451553791761
were O 0 0.004378208890557289
screened O 0 0.05810948461294174
for O 0 0.010268233716487885
mutations O 1 0.9726491570472717
in O 0 0.013183730654418468
TWIST O 0 0.280112087726593
, O 0 0.009895517490804195
FGFR2 O 0 0.3228539526462555
, O 0 0.010127389803528786
and O 0 0.011428456753492355
FGFR3 O 0 0.38030147552490234
. O 0 0.025835277512669563

Nine O 0 0.03363703936338425
novel O 0 0.03639776259660721
and O 0 0.010695522651076317
three O 0 0.015958530828356743
recurrent O 1 0.9657216668128967
TWIST O 1 0.7418726086616516
mutations O 1 0.9607297778129578
were O 0 0.005578906740993261
found O 0 0.007490336894989014
in O 0 0.006239254958927631
12 O 0 0.01331148762255907
families O 0 0.03450944647192955
. O 0 0.02120991237461567

Seven O 0 0.02308601513504982
families O 0 0.01518169604241848
were O 0 0.005052006337791681
found O 0 0.005256723612546921
to O 0 0.002988286316394806
have O 0 0.0034008293878287077
the O 0 0.004956230986863375
FGFR3 O 1 0.6712225675582886
P250R O 1 0.7788548469543457
mutation O 1 0.9437036514282227
, O 0 0.0044953785836696625
and O 0 0.0027917486149817705
one O 0 0.002739518880844116
individual O 0 0.0052730790339410305
was O 0 0.002534261206164956
found O 0 0.0036781870294362307
to O 0 0.002781787421554327
have O 0 0.003938453271985054
an O 0 0.008677671663463116
FGFR2 O 1 0.6988773941993713
VV269 O 1 0.6848010420799255
- O 0 0.4435526430606842
270 O 0 0.2838781476020813
deletion O 1 0.8958085179328918
. O 0 0.0362025648355484

To O 0 0.013692734763026237
date O 0 0.01186662632972002
, O 0 0.006461796350777149
our O 0 0.006169491447508335
detection O 0 0.15167006850242615
rate O 0 0.02398023195564747
for O 0 0.006840232759714127
TWIST O 0 0.3477456867694855
or O 0 0.07038208842277527
FGFR O 1 0.9280608296394348
mutations O 1 0.9723842144012451
is O 0 0.009322361089289188
68 O 0 0.01904280111193657
% O 0 0.011880132369697094
in O 0 0.007286739069968462
our O 0 0.020584428682923317
Saethre B-Disease 1 0.9645758867263794
- I-Disease 1 0.9702557325363159
Chotzen I-Disease 1 0.993605375289917
syndrome I-Disease 1 0.998542070388794
patients O 1 0.9813048243522644
, O 0 0.008071072399616241
including O 0 0.006740538403391838
our O 0 0.007441600318998098
five O 0 0.022075796499848366
patients O 1 0.9541019201278687
elsewhere O 0 0.06007450819015503
reported O 0 0.06891632080078125
with O 0 0.03091021440923214
TWIST O 1 0.7568193078041077
mutations O 1 0.9719827771186829
. O 0 0.057770583778619766

More O 0 0.015747269615530968
than O 0 0.010573700070381165
35 O 0 0.012781412340700626
different O 0 0.010526394471526146
TWIST O 0 0.4583444893360138
mutations O 1 0.943234384059906
are O 0 0.003771772375330329
now O 0 0.004042149055749178
known O 0 0.005433118902146816
in O 0 0.004155870992690325
the O 0 0.0054968781769275665
literature O 0 0.018497293815016747
. O 0 0.019061166793107986

The O 0 0.015986565500497818
most O 0 0.011526085436344147
common O 0 0.043226633220911026
phenotypic O 0 0.48720744252204895
features O 0 0.009152218699455261
, O 0 0.003438324434682727
present O 0 0.0032845870591700077
in O 0 0.002217254601418972
more O 0 0.0022194215562194586
than O 0 0.0023918617516756058
a O 0 0.0029680875595659018
third O 0 0.004048592410981655
of O 0 0.0034166264813393354
our O 0 0.013739237561821938
patients O 1 0.9562670588493347
with O 0 0.038808293640613556
TWIST O 1 0.8104316592216492
mutations O 1 0.9843583106994629
, O 0 0.00803389772772789
are O 0 0.006916282698512077
coronal B-Disease 1 0.7526149153709412
synostosis I-Disease 1 0.6403252482414246
, O 0 0.010920838452875614
brachycephaly B-Disease 1 0.6495040655136108
, O 0 0.023874443024396896
low B-Disease 1 0.5888907313346863
frontal I-Disease 1 0.9868828654289246
hairline I-Disease 1 0.9920830726623535
, O 0 0.2449575513601303
facial B-Disease 1 0.9905760288238525
asymmetry I-Disease 1 0.9646440148353577
, O 0 0.10589750111103058
ptosis B-Disease 1 0.9887326955795288
, O 0 0.027462691068649292
hypertelorism B-Disease 1 0.8745689392089844
, O 0 0.008572502993047237
broad B-Disease 0 0.02707010507583618
great I-Disease 0 0.011825134046375751
toes I-Disease 0 0.15982875227928162
, O 0 0.007876896299421787
and O 0 0.009437564760446548
clinodactyly B-Disease 0 0.38172271847724915
. O 0 0.028445811942219734

Significant O 0 0.05977679416537285
intra O 0 0.39826127886772156
- O 0 0.15300649404525757
and O 0 0.015317799523472786
interfamilial O 1 0.6689595580101013
phenotypic O 1 0.9249117970466614
variability O 1 0.7378251552581787
is O 0 0.007804648485034704
present O 0 0.007716076914221048
for O 0 0.007583870552480221
either O 0 0.025005947798490524
TWIST O 1 0.7454341650009155
mutations O 1 0.9855232238769531
or O 0 0.27818959951400757
FGFR O 1 0.9511073231697083
mutations O 1 0.9802419543266296
. O 0 0.05152639374136925

The O 0 0.02022363990545273
overlap O 0 0.058124102652072906
in O 0 0.010132133960723877
clinical O 0 0.3416988253593445
features O 0 0.007126707583665848
and O 0 0.002541867783293128
the O 0 0.0027175985742360353
presence O 0 0.0072004827670753
, O 0 0.00257258047349751
in O 0 0.0022821666207164526
the O 0 0.002452494576573372
same O 0 0.005327753257006407
genes O 1 0.5897943377494812
, O 0 0.003817630000412464
of O 0 0.004249136429280043
mutations O 1 0.9082606434822083
for O 0 0.0032834261655807495
more O 0 0.0033732554875314236
than O 0 0.004220078233629465
one O 0 0.006568715441972017
craniosynostotic B-Disease 1 0.7938418984413147
condition I-Disease 1 0.5830547213554382
- O 0 0.07797247916460037
such O 0 0.007126770913600922
as O 0 0.008062533102929592
Saethre B-Disease 1 0.7529836297035217
- I-Disease 0 0.41912123560905457
Chotzen I-Disease 1 0.6845612525939941
, I-Disease 0 0.01158017199486494
Crouzon I-Disease 1 0.5594345331192017
, I-Disease 0 0.010745619423687458
and I-Disease 0 0.022180354222655296
Pfeiffer I-Disease 1 0.9800470471382141
syndromes I-Disease 1 0.9952754974365234
- O 0 0.16214114427566528
support O 0 0.007279608398675919
the O 0 0.004054345656186342
hypothesis O 0 0.0756341889500618
that O 0 0.003743947483599186
TWIST O 0 0.059265900403261185
and O 0 0.003395866369828582
FGFRs O 0 0.08619236946105957
are O 0 0.0024410446640104055
components O 0 0.004396368749439716
of O 0 0.0020679752342402935
the O 0 0.0026650831568986177
same O 0 0.008250868879258633
molecular O 1 0.6504788398742676
pathway O 1 0.6985716819763184
involved O 0 0.013775086030364037
in O 0 0.003960287198424339
the O 0 0.005479209590703249
modulation O 1 0.65948086977005
of O 0 0.018460428342223167
craniofacial O 1 0.9778847098350525
and O 0 0.02407803013920784
limb O 1 0.9655857086181641
development O 0 0.06585852056741714
in O 0 0.01129127200692892
humans O 0 0.4680517017841339
. O 0 0.013378214091062546
. O 0 0.018844446167349815

Mutation O 1 0.9375673532485962
analysis O 0 0.1157575398683548
of O 0 0.04578769579529762
UBE3A O 1 0.9533721208572388
in O 1 0.8038319945335388
Angelman B-Disease 1 0.9943127632141113
syndrome I-Disease 1 0.9969965219497681
patients O 1 0.9784418940544128
. O 0 0.15004247426986694

Angelman B-Disease 1 0.9889835715293884
syndrome I-Disease 1 0.9928007125854492
( O 0 0.08682660758495331
AS B-Disease 0 0.01881621964275837
) O 0 0.01883118227124214
is O 0 0.009653251618146896
caused O 0 0.29895368218421936
by O 0 0.02780129201710224
chromosome O 1 0.98148512840271
15q11 O 1 0.8397855162620544
- O 1 0.5164198875427246
q13 O 1 0.7045976519584656
deletions O 1 0.6169608235359192
of O 0 0.009971502237021923
maternal O 1 0.768582820892334
origin O 0 0.04812600463628769
, O 0 0.008625156246125698
by O 0 0.017818881198763847
paternal O 1 0.9448564052581787
uniparental B-Disease 1 0.9884519577026367
disomy I-Disease 1 0.9402356743812561
( O 0 0.27445700764656067
UPD B-Disease 1 0.9610626101493835
) O 0 0.01754617877304554
15 O 0 0.008424808271229267
, O 0 0.005382300820201635
by O 0 0.011685220524668694
imprinting O 1 0.9616342782974243
defects O 1 0.9659053683280945
, O 0 0.0073578739538788795
and O 0 0.005183503031730652
by O 0 0.01087871566414833
mutations O 1 0.955742359161377
in O 0 0.011374764144420624
the O 0 0.01891503669321537
UBE3A O 1 0.9639140963554382
gene O 1 0.9559128880500793
. O 0 0.04517193138599396

UBE3A O 1 0.8309846520423889
encodes O 0 0.31207194924354553
a O 0 0.03962934762239456
ubiquitin O 1 0.6559633612632751
- O 0 0.32998061180114746
protein O 1 0.6886548399925232
ligase O 0 0.24611659348011017
and O 0 0.012741186656057835
shows O 0 0.07751622051000595
brain O 1 0.9699193239212036
- O 0 0.4050137996673584
specific O 0 0.17621731758117676
imprinting O 1 0.896613359451294
. O 0 0.04342999681830406

Here O 0 0.024657679721713066
we O 0 0.013963940553367138
describe O 0 0.10967330634593964
UBE3A O 1 0.9520902037620544
coding O 1 0.94729083776474
- O 1 0.6725026965141296
region O 0 0.3730379045009613
mutations O 1 0.9878815412521362
detected O 1 0.5250220894813538
by O 0 0.011598126031458378
SSCP O 0 0.3856760263442993
analysis O 0 0.019701851531863213
in O 0 0.004856082610785961
13 O 0 0.007058406248688698
AS B-Disease 0 0.0067925117909908295
individuals O 0 0.02280578948557377
or O 0 0.01359039917588234
families O 0 0.035161182284355164
. O 0 0.016417764127254486

Two O 0 0.026427971199154854
identical O 0 0.055375415831804276
de O 0 0.07030145078897476
novo O 0 0.21381829679012299
5 O 0 0.025480611249804497
- O 0 0.105075404047966
bp O 0 0.056873030960559845
duplications O 0 0.26513534784317017
in O 0 0.011296271346509457
exon O 0 0.1816961169242859
16 O 0 0.014022666029632092
were O 0 0.007512362208217382
found O 0 0.015706172212958336
. O 0 0.017810845747590065

Among O 0 0.01664687506854534
the O 0 0.007431453559547663
other O 0 0.005594244226813316
11 O 0 0.009660335257649422
unique O 0 0.03643651679158211
mutations O 1 0.9346969723701477
, O 0 0.0047809951938688755
8 O 0 0.004891886841505766
were O 0 0.00283745932392776
small O 0 0.008093462325632572
deletions O 0 0.397041916847229
or O 0 0.014082124456763268
insertions O 0 0.3834698796272278
predicted O 0 0.04525655508041382
to O 0 0.006974718067795038
cause O 1 0.6372935771942139
frameshifts O 0 0.30870938301086426
, O 0 0.003699938300997019
1 O 0 0.003998016007244587
was O 0 0.003063460346311331
a O 0 0.005562239792197943
mutation O 1 0.8060615062713623
to O 0 0.003376184031367302
a O 0 0.005210734438151121
stop O 0 0.011257016099989414
codon O 0 0.183014914393425
, O 0 0.003937046974897385
1 O 0 0.004713149741292
was O 0 0.0038819920737296343
a O 0 0.01208372414112091
missense O 1 0.9579185843467712
mutation O 1 0.9628986120223999
, O 0 0.004136151168495417
and O 0 0.0026063069235533476
1 O 0 0.0038993905764073133
was O 0 0.0025832962710410357
predicted O 0 0.010900327004492283
to O 0 0.003657072549685836
cause O 0 0.29760903120040894
insertion O 0 0.22469346225261688
of O 0 0.0036917792167514563
an O 0 0.00431991508230567
isoleucine O 0 0.1311861276626587
in O 0 0.004088662099093199
the O 0 0.004519403446465731
hect O 0 0.21595825254917145
domain O 0 0.01955988071858883
of O 0 0.004438558593392372
the O 0 0.0064881653524935246
UBE3A O 1 0.9094939231872559
protein O 0 0.4245668947696686
, O 0 0.004558739718049765
which O 0 0.003350668353959918
functions O 0 0.008221636526286602
in O 0 0.00560724688693881
E2 O 1 0.5829766392707825
binding O 0 0.06776764988899231
and O 0 0.009101386182010174
ubiquitin O 0 0.34667477011680603
transfer O 0 0.03012274205684662
. O 0 0.021978460252285004

Eight O 0 0.016104770824313164
of O 0 0.007430071011185646
the O 0 0.006600240245461464
cases O 0 0.03664233908057213
were O 0 0.005592537112534046
familial O 1 0.9203053116798401
, O 0 0.004843211267143488
and O 0 0.0036610043607652187
five O 0 0.005479435436427593
were O 0 0.006280568428337574
sporadic O 0 0.11537471413612366
. O 0 0.020726842805743217

In O 0 0.022186657413840294
two O 0 0.019377034157514572
familial O 1 0.9656824469566345
cases O 0 0.07211261987686157
and O 0 0.006069976836442947
one O 0 0.00672516692429781
sporadic O 0 0.23398526012897491
case O 0 0.03493155166506767
, O 0 0.01173363532871008
mosaicism O 1 0.9549575448036194
for O 0 0.03740985319018364
UBE3A O 1 0.9802129864692688
mutations O 1 0.9804391264915466
was O 0 0.00890284776687622
detected O 0 0.14526519179344177
in O 0 0.0037083150818943977
the O 0 0.0032101294491440058
mother O 0 0.008325102739036083
of O 0 0.002488415688276291
three O 0 0.0031273700296878815
AS B-Disease 0 0.004456991329789162
sons O 0 0.02048172615468502
, O 0 0.002370939590036869
in O 0 0.002286383183673024
the O 0 0.0031877204310148954
maternal O 1 0.5556074380874634
grandfather O 0 0.015601110644638538
of O 0 0.002809467725455761
two O 0 0.0028815357945859432
AS B-Disease 0 0.0030970750376582146
first O 0 0.0032093299087136984
cousins O 0 0.05957331135869026
, O 0 0.0025939850602298975
and O 0 0.0019478589529171586
in O 0 0.002388473367318511
the O 0 0.0028775271493941545
mother O 0 0.011646284721791744
of O 0 0.0033219598699361086
an O 0 0.00589641323313117
AS B-Disease 0 0.013143826276063919
daughter O 0 0.14804579317569733
. O 0 0.025144191458821297

The O 0 0.01618155650794506
frequencies O 0 0.023557346314191818
with O 0 0.007561662700027227
which O 0 0.004938132595270872
we O 0 0.004819794557988644
detected O 0 0.43133312463760376
mutations O 1 0.9144713282585144
were O 0 0.0035906294360756874
5 O 0 0.007021702826023102
( O 0 0.007443301845341921
14 O 0 0.004959867801517248
% O 0 0.005404961761087179
) O 0 0.003275595372542739
of O 0 0.001990851014852524
35 O 0 0.004558235872536898
in O 0 0.003435420338064432
sporadic O 0 0.10535384714603424
cases O 0 0.03580198436975479
and O 0 0.002884375862777233
8 O 0 0.005941677838563919
( O 0 0.008639762178063393
80 O 0 0.006075097247958183
% O 0 0.007451306562870741
) O 0 0.00426708348095417
of O 0 0.003285464830696583
10 O 0 0.006877280306071043
in O 0 0.017876653000712395
familial O 1 0.9778481125831604
cases O 0 0.27591657638549805
. O 0 0.016264546662569046
. O 0 0.020075492560863495

The O 0 0.09585004299879074
hemochromatosis B-Disease 1 0.9773882627487183
845 O 1 0.9294275641441345
G O 1 0.8921459913253784
- O 1 0.6043661832809448
- O 0 0.4297999441623688
> O 0 0.49177855253219604
A O 0 0.01254485547542572
and O 0 0.008713376708328724
187 O 0 0.2279021143913269
C O 1 0.6632340550422668
- O 1 0.7553234696388245
- O 1 0.8767027854919434
> O 1 0.9690203070640564
G O 1 0.9569676518440247
mutations O 1 0.9885079264640808
: O 0 0.10440492630004883
prevalence O 1 0.9471400380134583
in O 0 0.01461082138121128
non O 0 0.16790123283863068
- O 1 0.5467349290847778
Caucasian O 1 0.8664472699165344
populations O 1 0.619550347328186
. O 0 0.034837719053030014

Hemochromatosis B-Disease 1 0.9535616040229797
, O 0 0.03306679427623749
the O 0 0.043783318251371384
inherited B-Disease 1 0.9824249148368835
disorder I-Disease 1 0.9922946691513062
of I-Disease 0 0.019199850037693977
iron I-Disease 1 0.541012167930603
metabolism I-Disease 1 0.9456005692481995
, O 0 0.010222487151622772
leads O 0 0.07649693638086319
, O 0 0.00649957824498415
if O 0 0.011396910063922405
untreated O 1 0.7836815714836121
, O 0 0.00587757071480155
to O 0 0.0066267647780478
progressive O 0 0.477062463760376
iron B-Disease 1 0.5553677082061768
overload I-Disease 1 0.9456392526626587
and O 0 0.028213758021593094
premature B-Disease 1 0.9369319081306458
death I-Disease 0 0.30186089873313904
. O 0 0.036953721195459366

The O 0 0.10619845241308212
hemochromatosis B-Disease 1 0.9850485920906067
gene O 1 0.9499920010566711
, O 0 0.023378679528832436
HFE O 1 0.8882970213890076
, O 0 0.007519472390413284
recently O 0 0.008860466070473194
has O 0 0.003533888841047883
been O 0 0.0031404150649905205
identified O 0 0.005946577060967684
, O 0 0.0024694872554391623
and O 0 0.0020362536888569593
characterization O 0 0.016344252973794937
of O 0 0.003027498023584485
this O 0 0.004337651189416647
gene O 1 0.6295655965805054
has O 0 0.0032189295161515474
shown O 0 0.004433735273778439
that O 0 0.0019049736438319087
it O 0 0.0020051284227520227
contains O 0 0.004007325507700443
two O 0 0.004422699101269245
mutations O 1 0.9015344977378845
that O 0 0.004848141688853502
result O 0 0.021952861919999123
in O 0 0.007532095070928335
amino O 0 0.4804514944553375
acid O 1 0.7967292070388794
substitutions O 0 0.32981881499290466
- O 0 0.42061683535575867
cDNA O 1 0.8162411451339722
nucleotides O 1 0.9156255722045898
845 O 1 0.9449214339256287
G O 1 0.89902663230896
- O 1 0.6265023946762085
- O 1 0.516208827495575
> O 1 0.6920909881591797
A O 0 0.024749647825956345
( O 0 0.048305485397577286
C282Y O 0 0.3807874619960785
) O 0 0.010949131101369858
and O 0 0.005771859083324671
187 O 0 0.12145677208900452
C O 1 0.6202895045280457
- O 1 0.6157779097557068
- O 1 0.712875485420227
> O 1 0.9011328816413879
G O 1 0.7150294184684753
( O 0 0.09188465774059296
H63D O 1 0.613706111907959
) O 0 0.031551163643598557
. O 0 0.0214278195053339

Although O 0 0.1408376395702362
hemochromatosis B-Disease 1 0.9649769067764282
is O 0 0.02037031389772892
common O 0 0.04321257397532463
in O 0 0.011762268841266632
Caucasians O 1 0.591636061668396
, O 0 0.01530778594315052
affecting O 1 0.7422022223472595
> O 1 0.8616785407066345
= O 0 0.3344430923461914
1 O 0 0.013800373300909996
/ O 0 0.09093175083398819
300 O 0 0.005857136566191912
individuals O 0 0.00643313629552722
of O 0 0.002316289348527789
northern O 0 0.0032952006440609694
European O 0 0.004122546408325434
origin O 0 0.005176425911486149
, O 0 0.0022000481840223074
it O 0 0.001637819455936551
has O 0 0.0017319194739684463
not O 0 0.0016954141901805997
been O 0 0.0024837516248226166
recognized O 0 0.006000961177051067
in O 0 0.004702670965343714
other O 0 0.00835907831788063
populations O 0 0.2588084042072296
. O 0 0.020538121461868286

The O 0 0.016987452283501625
present O 0 0.013284058310091496
study O 0 0.015472273342311382
used O 0 0.01066470518708229
PCR O 0 0.3165700435638428
and O 0 0.008261383511126041
restriction O 0 0.19276179373264313
- O 0 0.4441308081150055
enzyme O 1 0.8960362672805786
digestion O 1 0.644288182258606
to O 0 0.00571562210097909
analyze O 0 0.011787169612944126
the O 0 0.003995535429567099
frequency O 0 0.01291496492922306
of O 0 0.0039011805783957243
the O 0 0.006017050240188837
845 O 1 0.8043248057365417
G O 1 0.78144770860672
- O 0 0.4160456955432892
- O 0 0.30631333589553833
> O 0 0.4229811728000641
A O 0 0.009524473920464516
and O 0 0.006799978204071522
187 O 0 0.21463918685913086
C O 1 0.6451761722564697
- O 1 0.6555228233337402
- O 1 0.7765800952911377
> O 1 0.9611701965332031
G O 1 0.9368574023246765
mutations O 1 0.9876075387001038
in O 0 0.06089957058429718
HLA O 1 0.979870080947876
- O 0 0.3004562556743622
typed O 0 0.1330242156982422
samples O 0 0.06585505604743958
from O 0 0.009747669100761414
non O 0 0.14740030467510223
- O 0 0.38290178775787354
Caucasian O 1 0.7411209344863892
populations O 0 0.368534117937088
, O 0 0.005245288833975792
comprising O 0 0.007029533386230469
Australian O 0 0.007852640934288502
Aboriginal O 0 0.016061067581176758
, O 0 0.004638934042304754
Chinese O 0 0.006302587687969208
, O 0 0.005081868730485439
and O 0 0.006246042903512716
Pacific O 0 0.026077082380652428
Islanders O 0 0.06524641811847687
. O 0 0.020691845566034317

Results O 0 0.03699225187301636
showed O 0 0.022686608135700226
that O 0 0.011162452399730682
the O 0 0.012766901403665543
845 O 1 0.7658253908157349
G O 1 0.8133497834205627
- O 1 0.63204425573349
- O 1 0.6218699812889099
> O 1 0.8044688701629639
A O 0 0.036645449697971344
mutation O 1 0.9314974546432495
was O 0 0.0048483675345778465
present O 0 0.0049025737680494785
in O 0 0.004081103950738907
these O 0 0.005952546838670969
populations O 1 0.516706645488739
( O 0 0.12002329528331757
allele O 1 0.9299286007881165
frequency O 0 0.1183718591928482
0 O 0 0.019050968810915947
. O 0 0.0034368145279586315
32 O 0 0.006966129876673222
% O 0 0.012908510863780975
) O 0 0.004226675722748041
, O 0 0.0020477790385484695
and O 0 0.0017231320962309837
, O 0 0.0019145992118865252
furthermore O 0 0.004693366587162018
, O 0 0.0016810809029266238
it O 0 0.0016207348089665174
was O 0 0.001832231180742383
always O 0 0.00254271668381989
seen O 0 0.0042546638287603855
in O 0 0.004463228862732649
conjunction O 0 0.1842183768749237
with O 0 0.060341283679008484
HLA O 1 0.9912180304527283
haplotypes O 1 0.9796685576438904
common O 0 0.15477846562862396
in O 0 0.010153715498745441
Caucasians O 1 0.7064536213874817
, O 0 0.0074128950946033
suggesting O 0 0.04073217138648033
that O 0 0.010935691185295582
845 O 1 0.8828620314598083
G O 1 0.8733391761779785
- O 1 0.5583024621009827
- O 0 0.4125065505504608
> O 0 0.49413904547691345
A O 0 0.00894179567694664
may O 0 0.005889226216822863
have O 0 0.0028830827213823795
been O 0 0.002993217436596751
introduced O 0 0.005699772387742996
into O 0 0.004783046897500753
these O 0 0.007344999350607395
populations O 0 0.29733455181121826
by O 0 0.02166556566953659
Caucasian O 1 0.8727677464485168
admixture O 1 0.939606249332428
. O 0 0.04224080219864845

187 O 0 0.3443540334701538
C O 1 0.588519275188446
- O 0 0.46557170152664185
- O 0 0.44969606399536133
> O 1 0.6272463202476501
G O 0 0.13529320061206818
was O 0 0.006523994728922844
present O 0 0.005945001263171434
at O 0 0.004657962825149298
an O 0 0.006829205434769392
allele O 1 0.7414906620979309
frequency O 0 0.029968980699777603
of O 0 0.008384628221392632
2 O 0 0.016926683485507965
. O 0 0.016709107905626297

68 O 0 0.038334716111421585
% O 0 0.01868615858256817
in O 0 0.007060969714075327
the O 0 0.005383736919611692
two O 0 0.006482180207967758
populations O 0 0.1603786200284958
analyzed O 0 0.041810084134340286
( O 0 0.01254653837531805
Australian O 0 0.01147331204265356
Aboriginal O 0 0.027835581451654434
and O 0 0.00659854244440794
Chinese O 0 0.013766821473836899
) O 0 0.01930621638894081
. O 0 0.017242148518562317

In O 0 0.015506328083574772
the O 0 0.008927983231842518
Australian O 0 0.013986327685415745
Aboriginal O 0 0.03876067325472832
samples O 0 0.06232381984591484
, O 0 0.01023393776267767
187 O 0 0.16156351566314697
C O 1 0.5702391266822815
- O 1 0.5610333681106567
- O 1 0.5888628363609314
> O 1 0.8335597515106201
G O 0 0.2679983079433441
was O 0 0.003932034596800804
found O 0 0.004194309469312429
to O 0 0.0026974882930517197
be O 0 0.00308430939912796
associated O 0 0.03792501986026764
with O 0 0.03581421077251434
HLA O 1 0.9882198572158813
haplotypes O 1 0.9775351285934448
common O 0 0.19389119744300842
in O 0 0.008614241145551205
Caucasians O 1 0.5418218374252319
, O 0 0.0049541243351995945
suggesting O 0 0.010092383250594139
that O 0 0.0024019533302634954
it O 0 0.002503403229638934
was O 0 0.0032565223518759012
introduced O 0 0.006813378538936377
by O 0 0.008028891868889332
recent O 0 0.03604992479085922
admixture O 1 0.8966171145439148
. O 0 0.03227033093571663

In O 0 0.015306210145354271
the O 0 0.008224623277783394
Chinese O 0 0.010778971947729588
samples O 0 0.024784235283732414
analyzed O 0 0.025581873953342438
, O 0 0.00955567043274641
187 O 0 0.11398855596780777
C O 0 0.4606906473636627
- O 0 0.48148974776268005
- O 1 0.5534178614616394
> O 1 0.791374146938324
G O 0 0.24308229982852936
was O 0 0.004097179044038057
present O 0 0.0036911023780703545
in O 0 0.002994948299601674
association O 0 0.006651321891695261
with O 0 0.0036418596282601357
a O 0 0.004493368789553642
wide O 0 0.009933018125593662
variety O 0 0.018731387332081795
of O 0 0.013564975000917912
HLA O 1 0.9879055023193359
haplotypes O 1 0.9617295265197754
, O 0 0.007268546149134636
showing O 0 0.01749604381620884
this O 0 0.005546791944652796
mutation O 1 0.8551453948020935
to O 0 0.002989022294059396
be O 0 0.0026250353548675776
widespread O 0 0.012873620726168156
and O 0 0.002661225153133273
likely O 0 0.005025363527238369
to O 0 0.003382551483809948
predate O 0 0.12109086662530899
the O 0 0.004845110699534416
more O 0 0.008789903484284878
genetically O 1 0.8344635963439941
restricted O 0 0.21888361871242523
845 O 1 0.9002285599708557
G O 1 0.8875184655189514
- O 1 0.7278252840042114
- O 1 0.6591156125068665
> O 1 0.8513655066490173
A O 0 0.13963285088539124
mutation O 1 0.9682207107543945
. O 0 0.03970075771212578

Genotype O 1 0.9400638341903687
- O 1 0.8993040919303894
phenotype O 1 0.964561939239502
correlations O 1 0.9101013541221619
in O 0 0.4650787115097046
attenuated B-Disease 1 0.9834108948707581
adenomatous I-Disease 1 0.9922194480895996
polyposis I-Disease 1 0.9892755150794983
coli I-Disease 1 0.9711503386497498
. O 0 0.124030701816082

Germ O 1 0.8863920569419861
- O 0 0.3260493576526642
line O 0 0.08839110285043716
mutations O 1 0.9427501559257507
of O 0 0.015445669181644917
the O 0 0.07326026260852814
tumor B-Disease 1 0.9936989545822144
suppressor O 1 0.9860202670097351
APC O 1 0.9381236433982849
are O 0 0.03847843408584595
implicated O 1 0.895751416683197
in O 1 0.501928448677063
attenuated B-Disease 1 0.9929366707801819
adenomatous I-Disease 1 0.9976835250854492
polyposis I-Disease 1 0.996745228767395
coli I-Disease 1 0.9943884015083313
( O 1 0.7068671584129333
AAPC B-Disease 1 0.9707115888595581
) O 0 0.03396468609571457
, O 0 0.010514897294342518
a O 0 0.025550564751029015
variant O 1 0.9315995573997498
of O 0 0.2968066334724426
familial B-Disease 1 0.9951077699661255
adenomatous I-Disease 1 0.9962584972381592
polyposis I-Disease 1 0.994062602519989
( O 1 0.7867698073387146
FAP B-Disease 1 0.961236834526062
) O 0 0.08799192309379578
. O 0 0.036101941019296646

AAPC B-Disease 1 0.7674737572669983
is O 0 0.019771168008446693
recognized O 0 0.01599711738526821
by O 0 0.00806714128702879
the O 0 0.006538772024214268
occurrence O 0 0.10809221863746643
of O 0 0.00937047228217125
< O 1 0.5956555604934692
100 O 0 0.03993643447756767
colonic B-Disease 1 0.9704374670982361
adenomas I-Disease 1 0.9669291973114014
and O 0 0.009528234601020813
a O 0 0.020527519285678864
later O 0 0.08462400734424591
onset O 1 0.9935975074768066
of O 1 0.6840559840202332
colorectal B-Disease 1 0.9990535378456116
cancer I-Disease 1 0.9980077147483826
( O 0 0.49618908762931824
age O 0 0.29567089676856995
> O 1 0.6618697643280029
40 O 0 0.01543501392006874
years O 0 0.015465796925127506
) O 0 0.019676513969898224
. O 0 0.017134295776486397

The O 0 0.013747194781899452
aim O 0 0.014330334030091763
of O 0 0.005242898594588041
this O 0 0.004900380503386259
study O 0 0.009464925155043602
was O 0 0.005113651975989342
to O 0 0.007927261292934418
assess O 0 0.4580790102481842
genotype O 1 0.9833391904830933
- O 1 0.881391167640686
phenotype O 1 0.9870196580886841
correlations O 1 0.8356356024742126
in O 0 0.059772390872240067
AAPC B-Disease 1 0.9406114220619202
families O 0 0.11887899786233902
. O 0 0.03434436023235321

By O 0 0.04321662336587906
protein O 1 0.6332870721817017
- O 0 0.18375526368618011
truncation O 0 0.34997686743736267
test O 0 0.036572784185409546
( O 0 0.019759828224778175
PTT O 0 0.06143702566623688
) O 0 0.01108271349221468
assay O 0 0.0301609355956316
, O 0 0.003704143688082695
the O 0 0.0032904744148254395
entire O 0 0.00920623354613781
coding O 0 0.426414430141449
region O 0 0.009343099780380726
of O 0 0.003715202445164323
the O 0 0.006882662419229746
APC B-Disease 1 0.8823217749595642
gene O 1 0.9117868542671204
was O 0 0.006854373961687088
screened O 0 0.05015737935900688
in O 0 0.007726104464381933
affected O 0 0.14496904611587524
individuals O 0 0.03268353268504143
from O 0 0.008781449869275093
11 O 0 0.06558946520090103
AAPC B-Disease 1 0.9746474027633667
kindreds O 1 0.7759681940078735
, O 0 0.005802416708320379
and O 0 0.0041088443249464035
their O 0 0.005082008894532919
phenotypic O 1 0.5029388666152954
differences O 0 0.05833376944065094
were O 0 0.008835859596729279
examined O 0 0.08171413093805313
. O 0 0.02170887030661106

Five O 0 0.04927259311079979
novel O 0 0.3236515522003174
germ O 1 0.924081563949585
- O 0 0.47407299280166626
line O 0 0.13178057968616486
APC B-Disease 1 0.9295303225517273
mutations O 1 0.9449593424797058
were O 0 0.008123994804918766
identified O 0 0.017159465700387955
in O 0 0.009359422139823437
seven O 0 0.016196953132748604
kindreds O 1 0.6614770889282227
. O 0 0.02687232941389084

Mutations O 1 0.684351921081543
were O 0 0.01071956567466259
located O 0 0.008026164956390858
in O 0 0.0043386188335716724
three O 0 0.004049380775541067
different O 0 0.004436175804585218
regions O 0 0.008830303326249123
of O 0 0.0036941654980182648
the O 0 0.007953491061925888
APC B-Disease 1 0.947598397731781
gene O 1 0.9623266458511353
( O 0 0.016663720831274986
1 O 0 0.0056847394444048405
) O 0 0.004325624089688063
at O 0 0.002810472622513771
the O 0 0.0025168205611407757
5 O 0 0.004782139323651791
end O 0 0.0054937503300607204
spanning O 0 0.03509888797998428
exons O 0 0.28153273463249207
4 O 0 0.006817236077040434
and O 0 0.0032697562128305435
5 O 0 0.005324100609868765
, O 0 0.003119149710983038
( O 0 0.006759492214769125
2 O 0 0.0054280683398246765
) O 0 0.005062997341156006
within O 0 0.004627284128218889
exon O 0 0.1446194052696228
9 O 0 0.0071044424548745155
, O 0 0.002942143939435482
and O 0 0.002605089917778969
( O 0 0.006070495117455721
3 O 0 0.005227157846093178
) O 0 0.00403946079313755
at O 0 0.002697652205824852
the O 0 0.002904155757278204
3 O 0 0.008323748596012592
distal O 1 0.6329454183578491
end O 0 0.00917802657932043
of O 0 0.005494412966072559
the O 0 0.01034284196794033
gene O 1 0.8929343819618225
. O 0 0.028390735387802124

Variability O 0 0.31681424379348755
in O 0 0.01134292408823967
the O 0 0.007699005305767059
number O 0 0.008556862361729145
of O 0 0.04409710317850113
colorectal B-Disease 1 0.997463583946228
adenomas I-Disease 1 0.9842755198478699
was O 0 0.009283727966248989
most O 0 0.007499922066926956
apparent O 0 0.1292829066514969
in O 0 0.006777295842766762
individuals O 0 0.06050100922584534
with O 0 0.015165186487138271
mutations O 1 0.9649001955986023
in O 0 0.006626080721616745
region O 0 0.01398458518087864
1 O 0 0.006426729261875153
, O 0 0.004292826168239117
and O 0 0.0054607088677585125
upper O 1 0.5013985633850098
- O 1 0.8344970345497131
gastrointestinal O 1 0.993626594543457
manifestations O 1 0.5588992238044739
were O 0 0.0069641550071537495
more O 0 0.012633969075977802
severe O 1 0.6978658437728882
in O 0 0.009922711178660393
them O 0 0.012539665214717388
. O 0 0.020318223163485527

In O 0 0.020886264741420746
individuals O 0 0.034718289971351624
with O 0 0.0152626046910882
mutations O 1 0.9203115701675415
in O 0 0.005656048189848661
either O 0 0.0066498382948338985
region O 0 0.007010248489677906
2 O 0 0.0046725766733288765
or O 0 0.0041882856748998165
region O 0 0.005258018150925636
3 O 0 0.0035480456426739693
, O 0 0.0019838486332446337
the O 0 0.0016960115171968937
average O 0 0.003991883713752031
number O 0 0.0031793024390935898
of O 0 0.0035485343541949987
adenomas B-Disease 1 0.8756864070892334
tended O 0 0.010028669610619545
to O 0 0.002613183343783021
be O 0 0.0019876351580023766
lower O 0 0.004727509804069996
than O 0 0.00253745773807168
those O 0 0.0025031701661646366
in O 0 0.0030059716664254665
individuals O 0 0.032718561589717865
with O 0 0.015990687534213066
mutations O 1 0.9742944240570068
in O 0 0.005286431405693293
region O 0 0.014080158434808254
1 O 0 0.007191810291260481
, O 0 0.003832255955785513
although O 0 0.006254350766539574
age O 0 0.029140053316950798
at O 0 0.014554237015545368
diagnosis O 1 0.9628279805183411
was O 0 0.009509115479886532
similar O 0 0.03437373787164688
. O 0 0.017968691885471344

In O 0 0.024747805669903755
all O 0 0.016311444342136383
AAPC B-Disease 1 0.9139074087142944
kindreds O 1 0.5903002619743347
, O 0 0.01062434446066618
a O 0 0.011504093185067177
predominance O 0 0.23988349735736847
of O 0 0.01177963986992836
right O 0 0.21502113342285156
- O 1 0.909313976764679
sided O 1 0.9776424169540405
colorectal B-Disease 1 0.9974742531776428
adenomas I-Disease 1 0.9921453595161438
and O 0 0.41314220428466797
rectal B-Disease 1 0.9888290762901306
polyp I-Disease 1 0.9849746823310852
sparing O 1 0.7651687860488892
was O 0 0.02423739992082119
observed O 0 0.08449408411979675
. O 0 0.0299846138805151

No O 0 0.05847428739070892
desmoid B-Disease 1 0.8359630107879639
tumors I-Disease 1 0.9669432640075684
were O 0 0.009651570580899715
found O 0 0.01206950657069683
in O 0 0.009082525968551636
these O 0 0.012907173484563828
kindreds O 1 0.6551376581192017
. O 0 0.029267193749547005

Our O 0 0.017430011183023453
data O 0 0.01295515801757574
suggest O 0 0.012320330366492271
that O 0 0.004495959263294935
, O 0 0.004547374323010445
in O 0 0.0062624793499708176
AAPC B-Disease 1 0.8293231129646301
families O 0 0.010215715505182743
, O 0 0.003658041823655367
the O 0 0.0026725202333182096
location O 0 0.004275188781321049
of O 0 0.0038778141606599092
the O 0 0.008243820630013943
APC B-Disease 1 0.9542377591133118
mutation O 1 0.9862527251243591
may O 0 0.09929831326007843
partially O 0 0.2267470359802246
predict O 0 0.1734727919101715
specific O 0 0.10051047056913376
phenotypic O 1 0.7484864592552185
expression O 0 0.26439380645751953
. O 0 0.03444041311740875

This O 0 0.01295026857405901
should O 0 0.0070955040864646435
help O 0 0.006616843398660421
in O 0 0.003108271164819598
the O 0 0.0031838982831686735
design O 0 0.0068206205032765865
of O 0 0.0065748365595936775
tailored O 1 0.6887989640235901
clinical O 1 0.942376971244812
- O 0 0.3872763216495514
management O 0 0.11785034090280533
protocols O 0 0.11537342518568039
in O 0 0.005319623276591301
this O 0 0.005021669901907444
subset O 0 0.2844077944755554
of O 0 0.029289310798048973
FAP B-Disease 1 0.9827672243118286
patients O 1 0.9681569933891296
. O 0 0.025607405230402946
. O 0 0.02614922821521759

Wilms B-Disease 1 0.9530408978462219
' I-Disease 0 0.36849382519721985
tumor I-Disease 1 0.9643452763557434
1 O 0 0.025517718866467476
and O 0 0.01181707438081503
Dax O 0 0.20291975140571594
- O 0 0.24620330333709717
1 O 0 0.02992253378033638
modulate O 1 0.7019893527030945
the O 0 0.015808282420039177
orphan O 1 0.8907130360603333
nuclear O 0 0.21525838971138
receptor O 1 0.9574782848358154
SF O 1 0.8849648237228394
- O 0 0.17456337809562683
1 O 0 0.013674483634531498
in O 0 0.01108898501843214
sex O 0 0.29509952664375305
- O 0 0.3979257345199585
specific O 0 0.22540052235126495
gene O 1 0.9400944113731384
expression O 0 0.32736292481422424
. O 0 0.036290280520915985

Products O 0 0.06380760669708252
of O 0 0.028045358136296272
steroidogenic O 1 0.9424353837966919
factor O 0 0.372382789850235
1 O 0 0.03921622037887573
( O 0 0.10630350559949875
SF O 1 0.8729107975959778
- O 0 0.23091906309127808
1 O 0 0.02056083455681801
) O 0 0.032833002507686615
and O 0 0.03109080158174038
Wilms B-Disease 1 0.992474377155304
tumor I-Disease 1 0.9926934242248535
1 O 0 0.10285366326570511
( O 0 0.2588305175304413
WT1 O 1 0.9776231646537781
) O 0 0.05873296782374382
genes O 1 0.6562878489494324
are O 0 0.005042279604822397
essential O 0 0.013428457081317902
for O 0 0.007606142666190863
mammalian O 1 0.8538326025009155
gonadogenesis O 1 0.5384723544120789
prior O 0 0.01941061019897461
to O 0 0.010388588532805443
sexual O 0 0.43478578329086304
differentiation O 1 0.8325547575950623
. O 0 0.029337814077734947

In O 0 0.02745503932237625
males O 0 0.15743762254714966
, O 0 0.017602097243070602
SF O 1 0.688389778137207
- O 0 0.1366463303565979
1 O 0 0.012799367308616638
participates O 0 0.0536322295665741
in O 0 0.006440400145947933
sexual O 0 0.06406615674495697
development O 0 0.011797389015555382
by O 0 0.006986853200942278
regulating O 0 0.15959317982196808
expression O 0 0.05492589995265007
of O 0 0.007600634358823299
the O 0 0.018221871927380562
polypeptide O 1 0.9749191403388977
hormone O 1 0.9927788376808167
Mullerian O 1 0.9916414022445679
inhibiting O 1 0.9891664385795593
substance O 1 0.9633625745773315
( O 0 0.3856349587440491
MIS O 1 0.9568639397621155
) O 0 0.04658861830830574
. O 0 0.024119850248098373

Here O 0 0.016722679138183594
, O 0 0.009126857854425907
we O 0 0.0058876932598650455
show O 0 0.010683582164347172
that O 0 0.011899649165570736
WT1 O 1 0.9501712918281555
- O 1 0.636025607585907
KTS O 1 0.9563801288604736
isoforms O 1 0.7135245203971863
associate O 0 0.04554266482591629
and O 0 0.009237593971192837
synergize O 1 0.7509893774986267
with O 0 0.02274397201836109
SF O 1 0.7213066816329956
- O 0 0.08444274216890335
1 O 0 0.012875021435320377
to O 0 0.008260461501777172
promote O 0 0.05042055621743202
MIS O 1 0.8990575671195984
expression O 0 0.2082214653491974
. O 0 0.028518103063106537

In O 0 0.030707452446222305
contrast O 0 0.07100871205329895
, O 0 0.047802701592445374
WT1 O 1 0.9733579158782959
missense O 1 0.9757627248764038
mutations O 1 0.9802396893501282
, O 0 0.016613030806183815
associated O 0 0.055158503353595734
with O 0 0.013326163403689861
male B-Disease 1 0.5742272734642029
pseudohermaphroditism I-Disease 1 0.9303378462791443
in O 0 0.1860647201538086
Denys B-Disease 1 0.9831075668334961
- I-Disease 1 0.9560165405273438
Drash I-Disease 1 0.9859865307807922
syndrome I-Disease 1 0.9962170720100403
, O 0 0.018233489245176315
fail O 0 0.16832472383975983
to O 0 0.011686909943819046
synergize O 1 0.8216586112976074
with O 0 0.04812221974134445
SF O 1 0.8225829601287842
- O 0 0.21709971129894257
1 O 0 0.026420466601848602
. O 0 0.024368582293391228

Additionally O 0 0.03734743595123291
, O 0 0.012959864921867847
the O 0 0.010216419585049152
X O 0 0.21616674959659576
- O 0 0.18448130786418915
linked O 0 0.21752779185771942
, O 0 0.008892238140106201
candidate O 0 0.04449992626905441
dosage O 1 0.8823519945144653
- O 0 0.4150281250476837
sensitive O 0 0.316780149936676
sex O 1 0.6006788611412048
- O 1 0.5784544944763184
reversal O 1 0.7666532397270203
gene O 1 0.9370517134666443
, O 0 0.011179596185684204
Dax O 0 0.13577885925769806
- O 0 0.11665599048137665
1 O 0 0.013094086199998856
, O 0 0.009283486753702164
antagonizes O 1 0.732197105884552
synergy O 1 0.5833566784858704
between O 0 0.05373596400022507
SF O 1 0.8225172162055969
- O 0 0.09255414456129074
1 O 0 0.010330507531762123
and O 0 0.0057625239714980125
WT1 O 1 0.8626680374145508
, O 0 0.004260542336851358
most O 0 0.0033891519997268915
likely O 0 0.005723792593926191
through O 0 0.00499229971319437
a O 0 0.0058543323539197445
direct O 0 0.014688202179968357
interaction O 0 0.097208172082901
with O 0 0.02105328068137169
SF O 1 0.8178648352622986
- O 0 0.20643223822116852
1 O 0 0.024510350078344345
. O 0 0.022712862119078636

We O 0 0.018932227045297623
propose O 0 0.030664239078760147
that O 0 0.01082055177539587
WT1 O 1 0.7865695953369141
and O 0 0.008973116055130959
Dax O 0 0.11456214636564255
- O 0 0.08036567270755768
1 O 0 0.012755488976836205
functionally O 0 0.21714182198047638
oppose O 0 0.013144916854798794
each O 0 0.004440233577042818
other O 0 0.004554565530270338
in O 0 0.008287106640636921
testis O 1 0.9125602841377258
development O 0 0.06560559570789337
by O 0 0.03374413773417473
modulating O 1 0.9669122695922852
SF O 1 0.9424329400062561
- O 0 0.43171989917755127
1 O 0 0.06299123167991638
- O 1 0.5269127488136292
mediated O 1 0.905193567276001
transactivation O 1 0.9088138341903687
. O 0 0.02452443353831768
. O 0 0.025513309985399246

A O 0 0.06476433575153351
mouse O 1 0.7950331568717957
model O 0 0.13293540477752686
for O 0 0.15191683173179626
Prader B-Disease 1 0.9872685670852661
- I-Disease 1 0.9762661457061768
Willi I-Disease 1 0.990829586982727
syndrome I-Disease 1 0.996100902557373
imprinting O 1 0.9753806591033936
- O 1 0.8118544816970825
centre O 0 0.4168011546134949
mutations O 1 0.9685302376747131
. O 0 0.05014199763536453

Imprinting O 1 0.503416121006012
in O 0 0.02059822902083397
the O 0 0.015395546332001686
15q11 O 1 0.549484372138977
- O 0 0.3113892078399658
q13 O 0 0.47269272804260254
region O 0 0.03094089962542057
involves O 0 0.09674303978681564
an O 0 0.011526443995535374
imprinting O 1 0.9089071750640869
centre O 0 0.06073835492134094
( O 0 0.04858662560582161
IC O 0 0.4075327217578888
) O 0 0.007781817112118006
, O 0 0.0029422645457088947
mapping O 0 0.00726753706112504
in O 0 0.0025968453846871853
part O 0 0.00272033060900867
to O 0 0.0020692104008048773
the O 0 0.002928038826212287
promoter O 0 0.045022010803222656
and O 0 0.0036671687848865986
first O 0 0.0060384576208889484
exon O 0 0.29645147919654846
of O 0 0.012862162664532661
SNRPN O 1 0.6838107705116272
. O 0 0.027552440762519836

Deletion O 0 0.45900964736938477
of O 0 0.015672562643885612
this O 0 0.013916113413870335
IC O 1 0.5075535774230957
abolishes O 1 0.6678608059883118
local O 0 0.02709835395216942
paternally O 1 0.8739147186279297
derived O 0 0.48084497451782227
gene O 1 0.9423959255218506
expression O 0 0.22419583797454834
and O 0 0.010514887049794197
results O 0 0.1711217164993286
in O 0 0.20381492376327515
Prader B-Disease 1 0.9918095469474792
- I-Disease 1 0.9814974069595337
Willi I-Disease 1 0.9921910166740417
syndrome I-Disease 1 0.996908962726593
( O 1 0.718422532081604
PWS B-Disease 1 0.9620485305786133
) O 0 0.08199982345104218
. O 0 0.03672783821821213

We O 0 0.013595590367913246
have O 0 0.008355912752449512
created O 0 0.014345631934702396
two O 0 0.017277276143431664
deletion O 1 0.9784851670265198
mutations O 1 0.9880980849266052
in O 0 0.030104387551546097
mice O 1 0.9279909133911133
to O 0 0.007905993610620499
understand O 0 0.06496194005012512
PWS B-Disease 1 0.9241446852684021
and O 0 0.004968083463609219
the O 0 0.00462647620588541
mechanism O 0 0.07198520749807358
of O 0 0.005786642897874117
this O 0 0.008719682693481445
IC O 0 0.3871205449104309
. O 0 0.021368786692619324

Mice O 1 0.9415112137794495
harbouring O 1 0.5856722593307495
an O 0 0.031153695657849312
intragenic O 1 0.6934415102005005
deletion O 1 0.7774776816368103
in O 0 0.012936708517372608
Snrpn O 0 0.41502639651298523
are O 0 0.00864870660007
phenotypically O 1 0.7782455086708069
normal O 0 0.12264321744441986
, O 0 0.005651938728988171
suggesting O 0 0.029908405616879463
that O 0 0.005564795341342688
mutations O 1 0.8993043303489685
of O 0 0.0060218460857868195
SNRPN O 0 0.22533473372459412
are O 0 0.004201216623187065
not O 0 0.004439359065145254
sufficient O 0 0.011449761688709259
to O 0 0.010434781201183796
induce O 1 0.8948453664779663
PWS B-Disease 1 0.9663577079772949
. O 0 0.0437563955783844

Mice O 1 0.7510323524475098
with O 0 0.018606116995215416
a O 0 0.014868111349642277
larger O 0 0.02268211916089058
deletion O 1 0.6222143769264221
involving O 0 0.0531444326043129
both O 0 0.009757578372955322
Snrpn O 0 0.22135387361049652
and O 0 0.006150884088128805
the O 0 0.01044110581278801
putative O 1 0.9249725937843323
PWS O 1 0.9871624112129211
- O 1 0.5719178318977356
IC O 1 0.5356934070587158
lack O 0 0.03120572865009308
expression O 0 0.037743404507637024
of O 0 0.0057153645902872086
the O 0 0.01177598349750042
imprinted O 1 0.9512128233909607
genes O 1 0.9831764698028564
Zfp127 O 1 0.9385374188423157
( O 0 0.24208520352840424
mouse O 1 0.8895539045333862
homologue O 1 0.8235048055648804
of O 0 0.014865696430206299
ZNF127 O 1 0.7078437805175781
) O 0 0.021432360634207726
, O 0 0.006574216764420271
Ndn O 1 0.5087025165557861
and O 0 0.0062691508792340755
Ipw O 0 0.20141437649726868
, O 0 0.005389329977333546
and O 0 0.00432939687743783
manifest O 0 0.06263463199138641
several O 0 0.013694576919078827
phenotypes O 1 0.9418797492980957
common O 0 0.2407793253660202
to O 0 0.033963970839977264
PWS B-Disease 1 0.9747705459594727
infants O 1 0.9627524018287659
. O 0 0.08200132846832275

These O 0 0.013425267301499844
data O 0 0.009280758909881115
demonstrate O 0 0.00797093752771616
that O 0 0.0026996133383363485
both O 0 0.002271329751238227
the O 0 0.0020304450299590826
position O 0 0.0023725414648652077
of O 0 0.0019520089263096452
the O 0 0.0027086406480520964
IC O 0 0.06651009619235992
and O 0 0.0019909683614969254
its O 0 0.0023246528580784798
role O 0 0.004155420698225498
in O 0 0.0023673917166888714
the O 0 0.002647971734404564
coordinate O 0 0.0328851155936718
expression O 0 0.05936645716428757
of O 0 0.005437696352601051
genes O 1 0.807571530342102
is O 0 0.007935257628560066
conserved O 0 0.17912042140960693
between O 0 0.02354438602924347
mouse O 1 0.7247322797775269
and O 0 0.0036535575054585934
human O 0 0.023366127163171768
, O 0 0.0026651034131646156
and O 0 0.0017037561628967524
indicate O 0 0.0040613156743347645
that O 0 0.0018801204860210419
the O 0 0.002636880613863468
mouse O 0 0.3614956736564636
is O 0 0.0029427872505038977
a O 0 0.003412417136132717
suitable O 0 0.011034329421818256
model O 0 0.010103287175297737
system O 0 0.0064698923379182816
in O 0 0.002162101911380887
which O 0 0.001822254853323102
to O 0 0.0020638734567910433
investigate O 0 0.005932227708399296
the O 0 0.0037570178974419832
molecular O 0 0.41297975182533264
mechanisms O 0 0.15245270729064941
of O 0 0.004446508828550577
imprinting O 1 0.572467565536499
in O 0 0.0038176842499524355
this O 0 0.0029176317621022463
region O 0 0.006056536920368671
of O 0 0.003792264498770237
the O 0 0.007126329001039267
genome O 1 0.5365456342697144
. O 0 0.014181009493768215
. O 0 0.018450168892741203

Mutations O 1 0.8767123222351074
of O 0 0.016526587307453156
the O 0 0.018507985398173332
ATM O 1 0.7915071249008179
gene O 1 0.970033586025238
detected O 1 0.6679977774620056
in O 0 0.0342901237308979
Japanese O 0 0.47321200370788574
ataxia B-Disease 1 0.9959457516670227
- I-Disease 1 0.979582667350769
telangiectasia I-Disease 1 0.9949693083763123
patients O 1 0.9822996258735657
: O 0 0.02549242042005062
possible O 0 0.021503230556845665
preponderance O 0 0.1045147106051445
of O 0 0.005283696576952934
the O 0 0.005927269347012043
two O 0 0.010396680794656277
founder O 0 0.2334446907043457
mutations O 1 0.9770883321762085
4612del165 O 1 0.5861048698425293
and O 0 0.01961228810250759
7883del5 O 0 0.40277349948883057
. O 0 0.03362608328461647

The O 0 0.0292509812861681
ATM O 0 0.23642215132713318
( O 0 0.04705873504281044
A O 0 0.05410199239850044
- O 1 0.6046121120452881
T O 1 0.9358958601951599
, O 0 0.03131462633609772
mutated O 1 0.9662646055221558
) O 0 0.10786782950162888
gene O 1 0.8809054493904114
on O 0 0.010254019871354103
human O 0 0.36660510301589966
chromosome O 1 0.9656693935394287
11q22 O 1 0.6782525181770325
. O 0 0.033049602061510086

3 O 0 0.02437124401330948
has O 0 0.010427368804812431
recently O 0 0.010735557414591312
been O 0 0.004921541549265385
identified O 0 0.00906238704919815
as O 0 0.003939643036574125
the O 0 0.005751604214310646
gene O 1 0.908805251121521
responsible O 0 0.04204569756984711
for O 0 0.010163851082324982
the O 0 0.09173309803009033
human O 1 0.9830912947654724
recessive B-Disease 1 0.9990425705909729
disease I-Disease 1 0.9990082383155823
ataxia B-Disease 1 0.9980535507202148
- I-Disease 1 0.9859024286270142
telangiectasia I-Disease 1 0.9936968684196472
( O 0 0.32575228810310364
A B-Disease 0 0.1813609004020691
- I-Disease 1 0.7496659755706787
T I-Disease 1 0.9465130567550659
) O 0 0.04633311554789543
. O 0 0.02376415766775608

In O 0 0.01601436920464039
order O 0 0.010442090220749378
to O 0 0.005478520877659321
define O 0 0.012653762474656105
the O 0 0.005913321860134602
types O 0 0.21270141005516052
of O 0 0.08992934226989746
disease O 1 0.9972434043884277
- O 1 0.8957489132881165
causing O 1 0.9418269991874695
ATM O 1 0.9028018116950989
mutations O 1 0.9786829948425293
in O 0 0.011084060184657574
Japanese O 0 0.025621876120567322
A B-Disease 0 0.13090460002422333
- I-Disease 1 0.8112560510635376
T I-Disease 1 0.9799212217330933
patients O 1 0.8652782440185547
as O 0 0.003949182573705912
well O 0 0.0028296406380832195
as O 0 0.002584431553259492
to O 0 0.002450915751978755
look O 0 0.005467246752232313
for O 0 0.005071531515568495
possible O 0 0.047049153596162796
mutational O 1 0.9387298226356506
hotspots O 1 0.5251635909080505
, O 0 0.009049293585121632
reverse O 0 0.4302549362182617
- O 0 0.4626435935497284
transcribed O 1 0.6799702644348145
RNA O 1 0.8121809959411621
derived O 0 0.051651932299137115
from O 0 0.006565645337104797
ten O 0 0.00985053088515997
patients O 1 0.8758275508880615
belonging O 0 0.010878699831664562
to O 0 0.0037393884267657995
eight O 0 0.006645606365054846
unrelated O 0 0.18466053903102875
Japanese O 0 0.01165846548974514
A B-Disease 0 0.04576115310192108
- I-Disease 0 0.46546125411987305
T I-Disease 1 0.8524642586708069
families O 0 0.018853891640901566
was O 0 0.005522886291146278
analyzed O 0 0.03088212013244629
for O 0 0.007208607159554958
mutations O 1 0.9098823070526123
by O 0 0.010016246698796749
the O 0 0.010947897098958492
restriction O 0 0.28246426582336426
endonuclease O 1 0.8580682873725891
fingerprinting O 0 0.31297409534454346
method O 0 0.0811939537525177
. O 0 0.029549555853009224

As O 0 0.014076214283704758
has O 0 0.008447615429759026
been O 0 0.005328067112714052
reported O 0 0.008319499902427197
by O 0 0.004421204794198275
others O 0 0.005989158060401678
, O 0 0.005898093339055777
mutations O 1 0.8707120418548584
that O 0 0.0038112085312604904
lead O 0 0.015047362074255943
to O 0 0.0060162777081131935
exon O 1 0.7164803147315979
skipping O 0 0.44022420048713684
or O 0 0.09241068363189697
premature O 1 0.906460165977478
protein O 1 0.7691364288330078
truncation O 0 0.31056544184684753
were O 0 0.005145796108990908
also O 0 0.004813631996512413
predominant O 0 0.023386698216199875
in O 0 0.006787905935198069
our O 0 0.010345103219151497
mutants O 0 0.4408073127269745
. O 0 0.024377569556236267

Six O 0 0.02637704461812973
different O 0 0.01762225106358528
mutations O 1 0.7246928215026855
were O 0 0.004987915977835655
identified O 0 0.007928544655442238
on O 0 0.0035068646539002657
12 O 0 0.00554854329675436
of O 0 0.004105347208678722
the O 0 0.007053334731608629
16 O 0 0.036117225885391235
alleles O 1 0.9594131708145142
examined O 0 0.2676910161972046
. O 0 0.02861541323363781

Four O 0 0.019002150744199753
were O 0 0.009386721067130566
deletions O 0 0.1807328462600708
involving O 0 0.02060212567448616
a O 0 0.00794235896319151
loss O 0 0.017736757174134254
of O 0 0.004228687379509211
a O 0 0.007197773549705744
single O 0 0.024468928575515747
exon O 1 0.7226613759994507
exon O 1 0.5135824680328369
7 O 0 0.016466571018099785
, O 0 0.007520568091422319
exon O 0 0.2747218608856201
16 O 0 0.012492147274315357
, O 0 0.008832331746816635
exon O 0 0.22231616079807281
33 O 0 0.019525503739714622
or O 0 0.01729121245443821
exon O 0 0.3642021119594574
35 O 0 0.03188985958695412
. O 0 0.022320479154586792

The O 0 0.015375242568552494
others O 0 0.011473593302071095
were O 0 0.00610136054456234
minute O 0 0.011808100156486034
deletions O 0 0.30593276023864746
, O 0 0.00719646830111742
4649delA O 0 0.12787717580795288
in O 0 0.007366153411567211
exon O 0 0.18394987285137177
33 O 0 0.01709117367863655
and O 0 0.007673096843063831
7883del5 O 0 0.23814761638641357
in O 0 0.013187267817556858
exon O 0 0.3694117069244385
55 O 0 0.036093760281801224
. O 0 0.02384883351624012

The O 0 0.03250432759523392
mutations O 1 0.946641743183136
4612del165 O 0 0.2418004423379898
and O 0 0.008585679344832897
7883del5 O 0 0.06393221020698547
were O 0 0.0040090954862535
found O 0 0.004524424206465483
in O 0 0.002501325448974967
more O 0 0.0024358646478503942
than O 0 0.0027523767203092575
two O 0 0.003744458081200719
unrelated O 0 0.2618952989578247
families O 0 0.028698915615677834
; O 0 0.008425991050899029
44 O 0 0.008142393082380295
% O 0 0.010253507643938065
( O 0 0.005475881975144148
7 O 0 0.003887784667313099
of O 0 0.002400399185717106
16 O 0 0.004588829819113016
) O 0 0.004043834283947945
of O 0 0.0023903532419353724
the O 0 0.004059848375618458
mutant O 1 0.7238612771034241
alleles O 1 0.8871359825134277
had O 0 0.0048721362836658955
one O 0 0.003120561596006155
of O 0 0.0033771756570786238
the O 0 0.005430012010037899
two O 0 0.013881534337997437
mutations O 1 0.9642071723937988
. O 0 0.03920874744653702

The O 0 0.024957118555903435
4612del165 O 1 0.6451380848884583
mutations O 1 0.8854725956916809
in O 0 0.006553588900715113
three O 0 0.004443766083568335
different O 0 0.004091643262654543
families O 0 0.004701020196080208
were O 0 0.002046345267444849
all O 0 0.0020234056282788515
ascribed O 0 0.012607757933437824
to O 0 0.002714569680392742
the O 0 0.003608391620218754
same O 0 0.01745152473449707
T O 1 0.9078837633132935
- O 0 0.47893837094306946
- O 0 0.31612884998321533
> O 0 0.470747709274292
A O 0 0.012667207978665829
substitution O 0 0.070346400141716
at O 0 0.007205216214060783
the O 0 0.008043540641665459
splice O 1 0.7723445296287537
donor O 1 0.567827045917511
site O 0 0.01844632811844349
in O 0 0.015582263469696045
intron O 1 0.8239673972129822
33 O 0 0.045494891703128815
. O 0 0.02814267762005329

Microsatellite O 1 0.8428235054016113
genotyping O 0 0.3376629650592804
around O 0 0.020282452926039696
the O 0 0.012990179471671581
ATM O 0 0.186399444937706
locus O 0 0.4038636088371277
also O 0 0.0060405549593269825
indicated O 0 0.008076701313257217
that O 0 0.0036932318471372128
a O 0 0.0067980592139065266
common O 0 0.09734056890010834
haplotype O 1 0.8822095990180969
was O 0 0.004900007974356413
shared O 0 0.007939649745821953
by O 0 0.00482580903917551
the O 0 0.006526774261146784
mutant O 1 0.871265709400177
alleles O 1 0.9627331495285034
in O 0 0.020894140005111694
both O 0 0.037212543189525604
mutations O 1 0.9742066264152527
. O 0 0.0513070784509182

This O 0 0.015356571413576603
suggests O 0 0.01907622255384922
that O 0 0.0055620125494897366
these O 0 0.004258285276591778
two O 0 0.00528086768463254
founder O 0 0.2380262166261673
mutations O 1 0.9781573414802551
may O 0 0.01855347491800785
be O 0 0.0045637935400009155
predominant O 0 0.04627389833331108
among O 0 0.010321117006242275
Japanese O 0 0.023503683507442474
ATM O 1 0.6104131937026978
mutant O 1 0.9277728199958801
alleles O 1 0.960309624671936
. O 0 0.05826285481452942

W474C O 1 0.5421182513237
amino O 1 0.5798787474632263
acid O 1 0.7973121404647827
substitution O 0 0.41924870014190674
affects O 1 0.5352895259857178
early O 0 0.010824477300047874
processing O 0 0.009646636433899403
of O 0 0.0042606983333826065
the O 0 0.005484005901962519
alpha O 0 0.09952104836702347
- O 0 0.13625460863113403
subunit O 0 0.3774275779724121
of O 0 0.008345512673258781
beta O 0 0.4481286108493805
- O 0 0.1899297684431076
hexosaminidase O 0 0.27679288387298584
A O 0 0.007697941269725561
and O 0 0.003860351862385869
is O 0 0.005986918695271015
associated O 0 0.06394009292125702
with O 0 0.05426405370235443
subacute O 1 0.9894077181816101
G B-Disease 1 0.8983470797538757
( I-Disease 0 0.19847270846366882
M2 I-Disease 1 0.7372587323188782
) I-Disease 0 0.04983803257346153
gangliosidosis I-Disease 0 0.4081239402294159
. O 0 0.02491580881178379

Mutations O 1 0.8903433680534363
in O 0 0.02691345103085041
the O 0 0.02548288367688656
HEXA O 1 0.9689441919326782
gene O 1 0.8921671509742737
, O 0 0.010189374908804893
encoding O 0 0.07835260778665543
the O 0 0.007191802840679884
alpha O 0 0.08108289539813995
- O 0 0.17082026600837708
subunit O 0 0.27053558826446533
of O 0 0.00733179971575737
beta O 0 0.4844541549682617
- O 0 0.18208415806293488
hexosaminidase O 0 0.3323436975479126
A O 0 0.012226356193423271
( O 0 0.0110841765999794
Hex O 0 0.02565588615834713
A O 0 0.006758592557162046
) O 0 0.005128300283104181
, O 0 0.003098475281149149
that O 0 0.003346592653542757
abolish O 0 0.036581672728061676
Hex O 0 0.1483103334903717
A O 0 0.08047249168157578
enzyme O 1 0.9723374247550964
activity O 1 0.8521942496299744
cause O 1 0.988857626914978
Tay B-Disease 1 0.9962745904922485
- I-Disease 1 0.9897339940071106
Sachs I-Disease 1 0.9950201511383057
disease I-Disease 1 0.9978557229042053
( O 1 0.7525752186775208
TSD B-Disease 1 0.9840429425239563
) O 0 0.04673362150788307
, O 0 0.007281070109456778
the O 0 0.013876131735742092
fatal O 1 0.9858399629592896
infantile B-Disease 1 0.988976001739502
form I-Disease 0 0.22799068689346313
of I-Disease 0 0.017880180850625038
G I-Disease 1 0.8430564403533936
( I-Disease 0 0.13863690197467804
M2 I-Disease 1 0.6833654642105103
) I-Disease 0 0.036329690366983414
gangliosidosis I-Disease 0 0.39492201805114746
, I-Disease 0 0.010803578421473503
Type I-Disease 0 0.06881056725978851
1 I-Disease 0 0.0170717965811491
. O 0 0.01758722774684429

Less O 0 0.24225382506847382
severe O 1 0.9580395817756653
, O 0 0.13642509281635284
subacute O 1 0.9867324233055115
( O 1 0.7078316807746887
juvenile O 1 0.9842186570167542
- O 1 0.9522585272789001
onset O 1 0.9935377240180969
) O 0 0.34626203775405884
and O 0 0.13100509345531464
chronic O 1 0.9961007833480835
( O 1 0.5754506587982178
adult O 1 0.9282701015472412
- O 1 0.9325063228607178
onset O 1 0.9918147921562195
) O 0 0.08066068589687347
variants O 0 0.4311346113681793
are O 0 0.0050606392323970795
characterized O 0 0.10211207717657089
by O 0 0.0047396766021847725
a O 0 0.0073074945248663425
broad O 0 0.047139715403318405
spectrum O 0 0.1348799765110016
of O 0 0.0074451155960559845
clinical O 1 0.8554766178131104
manifestations O 0 0.33427464962005615
and O 0 0.004378533456474543
are O 0 0.0038918228819966316
associated O 0 0.027695342898368835
with O 0 0.005547964945435524
residual O 0 0.23363147675991058
levels O 0 0.03571934252977371
of O 0 0.006694150622934103
Hex O 0 0.1341780126094818
A O 0 0.04062872380018234
enzyme O 1 0.8712370991706848
activity O 0 0.13659273087978363
. O 0 0.02551398240029812

We O 0 0.023569349199533463
identified O 0 0.03873505815863609
a O 0 0.028141483664512634
1422 O 1 0.9424739480018616
G O 1 0.8819549679756165
- O 1 0.7029898166656494
- O 1 0.7600107192993164
> O 1 0.9062175154685974
C O 0 0.47948160767555237
( O 0 0.07459581643342972
amino O 1 0.6293805241584778
acid O 1 0.8689519166946411
W474C O 0 0.49353182315826416
) O 0 0.010676397942006588
substitution O 0 0.020013077184557915
in O 0 0.0031963761430233717
the O 0 0.0021582739427685738
first O 0 0.002625694265589118
position O 0 0.0030515289399772882
of O 0 0.0030788395088166
exon O 0 0.15281857550144196
13 O 0 0.007268252782523632
of O 0 0.004653243813663721
HEXA O 1 0.8153243660926819
of O 0 0.005375527311116457
a O 0 0.009804117493331432
non O 0 0.047465868294239044
- O 0 0.13008904457092285
Jewish O 0 0.056509170681238174
proband O 1 0.5202540159225464
who O 0 0.015454595908522606
manifested O 1 0.6052334904670715
a O 0 0.08946477621793747
subacute O 1 0.9875275492668152
variant O 1 0.9212571382522583
of O 0 0.02465181052684784
G B-Disease 1 0.7171136736869812
( I-Disease 0 0.1261766105890274
M2 I-Disease 1 0.6298457384109497
) I-Disease 0 0.039938025176525116
gangliosidosis I-Disease 0 0.303353488445282
. O 0 0.02844582125544548

On O 0 0.019210848957300186
the O 0 0.013176238164305687
second O 0 0.02597830630838871
maternally O 1 0.9425116181373596
inherited O 1 0.965837836265564
allele O 1 0.9317960739135742
, O 0 0.008555576205253601
we O 0 0.005033462308347225
identified O 0 0.030843069776892662
the O 0 0.015339160338044167
common O 1 0.8819801211357117
infantile O 1 0.9968059062957764
disease O 1 0.9979888200759888
- O 1 0.92912757396698
causing O 1 0.8870568871498108
4 O 0 0.0863153487443924
- O 0 0.3812136650085449
bp O 0 0.1941402703523636
insertion O 1 0.5745564699172974
, O 0 0.01924634911119938
+ O 1 0.6603708863258362
TATC O 1 0.7178404927253723
1278 O 1 0.609070360660553
, O 0 0.010521030984818935
in O 0 0.01098571065813303
exon O 0 0.2470323145389557
11 O 0 0.028314847499132156
. O 0 0.022852446883916855

Pulse O 1 0.5234072208404541
- O 0 0.21145658195018768
chase O 0 0.1389414221048355
analysis O 0 0.03133011609315872
using O 0 0.019334161654114723
proband O 0 0.4981469213962555
fibroblasts O 1 0.713171660900116
revealed O 0 0.01531628891825676
that O 0 0.004832231439650059
the O 0 0.005854499526321888
W474C O 0 0.3610352873802185
- O 0 0.14818215370178223
containing O 0 0.0499982126057148
alpha O 0 0.21324056386947632
- O 0 0.41379764676094055
subunit O 1 0.692865252494812
precursor O 0 0.4405502676963806
was O 0 0.0052189575508236885
normally O 0 0.012374654412269592
synthesized O 0 0.09990634769201279
, O 0 0.0035271451342850924
but O 0 0.003046453930437565
not O 0 0.003493034513667226
phosphorylated O 0 0.16855500638484955
or O 0 0.012119969353079796
secreted O 0 0.18068312108516693
, O 0 0.004292516503483057
and O 0 0.00374072277918458
the O 0 0.007152691017836332
mature O 1 0.756118655204773
lysosomal O 1 0.9727177619934082
alpha O 0 0.36107733845710754
- O 0 0.3710659146308899
subunit O 0 0.3806484639644623
was O 0 0.00831281766295433
not O 0 0.009491054341197014
detected O 0 0.29232457280158997
. O 0 0.021393680945038795

When O 0 0.024321191012859344
the O 0 0.014386399649083614
W474C O 0 0.2668474614620209
- O 0 0.0967857763171196
containing O 0 0.04336153715848923
alpha O 0 0.1848505735397339
- O 0 0.25156688690185547
subunit O 0 0.4330298900604248
was O 0 0.010244830511510372
transiently O 1 0.6260692477226257
co O 0 0.13542494177818298
- O 0 0.04152045026421547
expressed O 0 0.008161659352481365
with O 0 0.004921693820506334
the O 0 0.004996886011213064
beta O 0 0.28487810492515564
- O 0 0.15019077062606812
subunit O 0 0.19956542551517487
to O 0 0.004685904365032911
produce O 0 0.014932263642549515
Hex O 0 0.06621991097927094
A O 0 0.014625336043536663
( O 0 0.03158969432115555
alphabeta O 0 0.38825997710227966
) O 0 0.011089528910815716
in O 0 0.008475251495838165
COS O 1 0.7547675967216492
- O 0 0.23058295249938965
7 O 0 0.04132099449634552
cells O 1 0.7230355739593506
, O 0 0.00432749604806304
the O 0 0.004619638901203871
mature O 0 0.3630584180355072
alpha O 0 0.17777836322784424
- O 0 0.10470258444547653
subunit O 0 0.14037321507930756
was O 0 0.0029535519424825907
present O 0 0.0028606117703020573
, O 0 0.0019247687887400389
but O 0 0.0016174251213669777
its O 0 0.0016028396785259247
level O 0 0.002444594632834196
was O 0 0.001712715602479875
much O 0 0.0022892893757671118
lower O 0 0.0041145398281514645
than O 0 0.002711571054533124
that O 0 0.002645917469635606
from O 0 0.004812873434275389
normal O 0 0.11401743441820145
alpha O 0 0.1794198602437973
- O 0 0.38533058762550354
subunit O 1 0.6815198659896851
transfections O 0 0.41635993123054504
, O 0 0.005357413087040186
although O 0 0.004395162686705589
higher O 0 0.005277339834719896
than O 0 0.003918743226677179
in O 0 0.00414010975509882
those O 0 0.011742104776203632
cells O 1 0.933120846748352
transfected O 1 0.9193655848503113
with O 0 0.009536374360322952
an O 0 0.009747954085469246
alpha O 0 0.3472622334957123
- O 1 0.6553448438644409
subunit O 1 0.8369547128677368
associated O 0 0.24073736369609833
with O 0 0.07718082517385483
infantile O 1 0.9807078242301941
TSD B-Disease 1 0.9517703652381897
. O 0 0.0627044290304184

Furthermore O 0 0.03409803286194801
, O 0 0.008462490513920784
the O 0 0.005634604953229427
precursor O 0 0.05135628953576088
level O 0 0.006513677537441254
of O 0 0.003551962086930871
the O 0 0.0047865090891718864
W474C O 0 0.3445587158203125
alpha O 0 0.1588210016489029
- O 0 0.16152562201023102
subunit O 0 0.1941842883825302
was O 0 0.003911422099918127
found O 0 0.004558882210403681
to O 0 0.00300952629186213
accumulate O 0 0.07501180469989777
in O 0 0.003516534110531211
comparison O 0 0.0067147728987038136
to O 0 0.002929218113422394
the O 0 0.004611690528690815
normal O 0 0.13742263615131378
alpha O 0 0.29893967509269714
- O 0 0.40849238634109497
subunit O 1 0.7628218531608582
precursor O 1 0.6647723317146301
levels O 0 0.1744130253791809
. O 0 0.027377987280488014

We O 0 0.018941177055239677
conclude O 0 0.024768756702542305
that O 0 0.009892803616821766
the O 0 0.014899194240570068
1422 O 1 0.9544875025749207
G O 1 0.9214566946029663
- O 1 0.8474185466766357
- O 1 0.8643412590026855
> O 1 0.9476931095123291
C O 1 0.7012587785720825
mutation O 1 0.950719952583313
is O 0 0.006107473745942116
the O 0 0.005475238431245089
cause O 0 0.22126908600330353
of O 0 0.006491159088909626
Hex B-Disease 0 0.3418133556842804
A I-Disease 0 0.28132206201553345
enzyme I-Disease 1 0.991430938243866
deficiency I-Disease 1 0.9955371618270874
in O 0 0.018003003671765327
the O 0 0.01771007664501667
proband O 1 0.6336139440536499
. O 0 0.034301258623600006

The O 0 0.027241745963692665
resulting O 0 0.15469738841056824
W474C O 0 0.2854650318622589
substitution O 0 0.10995963215827942
clearly O 0 0.025131741538643837
interferes O 0 0.29884111881256104
with O 0 0.011512299068272114
alpha O 0 0.1717940717935562
- O 0 0.2408003956079483
subunit O 0 0.41117340326309204
processing O 0 0.013983519747853279
, O 0 0.0036344993859529495
but O 0 0.002533175516873598
because O 0 0.0028157480992376804
the O 0 0.002408945234492421
base O 0 0.0037739232648164034
substitution O 0 0.024953017011284828
falls O 0 0.010630806908011436
at O 0 0.002727784216403961
the O 0 0.0019436503062024713
first O 0 0.0021344958804547787
position O 0 0.0029393560253083706
of O 0 0.0034822209272533655
exon O 0 0.26189589500427246
13 O 0 0.011972395703196526
, O 0 0.008195639587938786
aberrant O 1 0.7124319672584534
splicing O 1 0.7299567461013794
may O 0 0.012571929953992367
also O 0 0.004438095260411501
contribute O 0 0.022027621045708656
to O 0 0.00519619369879365
Hex B-Disease 0 0.16949012875556946
A I-Disease 0 0.11877195537090302
deficiency I-Disease 1 0.992517352104187
in O 0 0.009205429814755917
this O 0 0.008951646275818348
proband O 0 0.3404071033000946
. O 0 0.014728931710124016
. O 0 0.018694482743740082

Two O 0 0.05662848800420761
frequent O 1 0.5915416479110718
missense O 1 0.9531654715538025
mutations O 1 0.9738470911979675
in O 0 0.23910517990589142
Pendred B-Disease 1 0.9609153270721436
syndrome I-Disease 1 0.9908541440963745
. O 0 0.10761399567127228

Pendred B-Disease 1 0.9686001539230347
syndrome I-Disease 1 0.9943653345108032
is O 1 0.5367693901062012
an O 1 0.8921079635620117
autosomal B-Disease 1 0.9983736276626587
recessive I-Disease 1 0.9983123540878296
disorder I-Disease 1 0.9976184964179993
characterized O 1 0.9568462371826172
by O 0 0.10589485615491867
early O 0 0.33668991923332214
childhood O 1 0.972618818283081
deafness B-Disease 1 0.9898776412010193
and O 0 0.12757954001426697
goiter B-Disease 1 0.9748979806900024
. O 0 0.07815302163362503

A O 0 0.023320568725466728
century O 0 0.013625646941363811
after O 0 0.008638417348265648
its O 0 0.006087057758122683
recognition O 0 0.019877327606081963
as O 0 0.008126410655677319
a O 0 0.08906827867031097
syndrome O 1 0.9954336285591125
by O 0 0.025570467114448547
Vaughan O 0 0.33611515164375305
Pendred O 1 0.8141914010047913
, O 0 0.029211951419711113
the O 0 0.13440470397472382
disease O 1 0.9976498484611511
gene O 1 0.9897832274436951
( O 0 0.22994083166122437
PDS O 1 0.7924667000770569
) O 0 0.018161168321967125
was O 0 0.007434964179992676
mapped O 0 0.034095264971256256
to O 0 0.012939589098095894
chromosome O 1 0.9615269303321838
7q22 O 1 0.7479836344718933
- O 0 0.3879688084125519
q31 O 1 0.5584453344345093
. O 0 0.03422635421156883

1 O 0 0.020569738000631332
and O 0 0.007659065071493387
, O 0 0.00588685879483819
recently O 0 0.007960431277751923
, O 0 0.004071997944265604
found O 0 0.004914958495646715
to O 0 0.004796819295734167
encode O 0 0.05620262026786804
a O 0 0.024202918633818626
putative O 1 0.8262643814086914
sulfate O 1 0.9476078748703003
transporter O 1 0.8169116377830505
. O 0 0.04411102086305618

We O 0 0.020402472466230392
performed O 0 0.030818630009889603
mutation O 1 0.8627915978431702
analysis O 0 0.01673927903175354
of O 0 0.005137627013027668
the O 0 0.00973486714065075
PDS B-Disease 1 0.9566437602043152
gene O 1 0.971146821975708
in O 0 0.03190050274133682
patients O 1 0.9204267859458923
from O 0 0.008920821361243725
14 O 0 0.021685538813471794
Pendred B-Disease 1 0.5672047138214111
families O 0 0.022516541182994843
originating O 0 0.03307982534170151
from O 0 0.004606554284691811
seven O 0 0.0046395245008170605
countries O 0 0.004317191895097494
and O 0 0.004006247967481613
identified O 0 0.015043625608086586
all O 0 0.009152833372354507
mutations O 1 0.9608252644538879
. O 0 0.02785676345229149

The O 0 0.02630436420440674
mutations O 1 0.8582900762557983
include O 0 0.013807462528347969
three O 0 0.007863511331379414
single O 0 0.010067583061754704
base O 0 0.008906323462724686
deletions O 0 0.14894944429397583
, O 0 0.00597987649962306
one O 0 0.006769683212041855
splice O 1 0.6649168133735657
site O 0 0.0674787312746048
mutation O 1 0.9615064263343811
and O 0 0.01275909785181284
10 O 0 0.04502750560641289
missense O 1 0.9593958258628845
mutations O 1 0.9714734554290771
. O 0 0.06489236652851105

One O 0 0.05808660015463829
missense O 1 0.9595487117767334
mutation O 1 0.967416524887085
( O 0 0.0773756206035614
L236P O 0 0.3386949598789215
) O 0 0.010056445375084877
was O 0 0.004229566548019648
found O 0 0.004953922238200903
in O 0 0.003498343052342534
a O 0 0.004560421220958233
homozygous O 0 0.32112735509872437
state O 0 0.00426899828016758
in O 0 0.0038415456656366587
two O 0 0.0052993097342550755
consanguineous O 1 0.7278558611869812
families O 0 0.011446496471762657
and O 0 0.002942447317764163
in O 0 0.003449093783274293
a O 0 0.005601987242698669
heterozygous O 0 0.3365904986858368
state O 0 0.004802227020263672
in O 0 0.003976988606154919
five O 0 0.005563921760767698
additional O 0 0.010817050002515316
non O 0 0.0575534850358963
- O 0 0.3195173442363739
consanguineous O 1 0.8956102728843689
families O 0 0.09989430755376816
. O 0 0.030838077887892723

Another O 0 0.16092392802238464
missense O 1 0.9636706113815308
mutation O 1 0.9803311228752136
( O 0 0.11025209724903107
T416P O 0 0.3071352541446686
) O 0 0.008563878946006298
was O 0 0.0038602121639996767
found O 0 0.0042393142357468605
in O 0 0.003408341435715556
a O 0 0.004812723025679588
homozygous O 0 0.4376501441001892
state O 0 0.0035458833444863558
in O 0 0.0026073185727000237
one O 0 0.002684511709958315
family O 0 0.006290697958320379
and O 0 0.00247931107878685
in O 0 0.003099269699305296
a O 0 0.006039625499397516
heterozygous O 0 0.47079408168792725
state O 0 0.006063027773052454
in O 0 0.005137236323207617
four O 0 0.008487273007631302
families O 0 0.029306521639227867
. O 0 0.018368422985076904

Pendred B-Disease 1 0.8444517254829407
patients O 1 0.8137887120246887
in O 0 0.011746348813176155
three O 0 0.010835934430360794
non O 0 0.08445216715335846
- O 0 0.290010005235672
consanguineous O 1 0.8259140849113464
families O 0 0.013273236341774464
were O 0 0.003879430005326867
shown O 0 0.006261527072638273
to O 0 0.0034474909771233797
be O 0 0.004056465812027454
compound O 0 0.03856847807765007
heterozygotes O 1 0.6459596753120422
for O 0 0.009673330932855606
L236P O 0 0.29551127552986145
and O 0 0.013989945873618126
T416P O 0 0.35748445987701416
. O 0 0.025591447949409485

In O 0 0.01164676807820797
total O 0 0.00815068744122982
, O 0 0.004563294816762209
one O 0 0.0027152460534125566
or O 0 0.0029703518375754356
both O 0 0.0021810804028064013
of O 0 0.0021908925846219063
these O 0 0.004126009531319141
mutations O 1 0.796711266040802
were O 0 0.002255392028018832
found O 0 0.0033106503542512655
in O 0 0.0022353928070515394
nine O 0 0.003249353263527155
of O 0 0.0024476791732013226
the O 0 0.003869964275509119
14 O 0 0.010368538089096546
families O 0 0.028540316969156265
analyzed O 0 0.08699912577867508
. O 0 0.02193463407456875

The O 0 0.018130896613001823
identification O 0 0.019413338974118233
of O 0 0.008562660776078701
two O 0 0.010096561163663864
frequent O 0 0.29069778323173523
PDS B-Disease 1 0.9142072200775146
mutations O 1 0.974622368812561
will O 0 0.009669449180364609
facilitate O 0 0.06932134181261063
the O 0 0.016524193808436394
molecular O 1 0.9466021060943604
diagnosis O 1 0.9881735444068909
of O 0 0.2028161585330963
Pendred B-Disease 1 0.9856144785881042
syndrome I-Disease 1 0.9954686164855957
. O 0 0.1502637416124344

Insertional O 1 0.8576046228408813
mutation O 1 0.928817629814148
by O 0 0.027536511421203613
transposable O 1 0.7010871767997742
element O 0 0.047791026532649994
, O 0 0.011660411022603512
L1 O 0 0.36350518465042114
, O 0 0.006691757123917341
in O 0 0.007559047546237707
the O 0 0.025022437795996666
DMD B-Disease 1 0.9929319620132446
gene O 1 0.9738711714744568
results O 0 0.2099638283252716
in O 0 0.042062923312187195
X B-Disease 1 0.785763680934906
- I-Disease 1 0.8609189987182617
linked I-Disease 1 0.9610002636909485
dilated I-Disease 1 0.9852647185325623
cardiomyopathy I-Disease 1 0.9898120760917664
. O 0 0.12269096821546555

X B-Disease 1 0.8014077544212341
- I-Disease 1 0.880203902721405
linked I-Disease 1 0.9555947184562683
dilated I-Disease 1 0.9852036237716675
cardiomyopathy I-Disease 1 0.9943937063217163
( O 0 0.42837631702423096
XLDCM B-Disease 1 0.8127356767654419
) O 0 0.027971040457487106
is O 0 0.009557792916893959
a O 0 0.03187555447220802
clinical O 1 0.965167224407196
phenotype O 1 0.9789404273033142
of O 0 0.00836255308240652
dystrophinopathy B-Disease 0 0.4491594433784485
which O 0 0.006360704079270363
is O 0 0.007499602157622576
characterized O 0 0.43180620670318604
by O 0 0.02405792661011219
preferential O 1 0.8802650570869446
myocardial B-Disease 1 0.9923997521400452
involvement I-Disease 0 0.23452050983905792
without O 0 0.014952843077480793
any O 0 0.012136371806263924
overt O 1 0.5057247281074524
clinical O 1 0.9097530245780945
signs O 0 0.30986273288726807
of O 0 0.06005721911787987
skeletal B-Disease 1 0.9825714230537415
myopathy I-Disease 1 0.9847646951675415
. O 0 0.11813469976186752

To O 0 0.014973885379731655
date O 0 0.013804188929498196
, O 0 0.007838555611670017
several O 0 0.011286498978734016
mutations O 1 0.9671016931533813
in O 0 0.032329775393009186
the O 0 0.24296292662620544
Duchenne B-Disease 1 0.9972817897796631
muscular I-Disease 1 0.997830331325531
dystrophy I-Disease 1 0.9985588192939758
gene O 1 0.9937472343444824
, O 0 0.28528347611427307
DMD O 1 0.9904234409332275
, O 0 0.006970300804823637
have O 0 0.004153735935688019
been O 0 0.005060821771621704
identified O 0 0.029397601261734962
in O 0 0.01167974155396223
patients O 1 0.9353067278862
with O 0 0.014532675966620445
XLDCM B-Disease 1 0.5876786112785339
, O 0 0.004334458149969578
but O 0 0.003877184120938182
a O 0 0.010634786449372768
pathogenic O 1 0.919479489326477
correlation O 0 0.25293225049972534
of O 0 0.005839503835886717
these O 0 0.024508576840162277
cardiospecific O 1 0.9549758434295654
mutations O 1 0.9932290315628052
in O 0 0.10753674060106277
DMD O 1 0.989915132522583
with O 0 0.015579456463456154
the O 0 0.013699100352823734
XLDCM B-Disease 1 0.8914110660552979
phenotype O 1 0.9732354283332825
has O 0 0.008366608060896397
remained O 0 0.007723217364400625
to O 0 0.005192500073462725
be O 0 0.007643179502338171
elucidated O 0 0.3327043950557709
. O 0 0.02025749161839485

We O 0 0.012441794387996197
report O 0 0.009101909585297108
here O 0 0.004603939596563578
the O 0 0.0034626091364771128
identification O 0 0.0058679766952991486
of O 0 0.0030314645264297724
a O 0 0.005143015645444393
unique O 0 0.0129326106980443
de O 0 0.08392314612865448
novo O 1 0.5375788807868958
L1 O 1 0.8842788934707642
insertion O 1 0.6138054132461548
in O 0 0.007773378863930702
the O 0 0.011513780802488327
muscle O 1 0.9694420099258423
exon O 1 0.8143560290336609
1 O 0 0.026346789672970772
in O 0 0.02516230382025242
DMD O 1 0.9795682430267334
in O 0 0.01183461956679821
three O 0 0.02384038455784321
XLDCM B-Disease 1 0.9194344282150269
patients O 1 0.9382795691490173
from O 0 0.009051939472556114
two O 0 0.008299781940877438
unrelated O 0 0.24356190860271454
Japanese O 0 0.020745983347296715
families O 0 0.06887206435203552
. O 0 0.024626249447464943

The O 0 0.021651552990078926
insertion O 0 0.08694998174905777
was O 0 0.010527069680392742
a O 0 0.010079356841742992
5 O 0 0.013736446388065815
- O 0 0.0841294527053833
truncated O 0 0.139456108212471
form O 0 0.01928870379924774
of O 0 0.00498053478077054
human O 0 0.1179732009768486
L1 O 1 0.7874528765678406
inversely O 0 0.22851423919200897
integrated O 0 0.02726258710026741
in O 0 0.005486265756189823
the O 0 0.00438277330249548
5 O 0 0.016765151172876358
- O 0 0.14037872850894928
untranslated O 0 0.39343953132629395
region O 0 0.014904193580150604
in O 0 0.005881138611584902
the O 0 0.007615654729306698
muscle O 1 0.9565474987030029
exon O 1 0.5461402535438538
1 O 0 0.008479488082230091
, O 0 0.0032545432914048433
which O 0 0.002902628853917122
affected O 0 0.028909772634506226
the O 0 0.004198368638753891
transcription O 0 0.44069692492485046
or O 0 0.004697056487202644
the O 0 0.0025201893877238035
stability O 0 0.007157804910093546
of O 0 0.002763781463727355
the O 0 0.004919545259326696
muscle O 1 0.9149892926216125
form O 0 0.05304544419050217
of O 0 0.0074321674183011055
dystrophin O 1 0.9454994201660156
transcripts O 0 0.021941129118204117
but O 0 0.0027370303869247437
not O 0 0.001755469013005495
that O 0 0.0017089336179196835
of O 0 0.0024655598681420088
the O 0 0.008230316452682018
brain O 1 0.9839975833892822
or O 0 0.15312345325946808
Purkinje O 1 0.9835786819458008
cell O 1 0.8453105092048645
form O 0 0.039595186710357666
, O 0 0.0037042987532913685
probably O 0 0.004428804852068424
due O 0 0.004181430209428072
to O 0 0.0021367163863033056
its O 0 0.003035304369404912
unique O 0 0.005752092227339745
site O 0 0.0058010355569422245
of O 0 0.004985410254448652
integration O 0 0.027538934722542763
. O 0 0.01754138059914112

We O 0 0.014803345315158367
speculate O 0 0.020347127690911293
that O 0 0.005605970975011587
this O 0 0.004608802031725645
insertion O 0 0.05984082072973251
of O 0 0.003927199169993401
an O 0 0.0061880056746304035
L1 O 1 0.8014184236526489
sequence O 0 0.3185243308544159
in O 0 0.01956278830766678
DMD O 1 0.9846737384796143
is O 0 0.005182312801480293
responsible O 0 0.0056746224872767925
for O 0 0.002271923003718257
some O 0 0.0019393103430047631
of O 0 0.0018921286100521684
the O 0 0.0024335947819054127
population O 0 0.00591683853417635
of O 0 0.004466539714485407
Japanese O 0 0.02752808853983879
patients O 1 0.917083203792572
with O 0 0.022967053577303886
XLDCM B-Disease 1 0.6962018013000488
. O 0 0.016586223617196083
. O 0 0.020162880420684814

Severe O 1 0.9573703408241272
early O 1 0.566483736038208
- O 1 0.974582314491272
onset O 1 0.995278000831604
obesity B-Disease 1 0.9952078461647034
, O 1 0.5592998266220093
adrenal B-Disease 1 0.9941620230674744
insufficiency I-Disease 1 0.9879412055015564
and O 0 0.08279933035373688
red O 1 0.7283393740653992
hair O 1 0.9839491248130798
pigmentation O 1 0.9937346577644348
caused O 1 0.918822705745697
by O 0 0.2308875024318695
POMC O 1 0.9830202460289001
mutations O 1 0.980032742023468
in O 0 0.04591934755444527
humans O 1 0.667161762714386
. O 0 0.03869486227631569

Sequential O 0 0.20338965952396393
cleavage O 0 0.2944179177284241
of O 0 0.01225332636386156
the O 0 0.011974213644862175
precursor O 1 0.5603523254394531
protein O 1 0.7348231077194214
pre O 0 0.30056169629096985
- O 0 0.36342787742614746
pro O 0 0.14112143218517303
- O 1 0.5758687257766724
opiomelanocortin O 1 0.8150047659873962
( O 0 0.16745494306087494
POMC O 1 0.9395939111709595
) O 0 0.02089175581932068
generates O 0 0.03448951616883278
the O 0 0.012445392087101936
melanocortin O 1 0.9524810314178467
peptides O 1 0.9170809388160706
adrenocorticotrophin O 1 0.911536693572998
( O 0 0.22156278789043427
ACTH O 1 0.9620203971862793
) O 0 0.0456879585981369
, O 0 0.020047850906848907
melanocyte O 1 0.9829815030097961
- O 1 0.8351494669914246
stimulating O 1 0.9689328670501709
hormones O 1 0.9841814041137695
( O 0 0.44058138132095337
MSH O 1 0.9806602597236633
) O 0 0.02803613990545273
alpha O 0 0.05633826553821564
, O 0 0.005210660398006439
beta O 0 0.09715719521045685
and O 0 0.0037515300791710615
gamma O 0 0.031443044543266296
as O 0 0.0031911160331219435
well O 0 0.0036396177019923925
as O 0 0.004403251688927412
the O 0 0.00875619612634182
opioid O 1 0.9697484374046326
- O 1 0.8329274654388428
receptor O 1 0.9747207760810852
ligand O 1 0.9261225461959839
beta O 1 0.87757408618927
- O 1 0.6742981672286987
endorphin O 1 0.9225457310676575
. O 0 0.04874604195356369

While O 0 0.01787656359374523
a O 0 0.012351767159998417
few O 0 0.009946306236088276
cases O 0 0.05618266761302948
of O 0 0.013743245042860508
isolated O 1 0.8980888724327087
ACTH B-Disease 1 0.9914463758468628
deficiency I-Disease 1 0.9954752326011658
have O 0 0.013686091639101505
been O 0 0.011709966696798801
reported O 0 0.13500742614269257
( O 0 0.18849360942840576
OMIM O 1 0.9803830981254578
201400 O 1 0.7358553409576416
) O 0 0.02725590206682682
, O 0 0.008115913718938828
an O 0 0.01897449418902397
inherited O 1 0.9747339487075806
POMC O 1 0.9857206344604492
defect O 1 0.9123291373252869
has O 0 0.007786442991346121
not O 0 0.004180550575256348
been O 0 0.005035865120589733
described O 0 0.010168218053877354
so O 0 0.00867103785276413
far O 0 0.014261721633374691
. O 0 0.018827302381396294

Recent O 0 0.03749234229326248
studies O 0 0.03273304924368858
in O 0 0.009309488348662853
animal O 0 0.057100165635347366
models O 0 0.027518650516867638
elucidated O 0 0.23662333190441132
a O 0 0.007353577297180891
central O 0 0.006536260712891817
role O 0 0.008688758127391338
of O 0 0.005482845939695835
alpha O 0 0.16273897886276245
- O 0 0.24375152587890625
MSH O 1 0.8635817766189575
in O 0 0.0059224641881883144
the O 0 0.0043207453563809395
regulation O 0 0.03361683711409569
of O 0 0.004393181297928095
food O 0 0.04402145743370056
intake O 0 0.3567279577255249
by O 0 0.00990082137286663
activation O 1 0.5061807036399841
of O 0 0.00617309520021081
the O 0 0.024190213531255722
brain O 1 0.990113377571106
melanocortin O 1 0.9835842251777649
- O 1 0.7371330261230469
4 O 0 0.18129432201385498
- O 1 0.8002091646194458
receptor O 1 0.9715136885643005
( O 0 0.357827365398407
MC4 O 1 0.9730884432792664
- O 1 0.5317652225494385
R O 0 0.45782795548439026
; O 0 0.021690556779503822
refs O 0 0.14794550836086273
3 O 0 0.014272470958530903
- O 0 0.05081585794687271
5 O 0 0.008446641266345978
) O 0 0.0049667321145534515
and O 0 0.0024248678237199783
the O 0 0.003249958623200655
linkage O 0 0.3360425531864166
of O 0 0.00661639217287302
human O 1 0.513608992099762
obesity B-Disease 1 0.9922025203704834
to O 0 0.012765827588737011
chromosome O 1 0.9236903786659241
2 O 0 0.006809421349316835
in O 0 0.003984901122748852
close O 0 0.005001316778361797
proximity O 0 0.014865987934172153
to O 0 0.003491481300443411
the O 0 0.006257024593651295
POMC O 1 0.9656698703765869
locus O 1 0.6128228306770325
, O 0 0.004846704192459583
led O 0 0.0044326502829790115
to O 0 0.0025077820755541325
the O 0 0.0024684022646397352
proposal O 0 0.004604619462043047
of O 0 0.002740856958553195
an O 0 0.0040710968896746635
association O 0 0.01986526884138584
of O 0 0.009493407793343067
POMC O 1 0.9722030162811279
with O 0 0.07775808125734329
human O 1 0.7181055545806885
obesity B-Disease 1 0.9853537082672119
. O 0 0.07001035660505295

The O 0 0.019558031111955643
dual O 0 0.030353780835866928
role O 0 0.01716049760580063
of O 0 0.009221086278557777
alpha O 0 0.19430047273635864
- O 0 0.43993979692459106
MSH O 1 0.9551659226417542
in O 0 0.015023072250187397
regulating O 0 0.40743139386177063
food O 0 0.09187789261341095
intake O 0 0.495907187461853
and O 0 0.015645792707800865
influencing O 1 0.7655855417251587
hair O 1 0.973614513874054
pigmentation O 1 0.9910131096839905
predicts O 1 0.5361380577087402
that O 0 0.008677059784531593
the O 0 0.015100316144526005
phenotype O 1 0.9865643978118896
associated O 0 0.1051950678229332
with O 0 0.010067259892821312
a O 0 0.02983856573700905
defect O 1 0.9218629598617554
in O 0 0.04307890683412552
POMC O 1 0.9735080599784851
function O 0 0.19668637216091156
would O 0 0.011515897698700428
include O 0 0.1756187081336975
obesity B-Disease 1 0.990583062171936
, O 0 0.026585986837744713
alteration O 1 0.8165099620819092
in O 0 0.10481586307287216
pigmentation O 1 0.9878637194633484
and O 0 0.21759697794914246
ACTH B-Disease 1 0.9869715571403503
deficiency I-Disease 1 0.9927171468734741
. O 0 0.13105350732803345

The O 0 0.016944674775004387
observation O 0 0.020388629287481308
of O 0 0.007315343711525202
these O 0 0.010132400318980217
symptoms O 1 0.9308032393455505
in O 0 0.006935178767889738
two O 0 0.006437290925532579
probands O 0 0.27306079864501953
prompted O 0 0.021616917103528976
us O 0 0.006895297206938267
to O 0 0.003839914221316576
search O 0 0.009255630895495415
for O 0 0.007743616588413715
mutations O 1 0.9316986203193665
within O 0 0.017118917778134346
their O 0 0.02011209726333618
POMC O 1 0.9520057439804077
genes O 1 0.9192621111869812
. O 0 0.04421678185462952

Patient O 1 0.550808846950531
1 O 0 0.014763245359063148
was O 0 0.006939856801182032
found O 0 0.005586824845522642
to O 0 0.0029674835968762636
be O 0 0.00286420457996428
a O 0 0.0046600112691521645
compound O 0 0.0374092198908329
heterozygote O 1 0.5626130700111389
for O 0 0.005978135857731104
two O 0 0.010055853053927422
mutations O 1 0.9647188782691956
in O 0 0.013247751630842686
exon O 1 0.6204240322113037
3 O 0 0.022043004631996155
( O 0 0.02992899715900421
G7013T O 0 0.3141985833644867
, O 0 0.0076929740607738495
C7133delta O 0 0.27416345477104187
) O 0 0.008264591917395592
which O 0 0.004077214747667313
interfere O 0 0.023227576166391373
with O 0 0.005282791331410408
appropriate O 0 0.010531730018556118
synthesis O 0 0.13249529898166656
of O 0 0.008523887023329735
ACTH O 1 0.790844202041626
and O 0 0.012486247345805168
alpha O 0 0.24735498428344727
- O 1 0.5627010464668274
MSH O 1 0.9429820775985718
. O 0 0.04737246036529541

Patient O 1 0.629644513130188
2 O 0 0.025424130260944366
was O 0 0.012135337106883526
homozygous O 0 0.3994375467300415
for O 0 0.008968129754066467
a O 0 0.01877075992524624
mutation O 1 0.9497462511062622
in O 0 0.012626689858734608
exon O 1 0.5647627115249634
2 O 0 0.020735496655106544
( O 0 0.02862066589295864
C3804A O 0 0.3263290524482727
) O 0 0.015228814445436
which O 0 0.012415077537298203
abolishes O 1 0.7742307186126709
POMC O 1 0.9364385604858398
translation O 0 0.07348469644784927
. O 0 0.02867884933948517

These O 0 0.013135146349668503
findings O 0 0.012684469111263752
represent O 0 0.006638489197939634
the O 0 0.003656419226899743
first O 0 0.0036879528779536486
examples O 0 0.006042903289198875
of O 0 0.004296278115361929
a O 0 0.030186180025339127
genetic B-Disease 1 0.9866788983345032
defect I-Disease 1 0.95361328125
within O 0 0.01956787146627903
the O 0 0.022664112970232964
POMC O 1 0.9848824143409729
gene O 1 0.9016415476799011
and O 0 0.006866030395030975
define O 0 0.05961112305521965
a O 0 0.023971259593963623
new O 0 0.2356569468975067
monogenic B-Disease 1 0.9949070811271667
endocrine I-Disease 1 0.9975172281265259
disorder I-Disease 1 0.9972712397575378
resulting O 1 0.8814170360565186
in O 0 0.08352424949407578
early O 1 0.5657039284706116
- O 1 0.9853008389472961
onset O 1 0.9973558187484741
obesity B-Disease 1 0.9970799088478088
, O 1 0.5501601099967957
adrenal B-Disease 1 0.9941603541374207
insufficiency I-Disease 1 0.9893108606338501
and O 0 0.0707363411784172
red O 1 0.662248432636261
hair O 1 0.9572985172271729
pigmentation O 1 0.9768933057785034
. O 0 0.03522181138396263
. O 0 0.02760802023112774

A O 0 0.04688625782728195
European O 0 0.055617883801460266
multicenter O 1 0.8752937912940979
study O 0 0.06932433694601059
of O 0 0.025712279602885246
phenylalanine B-Disease 1 0.9689993262290955
hydroxylase I-Disease 1 0.9848203063011169
deficiency I-Disease 1 0.995267391204834
: O 0 0.0361347422003746
classification O 0 0.16974207758903503
of O 0 0.006214318331331015
105 O 0 0.03116784803569317
mutations O 1 0.9214536547660828
and O 0 0.00498165562748909
a O 0 0.0062386272475123405
general O 0 0.006899942643940449
system O 0 0.020175818353891373
for O 0 0.011371740140020847
genotype O 1 0.9535985589027405
- O 0 0.29273417592048645
based O 0 0.029256369918584824
prediction O 0 0.35168740153312683
of O 0 0.05361536890268326
metabolic O 1 0.9885967373847961
phenotype O 1 0.9821071028709412
. O 0 0.09829118847846985

Phenylketonuria B-Disease 1 0.9767632484436035
( O 1 0.6140430569648743
PKU B-Disease 1 0.9774745106697083
) O 0 0.10595600306987762
and O 0 0.019999202340841293
mild B-Disease 1 0.9464911222457886
hyperphenylalaninemia I-Disease 1 0.9623913168907166
( O 0 0.49129989743232727
MHP B-Disease 1 0.9849573373794556
) O 0 0.16222825646400452
are O 0 0.05930296331644058
allelic B-Disease 1 0.9903473854064941
disorders I-Disease 1 0.9970832467079163
caused O 1 0.8825651407241821
by O 0 0.05739694461226463
mutations O 1 0.9762052893638611
in O 0 0.013439732603728771
the O 0 0.02176889404654503
gene O 1 0.9676092267036438
encoding O 1 0.881870687007904
phenylalanine O 1 0.9478793144226074
hydroxylase O 1 0.9584577083587646
( O 0 0.44852158427238464
PAH O 1 0.97275710105896
) O 0 0.06300225108861923
. O 0 0.027240557596087456

Previous O 0 0.029729967936873436
studies O 0 0.02307358756661415
have O 0 0.00710662268102169
suggested O 0 0.009639021940529346
that O 0 0.004542207345366478
the O 0 0.006863494403660297
highly O 0 0.21197204291820526
variable O 1 0.949889600276947
metabolic O 1 0.9933761954307556
phenotypes O 1 0.9898444414138794
of O 1 0.5535252690315247
PAH B-Disease 1 0.9955209493637085
deficiency I-Disease 1 0.9956396818161011
correlate O 1 0.9461557865142822
with O 0 0.39566150307655334
PAH O 1 0.9831158518791199
genotypes O 1 0.9604703783988953
. O 0 0.08396557718515396

We O 0 0.021878326311707497
identified O 0 0.039504118263721466
both O 0 0.026828186586499214
causative O 1 0.975472629070282
mutations O 1 0.9848912358283997
in O 0 0.07118099927902222
686 O 1 0.8999476432800293
patients O 1 0.9296631217002869
from O 0 0.011830047704279423
seven O 0 0.011094393208622932
European O 0 0.02056623063981533
centers O 0 0.07948136329650879
. O 0 0.022755920886993408

On O 0 0.00977181177586317
the O 0 0.0065805064514279366
basis O 0 0.006013828795403242
of O 0 0.003740699728950858
the O 0 0.004888399504125118
phenotypic O 0 0.4298818111419678
characteristics O 0 0.07199334353208542
of O 0 0.010171624831855297
297 O 1 0.7923197150230408
functionally O 1 0.9684399962425232
hemizygous O 1 0.9457616806030273
patients O 1 0.933914840221405
, O 0 0.005596470553427935
105 O 0 0.007730572950094938
of O 0 0.003172797616571188
the O 0 0.0038048340938985348
mutations O 1 0.8214320540428162
were O 0 0.0023100620601326227
assigned O 0 0.0035493101458996534
to O 0 0.0019522494403645396
one O 0 0.002344835316762328
of O 0 0.00293922470882535
four O 0 0.005866951309144497
arbitrary O 0 0.07309096306562424
phenotype O 1 0.9724748730659485
categories O 0 0.11925939470529556
. O 0 0.027101915329694748

We O 0 0.0131904948502779
proposed O 0 0.015566282905638218
and O 0 0.006115091033279896
tested O 0 0.01777469553053379
a O 0 0.006632501725107431
simple O 0 0.009635253809392452
model O 0 0.011064175516366959
for O 0 0.006563583854585886
correlation O 0 0.3296947181224823
between O 0 0.0258108489215374
genotype O 1 0.8965181112289429
and O 0 0.01266719214618206
phenotypic O 1 0.6862308382987976
outcome O 0 0.11954549700021744
. O 0 0.030896978452801704

The O 0 0.03127625584602356
observed O 0 0.2594289481639862
phenotype O 1 0.9666454195976257
matched O 0 0.13591177761554718
the O 0 0.009597416035830975
predicted O 0 0.20652715861797333
phenotype O 1 0.9604427814483643
in O 0 0.006053570192307234
79 O 0 0.016832126304507256
% O 0 0.00614330405369401
of O 0 0.00230833375826478
the O 0 0.002663192804902792
cases O 0 0.01642504893243313
, O 0 0.002034396631643176
and O 0 0.0015499420696869493
in O 0 0.0019284996669739485
only O 0 0.0020697591826319695
5 O 0 0.004270242992788553
of O 0 0.003577066818252206
184 O 0 0.17851495742797852
patients O 1 0.866380512714386
was O 0 0.0037258181255310774
the O 0 0.004530663602054119
observed O 0 0.10652817040681839
phenotype O 1 0.9226933121681213
more O 0 0.0033580302260816097
than O 0 0.0031948282849043608
one O 0 0.0028520431369543076
category O 0 0.008234640583395958
away O 0 0.00521856127306819
from O 0 0.004923945292830467
that O 0 0.00518210930749774
expected O 0 0.012355194427073002
. O 0 0.01683630794286728

Among O 0 0.01870187371969223
the O 0 0.008067496120929718
seven O 0 0.007776071783155203
contributing O 0 0.030147507786750793
centers O 0 0.01552283763885498
, O 0 0.0032535844948142767
the O 0 0.002823921386152506
proportion O 0 0.02890595979988575
of O 0 0.005715510342270136
patients O 1 0.8622248768806458
for O 0 0.004110868088901043
whom O 0 0.010438601486384869
the O 0 0.0045570130459964275
observed O 0 0.143634632229805
phenotype O 1 0.9429360628128052
did O 0 0.0049004871398210526
not O 0 0.0028523700311779976
match O 0 0.004071920178830624
the O 0 0.004160246346145868
predicted O 0 0.11858762055635452
phenotype O 1 0.9567397236824036
was O 0 0.006218094378709793
4 O 0 0.011443497613072395
% O 0 0.031824856996536255
- O 0 0.09645865112543106
23 O 0 0.016746673732995987
% O 0 0.03322568163275719
( O 0 0.0503094382584095
P O 0 0.4411303699016571
< O 1 0.5978395938873291
. O 0 0.012084766291081905
0001 O 1 0.794606626033783
) O 0 0.008337355218827724
, O 0 0.0034953656140714884
suggesting O 0 0.006283580791205168
that O 0 0.0025274574290961027
differences O 0 0.00941736064851284
in O 0 0.00384143041446805
methods O 0 0.010707886889576912
used O 0 0.008558022789657116
for O 0 0.019183069467544556
mutation O 1 0.992393970489502
detection O 1 0.9401198029518127
or O 0 0.27975133061408997
phenotype O 1 0.9901864528656006
classification O 0 0.413011372089386
may O 0 0.012357893399894238
account O 0 0.0058644735254347324
for O 0 0.003468726761639118
a O 0 0.005396046210080385
considerable O 0 0.011549610644578934
proportion O 0 0.07963503897190094
of O 0 0.024330466985702515
genotype O 1 0.98195481300354
- O 1 0.8635287880897522
phenotype O 1 0.9796205163002014
inconsistencies O 1 0.5166037678718567
. O 0 0.04785234108567238

Our O 0 0.018893521279096603
data O 0 0.014673621393740177
indicate O 0 0.01529231108725071
that O 0 0.007496433332562447
the O 0 0.021189045161008835
PAH O 1 0.9922263622283936
- O 1 0.912865161895752
mutation O 1 0.9914383888244629
genotype O 1 0.9256429672241211
is O 0 0.007428235374391079
the O 0 0.005117563530802727
main O 0 0.009258740581572056
determinant O 1 0.60780930519104
of O 0 0.05243489146232605
metabolic O 1 0.9938685297966003
phenotype O 1 0.9920600652694702
in O 0 0.04996692016720772
most O 0 0.1806289106607437
patients O 1 0.9887838959693909
with O 1 0.6483834981918335
PAH B-Disease 1 0.993436872959137
deficiency I-Disease 1 0.9928200840950012
. O 0 0.14726972579956055

In O 0 0.012465962208807468
the O 0 0.007085248827934265
present O 0 0.007198915351182222
study O 0 0.009104005061089993
, O 0 0.003694918705150485
the O 0 0.003949516918510199
classification O 0 0.12411365658044815
of O 0 0.009601986035704613
105 O 1 0.5644505023956299
PAH O 1 0.9951103329658508
mutations O 1 0.9874375462532043
may O 0 0.029506001621484756
allow O 0 0.006067552138119936
the O 0 0.0037704005371779203
prediction O 0 0.03272212669253349
of O 0 0.004103145562112331
the O 0 0.008885873481631279
biochemical O 1 0.947428822517395
phenotype O 1 0.9854075312614441
in O 0 0.01937892846763134
> O 1 0.5424249172210693
10 O 0 0.00808277353644371
, O 0 0.005749573465436697
000 O 0 0.04051107168197632
genotypes O 1 0.7427132725715637
, O 0 0.004349537193775177
which O 0 0.0027682827785611153
may O 0 0.004069212358444929
be O 0 0.0020644962787628174
useful O 0 0.004442622885107994
for O 0 0.0025673757772892714
the O 0 0.0033777905628085136
management O 0 0.015996329486370087
of O 0 0.007049031089991331
hyperphenylalaninemia B-Disease 1 0.7013609409332275
in O 0 0.0409078411757946
newborns O 1 0.9572715759277344
. O 0 0.05061247944831848

Somatic O 1 0.8511927723884583
instability O 0 0.2846005856990814
of O 0 0.012107433751225471
the O 0 0.01205271203070879
CTG O 1 0.7022542953491211
repeat O 0 0.3632238805294037
in O 0 0.02889249287545681
mice O 1 0.9729254245758057
transgenic O 1 0.8583652377128601
for O 0 0.01876302994787693
the O 0 0.09823027998209
myotonic B-Disease 1 0.9951695799827576
dystrophy I-Disease 1 0.995525062084198
region O 0 0.11248161643743515
is O 0 0.011041340418159962
age O 0 0.028195681050419807
dependent O 0 0.032455239444971085
but O 0 0.004440939985215664
not O 0 0.003508560825139284
correlated O 0 0.07286863774061203
to O 0 0.0036477523390203714
the O 0 0.004710408393293619
relative O 0 0.06353071331977844
intertissue O 1 0.7472845315933228
transcription O 1 0.8861274719238281
levels O 0 0.20551663637161255
and O 0 0.021717064082622528
proliferative O 1 0.9689873456954956
capacities O 0 0.2112444043159485
. O 0 0.03903662785887718

A O 0 0.039090774953365326
( O 0 0.043072085827589035
CTG O 0 0.4952392578125
) O 0 0.01570664346218109
nexpansion O 0 0.0644657090306282
in O 0 0.0060653300024569035
the O 0 0.005959548521786928
3 O 0 0.016722004860639572
- O 0 0.19955278933048248
untranslated O 1 0.6539493203163147
region O 0 0.05717755854129791
( O 0 0.039966851472854614
UTR O 1 0.5488954782485962
) O 0 0.009934504516422749
of O 0 0.0052840327844023705
the O 0 0.022733742371201515
DM O 1 0.9919622540473938
protein O 1 0.9828006029129028
kinase O 1 0.9865871071815491
gene O 1 0.9780730605125427
( O 0 0.1233212947845459
DMPK O 1 0.7148023843765259
) O 0 0.01708035357296467
is O 0 0.008928152732551098
responsible O 0 0.043453410267829895
for O 0 0.05103687196969986
causing O 1 0.9755422472953796
myotonic B-Disease 1 0.9949002861976624
dystrophy I-Disease 1 0.9960134029388428
( O 1 0.8333945870399475
DM B-Disease 1 0.9792622327804565
) O 0 0.12334031611680984
. O 0 0.030489496886730194

Major O 0 0.04645000398159027
instability O 0 0.20598159730434418
, O 0 0.008033623918890953
with O 0 0.0049219876527786255
very O 0 0.004874744452536106
large O 0 0.005124983377754688
expansions O 0 0.020397840067744255
between O 0 0.0059343138709664345
generations O 0 0.015637142583727837
and O 0 0.0035003467928618193
high O 0 0.006936496123671532
levels O 0 0.04295926168560982
of O 0 0.009397804737091064
somatic O 1 0.96357262134552
mosaicism O 1 0.9682309627532959
, O 0 0.011727754957973957
is O 0 0.009796096943318844
observed O 0 0.06388146430253983
in O 0 0.026345038786530495
patients O 1 0.9474477767944336
. O 0 0.033597834408283234

There O 0 0.014402255415916443
is O 0 0.008193711750209332
a O 0 0.008775466121733189
good O 0 0.009642445482313633
correlation O 0 0.08586695045232773
between O 0 0.009387928061187267
repeat O 0 0.11129090934991837
size O 0 0.012273547239601612
( O 0 0.008712188340723515
at O 0 0.004086290020495653
least O 0 0.005739234853535891
in O 0 0.007709518074989319
leucocytes O 1 0.6549353003501892
) O 0 0.03479734808206558
, O 0 0.012274575419723988
clinical O 1 0.9008577466011047
severity O 1 0.7658641934394836
and O 0 0.0086986618116498
age O 0 0.05050227418541908
of O 0 0.021081503480672836
onset O 1 0.9752610921859741
. O 0 0.05585587024688721

The O 0 0.04554544389247894
trinucleotide O 1 0.9221433401107788
repeat O 1 0.7509645819664001
instability O 1 0.8682889342308044
mechanisms O 1 0.5675628781318665
involved O 0 0.0437128022313118
in O 0 0.015970440581440926
DM B-Disease 1 0.9692867398262024
and O 0 0.01043394859880209
other O 0 0.03085225075483322
human O 1 0.8892399072647095
genetic B-Disease 1 0.995676577091217
diseases I-Disease 1 0.9942480325698853
are O 0 0.01916622743010521
unknown O 0 0.10459841787815094
. O 0 0.024881646037101746

We O 0 0.022673938423395157
studied O 0 0.03893252834677696
somatic O 1 0.7775983214378357
instability O 0 0.2689689099788666
by O 0 0.01084162387996912
measuring O 0 0.02194470725953579
the O 0 0.008684918284416199
CTG O 1 0.6384427547454834
repeat O 0 0.09945735335350037
length O 0 0.011345850303769112
at O 0 0.0040956949815154076
several O 0 0.004116533324122429
ages O 0 0.016255119815468788
in O 0 0.0037044237833470106
various O 0 0.0054699438624084
tissues O 1 0.5724939107894897
of O 0 0.00886170007288456
transgenic O 1 0.9074748754501343
mice O 1 0.9410151243209839
carrying O 0 0.014154236763715744
a O 0 0.01395732443779707
( O 0 0.03250153735280037
CTG O 1 0.6565881371498108
) O 0 0.015293508768081665
55expansion O 0 0.1280757039785385
surrounded O 0 0.010661288164556026
by O 0 0.005635243374854326
45 O 0 0.007716334890574217
kb O 0 0.039152149111032486
of O 0 0.004195638466626406
the O 0 0.006148779299110174
human O 0 0.24758554995059967
DM B-Disease 1 0.974052906036377
region O 0 0.024954356253147125
, O 0 0.005987636744976044
using O 0 0.008637119084596634
small O 0 0.013182669878005981
- O 0 0.11028517782688141
pool O 0 0.1404222697019577
PCR O 1 0.6987907886505127
. O 0 0.029138503596186638

These O 0 0.025927521288394928
mice O 1 0.5514214634895325
have O 0 0.0077088805846869946
been O 0 0.004782901145517826
shown O 0 0.005534425377845764
to O 0 0.0034231627359986305
reproduce O 0 0.12107764184474945
the O 0 0.0060625504702329636
intergenerational O 1 0.7198020815849304
and O 0 0.007623669691383839
somatic O 1 0.7730334401130676
instability O 0 0.3015928268432617
of O 0 0.004595800302922726
the O 0 0.005140052177011967
55 O 0 0.030140621587634087
CTG O 1 0.7304267287254333
repeat O 0 0.171967551112175
suggesting O 0 0.02871803566813469
that O 0 0.00434831902384758
surrounding O 0 0.012085596099495888
sequences O 0 0.05422721058130264
and O 0 0.0035274235997349024
the O 0 0.005043678916990757
chromatin O 0 0.4695419669151306
environment O 0 0.022276276722550392
are O 0 0.0048472220078110695
involved O 0 0.013669841922819614
in O 0 0.011117210611701012
instability O 1 0.645307719707489
mechanisms O 0 0.4757744073867798
. O 0 0.031823884695768356

As O 0 0.014341666363179684
observed O 0 0.014892603270709515
in O 0 0.005006192717701197
some O 0 0.003735757665708661
of O 0 0.003685686271637678
the O 0 0.006094043143093586
tissues O 1 0.9288924932479858
of O 0 0.07174167782068253
DM B-Disease 1 0.9937835931777954
patients O 1 0.9460976719856262
, O 0 0.005353859625756741
there O 0 0.0032299368176609278
is O 0 0.003340750001370907
a O 0 0.004240149632096291
tendency O 0 0.0440429151058197
for O 0 0.004679905250668526
repeat O 0 0.1153094619512558
length O 0 0.025350207462906837
and O 0 0.006657653953880072
somatic O 1 0.9107519388198853
mosaicism O 1 0.8621457815170288
to O 0 0.00476218294352293
increase O 0 0.009839704260230064
with O 0 0.003992296755313873
the O 0 0.00396037008613348
age O 0 0.008253460749983788
of O 0 0.004748281557112932
the O 0 0.009617388248443604
mouse O 1 0.7650533318519592
. O 0 0.031488966196775436

Furthermore O 0 0.03426337242126465
, O 0 0.009397142566740513
we O 0 0.005194015335291624
observed O 0 0.01128949411213398
no O 0 0.0061280205845832825
correlation O 0 0.08229001611471176
between O 0 0.009532501921057701
the O 0 0.010524795390665531
somatic O 1 0.9795651435852051
mutation O 1 0.9888411164283752
rate O 0 0.3118285536766052
and O 0 0.02616279572248459
tissue O 1 0.9700590372085571
proliferation O 1 0.631070613861084
capacity O 0 0.029216039925813675
. O 0 0.023407410830259323

The O 0 0.03436530381441116
somatic O 1 0.9419446587562561
mutation O 1 0.9720997214317322
rates O 0 0.07015692442655563
in O 0 0.006365014705806971
different O 0 0.007179525215178728
tissues O 0 0.4134104251861572
were O 0 0.002784914569929242
also O 0 0.0024743631947785616
not O 0 0.0027439477853477
correlated O 0 0.07372596114873886
to O 0 0.002795108826830983
the O 0 0.0032041259109973907
relative O 0 0.03893882781267166
inter O 0 0.18668773770332336
- O 1 0.5500989556312561
tissue O 1 0.9279758930206299
difference O 0 0.049031686037778854
in O 0 0.006003015208989382
transcriptional O 0 0.3733571767807007
levels O 0 0.01787842996418476
of O 0 0.003282753750681877
the O 0 0.0035929791629314423
three O 0 0.010458564385771751
genes O 1 0.9340458512306213
( O 0 0.0742233470082283
DMAHP O 1 0.5980677604675293
, O 0 0.0073485043831169605
DMPK O 0 0.21924114227294922
and O 0 0.005369164515286684
59 O 0 0.016132524237036705
) O 0 0.007355408277362585
surrounding O 0 0.008603358641266823
the O 0 0.00612550089135766
repeat O 0 0.14537698030471802
. O 0 0.011951534077525139
. O 0 0.01708933152258396

A O 0 0.06099574267864227
novel O 0 0.4927545189857483
missense O 1 0.9709506630897522
mutation O 1 0.9818342328071594
in O 0 0.04816728085279465
patients O 1 0.940826416015625
from O 0 0.018468106165528297
a O 0 0.05316625162959099
retinoblastoma B-Disease 1 0.9758427739143372
pedigree O 1 0.6195186376571655
showing O 0 0.04120942950248718
only O 0 0.011559564620256424
mild O 1 0.7744807004928589
expression O 0 0.18887518346309662
of O 0 0.012558188289403915
the O 0 0.08115895837545395
tumor B-Disease 1 0.9917553663253784
phenotype O 1 0.9835317134857178
. O 0 0.08176182210445404

We O 0 0.014818849042057991
have O 0 0.008480166085064411
used O 0 0.008102627471089363
single O 0 0.012904269620776176
strand O 0 0.36941230297088623
conformation O 0 0.4900846481323242
polymorphism O 1 0.6021721363067627
analysis O 0 0.013174613937735558
to O 0 0.004036108497530222
study O 0 0.005465053953230381
the O 0 0.0037257808726280928
27 O 0 0.008024506270885468
exons O 0 0.2302839756011963
of O 0 0.0050547197461128235
the O 0 0.013474086299538612
RB1 O 1 0.983518123626709
gene O 1 0.9063507318496704
in O 0 0.007301537320017815
individuals O 0 0.015245027840137482
from O 0 0.005917965434491634
a O 0 0.008548040874302387
family O 0 0.04494667798280716
showing O 0 0.07151361554861069
mild O 1 0.8214281797409058
expression O 0 0.1598164588212967
of O 0 0.012821412645280361
the O 0 0.0513019785284996
retinoblastoma B-Disease 1 0.9851258993148804
phenotype O 1 0.9785876274108887
. O 0 0.06837756186723709

In O 0 0.022139420732855797
this O 0 0.013742799870669842
family O 0 0.06576678901910782
affected O 0 0.3404902517795563
individuals O 0 0.145558163523674
developed O 0 0.3820999562740326
unilateral B-Disease 1 0.7381449937820435
tumors I-Disease 1 0.9836720824241638
and O 0 0.0046555823646485806
, O 0 0.0032242094166576862
as O 0 0.002510068705305457
a O 0 0.004139381926506758
result O 0 0.014125552959740162
of O 0 0.005865838844329119
linkage O 1 0.7646167874336243
analysis O 0 0.1489054411649704
, O 0 0.02243436872959137
unaffected O 1 0.8988302946090698
mutation O 1 0.9881315231323242
carriers O 0 0.23198825120925903
were O 0 0.004124990664422512
also O 0 0.004285565577447414
identified O 0 0.010239547118544579
within O 0 0.006841563619673252
the O 0 0.009626056998968124
pedigree O 0 0.36834773421287537
. O 0 0.02510927803814411

A O 0 0.025740807875990868
single O 0 0.01850738748908043
band O 0 0.01689896546304226
shift O 0 0.01984003186225891
using O 0 0.01328942272812128
SSCP O 0 0.23499348759651184
was O 0 0.005881692748516798
identified O 0 0.011903923936188221
in O 0 0.0053542908281087875
exon O 0 0.1465170681476593
21 O 0 0.008695751428604126
which O 0 0.004452152643352747
resulted O 0 0.01334601454436779
in O 0 0.005294070113450289
a O 0 0.017012137919664383
missense O 1 0.9516194462776184
mutation O 1 0.9761204123497009
converting O 0 0.10077249258756638
a O 0 0.05745704099535942
cys O 1 0.9565633535385132
- O 1 0.6746318340301514
- O 1 0.6502186059951782
> O 1 0.8632118105888367
arg O 1 0.6390578150749207
at O 0 0.011252610944211483
nucleotide O 0 0.15140080451965332
position O 0 0.007873808965086937
28 O 0 0.00945303589105606
in O 0 0.005775392521172762
the O 0 0.009505095891654491
exon O 0 0.38084977865219116
. O 0 0.027133801952004433

The O 0 0.03860199451446533
mutation O 1 0.9242926836013794
destroyed O 0 0.03725890442728996
an O 0 0.01792197674512863
NdeI O 0 0.44163158535957336
restriction O 0 0.18359512090682983
enzyme O 1 0.7080931663513184
site O 0 0.031981922686100006
. O 0 0.025683993473649025

Analysis O 0 0.025084061548113823
of O 0 0.007188970688730478
all O 0 0.00495263421908021
family O 0 0.008153845556080341
members O 0 0.00474183214828372
demonstrated O 0 0.008615555241703987
that O 0 0.003986778203397989
the O 0 0.0094149773940444
missense O 1 0.9821122884750366
mutation O 1 0.9935895204544067
co O 1 0.797235906124115
- O 1 0.6376078724861145
segregated O 1 0.7467859983444214
with O 0 0.17686572670936584
patients O 1 0.988897979259491
with O 0 0.18709120154380798
tumors B-Disease 1 0.9941997528076172
or O 0 0.01363257598131895
who O 0 0.0035530796740204096
, O 0 0.00236390414647758
as O 0 0.0022901520133018494
a O 0 0.0035658383276313543
result O 0 0.0111923236399889
of O 0 0.0038973060436546803
linkage O 0 0.3879280686378479
analysis O 0 0.010141103528439999
had O 0 0.003608223283663392
been O 0 0.0033969900105148554
predicted O 0 0.009043748490512371
to O 0 0.003745429450646043
carry O 0 0.009474157355725765
the O 0 0.014963388442993164
predisposing O 1 0.9695730209350586
mutation O 1 0.9755107164382935
. O 0 0.04902365803718567

These O 0 0.013501832261681557
observations O 0 0.013691055588424206
point O 0 0.006160878576338291
to O 0 0.003392763203009963
another O 0 0.004577775951474905
region O 0 0.005999124608933926
of O 0 0.0038899637293070555
the O 0 0.010314138606190681
RB1 O 1 0.9794123768806458
gene O 1 0.9214862585067749
where O 0 0.011863877065479755
mutations O 1 0.940855860710144
only O 0 0.004255847539752722
modify O 0 0.04495380073785782
the O 0 0.0034802607260644436
function O 0 0.015340067446231842
of O 0 0.002860739827156067
the O 0 0.0043884324841201305
gene O 1 0.7154623866081238
and O 0 0.0039350539445877075
raise O 0 0.011722317896783352
important O 0 0.004882043693214655
questions O 0 0.007898344658315182
for O 0 0.007986471988260746
genetic O 1 0.9565277695655823
counseling O 1 0.5144465565681458
in O 0 0.006325642112642527
families O 0 0.01477657537907362
with O 0 0.007489008363336325
these O 0 0.008830352686345577
distinctive O 0 0.2958177626132965
phenotypes O 1 0.9346665740013123
. O 0 0.0176346804946661
. O 0 0.02086021564900875

Maternal B-Disease 1 0.9161452651023865
disomy I-Disease 1 0.855566143989563
and O 0 0.13566219806671143
Prader B-Disease 1 0.9831560850143433
- I-Disease 1 0.9693588018417358
Willi I-Disease 1 0.9893733859062195
syndrome I-Disease 1 0.99524986743927
consistent O 0 0.2408815622329712
with O 0 0.042891211807727814
gamete O 1 0.9449319839477539
complementation O 1 0.8938719034194946
in O 0 0.009154216386377811
a O 0 0.009664026089012623
case O 0 0.021070977672934532
of O 0 0.014504410326480865
familial O 1 0.9879578948020935
translocation O 1 0.9632091522216797
( O 0 0.07387812435626984
3 O 0 0.0194313433021307
; O 0 0.013604930602014065
15 O 0 0.010284660384058952
) O 0 0.015369901433587074
( O 0 0.03482057899236679
p25 O 1 0.8283246159553528
; O 0 0.02571372501552105
q11 O 0 0.24691347777843475
. O 0 0.007484048139303923
2 O 0 0.012473078444600105
) O 0 0.015128305181860924
. O 0 0.01567659340798855

Maternal B-Disease 1 0.931944727897644
uniparental I-Disease 1 0.9547211527824402
disomy I-Disease 1 0.9041105508804321
( I-Disease 0 0.29202792048454285
UPD I-Disease 1 0.9270622730255127
) I-Disease 0 0.023516511544585228
for I-Disease 0 0.009097563102841377
chromosome I-Disease 1 0.8577291369438171
15 I-Disease 0 0.006961833219975233
is O 0 0.003240956226363778
responsible O 0 0.005081179551780224
for O 0 0.002592243952676654
an O 0 0.002684851409867406
estimated O 0 0.006998925469815731
30 O 0 0.006060600280761719
% O 0 0.00987023301422596
of O 0 0.005293296184390783
cases O 0 0.20626546442508698
of O 0 0.0746234804391861
Prader B-Disease 1 0.9946455955505371
- I-Disease 1 0.9874667525291443
Willi I-Disease 1 0.9958738684654236
syndrome I-Disease 1 0.9977236390113831
( O 1 0.7755594253540039
PWS B-Disease 1 0.9734382629394531
) O 0 0.10085571557283401
. O 0 0.02999386377632618

We O 0 0.011011364869773388
report O 0 0.008870403282344341
on O 0 0.00447606947273016
an O 0 0.004324470181018114
unusual O 0 0.010886957868933678
case O 0 0.007346515078097582
of O 0 0.00459488807246089
maternal B-Disease 1 0.7219326496124268
disomy I-Disease 1 0.550673246383667
15 I-Disease 0 0.014380037784576416
in O 0 0.008974111638963223
PWS B-Disease 1 0.9301174879074097
that O 0 0.003488294081762433
is O 0 0.0027221397031098604
most O 0 0.0027740278746932745
consistent O 0 0.006042574532330036
with O 0 0.004051862750202417
adjacent O 0 0.015029330737888813
- O 0 0.06637812405824661
1 O 0 0.008065629750490189
segregation O 0 0.06470928341150284
of O 0 0.004371111746877432
a O 0 0.018590163439512253
paternal O 1 0.8382336497306824
t O 1 0.858636200428009
( O 0 0.038982417434453964
3 O 0 0.01432078517973423
; O 0 0.009099738672375679
15 O 0 0.00834670290350914
) O 0 0.01150653325021267
( O 0 0.020977525040507317
p25 O 1 0.7350643873214722
; O 0 0.015276715159416199
q11 O 0 0.16236306726932526
. O 0 0.004594131838530302
2 O 0 0.006559123285114765
) O 0 0.006924864836037159
with O 0 0.006829560734331608
simultaneous O 0 0.1172771006822586
maternal O 1 0.9480459094047546
meiotic O 1 0.9678182005882263
nondisjunction O 1 0.7619418501853943
for O 0 0.03284783288836479
chromosome O 1 0.9478162527084351
15 O 0 0.027577627450227737
. O 0 0.023975994437932968

The O 0 0.045488059520721436
patient O 1 0.9081346988677979
( O 0 0.11625592410564423
J O 1 0.7509850263595581
. O 0 0.00904861744493246
B O 0 0.09677958488464355
. O 0 0.005036659073084593
) O 0 0.0047393301501870155
, O 0 0.003106657648459077
a O 0 0.004250738769769669
17 O 0 0.009406776167452335
- O 0 0.049192797392606735
year O 0 0.010218651965260506
- O 0 0.09367573261260986
old O 0 0.029805375263094902
white O 0 0.08140051364898682
male O 0 0.29179486632347107
with O 0 0.018077069893479347
PWS B-Disease 1 0.9622608423233032
, O 0 0.004578029736876488
was O 0 0.0031487317755818367
found O 0 0.0033709718845784664
to O 0 0.0023365893866866827
have O 0 0.0029180338606238365
47 O 0 0.009289504028856754
chromosomes O 0 0.3082420229911804
with O 0 0.005961754824966192
a O 0 0.009192065335810184
supernumerary O 1 0.6060613393783569
, O 0 0.010546836070716381
paternal O 1 0.6137292981147766
der O 0 0.28959333896636963
( O 0 0.020884083583950996
15 O 0 0.006735591683536768
) O 0 0.004332810640335083
consisting O 0 0.0036479292903095484
of O 0 0.002227689838036895
the O 0 0.0029067557770758867
short O 0 0.01320039201527834
arm O 0 0.055471476167440414
and O 0 0.003783673979341984
the O 0 0.006347084417939186
proximal O 1 0.9423637986183167
long O 0 0.1639610379934311
arm O 0 0.2730107009410858
of O 0 0.017181072384119034
chromosome O 1 0.9701458811759949
15 O 0 0.02208520844578743
, O 0 0.009299143217504025
and O 0 0.015681913122534752
distal O 1 0.9730725288391113
chromosome O 1 0.9785327315330505
arm O 1 0.6261216402053833
3p O 1 0.7468457221984863
. O 0 0.038894154131412506

The O 0 0.024558931589126587
t O 1 0.5134195685386658
( O 0 0.021182961761951447
3 O 0 0.011325687170028687
; O 0 0.006801273208111525
15 O 0 0.004918613936752081
) O 0 0.0037967886310070753
was O 0 0.002070621820166707
present O 0 0.0027220321353524923
in O 0 0.0022209794260561466
the O 0 0.0025643615517765284
balanced O 0 0.01033981703221798
state O 0 0.0036821281537413597
in O 0 0.004043815657496452
the O 0 0.0070722647942602634
patients O 1 0.9101066589355469
father O 0 0.02539816126227379
and O 0 0.006150982808321714
a O 0 0.01434769481420517
sister O 0 0.09233561903238297
. O 0 0.02436826564371586

Fluorescent O 0 0.3363458216190338
in O 0 0.02590593881905079
situ O 0 0.466369092464447
hybridization O 0 0.2770516872406006
analysis O 0 0.022379646077752113
demonstrated O 0 0.015181032009422779
that O 0 0.005344948265701532
the O 0 0.0067064957693219185
PWS B-Disease 1 0.9471780061721802
critical O 0 0.038325630128383636
region O 0 0.010495606809854507
resided O 0 0.012287705205380917
on O 0 0.003932787571102381
the O 0 0.005169820040464401
derivative O 1 0.5457721948623657
chromosome O 1 0.9074314832687378
3 O 0 0.006552927196025848
and O 0 0.002143768360838294
that O 0 0.0016300785355269909
there O 0 0.0019059877377003431
was O 0 0.0022007045336067677
no O 0 0.0033820082899183035
deletion O 0 0.20851916074752808
of O 0 0.0035521239042282104
the O 0 0.006363348104059696
PWS B-Disease 1 0.9528672695159912
region O 0 0.01030819769948721
on O 0 0.003459380706772208
the O 0 0.0037011427339166403
normal O 0 0.024013154208660126
pair O 0 0.01162021979689598
of O 0 0.0059684449806809425
15s O 0 0.3919384181499481
present O 0 0.016040626913309097
in O 0 0.013820342719554901
J O 1 0.6279152035713196
. O 0 0.028627941384911537

B O 0 0.30416667461395264
. O 0 0.06273863464593887

Methylation O 0 0.3450580835342407
analysis O 0 0.03654082864522934
at O 0 0.015271027572453022
exon O 0 0.10331755876541138
alpha O 0 0.01972711831331253
of O 0 0.005478811915963888
the O 0 0.004891072399914265
small O 0 0.01105661690235138
nuclear O 0 0.06936448067426682
ribonucleoprotein O 1 0.9405807256698608
- O 1 0.5246021151542664
associated O 0 0.34678754210472107
polypeptide O 1 0.916212797164917
N O 0 0.4132503271102905
( O 0 0.08054181188344955
SNRPN O 1 0.708487868309021
) O 0 0.04488780349493027
gene O 1 0.7572447061538696
showed O 0 0.013538319617509842
a O 0 0.008117117919027805
pattern O 0 0.14100226759910583
characteristic O 0 0.05244910717010498
of O 0 0.003668414894491434
only O 0 0.004610342904925346
the O 0 0.010811945423483849
maternal O 1 0.9587252140045166
chromosome O 1 0.9746277928352356
15 O 0 0.03379940986633301
in O 0 0.01612398959696293
J O 1 0.6786089539527893
. O 0 0.02843492291867733

B O 0 0.22914861142635345
. O 0 0.07650727778673172

Maternal B-Disease 1 0.8550745248794556
disomy I-Disease 0 0.31659090518951416
was O 0 0.016148917376995087
confirmed O 0 0.02130935713648796
by O 0 0.01278606429696083
polymerase O 1 0.6397014856338501
chain O 0 0.21752190589904785
reaction O 0 0.13458997011184692
analysis O 0 0.024171903729438782
of O 0 0.007588778156787157
microsatellite O 1 0.8394011855125427
repeats O 0 0.10069800168275833
at O 0 0.008136952295899391
the O 0 0.010116386227309704
gamma O 1 0.7332944869995117
- O 1 0.6538533568382263
aminobutyric O 1 0.9301913380622864
acid O 1 0.9715374708175659
receptor O 1 0.9792699813842773
beta3 O 1 0.926257848739624
subunit O 1 0.8953758478164673
( O 0 0.20528638362884521
GABRB3 O 1 0.7943005561828613
) O 0 0.06709699332714081
locus O 1 0.7135469317436218
. O 0 0.034739021211862564

A O 0 0.05322312191128731
niece O 0 0.4488115608692169
( O 0 0.05213576555252075
B O 0 0.20328226685523987
. O 0 0.007011578883975744
B O 0 0.06692731380462646
. O 0 0.004111758433282375
) O 0 0.004392534494400024
with O 0 0.0030649432446807623
45 O 0 0.0055887773633003235
chromosomes O 0 0.17502461373806
and O 0 0.002827832940965891
the O 0 0.0029913370963186026
derivative O 0 0.07847969979047775
3 O 0 0.005155510269105434
but O 0 0.002662843093276024
without O 0 0.0035310392268002033
the O 0 0.003048491198569536
der O 0 0.09604199975728989
( O 0 0.013141761533915997
15 O 0 0.007369549944996834
) O 0 0.007611860521137714
demonstrated O 0 0.017752429470419884
a O 0 0.016731606796383858
phenotype O 1 0.9650613069534302
consistent O 0 0.023136118426918983
with O 0 0.004432914778590202
that O 0 0.0035607304889708757
reported O 0 0.009703599847853184
for O 0 0.0058306739665567875
haploinsufficiency O 0 0.3006047308444977
of O 0 0.011885842308402061
distal O 1 0.9145318269729614
3 O 0 0.055831559002399445
p O 0 0.25824838876724243
. O 0 0.0287619736045599

Uniparental B-Disease 1 0.9567124843597412
disomy I-Disease 1 0.7590458989143372
associated O 0 0.06550829857587814
with O 0 0.014589432626962662
unbalanced O 0 0.20315031707286835
segregation O 0 0.08201666921377182
of O 0 0.0085367476567626
non O 0 0.11848387122154236
- O 0 0.3414344787597656
Robertsonian O 1 0.7295823693275452
translocations O 1 0.8468373417854309
has O 0 0.006775713991373777
been O 0 0.004411495290696621
reported O 0 0.006439541932195425
previously O 0 0.0034332238137722015
but O 0 0.0018819109536707401
has O 0 0.0016200297977775335
not O 0 0.0013670568587258458
, O 0 0.0013396957656368613
to O 0 0.0013134831096976995
our O 0 0.001796535449102521
knowledge O 0 0.0034378785640001297
, O 0 0.0023946647997945547
been O 0 0.002641978207975626
observed O 0 0.009013479575514793
in O 0 0.003842328442260623
a O 0 0.0073486086912453175
case O 0 0.013512914068996906
of O 0 0.013713602907955647
PWS B-Disease 1 0.956379771232605
. O 0 0.04435066506266594

Furthermore O 0 0.038317710161209106
, O 0 0.009578466415405273
our O 0 0.006493413355201483
findings O 0 0.009054340422153473
are O 0 0.0038643749430775642
best O 0 0.005083223804831505
interpreted O 0 0.009326893836259842
as O 0 0.005897962022572756
true O 0 0.051740117371082306
gamete O 1 0.9466033577919006
complementation O 1 0.9742271304130554
resulting O 1 0.6536183953285217
in O 0 0.04951951280236244
maternal B-Disease 1 0.9465193152427673
UPD I-Disease 1 0.9447306394577026
15 I-Disease 0 0.05481702834367752
and O 0 0.035392116755247116
PWS B-Disease 1 0.937382698059082

Schwartz B-Disease 1 0.8648456335067749
- I-Disease 1 0.8987534642219543
Jampel I-Disease 1 0.9693426489830017
syndrome I-Disease 1 0.9934671521186829
type I-Disease 1 0.5501664280891418
2 I-Disease 0 0.04188334569334984
and O 0 0.02858477272093296
Stuve B-Disease 1 0.9617889523506165
- I-Disease 1 0.9668981432914734
Wiedemann I-Disease 1 0.9909589290618896
syndrome I-Disease 1 0.9968155026435852
: O 0 0.026535412296652794
a O 0 0.008877046406269073
case O 0 0.008525809273123741
for O 0 0.006075543817132711
" O 0 0.009507709182798862
lumping O 0 0.12680894136428833
" O 0 0.01652422547340393
. O 0 0.020776784047484398

Recent O 0 0.03343852609395981
studies O 0 0.023576922714710236
demonstrated O 0 0.010956238955259323
the O 0 0.004885804373770952
existence O 0 0.007645078003406525
of O 0 0.004463753663003445
a O 0 0.010256846435368061
genetically O 1 0.729660153388977
distinct O 0 0.1687474548816681
, O 0 0.006382112856954336
usually O 0 0.015022564679384232
lethal O 0 0.33133047819137573
form O 0 0.02274489402770996
of O 0 0.005913282744586468
the O 0 0.0254774559289217
Schwartz B-Disease 1 0.9542260766029358
- I-Disease 1 0.9751290082931519
Jampel I-Disease 1 0.993218719959259
syndrome I-Disease 1 0.9985365867614746
( O 1 0.8694255352020264
SJS B-Disease 1 0.9902513027191162
) O 0 0.061455849558115005
of O 0 0.02645180933177471
myotonia B-Disease 1 0.9879604578018188
and O 0 0.10838595032691956
skeletal B-Disease 1 0.9898698925971985
dysplasia I-Disease 1 0.9935939908027649
, O 0 0.010707609355449677
which O 0 0.006389361806213856
we O 0 0.0071650305762887
called O 0 0.07604340463876724
SJS B-Disease 1 0.9778472185134888
type I-Disease 0 0.3016795516014099
2 I-Disease 0 0.026668153703212738
. O 0 0.0242532417178154

This O 0 0.04758131876587868
disorder O 1 0.9743958711624146
is O 0 0.012318428605794907
reminiscent O 0 0.05377093330025673
of O 0 0.00674529280513525
another O 0 0.019986866042017937
rare O 0 0.3529001772403717
condition O 0 0.4910188615322113
, O 0 0.007822122424840927
the O 0 0.019330210983753204
Stuve B-Disease 1 0.9728726744651794
- I-Disease 1 0.981704592704773
Wiedemann I-Disease 1 0.9954283237457275
syndrome I-Disease 1 0.9984474778175354
( O 1 0.510025680065155
SWS B-Disease 1 0.9694324135780334
) O 0 0.014962089248001575
, O 0 0.004382111597806215
which O 0 0.004165552090853453
comprises O 0 0.010831857100129128
campomelia B-Disease 0 0.34597069025039673
at O 0 0.013113888911902905
birth O 1 0.6144719123840332
with O 0 0.23290231823921204
skeletal B-Disease 1 0.994137167930603
dysplasia I-Disease 1 0.996432900428772
, O 0 0.05945274233818054
contractures B-Disease 1 0.9616420865058899
, O 0 0.008569242432713509
and O 0 0.006837424822151661
early B-Disease 0 0.016508856788277626
death I-Disease 0 0.08839090168476105
. O 0 0.02640814334154129

To O 0 0.015552339144051075
test O 0 0.01871461607515812
for O 0 0.008488120511174202
possible O 0 0.02278938889503479
nosologic O 0 0.40374571084976196
identity O 0 0.07165705412626266
between O 0 0.013403885066509247
these O 0 0.01810929737985134
disorders O 1 0.9866532683372498
, O 0 0.0035695761907845736
we O 0 0.0023760406766086817
reviewed O 0 0.003905222052708268
the O 0 0.002008965006098151
literature O 0 0.003583719488233328
and O 0 0.0019676219671964645
obtained O 0 0.003243186278268695
a O 0 0.002677209209650755
follow O 0 0.004679996520280838
- O 0 0.009591152891516685
up O 0 0.0024631780106574297
of O 0 0.0017513734055683017
the O 0 0.0022042172495275736
only O 0 0.0025707895401865244
two O 0 0.004939815029501915
surviving O 0 0.29001039266586304
patients O 1 0.8749976754188538
, O 0 0.0042186761274933815
one O 0 0.004637237638235092
with O 0 0.022520923987030983
SJS B-Disease 1 0.9783157110214233
type I-Disease 0 0.14396069943904877
2 I-Disease 0 0.006942868698388338
at O 0 0.003917766269296408
age O 0 0.007991679944097996
10 O 0 0.0041194334626197815
years O 0 0.003781986655667424
and O 0 0.0029678039718419313
another O 0 0.00576991681009531
with O 0 0.008868906646966934
SWS B-Disease 1 0.8022382259368896
at O 0 0.009526601061224937
age O 0 0.02405424788594246
7 O 0 0.015111114829778671
years O 0 0.015269815921783447
. O 0 0.018692677840590477

Patients O 1 0.8997366428375244
reported O 0 0.04230582341551781
as O 0 0.014964927919209003
having O 0 0.038688525557518005
either O 0 0.3763181269168854
neonatal O 1 0.9933885335922241
SJS B-Disease 1 0.9863460659980774
or O 0 0.16090452671051025
SWS B-Disease 1 0.880786657333374
presented O 0 0.01629052311182022
a O 0 0.011053568683564663
combination O 0 0.1137603297829628
of O 0 0.008278974331915379
a O 0 0.11739082634449005
severe O 1 0.985372006893158
, O 0 0.4717063903808594
prenatal O 1 0.9964476823806763
- O 1 0.992442786693573
onset O 1 0.9984379410743713
neuromuscular B-Disease 1 0.9981156587600708
disorder I-Disease 1 0.9975983500480652
( O 1 0.8340549468994141
with O 1 0.7728137373924255
congenital B-Disease 1 0.9986287355422974
joint I-Disease 1 0.9650008082389832
contractures I-Disease 1 0.9934325218200684
, O 0 0.3740106523036957
respiratory O 1 0.9959586262702942
and O 0 0.02601567655801773
feeding O 1 0.7247072458267212
difficulties O 0 0.3573465943336487
, O 0 0.011217374354600906
tendency O 0 0.324311226606369
to O 0 0.014449188485741615
hyperthermia B-Disease 1 0.9750262498855591
, O 0 0.007862298749387264
and O 0 0.0050261979922652245
frequent O 0 0.14107295870780945
death O 0 0.10243353247642517
in O 0 0.01176085602492094
infancy O 1 0.7557464241981506
) O 0 0.01829511858522892
with O 0 0.006770901847630739
a O 0 0.013415108434855938
distinct O 0 0.45195019245147705
campomelic B-Disease 1 0.9356167912483215
- I-Disease 1 0.895442545413971
metaphyseal I-Disease 1 0.9697298407554626
skeletal I-Disease 1 0.9851021766662598
dysplasia I-Disease 1 0.9887209534645081
. O 0 0.11654353886842728

The O 0 0.017714032903313637
similarity O 0 0.03230801224708557
of O 0 0.006796128116548061
the O 0 0.006754637695848942
clinical O 1 0.740939736366272
and O 0 0.007347057107836008
radiographic O 1 0.6941714286804199
findings O 0 0.04292335361242294
is O 0 0.00439776387065649
so O 0 0.004346961155533791
extensive O 0 0.010547109879553318
that O 0 0.003637661226093769
these O 0 0.015303594060242176
disorders O 1 0.9902248978614807
appear O 0 0.011344757862389088
to O 0 0.0034579671919345856
be O 0 0.0029768121894448996
a O 0 0.006371251307427883
single O 0 0.01442248746752739
entity O 0 0.06299321353435516
. O 0 0.018960775807499886

The O 0 0.017417438328266144
follow O 0 0.016113681718707085
- O 0 0.018865609541535378
up O 0 0.005745971109718084
observation O 0 0.009296032600104809
of O 0 0.003350380342453718
an O 0 0.004101021680980921
identical O 0 0.01975315436720848
and O 0 0.0038316550198942423
unique O 0 0.019453264772892
pattern O 0 0.3650144040584564
of O 0 0.03875558823347092
progressive O 1 0.9670880436897278
bone B-Disease 1 0.9964852333068848
dysplasia I-Disease 1 0.9956747889518738
in O 0 0.00978140439838171
the O 0 0.006742779165506363
two O 0 0.019728772342205048
patients O 1 0.9629366397857666
( O 0 0.033731766045093536
one O 0 0.009198376908898354
with O 0 0.04977608844637871
SJS B-Disease 1 0.9885041117668152
type I-Disease 0 0.23038212954998016
2 I-Disease 0 0.007159506902098656
, O 0 0.0034784271847456694
one O 0 0.0038030450232326984
with O 0 0.0097991693764925
SWS B-Disease 1 0.9400898814201355
) O 0 0.02156614139676094
surviving O 0 0.06975775212049484
beyond O 0 0.016100464388728142
infancy O 0 0.44061440229415894
adds O 0 0.02011512592434883
to O 0 0.0036161919124424458
the O 0 0.0032851011492311954
evidence O 0 0.004994693212211132
in O 0 0.004170648753643036
favor O 0 0.008250538259744644
of O 0 0.006867496762424707
identity O 0 0.045534126460552216
. O 0 0.019718114286661148

The O 0 0.022520877420902252
hypothesis O 0 0.1726061850786209
that O 0 0.0174581166356802
SWS B-Disease 1 0.9362339973449707
and O 0 0.030126582831144333
SJS B-Disease 1 0.9760851860046387
type I-Disease 0 0.1226251870393753
2 I-Disease 0 0.006925871595740318
are O 0 0.0029690752271562815
the O 0 0.0032450533472001553
same O 0 0.01759617030620575
disorder O 1 0.9838261008262634
should O 0 0.0051895007491111755
be O 0 0.003642923664301634
testable O 0 0.09058237075805664
by O 0 0.008800932206213474
molecular O 0 0.32594218850135803
methods O 0 0.02496468648314476
. O 0 0.011466850526630878
. O 0 0.01846211403608322

A O 0 0.06322230398654938
mouse O 1 0.8082497715950012
model O 0 0.182994544506073
of O 0 0.1551693081855774
severe O 1 0.9898500442504883
von B-Disease 1 0.9896886348724365
Willebrand I-Disease 1 0.9974387884140015
disease I-Disease 1 0.9975610971450806
: O 1 0.5486763119697571
defects O 1 0.9841597676277161
in O 0 0.12224578857421875
hemostasis O 1 0.9761531352996826
and O 0 0.17464298009872437
thrombosis B-Disease 1 0.9849731922149658
. O 0 0.09017535299062729

von B-Disease 1 0.9144477844238281
Willebrand I-Disease 1 0.9800300002098083
factor I-Disease 1 0.9142057299613953
( I-Disease 1 0.8327325582504272
vWf I-Disease 1 0.9824336767196655
) I-Disease 1 0.9441945552825928
deficiency I-Disease 1 0.9974237680435181
causes O 1 0.9921031594276428
severe O 1 0.9923128485679626
von B-Disease 1 0.9875453114509583
Willebrand I-Disease 1 0.9948797225952148
disease I-Disease 1 0.9953711628913879
in O 0 0.1450701653957367
humans O 1 0.8476014137268066
. O 0 0.05107036978006363

We O 0 0.015559445135295391
generated O 0 0.022424880415201187
a O 0 0.015843719244003296
mouse O 1 0.507811427116394
model O 0 0.026545308530330658
for O 0 0.007374225649982691
this O 0 0.018366249278187752
disease O 1 0.9887900352478027
by O 0 0.016772061586380005
using O 0 0.05952392518520355
gene O 1 0.9207180738449097
targeting O 0 0.15767979621887207
. O 0 0.02925916016101837

vWf B-Disease 1 0.9496400356292725
- I-Disease 1 0.8789342045783997
deficient I-Disease 1 0.9598482251167297
mice O 1 0.935774564743042
appeared O 0 0.029339447617530823
normal O 0 0.09183897078037262
at O 0 0.00959126278758049
birth O 0 0.15815480053424835
; O 0 0.006644316017627716
they O 0 0.003110777586698532
were O 0 0.0036973748356103897
viable O 0 0.0308299008756876
and O 0 0.008392325602471828
fertile O 0 0.28708064556121826
. O 0 0.024654081091284752

Neither O 0 0.23983514308929443
vWf O 1 0.9152048826217651
nor O 0 0.36692145466804504
vWf O 1 0.9384660124778748
propolypeptide O 1 0.8886797428131104
( O 0 0.47847482562065125
von B-Disease 1 0.9647944569587708
Willebrand I-Disease 1 0.9925270080566406
antigen O 1 0.9842919111251831
II O 0 0.19804812967777252
) O 0 0.013208171352744102
were O 0 0.005001354496926069
detectable O 0 0.49119168519973755
in O 0 0.009073715656995773
plasma O 1 0.6369488835334778
, O 0 0.025210579857230186
platelets O 1 0.9631911516189575
, O 0 0.015400557778775692
or O 0 0.11672350019216537
endothelial O 1 0.9811696410179138
cells O 1 0.8683321475982666
of O 0 0.009325254708528519
the O 0 0.019797498360276222
homozygous O 1 0.966973602771759
mutant O 1 0.9622750878334045
mice O 1 0.9660130143165588
. O 0 0.06292611360549927

The O 0 0.046324942260980606
mutant O 1 0.9318944215774536
mice O 1 0.9731314182281494
exhibited O 1 0.6276277899742126
defects O 1 0.9740092754364014
in O 0 0.037159569561481476
hemostasis O 1 0.9618473052978516
with O 0 0.01574162393808365
a O 0 0.021598506718873978
highly O 0 0.3155515193939209
prolonged O 1 0.9548972249031067
bleeding O 1 0.9779690504074097
time O 0 0.01090684812515974
and O 0 0.010492329485714436
spontaneous O 1 0.7726070880889893
bleeding O 1 0.9663569927215576
events O 0 0.016774553805589676
in O 0 0.005690200254321098
approximately O 0 0.00851411186158657
10 O 0 0.007080929819494486
% O 0 0.012740064412355423
of O 0 0.009594125673174858
neonates O 1 0.8761175870895386
. O 0 0.033295221626758575

As O 0 0.015894005075097084
in O 0 0.009468743577599525
the O 0 0.009158339351415634
human O 0 0.40657293796539307
disease O 1 0.9906725287437439
, O 0 0.007279054261744022
the O 0 0.005792664363980293
factor O 0 0.2665954530239105
VIII O 0 0.3702888786792755
level O 0 0.0073420582339167595
in O 0 0.00413088733330369
these O 0 0.005777810700237751
mice O 1 0.895347535610199
was O 0 0.004470576532185078
reduced O 0 0.01312834769487381
strongly O 0 0.004546793643385172
as O 0 0.002364181913435459
a O 0 0.003031595842912793
result O 0 0.004367726854979992
of O 0 0.002067245077341795
the O 0 0.0027642615605145693
lack O 0 0.010153226554393768
of O 0 0.004098156001418829
protection O 0 0.032064106315374374
provided O 0 0.01265896949917078
by O 0 0.01760753057897091
vWf O 1 0.847004771232605
. O 0 0.03031213954091072

Defective O 1 0.9613361954689026
thrombosis B-Disease 1 0.9834647178649902
in O 0 0.05583585798740387
mutant O 1 0.9450764060020447
mice O 1 0.9275042414665222
was O 0 0.0081673888489604
also O 0 0.004650560673326254
evident O 0 0.009952643886208534
in O 0 0.004194483160972595
an O 0 0.005135219078511
in O 0 0.008190969936549664
vivo O 1 0.7819688320159912
model O 0 0.09985017031431198
of O 0 0.05253656208515167
vascular B-Disease 1 0.9905547499656677
injury I-Disease 1 0.9330394864082336
. O 0 0.06640380620956421

In O 0 0.018552685156464577
this O 0 0.00872211717069149
model O 0 0.013715357519686222
, O 0 0.006275082938373089
the O 0 0.007642860524356365
exteriorized O 0 0.3909774422645569
mesentery O 1 0.7600210309028625
was O 0 0.011311029084026814
superfused O 0 0.3087141215801239
with O 0 0.016815057024359703
ferric O 1 0.8948150873184204
chloride O 0 0.4660988748073578
and O 0 0.006148809101432562
the O 0 0.007669015787541866
accumulation O 0 0.3077923357486725
of O 0 0.01288621872663498
fluorescently O 1 0.8929915428161621
labeled O 1 0.6638604402542114
platelets O 1 0.9473574757575989
was O 0 0.012530669569969177
observed O 0 0.0316922664642334
by O 0 0.01919502578675747
intravital O 1 0.5463611483573914
microscopy O 0 0.3240869343280792
. O 0 0.03430178761482239

We O 0 0.014944572001695633
conclude O 0 0.019444933161139488
that O 0 0.007345694117248058
these O 0 0.01047955360263586
mice O 1 0.9366505742073059
very O 0 0.05075535550713539
closely O 0 0.37643328309059143
mimic O 1 0.9833369851112366
severe O 1 0.9894832968711853
human O 1 0.9720500111579895
von B-Disease 1 0.9924173355102539
Willebrand I-Disease 1 0.997680127620697
disease I-Disease 1 0.9959314465522766
and O 0 0.0064368643797934055
will O 0 0.0032279323786497116
be O 0 0.0025630565360188484
very O 0 0.0028507469687610865
useful O 0 0.004944087937474251
for O 0 0.0029855568427592516
investigating O 0 0.00587064353749156
the O 0 0.0032361107878386974
role O 0 0.008183790370821953
of O 0 0.006454954389482737
vWf O 1 0.9477114081382751
in O 0 0.014893241226673126
normal O 0 0.37465202808380127
physiology O 1 0.7977548837661743
and O 0 0.01236017607152462
in O 0 0.06671391427516937
disease O 1 0.9922871589660645
models O 0 0.13275980949401855
. O 0 0.015622134320437908
. O 0 0.019724249839782715

Oral O 1 0.6882654428482056
contraceptives O 1 0.6213461756706238
and O 0 0.015269843861460686
the O 0 0.020174557343125343
risk O 1 0.9166237711906433
of O 0 0.25636330246925354
hereditary B-Disease 1 0.9933152794837952
ovarian I-Disease 1 0.9973690509796143
cancer I-Disease 1 0.9944656491279602
. O 0 0.18905726075172424

Hereditary B-Disease 1 0.9851692914962769
Ovarian I-Disease 1 0.9955986738204956
Cancer I-Disease 1 0.9915880560874939
Clinical O 1 0.9540780186653137
Study O 0 0.22962386906147003
Group O 0 0.04968218505382538
. O 0 0.031673312187194824

BACKGROUND O 0 0.05958700180053711
Women O 0 0.033836621791124344
with O 0 0.01781604252755642
mutations O 1 0.9250051379203796
in O 0 0.008492829278111458
either O 0 0.015496348962187767
the O 0 0.013572883792221546
BRCA1 O 1 0.9890486001968384
or O 0 0.04771506413817406
the O 0 0.03734121844172478
BRCA2 O 1 0.994154155254364
gene O 1 0.9574039578437805
have O 0 0.010490666143596172
a O 0 0.017690138891339302
high O 0 0.08290613442659378
lifetime O 1 0.7515246868133545
risk O 1 0.9625640511512756
of O 0 0.3308696746826172
ovarian B-Disease 1 0.9973781108856201
cancer I-Disease 1 0.9937868118286133
. O 0 0.2151634693145752

Oral O 1 0.8714067935943604
contraceptives O 1 0.9366202354431152
protect O 1 0.5668302178382874
against O 1 0.622783899307251
ovarian B-Disease 1 0.9977128505706787
cancer I-Disease 1 0.9944309592247009
in O 0 0.010882928036153316
general O 0 0.0064358096569776535
, O 0 0.003288392210379243
but O 0 0.002400103257969022
it O 0 0.001838609343394637
is O 0 0.0018514548428356647
not O 0 0.0017680207965895534
known O 0 0.003238004632294178
whether O 0 0.0029161672573536634
they O 0 0.0021470554638653994
also O 0 0.0029773840215057135
protect O 0 0.026322273537516594
against O 0 0.027055079117417336
hereditary B-Disease 1 0.9584120512008667
forms I-Disease 1 0.6196696162223816
of I-Disease 0 0.43322962522506714
ovarian I-Disease 1 0.9975484013557434
cancer I-Disease 1 0.9938056468963623
. O 0 0.16796055436134338

METHODS O 0 0.04395979270339012
We O 0 0.015841102227568626
enrolled O 0 0.06861604005098343
207 O 0 0.37281131744384766
women O 0 0.2706325054168701
with O 0 0.4793906509876251
hereditary B-Disease 1 0.9960538148880005
ovarian I-Disease 1 0.9988369345664978
cancer I-Disease 1 0.9950098991394043
and O 0 0.00838027149438858
161 O 0 0.020651889964938164
of O 0 0.004211442079395056
their O 0 0.004195508547127247
sisters O 0 0.022939207032322884
as O 0 0.003775526536628604
controls O 0 0.01431918516755104
in O 0 0.004411254543811083
a O 0 0.008464803919196129
case O 0 0.026190875098109245
- O 0 0.1679387092590332
control O 0 0.06012934446334839
study O 0 0.054406747221946716
. O 0 0.021013937890529633

All O 0 0.017441634088754654
the O 0 0.015216226689517498
patients O 1 0.8317672610282898
carried O 0 0.024181975051760674
a O 0 0.10736767202615738
pathogenic O 1 0.9824799299240112
mutation O 1 0.978247344493866
in O 0 0.019607795402407646
either O 0 0.12439588457345963
BRCA1 O 1 0.9906875491142273
( O 0 0.0952477902173996
179 O 0 0.17862315475940704
women O 0 0.11511354893445969
) O 0 0.055353496223688126
or O 0 0.11250283569097519
BRCA2 O 1 0.9892551898956299
( O 0 0.055924490094184875
28 O 0 0.016619738191366196
women O 0 0.033441875129938126
) O 0 0.026049312204122543
. O 0 0.01859170012176037

The O 0 0.016026966273784637
control O 0 0.01819937862455845
women O 0 0.009633692912757397
were O 0 0.0041768536902964115
enrolled O 0 0.012283065356314182
regardless O 0 0.00616213446483016
of O 0 0.0033869592007249594
whether O 0 0.004302128218114376
or O 0 0.003913065418601036
not O 0 0.0027208428364247084
they O 0 0.002857381710782647
had O 0 0.005796974990516901
either O 0 0.021693330258131027
mutation O 1 0.9518619775772095
. O 0 0.03100690245628357

Lifetime O 0 0.23176255822181702
histories O 0 0.22079306840896606
of O 0 0.015516835264861584
oral O 1 0.6958978772163391
- O 0 0.40116313099861145
contraceptive O 1 0.8509933948516846
use O 0 0.007156134583055973
were O 0 0.00342373875901103
obtained O 0 0.005520924925804138
by O 0 0.0036481337156146765
interview O 0 0.006781633943319321
or O 0 0.0037631120067089796
by O 0 0.0027042748406529427
written O 0 0.00391128147020936
questionnaire O 0 0.019981639459729195
and O 0 0.0025946232490241528
were O 0 0.0020310189574956894
compared O 0 0.02306150272488594
between O 0 0.034869249910116196
patients O 1 0.9285390973091125
and O 0 0.004629909060895443
control O 0 0.03172381594777107
women O 0 0.020746732130646706
, O 0 0.0033775849733501673
after O 0 0.005089010577648878
adjustment O 0 0.023622676730155945
for O 0 0.0033863859716802835
year O 0 0.004718519747257233
of O 0 0.004644172731786966
birth O 0 0.24012373387813568
and O 0 0.010073135606944561
parity O 0 0.18481910228729248
. O 0 0.024631548672914505

RESULTS O 0 0.045748475939035416
The O 0 0.01734314300119877
adjusted O 0 0.06918112933635712
odds O 0 0.34615156054496765
ratio O 1 0.7060307264328003
for O 0 0.4268006980419159
ovarian B-Disease 1 0.9984433054924011
cancer I-Disease 1 0.9969995021820068
associated O 0 0.14751845598220825
with O 0 0.006247833836823702
any O 0 0.0045831636525690556
past O 0 0.005704065319150686
use O 0 0.006699904799461365
of O 0 0.005997662432491779
oral O 0 0.4929032325744629
contraceptives O 1 0.6913543939590454
was O 0 0.011933510191738605
0 O 0 0.03557902202010155
. O 0 0.0209624283015728

5 O 0 0.033147964626550674
( O 0 0.01977916620671749
95 O 0 0.01405966654419899
percent O 0 0.01116279885172844
confidence O 0 0.011204858310520649
interval O 0 0.024739935994148254
, O 0 0.004806281998753548
0 O 0 0.0077672176994383335
. O 0 0.003764959517866373
3 O 0 0.005163217894732952
to O 0 0.0032477814238518476
0 O 0 0.009141933172941208
. O 0 0.0053874049335718155
8 O 0 0.011129568330943584
) O 0 0.012982411310076714
. O 0 0.013769191689789295

The O 0 0.027009831741452217
risk O 1 0.60566645860672
decreased O 0 0.10484251379966736
with O 0 0.007508540991693735
increasing O 0 0.020603032782673836
duration O 0 0.02203751541674137
of O 0 0.004747788421809673
use O 0 0.008312582038342953
( O 0 0.0120305260643363
P O 0 0.06898167729377747
for O 0 0.004869244527071714
trend O 0 0.05745471268892288
, O 0 0.006041085347533226
< O 0 0.3366650938987732
0 O 0 0.014784255065023899
. O 0 0.00507538765668869
001 O 0 0.12880611419677734
) O 0 0.005591104738414288
; O 0 0.003362792544066906
use O 0 0.002930376911535859
for O 0 0.002040431136265397
six O 0 0.002625041641294956
or O 0 0.0026884032413363457
more O 0 0.002043183660134673
years O 0 0.003054662374779582
was O 0 0.0025340658612549305
associated O 0 0.0062674544751644135
with O 0 0.003325971309095621
a O 0 0.005038730334490538
60 O 0 0.008291676640510559
percent O 0 0.023486202582716942
reduction O 0 0.21336126327514648
in O 0 0.018943240866065025
risk O 1 0.6978693008422852
. O 0 0.024763526394963264

Oral O 1 0.8242054581642151
- O 1 0.65147465467453
contraceptive O 1 0.9288659691810608
use O 0 0.04269631579518318
protected O 0 0.28689849376678467
against O 0 0.45840659737586975
ovarian B-Disease 1 0.9975579977035522
cancer I-Disease 1 0.993169903755188
both O 0 0.011318928562104702
for O 0 0.007009057328104973
carriers O 0 0.13873526453971863
of O 0 0.007340181618928909
the O 0 0.06434028595685959
BRCA1 O 1 0.9964460730552673
mutation O 1 0.9918855428695679
( O 0 0.10118739306926727
odds O 0 0.16717597842216492
ratio O 0 0.10509473085403442
, O 0 0.004519461654126644
0 O 0 0.008958742953836918
. O 0 0.0035943416878581047
5 O 0 0.005011230707168579
; O 0 0.003885777899995446
95 O 0 0.004602170083671808
percent O 0 0.004956466145813465
confidence O 0 0.0076049696654081345
interval O 0 0.02439728006720543
, O 0 0.0029032418970018625
0 O 0 0.0054801274091005325
. O 0 0.0023355537559837103
3 O 0 0.003315509296953678
to O 0 0.0018964243354275823
0 O 0 0.005178479012101889
. O 0 0.002482697134837508
9 O 0 0.003505193628370762
) O 0 0.002939054276794195
and O 0 0.001822812482714653
for O 0 0.002523538190871477
carriers O 0 0.04930286481976509
of O 0 0.00495748920366168
the O 0 0.03646528720855713
BRCA2 O 1 0.9966830611228943
mutation O 1 0.9935913681983948
( O 0 0.1252843737602234
odds O 0 0.21357357501983643
ratio O 0 0.1289549469947815
, O 0 0.004509394522756338
0 O 0 0.00879430491477251
. O 0 0.0031525420490652323
4 O 0 0.00468145776540041
; O 0 0.003774667391553521
95 O 0 0.0046232580207288265
percent O 0 0.005152730271220207
confidence O 0 0.006238709669560194
interval O 0 0.016235701739788055
, O 0 0.0033091807272285223
0 O 0 0.005593711975961924
. O 0 0.002579318592324853
2 O 0 0.0036224268842488527
to O 0 0.0026350929401814938
1 O 0 0.005100272595882416
. O 0 0.004086583387106657
1 O 0 0.007603447884321213
) O 0 0.012842850759625435
. O 0 0.012901841662824154

CONCLUSIONS O 0 0.18360476195812225
Oral O 1 0.7029774785041809
- O 1 0.520782470703125
contraceptive O 1 0.9284059405326843
use O 0 0.027256356552243233
may O 0 0.0379587858915329
reduce O 0 0.1947949230670929
the O 0 0.021897122263908386
risk O 1 0.9632126092910767
of O 0 0.4251806437969208
ovarian B-Disease 1 0.9990730285644531
cancer I-Disease 1 0.9973215460777283
in O 0 0.04496903344988823
women O 0 0.24315766990184784
with O 0 0.17361019551753998
pathogenic O 1 0.9885728359222412
mutations O 1 0.9843652248382568
in O 0 0.035105153918266296
the O 0 0.07954030483961105
BRCA1 O 1 0.9897168874740601
or O 1 0.6806906461715698
BRCA2 O 1 0.9853472709655762
gene O 1 0.9602031111717224

A O 0 0.035099443048238754
Japanese O 0 0.025597484782338142
family O 0 0.03609137609601021
with O 0 0.017473772168159485
adrenoleukodystrophy B-Disease 1 0.9714619517326355
with O 0 0.013133390806615353
a O 0 0.01916111633181572
codon O 1 0.6912577748298645
291 O 1 0.5822113156318665
deletion O 1 0.9012680053710938
: O 0 0.020553801208734512
a O 0 0.02377384342253208
clinical O 1 0.8262795209884644
, O 0 0.010795509442687035
biochemical O 1 0.7577571272850037
, O 0 0.008976096287369728
pathological O 1 0.6771665811538696
, O 0 0.008877485990524292
and O 0 0.009884810075163841
genetic O 1 0.8898634910583496
report O 0 0.030108554288744926
. O 0 0.02214219979941845

We O 0 0.015836767852306366
report O 0 0.014161437749862671
a O 0 0.01135347317904234
Japanese O 0 0.014635350555181503
family O 0 0.11010817438364029
with O 0 0.10678839683532715
adrenoleukodystrophy B-Disease 1 0.9940259456634521
( O 1 0.5765742063522339
ALD B-Disease 1 0.9874926805496216
) O 0 0.012727991677820683
with O 0 0.00437129894271493
a O 0 0.004509167280048132
three O 0 0.004729370586574078
base O 0 0.00827079638838768
pair O 0 0.06946396827697754
deletion O 1 0.9314774870872498
( O 0 0.08607453107833862
delGAG O 1 0.5855973958969116
291 O 0 0.26327964663505554
) O 0 0.01586628518998623
in O 0 0.009922589175403118
the O 0 0.02892373502254486
ALD B-Disease 1 0.9838172197341919
gene O 1 0.9518249034881592
. O 0 0.042193107306957245

A O 0 0.02352193556725979
variety O 0 0.018988603726029396
of O 0 0.00881203729659319
phenotypes O 1 0.6825946569442749
were O 0 0.006538808811455965
observed O 0 0.017120523378252983
within O 0 0.00820576585829258
this O 0 0.007730294484645128
family O 0 0.02711411938071251
. O 0 0.01966310665011406

While O 0 0.02313966304063797
the O 0 0.016331370919942856
proband O 1 0.7070706486701965
( O 0 0.12008069455623627
patient O 1 0.8044413328170776
1 O 0 0.011733249761164188
) O 0 0.00661101657897234
was O 0 0.0031640625093132257
classified O 0 0.007524591404944658
as O 0 0.0028337202966213226
having O 0 0.005433850456029177
a O 0 0.006796456407755613
rare O 0 0.11788896471261978
intermediate O 0 0.2221805602312088
type O 0 0.28089484572410583
of O 0 0.009205020032823086
adult O 1 0.7632405757904053
cerebral O 1 0.9897393584251404
and O 0 0.06718562543392181
cerebello O 1 0.9711281657218933
- O 1 0.9521387219429016
brain O 1 0.9935061931610107
stem O 1 0.9540327787399292
forms O 0 0.14350290596485138
, O 0 0.007116339169442654
his O 0 0.010085991583764553
younger O 0 0.3890712857246399
brother O 0 0.32300734519958496
( O 0 0.24457401037216187
patient O 1 0.8997007012367249
2 O 0 0.024180589243769646
) O 0 0.019594131037592888
and O 0 0.00711625162512064
nephew O 0 0.4292106330394745
( O 0 0.0897691398859024
patient O 1 0.7654808163642883
3 O 0 0.01708882674574852
) O 0 0.009478435851633549
had O 0 0.007854918017983437
a O 0 0.03609054535627365
childhood O 1 0.9307777881622314
ALD B-Disease 1 0.9861052632331848
type O 1 0.6456210017204285
. O 0 0.03600384667515755

Another O 0 0.061384186148643494
nephew O 0 0.4454720616340637
( O 0 0.10173572599887848
patient O 1 0.7415813207626343
4 O 0 0.01572335511445999
) O 0 0.00925439689308405
of O 0 0.004721496254205704
patient O 1 0.5085581541061401
1 O 0 0.006295379716902971
was O 0 0.0038166469894349575
classified O 0 0.011050085537135601
as O 0 0.004407889675348997
having O 0 0.0077440934255719185
an O 0 0.008449197746813297
adolescent O 1 0.845183253288269
form O 0 0.13578182458877563
. O 0 0.027708839625120163

The O 0 0.02055826038122177
tau O 0 0.12490236759185791
level O 0 0.014663144014775753
in O 0 0.008915065787732601
the O 0 0.017704768106341362
cerebrospinal O 1 0.9905200004577637
fluid O 1 0.9781111478805542
( O 0 0.47804388403892517
CSF O 1 0.983651340007782
) O 0 0.04538293927907944
in O 0 0.01149511057883501
patient O 1 0.5562543869018555
1 O 0 0.004807163029909134
was O 0 0.0025790513027459383
as O 0 0.0023593350779265165
high O 0 0.003767689922824502
as O 0 0.002847899217158556
that O 0 0.003978649619966745
of O 0 0.026599762961268425
patients O 1 0.9919437170028687
with O 1 0.7601248025894165
Alzheimers B-Disease 1 0.9980687499046326
disease I-Disease 1 0.99685138463974
( O 0 0.361141562461853
AD B-Disease 0 0.30557897686958313
) O 0 0.03689040616154671
. O 0 0.02304706908762455

His O 0 0.056222103536129
brain O 1 0.9319539666175842
magnetic O 0 0.1880428045988083
resonance O 0 0.46301203966140747
image O 0 0.2949467897415161
( O 0 0.15921813249588013
MRI O 1 0.7972588539123535
) O 0 0.03142765536904335
showed O 0 0.05259407311677933
abnormalities B-Disease 1 0.9761091470718384
in I-Disease 0 0.00698408717289567
the I-Disease 0 0.007303998805582523
bilateral I-Disease 0 0.2883966267108917
cerebellar I-Disease 1 0.9895399212837219
hemispheres I-Disease 1 0.8863810896873474
and O 0 0.07784205675125122
brain O 1 0.9902253746986389
stem O 1 0.8408423066139221
, O 0 0.0060528297908604145
but O 0 0.0032543963752686977
not O 0 0.002377466531470418
in O 0 0.002845239592716098
the O 0 0.005343983415514231
cerebral O 1 0.9750185012817383
white O 0 0.05748804286122322
matter O 0 0.005382081028074026
, O 0 0.0026335669681429863
where O 0 0.0028604702092707157
marked O 0 0.00821611750870943
reductions O 0 0.02715553529560566
of O 0 0.0035410732962191105
the O 0 0.017973724752664566
cerebral O 1 0.9920586943626404
blood O 1 0.9270329475402832
flow O 0 0.32084953784942627
and O 0 0.013097463175654411
oxygen O 1 0.7326908111572266
metabolism O 1 0.8289012312889099
were O 0 0.005607699044048786
clearly O 0 0.011557092890143394
demonstrated O 0 0.03523252531886101
by O 0 0.01941690593957901
positron O 1 0.9363183379173279
emission O 1 0.8253811001777649
tomography O 1 0.9444273710250854
( O 0 0.14817333221435547
PET O 1 0.6374173164367676
) O 0 0.0421779602766037
. O 0 0.028568509966135025

In O 0 0.03205345198512077
patients O 1 0.7590319514274597
2 O 0 0.011976988986134529
and O 0 0.004954749718308449
3 O 0 0.006230184808373451
, O 0 0.003307327628135681
the O 0 0.003370746038854122
autopsy O 0 0.1843317449092865
findings O 0 0.04486110061407089
showed O 0 0.03130730614066124
massive O 0 0.36697152256965637
demyelination B-Disease 1 0.9746281504631042
of I-Disease 0 0.007519301492720842
the I-Disease 0 0.017247820273041725
cerebral I-Disease 1 0.9817318320274353
white I-Disease 0 0.0643061101436615
matter I-Disease 0 0.007860416546463966
with O 0 0.005145793315023184
sparing O 0 0.06932082027196884
of O 0 0.0039450074546039104
the O 0 0.0053604296408593655
U O 0 0.22439271211624146
- O 0 0.4262067377567291
fibers O 1 0.6184103488922119
, O 0 0.005617971532046795
compatible O 0 0.034758392721414566
with O 0 0.004829872865229845
the O 0 0.004991383291780949
findings O 0 0.03266112506389618
of O 0 0.015108190476894379
childhood O 1 0.924216628074646
ALD B-Disease 1 0.9799990653991699
. O 0 0.08835899829864502

Oleic O 1 0.6957160830497742
and O 0 0.03169993311166763
erucic O 1 0.881666898727417
acids O 1 0.6040465235710144
( O 0 0.031075187027454376
Lorenzos O 0 0.1903587281703949
Oil O 0 0.012615744024515152
) O 0 0.007505308371037245
were O 0 0.0036028376780450344
administered O 0 0.041742853820323944
to O 0 0.0044371760450303555
patients O 1 0.72320157289505
1 O 0 0.004954033065587282
and O 0 0.002462697448208928
4 O 0 0.004109329544007778
, O 0 0.0026013213209807873
but O 0 0.00273066945374012
sufficient O 0 0.006263372953981161
effectiveness O 0 0.033129069954156876
was O 0 0.00410164101049304
not O 0 0.005206067580729723
obtained O 0 0.012272229418158531
. O 0 0.014907405711710453

The O 0 0.014682929962873459
findings O 0 0.015836365520954132
in O 0 0.005377816967666149
this O 0 0.004123310558497906
family O 0 0.010730888694524765
suggest O 0 0.010662666521966457
that O 0 0.003479480277746916
delGAG291 O 0 0.07035651803016663
is O 0 0.002847436349838972
part O 0 0.0030482332222163677
of O 0 0.0026679744478315115
the O 0 0.004096556454896927
cause O 0 0.21789458394050598
of O 0 0.0071103377267718315
Japanese O 0 0.05587797611951828
ALD B-Disease 1 0.9840497374534607
with O 0 0.05881824716925621
phenotypic O 1 0.8794008493423462
variations O 0 0.45507243275642395
. O 0 0.044623833149671555

Moreover O 0 0.03649698570370674
, O 0 0.008970367722213268
although O 0 0.005746815353631973
the O 0 0.003611423773691058
scale O 0 0.0066075692884624004
of O 0 0.0026370135601609945
the O 0 0.002593293087556958
study O 0 0.006548421923071146
is O 0 0.0028521993663161993
limited O 0 0.004469703882932663
, O 0 0.0019229889148846269
there O 0 0.001741858315654099
is O 0 0.0019298337865620852
a O 0 0.003465820336714387
possibility O 0 0.017747409641742706
that O 0 0.004430011846125126
PET O 0 0.3825114667415619
can O 0 0.0227641798555851
detect O 1 0.640349268913269
an O 0 0.031134573742747307
insidious B-Disease 1 0.9533852338790894
lesion I-Disease 1 0.9816393852233887
which O 0 0.009058943949639797
is O 0 0.013793086633086205
undetectable O 1 0.9088336229324341
by O 0 0.021970368921756744
computed O 1 0.767383873462677
tomogram O 1 0.9205610752105713
( O 0 0.3096560537815094
CT O 1 0.9674693942070007
) O 0 0.0498402938246727
or O 0 0.020797738805413246
MRI O 0 0.3375588059425354
analysis O 0 0.008905843831598759
, O 0 0.0022999339271336794
and O 0 0.001609134254977107
that O 0 0.0016855057328939438
the O 0 0.001890175393782556
higher O 0 0.00426075654104352
level O 0 0.004692007787525654
of O 0 0.003651504870504141
tau O 0 0.11464352905750275
reflects O 0 0.011175284162163734
the O 0 0.005669024307280779
process O 0 0.015765363350510597
of O 0 0.022642016410827637
neuronal B-Disease 1 0.9849126935005188
degeneration I-Disease 1 0.9909871220588684
in O 0 0.27821382880210876
ALD B-Disease 1 0.979911744594574
. O 0 0.07049426436424255

Lorenzos O 0 0.13514749705791473
Oil O 0 0.017437616363167763
should O 0 0.006337584927678108
be O 0 0.00333173805847764
given O 0 0.0035866431426256895
in O 0 0.0029738161247223616
the O 0 0.003650413593277335
early O 0 0.0080978162586689
stage O 0 0.045209404081106186
. O 0 0.009977879002690315
. O 0 0.01699344627559185

Nonsense O 0 0.410200297832489
mutation O 1 0.9262987971305847
in O 0 0.01927642524242401
exon O 0 0.26426926255226135
4 O 0 0.014405544847249985
of O 0 0.007766721770167351
human O 0 0.10997644066810608
complement O 0 0.4391539990901947
C9 O 1 0.9699345827102661
gene O 1 0.8705167770385742
is O 0 0.006868242286145687
the O 0 0.005630665458738804
major O 0 0.020260950550436974
cause O 0 0.29567673802375793
of O 0 0.009025387465953827
Japanese O 0 0.05279332026839256
complement B-Disease 1 0.7128236889839172
C9 I-Disease 1 0.9823139905929565
deficiency I-Disease 1 0.9927230477333069
. O 0 0.10192537307739258

Deficiency B-Disease 1 0.9630116820335388
of I-Disease 0 0.012183626182377338
the I-Disease 0 0.008725828491151333
ninth I-Disease 0 0.015894051641225815
component I-Disease 0 0.02024967595934868
of I-Disease 0 0.005636740010231733
human I-Disease 0 0.07277519255876541
complement I-Disease 0 0.25203201174736023
( O 0 0.10897982120513916
C9 O 1 0.9065953493118286
) O 0 0.009776557795703411
is O 0 0.0032736219000071287
the O 0 0.0027749529108405113
most O 0 0.005170862190425396
common O 0 0.22348830103874207
complement B-Disease 1 0.8342262506484985
deficiency I-Disease 1 0.9971376657485962
in O 0 0.006740552838891745
Japan O 0 0.005479835905134678
but O 0 0.0030747372657060623
is O 0 0.0035269507206976414
rare O 0 0.02793392352759838
in O 0 0.00462403055280447
other O 0 0.005276175681501627
countries O 0 0.010128135792911053
. O 0 0.014658336527645588

We O 0 0.015218685381114483
studied O 0 0.016388196498155594
the O 0 0.008048217743635178
molecular O 0 0.14154089987277985
basis O 0 0.013123308308422565
of O 0 0.018157806247472763
C9 B-Disease 1 0.9800501465797424
deficiency I-Disease 1 0.9942699670791626
in O 0 0.012209196574985981
four O 0 0.014652840793132782
Japanese O 0 0.20091897249221802
C9 B-Disease 1 0.9884597063064575
- I-Disease 1 0.9653714895248413
deficient I-Disease 1 0.9893340468406677
patients O 1 0.9790482521057129
who O 0 0.028638260439038277
had O 0 0.0444287471473217
suffered O 1 0.9172486066818237
from O 1 0.540764570236206
meningococcal B-Disease 1 0.9943049550056458
meningitis I-Disease 1 0.9917997121810913
. O 0 0.18032093346118927

Direct O 0 0.05671796575188637
sequencing O 0 0.08091753721237183
of O 0 0.021801220253109932
amplified O 0 0.25176122784614563
C9 O 1 0.8454653024673462
cDNA O 0 0.23266898095607758
and O 0 0.011717754416167736
DNA O 0 0.18256472051143646
revealed O 0 0.019859913736581802
a O 0 0.013226605020463467
nonsense O 0 0.10527923703193665
substitution O 0 0.337671160697937
( O 0 0.07089424133300781
CGA O 0 0.3634989857673645
- O 0 0.44422265887260437
- O 1 0.5661764740943909
> O 1 0.8789485692977905
TGA O 1 0.9108061790466309
) O 0 0.01601804979145527
at O 0 0.0077452100813388824
codon O 0 0.14056514203548431
95 O 0 0.011123108677566051
in O 0 0.005632646847516298
exon O 0 0.13961446285247803
4 O 0 0.007415301166474819
in O 0 0.004500912968069315
the O 0 0.005692164413630962
four O 0 0.015892619267106056
C9 B-Disease 1 0.9649465084075928
- I-Disease 1 0.7466344237327576
deficient I-Disease 1 0.9420607089996338
individuals O 0 0.1466224491596222
. O 0 0.03304792195558548

An O 0 0.049991507083177567
allele O 1 0.902355968952179
- O 0 0.25954341888427734
specific O 0 0.08915253728628159
polymerase O 1 0.8078076839447021
chain O 0 0.27049216628074646
reaction O 0 0.09797714650630951
system O 0 0.01232518907636404
designed O 0 0.008513919077813625
to O 0 0.0032403096556663513
detect O 0 0.033445220440626144
exclusively O 0 0.004374884534627199
only O 0 0.0020977985113859177
one O 0 0.0018314117332920432
of O 0 0.0019395891577005386
the O 0 0.0028435976710170507
normal O 0 0.0690363347530365
and O 0 0.005426160991191864
mutant O 1 0.8699325919151306
alleles O 1 0.9568532705307007
indicated O 0 0.017235329374670982
that O 0 0.0024661945644766092
all O 0 0.0020409768912941217
the O 0 0.002613029209896922
four O 0 0.006097489967942238
patients O 1 0.7823912501335144
were O 0 0.0036342525854706764
homozygous O 1 0.6572287678718567
for O 0 0.004299461375921965
the O 0 0.006597111467272043
mutation O 1 0.9740449786186218
in O 0 0.009026862680912018
exon O 0 0.4196929633617401
4 O 0 0.006540742237120867
and O 0 0.0025725620798766613
that O 0 0.0023146215826272964
the O 0 0.0032685385085642338
parents O 0 0.014073144644498825
of O 0 0.005293403752148151
patient O 0 0.4892061650753021
2 O 0 0.012793686240911484
were O 0 0.00927741453051567
heterozygous O 1 0.708054780960083
. O 0 0.027706658467650414

The O 0 0.02439127117395401
common O 0 0.147444486618042
mutation O 1 0.9102837443351746
at O 0 0.013566333800554276
codon O 0 0.23965725302696228
95 O 0 0.014276927337050438
in O 0 0.007861570455133915
exon O 0 0.22168028354644775
4 O 0 0.009068473242223263
might O 0 0.0065004099160432816
be O 0 0.0030102659948170185
responsible O 0 0.006683372892439365
for O 0 0.0042333416640758514
most O 0 0.00798177719116211
Japanese O 0 0.10852540284395218
C9 B-Disease 1 0.9849098324775696
deficiency I-Disease 1 0.9944075345993042
. O 0 0.0304916650056839
. O 0 0.026033924892544746

BRCA1 O 1 0.9352684617042542
required O 0 0.03638223186135292
for O 0 0.021298808977007866
transcription O 1 0.8133735060691833
- O 0 0.38139644265174866
coupled O 0 0.4907895624637604
repair O 1 0.597296953201294
of O 0 0.041357994079589844
oxidative O 1 0.9785491824150085
DNA O 1 0.8809689283370972
damage O 1 0.5907475352287292
. O 0 0.03762612119317055

The O 0 0.36183375120162964
breast B-Disease 1 0.990400493144989
and I-Disease 1 0.895032525062561
ovarian I-Disease 1 0.99846351146698
cancer I-Disease 1 0.9982241988182068
susceptibility O 1 0.994243323802948
gene O 1 0.9915010929107666
BRCA1 O 1 0.9910584092140198
encodes O 1 0.8473583459854126
a O 0 0.09846177697181702
zinc O 1 0.8437646627426147
finger O 1 0.6222321391105652
protein O 1 0.5309177041053772
of O 0 0.010546697303652763
unknown O 0 0.06943695992231369
function O 0 0.15939930081367493
. O 0 0.022375870496034622

Association O 0 0.036118704825639725
of O 0 0.011562719941139221
the O 0 0.013313103467226028
BRCA1 O 1 0.9798807501792908
protein O 1 0.581006646156311
with O 0 0.009615153074264526
the O 0 0.00998994056135416
DNA O 1 0.8540781736373901
repair O 1 0.8411639928817749
protein O 1 0.8888382315635681
Rad51 O 1 0.9016562104225159
and O 0 0.0051628053188323975
changes O 0 0.007100232411175966
in O 0 0.0033087076153606176
the O 0 0.0033692920114845037
phosphorylation O 0 0.08651422709226608
and O 0 0.0045445640571415424
cellular O 0 0.31072279810905457
localization O 0 0.07265559583902359
of O 0 0.0038311455864459276
the O 0 0.004595254547894001
protein O 1 0.6563038229942322
after O 0 0.04111247509717941
exposure O 1 0.795769989490509
to O 0 0.008686063811182976
DNA O 1 0.7686428427696228
- O 0 0.2414952963590622
damaging O 0 0.31832584738731384
agents O 0 0.016163356602191925
are O 0 0.003484318032860756
consistent O 0 0.008510948158800602
with O 0 0.004433346446603537
a O 0 0.006161104422062635
role O 0 0.017534513026475906
for O 0 0.012378023937344551
BRCA1 O 1 0.9852793216705322
in O 0 0.049898624420166016
DNA O 1 0.8637703657150269
repair O 1 0.6287102699279785
. O 0 0.03497752174735069

Here O 0 0.014528553001582623
, O 0 0.007176925893872976
it O 0 0.004864242393523455
is O 0 0.004959660116583109
shown O 0 0.011787020601332188
that O 0 0.014709949493408203
mouse O 1 0.9813210368156433
embryonic O 1 0.993064820766449
stem O 1 0.9929651021957397
cells O 1 0.9915801882743835
deficient B-Disease 1 0.9835847616195679
in I-Disease 0 0.11227034032344818
BRCA1 I-Disease 1 0.9918198585510254
are O 0 0.010305026546120644
defective O 1 0.6946463584899902
in O 0 0.00504305912181735
the O 0 0.0034953721333295107
ability O 0 0.008793710730969906
to O 0 0.0038782896008342505
carry O 0 0.007583461236208677
out O 0 0.008907418698072433
transcription O 1 0.8850440979003906
- O 0 0.4773820638656616
coupled O 1 0.5539554953575134
repair O 1 0.6469314098358154
of O 0 0.025967435911297798
oxidative O 1 0.9816531538963318
DNA O 1 0.8474880456924438
damage O 0 0.2503305673599243
, O 0 0.005456395912915468
and O 0 0.0037999062333256006
are O 0 0.005094036925584078
hypersensitive O 0 0.434315949678421
to O 0 0.011755546554923058
ionizing O 1 0.8916975259780884
radiation O 1 0.8061782717704773
and O 0 0.01705899089574814
hydrogen O 0 0.4245356023311615
peroxide O 1 0.8185810446739197
. O 0 0.0373677983880043

These O 0 0.0185471810400486
results O 0 0.02063233219087124
suggest O 0 0.02063174732029438
that O 0 0.010029616765677929
BRCA1 O 1 0.9802548289299011
participates O 0 0.14091654121875763
, O 0 0.006182671058923006
directly O 0 0.0073426770977675915
or O 0 0.007615203969180584
indirectly O 0 0.020797016099095345
, O 0 0.005367942154407501
in O 0 0.008915537036955357
transcription O 1 0.8759621977806091
- O 0 0.42970049381256104
coupled O 1 0.5062450170516968
repair O 1 0.6227456331253052
of O 0 0.0337647907435894
oxidative O 1 0.9824610352516174
DNA O 1 0.9313865900039673
damage O 1 0.5943775177001953
. O 0 0.016424233093857765
. O 0 0.023885715752840042

Truncation O 1 0.7777710556983948
mutations O 1 0.8394750356674194
in O 0 0.01672685332596302
the O 0 0.013874773867428303
transactivation O 1 0.6304867267608643
region O 0 0.02218688651919365
of O 0 0.011413758620619774
PAX6 O 1 0.9110864400863647
result O 0 0.07269187271595001
in O 0 0.012813176959753036
dominant O 0 0.34243592619895935
- O 0 0.3999837636947632
negative O 0 0.3816961944103241
mutants O 1 0.7046235203742981
. O 0 0.03855675086379051

PAX6 O 1 0.7831809520721436
is O 0 0.021815141662955284
a O 0 0.01780916005373001
transcription O 1 0.5187937021255493
factor O 0 0.06896573305130005
with O 0 0.007037186063826084
two O 0 0.008129259571433067
DNA O 1 0.7184996008872986
- O 0 0.27047693729400635
binding O 0 0.2720526456832886
domains O 0 0.4019724726676941
( O 0 0.03398209437727928
paired O 0 0.14913398027420044
box O 0 0.04129195585846901
and O 0 0.008096609264612198
homeobox O 1 0.9616581201553345
) O 0 0.012128770351409912
and O 0 0.004851025063544512
a O 0 0.010844939388334751
proline O 1 0.6785069704055786
- O 0 0.4784682095050812
serine O 1 0.7539483904838562
- O 1 0.5473265051841736
threonine O 1 0.7342896461486816
( O 0 0.1165490448474884
PST O 1 0.6557521224021912
) O 0 0.02983805164694786
- O 0 0.12419692426919937
rich O 0 0.09262964874505997
transactivation O 1 0.8385570645332336
domain O 0 0.1781313270330429
. O 0 0.036383770406246185

PAX6 O 1 0.9273363947868347
regulates O 1 0.7066568732261658
eye O 0 0.4558856189250946
development O 0 0.02524971030652523
in O 0 0.00978173315525055
animals O 0 0.055038560181856155
ranging O 0 0.021999945864081383
from O 0 0.01085633598268032
jellyfish O 0 0.41697171330451965
to O 0 0.008977700024843216
Drosophila O 0 0.41824737191200256
to O 0 0.012746886350214481
humans O 0 0.420586496591568
. O 0 0.030956657603383064

Heterozygous O 1 0.9211804270744324
mutations O 1 0.9306515455245972
in O 0 0.01561508048325777
the O 0 0.012097005732357502
human O 0 0.4339390993118286
PAX6 O 1 0.9806419014930725
gene O 1 0.9498206377029419
result O 0 0.07123187929391861
in O 0 0.00755407614633441
various O 0 0.014102510176599026
phenotypes O 1 0.9174764156341553
, O 0 0.008453593589365482
including O 0 0.02411617711186409
aniridia B-Disease 1 0.8567105531692505
, O 0 0.04268075153231621
Peters B-Disease 1 0.8618600368499756
anomaly I-Disease 1 0.9752686023712158
, O 0 0.34623441100120544
autosomal B-Disease 1 0.9962487816810608
dominant I-Disease 1 0.9600915908813477
keratitis I-Disease 1 0.988303005695343
, O 0 0.04492942988872528
and O 0 0.05899184197187424
familial B-Disease 1 0.9854772686958313
foveal I-Disease 1 0.966585636138916
dysplasia I-Disease 1 0.9868988990783691
. O 0 0.08638708293437958

It O 0 0.013785306364297867
is O 0 0.008724604733288288
believed O 0 0.00913425162434578
that O 0 0.005129931028932333
the O 0 0.008022945374250412
mutated O 1 0.9613524079322815
allele O 1 0.9216294884681702
of O 0 0.019209034740924835
PAX6 O 1 0.9627037644386292
produces O 0 0.34491732716560364
an O 0 0.013827630318701267
inactive O 0 0.35196807980537415
protein O 1 0.7374399900436401
and O 0 0.009546216577291489
aniridia B-Disease 1 0.7095222473144531
is O 0 0.018475299701094627
caused O 0 0.33211246132850647
due O 0 0.04346548020839691
to O 0 0.015461963601410389
genetic O 1 0.9541892409324646
haploinsufficiency O 1 0.6659972071647644
. O 0 0.03515227511525154

However O 0 0.021903086453676224
, O 0 0.010589901357889175
several O 0 0.01305073406547308
truncation O 1 0.7047601342201233
mutations O 1 0.9236505627632141
have O 0 0.005959074012935162
been O 0 0.004555306863039732
found O 0 0.004900576081126928
to O 0 0.0032823055516928434
occur O 0 0.03270646557211876
in O 0 0.003772315802052617
the O 0 0.005206223111599684
C O 0 0.3005666732788086
- O 0 0.17212167382240295
terminal O 0 0.12315522134304047
half O 0 0.01076850388199091
of O 0 0.008944123052060604
PAX6 O 1 0.9633923768997192
in O 0 0.054326314479112625
patients O 1 0.9737324714660645
with O 0 0.04826807603240013
Aniridia B-Disease 1 0.9028323292732239
resulting O 0 0.30660974979400635
in O 0 0.009777308441698551
mutant O 1 0.7493818402290344
proteins O 0 0.295467734336853
that O 0 0.0055048163048923016
retain O 0 0.014385058544576168
the O 0 0.006647130008786917
DNA O 1 0.6445596814155579
- O 0 0.2101215124130249
binding O 0 0.10329374670982361
domains O 0 0.06192624196410179
but O 0 0.0035944445990025997
have O 0 0.002712934510782361
lost O 0 0.004396012052893639
most O 0 0.003479529870674014
of O 0 0.004316011909395456
the O 0 0.008078298531472683
transactivation O 1 0.8215256333351135
domain O 0 0.18306048214435577
. O 0 0.02888397127389908

It O 0 0.010712540708482265
is O 0 0.00654250243678689
not O 0 0.004052705597132444
clear O 0 0.00527877127751708
whether O 0 0.005440570414066315
such O 0 0.0051235053688287735
mutants O 0 0.20454469323158264
really O 0 0.010786271654069424
behave O 0 0.07417343556880951
as O 0 0.005390324629843235
loss O 0 0.11147253215312958
- O 0 0.10296552628278732
of O 0 0.007830219343304634
- O 0 0.24343346059322357
function O 0 0.19451671838760376
mutants O 0 0.4058426022529602
as O 0 0.00863321777433157
predicted O 0 0.04251266270875931
by O 0 0.016772888600826263
haploinsufficiency O 0 0.40830719470977783
. O 0 0.02759934403002262

Contrary O 0 0.023460466414690018
to O 0 0.008036368526518345
this O 0 0.005128324963152409
theory O 0 0.007582521066069603
, O 0 0.003227588487789035
our O 0 0.002804727992042899
data O 0 0.003820757381618023
showed O 0 0.004442046862095594
that O 0 0.002330188639461994
these O 0 0.0031182633247226477
mutants O 0 0.12532033026218414
are O 0 0.0046746511943638325
dominant O 0 0.2356272041797638
- O 0 0.22074751555919647
negative O 0 0.21554645895957947
in O 0 0.024908365681767464
transient O 1 0.9328649640083313
transfection O 1 0.9663370847702026
assays O 0 0.35256674885749817
when O 0 0.006164914928376675
they O 0 0.0036975331604480743
are O 0 0.004126495216041803
coexpressed O 0 0.19453833997249603
with O 0 0.01251255627721548
wild O 0 0.2157670557498932
- O 1 0.5454206466674805
type O 1 0.6407474279403687
PAX6 O 1 0.9184364080429077
. O 0 0.05219878628849983

We O 0 0.012804049998521805
found O 0 0.010597248561680317
that O 0 0.005282441154122353
the O 0 0.006019215099513531
dominant O 0 0.17604225873947144
- O 0 0.23371529579162598
negative O 0 0.26002559065818787
effects O 0 0.4355451464653015
result O 0 0.022658025845885277
from O 0 0.005288578104227781
the O 0 0.005633648484945297
enhanced O 0 0.27965855598449707
DNA O 1 0.5219002962112427
binding O 0 0.05382263660430908
ability O 0 0.01387586910277605
of O 0 0.005529091693460941
these O 0 0.008537635207176208
mutants O 0 0.3242567777633667
. O 0 0.02746630273759365

Kinetic O 0 0.05963945388793945
studies O 0 0.02486211061477661
of O 0 0.007517009973526001
binding O 0 0.03157120570540428
and O 0 0.005630721803754568
dissociation O 0 0.4492614269256592
revealed O 0 0.015960050746798515
that O 0 0.003963529597967863
various O 0 0.0055517698638141155
truncation O 0 0.4287877678871155
mutants O 0 0.1928635835647583
have O 0 0.005837826058268547
3 O 0 0.010542457923293114
- O 0 0.06236833706498146
5 O 0 0.012112562544643879
- O 0 0.0570283941924572
fold O 0 0.05992283299565315
higher O 0 0.011661394499242306
affinity O 0 0.08286197483539581
to O 0 0.004033684264868498
various O 0 0.007156497333198786
DNA O 1 0.5124452114105225
- O 0 0.05928150564432144
binding O 0 0.026338813826441765
sites O 0 0.005899388343095779
when O 0 0.004822933580726385
compared O 0 0.008607650175690651
with O 0 0.00444012600928545
the O 0 0.005866167135536671
wild O 0 0.13121743500232697
- O 1 0.5136541128158569
type O 1 0.6675540208816528
PAX6 O 1 0.9316190481185913
. O 0 0.04977346956729889

These O 0 0.015584253706037998
results O 0 0.01398459728807211
provide O 0 0.008354980498552322
a O 0 0.006050179246813059
new O 0 0.005036266520619392
insight O 0 0.013068472035229206
into O 0 0.005010869354009628
the O 0 0.004914832301437855
role O 0 0.012467175722122192
of O 0 0.009694719687104225
mutant O 1 0.9300850033760071
PAX6 O 1 0.9684951305389404
in O 0 0.05160344019532204
causing O 1 0.8168413043022156
aniridia B-Disease 1 0.7961457371711731
. O 0 0.02205081656575203
. O 0 0.02412932738661766

Reversal O 1 0.6626295447349548
of O 0 0.1354566365480423
severe O 1 0.9845064282417297
hypertrophic B-Disease 1 0.9915239810943604
cardiomyopathy I-Disease 1 0.9886456727981567
and O 0 0.01811784878373146
excellent O 0 0.04633033648133278
neuropsychologic O 0 0.37838277220726013
outcome O 0 0.03139040619134903
in O 0 0.007706472184509039
very B-Disease 0 0.01309722289443016
- I-Disease 0 0.24997201561927795
long I-Disease 0 0.17336763441562653
- I-Disease 1 0.669870138168335
chain I-Disease 1 0.8268346786499023
acyl I-Disease 1 0.9766343235969543
- I-Disease 1 0.8920602202415466
coenzyme I-Disease 1 0.9716430902481079
A I-Disease 1 0.6436660885810852
dehydrogenase I-Disease 1 0.9882978796958923
deficiency I-Disease 1 0.9905233979225159
. O 0 0.11311211436986923

Very B-Disease 0 0.05025959387421608
- I-Disease 0 0.20781375467777252
long I-Disease 0 0.10453107208013535
- I-Disease 0 0.4971334636211395
chain I-Disease 1 0.7195860743522644
acyl I-Disease 1 0.9607353806495667
- I-Disease 1 0.8034874796867371
coenzyme I-Disease 1 0.9606688022613525
A I-Disease 0 0.37082746624946594
dehydrogenase I-Disease 1 0.9873160123825073
( I-Disease 1 0.5241773128509521
VLCAD I-Disease 1 0.9697585105895996
) I-Disease 1 0.5084959268569946
deficiency I-Disease 1 0.9959561228752136
is O 0 0.022015953436493874
a O 0 0.10274407267570496
disorder O 1 0.993362545967102
of O 0 0.045385003089904785
fatty O 1 0.9865912795066833
acid O 1 0.9780436754226685
beta O 1 0.8188301920890808
oxidation O 1 0.7745606303215027
that O 0 0.005608602426946163
reportedly O 0 0.011301886290311813
has O 0 0.005139323882758617
high O 0 0.009769140742719173
rates O 0 0.06442815065383911
of O 0 0.016129450872540474
morbidity O 1 0.9659349322319031
and O 0 0.02280484139919281
mortality O 1 0.9071862697601318
. O 0 0.04454846307635307

We O 0 0.012559707276523113
describe O 0 0.016808098182082176
the O 0 0.006083839572966099
outcome O 0 0.009051947854459286
of O 0 0.0038231394719332457
a O 0 0.006129740737378597
5 O 0 0.010697128251194954
- O 0 0.08536618202924728
year O 0 0.014737320132553577
- O 0 0.20035132765769958
old O 0 0.053340278565883636
girl O 0 0.37741899490356445
with O 0 0.11094659566879272
VLCAD B-Disease 1 0.9830781817436218
deficiency I-Disease 1 0.9958552718162537
who O 0 0.006714505143463612
was O 0 0.003223930485546589
first O 0 0.003003643127158284
seen O 0 0.0048744254745543
at O 0 0.0038382059428840876
5 O 0 0.005881745833903551
months O 0 0.008630658499896526
of O 0 0.005149873439222574
age O 0 0.22109928727149963
with O 0 0.432711124420166
severe O 1 0.9957053065299988
hypertrophic B-Disease 1 0.9979386925697327
cardiomyopathy I-Disease 1 0.9973700046539307
, O 1 0.5064187049865723
hepatomegaly B-Disease 1 0.9897422790527344
, O 0 0.23654451966285706
encephalopathy B-Disease 1 0.9911414384841919
, O 0 0.031236041337251663
and O 0 0.022433241829276085
hypotonia B-Disease 1 0.9398210644721985
. O 0 0.0477459542453289

Biochemical O 1 0.8730083703994751
studies O 1 0.5748005509376526
indicated O 1 0.7503283023834229
VLCAD B-Disease 1 0.9796552062034607
deficiency I-Disease 1 0.9952770471572876
caused O 1 0.5825753808021545
by O 0 0.01560676284134388
a O 0 0.01931467093527317
stable O 0 0.2693457007408142
yet O 0 0.027407294139266014
inactive O 0 0.37994781136512756
enzyme O 1 0.8380033373832703
. O 0 0.03707132861018181

Molecular O 1 0.8400595784187317
genetic O 1 0.8217809796333313
analysis O 0 0.028340142220258713
of O 0 0.010386387817561626
her O 0 0.035549458116292953
VLCAD O 1 0.8945587277412415
gene O 1 0.9489849805831909
revealed O 0 0.09345900267362595
a O 0 0.023713838309049606
T1372C O 1 0.6949055790901184
( O 0 0.10256136953830719
F458L O 1 0.8193371295928955
) O 0 0.15861111879348755
missense O 1 0.9590153694152832
mutation O 1 0.9743415117263794
and O 0 0.011644040234386921
a O 0 0.029599836096167564
1668 O 1 0.8552742600440979
ACAG O 1 0.8432073593139648
1669 O 1 0.729544460773468
splice O 1 0.8485587239265442
site O 0 0.13824668526649475
mutation O 1 0.9389113783836365
. O 0 0.04442422464489937

After O 0 0.044766735285520554
initial O 0 0.09680359065532684
treatment O 1 0.6038287878036499
with O 0 0.033483028411865234
intravenous O 1 0.9596856832504272
glucose O 1 0.9175229072570801
and O 0 0.015364374965429306
carnitine O 1 0.895073652267456
, O 0 0.007531787268817425
the O 0 0.007151356432586908
patient O 1 0.6039121150970459
has O 0 0.006192437838762999
thrived O 0 0.03218755125999451
on O 0 0.004207450896501541
a O 0 0.008712018840014935
low O 0 0.11293686181306839
- O 0 0.2961633503437042
fat O 1 0.6816797852516174
diet O 1 0.5637590885162354
supplemented O 0 0.10128755122423172
with O 0 0.01513349823653698
medium O 0 0.129530668258667
- O 0 0.26664501428604126
chain O 0 0.3516928255558014
triglyceride O 1 0.7921532392501831
oil O 0 0.01973371021449566
and O 0 0.010508554056286812
carnitine O 1 0.8738371729850769
and O 0 0.01246048603206873
avoidance O 1 0.5953438878059387
of O 0 0.015019656158983707
fasting O 0 0.4092220366001129
. O 0 0.03157592564821243

Her O 0 0.38490059971809387
ventricular O 1 0.9698570370674133
hypertrophy O 1 0.9674697518348694
resolved O 0 0.06524081528186798
significantly O 0 0.03720880299806595
over O 0 0.007715605664998293
1 O 0 0.006358169950544834
year O 0 0.005598148331046104
, O 0 0.003892947221174836
and O 0 0.0034213117323815823
cognitively O 0 0.36147135496139526
, O 0 0.0035290662199258804
she O 0 0.0029901762027293444
is O 0 0.002474021865054965
in O 0 0.0025834375992417336
the O 0 0.00290180672891438
superior O 0 0.009369592182338238
range O 0 0.007920343428850174
for O 0 0.006712091621011496
age O 0 0.03142702206969261
. O 0 0.01911552995443344

Clinical O 1 0.8227742314338684
recognition O 0 0.139521524310112
of O 0 0.05638686567544937
VLCAD B-Disease 1 0.9832468628883362
deficiency I-Disease 1 0.9950696229934692
is O 0 0.008228152059018612
important O 0 0.004873925354331732
because O 0 0.00423566997051239
it O 0 0.0019616587087512016
is O 0 0.0018489327048882842
one O 0 0.0016970816068351269
of O 0 0.0020339777693152428
the O 0 0.002793696476146579
few O 0 0.011286318302154541
directly O 0 0.2264588177204132
treatable O 1 0.996626615524292
causes O 1 0.9778945446014404
of O 0 0.11097268015146255
cardiomyopathy B-Disease 1 0.9952917098999023
in O 0 0.03152988478541374
children O 0 0.16104775667190552
. O 0 0.01343601569533348
. O 0 0.01852097176015377

Cloning O 0 0.10823073983192444
of O 0 0.010481897741556168
a O 0 0.010504485107958317
novel O 0 0.01604756899178028
member O 0 0.006330883130431175
of O 0 0.00425482913851738
the O 0 0.006072293501347303
low O 0 0.18444010615348816
- O 1 0.6344375014305115
density O 1 0.8323692083358765
lipoprotein O 1 0.9875467419624329
receptor O 1 0.9604625701904297
family O 0 0.20901454985141754
. O 0 0.030663112178444862

A O 0 0.053487058728933334
gene O 1 0.843380331993103
encoding O 0 0.19422131776809692
a O 0 0.020627157762646675
novel O 0 0.11855736374855042
transmembrane O 1 0.7411946058273315
protein O 1 0.5184571146965027
was O 0 0.007632488384842873
identified O 0 0.01408994011580944
by O 0 0.0072713433764874935
DNA O 0 0.35672953724861145
sequence O 0 0.13887126743793488
analysis O 0 0.043601229786872864
within O 0 0.0129019133746624
the O 0 0.046703681349754333
insulin B-Disease 1 0.9934051632881165
- I-Disease 1 0.9751817584037781
dependent I-Disease 1 0.9844011664390564
diabetes I-Disease 1 0.998327910900116
mellitus I-Disease 1 0.9943230152130127
( O 1 0.5940390229225159
IDDM B-Disease 1 0.914631724357605
) O 0 0.14079101383686066
locus O 1 0.8924843668937683
IDDM4 O 1 0.6688300967216492
on O 0 0.02675539441406727
chromosome O 1 0.9556449055671692
11q13 O 1 0.5914741158485413
. O 0 0.0365905798971653

Based O 0 0.0221443772315979
on O 0 0.009410339407622814
its O 0 0.009101377800107002
chromosomal O 1 0.7519971132278442
position O 0 0.007640644442290068
, O 0 0.005190515425056219
this O 0 0.004866934847086668
gene O 1 0.6154879927635193
is O 0 0.004979915451258421
a O 0 0.005965348333120346
candidate O 0 0.013120467774569988
for O 0 0.0107540562748909
conferring O 1 0.6093016862869263
susceptibility O 1 0.9827773571014404
to O 0 0.13172006607055664
diabetes B-Disease 1 0.9914575219154358
. O 0 0.07902834564447403

The O 0 0.034255798906087875
gene O 1 0.8299463391304016
, O 0 0.016695816069841385
termed O 0 0.2237120270729065
low O 0 0.19039154052734375
- O 1 0.578427255153656
density O 1 0.7355223894119263
lipoprotein O 1 0.987625777721405
receptor O 1 0.9751215577125549
related O 1 0.6911721229553223
protein O 1 0.8476642966270447
5 O 0 0.04630081355571747
( O 0 0.06651823967695236
LRP5 O 1 0.5865316987037659
) O 0 0.0104698920622468
, O 0 0.004623740911483765
encodes O 0 0.06439335644245148
a O 0 0.00773276761174202
protein O 0 0.17248795926570892
of O 0 0.006420341320335865
1615 O 0 0.3198685050010681
amino O 0 0.30434316396713257
acids O 0 0.22081796824932098
that O 0 0.004010445438325405
contains O 0 0.006051951553672552
conserved O 0 0.0199067872017622
modules O 0 0.009419114328920841
which O 0 0.002522573573514819
are O 0 0.002272889483720064
characteristic O 0 0.011156663298606873
of O 0 0.003004762576892972
the O 0 0.0046037426218390465
low O 0 0.22081269323825836
- O 1 0.6318917274475098
density O 1 0.8496615290641785
lipoprotein O 1 0.9894765615463257
( O 1 0.6225195527076721
LDL O 1 0.988210916519165
) O 0 0.25884243845939636
receptor O 1 0.9116166234016418
family O 0 0.12620802223682404
. O 0 0.030081255361437798

These O 0 0.020078832283616066
modules O 0 0.026515047997236252
include O 0 0.014211338013410568
a O 0 0.0106525719165802
putative O 0 0.44208353757858276
signal O 0 0.08274872601032257
peptide O 1 0.5312474966049194
for O 0 0.0075947013683617115
protein O 0 0.2438044250011444
export O 0 0.010344370268285275
, O 0 0.006103529594838619
four O 0 0.016856225207448006
epidermal O 1 0.9842625856399536
growth O 1 0.5875694751739502
factor O 1 0.6808147430419922
( O 0 0.23724369704723358
EGF O 1 0.9719138741493225
) O 0 0.03366191312670708
repeats O 0 0.2254987508058548
with O 0 0.012885953299701214
associated O 0 0.12045177817344666
spacer O 1 0.8774756789207458
domains O 0 0.3853859007358551
, O 0 0.00975958351045847
three O 0 0.040650419890880585
LDL O 1 0.9925743341445923
- O 1 0.8903076648712158
receptor O 1 0.9740308523178101
( O 0 0.14584067463874817
LDLR O 1 0.6890960335731506
) O 0 0.0127743324264884
repeats O 0 0.03904309496283531
, O 0 0.0038425053935498
a O 0 0.004548766650259495
single O 0 0.008844185620546341
transmembrane O 0 0.35394087433815
spanning O 0 0.046755507588386536
domain O 0 0.024580277502536774
, O 0 0.004376082681119442
and O 0 0.004390401765704155
a O 0 0.010889401659369469
cytoplasmic O 1 0.5611476302146912
domain O 0 0.11072157323360443
. O 0 0.02273346483707428

The O 0 0.022078797221183777
encoded O 0 0.05467185378074646
protein O 0 0.14077886939048767
has O 0 0.006437944248318672
a O 0 0.006074452307075262
unique O 0 0.008468502201139927
organization O 0 0.008397000841796398
of O 0 0.005914808250963688
EGF O 1 0.9177044630050659
and O 0 0.009287175722420216
LDLR O 1 0.7216857671737671
repeats O 0 0.39713940024375916
; O 0 0.01298205740749836
therefore O 0 0.007411357946693897
, O 0 0.00427356967702508
LRP5 O 0 0.08665262907743454
likely O 0 0.00723807979375124
represents O 0 0.006626833695918322
a O 0 0.0047168736346066
new O 0 0.004384648986160755
category O 0 0.008590304292738438
of O 0 0.0043965671211481094
the O 0 0.008642090484499931
LDLR O 1 0.5826281309127808
family O 0 0.08433756232261658
. O 0 0.026357224211096764

Both O 0 0.022310854867100716
human O 0 0.06283372640609741
and O 0 0.014889526180922985
mouse O 1 0.8711239099502563
LRP5 O 1 0.697073757648468
cDNAs O 0 0.23761647939682007
have O 0 0.005676409229636192
been O 0 0.004489211831241846
isolated O 0 0.023876234889030457
and O 0 0.0032363738864660263
the O 0 0.003971628379076719
encoded O 0 0.08451319485902786
mature O 0 0.39238566160202026
proteins O 0 0.17616112530231476
are O 0 0.0038273115642368793
95 O 0 0.008240352384746075
% O 0 0.009046196937561035
identical O 0 0.025592204183340073
, O 0 0.003512189257889986
indicating O 0 0.009510683827102184
a O 0 0.004735624883323908
high O 0 0.0058970083482563496
degree O 0 0.008059917017817497
of O 0 0.005660707596689463
evolutionary O 0 0.21717143058776855
conservation O 0 0.027245163917541504
. O 0 0.012619850225746632
. O 0 0.01845000870525837

The O 0 0.04154353216290474
APC B-Disease 1 0.6868431568145752
variants O 0 0.45604708790779114
I1307K O 0 0.2801290452480316
and O 0 0.01276435423642397
E1317Q O 0 0.37321293354034424
are O 0 0.011143960990011692
associated O 0 0.25182414054870605
with O 0 0.34856611490249634
colorectal B-Disease 1 0.998397171497345
tumors I-Disease 1 0.9963446259498596
, O 0 0.007063189521431923
but O 0 0.0038582761771976948
not O 0 0.0025984898675233126
always O 0 0.0033122196327894926
with O 0 0.003344405209645629
a O 0 0.005872031673789024
family O 0 0.017190124839544296
history O 0 0.013695009052753448
. O 0 0.016166768968105316

Classical O 1 0.8469873666763306
familial B-Disease 1 0.9914360642433167
adenomatous I-Disease 1 0.9927524328231812
polyposis I-Disease 1 0.9924364686012268
( O 1 0.5756613612174988
FAP B-Disease 1 0.958869457244873
) O 0 0.02762775495648384
is O 0 0.009230556897819042
a O 0 0.014607086777687073
high O 0 0.16622117161750793
- O 1 0.9491895437240601
penetrance O 1 0.9949200749397278
autosomal B-Disease 1 0.9980359673500061
dominant I-Disease 1 0.9846935272216797
disease I-Disease 1 0.9954895377159119
that O 0 0.02101130038499832
predisposes O 1 0.835952877998352
to O 0 0.007326955907046795
hundreds O 0 0.016381751745939255
or O 0 0.014208512380719185
thousands O 0 0.051493752747774124
of O 0 0.22689618170261383
colorectal B-Disease 1 0.9986425042152405
adenomas I-Disease 1 0.9957247972488403
and I-Disease 0 0.14770548045635223
carcinoma I-Disease 1 0.9950356483459473
and O 0 0.007908114232122898
that O 0 0.005880636163055897
results O 0 0.03762197494506836
from O 0 0.022153353318572044
truncating O 1 0.9120602011680603
mutations O 1 0.975498616695404
in O 0 0.015429564751684666
the O 0 0.023657210171222687
APC B-Disease 1 0.9460228681564331
gene O 1 0.9497600197792053
. O 0 0.039865266531705856

A O 0 0.056609347462654114
variant O 1 0.7627588510513306
of O 0 0.045200008898973465
FAP B-Disease 1 0.9749531149864197
is O 1 0.5429125428199768
attenuated B-Disease 1 0.9918966889381409
adenomatous I-Disease 1 0.9972606897354126
polyposis I-Disease 1 0.9961428046226501
coli I-Disease 1 0.9896285533905029
, O 0 0.01533347275108099
which O 0 0.007905085571110249
results O 0 0.03963690623641014
from O 0 0.018496613949537277
germ O 1 0.9304832816123962
- O 0 0.29199498891830444
line O 0 0.03585182502865791
mutations O 1 0.9150167107582092
in O 0 0.005061143543571234
the O 0 0.0036516173277050257
5 O 0 0.005311273038387299
and O 0 0.003189422655850649
3 O 0 0.0060844821855425835
regions O 0 0.013574071228504181
of O 0 0.005218281410634518
the O 0 0.012027472257614136
APC B-Disease 1 0.9136795401573181
gene O 1 0.9477561712265015
. O 0 0.03629239648580551

Attenuated B-Disease 1 0.9755395650863647
adenomatous I-Disease 1 0.991849422454834
polyposis I-Disease 1 0.9926839470863342
coli I-Disease 1 0.9885377883911133
patients O 1 0.9389603734016418
have O 0 0.019297165796160698
" O 0 0.020574333146214485
multiple O 1 0.5065772533416748
" O 0 0.29724788665771484
colorectal B-Disease 1 0.9972988963127136
adenomas I-Disease 1 0.9917096495628357
( O 0 0.059954144060611725
typically O 0 0.013156190514564514
fewer O 0 0.012069256976246834
than O 0 0.00453513627871871
100 O 0 0.00558497104793787
) O 0 0.006442749407142401
without O 0 0.006244045682251453
the O 0 0.007247082889080048
florid O 1 0.8212171196937561
phenotype O 1 0.9590481519699097
of O 0 0.015314809046685696
classical O 0 0.11580531299114227
FAP B-Disease 1 0.9375807642936707
. O 0 0.04890817031264305

Another O 0 0.031209737062454224
group O 0 0.0215316005051136
of O 0 0.011289973743259907
patients O 1 0.9399681687355042
with O 0 0.022921279072761536
multiple O 1 0.6169705986976624
adenomas B-Disease 1 0.98173987865448
has O 0 0.012115978635847569
no O 0 0.014255523681640625
mutations O 1 0.9554524421691895
in O 0 0.0091526685282588
the O 0 0.012086467817425728
APC B-Disease 1 0.949206531047821
gene O 1 0.9290235638618469
, O 0 0.005267398897558451
and O 0 0.003701594425365329
their O 0 0.00730309309437871
phenotype O 1 0.9757546782493591
probably O 0 0.018260110169649124
results O 0 0.016436198726296425
from O 0 0.005159351509064436
variation O 0 0.08881299942731857
at O 0 0.0063486723229289055
a O 0 0.012409178540110588
locus O 1 0.840754508972168
, O 0 0.00782967172563076
or O 0 0.018666720017790794
loci O 1 0.7687740325927734
, O 0 0.006050733383744955
elsewhere O 0 0.00916558038443327
in O 0 0.0059019532054662704
the O 0 0.008724628947675228
genome O 1 0.6307671070098877
. O 0 0.026364067569375038

Recently O 0 0.029379388317465782
, O 0 0.00951465405523777
however O 0 0.00792835745960474
, O 0 0.005607296712696552
a O 0 0.00977580901235342
missense O 1 0.8843282461166382
variant O 1 0.8399370312690735
of O 0 0.01765092834830284
APC B-Disease 1 0.9180064797401428
( O 0 0.08817800134420395
I1307K O 0 0.41867151856422424
) O 0 0.009826969355344772
was O 0 0.004055678378790617
described O 0 0.008524676784873009
that O 0 0.004616528283804655
confers O 0 0.35352441668510437
an O 0 0.011736931279301643
increased O 0 0.33549028635025024
risk O 1 0.9631091952323914
of O 0 0.30067235231399536
colorectal B-Disease 1 0.9988454580307007
tumors I-Disease 1 0.9969521760940552
, O 0 0.03537660464644432
including O 0 0.041853222995996475
multiple O 1 0.7506616711616516
adenomas B-Disease 1 0.9797320365905762
, O 0 0.012597017921507359
in O 0 0.015190547332167625
Ashkenazim O 1 0.6591256856918335
. O 0 0.031323157250881195

We O 0 0.011583437211811543
have O 0 0.006906342227011919
studied O 0 0.009053218178451061
a O 0 0.005443871486932039
set O 0 0.005570754408836365
of O 0 0.006244081538170576
164 O 1 0.5049375295639038
patients O 1 0.9865684509277344
with O 0 0.26048964262008667
multiple O 1 0.9803968667984009
colorectal B-Disease 1 0.9985213875770569
adenomas I-Disease 1 0.9952750205993652
and I-Disease 0 0.10171425342559814
/ I-Disease 1 0.9252417683601379
or I-Disease 0 0.36592692136764526
carcinoma I-Disease 1 0.9947382807731628
and O 0 0.020321117714047432
analyzed O 0 0.47282278537750244
codons O 1 0.9394502639770508
1263 O 1 0.9425435066223145
- O 1 0.6749600172042847
1377 O 1 0.8538265228271484
( O 0 0.12073171138763428
exon O 1 0.7435391545295715
15G O 1 0.630774199962616
) O 0 0.011471008881926537
of O 0 0.0054792179726064205
the O 0 0.010316144675016403
APC B-Disease 1 0.9158473610877991
gene O 1 0.9555350542068481
for O 0 0.02391485869884491
germ O 1 0.9276774525642395
- O 0 0.36994612216949463
line O 0 0.06323416531085968
variants O 1 0.5263071656227112
. O 0 0.031375154852867126

Three O 0 0.03717091679573059
patients O 1 0.79765385389328
with O 0 0.013189042918384075
the O 0 0.010945964604616165
I1307K O 1 0.7101800441741943
allele O 1 0.8487492203712463
were O 0 0.007437156978994608
detected O 0 0.1509372442960739
, O 0 0.005517321638762951
each O 0 0.006091387011110783
of O 0 0.00785121414810419
Ashkenazi O 0 0.45073580741882324
descent O 0 0.13948795199394226
. O 0 0.026572613045573235

Four O 0 0.03915420547127724
patients O 1 0.8314551711082458
had O 0 0.013374637812376022
a O 0 0.018714752048254013
germ O 1 0.8138580918312073
- O 0 0.17321103811264038
line O 0 0.04082147404551506
E1317Q O 1 0.7574982047080994
missense O 1 0.9520490765571594
variant O 1 0.7344342470169067
of O 0 0.006965328939259052
APC O 0 0.3071718215942383
that O 0 0.0035355568397790194
was O 0 0.0025803588796406984
not O 0 0.001815495197661221
present O 0 0.00274858670309186
in O 0 0.0022230888716876507
controls O 0 0.009341401048004627
; O 0 0.0030135021079331636
one O 0 0.0017149541527032852
of O 0 0.0016173426993191242
these O 0 0.0019697854295372963
individuals O 0 0.007430710829794407
had O 0 0.002867204835638404
an O 0 0.0030221815686672926
unusually O 0 0.01973223127424717
large O 0 0.0056733931414783
number O 0 0.004580429755151272
of O 0 0.006824710872024298
metaplastic B-Disease 1 0.7801898121833801
polyps I-Disease 1 0.9616450667381287
of I-Disease 0 0.009271788410842419
the I-Disease 0 0.012208925560116768
colorectum I-Disease 1 0.5005830526351929
. O 0 0.030269786715507507

There O 0 0.014095504768192768
is O 0 0.007055709138512611
increasing O 0 0.008950148709118366
evidence O 0 0.005440198350697756
that O 0 0.0032128216698765755
there O 0 0.003439252497628331
exist O 0 0.022294996306300163
germ O 1 0.7264347672462463
- O 0 0.06741303950548172
line O 0 0.010507944040000439
variants O 0 0.20966722071170807
of O 0 0.0038497603964060545
the O 0 0.00755951227620244
APC B-Disease 1 0.9388130307197571
gene O 1 0.9251977801322937
that O 0 0.006292301695793867
predispose O 1 0.6754291653633118
to O 0 0.003499693004414439
the O 0 0.00418482068926096
development O 0 0.023548683151602745
of O 0 0.02680961601436138
multiple O 1 0.9765434861183167
colorectal B-Disease 1 0.9989088773727417
adenomas I-Disease 1 0.9966410398483276
and I-Disease 0 0.1868421733379364
carcinoma I-Disease 1 0.9964187145233154
, O 0 0.008343287743628025
but O 0 0.004998242016881704
without O 0 0.006291812751442194
the O 0 0.00722719868645072
florid O 1 0.9097063541412354
phenotype O 1 0.9818930625915527
of O 0 0.0077119008637964725
classical O 0 0.10777597874403
FAP B-Disease 1 0.9527601003646851
, O 0 0.006422717589884996
and O 0 0.0039057156536728144
possibly O 0 0.02559163235127926
with O 0 0.009442724287509918
importance O 0 0.09177043288946152
for O 0 0.4064081609249115
colorectal B-Disease 1 0.999011754989624
cancer I-Disease 1 0.9979630708694458
risk O 1 0.8903189897537231
in O 0 0.007972607389092445
the O 0 0.005902968347072601
general O 0 0.00808276142925024
population O 0 0.017915330827236176
. O 0 0.011958984658122063
. O 0 0.017102839425206184

Genomic O 1 0.7016247510910034
structure O 0 0.04118289053440094
of O 0 0.015135233290493488
the O 0 0.04441657289862633
human O 1 0.9467852115631104
congenital B-Disease 1 0.9979523420333862
chloride I-Disease 1 0.9925968647003174
diarrhea I-Disease 1 0.9962544441223145
( O 1 0.8409597277641296
CLD B-Disease 1 0.9764566421508789
) O 0 0.33273041248321533
gene O 1 0.9404064416885376
. O 0 0.04019797965884209

Congenital B-Disease 1 0.994179368019104
chloride I-Disease 1 0.9844671487808228
diarrhea I-Disease 1 0.9940868616104126
( O 1 0.6907686591148376
CLD B-Disease 1 0.9745025038719177
) O 0 0.04039211943745613
is O 0 0.012578561902046204
caused O 0 0.23026061058044434
by O 0 0.01771700195968151
mutations O 1 0.9661991596221924
in O 0 0.009234027937054634
a O 0 0.02205062098801136
gene O 1 0.9130789637565613
which O 0 0.016321508213877678
encodes O 1 0.7597737908363342
an O 0 0.10985760390758514
intestinal O 1 0.9925690293312073
anion O 1 0.9638012647628784
transporter O 1 0.9168477654457092
. O 0 0.046323955059051514

We O 0 0.01260167546570301
report O 0 0.008427955210208893
here O 0 0.004771729465574026
the O 0 0.003723285859450698
complete O 0 0.010943756438791752
genomic O 1 0.6277551054954529
organization O 0 0.009906282648444176
of O 0 0.003968526609241962
the O 0 0.006931101903319359
human O 0 0.4731118083000183
CLD B-Disease 1 0.9832209348678589
gene O 1 0.9048827886581421
which O 0 0.009302552789449692
spans O 0 0.0604947991669178
approximately O 0 0.013275323435664177
39kb O 0 0.16183120012283325
, O 0 0.005963318515568972
and O 0 0.00542529858648777
comprises O 0 0.013916146010160446
21 O 0 0.02134723775088787
exons O 0 0.4306386709213257
. O 0 0.027654847130179405

All O 0 0.03294972702860832
exon O 1 0.5121282339096069
/ O 0 0.3718777000904083
intron O 1 0.6469230055809021
boundaries O 0 0.017502635717391968
conform O 0 0.020663654431700706
to O 0 0.00753924110904336
the O 0 0.010357529856264591
GT O 1 0.7275215983390808
/ O 1 0.7297448515892029
AG O 1 0.7140581011772156
rule O 0 0.058251358568668365
. O 0 0.02602619118988514

An O 0 0.015244890935719013
analysis O 0 0.01559306401759386
of O 0 0.006039542146027088
the O 0 0.007203384302556515
putative O 0 0.4760791063308716
promoter O 0 0.31136658787727356
region O 0 0.017350567504763603
sequence O 0 0.03453546389937401
shows O 0 0.009828583337366581
a O 0 0.009052935987710953
putative O 1 0.6065673232078552
TATA O 0 0.41968509554862976
box O 0 0.04445362836122513
and O 0 0.007865780964493752
predicts O 0 0.33568698167800903
multiple O 0 0.4797900319099426
transcription O 1 0.8914920091629028
factor O 0 0.244207501411438
binding O 0 0.0940600037574768
sites O 0 0.024760136380791664
. O 0 0.020677007734775543

The O 0 0.02217557094991207
genomic O 0 0.4473693072795868
structure O 0 0.01671258546411991
was O 0 0.005456109531223774
determined O 0 0.00758294528350234
using O 0 0.007229415699839592
DNA O 0 0.08663500845432281
from O 0 0.004220811650156975
several O 0 0.003579571144655347
sources O 0 0.004859542939811945
including O 0 0.004968738183379173
multiple O 0 0.06274659931659698
large O 0 0.018495868891477585
- O 0 0.2331564873456955
insert O 1 0.5728247165679932
libaries O 1 0.6332064867019653
and O 0 0.01629689708352089
genomic O 1 0.9491006135940552
DNA O 1 0.7659075260162354
from O 0 0.0419023260474205
Finnish O 1 0.712643027305603
CLD B-Disease 1 0.9827303886413574
patients O 1 0.956375002861023
and O 0 0.014601639471948147
controls O 0 0.07538402825593948
. O 0 0.02854558639228344

Exon O 1 0.722358763217926
- O 0 0.20213580131530762
specific O 0 0.034578144550323486
primers O 0 0.22010384500026703
developed O 0 0.02861085720360279
in O 0 0.006047324277460575
this O 0 0.0043924469500780106
study O 0 0.015278357081115246
will O 0 0.006788542494177818
facilitate O 0 0.31566205620765686
mutation O 1 0.9873512387275696
screening O 1 0.6360222697257996
studies O 0 0.15644103288650513
of O 0 0.013474764302372932
patients O 1 0.9531421661376953
with O 0 0.025546664372086525
the O 0 0.060525082051754
disease O 1 0.9917688369750977
. O 0 0.0813286304473877

Genomic O 1 0.5840733051300049
sequencing O 0 0.08859328925609589
of O 0 0.01896517165005207
a O 0 0.030877266079187393
BAC O 1 0.9320615530014038
clone O 1 0.9272584915161133
H O 1 0.6469462513923645
_ O 0 0.026474425569176674
RG364P16 O 0 0.1473475992679596
revealed O 0 0.01115642674267292
the O 0 0.0042901793494820595
presence O 0 0.006592934485524893
of O 0 0.0033898670226335526
another O 0 0.005803458858281374
, O 0 0.005273973569273949
highly O 0 0.07910942286252975
homologous O 1 0.953314483165741
gene O 1 0.9070783257484436
3 O 0 0.011602611280977726
of O 0 0.004943283274769783
the O 0 0.011511670425534248
CLD B-Disease 1 0.9860914349555969
gene O 1 0.9109171628952026
, O 0 0.005706315860152245
with O 0 0.004647648427635431
a O 0 0.005760844796895981
similar O 0 0.03271922841668129
genomic O 1 0.8456640839576721
structure O 0 0.041413504630327225
, O 0 0.004451890476047993
recently O 0 0.009310474619269371
identified O 0 0.015135389752686024
as O 0 0.006766545120626688
the O 0 0.058659907430410385
Pendred B-Disease 1 0.991763710975647
syndrome I-Disease 1 0.9985539317131042
gene O 1 0.9886771440505981
( O 0 0.3468940258026123
PDS B-Disease 1 0.8449729084968567
) O 0 0.03592776134610176
. O 0 0.014301374554634094
. O 0 0.018836425617337227

The O 0 0.04558877646923065
APCI1307K O 1 0.9243043065071106
allele O 1 0.9622299075126648
and O 0 0.15913040935993195
cancer B-Disease 1 0.993156373500824
risk O 1 0.6815200448036194
in O 0 0.0084642069414258
a O 0 0.008064085617661476
community O 0 0.012188591994345188
- O 0 0.05635958909988403
based O 0 0.008368268609046936
study O 0 0.013034948147833347
of O 0 0.008018841035664082
Ashkenazi O 0 0.3604247570037842
Jews O 0 0.029520342126488686
. O 0 0.02428453415632248

Mutations O 1 0.952574610710144
in O 0 0.031044572591781616
APC O 1 0.6422077417373657
are O 0 0.02312929928302765
classically O 1 0.867544949054718
associated O 1 0.56937575340271
with O 1 0.6340885758399963
familial B-Disease 1 0.9962982535362244
adenomatous I-Disease 1 0.9975067973136902
polyposis I-Disease 1 0.9966092109680176
( O 1 0.7449262738227844
FAP B-Disease 1 0.9733913540840149
) O 0 0.0361923910677433
, O 0 0.01073095016181469
a O 0 0.03099248930811882
highly O 1 0.7820619940757751
penetrant O 1 0.9938335418701172
autosomal B-Disease 1 0.9981698989868164
dominant I-Disease 1 0.9891452193260193
disorder I-Disease 1 0.9975680708885193
characterized O 1 0.9688103199005127
by O 0 0.35523879528045654
multiple O 1 0.9750514030456543
intestinal O 1 0.9976544976234436
polyps B-Disease 1 0.9913684725761414
and O 0 0.013380719348788261
, O 0 0.010359109379351139
without O 0 0.02863735891878605
surgical O 1 0.8253979682922363
intervention O 0 0.20025816559791565
, O 0 0.005467301234602928
the O 0 0.005955457221716642
development O 0 0.14230425655841827
of O 0 0.4023045003414154
colorectal B-Disease 1 0.9989941716194153
cancer I-Disease 1 0.9977996945381165
( O 1 0.6577816009521484
CRC B-Disease 1 0.9501851797103882
) O 0 0.05564649775624275
. O 0 0.025150101631879807

APC B-Disease 1 0.714666485786438
is O 0 0.03934945911169052
a O 0 0.16028298437595367
tumour O 1 0.9920305013656616
- O 1 0.9514082074165344
suppressor O 1 0.9877153038978577
gene O 1 0.9652132987976074
, O 0 0.012861980125308037
and O 0 0.01091033685952425
somatic O 1 0.9219492673873901
loss O 1 0.6791980266571045
occurs O 1 0.7045630216598511
in O 0 0.050462257117033005
tumours B-Disease 1 0.9783853888511658
. O 0 0.057054221630096436

The O 0 0.04687890410423279
germline O 1 0.9576163291931152
T O 1 0.8444181084632874
- O 0 0.10266482084989548
to O 0 0.008915605023503304
- O 0 0.07205794751644135
A O 0 0.012053937651216984
transversion O 0 0.17214614152908325
responsible O 0 0.011736699379980564
for O 0 0.005300355609506369
the O 0 0.0075206574983894825
APC O 1 0.795206606388092
I1307K O 1 0.6961098909378052
allele O 1 0.850043535232544
converts O 0 0.03911028429865837
the O 0 0.007973491214215755
wild O 0 0.09738814830780029
- O 0 0.2045809030532837
type O 0 0.14797750115394592
sequence O 0 0.04768188297748566
to O 0 0.0065821376629173756
a O 0 0.024709878489375114
homopolymer O 1 0.9280787706375122
tract O 1 0.983200192451477
( O 0 0.14957989752292633
A8 O 1 0.8258430361747742
) O 0 0.017754942178726196
that O 0 0.005645071621984243
is O 0 0.009261639788746834
genetically O 1 0.8256168365478516
unstable O 1 0.6781474351882935
and O 0 0.011613689363002777
prone O 1 0.7265334725379944
to O 0 0.02631279267370701
somatic O 1 0.9720527529716492
mutation O 1 0.978367030620575
. O 0 0.06449993699789047

The O 0 0.03798111900687218
I1307K O 0 0.39032524824142456
allele O 1 0.5659195780754089
was O 0 0.014986268244683743
found O 0 0.01628706231713295
in O 0 0.013483501970767975
6 O 0 0.02618199773132801
. O 0 0.02393290214240551

1 O 0 0.027471797540783882
% O 0 0.017269786447286606
of O 0 0.010588755831122398
unselected O 0 0.280571311712265
Ashkenazi O 0 0.1697862446308136
Jews O 0 0.009958108887076378
and O 0 0.004667858127504587
higher O 0 0.010058472864329815
proportions O 0 0.17892324924468994
of O 0 0.006738593336194754
Ashkenazim O 1 0.6873835921287537
with O 0 0.013394637033343315
family O 0 0.03975642845034599
or O 0 0.009682782925665379
personal O 0 0.01820545271039009
histories O 0 0.23537050187587738
of O 0 0.01013034489005804
CRC B-Disease 1 0.8662367463111877
( O 0 0.07869653403759003
ref O 0 0.4477080702781677
. O 0 0.009599197655916214
2 O 0 0.01343737356364727
) O 0 0.016553455963730812
. O 0 0.0158187635242939

To O 0 0.01412624679505825
evaluate O 0 0.018138790503144264
the O 0 0.005670881364494562
role O 0 0.00931477639824152
of O 0 0.0060524423606693745
I1307K O 1 0.7172163128852844
in O 0 0.057474832981824875
cancer B-Disease 1 0.9910797476768494
, O 0 0.006812917068600655
we O 0 0.004997796379029751
genotyped O 0 0.22088906168937683
5 O 0 0.012598969973623753
, O 0 0.008452793583273888
081 O 1 0.7027455568313599
Ashkenazi O 0 0.32920828461647034
volunteers O 0 0.018315576016902924
in O 0 0.006661439314484596
a O 0 0.008833675645291805
community O 0 0.015618687495589256
survey O 0 0.022780748084187508
. O 0 0.020552106201648712

Risk O 1 0.7724286913871765
of O 0 0.048912808299064636
developing O 1 0.9393962025642395
colorectal B-Disease 1 0.9961264729499817
, I-Disease 0 0.15848295390605927
breast I-Disease 1 0.9909546971321106
and I-Disease 0 0.01178869791328907
other I-Disease 0 0.019818561151623726
cancers I-Disease 1 0.9843834638595581
were O 0 0.005392714403569698
compared O 0 0.04321296140551567
between O 0 0.030541660264134407
genotyped O 1 0.80963534116745
I1307K O 1 0.7986729145050049
carriers O 0 0.3475706875324249
and O 0 0.0067852637730538845
non O 0 0.06530242413282394
- O 0 0.14291714131832123
carriers O 0 0.0855298638343811
and O 0 0.0037727439776062965
their O 0 0.0037476415745913982
first O 0 0.006482880562543869
- O 0 0.13396568596363068
degree O 0 0.03766559436917305
relatives O 0 0.07123395055532455
. O 0 0.021069621667265892

Sperm O 1 0.846452534198761
DNA O 1 0.519277036190033
analysis O 0 0.04072648286819458
in O 0 0.01817583106458187
a O 0 0.05075336620211601
Friedreich B-Disease 1 0.9765898585319519
ataxia I-Disease 1 0.9867743253707886
premutation O 1 0.8675492405891418
carrier O 0 0.3198843002319336
suggests O 0 0.08230999112129211
both O 0 0.012734032236039639
meiotic O 1 0.7446384429931641
and O 0 0.011555289849638939
mitotic O 0 0.40611183643341064
expansion O 0 0.02378588356077671
in O 0 0.010951577685773373
the O 0 0.0139691811054945
FRDA B-Disease 1 0.828436553478241
gene O 1 0.9394271373748779
. O 0 0.045433368533849716

Friedreich B-Disease 1 0.9471901059150696
ataxia I-Disease 1 0.9562727212905884
is O 0 0.023471103981137276
usually O 0 0.019564971327781677
caused O 0 0.046958863735198975
by O 0 0.0067024375312030315
an O 0 0.004727029241621494
expansion O 0 0.008920316584408283
of O 0 0.004787343088537455
a O 0 0.009795792400836945
GAA O 0 0.18916183710098267
trinucleotide O 1 0.8846880197525024
repeat O 0 0.2884155213832855
in O 0 0.013736777007579803
intron O 1 0.7543952465057373
1 O 0 0.012181997299194336
of O 0 0.006572008598595858
the O 0 0.011589947156608105
FRDA B-Disease 1 0.8442662358283997
gene O 1 0.9407037496566772
. O 0 0.036822449415922165

Occasionally O 0 0.033847760409116745
, O 0 0.00951120350509882
a O 0 0.008401958271861076
fully O 0 0.008916080929338932
expanded O 0 0.012892219237983227
allele O 1 0.6295218467712402
has O 0 0.004394956398755312
been O 0 0.0032391638960689306
found O 0 0.0035912315361201763
to O 0 0.002726281061768532
arise O 0 0.06647372245788574
from O 0 0.0038422427605837584
a O 0 0.005000936333090067
premutation O 0 0.08558402955532074
of O 0 0.003707893891260028
100 O 0 0.006215360946953297
or O 0 0.01032575499266386
less O 0 0.022562677040696144
triplet O 1 0.8830794095993042
repeats O 0 0.49173951148986816
. O 0 0.02836751379072666

We O 0 0.013177131302654743
have O 0 0.007935610599815845
examined O 0 0.018182363361120224
the O 0 0.006976406555622816
sperm O 0 0.46088266372680664
DNA O 0 0.19576296210289001
of O 0 0.00670934934169054
a O 0 0.014811505563557148
premutation O 1 0.5158398747444153
carrier O 0 0.22493968904018402
. O 0 0.029563097283244133

This O 0 0.022803017869591713
mans O 0 0.18526341021060944
leucocyte O 1 0.5814101099967957
DNA O 0 0.2864023745059967
showed O 0 0.019724087789654732
one O 0 0.011329231783747673
normal O 0 0.13677909970283508
allele O 1 0.6273464560508728
and O 0 0.005528800189495087
one O 0 0.006186228711158037
allele O 0 0.38734400272369385
of O 0 0.005950646009296179
approximately O 0 0.011221442371606827
100 O 0 0.012815313413739204
repeats O 0 0.10821200162172318
. O 0 0.019829915836453438

His O 0 0.02817760407924652
sperm O 0 0.21264013648033142
showed O 0 0.018254974856972694
an O 0 0.010087268427014351
expanded O 0 0.017275014892220497
allele O 0 0.4553169906139374
in O 0 0.0069215442053973675
a O 0 0.006947521585971117
tight O 0 0.011660333722829819
range O 0 0.007617632858455181
centering O 0 0.012192674912512302
on O 0 0.0038665062747895718
a O 0 0.005179035011678934
size O 0 0.007867352105677128
of O 0 0.006858672946691513
approximately O 0 0.018817733973264694
320 O 0 0.1456785351037979
trinucleotide O 1 0.8819589614868164
repeats O 0 0.35236433148384094
. O 0 0.03333072364330292

His O 0 0.033171311020851135
affected O 0 0.1186569407582283
son O 0 0.03191562369465828
has O 0 0.012793970294296741
repeat O 0 0.06946785748004913
sizes O 0 0.019325971603393555
of O 0 0.00884956307709217
1040 O 0 0.4451182782649994
and O 0 0.012691475450992584
540 O 0 0.12384114414453506
. O 0 0.024206111207604408

These O 0 0.013863438740372658
data O 0 0.011515279300510883
suggest O 0 0.010007900185883045
that O 0 0.0037622309755533934
expansion O 0 0.009357388131320477
occurs O 0 0.028801171109080315
in O 0 0.002874592551961541
two O 0 0.002757379552349448
stages O 0 0.016662858426570892
, O 0 0.0027876466047018766
the O 0 0.002432609675452113
first O 0 0.00308552966453135
during O 0 0.00816658977419138
meiosis O 1 0.6083002090454102
followed O 0 0.010143565014004707
by O 0 0.005284114740788937
a O 0 0.00711015984416008
second O 0 0.012872663326561451
mitotic O 1 0.5314999222755432
expansion O 0 0.06698434799909592
. O 0 0.025707639753818512

We O 0 0.011638888157904148
also O 0 0.0063011543825268745
show O 0 0.0055616614408791065
that O 0 0.0027268375270068645
in O 0 0.002820137655362487
all O 0 0.002716767368838191
informative O 0 0.024703318253159523
carrier O 0 0.05804119259119034
father O 0 0.009802269749343395
to O 0 0.004876317456364632
affected O 0 0.17488402128219604
child O 0 0.16474227607250214
transmissions O 0 0.12894950807094574
, O 0 0.003655811073258519
with O 0 0.00283885863609612
the O 0 0.0022433761041611433
notable O 0 0.004826532676815987
exception O 0 0.004926363471895456
of O 0 0.0028002881444990635
the O 0 0.004139624070376158
premutation O 0 0.3027219772338867
carrier O 0 0.06854650378227234
, O 0 0.00449456786736846
the O 0 0.004950585309416056
expansion O 0 0.01982838846743107
size O 0 0.023767855018377304
decreases O 0 0.19353221356868744
. O 0 0.013459636829793453
. O 0 0.017659762874245644

The O 0 0.033369291573762894
R496H O 1 0.6476051211357117
mutation O 1 0.9104195833206177
of O 0 0.014518349431455135
arylsulfatase O 0 0.32562023401260376
A O 0 0.018703032284975052
does O 0 0.018377916887402534
not O 0 0.015008458867669106
cause O 1 0.7949329614639282
metachromatic B-Disease 1 0.9327523112297058
leukodystrophy I-Disease 1 0.971707284450531
. O 0 0.06791664659976959

Deficiency B-Disease 1 0.9712623953819275
of I-Disease 0 0.031100565567612648
arylsulfatase I-Disease 0 0.4828818738460541
A I-Disease 0 0.04358465597033501
( O 0 0.1815492808818817
ARSA O 1 0.9503756761550903
) O 0 0.23710988461971283
enzyme O 1 0.9620537161827087
activity O 1 0.7240550518035889
causes O 1 0.9761147499084473
metachromatic B-Disease 1 0.9729670882225037
leukodystrophy I-Disease 1 0.9862715005874634
( O 0 0.47693678736686707
MLD B-Disease 1 0.9451214671134949
) O 0 0.06063050404191017
. O 0 0.03183403238654137

A O 0 0.02716483548283577
number O 0 0.01701689139008522
of O 0 0.020746368914842606
ARSA O 1 0.9693664312362671
gene O 1 0.980789840221405
mutations O 1 0.9772311449050903
responsible O 0 0.0695812776684761
for O 0 0.01386162731796503
MLD B-Disease 1 0.8191332817077637
have O 0 0.010949172079563141
been O 0 0.011274121701717377
identified O 0 0.03156458958983421
. O 0 0.024314742535352707

Recently O 0 0.04083337262272835
, O 0 0.013760531321167946
the O 0 0.01200913917273283
R496H O 1 0.5423351526260376
mutation O 1 0.9088834524154663
of O 0 0.009899175725877285
ARSA O 1 0.7029495239257812
was O 0 0.006425194907933474
proposed O 0 0.008141372352838516
to O 0 0.003941869828850031
be O 0 0.003282762598246336
a O 0 0.00763960974290967
cause O 0 0.2648550271987915
of O 0 0.014434834942221642
MLD B-Disease 1 0.9759941101074219
( O 0 0.1552620530128479
Draghia O 1 0.8137391209602356
et O 0 0.37948036193847656
al O 0 0.02820734865963459
. O 0 0.007363371085375547
, O 0 0.00691527733579278
1997 O 0 0.017346175387501717
) O 0 0.01624872162938118
. O 0 0.01581266149878502

We O 0 0.011956674046814442
have O 0 0.007909966632723808
investigated O 0 0.015786902979016304
the O 0 0.006617586128413677
R496H O 1 0.6475290060043335
mutation O 1 0.9580259919166565
and O 0 0.005183581728488207
found O 0 0.00818751472979784
this O 0 0.005251388531178236
mutation O 1 0.9160265326499939
at O 0 0.004237152636051178
a O 0 0.004593826364725828
relatively O 0 0.01371502224355936
high O 0 0.006190436892211437
frequency O 0 0.016470732167363167
in O 0 0.003128134412690997
an O 0 0.0032539681997150183
African O 0 0.014819671399891376
American O 0 0.011571874842047691
population O 0 0.02812878228724003
( O 0 0.030775757506489754
f O 0 0.11382502317428589
= O 0 0.1096925213932991
0 O 0 0.013259872794151306
. O 0 0.005430432036519051
09 O 0 0.02633831463754177
, O 0 0.006768953055143356
n O 0 0.03983444720506668
= O 0 0.12249623984098434
61 O 0 0.025967195630073547
subjects O 0 0.04342282563447952
) O 0 0.022100552916526794
. O 0 0.017551621422171593

The O 0 0.03741501644253731
ARSA O 1 0.9217793941497803
enzyme O 1 0.7894102334976196
activity O 0 0.030553357675671577
in O 0 0.0073179942555725574
subjects O 0 0.009575046598911285
with O 0 0.004130969289690256
and O 0 0.002948508132249117
without O 0 0.004992579109966755
the O 0 0.005075728986412287
R496H O 1 0.5926005244255066
mutation O 1 0.9425910711288452
was O 0 0.004623613320291042
determined O 0 0.006526968441903591
and O 0 0.002979377517476678
found O 0 0.005123998504132032
to O 0 0.003821047954261303
be O 0 0.0050614746287465096
normal O 0 0.05287201702594757
. O 0 0.018797393888235092

It O 0 0.012989092618227005
is O 0 0.008054268546402454
therefore O 0 0.006873577833175659
concluded O 0 0.0091231195256114
that O 0 0.004024912137538195
the O 0 0.0056295921094715595
R496H O 1 0.5708760619163513
mutation O 1 0.9562645554542542
of O 0 0.010635838843882084
ARSA O 1 0.883419394493103
does O 0 0.010797098278999329
not O 0 0.004555404651910067
negatively O 0 0.01949443481862545
influence O 0 0.007961022667586803
the O 0 0.004092358984053135
activity O 0 0.01096806675195694
of O 0 0.005886278580874205
ARSA O 1 0.7457230091094971
and O 0 0.005281887482851744
is O 0 0.005003746133297682
not O 0 0.004449819680303335
a O 0 0.00995420478284359
cause O 0 0.30991092324256897
of O 0 0.023723971098661423
MLD B-Disease 1 0.9412997961044312

Down O 0 0.047867245972156525
- O 0 0.11417326331138611
regulation O 0 0.09640799462795258
of O 0 0.020051365718245506
transmembrane O 1 0.9410215616226196
carbonic O 1 0.9750989079475403
anhydrases O 1 0.9595990777015686
in O 1 0.6864675283432007
renal B-Disease 1 0.9980213642120361
cell I-Disease 1 0.993582010269165
carcinoma I-Disease 1 0.9978979825973511
cell O 1 0.9428623914718628
lines O 0 0.1478848159313202
by O 0 0.02631550468504429
wild O 0 0.3396076560020447
- O 1 0.7070373296737671
type O 1 0.8493490815162659
von B-Disease 1 0.8886237144470215
Hippel I-Disease 1 0.9679072499275208
- I-Disease 1 0.801508367061615
Lindau I-Disease 1 0.9499863982200623
transgenes O 1 0.8543009161949158
. O 0 0.06103765219449997

To O 0 0.02713632397353649
discover O 0 0.24308928847312927
genes O 1 0.7819002866744995
involved O 0 0.049180176109075546
in O 0 0.029903318732976913
von B-Disease 1 0.8987295627593994
Hippel I-Disease 1 0.9798414707183838
- I-Disease 1 0.9494666457176208
Lindau I-Disease 1 0.9863613843917847
( O 1 0.6451357007026672
VHL B-Disease 1 0.9859659075737
) O 0 0.27735692262649536
- O 1 0.7443854808807373
mediated O 1 0.9620962738990784
carcinogenesis O 1 0.9749683141708374
, O 0 0.01187499426305294
we O 0 0.010386833921074867
used O 0 0.32754749059677124
renal B-Disease 1 0.9975778460502625
cell I-Disease 1 0.9931122660636902
carcinoma I-Disease 1 0.9979062080383301
cell O 1 0.9654843807220459
lines O 1 0.5062171220779419
stably O 1 0.9120261073112488
transfected O 1 0.9516481161117554
with O 0 0.056043367832899094
wild O 0 0.4782092571258545
- O 1 0.781047523021698
type O 1 0.8418383002281189
VHL O 1 0.9737908244132996
- O 1 0.5407143235206604
expressing O 0 0.22301718592643738
transgenes O 1 0.7784168720245361
. O 0 0.04663765802979469

Large O 0 0.04340039938688278
- O 0 0.11838524043560028
scale O 0 0.08159757405519485
RNA O 1 0.5068798065185547
differential O 0 0.0929531455039978
display O 0 0.009928902611136436
technology O 0 0.010067606344819069
applied O 0 0.006297751795500517
to O 0 0.003353065811097622
these O 0 0.004907663911581039
cell O 0 0.38542917370796204
lines O 0 0.029566405341029167
identified O 0 0.025363080203533173
several O 0 0.0074638864025473595
differentially O 1 0.5277149081230164
expressed O 0 0.029706085100769997
genes O 1 0.7342535853385925
, O 0 0.006257706321775913
including O 0 0.00788611825555563
an O 0 0.01175658218562603
alpha O 0 0.4737201929092407
carbonic O 1 0.9722574353218079
anhydrase O 1 0.9699421525001526
gene O 1 0.9607307314872742
, O 0 0.023392125964164734
termed O 0 0.363963782787323
CA12 O 1 0.7138240933418274
. O 0 0.036370597779750824

The O 0 0.022972092032432556
deduced O 0 0.06600558012723923
protein O 0 0.29611918330192566
sequence O 0 0.026716040447354317
was O 0 0.006016630679368973
classified O 0 0.009917784482240677
as O 0 0.003700653789564967
a O 0 0.004937654826790094
one O 0 0.005100679583847523
- O 0 0.07459308952093124
pass O 0 0.03186693415045738
transmembrane O 0 0.4813521206378937
CA O 0 0.03787645325064659
possessing O 0 0.01833280734717846
an O 0 0.005656243301928043
apparently O 0 0.018302055075764656
intact O 0 0.07330872863531113
catalytic O 0 0.3217043876647949
domain O 0 0.028561782091856003
in O 0 0.005987855140119791
the O 0 0.007681974675506353
extracellular O 0 0.45116424560546875
CA O 0 0.07432270795106888
module O 0 0.09081915766000748
. O 0 0.02547748014330864

Reintroduced O 0 0.40634986758232117
wild O 0 0.31998491287231445
- O 1 0.6303750872612
type O 1 0.7238040566444397
VHL B-Disease 1 0.9628849029541016
strongly O 0 0.039349064230918884
inhibited O 0 0.45276111364364624
the O 0 0.008001820184290409
overexpression O 1 0.5798041820526123
of O 0 0.005883184727281332
the O 0 0.009172365069389343
CA12 O 1 0.9016079306602478
gene O 1 0.9561490416526794
in O 0 0.01879899390041828
the O 0 0.06877529621124268
parental O 1 0.9858502745628357
renal B-Disease 1 0.9975525736808777
cell I-Disease 1 0.9916715025901794
carcinoma I-Disease 1 0.9961718916893005
cell O 1 0.952521800994873
lines O 0 0.2703928053379059
. O 0 0.04583151638507843

Similar O 0 0.028513822704553604
results O 0 0.01836552284657955
were O 0 0.005918100010603666
obtained O 0 0.00956758763641119
with O 0 0.00901810172945261
CA9 O 1 0.8304605484008789
, O 0 0.007783567067235708
encoding O 0 0.16887781023979187
another O 0 0.015078533440828323
transmembrane O 0 0.4953540563583374
CA O 0 0.024720799177885056
with O 0 0.005738976411521435
an O 0 0.007806915789842606
intact O 0 0.10273002833127975
catalytic O 1 0.5869482755661011
domain O 0 0.1345658153295517
. O 0 0.025566264986991882

Although O 0 0.021978531032800674
both O 0 0.011495782993733883
domains O 0 0.027174172922968864
of O 0 0.006336458958685398
the O 0 0.010342101566493511
VHL B-Disease 1 0.9742882251739502
protein O 1 0.692508339881897
contribute O 0 0.03470814228057861
to O 0 0.005524950567632914
regulation O 0 0.023883335292339325
of O 0 0.005640937481075525
CA12 O 0 0.3407905399799347
expression O 0 0.04140229895710945
, O 0 0.004557749256491661
the O 0 0.005037540104240179
elongin O 0 0.3135690689086914
binding O 0 0.15626351535320282
domain O 0 0.076996810734272
alone O 0 0.019095255061984062
could O 0 0.011423409916460514
effectively O 0 0.0819532573223114
regulate O 1 0.7354889512062073
CA9 O 1 0.9429710507392883
expression O 0 0.3592830300331116
. O 0 0.03634138032793999

We O 0 0.027490099892020226
mapped O 0 0.05749162286520004
CA12 O 0 0.38517048954963684
and O 0 0.02608020231127739
CA9 O 1 0.9197352528572083
loci O 1 0.8644845485687256
to O 0 0.022674838081002235
chromosome O 1 0.929847002029419
bands O 0 0.05837441608309746
15q22 O 0 0.32887518405914307
and O 0 0.020261533558368683
17q21 O 0 0.3315420150756836
. O 0 0.033693160861730576

2 O 0 0.03159483149647713
respectively O 0 0.019333617761731148
, O 0 0.01028845552355051
regions O 0 0.03728504106402397
prone O 0 0.23636557161808014
to O 0 0.008064646273851395
amplification O 0 0.4145279824733734
in O 0 0.01012385357171297
some O 0 0.014861099421977997
human O 1 0.5910093188285828
cancers B-Disease 1 0.9879911541938782
. O 0 0.0766838937997818

Additional O 0 0.024914568290114403
experiments O 0 0.02127654291689396
are O 0 0.005874760448932648
needed O 0 0.007246382534503937
to O 0 0.003451055847108364
define O 0 0.007439255248755217
the O 0 0.003485526889562607
role O 0 0.0069025433622300625
of O 0 0.004164679441601038
CA O 0 0.04181545227766037
IX O 0 0.35599446296691895
and O 0 0.005064013879746199
CA O 0 0.060546692460775375
XII O 0 0.393048495054245
enzymes O 0 0.3790178894996643
in O 0 0.003954509273171425
the O 0 0.0035291353706270456
regulation O 0 0.02039824239909649
of O 0 0.004006857052445412
pH O 1 0.5796977877616882
in O 0 0.004635083023458719
the O 0 0.005999863613396883
extracellular O 1 0.7538569569587708
microenvironment O 1 0.8615962862968445
and O 0 0.005282471422106028
its O 0 0.006195631809532642
potential O 0 0.11607655882835388
impact O 0 0.1987425535917282
on O 0 0.049975570291280746
cancer B-Disease 1 0.9948411583900452
cell O 1 0.946956217288971
growth O 1 0.5115956664085388
. O 0 0.037421293556690216

A O 0 0.06739497184753418
gene O 1 0.8556787967681885
encoding O 0 0.3431253433227539
a O 0 0.03144468367099762
transmembrane O 1 0.8775395750999451
protein O 1 0.9302651286125183
is O 0 0.12771901488304138
mutated O 1 0.9847275018692017
in O 0 0.42626237869262695
patients O 1 0.9943680167198181
with O 1 0.8773326873779297
diabetes B-Disease 1 0.998689591884613
mellitus I-Disease 1 0.9952762126922607
and O 1 0.6927313208580017
optic B-Disease 1 0.9938080906867981
atrophy I-Disease 1 0.9930012226104736
( O 1 0.9361686110496521
Wolfram B-Disease 1 0.9864184260368347
syndrome I-Disease 1 0.9950529932975769
) O 0 0.20850485563278198
. O 0 0.04381297156214714

Wolfram B-Disease 1 0.9672983884811401
syndrome I-Disease 1 0.9931586384773254
( O 1 0.7153661251068115
WFS B-Disease 1 0.9613342881202698
; O 0 0.45805835723876953
OMIM O 1 0.9777997732162476
222300 O 1 0.8637005686759949
) O 0 0.11678557097911835
is O 0 0.08166228979825974
an O 1 0.6188076138496399
autosomal B-Disease 1 0.9986801743507385
recessive I-Disease 1 0.9988613128662109
neurodegenerative I-Disease 1 0.9984442591667175
disorder I-Disease 1 0.996577799320221
defined O 0 0.49962419271469116
by O 0 0.07078853249549866
young O 1 0.7233096361160278
- O 1 0.9740894436836243
onset O 1 0.9961275458335876
non O 1 0.9666310548782349
- O 1 0.9885514974594116
immune O 1 0.9976020455360413
insulin B-Disease 1 0.9952894449234009
- I-Disease 1 0.9825663566589355
dependent I-Disease 1 0.9828774929046631
diabetes I-Disease 1 0.9981070756912231
mellitus I-Disease 1 0.9915778636932373
and O 0 0.23273736238479614
progressive O 1 0.9463136792182922
optic B-Disease 1 0.9809665679931641
atrophy I-Disease 1 0.9729568362236023
. O 0 0.09598283469676971

Linkage O 0 0.21301287412643433
to O 0 0.023304684087634087
markers O 0 0.13287879526615143
on O 0 0.01655999943614006
chromosome O 1 0.9441039562225342
4p O 0 0.49067598581314087
was O 0 0.010635724291205406
confirmed O 0 0.014499866403639317
in O 0 0.00751775037497282
five O 0 0.01115622092038393
families O 0 0.030554059892892838
. O 0 0.022018376737833023

On O 0 0.01272345520555973
the O 0 0.009502088651061058
basis O 0 0.010862857103347778
of O 0 0.010117118246853352
meiotic O 1 0.9703646302223206
recombinants O 1 0.9310663342475891
and O 0 0.21508987247943878
disease O 1 0.9964459538459778
- O 1 0.8553377985954285
associated O 1 0.5735531449317932
haplotypes O 1 0.9477812647819519
, O 0 0.010857677087187767
the O 0 0.015276993624866009
WFS B-Disease 1 0.9691160917282104
gene O 1 0.9342958331108093
was O 0 0.01227398682385683
localized O 1 0.5215868949890137
to O 0 0.006817820016294718
a O 0 0.022298449650406837
BAC O 1 0.9145828485488892
/ O 0 0.47327110171318054
P1 O 1 0.5025874376296997
contig O 0 0.17244049906730652
of O 0 0.006149992812424898
less O 0 0.00918104499578476
than O 0 0.00878722034394741
250 O 0 0.022955210879445076
kb O 0 0.17708487808704376
. O 0 0.028816822916269302

Mutations O 1 0.9312005043029785
in O 0 0.01974954828619957
a O 0 0.021213727071881294
novel O 0 0.38952845335006714
gene O 1 0.959048330783844
( O 0 0.06041296571493149
WFS1 O 1 0.5904068350791931
) O 0 0.02005854621529579
encoding O 0 0.16276058554649353
a O 0 0.011716771870851517
putative O 1 0.717163622379303
transmembrane O 1 0.6827977299690247
protein O 0 0.24277852475643158
were O 0 0.003354541724547744
found O 0 0.004155069589614868
in O 0 0.0026557319797575474
all O 0 0.0023878123611211777
affected O 0 0.046447381377220154
individuals O 0 0.01414454635232687
in O 0 0.004226840566843748
six O 0 0.014842841774225235
WFS B-Disease 1 0.9173119068145752
families O 0 0.026316678151488304
, O 0 0.0042313262820243835
and O 0 0.0032110754400491714
these O 0 0.007412186358124018
mutations O 1 0.932781457901001
were O 0 0.005281288642436266
associated O 0 0.06381024420261383
with O 0 0.018208930268883705
the O 0 0.11098407208919525
disease O 1 0.9957786798477173
phenotype O 1 0.985813319683075
. O 0 0.07911699265241623

WFS1 O 0 0.4368615448474884
appears O 0 0.03353645280003548
to O 0 0.009533789940178394
function O 0 0.029335547238588333
in O 0 0.00834339763969183
survival O 0 0.3458021581172943
of O 0 0.01218600757420063
islet O 1 0.9532665014266968
beta O 1 0.9139874577522278
- O 1 0.7942129373550415
cells O 1 0.9301273226737976
and O 0 0.015182003378868103
neurons O 1 0.7457050681114197
. O 0 0.01829499751329422
. O 0 0.019550452008843422

Stable O 0 0.14319159090518951
interaction O 0 0.03269301727414131
between O 0 0.009853656403720379
the O 0 0.0056434497237205505
products O 0 0.01386274117976427
of O 0 0.006354432087391615
the O 0 0.03864751756191254
BRCA1 O 1 0.9940920472145081
and O 1 0.553081214427948
BRCA2 O 1 0.9977163076400757
tumor B-Disease 1 0.997373104095459
suppressor O 1 0.9898375272750854
genes O 1 0.9693523049354553
in O 0 0.0536123663187027
mitotic O 1 0.9009503126144409
and O 0 0.043295133858919144
meiotic O 1 0.9699239134788513
cells O 1 0.93121737241745
. O 0 0.053960926830768585

BRCA1 O 1 0.9570918679237366
and O 0 0.030934449285268784
BRCA2 O 1 0.9554756283760071
account O 0 0.017204759642481804
for O 0 0.007631920278072357
most O 0 0.00747236842289567
cases O 0 0.1104058027267456
of O 0 0.018562976270914078
familial O 1 0.9885802865028381
, O 0 0.07221229374408722
early O 1 0.596122145652771
onset O 1 0.9972579479217529
breast B-Disease 1 0.9976951479911804
and I-Disease 0 0.2198811173439026
/ I-Disease 1 0.9756675362586975
or I-Disease 1 0.8513252139091492
ovarian I-Disease 1 0.9987326264381409
cancer I-Disease 1 0.9955295920372009
and O 0 0.011616378091275692
encode O 0 0.11878077685832977
products O 0 0.02289584092795849
that O 0 0.005731882061809301
each O 0 0.007584818173199892
interact O 0 0.08465045690536499
with O 0 0.0165020152926445
hRAD51 O 1 0.526452362537384
. O 0 0.026103829964995384

Results O 0 0.030544735491275787
presented O 0 0.015810605138540268
here O 0 0.007743971887975931
show O 0 0.010499543510377407
that O 0 0.010578202083706856
BRCA1 O 1 0.9816842675209045
and O 0 0.021001413464546204
BRCA2 O 1 0.9842861294746399
coexist O 0 0.21628862619400024
in O 0 0.0066861179657280445
a O 0 0.010245883837342262
biochemical O 1 0.5161162614822388
complex O 0 0.037287771701812744
and O 0 0.006458503659814596
colocalize O 0 0.30849689245224
in O 0 0.0117079121991992
subnuclear O 1 0.698206901550293
foci O 1 0.8549579381942749
in O 0 0.022124603390693665
somatic O 1 0.9493699073791504
cells O 1 0.7102252244949341
and O 0 0.004399651661515236
on O 0 0.0032242550514638424
the O 0 0.00453729834407568
axial O 0 0.1643119752407074
elements O 0 0.012997237965464592
of O 0 0.00856216624379158
developing O 0 0.26230406761169434
synaptonemal O 1 0.6689189672470093
complexes O 0 0.45091795921325684
. O 0 0.03241750970482826

Like O 0 0.1095670536160469
BRCA1 O 1 0.9430578351020813
and O 0 0.03449883311986923
RAD51 O 1 0.9027578234672546
, O 0 0.042067527770996094
BRCA2 O 1 0.9746181964874268
relocates O 1 0.5724276900291443
to O 0 0.028429999947547913
PCNA O 1 0.9496781826019287
+ O 1 0.767192542552948
replication O 1 0.760009229183197
sites O 0 0.016727322712540627
following O 0 0.016950801014900208
exposure O 0 0.4102077782154083
of O 0 0.00889829732477665
S O 0 0.4978015124797821
phase O 1 0.6622322797775269
cells O 1 0.9246709942817688
to O 0 0.02367776446044445
hydroxyurea O 1 0.9610289931297302
or O 0 0.1639508605003357
UV O 1 0.9436867237091064
irradiation O 1 0.7058922648429871
. O 0 0.03826116397976875

Thus O 0 0.05059310793876648
, O 0 0.02837875671684742
BRCA1 O 1 0.9651005864143372
and O 0 0.013373784720897675
BRCA2 O 1 0.9487059712409973
participate O 0 0.011048439890146255
, O 0 0.0048211622051894665
together O 0 0.004459553863853216
, O 0 0.00330414273776114
in O 0 0.0037162175867706537
a O 0 0.009515323676168919
pathway O 1 0.81092768907547
( O 0 0.03684190288186073
s O 0 0.11946123838424683
) O 0 0.009846624918282032
associated O 0 0.01403865497559309
with O 0 0.003148468676954508
the O 0 0.0034207075368613005
activation O 0 0.3158973455429077
of O 0 0.005140616092830896
double O 0 0.13295389711856842
- O 0 0.4495193660259247
strand O 1 0.6518517136573792
break O 0 0.1412021368741989
repair O 1 0.5621556639671326
and O 0 0.011403593234717846
/ O 0 0.4052407145500183
or O 0 0.061480652540922165
homologous O 1 0.9477694630622864
recombination O 1 0.9110959768295288
. O 0 0.041374579071998596

Dysfunction O 1 0.9404371380805969
of O 0 0.012077732011675835
this O 0 0.009351563639938831
pathway O 0 0.39934852719306946
may O 0 0.008113311603665352
be O 0 0.0032451797742396593
a O 0 0.003923506010323763
general O 0 0.003867852734401822
phenomenon O 0 0.04923905432224274
in O 0 0.0027611099649220705
the O 0 0.00276010949164629
majority O 0 0.008520725183188915
of O 0 0.0051369983702898026
cases O 0 0.3382910490036011
of O 0 0.09041796624660492
hereditary B-Disease 1 0.9951240420341492
breast I-Disease 1 0.997631311416626
and I-Disease 0 0.2616503834724426
/ I-Disease 1 0.9788621664047241
or I-Disease 1 0.9153433442115784
ovarian I-Disease 1 0.9985118508338928
cancer I-Disease 1 0.9955512285232544
. O 0 0.0718737244606018
. O 0 0.03485272452235222

A O 0 0.04561615735292435
novel O 0 0.15650007128715515
Arg362Ser O 1 0.710189938545227
mutation O 1 0.9237346649169922
in O 0 0.01581193506717682
the O 0 0.01480452623218298
sterol O 1 0.9026464819908142
27 O 0 0.17508386075496674
- O 1 0.7899312973022461
hydroxylase O 1 0.9684171080589294
gene O 1 0.973015308380127
( O 0 0.10765630751848221
CYP27 O 1 0.5521181225776672
) O 0 0.009634098038077354
: O 0 0.0055069285444915295
its O 0 0.004631408024579287
effects O 0 0.08614322543144226
on O 0 0.006091617979109287
pre O 0 0.11397077888250351
- O 0 0.2667470872402191
mRNA O 1 0.6039061546325684
splicing O 1 0.7847005128860474
and O 0 0.015270697884261608
enzyme O 1 0.8167481422424316
activity O 0 0.09392447769641876
. O 0 0.02561410330235958

A O 0 0.03889722004532814
novel O 0 0.07332412898540497
C O 0 0.043631527572870255
to O 0 0.007725752890110016
A O 0 0.0133921317756176
mutation O 1 0.8525427579879761
in O 0 0.0077929189428687096
the O 0 0.00979410856962204
sterol O 1 0.9149700403213501
27 O 0 0.2170598953962326
- O 1 0.8279566764831543
hydroxylase O 1 0.9796642065048218
gene O 1 0.9802061319351196
( O 0 0.13012796640396118
CYP27 O 1 0.515813946723938
) O 0 0.012179071083664894
was O 0 0.004361193161457777
identified O 0 0.010722706094384193
by O 0 0.008273334242403507
sequencing O 1 0.5360232591629028
amplified O 1 0.7763104438781738
CYP27 O 1 0.9320653676986694
gene O 1 0.9495722055435181
products O 0 0.09158164262771606
from O 0 0.01281855907291174
a O 0 0.04229488968849182
patient O 1 0.902340829372406
with O 0 0.05410750210285187
cerebrotendinous B-Disease 1 0.9287941455841064
xanthomatosis I-Disease 1 0.9253260493278503
( O 0 0.2282313108444214
CTX B-Disease 1 0.9325881600379944
) O 0 0.05057327821850777
. O 0 0.02790287509560585

The O 0 0.03422375023365021
mutation O 1 0.8438714742660522
changed O 0 0.021813636645674706
the O 0 0.011020734906196594
adrenodoxin O 0 0.38335296511650085
cofactor O 0 0.49675652384757996
binding O 0 0.1753634214401245
residue O 0 0.29569998383522034
362Arg O 0 0.3671625554561615
to O 0 0.011009370908141136
362Ser O 0 0.46381497383117676
( O 0 0.05571289733052254
CGT O 1 0.5546894669532776
362Arg O 1 0.5361135601997375
to O 0 0.016553595662117004
AGT O 1 0.9685989022254944
362Ser O 1 0.606523334980011
) O 0 0.011655235663056374
, O 0 0.004313270561397076
and O 0 0.0029857205227017403
was O 0 0.0032981806434690952
responsible O 0 0.020011702552437782
for O 0 0.012001072987914085
deficiency O 1 0.9904218912124634
in O 0 0.007818811573088169
the O 0 0.009629104286432266
sterol O 1 0.9237374663352966
27 O 0 0.1131482943892479
- O 1 0.5360490083694458
hydroxylase O 1 0.8622657060623169
activity O 0 0.026331672444939613
, O 0 0.004572542384266853
as O 0 0.004069034475833178
confirmed O 0 0.008117133751511574
by O 0 0.005849217996001244
expression O 0 0.028925718739628792
of O 0 0.00794487725943327
mutant O 1 0.755651593208313
cDNA O 1 0.5639525651931763
into O 0 0.03804885596036911
COS O 1 0.8485089540481567
- O 0 0.41908228397369385
1 O 0 0.07279618829488754
cells O 1 0.8907773494720459
. O 0 0.033558160066604614

Quantitative O 0 0.06523176282644272
analysis O 0 0.02129598706960678
showed O 0 0.012188544496893883
that O 0 0.005564553197473288
the O 0 0.005079444032162428
expression O 0 0.02481839992105961
of O 0 0.007358619477599859
CYP27 O 1 0.8074929118156433
gene O 1 0.9424353837966919
mRNA O 0 0.3363281190395355
in O 0 0.007549113128334284
the O 0 0.006918297149240971
patient O 1 0.5279954075813293
represented O 0 0.01643313281238079
52 O 0 0.03721855953335762
. O 0 0.022337449714541435

5 O 0 0.029689719900488853
% O 0 0.015442661009728909
of O 0 0.007680302951484919
the O 0 0.008242608979344368
normal O 0 0.03142060339450836
level O 0 0.021181287243962288
. O 0 0.023594480007886887

As O 0 0.020642483606934547
the O 0 0.016344435513019562
mutation O 1 0.8844823241233826
occurred O 0 0.01889234408736229
at O 0 0.0062025850638747215
the O 0 0.005455498583614826
penultimate O 0 0.2493125945329666
nucleotide O 0 0.41593867540359497
of O 0 0.009337788447737694
exon O 1 0.5078355073928833
6 O 0 0.023753806948661804
( O 0 0.020858829841017723
- O 0 0.025833794847130775
2 O 0 0.00685169966891408
position O 0 0.005102073773741722
of O 0 0.005216986872255802
exon O 0 0.443734735250473
6 O 0 0.04619770124554634
- O 0 0.3157881200313568
intron O 1 0.9154466986656189
6 O 0 0.029182681813836098
splice O 1 0.6145259737968445
site O 0 0.01204762514680624
) O 0 0.005403778050094843
of O 0 0.0025232259649783373
the O 0 0.00400644913315773
gene O 1 0.7146911025047302
, O 0 0.003392271464690566
we O 0 0.003020390635356307
hypothesized O 0 0.1213056668639183
that O 0 0.0032371541019529104
the O 0 0.006777232512831688
mutation O 1 0.9794977903366089
may O 0 0.047125644981861115
partially O 0 0.14754222333431244
affect O 0 0.050337858498096466
the O 0 0.00545002706348896
normal O 0 0.12094447761774063
splicing O 1 0.6735401153564453
efficiency O 0 0.0572950541973114
in O 0 0.010050280950963497
exon O 0 0.47467997670173645
6 O 0 0.01281854696571827
and O 0 0.00555705139413476
cause O 0 0.37602686882019043
alternative O 0 0.0647241398692131
splicing O 1 0.6654168367385864
elsewhere O 0 0.012250400148332119
, O 0 0.004401118028908968
which O 0 0.003725982503965497
resulted O 0 0.02352408692240715
in O 0 0.006317842286080122
decreased O 0 0.3039966821670532
transcript O 0 0.11830203235149384
in O 0 0.008105501532554626
the O 0 0.011116565205156803
patient O 1 0.790730357170105
. O 0 0.03396431729197502

Transfection O 0 0.49834856390953064
of O 0 0.018228527158498764
constructed O 0 0.020404573529958725
minigenes O 0 0.1853800266981125
, O 0 0.005931316874921322
with O 0 0.004294836428016424
or O 0 0.005499673541635275
without O 0 0.005926973652094603
the O 0 0.005771902855485678
mutation O 1 0.915280282497406
, O 0 0.006647211965173483
into O 0 0.011116120032966137
COS O 1 0.8439919352531433
- O 0 0.3338257968425751
1 O 0 0.04546650871634483
cells O 1 0.8096010684967041
confirmed O 0 0.013970513828098774
that O 0 0.0033885736484080553
the O 0 0.004418174736201763
mutant O 1 0.5950223803520203
minigene O 0 0.26830631494522095
was O 0 0.005277176853269339
responsible O 0 0.008963646367192268
for O 0 0.004360835067927837
a O 0 0.008255384862422943
mRNA O 0 0.41627374291419983
species O 0 0.12530311942100525
alternatively O 0 0.24840177595615387
spliced O 0 0.4966859519481659
at O 0 0.008342782035470009
an O 0 0.00937327928841114
activated O 0 0.2824471890926361
cryptic O 0 0.3172703981399536
5 O 0 0.01367978472262621
splice O 0 0.2741113603115082
site O 0 0.010075926780700684
88 O 0 0.014941918663680553
bp O 0 0.024787159636616707
upstream O 0 0.01740618795156479
from O 0 0.005327874328941107
the O 0 0.004002263769507408
3 O 0 0.007363392040133476
end O 0 0.007428077049553394
of O 0 0.007698917295783758
exon O 0 0.3478858470916748
6 O 0 0.027479583397507668
. O 0 0.0221554022282362

Our O 0 0.01727200299501419
data O 0 0.010620745830237865
suggest O 0 0.010682574473321438
that O 0 0.0038141696713864803
the O 0 0.003701809560880065
C O 0 0.021060002967715263
to O 0 0.0038820288609713316
A O 0 0.009021395817399025
mutation O 1 0.8387829065322876
at O 0 0.004178217146545649
the O 0 0.004422463942319155
penultimate O 0 0.16156531870365143
nucleotide O 0 0.37978336215019226
of O 0 0.006829097401350737
exon O 0 0.374490886926651
6 O 0 0.008035904727876186
of O 0 0.004166057799011469
the O 0 0.0065629067830741405
CYP27 O 1 0.8386803269386292
gene O 1 0.9054078459739685
not O 0 0.0053990972228348255
only O 0 0.006954604759812355
causes O 1 0.8459694981575012
the O 0 0.03361039236187935
deficiency B-Disease 1 0.9938894510269165
in I-Disease 0 0.008783367462456226
the I-Disease 0 0.010376805439591408
sterol I-Disease 1 0.913853645324707
27 I-Disease 0 0.10663356631994247
- I-Disease 0 0.4876345694065094
hydroxylase I-Disease 1 0.8554111123085022
activity I-Disease 0 0.0321517251431942
, O 0 0.0041531953029334545
but O 0 0.0028610508888959885
also O 0 0.0030463659204542637
partially O 0 0.018000300973653793
leads O 0 0.01122074481099844
to O 0 0.003676014021039009
alternative O 0 0.030318601056933403
pre O 0 0.12100164592266083
- O 0 0.1824331134557724
mRNA O 0 0.3651273846626282
splicing O 0 0.45881927013397217
of O 0 0.008510377258062363
the O 0 0.014582975767552853
gene O 1 0.8906393647193909
. O 0 0.03258224204182625

To O 0 0.010581077076494694
our O 0 0.008219028823077679
knowledge O 0 0.007614393252879381
, O 0 0.003403778886422515
this O 0 0.0022900693584233522
is O 0 0.0019298457773402333
the O 0 0.0018233053851872683
first O 0 0.0026793975848704576
report O 0 0.0038676010444760323
regarding O 0 0.006788478698581457
effects O 0 0.13862986862659454
on O 0 0.004087101202458143
pre O 0 0.08902457356452942
- O 0 0.18673056364059448
mRNA O 0 0.4187822639942169
splicing O 0 0.4671049118041992
of O 0 0.004660844802856445
a O 0 0.011284162290394306
mutation O 1 0.8600297570228577
at O 0 0.004828649573028088
the O 0 0.0042845443822443485
- O 0 0.020829498767852783
2 O 0 0.004906360525637865
position O 0 0.0041180760599672794
of O 0 0.0035997319500893354
a O 0 0.007854060269892216
5 O 0 0.013870338909327984
splice O 0 0.4823126196861267
site O 0 0.02466084435582161
. O 0 0.021407801657915115

ATM O 1 0.8657950758934021
germline O 1 0.9572052359580994
mutations O 1 0.9630244970321655
in O 0 0.07345357537269592
classical O 1 0.7379052042961121
ataxia B-Disease 1 0.9957283139228821
- I-Disease 1 0.974570095539093
telangiectasia I-Disease 1 0.9926915764808655
patients O 1 0.9543969631195068
in O 0 0.013937125913798809
the O 0 0.010773777961730957
Dutch O 0 0.05091583728790283
population O 0 0.04602161422371864
. O 0 0.026515847072005272

Germline O 1 0.9551456570625305
mutations O 1 0.9399281740188599
in O 0 0.01714390330016613
the O 0 0.013640452176332474
ATM O 1 0.623440682888031
gene O 1 0.8618162870407104
are O 0 0.008453086018562317
responsible O 0 0.047455672174692154
for O 0 0.040131326764822006
the O 1 0.6023907661437988
autosomal B-Disease 1 0.9990063309669495
recessive I-Disease 1 0.999153733253479
disorder I-Disease 1 0.9991469383239746
ataxia B-Disease 1 0.9979660511016846
- I-Disease 1 0.9847396612167358
telangiectasia I-Disease 1 0.9913643598556519
( O 0 0.3923615515232086
A B-Disease 0 0.2312629520893097
- I-Disease 1 0.7590130567550659
T I-Disease 1 0.9231515526771545
) O 0 0.0492316409945488
. O 0 0.02564164623618126

In O 0 0.014530716463923454
our O 0 0.009022061713039875
study O 0 0.008972293697297573
, O 0 0.0035157972015440464
we O 0 0.002505787182599306
have O 0 0.0026144373696297407
determined O 0 0.005288221873342991
the O 0 0.0049345772713422775
ATM O 0 0.4736708104610443
mutation O 1 0.9709171652793884
spectrum O 0 0.11319040507078171
in O 0 0.005907113663852215
19 O 0 0.011659795418381691
classical O 0 0.04094688221812248
A B-Disease 0 0.20115520060062408
- I-Disease 1 0.905241847038269
T I-Disease 1 0.9891096353530884
patients O 1 0.9661376476287842
, O 0 0.003993054386228323
including O 0 0.003761409316211939
some O 0 0.0034194914624094963
immigrant O 0 0.08002140372991562
populations O 0 0.11223721504211426
, O 0 0.0030383376870304346
as O 0 0.0024227199610322714
well O 0 0.0026210618671029806
as O 0 0.0026896155904978514
12 O 0 0.004577295389026403
of O 0 0.004124097991734743
Dutch O 0 0.015194532461464405
ethnic O 0 0.020727623254060745
origin O 0 0.035977136343717575
. O 0 0.01994914375245571

Both O 0 0.0204468946903944
the O 0 0.01269019115716219
protein O 0 0.46575722098350525
truncation O 1 0.5250405669212341
test O 0 0.04020022600889206
( O 0 0.019603103399276733
PTT O 0 0.047733746469020844
) O 0 0.007639505434781313
and O 0 0.0035175117664039135
the O 0 0.004848132375627756
restriction O 0 0.12656569480895996
endonuclease O 1 0.8921270370483398
fingerprinting O 0 0.3858222961425781
( O 0 0.034454595297575
REF O 0 0.38897088170051575
) O 0 0.007172234822064638
method O 0 0.006922963075339794
were O 0 0.002189400140196085
used O 0 0.002816220745444298
and O 0 0.0020110425539314747
compared O 0 0.00547071686014533
for O 0 0.002852673875167966
their O 0 0.0038681174628436565
detection O 0 0.24832120537757874
efficiency O 0 0.026900069788098335
, O 0 0.004917570855468512
identifying O 0 0.029706349596381187
76 O 0 0.010861304588615894
% O 0 0.005717535503208637
and O 0 0.0027555194683372974
60 O 0 0.005376965738832951
% O 0 0.005424570757895708
of O 0 0.004053957294672728
the O 0 0.0064981370232999325
mutations O 1 0.9511180520057678
, O 0 0.009654720313847065
respectively O 0 0.01736348122358322
. O 0 0.018889686092734337

Most O 0 0.03476273640990257
patients O 1 0.6536900401115417
were O 0 0.00806089024990797
found O 0 0.009479210712015629
to O 0 0.006832938641309738
be O 0 0.007386878132820129
compound O 0 0.07339135557413101
heterozygote O 1 0.8089455366134644
. O 0 0.027768805623054504

Seventeen O 0 0.058682724833488464
mutations O 1 0.7457560896873474
were O 0 0.00850297324359417
distinct O 0 0.01578311063349247
, O 0 0.004412001930177212
of O 0 0.0029843526426702738
which O 0 0.0026582502759993076
10 O 0 0.0037503435742110014
were O 0 0.0026974112261086702
not O 0 0.0037811098154634237
reported O 0 0.009505877271294594
previously O 0 0.012182950042188168
. O 0 0.014251931570470333

Mutations O 1 0.8955879807472229
are O 0 0.016875550150871277
small O 0 0.02442077361047268
deletions O 0 0.4512743353843689
or O 0 0.018391568213701248
point O 0 0.019534675404429436
mutations O 1 0.968579113483429
frequently O 0 0.09220811724662781
affecting O 1 0.5788792967796326
splice O 1 0.6935707926750183
sites O 0 0.03752410411834717
. O 0 0.030939165502786636

Moreover O 0 0.05659809336066246
, O 0 0.019443251192569733
a O 0 0.023424478247761726
16 O 0 0.03027973882853985
. O 0 0.025975022464990616

7 O 0 0.05327989533543587
- O 0 0.22023113071918488
kb O 0 0.4969336986541748
genomic O 1 0.8085456490516663
deletion O 0 0.31124937534332275
of O 0 0.00494168559089303
the O 0 0.00380248692817986
3 O 0 0.004560103639960289
end O 0 0.0035705817863345146
of O 0 0.002514544641599059
the O 0 0.0038753540720790625
gene O 1 0.7326498627662659
, O 0 0.0028090043924748898
most O 0 0.0024851723574101925
likely O 0 0.005260954611003399
a O 0 0.003676151856780052
result O 0 0.009944969788193703
of O 0 0.0037134606391191483
recombination O 1 0.5310430526733398
between O 0 0.004823478404432535
two O 0 0.00357065349817276
LINE O 0 0.006604599300771952
elements O 0 0.007632795255631208
, O 0 0.005033664871007204
was O 0 0.00643910001963377
identified O 0 0.023832576349377632
. O 0 0.018441742286086082

The O 0 0.015965569764375687
most O 0 0.012283933348953724
frequently O 0 0.022288959473371506
found O 0 0.053230758756399155
mutation O 1 0.9475430250167847
, O 0 0.006886780261993408
identified O 0 0.010269851423799992
in O 0 0.0038733482360839844
three O 0 0.004798624664545059
unrelated O 0 0.1957552134990692
Turkish O 0 0.027703961357474327
A B-Disease 0 0.06550908833742142
- I-Disease 1 0.5106306672096252
T I-Disease 1 0.8596516251564026
individuals O 0 0.025908570736646652
, O 0 0.003308643354102969
was O 0 0.002346920548006892
previously O 0 0.003763825399801135
described O 0 0.004770474974066019
to O 0 0.002168570877984166
be O 0 0.0021454717498272657
a O 0 0.004760310053825378
Turkish O 0 0.015237569808959961
A B-Disease 0 0.053811732679605484
- I-Disease 1 0.6598902344703674
T I-Disease 1 0.9595943689346313
founder O 1 0.6059305667877197
mutation O 1 0.9731321334838867
. O 0 0.04166413098573685

The O 0 0.013991478830575943
presence O 0 0.016381796449422836
of O 0 0.006786144804209471
a O 0 0.009943411685526371
founder O 0 0.1186140701174736
mutation O 1 0.9460447430610657
among O 0 0.009937901049852371
relatively O 0 0.015327110886573792
small O 0 0.0059454613365232944
ethnic O 0 0.008830277249217033
population O 0 0.007639786694198847
groups O 0 0.004600959829986095
in O 0 0.0027933469973504543
Western O 0 0.0045221056789159775
Europe O 0 0.0048346794210374355
could O 0 0.0036314858589321375
indicate O 0 0.008733847178518772
a O 0 0.0052167195826768875
high O 0 0.008661266416311264
carrier O 0 0.07243893295526505
frequency O 0 0.029251625761389732
in O 0 0.0059488918632268906
such O 0 0.009232458658516407
communities O 0 0.029127424582839012
. O 0 0.02090098336338997

In O 0 0.028429236263036728
patients O 1 0.5344504117965698
of O 0 0.008320648223161697
Dutch O 0 0.016798770055174828
ethnic O 0 0.013387683779001236
origin O 0 0.011504102498292923
, O 0 0.0036416309885680676
however O 0 0.003565330058336258
, O 0 0.0027571162208914757
no O 0 0.003333891974762082
significant O 0 0.009028679691255093
founder O 0 0.025498289614915848
effect O 0 0.03803551197052002
could O 0 0.006089074537158012
be O 0 0.005229719448834658
identified O 0 0.026777109131217003
. O 0 0.016653744503855705

The O 0 0.02648242749273777
observed O 0 0.10190077871084213
genetic O 1 0.8117777109146118
heterogeneity O 0 0.2855539321899414
including O 0 0.008716647513210773
the O 0 0.005119044333696365
relative O 0 0.012263256125152111
high O 0 0.007618213538080454
percentage O 0 0.013453952036798
of O 0 0.006396573502570391
splice O 1 0.8394590616226196
- O 0 0.283448189496994
site O 0 0.03057171031832695
mutations O 1 0.9205250144004822
had O 0 0.0074572185985744
no O 0 0.0057411398738622665
reflection O 0 0.013390039093792439
on O 0 0.006464913487434387
the O 0 0.0130327632650733
phenotype O 1 0.9515571594238281
. O 0 0.03223056718707085

All O 0 0.026220662519335747
patients O 1 0.9056004881858826
manifested O 0 0.39399683475494385
classical O 0 0.04760425165295601
A B-Disease 0 0.06039625033736229
- I-Disease 0 0.4566439688205719
T I-Disease 1 0.7896918058395386
and O 0 0.011732088401913643
increased O 0 0.07816200703382492
cellular O 1 0.6969304084777832
radioresistant O 1 0.7819535136222839
DNA O 1 0.7667611241340637
synthesis O 1 0.5629258155822754
. O 0 0.03745798021554947

Determination O 0 0.026925956830382347
of O 0 0.009990407153964043
the O 0 0.00820398423820734
genomic O 0 0.41901615262031555
structure O 0 0.01316162757575512
of O 0 0.004950336646288633
the O 0 0.007462256588041782
COL4A4 O 1 0.8206192255020142
gene O 1 0.9086177349090576
and O 0 0.010381276719272137
of O 0 0.023026801645755768
novel O 1 0.9112591743469238
mutations O 1 0.9956004619598389
causing O 1 0.9937029480934143
autosomal B-Disease 1 0.9983155727386475
recessive I-Disease 1 0.9971942901611328
Alport I-Disease 1 0.9918734431266785
syndrome I-Disease 1 0.9939703941345215
. O 0 0.23610009253025055

Autosomal B-Disease 1 0.9930785298347473
recessive I-Disease 1 0.9946862459182739
Alport I-Disease 1 0.991683840751648
syndrome I-Disease 1 0.9937909245491028
is O 0 0.057250406593084335
a O 0 0.058943260461091995
progressive O 1 0.8512405753135681
hematuric B-Disease 1 0.9696288108825684
glomerulonephritis I-Disease 1 0.989158034324646
characterized O 1 0.9293370842933655
by O 0 0.22163283824920654
glomerular B-Disease 1 0.9900398850440979
basement I-Disease 1 0.8094378113746643
membrane I-Disease 1 0.9702556133270264
abnormalities I-Disease 1 0.9910750389099121
and O 0 0.010789294727146626
associated O 0 0.0914175808429718
with O 0 0.0162825845181942
mutations O 1 0.9479461908340454
in O 0 0.00489424541592598
either O 0 0.0062135495245456696
the O 0 0.004556338768452406
COL4A3 O 0 0.38188436627388
or O 0 0.014380734413862228
the O 0 0.00779845891520381
COL4A4 O 1 0.8111913204193115
gene O 1 0.8162471652030945
, O 0 0.004950566217303276
which O 0 0.003920565824955702
encode O 0 0.021599194034934044
the O 0 0.005625101737678051
alpha3 O 0 0.4037644863128662
and O 0 0.014367303811013699
alpha4 O 1 0.8800227046012878
type O 1 0.8524784445762634
IV O 1 0.9346705079078674
collagen O 1 0.9745398163795471
chains O 0 0.2934655249118805
, O 0 0.01207161694765091
respectively O 0 0.019912365823984146
. O 0 0.018702281638979912

To O 0 0.01584649085998535
date O 0 0.018378471955657005
, O 0 0.010841671377420425
mutation O 1 0.9222102761268616
screening O 0 0.0763126090168953
in O 0 0.004612261895090342
the O 0 0.0034984461963176727
two O 0 0.004935921635478735
genes O 1 0.6866714954376221
has O 0 0.0050537777133286
been O 0 0.0046080187894403934
hampered O 0 0.08911626040935516
by O 0 0.0041783773340284824
the O 0 0.0037546432577073574
lack O 0 0.01275776419788599
of O 0 0.005876766052097082
genomic O 1 0.7965717315673828
structure O 0 0.07841475307941437
information O 0 0.018715282902121544
. O 0 0.018436377868056297

We O 0 0.01206128764897585
report O 0 0.008594679646193981
here O 0 0.004741615615785122
the O 0 0.0032442514784634113
complete O 0 0.0051208371296525
characterization O 0 0.010884083807468414
of O 0 0.002901599742472172
the O 0 0.0035128435119986534
48 O 0 0.00826324988156557
exons O 0 0.169692263007164
of O 0 0.004038211889564991
the O 0 0.006889432203024626
COL4A4 O 1 0.8700816035270691
gene O 1 0.9207630157470703
, O 0 0.006001755595207214
a O 0 0.009671463631093502
comprehensive O 0 0.2427375167608261
gene O 1 0.8891209363937378
screen O 0 0.03188258409500122
, O 0 0.0032206224277615547
and O 0 0.002156107220798731
the O 0 0.0027557173743844032
subsequent O 0 0.046664293855428696
detection O 0 0.20109352469444275
of O 0 0.004767009988427162
10 O 0 0.021614786237478256
novel O 1 0.5902965664863586
mutations O 1 0.9906578063964844
in O 0 0.09605148434638977
eight O 1 0.512876033782959
patients O 1 0.996100664138794
diagnosed O 1 0.9975666999816895
with O 1 0.9607741236686707
autosomal B-Disease 1 0.9981386661529541
recessive I-Disease 1 0.9971364736557007
Alport I-Disease 1 0.9932613968849182
syndrome I-Disease 1 0.9937102794647217
. O 0 0.27901604771614075

Furthermore O 0 0.03630462661385536
, O 0 0.009489226154983044
we O 0 0.005929784849286079
identified O 0 0.009793480858206749
a O 0 0.006844998802989721
glycine O 0 0.05975591391324997
to O 0 0.006342935375869274
alanine O 0 0.23012545704841614
substitution O 0 0.04448912665247917
in O 0 0.005255704279989004
the O 0 0.005905679892748594
collagenous O 1 0.8592955470085144
domain O 0 0.04674668610095978
that O 0 0.0037675248458981514
is O 0 0.00428604194894433
apparently O 0 0.010570264421403408
silent O 0 0.025668838992714882
in O 0 0.0052535212598741055
the O 0 0.007620542775839567
heterozygous O 1 0.8951311707496643
carriers O 0 0.3147725760936737
, O 0 0.007380839437246323
in O 0 0.007612678222358227
11 O 0 0.016337107867002487
. O 0 0.017752571031451225

5 O 0 0.022461848333477974
% O 0 0.01100741233676672
of O 0 0.004492468666285276
all O 0 0.003679052460938692
control O 0 0.00968517828732729
individuals O 0 0.0065732672810554504
, O 0 0.0024094744585454464
and O 0 0.002164756413549185
in O 0 0.0026466548442840576
one O 0 0.0033917007967829704
control O 0 0.027032770216464996
individual O 0 0.02379019185900688
homozygous O 1 0.5974321961402893
for O 0 0.007331011816859245
this O 0 0.00823924969881773
glycine O 0 0.20569011569023132
substitution O 0 0.2283051460981369
. O 0 0.027563301846385002

There O 0 0.01152554526925087
has O 0 0.005874670576304197
been O 0 0.003764444263651967
no O 0 0.0026084203273057938
previous O 0 0.003465814283117652
finding O 0 0.004473669454455376
of O 0 0.0023859709035605192
a O 0 0.004470102954655886
glycine O 0 0.1297960877418518
substitution O 0 0.039360709488391876
that O 0 0.0028612837195396423
is O 0 0.002826268319040537
not O 0 0.00268288841471076
associated O 0 0.010796288959681988
with O 0 0.004515687935054302
any O 0 0.007959656417369843
obvious O 0 0.21544712781906128
phenotype O 1 0.9770456552505493
in O 0 0.02731231413781643
homozygous O 1 0.93412846326828
individuals O 0 0.2192935049533844
. O 0 0.02924995869398117

Founder O 1 0.630098819732666
BRCA1 O 1 0.9655877351760864
and O 0 0.13372017443180084
BRCA2 O 1 0.9839695692062378
mutations O 1 0.9727335572242737
in O 0 0.04487910494208336
French O 0 0.3612525165081024
Canadian O 1 0.7645447850227356
breast B-Disease 1 0.9955782294273376
and I-Disease 1 0.6566169261932373
ovarian I-Disease 1 0.9978476762771606
cancer I-Disease 1 0.994831383228302
families O 0 0.45335447788238525
. O 0 0.07057826966047287

We O 0 0.014618690125644207
have O 0 0.010057219304144382
identified O 0 0.014282725751399994
four O 0 0.008370520547032356
mutations O 1 0.8792283535003662
in O 0 0.005937645677477121
each O 0 0.005450383294373751
of O 0 0.01020120270550251
the O 0 0.3230728507041931
breast B-Disease 1 0.9985822439193726
cancer I-Disease 1 0.9987878203392029
- O 1 0.9860434532165527
susceptibility O 1 0.9962247610092163
genes O 1 0.9916776418685913
, O 0 0.20677252113819122
BRCA1 O 1 0.9938790798187256
and O 0 0.0664374828338623
BRCA2 O 1 0.9917855858802795
, O 0 0.01324958261102438
in O 0 0.01734411157667637
French O 0 0.42771241068840027
Canadian O 1 0.916167676448822
breast B-Disease 1 0.9985154271125793
cancer I-Disease 1 0.9983229041099548
and O 1 0.9012980461120605
breast B-Disease 1 0.9984252452850342
/ I-Disease 1 0.994417667388916
ovarian I-Disease 1 0.9985151886940002
cancer I-Disease 1 0.9957196116447449
families O 0 0.287168025970459
from O 0 0.028852147981524467
Quebec O 0 0.17090468108654022
. O 0 0.03128361701965332

To O 0 0.02280382812023163
identify O 0 0.04361671954393387
founder O 0 0.03993155434727669
effects O 0 0.12760454416275024
, O 0 0.0062364935874938965
we O 0 0.0042475261725485325
examined O 0 0.02288900688290596
independently O 0 0.013757581822574139
ascertained O 0 0.14070041477680206
French O 0 0.06261182576417923
Canadian O 0 0.17956139147281647
cancer B-Disease 1 0.9844838976860046
families O 0 0.013435217551887035
for O 0 0.0036063517909497023
the O 0 0.0032906781416386366
distribution O 0 0.006591270677745342
of O 0 0.0036007538437843323
these O 0 0.006106995977461338
eight O 0 0.023026078939437866
mutations O 1 0.9658961296081543
. O 0 0.03402845561504364

Mutations O 1 0.7949020266532898
were O 0 0.014636925421655178
found O 0 0.0149004478007555
in O 0 0.008432921953499317
41 O 0 0.014865554869174957
of O 0 0.008915077894926071
97 O 0 0.02755233831703663
families O 0 0.031549420207738876
. O 0 0.024339094758033752

Six O 0 0.02142852358520031
of O 0 0.01078092958778143
eight O 0 0.014720913954079151
mutations O 1 0.8781331181526184
were O 0 0.006561522837728262
observed O 0 0.014255938120186329
at O 0 0.0073621999472379684
least O 0 0.011171233840286732
twice O 0 0.020940206944942474
. O 0 0.01814214326441288

The O 0 0.06525474041700363
BRCA1 O 1 0.9815090894699097
C4446T O 1 0.8775883316993713
mutation O 1 0.9360852241516113
was O 0 0.00794214103370905
the O 0 0.006207093130797148
most O 0 0.007808903697878122
common O 0 0.3623175024986267
mutation O 1 0.9727854132652283
found O 0 0.013706627301871777
, O 0 0.005269528366625309
followed O 0 0.011360600590705872
by O 0 0.009751287288963795
the O 0 0.03050181455910206
BRCA2 O 1 0.9901137351989746
8765delAG O 1 0.9570528864860535
mutation O 1 0.9796053171157837
. O 0 0.05860057473182678

Together O 0 0.020767664536833763
, O 0 0.008853085339069366
these O 0 0.007835110649466515
mutations O 1 0.7574915289878845
were O 0 0.003468278795480728
found O 0 0.004343470558524132
in O 0 0.0027994520496577024
28 O 0 0.004489111714065075
of O 0 0.002969693625345826
41 O 0 0.009412908926606178
families O 0 0.012041253969073296
identified O 0 0.010006681084632874
to O 0 0.003927094396203756
have O 0 0.00568561302497983
a O 0 0.018112709745764732
mutation O 1 0.9479526877403259
. O 0 0.030842309817671776

The O 0 0.016584808006882668
odds O 0 0.025070132687687874
of O 0 0.006585761439055204
detection O 0 0.02426447719335556
of O 0 0.0038320193998515606
any O 0 0.0038961826357990503
of O 0 0.0037494597490876913
the O 0 0.0057989624328911304
four O 0 0.03934098035097122
BRCA1 O 1 0.9931694269180298
mutations O 1 0.9797263145446777
was O 0 0.016297919675707817
18 O 0 0.023410296067595482
. O 0 0.021904518827795982

7x O 1 0.6114209294319153
greater O 0 0.02387457899749279
if O 0 0.007929648272693157
one O 0 0.00521881366148591
or O 0 0.006435747724026442
more O 0 0.006721677724272013
cases O 0 0.3042890727519989
of O 0 0.16196826100349426
ovarian B-Disease 1 0.998869001865387
cancer I-Disease 1 0.9950150847434998
were O 0 0.004922260530292988
also O 0 0.0038095831405371428
present O 0 0.005341236479580402
in O 0 0.004292644560337067
the O 0 0.006047800183296204
family O 0 0.03943539038300514
. O 0 0.020472541451454163

The O 0 0.01693294569849968
odds O 0 0.023005690425634384
of O 0 0.006432011257857084
detection O 0 0.029384996742010117
of O 0 0.0036614793352782726
any O 0 0.0035493168979883194
of O 0 0.0032691936939954758
the O 0 0.005209385417401791
four O 0 0.030997034162282944
BRCA2 O 1 0.9937951564788818
mutations O 1 0.9807432889938354
was O 0 0.01471626665443182
5 O 0 0.022898506373167038
. O 0 0.01924671046435833

3x O 0 0.12463580071926117
greater O 0 0.01900559663772583
if O 0 0.006580837536603212
there O 0 0.0034004352055490017
were O 0 0.0022696498781442642
at O 0 0.0031863145995885134
least O 0 0.004968948196619749
five O 0 0.008579099550843239
cases O 0 0.40186426043510437
of O 0 0.1583113819360733
breast B-Disease 1 0.9980702996253967
cancer I-Disease 1 0.9942202568054199
in O 0 0.013556906953454018
the O 0 0.011261703446507454
family O 0 0.10822971910238266
. O 0 0.028113169595599174

Interestingly O 0 0.05738869309425354
, O 0 0.012748032808303833
the O 0 0.008173084817826748
presence O 0 0.01728891208767891
of O 0 0.009931137785315514
a O 0 0.4980625808238983
breast B-Disease 1 0.9982249140739441
cancer I-Disease 1 0.9970217347145081
case O 0 0.32336345314979553
< O 1 0.6653034090995789
36 O 0 0.012407016940414906
years O 0 0.00443631736561656
of O 0 0.002888998482376337
age O 0 0.005653135944157839
was O 0 0.002915586344897747
strongly O 0 0.005764732602983713
predictive O 0 0.09903587400913239
of O 0 0.002365067368373275
the O 0 0.0024104523472487926
presence O 0 0.004803890828043222
of O 0 0.002196161076426506
any O 0 0.0027638052124530077
of O 0 0.0033365499693900347
the O 0 0.004833531565964222
eight O 0 0.02715209871530533
mutations O 1 0.9809914231300354
screened O 0 0.2925439178943634
. O 0 0.028616327792406082

Carriers O 0 0.07731401175260544
of O 0 0.008284795098006725
the O 0 0.006610781420022249
same O 0 0.012844252400100231
mutation O 1 0.9313437938690186
, O 0 0.004386243410408497
from O 0 0.003487344365566969
different O 0 0.0037171535659581423
families O 0 0.008815241046249866
, O 0 0.003447753144428134
shared O 0 0.011828086338937283
similar O 0 0.04707929119467735
haplotypes O 1 0.8754855990409851
, O 0 0.0036213963758200407
indicating O 0 0.008902334608137608
that O 0 0.0026241426821798086
the O 0 0.0036853693891316652
mutant O 1 0.68355393409729
alleles O 1 0.901358962059021
were O 0 0.00309318071231246
likely O 0 0.005074530839920044
to O 0 0.0023459529038518667
be O 0 0.0022960992064327
identical O 0 0.020566653460264206
by O 0 0.004022638313472271
descent O 0 0.03023211471736431
for O 0 0.0039005025755614042
a O 0 0.011623638682067394
mutation O 1 0.9256367683410645
in O 0 0.006977376993745565
the O 0 0.007087939418852329
founder O 0 0.04747066646814346
population O 0 0.03802004083991051
. O 0 0.022382810711860657

The O 0 0.0186811201274395
identification O 0 0.025525806471705437
of O 0 0.011642230674624443
common O 1 0.546322226524353
BRCA1 O 1 0.9925183057785034
and O 0 0.14497151970863342
BRCA2 O 1 0.9952943921089172
mutations O 1 0.9834463000297546
will O 0 0.014808611012995243
facilitate O 0 0.19247286021709442
carrier O 0 0.4525502622127533
detection O 1 0.541479229927063
in O 0 0.025890827178955078
French O 0 0.48089799284935
Canadian O 1 0.8616734147071838
breast B-Disease 1 0.9977374076843262
cancer I-Disease 1 0.9977222084999084
and O 1 0.8536732196807861
breast B-Disease 1 0.9978733062744141
/ I-Disease 1 0.9937301874160767
ovarian I-Disease 1 0.9982495903968811
cancer I-Disease 1 0.9957297444343567
families O 0 0.48703235387802124
. O 0 0.06425189226865768

Are O 0 0.029489435255527496
Dp71 O 0 0.48108646273612976
and O 0 0.03497479483485222
Dp140 O 1 0.9316753149032593
brain O 1 0.9870964288711548
dystrophin O 1 0.9767556190490723
isoforms O 1 0.9327146410942078
related O 1 0.5082157254219055
to O 0 0.03629571199417114
cognitive B-Disease 1 0.9661915302276611
impairment I-Disease 1 0.9810973405838013
in O 1 0.5354552865028381
Duchenne B-Disease 1 0.9915412068367004
muscular I-Disease 1 0.9914037585258484
dystrophy I-Disease 1 0.9900137186050415
? O 1 0.6936413645744324

Molecular O 0 0.4876748323440552
study O 0 0.03215507045388222
and O 0 0.010530427098274231
neuropsychological O 0 0.3546329438686371
analysis O 0 0.013425539247691631
were O 0 0.004428849555552006
performed O 0 0.00843881443142891
concurrently O 0 0.010212722234427929
on O 0 0.007420786190778017
49 O 0 0.3091489374637604
patients O 1 0.9875575304031372
with O 1 0.7184445858001709
Duchenne B-Disease 1 0.9973515272140503
muscular I-Disease 1 0.9975473284721375
dystrophy I-Disease 1 0.9978179931640625
( O 1 0.8729271292686462
DMD B-Disease 1 0.9913557171821594
) O 0 0.01721370592713356
in O 0 0.0043495954014360905
order O 0 0.003990018740296364
to O 0 0.002963914768770337
find O 0 0.005259884055703878
a O 0 0.005673067178577185
molecular O 0 0.3020486533641815
explanation O 0 0.02026182971894741
for O 0 0.005335334222763777
the O 0 0.010664165951311588
cognitive B-Disease 1 0.9471403360366821
impairment I-Disease 1 0.9697989821434021
observed O 0 0.23436707258224487
in O 0 0.03126544505357742
most O 0 0.22001580893993378
DMD B-Disease 1 0.9916676878929138
patients O 1 0.9780368208885193
. O 0 0.07004480063915253

Complete O 0 0.027340862900018692
analysis O 0 0.017399650067090988
of O 0 0.007167103234678507
the O 0 0.009492984041571617
dystrophin O 1 0.9533973932266235
gene O 1 0.756615936756134
was O 0 0.006031286437064409
performed O 0 0.006985669024288654
to O 0 0.003364144591614604
define O 0 0.0082504628226161
the O 0 0.0041550383903086185
localization O 0 0.05996483191847801
of O 0 0.004746727179735899
deletions O 0 0.3268482983112335
and O 0 0.0057358406484127045
duplications O 0 0.304914265871048
in O 0 0.005220071412622929
relation O 0 0.014720049686729908
to O 0 0.004619691055268049
the O 0 0.006419581361114979
different O 0 0.03732693940401077
DMD B-Disease 1 0.9809157252311707
promoters O 1 0.5783430337905884
. O 0 0.04225168749690056

Qualitative O 0 0.05018696188926697
analysis O 0 0.022561650723218918
of O 0 0.007642560638487339
the O 0 0.007463242392987013
Dp71 O 0 0.18774622678756714
transcript O 0 0.038061726838350296
and O 0 0.004723371937870979
testing O 0 0.01055944338440895
for O 0 0.003264523344114423
the O 0 0.0030598740559071302
specific O 0 0.006601881235837936
first O 0 0.004855619743466377
exon O 0 0.12444620579481125
of O 0 0.00523204542696476
Dp140 O 0 0.05355219170451164
were O 0 0.003911872394382954
also O 0 0.004636205267161131
carried O 0 0.008616012521088123
out O 0 0.011771628633141518
. O 0 0.018199220299720764

Neuropsychological O 1 0.7997859120368958
analysis O 0 0.05071378871798515
assessed O 0 0.04846126586198807
verbal O 0 0.05248578265309334
and O 0 0.013044643215835094
visuospatial O 1 0.721518874168396
intelligence O 0 0.01946798898279667
, O 0 0.007784645538777113
verbal O 0 0.02854679711163044
memory O 0 0.032666563987731934
, O 0 0.006239503156393766
and O 0 0.005682538263499737
reading O 0 0.014639340341091156
skills O 0 0.03235294297337532
. O 0 0.021490545943379402

Comparison O 0 0.03579118102788925
of O 0 0.012363709509372711
molecular O 0 0.13821297883987427
and O 0 0.0077399867586791515
psychometric O 0 0.38266825675964355
findings O 0 0.04435686767101288
demonstrated O 0 0.02076140232384205
that O 0 0.004415235016494989
deletions O 0 0.21633584797382355
and O 0 0.004137189127504826
duplications O 0 0.18715132772922516
that O 0 0.0032412537839263678
were O 0 0.0031519634649157524
localized O 0 0.3608274757862091
in O 0 0.004008118994534016
the O 0 0.004766035359352827
distal O 1 0.7075278162956238
part O 0 0.005440466571599245
of O 0 0.0033324442338198423
the O 0 0.005383106879889965
gene O 1 0.8094201683998108
seemed O 0 0.011689400300383568
to O 0 0.004290883429348469
be O 0 0.005885589402168989
preferentially O 0 0.45708510279655457
associated O 0 0.12774693965911865
with O 0 0.04092903807759285
cognitive B-Disease 1 0.94740229845047
impairment I-Disease 1 0.9649474024772644
. O 0 0.05473135784268379

Two O 0 0.027991654351353645
altered O 0 0.17177395522594452
Dp71 O 0 0.20253631472587585
transcripts O 0 0.02313896454870701
and O 0 0.0060570999048650265
two O 0 0.0070911613292992115
deleted O 0 0.08778651803731918
Dp140 O 0 0.4505356550216675
DNA O 0 0.3794006109237671
sequences O 0 0.04444016143679619
were O 0 0.0047809043899178505
found O 0 0.009006215259432793
in O 0 0.006962057668715715
four O 0 0.035599902272224426
patients O 1 0.9867657423019409
with O 1 0.5096654295921326
severe O 1 0.9919028878211975
cerebral B-Disease 1 0.9927045106887817
dysfunction I-Disease 1 0.9876956939697266
. O 0 0.17329177260398865

These O 0 0.017132626846432686
findings O 0 0.017770741134881973
suggest O 0 0.010883498005568981
that O 0 0.0036724915262311697
some O 0 0.003771317657083273
sequences O 0 0.021044595167040825
located O 0 0.004059921950101852
in O 0 0.0030753519386053085
the O 0 0.003217121819034219
distal O 1 0.6307193636894226
part O 0 0.004507181700319052
of O 0 0.0029155698139220476
the O 0 0.004675835836678743
gene O 1 0.7657744288444519
and O 0 0.0027775100897997618
, O 0 0.002547748852521181
in O 0 0.002691857283934951
particular O 0 0.006066554691642523
, O 0 0.003695364110171795
some O 0 0.009063208475708961
DMD B-Disease 1 0.9855520129203796
isoforms O 1 0.5057727694511414
expressed O 0 0.011720904149115086
in O 0 0.006137734279036522
the O 0 0.010419449768960476
brain O 1 0.9649553894996643
may O 0 0.02554325945675373
be O 0 0.003686915384605527
related O 0 0.019663481041789055
to O 0 0.004019428510218859
the O 0 0.008923466317355633
cognitive B-Disease 1 0.9616241455078125
impairment I-Disease 1 0.9837717413902283
associated O 0 0.37342628836631775
with O 0 0.09521858394145966
DMD B-Disease 1 0.9812763929367065
. O 0 0.026287822052836418
. O 0 0.026532692834734917

I1307K O 1 0.5578905344009399
APC O 1 0.5810205340385437
and O 0 0.025948893278837204
hMLH1 O 1 0.6899683475494385
mutations O 1 0.9273178577423096
in O 0 0.011227549985051155
a O 0 0.010842693038284779
non O 0 0.040364623069763184
- O 0 0.14330002665519714
Jewish O 0 0.05660952255129814
family O 0 0.12142681330442429
with O 0 0.12472891062498093
hereditary B-Disease 1 0.9832659959793091
non I-Disease 1 0.9537355899810791
- I-Disease 1 0.988004744052887
polyposis I-Disease 1 0.9975599050521851
colorectal I-Disease 1 0.9980156421661377
cancer I-Disease 1 0.9936578869819641
. O 0 0.25261881947517395

We O 0 0.01888890750706196
describe O 0 0.027358006685972214
a O 0 0.01590108498930931
French O 0 0.06280501931905746
Canadian O 0 0.2586527168750763
hereditary B-Disease 1 0.9789227247238159
non I-Disease 1 0.957833468914032
- I-Disease 1 0.99062180519104
polyposis I-Disease 1 0.9983400106430054
colorectal I-Disease 1 0.9991171956062317
cancer I-Disease 1 0.998231828212738
( O 1 0.9150631427764893
HNPCC B-Disease 1 0.9915743470191956
) O 0 0.12791840732097626
kindred O 1 0.5841138958930969
which O 0 0.008906079456210136
carries O 0 0.01944867894053459
a O 0 0.014268922619521618
novel O 0 0.28126320242881775
truncating O 1 0.9350472688674927
mutation O 1 0.9745942950248718
in O 0 0.03644714504480362
hMLH1 O 1 0.6511411070823669
. O 0 0.033164702355861664

Interestingly O 0 0.07530834525823593
, O 0 0.01696828193962574
the O 0 0.013782861642539501
I1307K O 1 0.5980783104896545
APC O 1 0.8889098167419434
polymorphism O 1 0.8092235326766968
, O 0 0.011140719056129456
associated O 0 0.035482008010149
with O 0 0.0056502800434827805
an O 0 0.009731810539960861
increased O 0 0.2988564670085907
risk O 1 0.9616727828979492
of O 0 0.4064607322216034
colorectal B-Disease 1 0.9991905093193054
cancer I-Disease 1 0.996927797794342
, O 0 0.009067355655133724
is O 0 0.004396375268697739
also O 0 0.0034475058782845736
present O 0 0.0050226012244820595
in O 0 0.004538136534392834
this O 0 0.006241681985557079
family O 0 0.0359751358628273
. O 0 0.021371042355895042

The O 0 0.027499444782733917
I1307K O 0 0.3930257260799408
polymorphism O 0 0.4229065775871277
has O 0 0.008698965422809124
previously O 0 0.006775187328457832
only O 0 0.0035606997553259134
been O 0 0.0035223152954131365
identified O 0 0.007051261141896248
in O 0 0.0037134927697479725
individuals O 0 0.010148703120648861
of O 0 0.005390324629843235
self O 0 0.08687569946050644
- O 0 0.2306264489889145
reported O 0 0.08566015213727951
Ashkenazi O 0 0.45675888657569885
Jewish O 0 0.04662364348769188
origins O 0 0.13923324644565582
. O 0 0.028967682272195816

In O 0 0.014164313673973083
addition O 0 0.0112547492608428
, O 0 0.004855290055274963
in O 0 0.003369091311469674
this O 0 0.0028138929046690464
family O 0 0.005544345360249281
, O 0 0.002501194830983877
there O 0 0.0021461863070726395
appears O 0 0.004951355513185263
to O 0 0.001955987187102437
be O 0 0.0016613051993772388
no O 0 0.0028573418967425823
relationship O 0 0.014804938808083534
between O 0 0.004239439032971859
the O 0 0.004289159085601568
I1307K O 0 0.4587901532649994
polymorphism O 1 0.5293520092964172
and O 0 0.0040166196413338184
the O 0 0.0043605538085103035
presence O 0 0.03457629680633545
or O 0 0.014077266678214073
absence O 0 0.10238169133663177
of O 0 0.03177420422434807
cancer B-Disease 1 0.9896407723426819
. O 0 0.02278309315443039
. O 0 0.024776998907327652

Identification O 0 0.030876509845256805
of O 0 0.010568632744252682
a O 0 0.011868595145642757
novel O 0 0.09463255107402802
mutation O 1 0.89848393201828
of O 0 0.006099585443735123
the O 0 0.007131888531148434
CPO O 0 0.35687825083732605
gene O 1 0.8662168979644775
in O 0 0.007290788926184177
a O 0 0.010423166677355766
Japanese O 0 0.03369469940662384
hereditary B-Disease 1 0.9462626576423645
coproporphyria I-Disease 1 0.7870246171951294
family O 0 0.16636621952056885
. O 0 0.02899673767387867

Hereditary B-Disease 1 0.9509112238883972
coproporphyria I-Disease 1 0.8893268704414368
( O 0 0.3539130985736847
HCP B-Disease 1 0.954675018787384
) O 0 0.06291309744119644
is O 0 0.02116001397371292
an O 0 0.15390489995479584
autosomal B-Disease 1 0.9976769089698792
dominant I-Disease 1 0.9859892129898071
disease I-Disease 1 0.997811496257782
characterized O 1 0.9142405986785889
by O 0 0.042520347982645035
a O 0 0.24073255062103271
deficiency B-Disease 1 0.9958322644233704
of I-Disease 0 0.04467080533504486
coproporphyrinogen I-Disease 1 0.9628211259841919
oxidase I-Disease 1 0.9839766025543213
( O 0 0.191328227519989
CPO O 0 0.4932847321033478
) O 0 0.03184094652533531
caused O 0 0.1346302479505539
by O 0 0.007089067250490189
a O 0 0.013140301220119
mutation O 1 0.9374864101409912
in O 0 0.008857563138008118
the O 0 0.011447856202721596
CPO O 0 0.47651568055152893
gene O 1 0.9287238121032715
. O 0 0.036250513046979904

Only O 0 0.01866782456636429
11 O 0 0.024747714400291443
mutations O 1 0.7996048331260681
of O 0 0.007003679871559143
the O 0 0.007404594216495752
gene O 1 0.7253847122192383
have O 0 0.006387334782630205
been O 0 0.007044553756713867
reported O 0 0.03764883428812027
in O 0 0.05082123354077339
HCP B-Disease 1 0.9814097881317139
patients O 1 0.9772924184799194
. O 0 0.04575945436954498

We O 0 0.01591859944164753
report O 0 0.01504414714872837
another O 0 0.015661098062992096
mutation O 1 0.8092623353004456
in O 0 0.008847514167428017
a O 0 0.010687907226383686
Japanese O 0 0.016758715733885765
family O 0 0.03708905726671219
. O 0 0.02260354533791542

Polymerase O 1 0.8570933938026428
chain O 0 0.4345720112323761
reaction O 0 0.33132728934288025
- O 0 0.22202599048614502
single O 0 0.055249106138944626
strand O 1 0.6199623942375183
conformational O 1 0.7441773414611816
polymorphism O 0 0.37232422828674316
and O 0 0.006239508744329214
direct O 0 0.011349622160196304
sequence O 0 0.03631170094013214
analyses O 0 0.02730332314968109
demonstrated O 0 0.015183985233306885
a O 0 0.0070173125714063644
C O 0 0.055268820375204086
to O 0 0.0050652893260121346
T O 0 0.49458444118499756
substitution O 0 0.05363379046320915
in O 0 0.005186351016163826
exon O 0 0.16894663870334625
1 O 0 0.0050593167543411255
of O 0 0.0032292455434799194
the O 0 0.0041474769823253155
CPO O 0 0.2620033323764801
gene O 1 0.7702816128730774
at O 0 0.0062509262934327126
nucleotide O 0 0.1516958326101303
position O 0 0.0047711520455777645
85 O 0 0.007229251321405172
, O 0 0.0027332755271345377
which O 0 0.0023939302191138268
lies O 0 0.004369334317743778
in O 0 0.003003651974722743
the O 0 0.004418541677296162
putative O 0 0.39745035767555237
presequence O 0 0.26696667075157166
for O 0 0.008130486123263836
targeting O 0 0.03481351584196091
to O 0 0.013403362594544888
mitochondria O 1 0.6662407517433167
. O 0 0.027532581239938736

This O 0 0.029283778741955757
mutation O 1 0.7447280883789062
changes O 0 0.018982982262969017
the O 0 0.007699690293520689
codon O 0 0.10445058345794678
for O 0 0.008068365976214409
glutamine O 0 0.09455519169569016
to O 0 0.006344215478748083
a O 0 0.011466818861663342
termination O 0 0.4082261621952057
codon O 0 0.35322409868240356
at O 0 0.012961793690919876
amino O 0 0.3615395128726959
acid O 1 0.5724906921386719
position O 0 0.015165101736783981
29 O 0 0.025562435388565063
. O 0 0.02105933614075184

MaeI O 0 0.330451637506485
restriction O 0 0.05856981500983238
analysis O 0 0.02419990673661232
showed O 0 0.013833797536790371
two O 0 0.006837845779955387
other O 0 0.006439783610403538
carriers O 0 0.0632614865899086
in O 0 0.006946419831365347
the O 0 0.008380184881389141
family O 0 0.029253406450152397
. O 0 0.018906809389591217

The O 0 0.0361768901348114
C O 1 0.6358222365379333
- O 1 0.6941986680030823
T O 1 0.9255056977272034
mutation O 1 0.9415307641029358
is O 0 0.007027453277260065
located O 0 0.00627263356000185
within O 0 0.005003782454878092
a O 0 0.005405654199421406
recently O 0 0.007755691185593605
proposed O 0 0.010986533015966415
putative O 0 0.2627110183238983
alternative O 0 0.03900206834077835
translation O 0 0.10242864489555359
initiation O 1 0.8042973279953003
codon O 1 0.8838149905204773
( O 0 0.2768680453300476
TIC O 1 0.9386802315711975
- O 0 0.19221988320350647
1 O 0 0.011556590907275677
) O 0 0.007929107174277306
, O 0 0.0038167175371199846
supporting O 0 0.009989840909838676
that O 0 0.006284343544393778
TIC O 1 0.7543323636054993
- O 0 0.059911519289016724
1 O 0 0.00664297491312027
is O 0 0.003914121072739363
the O 0 0.0040593985468149185
real O 0 0.024454763159155846
TIC O 1 0.7396008968353271
rather O 0 0.016098635271191597
than O 0 0.02009456418454647
TIC O 1 0.86466383934021
- O 0 0.10515335947275162
2 O 0 0.01526322029531002
. O 0 0.012420707382261753
. O 0 0.017625100910663605

Human B-Disease 0 0.4859682619571686
complement I-Disease 1 0.7266612648963928
factor I-Disease 1 0.9377039670944214
H I-Disease 1 0.9779955148696899
deficiency I-Disease 1 0.9963089823722839
associated O 1 0.9505793452262878
with O 1 0.9006236791610718
hemolytic B-Disease 1 0.9973142743110657
uremic I-Disease 1 0.9962829947471619
syndrome I-Disease 1 0.9936832189559937
. O 0 0.26433268189430237

This O 0 0.015805013477802277
study O 0 0.016137519851326942
reports O 0 0.008441722951829433
on O 0 0.004278823733329773
six O 0 0.007124541327357292
cases O 0 0.059626612812280655
of O 0 0.014408557675778866
deficiency B-Disease 1 0.9930933713912964
in I-Disease 0 0.006287411320954561
the I-Disease 0 0.00557251600548625
human I-Disease 0 0.20047429203987122
complement I-Disease 1 0.5097430348396301
regulatory I-Disease 1 0.8958232402801514
protein I-Disease 1 0.969109296798706
Factor I-Disease 1 0.8834178447723389
H I-Disease 1 0.88226717710495
( O 0 0.1475764662027359
FH O 1 0.9323157668113708
) O 0 0.009555061347782612
in O 0 0.003434261539950967
the O 0 0.004099652636796236
context O 0 0.025040848180651665
of O 0 0.013142763637006283
an O 0 0.42976465821266174
acute B-Disease 1 0.9967731833457947
renal I-Disease 1 0.9985219836235046
disease I-Disease 1 0.9958940744400024
. O 0 0.28833112120628357

Five O 0 0.016425881534814835
of O 0 0.007860781624913216
the O 0 0.006242785602807999
cases O 0 0.01728730835020542
were O 0 0.004072337877005339
observed O 0 0.02415456809103489
in O 0 0.007889274507761002
children O 0 0.2410682737827301
presenting O 1 0.6821404695510864
with O 1 0.9163705110549927
idiopathic O 1 0.9982205033302307
hemolytic B-Disease 1 0.9991605281829834
uremic I-Disease 1 0.9986318945884705
syndrome I-Disease 1 0.9980410933494568
( O 1 0.8805747032165527
HUS B-Disease 1 0.9780129790306091
) O 0 0.12515880167484283
. O 0 0.03173285722732544

Two O 0 0.013611062429845333
of O 0 0.006932293064892292
the O 0 0.006656843237578869
children O 0 0.06237132102251053
exhibited O 0 0.1952090710401535
a O 0 0.20933930575847626
homozygous O 1 0.9935564398765564
deficiency O 1 0.9975512623786926
characterized O 1 0.6536529064178467
by O 0 0.006339925341308117
the O 0 0.003439458319917321
absence O 0 0.00881369598209858
of O 0 0.0030874251388013363
the O 0 0.0037766455207020044
150 O 0 0.0113132419064641
- O 0 0.1938532292842865
kD O 1 0.5860493183135986
form O 0 0.030144119635224342
of O 0 0.005453621037304401
Factor O 0 0.18736547231674194
H O 0 0.20188544690608978
and O 0 0.0031244743149727583
the O 0 0.0029039736837148666
presence O 0 0.008007857017219067
, O 0 0.003465988440439105
upon O 0 0.004498751368373632
immunoblotting O 0 0.08119144290685654
, O 0 0.0032043836545199156
of O 0 0.0030012179631739855
the O 0 0.004848279990255833
42 O 0 0.061912450939416885
- O 0 0.4868553578853607
kD O 1 0.8768230080604553
Factor O 1 0.6827282309532166
H O 1 0.8050452470779419
- O 0 0.21205931901931763
like O 0 0.032111745327711105
protein O 1 0.6379797458648682
1 O 0 0.025001192465424538
( O 0 0.06110173836350441
FHL O 1 0.9223358035087585
- O 0 0.14470525085926056
1 O 0 0.011714794673025608
) O 0 0.0076037137769162655
and O 0 0.004590713884681463
other O 0 0.013178217224776745
FH O 1 0.9745696187019348
- O 1 0.6179541945457458
related O 1 0.5373285412788391
protein O 1 0.906274676322937
( O 0 0.1288888156414032
FHR O 1 0.5788378119468689
) O 0 0.02428901009261608
bands O 0 0.027182303369045258
. O 0 0.022133847698569298

Southern O 0 0.04310068115592003
blot O 0 0.17459429800510406
and O 0 0.013988510705530643
PCR O 0 0.24224062263965607
analysis O 0 0.014425802044570446
of O 0 0.005415976978838444
DNA O 0 0.1352006494998932
of O 0 0.00507586682215333
one O 0 0.01082614716142416
patient O 1 0.8914677500724792
with O 0 0.12304253876209259
homozygous O 1 0.9906796813011169
deficiency O 1 0.9963716268539429
ruled O 0 0.039503518491983414
out O 0 0.004187528043985367
the O 0 0.0031422085594385862
presence O 0 0.006435034796595573
of O 0 0.0030108054634183645
a O 0 0.00442098593339324
large O 0 0.008151867426931858
deletion O 1 0.5337780117988586
of O 0 0.006097498349845409
the O 0 0.012310435995459557
FH O 1 0.9798957109451294
gene O 1 0.9004542827606201
as O 0 0.00656529376283288
the O 0 0.0069626709446311
underlying O 0 0.48515385389328003
defect O 1 0.9282916784286499
for O 0 0.01725187711417675
the O 0 0.04602311924099922
deficiency O 1 0.9888736009597778
. O 0 0.062125954777002335

The O 0 0.013959653675556183
other O 0 0.008859703317284584
four O 0 0.008495070040225983
children O 0 0.02209787629544735
presented O 0 0.015164759941399097
with O 0 0.04637585207819939
heterozygous O 1 0.9835671186447144
deficiency O 1 0.9942319989204407
and O 0 0.009147090837359428
exhibited O 0 0.03637056425213814
a O 0 0.011858600191771984
normal O 0 0.26688718795776367
immunoblotting O 1 0.5853012800216675
pattern O 0 0.18879461288452148
of O 0 0.0067568933591246605
proteins O 0 0.2824003994464874
of O 0 0.008117594756186008
the O 0 0.01495281606912613
FH O 1 0.9454554915428162
family O 0 0.13206985592842102
. O 0 0.02511313557624817

Factor B-Disease 1 0.8993349671363831
H I-Disease 1 0.9559314250946045
deficiency I-Disease 1 0.9876732230186462
is O 0 0.013577097095549107
the O 0 0.010392707772552967
only O 0 0.01689107157289982
complement B-Disease 1 0.8690522909164429
deficiency I-Disease 1 0.9955768585205078
associated O 0 0.4381048381328583
with O 0 0.07414297759532928
HUS B-Disease 1 0.9522326588630676
. O 0 0.05193738266825676

These O 0 0.01700667291879654
observations O 0 0.016787897795438766
suggest O 0 0.015585307963192463
a O 0 0.009067591279745102
role O 0 0.014151476323604584
for O 0 0.010197457857429981
FH O 1 0.9440176486968994
and O 0 0.0239546075463295
/ O 1 0.753297746181488
or O 0 0.1752074956893921
FH O 1 0.9812833666801453
receptors O 1 0.8257061243057251
in O 0 0.010838449001312256
the O 0 0.02216128632426262
pathogenesis O 1 0.9820587038993835
of O 0 0.12378006428480148
idiopathic O 1 0.9916675686836243
HUS B-Disease 1 0.9749470353126526
. O 0 0.0381411649286747
. O 0 0.03137558698654175

Further O 0 0.022175921127200127
evidence O 0 0.01363583467900753
for O 0 0.007284876890480518
a O 0 0.009662908501923084
major O 0 0.024147428572177887
ancient O 0 0.13829226791858673
mutation O 1 0.9920365810394287
underlying O 1 0.9760782718658447
myotonic B-Disease 1 0.9956203103065491
dystrophy I-Disease 1 0.9950199127197266
from O 0 0.15649978816509247
linkage O 1 0.9411194324493408
disequilibrium O 1 0.9415944814682007
studies O 0 0.08282309025526047
in O 0 0.007543331012129784
the O 0 0.0073303356766700745
Japanese O 0 0.015934571623802185
population O 0 0.035901837050914764
. O 0 0.022885343059897423

The O 0 0.389475554227829
myotonic B-Disease 1 0.9869993329048157
dystrophy I-Disease 1 0.9930742979049683
( O 1 0.8308317065238953
DM B-Disease 1 0.9863611459732056
) O 0 0.38914886116981506
mutation O 1 0.9752848148345947
is O 0 0.011913326568901539
an O 0 0.013175408355891705
unstable O 1 0.828305721282959
( O 0 0.09670150279998779
CTG O 1 0.7733012437820435
) O 0 0.01920306496322155
n O 0 0.029359102249145508
repeat O 0 0.03942739591002464
, O 0 0.0032502489630132914
present O 0 0.003380022244527936
at O 0 0.0025268697645515203
a O 0 0.0031435578130185604
copy O 0 0.006398956757038832
number O 0 0.0027609483804553747
of O 0 0.002975134178996086
5 O 0 0.008268511854112148
- O 0 0.030749045312404633
37 O 0 0.012659672647714615
repeats O 0 0.056490182876586914
on O 0 0.004160807467997074
normal O 0 0.09786045551300049
chromosomes O 0 0.39145976305007935
but O 0 0.00511993607506156
amplified O 0 0.03691708296537399
to O 0 0.0042153638787567616
50 O 0 0.009302938356995583
- O 0 0.06364676356315613
3000 O 0 0.10357841849327087
copies O 0 0.020775048062205315
on O 0 0.013318829238414764
DM B-Disease 1 0.9667704105377197
chromosomes O 1 0.8350123167037964
. O 0 0.03680713102221489

Previous O 0 0.030878879129886627
findings O 0 0.03218373283743858
in O 0 0.014295218512415886
Caucasian O 1 0.6236687302589417
populations O 0 0.20174981653690338
of O 0 0.008090189658105373
a O 0 0.05528407171368599
DM B-Disease 1 0.9856926202774048
founder O 0 0.348896324634552
chromosome O 1 0.9074335694313049
raise O 0 0.01590210758149624
a O 0 0.006470290943980217
question O 0 0.004953044932335615
about O 0 0.0036873077042400837
the O 0 0.003915895242244005
molecular O 0 0.1933366060256958
events O 0 0.009405363351106644
involved O 0 0.009546603076159954
in O 0 0.005346495192497969
the O 0 0.008175953291356564
expansion O 0 0.1596597135066986
mutation O 1 0.9693061709403992
. O 0 0.03910006955265999

To O 0 0.02039228193461895
investigate O 0 0.025793572887778282
whether O 0 0.014683572575449944
a O 0 0.013016851618885994
founder O 0 0.11239500343799591
chromosome O 1 0.8946117758750916
for O 0 0.007751325145363808
the O 0 0.022523183375597
DM B-Disease 1 0.9921437501907349
mutation O 1 0.9836063385009766
exists O 0 0.037161462008953094
in O 0 0.00336959445849061
the O 0 0.0026793924625962973
Japanese O 0 0.004522092640399933
population O 0 0.006286574061959982
, O 0 0.0032216724939644337
we O 0 0.003364136442542076
genotyped O 0 0.11110298335552216
families O 0 0.018505467101931572
using O 0 0.017582476139068604
polymorphic O 1 0.8707233667373657
markers O 0 0.23515786230564117
near O 0 0.01243510376662016
the O 0 0.007070377003401518
( O 0 0.03235394507646561
CTG O 1 0.6964542269706726
) O 0 0.026458334177732468
n O 0 0.06367921829223633
repeat O 0 0.10206978768110275
region O 0 0.012764306738972664
and O 0 0.007725720759481192
constructed O 0 0.02647613175213337
haplotypes O 1 0.8710926175117493
. O 0 0.02762030065059662

Six O 0 0.027546435594558716
different O 0 0.01892942190170288
haplotypes O 1 0.5730323791503906
were O 0 0.008344359695911407
found O 0 0.016391711309552193
and O 0 0.01557682454586029
DM B-Disease 1 0.9770419001579285
alleles O 1 0.9434269666671753
were O 0 0.011058165691792965
always O 0 0.018653614446520805
haplotype O 1 0.8688603639602661
A O 0 0.025683676823973656
. O 0 0.023947572335600853

To O 0 0.01244377437978983
find O 0 0.009992793202400208
an O 0 0.00531174149364233
origin O 0 0.006421646568924189
of O 0 0.0033428894821554422
the O 0 0.00473755830898881
( O 0 0.033425506204366684
CTG O 1 0.7141075730323792
) O 0 0.023288391530513763
n O 0 0.14178618788719177
repeat O 0 0.4856857359409332
mutation O 1 0.8877654671669006
and O 0 0.003440772881731391
to O 0 0.002364871557801962
investigate O 0 0.005570418667048216
the O 0 0.002562595997005701
mechanism O 0 0.02675331011414528
of O 0 0.002592236502096057
the O 0 0.0031462109182029963
expansion O 0 0.04286836460232735
mutation O 1 0.9072654247283936
in O 0 0.0033695977181196213
the O 0 0.00211612437851727
Japanese O 0 0.0039229243993759155
population O 0 0.004994595889002085
we O 0 0.0021017040126025677
have O 0 0.002523617586120963
studied O 0 0.005836415104568005
90 O 0 0.009253623895347118
Japanese O 0 0.014474594965577126
DM B-Disease 1 0.9635708332061768
families O 0 0.036592599004507065
comprising O 0 0.01641499251127243
190 O 0 0.023087788373231888
affected O 0 0.06198524311184883
and O 0 0.007432969287037849
130 O 0 0.02310124784708023
unaffected O 0 0.23512917757034302
members O 0 0.016932103782892227
. O 0 0.02116463892161846

The O 0 0.016299832612276077
results O 0 0.017779750749468803
suggest O 0 0.012717473320662975
that O 0 0.005010776687413454
a O 0 0.006013871170580387
few O 0 0.006939834449440241
common O 0 0.08018764108419418
ancestral O 1 0.5119854211807251
mutations O 1 0.9530444741249084
in O 0 0.0062505933456122875
both O 0 0.0069985343143343925
Caucasian O 0 0.37463387846946716
and O 0 0.004653137642890215
Japanese O 0 0.009123800322413445
populations O 0 0.11540140956640244
have O 0 0.003863249672576785
originated O 0 0.012312453240156174
by O 0 0.003984040580689907
expansion O 0 0.00640287809073925
of O 0 0.0031921174377202988
an O 0 0.004986171144992113
ancestral O 0 0.15762804448604584
n O 0 0.11780142039060593
= O 0 0.1609468013048172
5 O 0 0.010056081227958202
repeat O 0 0.05384639650583267
to O 0 0.005327373743057251
n O 0 0.05789971724152565
= O 0 0.13291580975055695
19 O 0 0.015165685676038265
- O 0 0.04654891416430473
37 O 0 0.01877412386238575
copies O 0 0.023155929520726204
. O 0 0.019560227170586586

These O 0 0.01598384603857994
data O 0 0.014439632184803486
support O 0 0.011404061689972878
multistep O 0 0.1667567938566208
models O 0 0.01524489838629961
of O 0 0.006696005817502737
triplet O 1 0.7587473392486572
repeat O 0 0.12767332792282104
expansion O 0 0.010333368554711342
that O 0 0.003027457743883133
have O 0 0.002638724399730563
been O 0 0.0031713242642581463
proposed O 0 0.006417978089302778
for O 0 0.004275806248188019
both O 0 0.011509537696838379
DM B-Disease 1 0.9738871455192566
and O 0 0.03937307745218277
Friedreichs B-Disease 1 0.9428375959396362
ataxia I-Disease 1 0.9836803674697876
. O 0 0.026005078107118607
. O 0 0.026295017451047897

The O 0 0.02495361492037773
molecular O 0 0.1883668452501297
basis O 0 0.020161526277661324
of O 0 0.022279173135757446
C6 B-Disease 1 0.9843629002571106
deficiency I-Disease 1 0.9938268065452576
in O 0 0.008555106818675995
the O 0 0.005246593151241541
western O 0 0.010422596707940102
Cape O 0 0.03143441677093506
, O 0 0.00722263939678669
South O 0 0.011101044714450836
Africa O 0 0.027161631733179092
. O 0 0.019108936190605164

Deficiency B-Disease 1 0.9652700424194336
of I-Disease 0 0.010359186679124832
the I-Disease 0 0.00782717578113079
sixth I-Disease 0 0.013341457583010197
component I-Disease 0 0.019975600764155388
of I-Disease 0 0.006359926890581846
human I-Disease 0 0.11456122249364853
complement I-Disease 0 0.23333241045475006
( O 0 0.08178708702325821
C6 O 1 0.8161059617996216
) O 0 0.0072817387990653515
has O 0 0.0026340491604059935
been O 0 0.0023041898384690285
reported O 0 0.0037669972516596317
in O 0 0.0020811674185097218
a O 0 0.002330157905817032
number O 0 0.0017536183586344123
of O 0 0.0019393028924241662
families O 0 0.004480225499719381
from O 0 0.0030053569935262203
the O 0 0.0028261702973395586
western O 0 0.006190906278789043
Cape O 0 0.02198389172554016
, O 0 0.005327131599187851
South O 0 0.009573369286954403
Africa O 0 0.02652941644191742
. O 0 0.017099473625421524

Meningococcal B-Disease 1 0.9900471568107605
disease I-Disease 1 0.9884958267211914
is O 0 0.028599971905350685
endemic O 0 0.2350318878889084
in O 0 0.0059249913319945335
the O 0 0.0043121399357914925
Cape O 0 0.009315806441009045
and O 0 0.0025999408680945635
almost O 0 0.003514858428388834
all O 0 0.0032421997748315334
pedigrees O 0 0.19596202671527863
of O 0 0.00937548466026783
total O 0 0.19597215950489044
C6 B-Disease 1 0.9944427609443665
deficiency I-Disease 1 0.9983229041099548
( O 0 0.24161894619464874
C6Q0 O 1 0.6966201066970825
) O 0 0.010303543880581856
have O 0 0.004211262799799442
been O 0 0.0051316008903086185
ascertained O 0 0.1701764166355133
because O 0 0.01812884770333767
of O 0 0.02527761086821556
recurrent O 1 0.9884499311447144
disease O 1 0.9917085766792297
. O 0 0.12402995675802231

We O 0 0.012136691249907017
have O 0 0.008183419704437256
sequenced O 0 0.02746570110321045
the O 0 0.0060564251616597176
expressed O 0 0.009072789922356606
exons O 0 0.1851631999015808
of O 0 0.005151572171598673
the O 0 0.009372826665639877
C6 O 1 0.9433438777923584
gene O 1 0.8263834714889526
from O 0 0.005983578972518444
selected O 0 0.005001999903470278
cases O 0 0.01844039559364319
and O 0 0.0022109432611614466
have O 0 0.0025672721676528454
found O 0 0.0062918635085225105
three O 0 0.008560852147638798
molecular O 1 0.9063183665275574
defects O 1 0.9777753949165344
leading O 0 0.037960272282361984
to O 0 0.00735687417909503
total O 0 0.10345681756734848
deficiency O 1 0.9968740940093994
879delG O 1 0.5399534106254578
, O 0 0.004284410271793604
which O 0 0.0028089748229831457
is O 0 0.0025155115872621536
the O 0 0.00276185036636889
common O 0 0.08060268312692642
defect O 1 0.6665385365486145
in O 0 0.0037124059163033962
the O 0 0.0030084720347076654
Cape O 0 0.01839527115225792
and O 0 0.0032948313746601343
hitherto O 0 0.056104354560375214
unreported O 0 0.09982996433973312
, O 0 0.004696269985288382
and O 0 0.0038743435870856047
1195delC O 0 0.1564854383468628
and O 0 0.00370916910469532
1936delG O 0 0.11417751014232635
, O 0 0.0034764837473630905
which O 0 0.002407246269285679
have O 0 0.0020486260764300823
been O 0 0.0024787369184195995
previously O 0 0.004859464708715677
reported O 0 0.009177259169518948
in O 0 0.00590141024440527
African O 0 0.0589909628033638
- O 0 0.1394399255514145
Americans O 0 0.04344048723578453
. O 0 0.022376978769898415

We O 0 0.011193662881851196
also O 0 0.006408907473087311
show O 0 0.006262556649744511
that O 0 0.0036456782836467028
the O 0 0.004710006527602673
879delG O 0 0.4162958562374115
and O 0 0.011740030720829964
1195delC O 1 0.8856311440467834
defects O 1 0.9681112170219421
are O 0 0.008611483499407768
associated O 0 0.10287564992904663
with O 0 0.02622164413332939
characteristic O 1 0.8111394643783569
C6 O 1 0.9808942675590515
/ O 1 0.9164392352104187
C7 O 1 0.9565300941467285
region O 0 0.19869039952754974
DNA O 1 0.829727053642273
marker O 1 0.5585379004478455
haplotypes O 1 0.8992847204208374
, O 0 0.008010522462427616
although O 0 0.007378485053777695
small O 0 0.008682681247591972
variations O 0 0.027705058455467224
were O 0 0.008170212619006634
observed O 0 0.045171331614255905
. O 0 0.02234165370464325

The O 0 0.028558487072587013
1936delG O 1 0.5323708653450012
defect O 1 0.6272857189178467
was O 0 0.00960269384086132
observed O 0 0.011836166493594646
only O 0 0.003593382192775607
once O 0 0.0037045273929834366
in O 0 0.0028614334296435118
the O 0 0.003085394622758031
Cape O 0 0.01219930313527584
, O 0 0.0031874324195086956
but O 0 0.0033173866104334593
its O 0 0.005530502647161484
associated O 0 0.15062224864959717
haplotype O 1 0.8839359879493713
could O 0 0.009256880730390549
be O 0 0.006592856254428625
deduced O 0 0.03674125671386719
. O 0 0.017566362395882607

The O 0 0.013223295100033283
data O 0 0.010721366852521896
from O 0 0.006386147812008858
the O 0 0.00560857355594635
haplotypes O 1 0.7251415252685547
indicate O 0 0.012501931749284267
that O 0 0.0029343669302761555
these O 0 0.003448682138696313
three O 0 0.006720502395182848
molecular O 1 0.8308625221252441
defects O 1 0.9558568000793457
account O 0 0.00873833429068327
for O 0 0.002902947599068284
the O 0 0.003633586224168539
defects O 1 0.7611046433448792
in O 0 0.0026811130810528994
all O 0 0.002087021479383111
the O 0 0.003183456137776375
38 O 0 0.022503074258565903
unrelated O 0 0.42375117540359497
C6Q0 O 0 0.4961836040019989
individuals O 0 0.013557919301092625
we O 0 0.0031868626829236746
have O 0 0.0033388228621333838
studied O 0 0.00590480724349618
from O 0 0.00549613730981946
the O 0 0.008510715328156948
Cape O 0 0.04743259400129318
. O 0 0.022506985813379288

We O 0 0.014065735973417759
have O 0 0.008078833110630512
also O 0 0.006653154734522104
observed O 0 0.013192021287977695
the O 0 0.007192289922386408
879delG O 1 0.5321530103683472
defect O 1 0.7583378553390503
in O 0 0.008411108516156673
two O 0 0.010714976117014885
Dutch O 0 0.38336384296417236
C6 B-Disease 1 0.9843342900276184
- I-Disease 1 0.87309330701828
deficient I-Disease 1 0.9815892577171326
kindreds O 1 0.7794008255004883
, O 0 0.006528750061988831
but O 0 0.004339574836194515
the O 0 0.005487384740263224
879delG O 1 0.5989775061607361
defect O 1 0.7134908437728882
in O 0 0.00436678109690547
the O 0 0.0036556825507432222
Cape O 0 0.014107495546340942
probably O 0 0.00563717819750309
did O 0 0.003078412264585495
not O 0 0.0023490586318075657
come O 0 0.0031625437550246716
from O 0 0.003583682468160987
The O 0 0.0046096923761069775
Netherlands O 0 0.013344785198569298
. O 0 0.009017441421747208
. O 0 0.014671317301690578

Complement B-Disease 1 0.8499671220779419
C7 I-Disease 1 0.9753899574279785
deficiency I-Disease 1 0.989790141582489
: O 0 0.028392039239406586
seven O 0 0.01531464233994484
further O 0 0.03449598327279091
molecular O 1 0.8384424448013306
defects O 1 0.9416921734809875
and O 0 0.007347536738961935
their O 0 0.0096137011423707
associated O 0 0.15237504243850708
marker O 1 0.5649137496948242
haplotypes O 1 0.9489856362342834
. O 0 0.041119884699583054

Seven O 0 0.036005888134241104
further O 0 0.02612011507153511
molecular O 0 0.3057076334953308
bases O 0 0.02573620341718197
of O 0 0.03615943342447281
C7 B-Disease 1 0.9852398633956909
deficiency I-Disease 1 0.9920197129249573
are O 0 0.01902308128774166
described O 0 0.0596773587167263
. O 0 0.02662566304206848

All O 0 0.012296320870518684
these O 0 0.009976372122764587
new O 0 0.013616068288683891
molecular O 1 0.828156054019928
defects O 1 0.9751657843589783
involve O 0 0.184454545378685
single O 0 0.050294406712055206
- O 0 0.24332791566848755
nucleotide O 0 0.4961700439453125
events O 0 0.014130535535514355
, O 0 0.005958667024970055
deletions O 0 0.12865608930587769
and O 0 0.0034051048569381237
substitutions O 0 0.0104729775339365
, O 0 0.002843251684680581
some O 0 0.002541819354519248
of O 0 0.0026499624364078045
which O 0 0.0042159585282206535
alter O 0 0.3177511394023895
splice O 1 0.5983056426048279
sites O 0 0.009942874312400818
, O 0 0.005877634510397911
and O 0 0.0058085923083126545
others O 0 0.013754954561591148
codons O 0 0.36329618096351624
. O 0 0.02300712652504444

They O 0 0.011941960081458092
are O 0 0.007799313869327307
distributed O 0 0.011348070576786995
along O 0 0.008142341859638691
the O 0 0.00888293981552124
C7 O 1 0.9391865730285645
gene O 1 0.8076305985450745
, O 0 0.006222086027264595
but O 0 0.004241178743541241
predominantly O 0 0.007106164935976267
towards O 0 0.006728054489940405
the O 0 0.0054008313454687595
3 O 0 0.010946848429739475
end O 0 0.014980006031692028
. O 0 0.0182727612555027

All O 0 0.013735782355070114
were O 0 0.008316116407513618
found O 0 0.011477687396109104
in O 0 0.01015852764248848
compound O 0 0.13590142130851746
heterozygous O 1 0.870840311050415
individuals O 0 0.13663089275360107
. O 0 0.030114969238638878

The O 0 0.06267590820789337
C6 O 1 0.9036015868186951
/ O 1 0.8025330901145935
C7 O 1 0.9308555722236633
marker O 1 0.6877550482749939
haplotypes O 1 0.95086270570755
associated O 0 0.0903446152806282
with O 0 0.012256782501935959
most O 0 0.021255360916256905
C7 B-Disease 1 0.9614372253417969
defects I-Disease 1 0.9385058283805847
are O 0 0.009063854813575745
tabulated O 0 0.021185442805290222
. O 0 0.01264302060008049
. O 0 0.01638781651854515

A O 0 0.052082061767578125
genome O 1 0.6400474309921265
- O 0 0.07728229463100433
wide O 0 0.023205948993563652
search O 0 0.02211230993270874
for O 0 0.026205778121948242
chromosomal O 1 0.9878399968147278
loci O 1 0.9766419529914856
linked O 1 0.8087823987007141
to O 0 0.0331946425139904
mental O 1 0.9684907793998718
health O 1 0.8281220197677612
wellness O 1 0.7912034392356873
in O 0 0.011918829753994942
relatives O 0 0.08896259218454361
at O 0 0.012427798472344875
high O 0 0.13106019794940948
risk O 1 0.9673430323600769
for O 0 0.3586370050907135
bipolar B-Disease 1 0.9973067045211792
affective I-Disease 1 0.9935898780822754
disorder I-Disease 1 0.9929018616676331
among O 0 0.02282712794840336
the O 0 0.009083118289709091
Old O 0 0.02599964663386345
Order O 0 0.02060496248304844
Amish O 0 0.14620208740234375
. O 0 0.025986764580011368

Bipolar B-Disease 1 0.9888006448745728
affective I-Disease 1 0.9857730269432068
disorder I-Disease 1 0.9927865862846375
( O 1 0.8381319642066956
BPAD B-Disease 1 0.9796229004859924
; O 1 0.8670800924301147
manic B-Disease 1 0.99366295337677
- I-Disease 1 0.9853211045265198
depressive I-Disease 1 0.9959661960601807
illness I-Disease 1 0.9934266805648804
) O 0 0.10069169849157333
is O 0 0.011532112024724483
characterized O 0 0.20018163323402405
by O 0 0.00811450183391571
episodes O 0 0.04940943419933319
of O 0 0.01059243455529213
mania B-Disease 1 0.9617714285850525
and O 0 0.018958045169711113
/ O 1 0.6406643390655518
or O 0 0.08505650609731674
hypomania B-Disease 1 0.9751074910163879
interspersed O 0 0.24155710637569427
with O 0 0.012249707244336605
periods O 0 0.0657394602894783
of O 0 0.015821540728211403
depression B-Disease 1 0.9200601577758789
. O 0 0.040174953639507294

Compelling O 0 0.04529132694005966
evidence O 0 0.018575584515929222
supports O 0 0.01676386222243309
a O 0 0.01059008575975895
significant O 0 0.023236848413944244
genetic O 1 0.807035505771637
component O 0 0.06391535699367523
in O 0 0.008101340383291245
the O 0 0.01059779804199934
susceptibility O 1 0.9458097219467163
to O 0 0.017953258007764816
develop O 1 0.525578498840332
BPAD B-Disease 1 0.8374414443969727
. O 0 0.038408130407333374

To O 0 0.01309795118868351
date O 0 0.011259160004556179
, O 0 0.005215296987444162
however O 0 0.004779616370797157
, O 0 0.004206547979265451
linkage O 0 0.13898947834968567
studies O 0 0.009998275898396969
have O 0 0.003092133905738592
attempted O 0 0.006247170269489288
only O 0 0.003577405121177435
to O 0 0.004516133572906256
identify O 0 0.316478967666626
chromosomal O 1 0.9876565933227539
loci O 1 0.9369810819625854
that O 0 0.012486901134252548
cause O 0 0.4526611566543579
or O 0 0.012734092772006989
increase O 0 0.018894193693995476
the O 0 0.008864883333444595
risk O 1 0.6188517212867737
of O 0 0.012014945037662983
developing O 0 0.4749038517475128
BPAD B-Disease 1 0.8286905884742737
. O 0 0.03899472951889038

To O 0 0.013684147037565708
determine O 0 0.012603817507624626
whether O 0 0.007096059154719114
there O 0 0.0039198920130729675
could O 0 0.0043706889264285564
be O 0 0.004922408144921064
protective O 1 0.5716280341148376
alleles O 1 0.9546501040458679
that O 0 0.00763791473582387
prevent O 0 0.18805411458015442
or O 0 0.011923928745090961
reduce O 0 0.08530880510807037
the O 0 0.005194956436753273
risk O 1 0.5112398862838745
of O 0 0.005928972736001015
developing O 0 0.3151724338531494
BPAD B-Disease 1 0.7220700979232788
, O 0 0.003948150668293238
similar O 0 0.005161360837519169
to O 0 0.0024782747495919466
what O 0 0.0029698433354496956
is O 0 0.0031200991943478584
observed O 0 0.02523713931441307
in O 0 0.007010560482740402
other O 0 0.04885239154100418
genetic B-Disease 1 0.9956395626068115
disorders I-Disease 1 0.9968910813331604
, O 0 0.009856438264250755
we O 0 0.005148835945874453
used O 0 0.05177130922675133
mental O 1 0.9778448343276978
health O 1 0.9483596086502075
wellness O 1 0.9363032579421997
( O 0 0.06739853322505951
absence O 0 0.10683204233646393
of O 0 0.009050361812114716
any O 0 0.11073914170265198
psychiatric B-Disease 1 0.9903702139854431
disorder I-Disease 1 0.9956603646278381
) O 0 0.028788022696971893
as O 0 0.004696111660450697
the O 0 0.006296283099800348
phenotype O 1 0.9510872960090637
in O 0 0.006106906104832888
our O 0 0.00931578129529953
genome O 1 0.8622139692306519
- O 0 0.22204835712909698
wide O 0 0.05284000560641289
linkage O 1 0.5727813243865967
scan O 0 0.09130318462848663
of O 0 0.004288399126380682
several O 0 0.004563420545309782
large O 0 0.008562413975596428
multigeneration O 0 0.2958897650241852
Old O 0 0.01853538118302822
Order O 0 0.012987112626433372
Amish O 0 0.23012742400169373
pedigrees O 1 0.5539947152137756
exhibiting O 0 0.2974250018596649
an O 0 0.011685583740472794
extremely O 0 0.08542575687170029
high O 0 0.06809353083372116
incidence O 1 0.9456257224082947
of O 0 0.021686095744371414
BPAD B-Disease 1 0.7569673657417297
. O 0 0.037898339331150055

We O 0 0.012054073624312878
have O 0 0.006431563291698694
found O 0 0.006518085021525621
strong O 0 0.005602217745035887
evidence O 0 0.005504949484020472
for O 0 0.00469561479985714
a O 0 0.008208835497498512
locus O 1 0.620255172252655
on O 0 0.010834106244146824
chromosome O 1 0.9606202840805054
4p O 1 0.7191254496574402
at O 0 0.014051790349185467
D4S2949 O 0 0.2610965967178345
( O 0 0.021355384960770607
maximum O 0 0.021972034126520157
GENEHUNTER O 1 0.5832979083061218
- O 0 0.15071521699428558
PLUS O 0 0.038645993918180466
nonparametric O 0 0.4605005085468292
linkage O 0 0.40486061573028564
score O 0 0.012178038246929646
= O 0 0.0883224606513977
4 O 0 0.009638968855142593
. O 0 0.005598949734121561
05 O 0 0.03454634174704552
, O 0 0.006708817556500435
P O 0 0.1310960203409195
= O 0 0.08784689754247665
5 O 0 0.0072668734937906265
. O 0 0.0041419146582484245
22 O 0 0.006630381569266319
x O 0 0.029124120250344276
10 O 0 0.0072715189307928085
( O 0 0.014167376793920994
- O 0 0.06668225675821304
4 O 0 0.013247120194137096
) O 0 0.013536122627556324
; O 0 0.01227826438844204
SIBPAL O 0 0.41434451937675476
Pempirical O 0 0.32179734110832214
value O 0 0.01562253013253212
< O 0 0.39391419291496277
3 O 0 0.012975399382412434
x O 0 0.05426898971199989
10 O 0 0.008089485578238964
( O 0 0.013945136219263077
- O 0 0.05911696329712868
5 O 0 0.009675961919128895
) O 0 0.005625040270388126
) O 0 0.004148609470576048
and O 0 0.0024189625401049852
suggestive O 0 0.06738004833459854
evidence O 0 0.0046638366766273975
for O 0 0.0036674090661108494
a O 0 0.009686404839158058
locus O 1 0.8010748028755188
on O 0 0.01209020335227251
chromosome O 1 0.9793582558631897
4q O 1 0.9203826785087585
at O 0 0.02025528810918331
D4S397 O 1 0.5210416316986084
( O 0 0.029940158128738403
maximum O 0 0.024645091965794563
GENEHUNTER O 1 0.5274708271026611
- O 0 0.1380312591791153
PLUS O 0 0.035440899431705475
nonparametric O 1 0.5079190135002136
linkage O 0 0.4017163813114166
score O 0 0.01180422306060791
= O 0 0.09848154336214066
3 O 0 0.00752245495095849
. O 0 0.003958739340305328
29 O 0 0.006785309873521328
, O 0 0.004703880753368139
P O 0 0.08191639184951782
= O 0 0.06118207797408104
2 O 0 0.0070008146576583385
. O 0 0.004090377129614353
57 O 0 0.009232791140675545
x O 0 0.028788866475224495
10 O 0 0.007745195180177689
( O 0 0.020117778331041336
- O 0 0.0677892193198204
3 O 0 0.011062505654990673
) O 0 0.011545082554221153
; O 0 0.015733418986201286
SIBPAL O 0 0.42836758494377136
Pempirical O 0 0.37539026141166687
value O 0 0.01485525257885456
< O 0 0.49698376655578613
1 O 0 0.011975995264947414
x O 0 0.03477709740400314
10 O 0 0.008843881078064442
( O 0 0.01807115413248539
- O 0 0.043194495141506195
3 O 0 0.0090689267963171
) O 0 0.009074177592992783
) O 0 0.0045572491362690926
that O 0 0.002736244583502412
are O 0 0.003785531036555767
linked O 0 0.20409761369228363
to O 0 0.013696818612515926
mental O 1 0.9187435507774353
health O 1 0.8642001152038574
wellness O 1 0.8616041541099548
. O 0 0.037885405123233795

These O 0 0.014160512015223503
findings O 0 0.01565518043935299
are O 0 0.005184948910027742
consistent O 0 0.008854750543832779
with O 0 0.0041399444453418255
the O 0 0.003801788203418255
hypothesis O 0 0.1096019446849823
that O 0 0.004290794488042593
certain O 0 0.02809140831232071
alleles O 1 0.9577915072441101
could O 0 0.015071198344230652
prevent O 0 0.19929741322994232
or O 0 0.014335979707539082
modify O 0 0.19439581036567688
the O 0 0.01142443809658289
clinical O 1 0.9154636859893799
manifestations O 0 0.4486072361469269
of O 0 0.009061316959559917
BPAD B-Disease 1 0.7688854336738586
and O 0 0.009569092653691769
perhaps O 0 0.04613601043820381
other O 0 0.02659262716770172
related O 1 0.8131236433982849
affective B-Disease 1 0.989027738571167
disorders I-Disease 1 0.9926406741142273
. O 0 0.13493046164512634

Segregation O 1 0.5603153109550476
distortion O 1 0.6753727793693542
in O 0 0.17911364138126373
myotonic B-Disease 1 0.9672388434410095
dystrophy I-Disease 1 0.9740294814109802
. O 0 0.12175558507442474

Myotonic B-Disease 1 0.9824057221412659
dystrophy I-Disease 1 0.9888244271278381
( O 1 0.6852332949638367
DM B-Disease 1 0.9751940965652466
) O 0 0.10670884698629379
is O 0 0.03125811740756035
an O 0 0.15963688492774963
autosomal B-Disease 1 0.997505247592926
dominant I-Disease 1 0.9577261209487915
disease I-Disease 1 0.9945214986801147
which O 0 0.005828933324664831
, O 0 0.0033041650895029306
in O 0 0.0028293728828430176
the O 0 0.003174412762746215
typical O 0 0.05107783526182175
pedigree O 0 0.21950982511043549
, O 0 0.0036892653442919254
shows O 0 0.005279570817947388
a O 0 0.00566605431959033
three O 0 0.0063251624815166
generation O 0 0.06628987938165665
anticipation O 0 0.1176539734005928
cascade O 1 0.6945120692253113
. O 0 0.030415846034884453

This O 0 0.027413975447416306
results O 0 0.15715231001377106
in O 0 0.18383271992206573
infertility B-Disease 1 0.9940802454948425
and O 1 0.8226816654205322
congenital B-Disease 1 0.9987114667892456
myotonic I-Disease 1 0.9973005652427673
dystrophy I-Disease 1 0.9971247315406799
( O 1 0.5593568086624146
CDM B-Disease 1 0.926099956035614
) O 0 0.018539058044552803
with O 0 0.005965664517134428
the O 0 0.005119443405419588
disappearance O 0 0.08129088580608368
of O 0 0.009188935160636902
DM B-Disease 1 0.954449474811554
in O 0 0.013262120075523853
that O 0 0.012875668704509735
pedigree O 1 0.5215593576431274
. O 0 0.028870947659015656

The O 0 0.015634149312973022
concept O 0 0.01709746941924095
of O 0 0.007466472219675779
segregation O 0 0.09233491867780685
distortion O 0 0.08602114766836166
, O 0 0.004323482979089022
where O 0 0.002850356511771679
there O 0 0.0027635530568659306
is O 0 0.003092429367825389
preferential O 0 0.051662422716617584
transmission O 0 0.1327943205833435
of O 0 0.003176935249939561
the O 0 0.003806658089160919
larger O 0 0.03002018854022026
allele O 1 0.8131035566329956
at O 0 0.007213218603283167
the O 0 0.012690089643001556
DM B-Disease 1 0.9853829145431519
locus O 1 0.8479726314544678
, O 0 0.003919616341590881
has O 0 0.0029151011258363724
been O 0 0.0027007111348211765
put O 0 0.0037128839176148176
forward O 0 0.003404629183933139
to O 0 0.002748277969658375
explain O 0 0.007963629439473152
partially O 0 0.019344769418239594
the O 0 0.0041848584078252316
maintenance O 0 0.03205307573080063
of O 0 0.0067272065207362175
DM B-Disease 1 0.9488871097564697
in O 0 0.00816572830080986
the O 0 0.008418341167271137
population O 0 0.03155199810862541
. O 0 0.021631639450788498

In O 0 0.01893099769949913
a O 0 0.013993351720273495
survey O 0 0.013595214113593102
of O 0 0.008636192418634892
DM B-Disease 1 0.8598411083221436
in O 0 0.00864469725638628
Northern O 0 0.010959855280816555
Ireland O 0 0.012063845060765743
, O 0 0.0074278488755226135
59 O 0 0.018870705738663673
pedigrees O 0 0.14639416337013245
were O 0 0.010817447677254677
ascertained O 0 0.13604718446731567
. O 0 0.024848995730280876

Sibships O 0 0.10726186633110046
where O 0 0.010566015727818012
the O 0 0.004940513521432877
status O 0 0.005455431062728167
of O 0 0.0020614718087017536
all O 0 0.0016007067169994116
the O 0 0.0020175327081233263
members O 0 0.002572174184024334
had O 0 0.0024892359506338835
been O 0 0.0023155161179602146
identified O 0 0.004570808261632919
were O 0 0.001930593396537006
examined O 0 0.006192597094923258
to O 0 0.002065767999738455
determine O 0 0.003786529414355755
the O 0 0.002965514548122883
transmission O 0 0.24581953883171082
of O 0 0.003314509056508541
the O 0 0.009003929793834686
DM B-Disease 1 0.9816902279853821
expansion O 0 0.045463260263204575
from O 0 0.00781947746872902
affected O 0 0.10416368395090103
parents O 0 0.015322511084377766
to O 0 0.005957388319075108
their O 0 0.010820969007909298
offspring O 1 0.6264545321464539
. O 0 0.031259991228580475

Where O 0 0.02335296757519245
the O 0 0.01781579852104187
transmitting O 0 0.28709232807159424
parent O 0 0.15391981601715088
was O 0 0.011699220165610313
male O 0 0.09518726915121078
, O 0 0.013146660290658474
58 O 0 0.029553374275565147
. O 0 0.023389510810375214

3 O 0 0.020818842574954033
% O 0 0.012048986740410328
of O 0 0.005164192058146
the O 0 0.004677269607782364
offspring O 0 0.22638067603111267
were O 0 0.0034752734936773777
affected O 0 0.033784836530685425
, O 0 0.002904281485825777
and O 0 0.0018781162798404694
in O 0 0.002044742926955223
the O 0 0.002126250881701708
case O 0 0.003952397033572197
of O 0 0.002935481956228614
a O 0 0.00843290239572525
female O 0 0.18526314198970795
transmitting O 1 0.5910731554031372
parent O 0 0.3151465952396393
, O 0 0.013848870992660522
68 O 0 0.038835689425468445
. O 0 0.022452594712376595

7 O 0 0.048399750143289566
% O 0 0.03197098523378372
were O 0 0.016426851972937584
affected O 0 0.06815776973962784
. O 0 0.030406886711716652

Studies O 0 0.04904046654701233
on O 0 0.018093660473823547
meiotic O 1 0.6111493706703186
drive O 0 0.030000783503055573
in O 0 0.015386125072836876
DM B-Disease 1 0.8791384100914001
have O 0 0.007004222832620144
shown O 0 0.011423523537814617
increased O 0 0.012370426207780838
transmission O 0 0.0855906680226326
of O 0 0.004100065678358078
the O 0 0.004877960309386253
larger O 0 0.027699682861566544
allele O 1 0.7683772444725037
at O 0 0.0088046221062541
the O 0 0.016500715166330338
DM B-Disease 1 0.9822117686271667
locus O 1 0.936553418636322
in O 0 0.03812815621495247
non O 0 0.35508114099502563
- O 1 0.8324882984161377
DM O 1 0.9826467633247375
heterozygotes O 1 0.9360785484313965
for O 0 0.029926199465990067
CTGn O 1 0.5580929517745972
. O 0 0.037005066871643066

This O 0 0.01777837611734867
study O 0 0.017741119489073753
provides O 0 0.013759651221334934
further O 0 0.006428562104701996
evidence O 0 0.006303226109594107
that O 0 0.004396005999296904
the O 0 0.005760257598012686
DM B-Disease 1 0.948611319065094
expansion O 0 0.053449101746082306
tends O 0 0.05631084740161896
to O 0 0.005856759380549192
be O 0 0.009198702871799469
transmitted O 1 0.7035387754440308
preferentially O 0 0.3838930130004883
. O 0 0.02690914459526539

Diagnosis O 1 0.9390624165534973
of O 0 0.07448460906744003
hemochromatosis B-Disease 1 0.9450631141662598
. O 0 0.07820233702659607

If O 0 0.139629527926445
untreated O 1 0.9630382061004639
, O 0 0.25250089168548584
hemochromatosis B-Disease 1 0.9930859804153442
can O 0 0.49635323882102966
cause O 1 0.9758604764938354
serious O 1 0.9256246089935303
illness O 1 0.9825438857078552
and O 0 0.007074777036905289
early B-Disease 0 0.014885888434946537
death I-Disease 0 0.07230307906866074
, O 0 0.004730867687612772
but O 0 0.004586891736835241
the O 0 0.016509003937244415
disease O 1 0.9933524131774902
is O 0 0.010667507536709309
still O 0 0.011646810919046402
substantially O 0 0.2473725825548172
under O 0 0.03354445844888687
- O 1 0.8415526151657104
diagnosed O 1 0.9889426231384277
. O 0 0.0661109909415245

The O 0 0.015296668745577335
cornerstone O 0 0.030765468254685402
of O 0 0.007743231952190399
screening O 0 0.10295356810092926
and O 0 0.00434879818931222
case O 0 0.01216551661491394
detection O 0 0.09698302298784256
is O 0 0.0038128835149109364
the O 0 0.0036267824470996857
measurement O 0 0.04099471494555473
of O 0 0.008776876144111156
serum O 1 0.9130497574806213
transferrin O 1 0.8287034630775452
saturation O 0 0.34321728348731995
and O 0 0.00888440478593111
the O 0 0.011791837401688099
serum O 1 0.8728097081184387
ferritin O 1 0.8182069659233093
level O 0 0.058165792375802994
. O 0 0.029904033988714218

Once O 0 0.034627627581357956
the O 0 0.02243114821612835
diagnosis O 1 0.9532669186592102
is O 0 0.012731203809380531
suspected O 0 0.07003741711378098
, O 0 0.007255746982991695
physicians O 0 0.14508378505706787
must O 0 0.007620514370501041
use O 0 0.014761768281459808
serum O 1 0.8804003000259399
ferritin O 1 0.8635045289993286
levels O 0 0.2532823085784912
and O 0 0.021384738385677338
hepatic O 1 0.9881172776222229
iron O 0 0.2946830093860626
stores O 0 0.06518211960792542
on O 0 0.047211796045303345
liver O 1 0.9961974620819092
biopsy O 1 0.9780576825141907
specimens O 0 0.38194361329078674
to O 0 0.009450349025428295
assess O 0 0.33777177333831787
patients O 1 0.8589791059494019
for O 0 0.005071219056844711
the O 0 0.005541959311813116
presence O 0 0.017577961087226868
of O 0 0.009028799831867218
iron B-Disease 0 0.377596914768219
overload I-Disease 1 0.9093170762062073
. O 0 0.04006986692547798

Liver O 1 0.9811122417449951
biopsy O 1 0.7098130583763123
is O 0 0.009224515408277512
also O 0 0.004748758859932423
used O 0 0.0038239420391619205
to O 0 0.002653920091688633
establish O 0 0.005137529689818621
the O 0 0.0031439431477338076
presence O 0 0.019860373809933662
or O 0 0.009480543434619904
absence O 0 0.051119569689035416
of O 0 0.012143072672188282
cirrhosis B-Disease 1 0.9922214150428772
, O 0 0.007425264921039343
which O 0 0.005969262216240168
can O 0 0.023102344945073128
affect O 0 0.49245911836624146
prognosis O 1 0.937217652797699
and O 0 0.01168842613697052
management O 0 0.0648437887430191
. O 0 0.019198795780539513

A O 0 0.04897606000304222
DNA O 0 0.42629411816596985
- O 0 0.06605525314807892
based O 0 0.009880013763904572
test O 0 0.010852620005607605
for O 0 0.005769582465291023
the O 0 0.008519564755260944
HFE O 1 0.973755419254303
gene O 1 0.8518956303596497
is O 0 0.005683508235961199
commercially O 0 0.007775201462209225
available O 0 0.003288842272013426
, O 0 0.001970981014892459
but O 0 0.0017281608888879418
its O 0 0.0017965270671993494
place O 0 0.0023399554193019867
in O 0 0.00292002409696579
the O 0 0.006086905021220446
diagnosis O 1 0.9711139798164368
of O 0 0.019807133823633194
hemochromatosis B-Disease 1 0.9898967742919922
is O 0 0.00835276860743761
still O 0 0.00801608432084322
being O 0 0.010056174360215664
evaluated O 0 0.09696533530950546
. O 0 0.021742668002843857

Currently O 0 0.014283028431236744
, O 0 0.0058309342712163925
the O 0 0.003856128780171275
most O 0 0.0031437308061867952
useful O 0 0.00540590938180685
role O 0 0.004553990438580513
for O 0 0.0022633203770965338
this O 0 0.0023407682310789824
test O 0 0.004859750159084797
is O 0 0.002335301600396633
in O 0 0.0022228050511330366
the O 0 0.002955082803964615
detection O 0 0.17598722875118256
of O 0 0.006539184134453535
hemochromatosis B-Disease 1 0.9857416152954102
in O 0 0.005944765172898769
the O 0 0.003988883923739195
family O 0 0.013362495228648186
members O 0 0.003953658975660801
of O 0 0.006501426454633474
patients O 1 0.9372276067733765
with O 0 0.007424706593155861
a O 0 0.007791587617248297
proven O 0 0.05563056096434593
case O 0 0.01530445832759142
of O 0 0.007909326814115047
the O 0 0.033182576298713684
disease O 1 0.9895840287208557
. O 0 0.06479823589324951

It O 0 0.020265981554985046
is O 0 0.014849873259663582
crucial O 0 0.030518189072608948
to O 0 0.05018671229481697
diagnose O 1 0.9923351407051086
hemochromatosis B-Disease 1 0.993683934211731
before O 1 0.8502208590507507
hepatic B-Disease 1 0.9970883727073669
cirrhosis I-Disease 1 0.9971278309822083
develops O 1 0.983684778213501
because O 1 0.7377042770385742
phlebotomy O 1 0.9893631339073181
therapy O 1 0.9909311532974243
can O 1 0.6348184943199158
avert O 1 0.9844532608985901
serious O 1 0.9904261231422424
chronic O 1 0.9986652135848999
disease O 1 0.9966863989830017
and O 0 0.010026412084698677
can O 0 0.00796518288552761
even O 0 0.006299828179180622
lead O 0 0.017465297132730484
to O 0 0.006521161179989576
normal O 0 0.10911291092634201
life O 0 0.04391727223992348
expectancy O 1 0.5923564434051514
. O 0 0.018653713166713715
. O 0 0.020990289747714996

Prevalence O 1 0.635255753993988
of O 0 0.019129125401377678
the O 0 0.018892740830779076
I1307K O 1 0.8350903391838074
APC B-Disease 1 0.9466162919998169
gene O 1 0.9565885066986084
variant O 1 0.5970224738121033
in O 0 0.007642216980457306
Israeli O 0 0.009372545406222343
Jews O 0 0.008152881637215614
of O 0 0.004646258428692818
differing O 0 0.02074744738638401
ethnic O 0 0.026558037847280502
origin O 0 0.0699048563838005
and O 0 0.03315122053027153
risk O 1 0.9647911190986633
for O 0 0.4107843041419983
colorectal B-Disease 1 0.9976314306259155
cancer I-Disease 1 0.9935827851295471
. O 0 0.14776243269443512

BACKGROUND O 0 0.056644778698682785
& O 0 0.03794027864933014
AIMS O 0 0.02259182371199131
Israeli O 0 0.011213536374270916
Jews O 0 0.007672479376196861
of O 0 0.004151921719312668
European O 0 0.008423501625657082
birth O 0 0.16279537975788116
, O 0 0.004055333323776722
i O 0 0.003577574621886015
. O 0 0.00375954806804657
e O 0 0.023532714694738388
. O 0 0.0033313212916254997
, O 0 0.0038324834313243628
Ashkenazim O 0 0.1372057944536209
, O 0 0.0036537779960781336
have O 0 0.003679132554680109
the O 0 0.010685457848012447
highest O 1 0.7187141180038452
colorectal B-Disease 1 0.999000608921051
cancer I-Disease 1 0.9979902505874634
incidence O 1 0.9713558554649353
of O 0 0.008306825533509254
any O 0 0.008856742642819881
Israeli O 0 0.013507695868611336
ethnic O 0 0.022792518138885498
group O 0 0.022785089910030365
. O 0 0.022332685068249702

The O 0 0.04179229959845543
I1307K O 1 0.7918689250946045
APC B-Disease 1 0.9477736353874207
gene O 1 0.9565266966819763
variant O 1 0.7362578511238098
was O 0 0.014449476264417171
found O 0 0.013874017633497715
in O 0 0.012493640184402466
6 O 0 0.02183840423822403
. O 0 0.021877471357584

1 O 0 0.022834284231066704
% O 0 0.01385109219700098
of O 0 0.00592357013374567
American O 0 0.006821285933256149
Jews O 0 0.0069668530486524105
, O 0 0.003876876551657915
28 O 0 0.006301339250057936
% O 0 0.010920909233391285
of O 0 0.008388620801270008
their O 0 0.2737048268318176
familial O 1 0.9983945488929749
colorectal B-Disease 1 0.9992757439613342
cancer I-Disease 1 0.99819415807724
cases O 1 0.6031908988952637
, O 0 0.006663213018327951
but O 0 0.003568073734641075
not O 0 0.003275523893535137
in O 0 0.005277588032186031
non O 0 0.03383298218250275
- O 0 0.10207252949476242
Jews O 0 0.027289433404803276
. O 0 0.023123865947127342

We O 0 0.019946081563830376
assessed O 0 0.025248439982533455
the O 0 0.010265281423926353
I1307K O 0 0.4189424216747284
prevalence O 1 0.7488254904747009
in O 0 0.005979496985673904
Israeli O 0 0.007528919260948896
Jews O 0 0.006304376758635044
of O 0 0.0038053870666772127
differing O 0 0.03266162425279617
ethnic O 0 0.030387118458747864
origin O 0 0.08255526423454285
and O 0 0.03157784417271614
risk O 1 0.9579289555549622
for O 0 0.3867951035499573
colorectal B-Disease 1 0.9978222846984863
cancer I-Disease 1 0.9949533343315125
. O 0 0.16687777638435364

METHODS O 0 0.06477294117212296
DNA O 0 0.258932888507843
samples O 0 0.02755366824567318
from O 0 0.008681676350533962
500 O 0 0.011973434127867222
unrelated O 0 0.04131081700325012
Jews O 0 0.005488807801157236
of O 0 0.003633796703070402
European O 0 0.006971743423491716
or O 0 0.006700536236166954
non O 0 0.01830875314772129
- O 0 0.0386735163629055
European O 0 0.006919980514794588
origin O 0 0.008815129287540913
, O 0 0.0029993965290486813
with O 0 0.0029390500858426094
or O 0 0.003519889432936907
without O 0 0.0035270394291728735
a O 0 0.0036659075412899256
personal O 0 0.008885663002729416
and O 0 0.0040405369363725185
/ O 0 0.22282320261001587
or O 0 0.007547787390649319
family O 0 0.00895386841148138
history O 0 0.005382655654102564
of O 0 0.005624003242701292
neoplasia B-Disease 1 0.9490272998809814
, O 0 0.004725841339677572
were O 0 0.0029497770592570305
examined O 0 0.013826902024447918
for O 0 0.0038940238300710917
the O 0 0.005242112558335066
I1307K O 1 0.5251908302307129
variant O 1 0.7915017604827881
by O 0 0.011831682175397873
the O 0 0.010909447446465492
allele O 1 0.9622431993484497
- O 0 0.444381982088089
specific O 0 0.14686362445354462
oligonucleotide O 1 0.8565373420715332
( O 0 0.07990436255931854
ASO O 0 0.3935413658618927
) O 0 0.028161074966192245
method O 0 0.04541368782520294
. O 0 0.02522057667374611

RESULTS O 0 0.04416359215974808
In O 0 0.013544400222599506
persons O 0 0.02479453943669796
at O 0 0.012345138005912304
average O 0 0.18966107070446014
risk O 1 0.9684491753578186
for O 1 0.5071594715118408
colorectal B-Disease 1 0.9986802935600281
cancer I-Disease 1 0.9961543679237366
, O 0 0.027320152148604393
I1307K O 0 0.48895561695098877
was O 0 0.007150279823690653
found O 0 0.009969666600227356
in O 0 0.00831025093793869
5 O 0 0.01655018888413906
. O 0 0.017505882307887077

0 O 0 0.03199309855699539
% O 0 0.015157545916736126
of O 0 0.0070822471752762794
120 O 0 0.012413269840180874
European O 0 0.010550389066338539
and O 0 0.007705189287662506
1 O 0 0.016383519396185875
. O 0 0.018815550953149796

6 O 0 0.02910800278186798
% O 0 0.016956990584731102
of O 0 0.008548641577363014
188 O 0 0.02296476438641548
non O 0 0.02744358591735363
- O 0 0.04713745415210724
European O 0 0.012433874420821667
Jews O 0 0.0158980805426836
( O 0 0.03669951483607292
P O 0 0.3274782598018646
= O 0 0.1292869597673416
0 O 0 0.02163068577647209
. O 0 0.008721222169697285
08 O 0 0.06158653646707535
) O 0 0.01848442293703556
. O 0 0.016506193205714226

It O 0 0.02845402993261814
occurred O 0 0.034288451075553894
in O 0 0.017224857583642006
15 O 0 0.025382041931152344
. O 0 0.02289658598601818

4 O 0 0.03137657418847084
% O 0 0.017853310331702232
of O 0 0.010288971476256847
52 O 0 0.032252389937639236
Ashkenazi O 1 0.5418043732643127
Israelis O 0 0.16456882655620575
with O 0 0.24960783123970032
familial O 1 0.995347797870636
cancer B-Disease 1 0.9963730573654175
( O 0 0.3682011067867279
P O 1 0.738284707069397
= O 0 0.293364554643631
0 O 0 0.027919812127947807
. O 0 0.005982541479170322
02 O 0 0.19963757693767548
) O 0 0.00648334389552474
and O 0 0.0023524996358901262
was O 0 0.0024558554869145155
not O 0 0.0026191940996795893
detected O 0 0.08493901044130325
in O 0 0.0038211606442928314
51 O 0 0.014987763017416
non O 0 0.020999323576688766
- O 0 0.04405944421887398
European O 0 0.011116991750895977
Jews O 0 0.01860741339623928
at O 0 0.027514463290572166
increased O 1 0.7183260321617126
cancer B-Disease 1 0.9945464134216309
risk O 1 0.925257682800293
. O 0 0.05876564979553223

Colorectal B-Disease 1 0.9836937785148621
neoplasia I-Disease 1 0.9567410349845886
occurred O 0 0.06527373194694519
personally O 0 0.02094205655157566
or O 0 0.007762148976325989
in O 0 0.0038143054116517305
the O 0 0.0030611632391810417
families O 0 0.004986800719052553
of O 0 0.0032061750534921885
13 O 0 0.005443752743303776
of O 0 0.0036192946135997772
20 O 0 0.013584456406533718
Ashkenazi O 1 0.73709636926651
I1307K O 1 0.6594700217247009
carriers O 0 0.2389676421880722
, O 0 0.003969612531363964
8 O 0 0.004566150717437267
of O 0 0.002599336439743638
whom O 0 0.004795952700078487
also O 0 0.002500202739611268
had O 0 0.002758680609986186
a O 0 0.003950220067054033
personal O 0 0.008910022675991058
or O 0 0.00805271603167057
family O 0 0.012316351756453514
history O 0 0.009622975252568722
of O 0 0.01319450605660677
noncolonic O 1 0.8795634508132935
neoplasia B-Disease 1 0.9726632833480835
. O 0 0.05435642972588539

CONCLUSIONS O 0 0.049426790326833725
The O 0 0.024426294490695
I1307K O 1 0.6839638352394104
APC O 1 0.8772899508476257
variant O 1 0.8262460231781006
may O 0 0.031048336997628212
represent O 0 0.025906994938850403
a O 0 0.14528235793113708
susceptibility O 1 0.9929814338684082
gene O 1 0.9878286123275757
for O 0 0.13841071724891663
colorectal B-Disease 1 0.9963311553001404
, I-Disease 0 0.011384590528905392
or I-Disease 0 0.013851839117705822
other I-Disease 0 0.007415174972265959
, I-Disease 0 0.019951647147536278
cancers I-Disease 1 0.992000937461853
in O 0 0.013363496400415897
Ashkenazi O 0 0.488089919090271
Jews O 0 0.010437573306262493
, O 0 0.0037542504724115133
and O 0 0.003202180378139019
partially O 0 0.06536416709423065
explains O 0 0.03967666998505592
the O 0 0.007419254630804062
higher O 0 0.3161601424217224
incidence O 1 0.9926208257675171
of O 1 0.503332793712616
colorectal B-Disease 1 0.998677670955658
cancer I-Disease 1 0.9950672388076782
in O 0 0.02204260416328907
European O 0 0.03754062578082085
Israelis O 0 0.07319018989801407
. O 0 0.027346951887011528

Systematic O 0 0.15342149138450623
analysis O 0 0.054445624351501465
of O 0 0.026706380769610405
coproporphyrinogen O 1 0.9502330422401428
oxidase O 1 0.9880319833755493
gene O 1 0.9887434244155884
defects O 1 0.9846371412277222
in O 0 0.09940008819103241
hereditary B-Disease 1 0.965580940246582
coproporphyria I-Disease 1 0.8492678999900818
and O 0 0.04848647117614746
mutation O 1 0.9748082160949707
update O 0 0.49212753772735596
. O 0 0.03781028464436531

Hereditary B-Disease 1 0.9454790949821472
coproporphyria I-Disease 1 0.8453673124313354
( O 0 0.15641696751117706
HC B-Disease 1 0.644649863243103
) O 0 0.0489627867937088
is O 0 0.026455959305167198
an O 0 0.1993708610534668
acute O 1 0.9950632452964783
hepatic B-Disease 1 0.9970768690109253
porphyria I-Disease 1 0.9944887161254883
with O 1 0.7385090589523315
autosomal O 1 0.9968065023422241
dominant O 1 0.9421330094337463
inheritance O 1 0.9605725407600403
caused O 1 0.725267231464386
by O 0 0.029848255217075348
deficient B-Disease 1 0.8775742650032043
activity I-Disease 0 0.06182750687003136
of I-Disease 0 0.01457441970705986
coproporphyrinogen I-Disease 1 0.8458499908447266
III I-Disease 1 0.8029184937477112
oxidase I-Disease 1 0.9566741585731506
( O 0 0.06842059642076492
CPO O 0 0.21043092012405396
) O 0 0.028158271685242653
. O 0 0.021208535879850388

Clinical O 1 0.8918097615242004
manifestations O 0 0.3845159709453583
of O 0 0.014067296870052814
the O 0 0.08027724176645279
disease O 1 0.9954896569252014
are O 0 0.03626970574259758
characterized O 1 0.8976723551750183
by O 0 0.13550934195518494
acute O 1 0.9908697009086609
attacks O 1 0.6039162278175354
of O 0 0.28087252378463745
neurological B-Disease 1 0.9970842003822327
dysfunction I-Disease 1 0.9944885969161987
often O 0 0.3043034076690674
precipitated O 1 0.9166618585586548
by O 0 0.054234184324741364
drugs O 1 0.7987907528877258
, O 0 0.018751464784145355
fasting O 1 0.5978083610534668
, O 0 0.05066332966089249
cyclical O 1 0.9560465812683105
hormonal O 1 0.9855587482452393
changes O 0 0.4058704376220703
, O 0 0.058995623141527176
or O 1 0.5252097845077515
infectious B-Disease 1 0.9919390082359314
diseases I-Disease 1 0.9918819069862366
. O 0 0.11785005033016205

Skin O 1 0.969270646572113
photosensitivity O 1 0.9451952576637268
may O 0 0.03057248704135418
also O 0 0.011421267874538898
be O 0 0.009378395043313503
present O 0 0.01571025513112545
. O 0 0.02125571109354496

The O 0 0.018108487129211426
seven O 0 0.019589737057685852
exons O 0 0.1575012356042862
, O 0 0.008578676730394363
the O 0 0.008253035135567188
exon O 1 0.6854400038719177
/ O 0 0.3810628056526184
intron O 1 0.5606419444084167
boundaries O 0 0.007963445968925953
and O 0 0.003665101481601596
part O 0 0.004175231792032719
of O 0 0.003566444618627429
3 O 0 0.008007018826901913
noncoding O 0 0.41790470480918884
sequence O 0 0.016622787341475487
of O 0 0.004125845152884722
the O 0 0.005352450534701347
CPO O 0 0.20747816562652588
gene O 1 0.659870445728302
were O 0 0.004230800084769726
systematically O 0 0.022971147671341896
analyzed O 0 0.022967930883169174
by O 0 0.006116908043622971
an O 0 0.006814633496105671
exon O 1 0.7023572325706482
- O 0 0.2586475610733032
by O 0 0.024419842287898064
- O 1 0.5557499527931213
exon O 1 0.912000298500061
denaturing O 1 0.9666229486465454
gradient O 1 0.9477689266204834
gel O 1 0.9820762872695923
electrophoresis O 1 0.9647210240364075
( O 0 0.1284273862838745
DGGE O 1 0.55892014503479
) O 0 0.01510873157531023
strategy O 0 0.01589631848037243
followed O 0 0.0070591215044260025
by O 0 0.004782345611602068
direct O 0 0.012630530633032322
sequencing O 0 0.13225699961185455
in O 0 0.006715720519423485
seven O 0 0.01881348341703415
unrelated O 1 0.8345770239830017
heterozygous O 1 0.9774414896965027
HC B-Disease 1 0.9562145471572876
patients O 1 0.9591694474220276
from O 0 0.009973959997296333
France O 0 0.022697139531373978
, O 0 0.006858558859676123
Holland O 0 0.025745408609509468
, O 0 0.005133578088134527
and O 0 0.00508024450391531
Czech O 0 0.015223901718854904
Republic O 0 0.015322763472795486
. O 0 0.017498861998319626

Seven O 0 0.041841208934783936
novel O 0 0.2064967155456543
mutations O 1 0.8800857663154602
and O 0 0.00863858126103878
two O 0 0.008017357438802719
new O 0 0.012555166147649288
polymorphisms O 1 0.8179141879081726
were O 0 0.011390605010092258
detected O 0 0.3030913174152374
. O 0 0.027813280001282692

Among O 0 0.02614155039191246
these O 0 0.014742153696715832
mutations O 1 0.8201624751091003
two O 0 0.007576390635222197
are O 0 0.0077700079418718815
missense O 1 0.9114075899124146
( O 0 0.04359469190239906
G197W O 0 0.34730425477027893
, O 0 0.007089661434292793
W427R O 0 0.21594540774822235
) O 0 0.006933964788913727
, O 0 0.002798227360472083
two O 0 0.002751655876636505
are O 0 0.002953619696199894
nonsense O 0 0.05025215074419975
( O 0 0.03504244238138199
Q306X O 0 0.3602830171585083
, O 0 0.0062325759790837765
Q385X O 0 0.3088885247707367
) O 0 0.007064842153340578
, O 0 0.002666272222995758
two O 0 0.0026732804253697395
are O 0 0.0029447830747812986
small O 0 0.009034677408635616
deletions O 1 0.6076586246490479
( O 0 0.05131087824702263
662de14bp O 0 0.443403422832489
; O 0 0.012940263375639915
1168del3bp O 0 0.13359904289245605
removing O 0 0.03513191640377045
a O 0 0.009093188680708408
glycine O 0 0.06788843125104904
at O 0 0.006040775217115879
position O 0 0.0061701382510364056
390 O 0 0.05195901170372963
) O 0 0.0063781291246414185
, O 0 0.0024507513735443354
and O 0 0.00235056784003973
one O 0 0.002986102132126689
is O 0 0.004147585481405258
a O 0 0.01965954340994358
splicing O 1 0.9704214334487915
mutation O 1 0.9907636046409607
( O 0 0.3311833441257477
IVS1 O 1 0.9396318793296814
- O 1 0.8140340447425842
15c O 1 0.9615300297737122
- O 1 0.858428418636322
- O 1 0.768151581287384
> O 1 0.8615675568580627
g O 0 0.3210468292236328
) O 0 0.010136447846889496
which O 0 0.0042947810143232346
creates O 0 0.01704571768641472
a O 0 0.0072197988629341125
new O 0 0.010596717707812786
acceptor O 1 0.5758734345436096
splice O 1 0.6917858123779297
site O 0 0.031056763604283333
. O 0 0.026936963200569153

The O 0 0.020807763561606407
pathological O 0 0.16092583537101746
significance O 0 0.013877161778509617
of O 0 0.005646270699799061
the O 0 0.005869683343917131
point O 0 0.014477022923529148
mutations O 1 0.9801006317138672
G197W O 1 0.6221886277198792
, O 0 0.007466273847967386
W427R O 0 0.09370537847280502
, O 0 0.0034783759620040655
and O 0 0.0024679559282958508
the O 0 0.002648866269737482
in O 0 0.0048141167499125
- O 0 0.09377892315387726
frame O 0 0.12143388390541077
deletion O 1 0.8401901721954346
390delGly O 0 0.23303599655628204
were O 0 0.003853825619444251
assessed O 0 0.009916599839925766
by O 0 0.00366107071749866
their O 0 0.0032425883691757917
respective O 0 0.0072510698810219765
expression O 0 0.02769586816430092
in O 0 0.004861787427216768
a O 0 0.0082297557964921
prokaryotic O 0 0.3309881091117859
system O 0 0.017077559605240822
using O 0 0.012226506136357784
site O 0 0.013821026310324669
- O 0 0.09627715498209
directed O 0 0.03428228572010994
mutagenesis O 1 0.5313570499420166
. O 0 0.038157738745212555

These O 0 0.02921159379184246
mutations O 1 0.9099854230880737
resulted O 0 0.02689928002655506
in O 0 0.0064880200661718845
the O 0 0.005360770970582962
absence O 0 0.015491826459765434
or O 0 0.006532540079206228
a O 0 0.007389500737190247
dramatic O 0 0.06257840991020203
decrease O 0 0.13574527204036713
of O 0 0.009298009797930717
CPO O 0 0.2151254564523697
activity O 0 0.08244578540325165
. O 0 0.024975642561912537

The O 0 0.01898912899196148
two O 0 0.014283545315265656
polymorphisms O 1 0.6796881556510925
were O 0 0.007457014173269272
localized O 0 0.4924560785293579
in O 0 0.007924139499664307
noncoding O 1 0.5484969615936279
part O 0 0.006848393473774195
of O 0 0.004531366750597954
the O 0 0.007108493708074093
gene O 1 0.8920648694038391
1 O 0 0.017999427393078804
) O 0 0.01698363572359085
a O 0 0.014316903427243233
C O 0 0.49543923139572144
/ O 1 0.6025752425193787
G O 1 0.5643733739852905
polymorphism O 0 0.4638682007789612
in O 0 0.005238143727183342
the O 0 0.005817603785544634
promotor O 0 0.48428642749786377
region O 0 0.012142393738031387
, O 0 0.004802315030246973
142 O 0 0.013467212207615376
bp O 0 0.024610374122858047
upstream O 0 0.01868356764316559
from O 0 0.00563651230186224
the O 0 0.0054786610417068005
transcriptional O 1 0.7074198126792908
initiation O 1 0.5068169236183167
site O 0 0.02774098888039589
( O 0 0.08933816850185394
- O 0 0.46557459235191345
142C O 1 0.8592952489852905
/ O 1 0.6928086280822754
G O 0 0.4637618064880371
) O 0 0.009588861837983131
, O 0 0.003118837019428611
and O 0 0.0025779425632208586
2 O 0 0.00484670652076602
) O 0 0.005336114205420017
a O 0 0.0048515526577830315
6 O 0 0.009153620339930058
bp O 0 0.07547900825738907
deletion O 1 0.7310039401054382
polymorphism O 0 0.2671496570110321
in O 0 0.004825630225241184
the O 0 0.00396938668563962
3 O 0 0.007889079861342907
noncoding O 0 0.32813289761543274
part O 0 0.004465257283300161
of O 0 0.0035787431988865137
the O 0 0.005416730418801308
CPO O 0 0.36172419786453247
gene O 1 0.8904590010643005
, O 0 0.008116934448480606
574 O 0 0.12330396473407745
bp O 0 0.029243050143122673
downstream O 0 0.016421891748905182
of O 0 0.003169426927343011
the O 0 0.002826132345944643
last O 0 0.0035062581300735474
base O 0 0.0038378413300961256
of O 0 0.003291996894404292
the O 0 0.0054135993123054504
normal O 0 0.24748021364212036
termination O 1 0.8096683621406555
codon O 1 0.8473302125930786
( O 0 0.19205017387866974
+ O 1 0.7169999480247498
574 O 1 0.6658473014831543
delATTCTT O 1 0.6595274806022644
) O 0 0.03415133059024811
. O 0 0.022107822820544243

Five O 0 0.03306886553764343
intragenic O 0 0.3345288336277008
dimorphisms O 0 0.1475549340248108
are O 0 0.0071175722405314445
now O 0 0.005337386857718229
well O 0 0.0049267117865383625
characterized O 0 0.037634722888469696
and O 0 0.002653061877936125
the O 0 0.002948069479316473
high O 0 0.006015832535922527
degree O 0 0.010213959962129593
of O 0 0.005405266769230366
allelic O 1 0.9133920669555664
heterogeneity O 1 0.7621477246284485
in O 0 0.009204555302858353
HC B-Disease 0 0.2880675792694092
is O 0 0.005031174514442682
demonstrated O 0 0.008424353785812855
with O 0 0.00385334063321352
seven O 0 0.0039420886896550655
new O 0 0.004652984905987978
different O 0 0.007231640629470348
mutations O 1 0.8064531683921814
making O 0 0.0048008752055466175
a O 0 0.004174216650426388
total O 0 0.003999795764684677
of O 0 0.004983683116734028
nineteen O 0 0.14315681159496307
CPO O 1 0.8535427451133728
gene B-Disease 1 0.9880361557006836
defects I-Disease 1 0.9849680066108704
reported O 0 0.07189586758613586
so O 0 0.00886473711580038
far O 0 0.010627497918903828
. O 0 0.011420998722314835
. O 0 0.017661696299910545

Coincidence O 0 0.04281758517026901
of O 0 0.012080872431397438
two O 0 0.010534919798374176
novel O 0 0.09519927948713303
arylsulfatase O 1 0.547819972038269
A O 0 0.04835837334394455
alleles O 1 0.9688827395439148
and O 0 0.03845949098467827
mutation O 1 0.9853726029396057
459 O 1 0.8405337333679199
+ O 1 0.8183947205543518
1G O 1 0.8627303242683411
> O 0 0.47801482677459717
A O 0 0.010242320597171783
within O 0 0.007258319761604071
a O 0 0.007811933755874634
family O 0 0.027074038982391357
with O 0 0.02103717438876629
metachromatic B-Disease 1 0.938138484954834
leukodystrophy I-Disease 1 0.9846648573875427
: O 0 0.03562897443771362
molecular O 0 0.30845943093299866
basis O 0 0.015765422955155373
of O 0 0.013361198827624321
phenotypic O 1 0.8179141879081726
heterogeneity O 1 0.7196838855743408
. O 0 0.03506503999233246

In O 0 0.015789801254868507
a O 0 0.011021432466804981
family O 0 0.012274147942662239
with O 0 0.005418040324002504
three O 0 0.005973184946924448
siblings O 0 0.12179815024137497
, O 0 0.004959875252097845
one O 0 0.00599122466519475
developed O 0 0.05620623379945755
classical O 0 0.06523670256137848
late O 0 0.2879168391227722
infantile O 1 0.9942508935928345
metachromatic B-Disease 1 0.9878892302513123
leukodystrophy I-Disease 1 0.9938828945159912
( O 1 0.628637969493866
MLD B-Disease 1 0.972796618938446
) O 0 0.04320070520043373
, O 0 0.009848717600107193
fatal O 1 0.8121058940887451
at O 0 0.007992515340447426
age O 0 0.01855316571891308
5 O 0 0.008271096274256706
years O 0 0.006611162796616554
, O 0 0.004758667200803757
with O 0 0.011410628445446491
deficient O 1 0.9198715090751648
arylsulfatase O 1 0.6473223567008972
A O 0 0.0412253737449646
( O 0 0.10287140309810638
ARSA O 1 0.9237437844276428
) O 0 0.020636551082134247
activity O 0 0.02121066302061081
and O 0 0.006955424789339304
increased O 0 0.04672432318329811
galactosylsulfatide O 1 0.7075055241584778
( O 0 0.1597774475812912
GS O 1 0.9386922121047974
) O 0 0.1098017692565918
excretion O 1 0.8603691458702087
. O 0 0.03346291929483414

The O 0 0.013419779017567635
two O 0 0.009590347297489643
other O 0 0.007947726175189018
siblings O 0 0.09049823135137558
, O 0 0.006699854042381048
apparently O 0 0.020910393446683884
healthy O 0 0.19157671928405762
at O 0 0.0049965777434408665
12 O 0 0.008658762089908123
( O 0 0.019000262022018433
1 O 0 0.014395447447896004
/ O 0 0.19195757806301117
2 O 0 0.006581703666597605
) O 0 0.004451320040971041
and O 0 0.0018907046178355813
15 O 0 0.0028759483247995377
years O 0 0.0026784457731992006
, O 0 0.0019520751666277647
respectively O 0 0.003137392457574606
, O 0 0.0018418008694425225
and O 0 0.0017727137310430408
their O 0 0.0023815559688955545
father O 0 0.006744814105331898
, O 0 0.0030985462944954634
apparently O 0 0.011888301931321621
healthy O 0 0.1348440945148468
as O 0 0.003101499518379569
well O 0 0.003748056711629033
, O 0 0.004324646666646004
presented O 0 0.010230242274701595
ARSA O 1 0.756584107875824
and O 0 0.007642336189746857
GS O 1 0.5759381055831909
values O 0 0.009590628556907177
within O 0 0.006420958787202835
the O 0 0.005828007590025663
range O 0 0.014516357332468033
of O 0 0.02125731110572815
MLD B-Disease 1 0.9707550406455994
patients O 1 0.9632299542427063
. O 0 0.05500038340687752

Mutation O 1 0.9537885189056396
screening O 0 0.17957079410552979
and O 0 0.01244912575930357
sequence O 0 0.03950519859790802
analysis O 0 0.01644868589937687
disclosed O 0 0.011646817438304424
the O 0 0.004253141116350889
involvement O 0 0.009527258574962616
of O 0 0.0038008594419807196
three O 0 0.005932480562478304
different O 0 0.02389588952064514
ARSA O 1 0.973839282989502
mutations O 1 0.9693456888198853
being O 0 0.007230894174426794
the O 0 0.005449902731925249
molecular O 0 0.144412562251091
basis O 0 0.01063672173768282
of O 0 0.009521267376840115
intrafamilial O 1 0.6428906917572021
phenotypic O 1 0.8954195380210876
heterogeneity O 1 0.8345719575881958
. O 0 0.03730790689587593

The O 0 0.03679347410798073
late O 0 0.2433318942785263
infantile O 1 0.9850744009017944
patient O 1 0.9602333307266235
inherited O 1 0.7394199371337891
from O 0 0.010141759179532528
his O 0 0.00754766259342432
mother O 0 0.036822009831666946
the O 0 0.0077278087846934795
frequent O 0 0.2721206247806549
0 O 0 0.16680359840393066
- O 1 0.6442543864250183
type O 1 0.824530839920044
mutation O 1 0.9885735511779785
459 O 1 0.9018276929855347
+ O 1 0.8910377621650696
1G O 1 0.9172691702842712
> O 0 0.46820905804634094
A O 0 0.008553671650588512
, O 0 0.003421985311433673
and O 0 0.0022789258509874344
from O 0 0.0027303253300487995
his O 0 0.003095818217843771
father O 0 0.007127655670046806
a O 0 0.005608023144304752
novel O 0 0.039171766489744186
, O 0 0.005040389951318502
single O 0 0.01444285549223423
basepair O 0 0.3677094280719757
microdeletion O 0 0.2337479591369629
of O 0 0.006723797880113125
guanine O 0 0.322092741727829
at O 0 0.0096852146089077
nucleotide O 0 0.4196477234363556
7 O 0 0.013826219365000725
in O 0 0.010123586282134056
exon O 0 0.4956965148448944
1 O 0 0.021080903708934784
( O 0 0.04764818400144577
7delG O 0 0.3211197555065155
) O 0 0.02296331711113453
. O 0 0.02064937725663185

The O 0 0.025053761899471283
two O 0 0.02293475903570652
clinically O 1 0.8663671016693115
unaffected O 1 0.7165555953979492
siblings O 0 0.4301799237728119
carried O 0 0.025850284844636917
the O 0 0.030283600091934204
maternal O 1 0.9784303903579712
mutation O 1 0.9914172291755676
459 O 1 0.941145122051239
+ O 1 0.9366413950920105
1G O 1 0.910643458366394
> O 0 0.48927098512649536
A O 0 0.009686815552413464
and O 0 0.004039136692881584
, O 0 0.0032591684721410275
on O 0 0.0031035346910357475
their O 0 0.0051984768360853195
paternal O 1 0.6780294179916382
allele O 1 0.8557009696960449
, O 0 0.00754930917173624
a O 0 0.008301115594804287
novel O 0 0.05626525357365608
cytosine O 0 0.2987620234489441
to O 0 0.007499325554817915
thymidine O 1 0.5997876524925232
transition O 0 0.05451379716396332
at O 0 0.011636223644018173
nucleotide O 1 0.6350409984588623
2435 O 1 0.7853589057922363
in O 0 0.012226592749357224
exon O 0 0.3612096309661865
8 O 0 0.011377232149243355
, O 0 0.0050684744492173195
resulting O 0 0.03692285344004631
in O 0 0.005809782072901726
substitution O 0 0.05083836242556572
of O 0 0.008517337031662464
alanine O 1 0.5808200240135193
464 O 0 0.4460184872150421
by O 0 0.020529111847281456
valine O 1 0.6881216168403625
( O 0 0.07134362310171127
A464V O 1 0.5122490525245667
) O 0 0.033625438809394836
. O 0 0.025325097143650055

The O 0 0.03645167499780655
fathers O 0 0.17814959585666656
genotype O 1 0.8280329704284668
thus O 0 0.03535563498735428
was O 0 0.02169089950621128
7delG O 1 0.6490350365638733
/ O 1 0.562678337097168
A464V O 0 0.4952702224254608
. O 0 0.0388566292822361

Mutation O 1 0.9453102946281433
A464V O 0 0.1878647357225418
was O 0 0.010862432420253754
not O 0 0.006973030976951122
found O 0 0.009152032434940338
in O 0 0.00804018136113882
18 O 0 0.05944647639989853
unrelated O 1 0.8636085987091064
MLD B-Disease 1 0.9822953939437866
patients O 1 0.9513373970985413
and O 0 0.012229127809405327
50 O 0 0.020405026152729988
controls O 0 0.04914715141057968
. O 0 0.021331874653697014

A464V O 0 0.18442180752754211
, O 0 0.01832839474081993
although O 0 0.01592126674950123
clearly O 0 0.021160239353775978
modifying O 1 0.6133690476417542
ARSA O 1 0.9171329736709595
and O 0 0.013162245973944664
GS O 1 0.9049581289291382
levels O 0 0.1164790689945221
, O 0 0.006728742271661758
apparently O 0 0.014246003702282906
bears O 0 0.01416714396327734
little O 0 0.008557436056435108
significance O 0 0.012107804417610168
for O 0 0.008487778715789318
clinical O 1 0.8106493949890137
manifestation O 0 0.45302268862724304
of O 0 0.014176695607602596
MLD B-Disease 1 0.9590488076210022
, O 0 0.016430504620075226
mimicking O 0 0.48131492733955383
the O 0 0.019102158024907112
frequent O 1 0.6247578263282776
ARSA O 1 0.9548887610435486
pseudodeficiency O 1 0.8899067640304565
allele O 1 0.9300917387008667
. O 0 0.04550251364707947

Our O 0 0.019168946892023087
results O 0 0.019909337162971497
demonstrate O 0 0.013553107157349586
that O 0 0.005598658230155706
in O 0 0.0059861489571630955
certain O 0 0.049270160496234894
genetic O 1 0.9787230491638184
conditions O 1 0.7392328381538391
MLD B-Disease 1 0.9805462956428528
- O 0 0.3861125111579895
like O 0 0.03894081339240074
ARSA O 1 0.8733468055725098
and O 0 0.008023055270314217
GS O 1 0.5563861727714539
values O 0 0.010078899562358856
need O 0 0.006111454218626022
not O 0 0.003460751613602042
be O 0 0.003845255123451352
paralleled O 0 0.48683005571365356
by O 0 0.12084325402975082
clinical O 1 0.9908292293548584
disease O 1 0.9952602982521057
, O 0 0.007760374341160059
a O 0 0.007986588403582573
finding O 0 0.02176354080438614
with O 0 0.012094737030565739
serious O 1 0.5101032257080078
diagnostic O 1 0.81572026014328
and O 0 0.025707969442009926
prognostic O 1 0.9456992745399475
implications O 1 0.6740626096725464
. O 0 0.038075514137744904

Moreover O 0 0.06586535274982452
, O 0 0.02059284597635269
further O 0 0.03397221863269806
ARSA O 1 0.9539141058921814
alleles O 1 0.9684365391731262
functionally O 1 0.5933878421783447
similar O 0 0.016983438283205032
to O 0 0.005742623470723629
A464V O 0 0.23579584062099457
might O 0 0.006973054725676775
exist O 0 0.005194471217691898
which O 0 0.002566390670835972
, O 0 0.002634574193507433
together O 0 0.004095051437616348
with O 0 0.005622211378067732
0 O 0 0.1247260794043541
- O 1 0.655707597732544
type O 1 0.8858298063278198
mutations O 1 0.9903538227081299
, O 0 0.03034341149032116
may O 0 0.2331768125295639
cause O 1 0.9172903299331665
pathological O 1 0.9732165336608887
ARSA O 1 0.9643163084983826
and O 0 0.021082209423184395
GS O 1 0.9449474811553955
levels O 0 0.145332932472229
, O 0 0.006412060931324959
but O 0 0.005854465998709202
not O 0 0.009980158880352974
clinical O 1 0.9492278099060059
outbreak O 1 0.9503598809242249
of O 0 0.011357023380696774
the O 0 0.048335831612348557
disease O 1 0.992510199546814
. O 0 0.025052526965737343
. O 0 0.026521313935518265

Human O 1 0.8896573185920715
MLH1 O 1 0.961312472820282
deficiency O 1 0.9910229444503784
predisposes O 1 0.964323103427887
to O 0 0.1885446161031723
hematological B-Disease 1 0.9815857410430908
malignancy I-Disease 1 0.984351634979248
and O 0 0.12862125039100647
neurofibromatosis B-Disease 1 0.9817669987678528
type I-Disease 0 0.4594500958919525
1 I-Disease 0 0.035458773374557495
. O 0 0.02901792712509632

Heterozygous O 1 0.9190540313720703
germ O 1 0.9035301804542542
- O 0 0.3267340064048767
line O 0 0.061150018125772476
mutations O 1 0.9319865703582764
in O 0 0.01212047878652811
the O 0 0.014228838495910168
DNA O 1 0.913610577583313
mismatch O 1 0.9604997634887695
repair O 1 0.9279063940048218
genes O 1 0.9617253541946411
lead O 0 0.3433179557323456
to O 0 0.09419989585876465
hereditary B-Disease 1 0.9873650670051575
nonpolyposis I-Disease 1 0.9865773916244507
colorectal I-Disease 1 0.9973658919334412
cancer I-Disease 1 0.9927586317062378
. O 0 0.18419285118579865

The O 0 0.1712622046470642
disease O 1 0.9903036952018738
susceptibility O 1 0.9236006736755371
of O 0 0.010939205065369606
individuals O 0 0.035567257553339005
who O 0 0.008418302983045578
constitutionally O 0 0.04567045718431473
lack O 0 0.019542591646313667
both O 0 0.010513368993997574
wild O 0 0.24652907252311707
- O 1 0.7653689980506897
type O 1 0.8288338780403137
alleles O 1 0.9705969095230103
is O 0 0.016256239265203476
unknown O 0 0.051796287298202515
. O 0 0.02216387167572975

We O 0 0.01426861621439457
have O 0 0.008047628216445446
identified O 0 0.011646532453596592
three O 0 0.008156109601259232
offspring O 1 0.5587757229804993
in O 0 0.014851052314043045
a O 0 0.1771608144044876
hereditary B-Disease 1 0.9936853051185608
nonpolyposis I-Disease 1 0.9943286776542664
colorectal I-Disease 1 0.9991480112075806
cancer I-Disease 1 0.9978863596916199
family O 1 0.553114116191864
who O 0 0.06256361305713654
developed O 1 0.7771587371826172
hematological B-Disease 1 0.9903817772865295
malignancy I-Disease 1 0.9799577593803406
at O 0 0.007565217092633247
a O 0 0.005763764958828688
very O 0 0.004716264549642801
early O 0 0.005139369983226061
age O 0 0.006371574942022562
, O 0 0.002321646548807621
and O 0 0.0017732023261487484
at O 0 0.001975524937734008
least O 0 0.002624250017106533
two O 0 0.001994558610022068
of O 0 0.00196280051022768
them O 0 0.002757762325927615
displayed O 0 0.006728002335876226
signs O 0 0.08369632810354233
of O 0 0.030072687193751335
neurofibromatosis B-Disease 1 0.9930469393730164
type I-Disease 1 0.7356006503105164
1 I-Disease 0 0.07247883081436157
( O 0 0.17194344103336334
NF1 B-Disease 1 0.9494810104370117
) O 0 0.038792822510004044
. O 0 0.02371584251523018

DNA O 0 0.4306676387786865
sequence O 0 0.06978604197502136
analysis O 0 0.03551429882645607
and O 0 0.013492314144968987
allele O 1 0.9340793490409851
- O 0 0.17933888733386993
specific O 0 0.04199656471610069
amplification O 0 0.31933456659317017
in O 0 0.006817649118602276
two O 0 0.007975973188877106
siblings O 0 0.3434184491634369
revealed O 0 0.11532661318778992
a O 0 0.0653061643242836
homozygous O 1 0.9765841960906982
MLH1 O 1 0.9838648438453674
mutation O 1 0.9890210032463074
( O 0 0.38230788707733154
C676T O 1 0.9128474593162537
- O 1 0.7708158493041992
- O 1 0.7433474659919739
> O 1 0.8917669057846069
Arg226Stop O 1 0.7230477929115295
) O 0 0.03700661659240723
. O 0 0.025839239358901978

Thus O 0 0.040359124541282654
, O 0 0.01777895912528038
a O 0 0.025381557643413544
homozygous O 1 0.9540228247642517
germ O 1 0.963854193687439
- O 1 0.6759437322616577
line O 0 0.29315873980522156
MLH1 O 1 0.9783543944358826
mutation O 1 0.9849969148635864
and O 0 0.062267471104860306
consequent O 1 0.9572967886924744
mismatch O 1 0.9854497909545898
repair O 1 0.9796100854873657
deficiency O 1 0.9951689839363098
results O 0 0.23529404401779175
in O 0 0.03297630697488785
a O 0 0.19930528104305267
mutator O 1 0.989413857460022
phenotype O 1 0.9951411485671997
characterized O 1 0.9734066128730774
by O 1 0.5568676590919495
leukemia B-Disease 1 0.9970856308937073
and O 0 0.1761370450258255
/ O 1 0.9663516879081726
or O 1 0.7342633605003357
lymphoma B-Disease 1 0.9971792697906494
associated O 1 0.6242895126342773
with O 0 0.16634798049926758
neurofibromatosis B-Disease 1 0.9882549047470093
type I-Disease 0 0.41282057762145996
1 I-Disease 0 0.02086961455643177
. O 0 0.012905963696539402
. O 0 0.01906735636293888

Missense O 1 0.8998542428016663
mutations O 1 0.8450685739517212
in O 0 0.010538488626480103
the O 0 0.005375787150114775
most O 0 0.004879618063569069
ancient O 0 0.007426699157804251
residues O 0 0.0350787527859211
of O 0 0.00501050753518939
the O 0 0.0088887894526124
PAX6 O 1 0.9557850360870361
paired O 1 0.5394085645675659
domain O 0 0.23738989233970642
underlie O 1 0.7348816990852356
a O 0 0.02213604748249054
spectrum O 0 0.29930680990219116
of O 0 0.05227241665124893
human O 1 0.9546404480934143
congenital B-Disease 1 0.9974372386932373
eye I-Disease 1 0.9825913310050964
malformations I-Disease 1 0.9856132864952087
. O 0 0.12584932148456573

Mutations O 1 0.8610010743141174
of O 0 0.018266800791025162
the O 0 0.01817799173295498
human O 1 0.7465241551399231
PAX6 O 1 0.9856557846069336
gene O 1 0.9892704486846924
underlie O 1 0.9818987846374512
aniridia B-Disease 1 0.9814789295196533
( O 1 0.7167046666145325
congenital B-Disease 1 0.9961869120597839
absence I-Disease 0 0.12173403799533844
of I-Disease 0 0.006430777255445719
the I-Disease 0 0.008949361741542816
iris I-Disease 1 0.7144036889076233
) O 0 0.011913145892322063
, O 0 0.005332584027200937
a O 0 0.01066562533378601
rare O 0 0.31857970356941223
dominant O 1 0.6413437128067017
malformation B-Disease 1 0.9785133600234985
of I-Disease 0 0.009139558300375938
the I-Disease 0 0.016286121681332588
eye I-Disease 1 0.7004249095916748
. O 0 0.03496081754565239

The O 0 0.022263504564762115
spectrum O 0 0.08716282248497009
of O 0 0.022651052102446556
PAX6 O 1 0.975795328617096
mutations O 1 0.9823204278945923
in O 0 0.06392310559749603
aniridia B-Disease 1 0.958408534526825
patients O 1 0.9554800987243652
is O 0 0.00947595201432705
highly O 0 0.01924915611743927
biased O 0 0.02114926464855671
, O 0 0.0033997143618762493
with O 0 0.0031978576444089413
92 O 0 0.009860707446932793
% O 0 0.0053455219604074955
of O 0 0.0025932856369763613
all O 0 0.0033727537374943495
reported O 0 0.05946365371346474
mutations O 1 0.9424113631248474
leading O 0 0.019091617316007614
to O 0 0.005893006455153227
premature O 1 0.7372816801071167
truncation O 0 0.27671170234680176
of O 0 0.004063194617629051
the O 0 0.005382053088396788
protein O 1 0.5890346169471741
( O 0 0.025858024135231972
nonsense O 0 0.04821712523698807
, O 0 0.005558268632739782
splicing O 1 0.5450039505958557
, O 0 0.006084709893912077
insertions O 0 0.2593870460987091
and O 0 0.0046311053447425365
deletions O 0 0.2162928730249405
) O 0 0.004978933371603489
and O 0 0.002120845951139927
just O 0 0.0024223364889621735
2 O 0 0.003582657314836979
% O 0 0.004820070695132017
leading O 0 0.00403487216681242
to O 0 0.0023269986268132925
substitution O 0 0.01933528669178486
of O 0 0.0034031704999506474
one O 0 0.005489178001880646
amino O 0 0.43608760833740234
acid O 1 0.6799564957618713
by O 0 0.01172428485006094
another O 0 0.021463142707943916
( O 0 0.06930364668369293
missense O 1 0.8821732401847839
) O 0 0.034772392362356186
. O 0 0.0211239792406559

The O 0 0.018388554453849792
extraordinary O 0 0.019102321937680244
conservation O 0 0.015115329064428806
of O 0 0.005725776311010122
the O 0 0.0072022732347249985
PAX6 O 1 0.8844279646873474
protein O 0 0.26544812321662903
at O 0 0.006616194732487202
the O 0 0.0053139845840632915
amino O 0 0.36516064405441284
acid O 1 0.63575279712677
level O 0 0.01816047541797161
amongst O 0 0.04611305147409439
vertebrates O 1 0.5855518579483032
predicts O 0 0.45399734377861023
that O 0 0.020550234243273735
pathological O 1 0.9549272656440735
missense O 1 0.9816363453865051
mutations O 1 0.973251461982727
should O 0 0.006887501105666161
in O 0 0.003661347320303321
fact O 0 0.0036637750454247
be O 0 0.002267500152811408
common O 0 0.00862576812505722
even O 0 0.0028465548530220985
though O 0 0.003104489529505372
they O 0 0.0018191818380728364
are O 0 0.0022043061908334494
hardly O 0 0.006905406713485718
ever O 0 0.005974116735160351
seen O 0 0.012577022425830364
in O 0 0.02071087807416916
aniridia B-Disease 1 0.943357527256012
patients O 1 0.9719170331954956
. O 0 0.046702075749635696

This O 0 0.013802683912217617
indicates O 0 0.01652408577501774
that O 0 0.004578990861773491
there O 0 0.003561273217201233
is O 0 0.003822801634669304
a O 0 0.005189254879951477
heavy O 0 0.015206748619675636
ascertainment O 1 0.5798242092132568
bias O 0 0.07343978434801102
in O 0 0.004238671623170376
the O 0 0.0036597002763301134
selection O 0 0.00938822515308857
of O 0 0.010356053709983826
patients O 1 0.9723499417304993
for O 0 0.047505080699920654
PAX6 O 1 0.9878573417663574
mutation O 1 0.9844089150428772
analysis O 0 0.04323899745941162
and O 0 0.004462054930627346
that O 0 0.004290692508220673
the O 0 0.00745721161365509
missing O 0 0.21852198243141174
PAX6 O 1 0.982754647731781
missense O 1 0.9832834005355835
mutations O 1 0.9864248037338257
frequently O 0 0.20174750685691833
may O 0 0.17661650478839874
underlie O 1 0.934727668762207
phenotypes O 1 0.9571027159690857
distinct O 0 0.2716967761516571
from O 0 0.028216931968927383
textbook O 0 0.36210545897483826
aniridia B-Disease 1 0.7486269474029541
. O 0 0.04700569063425064

Here O 0 0.014224637299776077
we O 0 0.007172405254095793
present O 0 0.008871103636920452
four O 0 0.010457039810717106
novel O 0 0.3425973653793335
PAX6 O 1 0.9805392026901245
missense O 1 0.9788227677345276
mutations O 1 0.9752154350280762
, O 0 0.008225389756262302
two O 0 0.005991872865706682
in O 0 0.0061936210840940475
association O 0 0.03538694232702255
with O 0 0.06526844203472137
atypical O 1 0.9902974963188171
phenotypes O 1 0.9908878803253174
ectopia B-Disease 1 0.9673423171043396
pupillae I-Disease 1 0.948541522026062
( O 0 0.2331581711769104
displaced B-Disease 1 0.5577282905578613
pupils I-Disease 0 0.31372761726379395
) O 0 0.15434926748275757
and O 0 0.12616556882858276
congenital B-Disease 1 0.9980376362800598
nystagmus I-Disease 1 0.9872915744781494
( O 0 0.08527927100658417
searching B-Disease 0 0.03152608498930931
gaze I-Disease 0 0.08123024553060532
) O 0 0.007216836325824261
, O 0 0.0027198870666325092
and O 0 0.002054445445537567
two O 0 0.0021743513643741608
in O 0 0.002789789577946067
association O 0 0.007636466063559055
with O 0 0.005273278336971998
more O 0 0.010568852536380291
recognizable O 1 0.5020534992218018
aniridia B-Disease 1 0.9319201111793518
phenotypes O 1 0.9623664617538452
. O 0 0.055136773735284805

Strikingly O 0 0.05779854953289032
, O 0 0.009995968081057072
all O 0 0.00541592575609684
four O 0 0.0066390871070325375
mutations O 1 0.7676029205322266
are O 0 0.0037413551472127438
located O 0 0.0044896528124809265
within O 0 0.004631753079593182
the O 0 0.004972684197127819
PAX6 O 1 0.903934121131897
paired O 0 0.30086493492126465
domain O 0 0.05736472085118294
and O 0 0.00478059146553278
affect O 0 0.08878284692764282
amino O 0 0.35933196544647217
acids O 0 0.22953970730304718
which O 0 0.0030094031244516373
are O 0 0.0024865746963769197
highly O 0 0.013516593724489212
conserved O 0 0.03420783951878548
in O 0 0.003548827487975359
all O 0 0.0033850858453661203
known O 0 0.01886580139398575
paired O 0 0.279469758272171
domain O 0 0.26538535952568054
proteins O 1 0.5490620732307434
. O 0 0.027743225917220116

Our O 0 0.016434496268630028
results O 0 0.014122008346021175
support O 0 0.006479987874627113
the O 0 0.003924497403204441
hypothesis O 0 0.02102585881948471
that O 0 0.0031911584082990885
the O 0 0.0034211690071970224
under O 0 0.004734869580715895
- O 0 0.027784273028373718
representation O 0 0.012007287703454494
of O 0 0.012716755270957947
missense O 1 0.9821771383285522
mutations O 1 0.9888190627098083
is O 0 0.0271189883351326
caused O 0 0.3033992350101471
by O 0 0.011258570477366447
ascertainment O 1 0.6940546035766602
bias O 0 0.138507679104805
and O 0 0.004128811880946159
suggest O 0 0.00830860435962677
that O 0 0.0034925697837024927
a O 0 0.0060403780080378056
substantial O 0 0.03624585643410683
burden O 0 0.24573248624801636
of O 0 0.043609365820884705
PAX6 B-Disease 1 0.9919182658195496
- I-Disease 1 0.9088699817657471
related I-Disease 1 0.9233713746070862
disease I-Disease 1 0.9934743046760559
remains O 0 0.01843619905412197
to O 0 0.004991468507796526
be O 0 0.0054610795341432095
uncovered O 0 0.03337239846587181
. O 0 0.009604493156075478
. O 0 0.014583469368517399

The O 0 0.028377961367368698
chromosomal O 1 0.8961803913116455
order O 0 0.014950201846659184
of O 0 0.007959512993693352
genes O 1 0.8158783316612244
controlling O 0 0.2950286567211151
the O 0 0.00808194000273943
major O 0 0.07799335569143295
histocompatibility O 1 0.971927285194397
complex O 0 0.12058248370885849
, O 0 0.015529105439782143
properdin O 1 0.7874956130981445
factor O 1 0.5914291143417358
B O 0 0.41870859265327454
, O 0 0.006486369762569666
and O 0 0.007045180536806583
deficiency B-Disease 1 0.9811479449272156
of I-Disease 0 0.0044316863641142845
the I-Disease 0 0.004170016851276159
second I-Disease 0 0.006182697601616383
component I-Disease 0 0.025475336238741875
of I-Disease 0 0.008116512559354305
complement I-Disease 0 0.07138160616159439
. O 0 0.021510891616344452

The O 0 0.017958806827664375
relationship O 0 0.025515129789710045
of O 0 0.0067249503917992115
the O 0 0.009459195658564568
genes O 1 0.9382352232933044
coding O 1 0.8624075651168823
for O 0 0.01461554504930973
HLA O 1 0.8812872767448425
to O 0 0.0053512342274188995
those O 0 0.0077466657385230064
coding O 1 0.6353126168251038
for O 0 0.012433149851858616
properdin O 1 0.7651323676109314
Factor O 1 0.5605725049972534
B O 1 0.5330101847648621
allotypes O 0 0.3994813561439514
and O 0 0.0058805388398468494
for O 0 0.009606512263417244
deficiency B-Disease 1 0.9816022515296936
of I-Disease 0 0.0034882258623838425
the I-Disease 0 0.003286036429926753
second I-Disease 0 0.005043140612542629
component I-Disease 0 0.020707381889224052
of I-Disease 0 0.0049413107335567474
complement I-Disease 0 0.19028376042842865
( O 0 0.09659624099731445
C2 O 1 0.9292576909065247
) O 0 0.010180761106312275
was O 0 0.0038961770478636026
studied O 0 0.007747849449515343
in O 0 0.004646686837077141
families O 0 0.039393652230501175
of O 0 0.028460994362831116
patients O 1 0.9913626313209534
with O 1 0.6862838268280029
connective O 1 0.9962149262428284
tissue O 1 0.9945955872535706
disorders O 1 0.993907630443573
. O 0 0.18332214653491974

Patients O 1 0.6492406129837036
were O 0 0.009073586203157902
selected O 0 0.0090406509116292
because O 0 0.00741947628557682
they O 0 0.0041033439338207245
were O 0 0.005051463842391968
heterozygous O 1 0.7893224358558655
or O 0 0.11604810506105423
homozygous O 1 0.9670659899711609
for O 0 0.2580132484436035
C2 B-Disease 1 0.9901543259620667
deficiency I-Disease 1 0.9939866065979004
. O 0 0.13054467737674713

12 O 0 0.032896824181079865
families O 0 0.02554674819111824
with O 0 0.013208606280386448
15 O 0 0.021520141512155533
matings O 1 0.7707610726356506
informative O 0 0.2808058261871338
for O 0 0.08831289410591125
C2 B-Disease 1 0.9854122996330261
deficiency I-Disease 1 0.9922549724578857
were O 0 0.015561315231025219
found O 0 0.028228329494595528
. O 0 0.027596449479460716

Of O 0 0.021196892485022545
57 O 0 0.027250058948993683
informative O 0 0.03315325453877449
meioses O 0 0.09570468962192535
, O 0 0.006080875638872385
two O 0 0.004539222456514835
crossovers O 0 0.01909179799258709
were O 0 0.003999787848442793
noted O 0 0.008263391442596912
between O 0 0.014847857877612114
the O 0 0.07845132052898407
C2 B-Disease 1 0.9962409734725952
deficiency I-Disease 1 0.9987474679946899
gene O 1 0.9822981357574463
and O 0 0.016259023919701576
the O 0 0.03821471333503723
HLA O 1 0.9911150932312012
- O 1 0.8247708082199097
B O 1 0.7569977045059204
gene O 1 0.8956329226493835
, O 0 0.005886775441467762
with O 0 0.0057688141241669655
a O 0 0.008994057774543762
recombinant O 1 0.6171276569366455
fraction O 0 0.03935560956597328
of O 0 0.01073707640171051
0 O 0 0.03408043459057808
. O 0 0.022641167044639587

035 O 1 0.7028401494026184
. O 0 0.10225354135036469

A O 0 0.030740266665816307
lod O 0 0.051938582211732864
score O 0 0.010327206924557686
of O 0 0.005633421242237091
13 O 0 0.007372298743575811
was O 0 0.004143118392676115
calculated O 0 0.008621993474662304
for O 0 0.00761530501767993
linkage O 1 0.8335126638412476
between O 0 0.46202465891838074
C2 B-Disease 1 0.994186282157898
deficiency I-Disease 1 0.9978300929069519
and O 0 0.1780690848827362
HLA O 1 0.9868040680885315
- O 0 0.4194655120372772
B O 0 0.12804752588272095
at O 0 0.0057467008009552956
a O 0 0.005121796857565641
maximum O 0 0.007781040854752064
likelihood O 0 0.022263016551733017
value O 0 0.0045056589879095554
of O 0 0.0037217920180410147
the O 0 0.005848308093845844
recombinant O 1 0.6542394161224365
fraction O 0 0.02649214118719101
of O 0 0.00962027721107006
0 O 0 0.036134880036115646
. O 0 0.020693566650152206

04 O 0 0.2365267425775528
. O 0 0.09292618930339813

18 O 0 0.03224265202879906
families O 0 0.022281894460320473
with O 0 0.010869544930756092
21 O 0 0.013433202169835567
informative O 0 0.04831475764513016
matings O 0 0.45035144686698914
for O 0 0.00782378762960434
both O 0 0.011529143899679184
properdin O 1 0.8159511685371399
Factor O 1 0.7508240342140198
B O 1 0.7040461301803589
allotype O 1 0.7830015420913696
and O 0 0.029717713594436646
HLA O 1 0.9793615937232971
- O 0 0.37798264622688293
B O 0 0.15086062252521515
were O 0 0.008547534234821796
found O 0 0.0170503668487072
. O 0 0.019228259101510048

Of O 0 0.019115764647722244
72 O 0 0.03179570287466049
informative O 0 0.04877424240112305
meioses O 0 0.13468009233474731
, O 0 0.007488529663532972
three O 0 0.005829856265336275
recombinants O 0 0.04205167666077614
were O 0 0.003813290735706687
found O 0 0.005197946447879076
, O 0 0.004047027789056301
giving O 0 0.008427628315985203
a O 0 0.008366084657609463
recombinant O 1 0.6157352924346924
fraction O 0 0.027811629697680473
of O 0 0.010104681365191936
0 O 0 0.03375781327486038
. O 0 0.02098308876156807

042 O 0 0.3348918557167053
. O 0 0.08880671113729477

A O 0 0.031819961965084076
lod O 0 0.05433165654540062
score O 0 0.012528279796242714
of O 0 0.007004282437264919
16 O 0 0.011864302679896355
between O 0 0.051799871027469635
HLA O 1 0.9832265973091125
- O 1 0.5136242508888245
B O 0 0.3509368598461151
and O 0 0.006490833591669798
Factor O 0 0.3546859622001648
B O 0 0.31643787026405334
allotypes O 0 0.17235657572746277
was O 0 0.005020502023398876
calculated O 0 0.007325250655412674
at O 0 0.003937940578907728
a O 0 0.003832255955785513
maximum O 0 0.006003300193697214
likelihood O 0 0.019498052075505257
value O 0 0.004188844468444586
of O 0 0.0034651027526706457
the O 0 0.004665308631956577
recombinant O 1 0.5207772254943848
fraction O 0 0.027740025892853737
of O 0 0.009732234291732311
0 O 0 0.03068040870130062
. O 0 0.022254765033721924

04 O 0 0.23734121024608612
. O 0 0.08505643159151077

A O 0 0.02637072652578354
crossover O 0 0.024860939010977745
was O 0 0.00805225782096386
shown O 0 0.006332446355372667
to O 0 0.003407761687412858
have O 0 0.0033134303521364927
occurred O 0 0.015315843746066093
between O 0 0.015488378703594208
genes O 1 0.8692344427108765
for O 0 0.01305870246142149
Factor O 1 0.5396411418914795
B O 1 0.5842805504798889
and O 0 0.03076883964240551
HLA O 1 0.988186240196228
- O 1 0.6518343091011047
D O 0 0.4773709177970886
, O 0 0.006205789744853973
in O 0 0.006987434811890125
which O 0 0.027097420766949654
HLA O 1 0.988861620426178
- O 1 0.8418559432029724
D O 1 0.9189338684082031
segregared O 1 0.8707765936851501
with O 0 0.10796071588993073
HLA O 1 0.9778000116348267
- O 0 0.2962097227573395
A O 0 0.02069889008998871
and O 0 0.01187154371291399
B O 0 0.21585839986801147
. O 0 0.023219214752316475

These O 0 0.01866786554455757
studies O 0 0.023345453664660454
suggest O 0 0.013633071444928646
that O 0 0.004813613835722208
the O 0 0.005305139813572168
genes O 1 0.749303936958313
for O 0 0.010498053394258022
Factor O 1 0.5267966389656067
B O 1 0.6522762775421143
and O 0 0.04144904389977455
C2 B-Disease 1 0.9933884143829346
deficiency I-Disease 1 0.9962246417999268
are O 0 0.005314866546541452
located O 0 0.004402780905365944
outside O 0 0.0035673463717103004
those O 0 0.003013122593984008
for O 0 0.0045791687443852425
HLA O 1 0.8409836888313293
, O 0 0.0027654371224343777
that O 0 0.001873518223874271
the O 0 0.0020250556990504265
order O 0 0.0035352427512407303
of O 0 0.004217582289129496
genese O 1 0.6395514011383057
is O 0 0.03839056193828583
HLA O 1 0.9784634709358215
- O 0 0.280595064163208
A O 0 0.0193259809166193
, O 0 0.011742536909878254
- O 0 0.32516440749168396
B O 0 0.47275054454803467
, O 0 0.014830582775175571
- O 0 0.40805885195732117
D O 1 0.6317779421806335
, O 0 0.017292363569140434
Factor O 1 0.6235113143920898
B O 1 0.8041214942932129
allotype O 1 0.9093385338783264
, O 0 0.17116530239582062
C2 B-Disease 1 0.9932490587234497
deficiency I-Disease 1 0.996417760848999
, O 0 0.008825508877635002
that O 0 0.005756200756877661
the O 0 0.010451585054397583
genes O 1 0.9729836583137512
coding O 1 0.962925910949707
for O 0 0.2819538116455078
C2 B-Disease 1 0.9949530363082886
deficiency I-Disease 1 0.9975149631500244
and O 0 0.02147379331290722
Factor O 1 0.5385012626647949
B O 0 0.41960108280181885
allotypes O 0 0.23623909056186676
are O 0 0.004595665261149406
approximately O 0 0.008472722955048084
3 O 0 0.013457856141030788
- O 0 0.12322423607110977
- O 0 0.08793267607688904
5 O 0 0.015901464968919754
centimorgans O 0 0.3265385627746582
from O 0 0.007748868316411972
the O 0 0.010780208744108677
HLA O 1 0.9701629281044006
- O 0 0.26966777443885803
A O 0 0.030323466286063194
and O 0 0.02326616272330284
HLA O 1 0.9846631288528442
- O 1 0.709740400314331
B O 1 0.6493025422096252
loci O 1 0.8301281929016113
, O 0 0.004399878904223442
and O 0 0.002438702853396535
that O 0 0.0021305375266820192
the O 0 0.0030335693154484034
apparent O 0 0.029447568580508232
lack O 0 0.0102051617577672
of O 0 0.004606273956596851
recombinants O 0 0.3057667016983032
between O 0 0.01173441018909216
the O 0 0.01050635613501072
Factor O 1 0.8250061273574829
B O 1 0.9544629454612732
gene O 1 0.9923615455627441
and O 0 0.32467368245124817
C2 B-Disease 1 0.9969985485076904
deficiency I-Disease 1 0.9988226294517517
gene O 1 0.9778414964675903
suggests O 0 0.05721557140350342
that O 0 0.0035477657802402973
these O 0 0.0033644228242337704
two O 0 0.004682142753154039
genes O 1 0.7452678084373474
lie O 0 0.010177192278206348
in O 0 0.004261804278939962
close O 0 0.006462310906499624
proximity O 0 0.011959661729633808
to O 0 0.004678193014115095
one O 0 0.005890554748475552
another O 0 0.0129713024944067
. O 0 0.015689298510551453

Distribution O 0 0.04154651612043381
of O 0 0.01590847410261631
emerin O 0 0.17178119719028473
and O 0 0.009486197493970394
lamins O 0 0.3793732225894928
in O 0 0.008296527899801731
the O 0 0.00834992527961731
heart O 1 0.5148822069168091
and O 0 0.011103793978691101
implications O 0 0.35770976543426514
for O 0 0.03280987590551376
Emery B-Disease 1 0.907934844493866
- I-Disease 1 0.9249181151390076
Dreifuss I-Disease 1 0.9811036586761475
muscular I-Disease 1 0.9889472723007202
dystrophy I-Disease 1 0.9881014823913574
. O 0 0.15952257812023163

Emerin O 0 0.14743278920650482
is O 0 0.015867818146944046
a O 0 0.013762090355157852
nuclear O 0 0.024983985349535942
membrane O 0 0.27354320883750916
protein O 0 0.2503524720668793
which O 0 0.005057619884610176
is O 0 0.005196588113903999
missing O 0 0.01791791431605816
or O 0 0.023816045373678207
defective O 1 0.8957734107971191
in O 0 0.04653089493513107
Emery B-Disease 1 0.9289306402206421
- I-Disease 1 0.9436396360397339
Dreifuss I-Disease 1 0.9880974888801575
muscular I-Disease 1 0.9945693612098694
dystrophy I-Disease 1 0.9957529306411743
( O 1 0.6159095764160156
EDMD B-Disease 1 0.927791178226471
) O 0 0.06375975161790848
. O 0 0.028423994779586792

It O 0 0.010131138376891613
is O 0 0.0049324799329042435
one O 0 0.003066285513341427
member O 0 0.00399955827742815
of O 0 0.0027114630211144686
a O 0 0.005089569836854935
family O 0 0.013528615236282349
of O 0 0.006680795922875404
lamina O 1 0.9025598764419556
- O 0 0.4349993169307709
associated O 0 0.1688535362482071
proteins O 0 0.39278271794319153
which O 0 0.006472936365753412
includes O 0 0.013128608465194702
LAP1 O 1 0.5409363508224487
, O 0 0.01115261297672987
LAP2 O 1 0.6525890231132507
and O 0 0.02159802056849003
lamin O 1 0.9581733345985413
B O 1 0.8317450284957886
receptor O 1 0.9547824859619141
( O 0 0.23752768337726593
LBR O 1 0.9237737059593201
) O 0 0.043868985027074814
. O 0 0.024395836517214775

A O 0 0.029639115557074547
panel O 0 0.024672111496329308
of O 0 0.011515186168253422
16 O 0 0.07488521933555603
monoclonal O 1 0.9783211946487427
antibodies O 1 0.9825037121772766
( O 0 0.18986667692661285
mAbs O 1 0.8174686431884766
) O 0 0.007903612218797207
has O 0 0.0033786476124078035
been O 0 0.002845450770109892
mapped O 0 0.005162316374480724
to O 0 0.0022721998393535614
six O 0 0.0034820588771253824
specific O 0 0.005319718737155199
sites O 0 0.004903614055365324
throughout O 0 0.004985757637768984
the O 0 0.005221351515501738
emerin O 0 0.4466819763183594
molecule O 0 0.43621671199798584
using O 0 0.040658120065927505
phage O 1 0.9461067318916321
- O 0 0.1433217078447342
displayed O 0 0.02071511000394821
peptide O 1 0.6325181722640991
libraries O 0 0.011822208762168884
and O 0 0.0033601918257772923
has O 0 0.0029066489078104496
been O 0 0.002704991027712822
used O 0 0.0034837815910577774
to O 0 0.004098035395145416
localize O 1 0.6020058393478394
emerin O 0 0.41670188307762146
in O 0 0.011419226415455341
human O 0 0.11826921999454498
and O 0 0.020838117226958275
rabbit O 1 0.9415024518966675
heart O 1 0.9168162941932678
. O 0 0.050738632678985596

Several O 0 0.04088107496500015
mAbs O 0 0.4252673089504242
against O 0 0.01952463574707508
different O 0 0.015420554205775261
emerin O 0 0.4832383096218109
epitopes O 0 0.4953146278858185
did O 0 0.007321888115257025
not O 0 0.00430065393447876
recognize O 0 0.03186803311109543
intercalated O 0 0.3226785361766815
discs O 0 0.040389534085989
in O 0 0.004878400359302759
the O 0 0.004790574312210083
heart O 0 0.32657259702682495
, O 0 0.003301080549135804
though O 0 0.004200121387839317
they O 0 0.0028891826514154673
recognized O 0 0.015726227313280106
cardiomyocyte O 0 0.2711685001850128
nuclei O 0 0.15400145947933197
strongly O 0 0.007578080054372549
, O 0 0.0029936442151665688
both O 0 0.0025150806177407503
at O 0 0.0029770724941045046
the O 0 0.0029328956734389067
rim O 0 0.04527124762535095
and O 0 0.003915173467248678
in O 0 0.006896747276186943
intranuclear O 0 0.373140424489975
spots O 0 0.0782739594578743
or O 0 0.01910354755818844
channels O 0 0.05282934010028839
. O 0 0.023548416793346405

A O 0 0.07435572147369385
polyclonal O 1 0.9062204360961914
rabbit O 1 0.8721373677253723
antiserum O 1 0.7520870566368103
against O 0 0.02267475053668022
emerin O 0 0.1968422681093216
did O 0 0.00994162168353796
recognize O 0 0.016081063076853752
both O 0 0.006146163679659367
nuclear O 0 0.013775165192782879
membrane O 0 0.0995902344584465
and O 0 0.005001483019441366
intercalated O 0 0.2911035120487213
discs O 0 0.019775111228227615
but O 0 0.003966576419770718
, O 0 0.0035168167669326067
after O 0 0.005155634600669146
affinity O 0 0.07589927315711975
purification O 0 0.04939602315425873
against O 0 0.0062086815014481544
a O 0 0.006722819991409779
pure O 0 0.0265949796885252
- O 0 0.08963671326637268
emerin O 0 0.2090705782175064
band O 0 0.009466901421546936
on O 0 0.0036522834561765194
a O 0 0.005391295067965984
western O 0 0.007347683887928724
blot O 0 0.10804733633995056
, O 0 0.004757174756377935
it O 0 0.003827082458883524
stained O 0 0.09967699646949768
only O 0 0.004429759457707405
the O 0 0.005787570960819721
nuclear O 0 0.026385443285107613
membrane O 0 0.32073819637298584
. O 0 0.022088659927248955

These O 0 0.013490278273820877
results O 0 0.012906109914183617
would O 0 0.0041988808661699295
not O 0 0.0030310549773275852
be O 0 0.00209024571813643
expected O 0 0.003462498774752021
if O 0 0.00384490261785686
immunostaining O 0 0.07757236808538437
at O 0 0.004567435942590237
intercalated O 0 0.1904536336660385
discs O 0 0.012602785602211952
were O 0 0.002569283824414015
due O 0 0.003777791978791356
to O 0 0.0020415051840245724
a O 0 0.003016433212906122
product O 0 0.0046366010792553425
of O 0 0.002373632276430726
the O 0 0.0040068840608000755
emerin O 1 0.692563533782959
gene O 1 0.8238321542739868
and O 0 0.0035592433996498585
, O 0 0.002662941813468933
therefore O 0 0.003257537493482232
, O 0 0.002118566306307912
cast O 0 0.0029305536299943924
some O 0 0.0022014565765857697
doubt O 0 0.004625252448022366
upon O 0 0.00336208613589406
the O 0 0.004471036605536938
hypothesis O 1 0.7139663696289062
that O 0 0.12404143065214157
cardiac B-Disease 1 0.9972182512283325
defects I-Disease 1 0.9919375777244568
in O 0 0.06021610274910927
EDMD B-Disease 1 0.8498140573501587
are O 0 0.0066870274022221565
caused O 0 0.16023753583431244
by O 0 0.005931153427809477
absence O 0 0.02382039837539196
of O 0 0.006811566185206175
emerin O 0 0.3677418828010559
from O 0 0.01694791577756405
intercalated O 1 0.6686446070671082
discs O 0 0.15293703973293304
. O 0 0.03190256655216217

Although O 0 0.03252318128943443
emerin O 0 0.08720068633556366
was O 0 0.009571488946676254
abundant O 0 0.012718217447400093
in O 0 0.004732969217002392
the O 0 0.004450762178748846
membranes O 0 0.3014567196369171
of O 0 0.0060751717537641525
cardiomyocyte O 0 0.4302286207675934
nuclei O 0 0.15523268282413483
, O 0 0.0038664955645799637
it O 0 0.0025519365444779396
was O 0 0.0028039601165801287
absent O 0 0.018145879730582237
from O 0 0.00442957878112793
many O 0 0.0064596752636134624
non O 0 0.17449551820755005
- O 1 0.6143866777420044
myocyte O 1 0.9795661568641663
cells O 1 0.9276456832885742
in O 0 0.010213036090135574
the O 0 0.011567015200853348
heart O 1 0.7992040514945984
. O 0 0.031334854662418365

This O 0 0.014685110189020634
distribution O 0 0.0171896331012249
of O 0 0.006475010421127081
emerin O 0 0.06855059415102005
was O 0 0.004668486770242453
similar O 0 0.005551164969801903
to O 0 0.0024997268337756395
that O 0 0.00250079482793808
of O 0 0.003395957173779607
lamin O 1 0.5541039705276489
A O 0 0.007346536032855511
, O 0 0.003509741509333253
a O 0 0.005717746447771788
candidate O 0 0.03229868784546852
gene O 1 0.8487210869789124
for O 0 0.010280336253345013
an O 0 0.02998228929936886
autosomal O 1 0.9917089343070984
form O 0 0.09093782305717468
of O 0 0.017978709191083908
EDMD B-Disease 1 0.7993172407150269
. O 0 0.03561243787407875

In O 0 0.024922095239162445
contrast O 0 0.04986777901649475
, O 0 0.02122396230697632
lamin O 1 0.8759605288505554
B1 O 1 0.786442756652832
was O 0 0.012096942402422428
absent O 0 0.048350635915994644
from O 0 0.010089644230902195
cardiomyocyte O 1 0.5043824911117554
nuclei O 0 0.22133125364780426
, O 0 0.006475937087088823
showing O 0 0.01798778399825096
that O 0 0.00848019402474165
lamin O 1 0.9032673835754395
B1 O 1 0.7735194563865662
is O 0 0.004855440463870764
not O 0 0.0033501875586807728
essential O 0 0.006614831741899252
for O 0 0.0037993467412889004
localization O 0 0.04426422715187073
of O 0 0.0048646884970366955
emerin O 0 0.08726272732019424
to O 0 0.005316364578902721
the O 0 0.007957898080348969
nuclear O 0 0.03696327656507492
lamina O 1 0.7089952826499939
. O 0 0.02565523236989975

Lamin O 1 0.8923099637031555
B1 O 1 0.7501845359802246
is O 0 0.016149122267961502
also O 0 0.008903132751584053
almost O 0 0.010379166342318058
completely O 0 0.016802489757537842
absent O 0 0.128123939037323
from O 0 0.04299165681004524
skeletal O 1 0.9764629602432251
muscle O 1 0.9720825552940369
nuclei O 1 0.7318606376647949
. O 0 0.058442555367946625

In O 0 0.02632059156894684
EDMD B-Disease 0 0.24975024163722992
, O 0 0.010167157277464867
the O 0 0.006619386374950409
additional O 0 0.00906597450375557
absence O 0 0.02790355496108532
of O 0 0.013273162767291069
lamin O 1 0.968377411365509
B1 O 1 0.9764915108680725
from O 0 0.0842808336019516
heart O 1 0.9359363913536072
and O 0 0.05101713165640831
skeletal O 1 0.9883497953414917
muscle O 1 0.9826143383979797
nuclei O 0 0.4478788375854492
which O 0 0.007581096608191729
already O 0 0.010475093498826027
lack O 0 0.035432588309049606
emerin O 0 0.309522807598114
may O 0 0.00802611093968153
offer O 0 0.005389224737882614
an O 0 0.003317943075671792
alternative O 0 0.009378014132380486
explanation O 0 0.008327281102538109
of O 0 0.003189249662682414
why O 0 0.007225641515105963
these O 0 0.006412607617676258
tissues O 1 0.7279274463653564
are O 0 0.007061969954520464
particularly O 0 0.028787298128008842
affected O 0 0.14792394638061523
. O 0 0.013145897537469864
. O 0 0.01823551394045353

Genetic O 1 0.6662915349006653
mapping O 0 0.038548409938812256
of O 0 0.010199148207902908
the O 0 0.012045660987496376
copper B-Disease 0 0.2395888864994049
toxicosis I-Disease 1 0.9674363732337952
locus O 1 0.9284347891807556
in O 0 0.035463765263557434
Bedlington O 1 0.933558464050293
terriers O 1 0.7784695029258728
to O 0 0.015526917763054371
dog O 1 0.516166627407074
chromosome O 1 0.9306745529174805
10 O 0 0.007849376648664474
, O 0 0.004248773213475943
in O 0 0.003970583435148001
a O 0 0.005703581031411886
region O 0 0.013141593895852566
syntenic O 0 0.27991899847984314
to O 0 0.008960437029600143
human O 0 0.4044490158557892
chromosome O 1 0.9703810214996338
region O 0 0.1275150179862976
2p13 O 1 0.7559481263160706
- O 1 0.5552052855491638
p16 O 1 0.91234290599823
. O 0 0.04160613939166069

Abnormal O 1 0.974651038646698
hepatic B-Disease 1 0.9815334677696228
copper I-Disease 0 0.3444439470767975
accumulation I-Disease 1 0.5927431583404541
is O 0 0.012290879152715206
recognized O 0 0.021614395081996918
as O 0 0.007875696755945683
an O 0 0.054336778819561005
inherited B-Disease 1 0.9900446534156799
disorder I-Disease 1 0.9947551488876343
in O 0 0.018786130473017693
man O 0 0.04911786690354347
, O 0 0.01502012275159359
mouse O 1 0.8361650109291077
, O 0 0.0158535148948431
rat O 1 0.7475623488426208
and O 0 0.01436317153275013
dog O 0 0.22708682715892792
. O 0 0.027167150750756264

The O 0 0.02085033990442753
major O 0 0.02692018449306488
cause O 0 0.39338067173957825
of O 0 0.027091389521956444
hepatic B-Disease 1 0.988704264163971
copper I-Disease 0 0.37370774149894714
accumulation I-Disease 1 0.7130977511405945
in O 0 0.00995416659861803
man O 0 0.02139515057206154
is O 0 0.010539527982473373
a O 0 0.05066101625561714
dysfunctional O 1 0.9755033850669861
ATP7B O 1 0.9768956899642944
gene O 1 0.9877721071243286
, O 0 0.1414957344532013
causing O 1 0.9693106412887573
Wilson B-Disease 1 0.9593245387077332
disease I-Disease 1 0.9959285855293274
( O 1 0.6471756100654602
WD B-Disease 1 0.9769097566604614
) O 0 0.054401278495788574
. O 0 0.025471709668636322

Mutations O 1 0.8975396752357483
in O 0 0.01550186425447464
the O 0 0.01101832464337349
ATP7B O 1 0.6158567070960999
genes O 1 0.5471301078796387
have O 0 0.006017007399350405
also O 0 0.004769295919686556
been O 0 0.004550844430923462
demonstrated O 0 0.01465910766273737
in O 0 0.009697003290057182
mouse O 1 0.7038043737411499
and O 0 0.017057450488209724
rat O 1 0.8496217727661133
. O 0 0.036286383867263794

The O 0 0.030534008517861366
ATP7B O 1 0.7086169719696045
gene O 1 0.6648816466331482
has O 0 0.009569784626364708
been O 0 0.005853797309100628
excluded O 0 0.010812596417963505
in O 0 0.004331027157604694
the O 0 0.004522002302110195
much O 0 0.014044294133782387
rarer O 1 0.8980308771133423
human O 1 0.7094472646713257
copper B-Disease 1 0.9286707639694214
overload I-Disease 1 0.9933168888092041
disease O 1 0.9967371821403503
non B-Disease 1 0.7057234644889832
- I-Disease 1 0.7614883780479431
Indian I-Disease 0 0.2509254813194275
childhood I-Disease 1 0.9783483147621155
cirrhosis I-Disease 1 0.9923140406608582
, O 0 0.07446863502264023
indicating O 1 0.5730575919151306
genetic O 1 0.9758241772651672
heterogeneity O 1 0.8399983048439026
. O 0 0.039907485246658325

By O 0 0.03404565528035164
investigating O 0 0.05413372069597244
the O 0 0.037615712732076645
common O 1 0.9284482598304749
autosomal O 1 0.9965811371803284
recessive O 1 0.9952902793884277
copper B-Disease 1 0.9228222370147705
toxicosis I-Disease 1 0.9835258722305298
( O 0 0.4189210832118988
CT B-Disease 1 0.9394639730453491
) O 0 0.02435179054737091
in O 0 0.01225269678980112
Bedlington O 1 0.7714567184448242
terriers O 0 0.33797594904899597
, O 0 0.005429824348539114
we O 0 0.0031080315820872784
have O 0 0.0031815776601433754
identified O 0 0.007414925843477249
a O 0 0.006104328669607639
new O 0 0.010556175373494625
locus O 1 0.8977888822555542
involved O 0 0.2285235971212387
in O 0 0.16101251542568207
progressive O 1 0.9834496378898621
liver B-Disease 1 0.9976567029953003
disease I-Disease 1 0.9955612421035767
. O 0 0.19609662890434265

We O 0 0.020663058385252953
examined O 0 0.0353236123919487
whether O 0 0.015191459096968174
the O 0 0.01909814588725567
WD B-Disease 1 0.983951985836029
gene O 1 0.9640829563140869
ATP7B O 1 0.5451539158821106
was O 0 0.00783602986484766
also O 0 0.007044593337923288
causative O 1 0.8392360806465149
for O 0 0.011903534643352032
CT B-Disease 1 0.8300215005874634
by O 0 0.007752586621791124
investigating O 0 0.023826779797673225
the O 0 0.009832060895860195
chromosomal O 1 0.9840617775917053
co O 0 0.4406214952468872
- O 0 0.18620289862155914
localization O 0 0.23396292328834534
of O 0 0.0069327461533248425
ATP7B O 0 0.46524956822395325
and O 0 0.006189463194459677
C04107 O 0 0.13540945947170258
, O 0 0.0057338448241353035
using O 0 0.011178893968462944
fluorescence O 0 0.3460615277290344
in O 0 0.014326670207083225
situ O 1 0.7209657430648804
hybridization O 1 0.634107768535614
( O 0 0.045849502086639404
FISH O 0 0.03765268623828888
) O 0 0.02367294579744339
. O 0 0.021939821541309357

C04107 O 0 0.20696817338466644
is O 0 0.020331677049398422
an O 0 0.01726563461124897
anonymous O 0 0.15140515565872192
microsatellite O 1 0.8742963075637817
marker O 0 0.31730949878692627
closely O 0 0.08156317472457886
linked O 0 0.30499008297920227
to O 0 0.01885570026934147
CT B-Disease 1 0.8007425665855408
. O 0 0.03861631453037262

However O 0 0.029713522642850876
, O 0 0.0198089387267828
BAC O 1 0.7601633071899414
clones O 1 0.5290393829345703
containing O 0 0.04272075369954109
ATP7B O 0 0.3712884783744812
and O 0 0.00897662341594696
C04107 O 0 0.1138438954949379
mapped O 0 0.019637003540992737
to O 0 0.006590582896023989
the O 0 0.012826429679989815
canine O 1 0.9772742986679077
chromosome O 1 0.9854114651679993
regions O 0 0.2820209562778473
CFA22q11 O 1 0.52323317527771
and O 0 0.007292619440704584
CFA10q26 O 0 0.24468664824962616
, O 0 0.005408497992902994
respectively O 0 0.006892502773553133
, O 0 0.004413263406604528
demonstrating O 0 0.012649069540202618
that O 0 0.0079432912170887
WD B-Disease 1 0.9011067152023315
cannot O 0 0.013140710070729256
be O 0 0.007761343847960234
homologous O 1 0.7304290533065796
to O 0 0.016115782782435417
CT B-Disease 1 0.8792721629142761
. O 0 0.027501650154590607

The O 0 0.022222179919481277
copper O 0 0.058730196207761765
transport O 0 0.08517462760210037
genes O 1 0.8651965260505676
CTR1 O 0 0.387935072183609
and O 0 0.007839145138859749
CTR2 O 0 0.07332873344421387
were O 0 0.003968965727835894
also O 0 0.0038255227264016867
excluded O 0 0.011844824068248272
as O 0 0.004515616688877344
candidate O 0 0.018068300560116768
genes O 1 0.7680374979972839
for O 0 0.009833931922912598
CT B-Disease 1 0.7513458132743835
since O 0 0.008096858859062195
they O 0 0.00361843453720212
both O 0 0.005068520549684763
mapped O 0 0.04008498042821884
to O 0 0.014492223039269447
canine O 1 0.9693822264671326
chromosome O 1 0.9707074165344238
region O 0 0.11435258388519287
CFA11q22 O 1 0.6344943046569824
. O 0 0.03658110275864601

2 O 0 0.06574273109436035
- O 0 0.08405661582946777
22 O 0 0.04737012833356857
. O 0 0.03831539303064346

5 O 0 0.0899164006114006
. O 0 0.056635528802871704

A O 0 0.03504154831171036
transcribed O 0 0.08819203823804855
sequence O 0 0.03363940492272377
identified O 0 0.014719026163220406
from O 0 0.00785423070192337
the O 0 0.0074225980788469315
C04107 O 1 0.5180134177207947
- O 0 0.17306016385555267
containing O 0 0.0468875989317894
BAC O 0 0.476765513420105
was O 0 0.004388561937958002
found O 0 0.004384184256196022
to O 0 0.0024219031911343336
be O 0 0.0030908407643437386
homologous O 0 0.4668133556842804
to O 0 0.004383135586977005
a O 0 0.012210576795041561
gene O 1 0.8380417227745056
expressed O 0 0.02066314034163952
from O 0 0.017482582479715347
human O 1 0.641059935092926
chromosome O 1 0.9868636131286621
2p13 O 1 0.8635963797569275
- O 1 0.5431110858917236
p16 O 1 0.8748656511306763
, O 0 0.0065469578839838505
a O 0 0.007577807176858187
region O 0 0.009808510541915894
devoid O 0 0.01683753915131092
of O 0 0.0059212371706962585
any O 0 0.009372835978865623
positional O 0 0.21587111055850983
candidate O 0 0.07581661641597748
genes O 1 0.8455658555030823
. O 0 0.032124586403369904

Molecular O 0 0.25658151507377625
analysis O 0 0.025956513360142708
of O 0 0.008899540640413761
the O 0 0.010997113771736622
APC B-Disease 1 0.7858431339263916
gene O 1 0.8416568040847778
in O 0 0.01010308787226677
205 O 0 0.07724921405315399
families O 0 0.0504782535135746
: O 0 0.024751050397753716
extended O 0 0.16314753890037537
genotype O 1 0.9851258993148804
- O 1 0.899549126625061
phenotype O 1 0.989793062210083
correlations O 1 0.7836736440658569
in O 0 0.018729565665125847
FAP B-Disease 1 0.8473093509674072
and O 0 0.004318913910537958
evidence O 0 0.004333468619734049
for O 0 0.0030088627245277166
the O 0 0.003515046089887619
role O 0 0.008444827049970627
of O 0 0.007326941937208176
APC B-Disease 1 0.9138686656951904
amino O 1 0.9114360809326172
acid O 1 0.9699161648750305
changes O 1 0.7524124383926392
in O 1 0.7407815456390381
colorectal B-Disease 1 0.9986107349395752
cancer I-Disease 1 0.9974225759506226
predisposition O 1 0.9842920303344727
. O 0 0.15598644316196442

BACKGROUND O 0 0.14180690050125122
/ O 0 0.2015179842710495
AIMS O 0 0.03769763559103012
The O 0 0.009748215787112713
development O 0 0.07517184317111969
of O 0 0.19461800158023834
colorectal B-Disease 1 0.9985450506210327
cancer I-Disease 1 0.9952398538589478
and O 0 0.008740099146962166
a O 0 0.010392040014266968
variable O 0 0.19311968982219696
range O 0 0.015371170826256275
of O 0 0.011115302331745625
extracolonic O 1 0.8984655141830444
manifestations O 1 0.9561808705329895
in O 1 0.6946601867675781
familial B-Disease 1 0.9977210164070129
adenomatous I-Disease 1 0.9981961846351624
polyposis I-Disease 1 0.9972892999649048
( O 1 0.7873283624649048
FAP B-Disease 1 0.9802411794662476
) O 0 0.019942861050367355
is O 0 0.004137244075536728
the O 0 0.003895991947501898
result O 0 0.007730243727564812
of O 0 0.004358864855021238
the O 0 0.00819860864430666
dominant O 1 0.6599245071411133
inheritance O 1 0.9468221068382263
of O 1 0.5640853643417358
adenomatous B-Disease 1 0.9975148439407349
polyposis I-Disease 1 0.9972482323646545
coli I-Disease 1 0.9952471852302551
( O 1 0.8319674730300903
APC B-Disease 1 0.9712146520614624
) O 1 0.5675315856933594
gene O 1 0.9775676727294922
mutations O 1 0.9753417372703552
. O 0 0.05232974886894226

In O 0 0.013508985750377178
this O 0 0.008104397915303707
study O 0 0.012499460950493813
, O 0 0.005458433646708727
direct O 0 0.023313304409384727
mutation O 1 0.881058394908905
analysis O 0 0.013968207873404026
of O 0 0.004008684307336807
the O 0 0.0059403483755886555
APC B-Disease 1 0.8460573554039001
gene O 1 0.8454900979995728
was O 0 0.005196797661483288
performed O 0 0.009890883229672909
to O 0 0.0057005914859473705
determine O 0 0.15309733152389526
genotype O 1 0.9840618968009949
- O 1 0.8677880764007568
phenotype O 1 0.9879130721092224
correlations O 1 0.5030214786529541
for O 0 0.006346125155687332
nine O 0 0.01164732314646244
extracolonic O 0 0.429227739572525
manifestations O 0 0.14745333790779114
and O 0 0.0036265100352466106
to O 0 0.00367260305210948
investigate O 0 0.01786191761493683
the O 0 0.00840512104332447
incidence O 1 0.9703628420829773
of O 0 0.04791425168514252
APC B-Disease 1 0.9817306995391846
mutations O 1 0.9918312430381775
in O 0 0.13594754040241241
non O 1 0.840078592300415
- O 1 0.981486976146698
FAP O 1 0.9946594834327698
colorectal B-Disease 1 0.9974708557128906
cancer I-Disease 1 0.992004930973053
. O 0 0.20619219541549683

METHODS O 0 0.05543695017695427
The O 0 0.022497819736599922
APC B-Disease 1 0.7781074047088623
gene O 1 0.7075791358947754
was O 0 0.010245071724057198
analysed O 0 0.0340140238404274
in O 0 0.009805390611290932
190 O 0 0.07480178773403168
unrelated O 1 0.7647503614425659
FAP B-Disease 1 0.9497627019882202
and O 0 0.012416163459420204
15 O 0 0.09674787521362305
non O 1 0.7445876002311707
- O 1 0.9823249578475952
FAP O 1 0.9966979026794434
colorectal B-Disease 1 0.999093770980835
cancer I-Disease 1 0.9983892440795898
patients O 1 0.9893163442611694
using O 0 0.29636213183403015
denaturing O 1 0.9611111879348755
gradient O 1 0.8973473906517029
gel O 1 0.9624108672142029
electrophoresis O 1 0.8921131491661072
, O 0 0.009383060969412327
the O 0 0.007820401340723038
protein O 1 0.6655411124229431
truncation O 0 0.4590514302253723
test O 0 0.017992906272411346
, O 0 0.005908097140491009
and O 0 0.0060411421582102776
direct O 0 0.019603164866566658
sequencing O 0 0.21934039890766144
. O 0 0.02442558854818344

RESULTS O 0 0.11752624809741974
Chain O 0 0.18533413112163544
terminating O 0 0.1477385014295578
signals O 0 0.017869096249341965
were O 0 0.004415318835526705
only O 0 0.004136713687330484
identified O 0 0.01811624877154827
in O 0 0.008523310534656048
patients O 1 0.8594627976417542
belonging O 0 0.015901003032922745
to O 0 0.005941750481724739
the O 0 0.009790096431970596
FAP B-Disease 1 0.9665870666503906
group O 0 0.12357023358345032
( O 0 0.10984053462743759
105 O 0 0.1879482865333557
patients O 1 0.9677024483680725
) O 0 0.037272557616233826
. O 0 0.02232941798865795

Amino O 0 0.4895099103450775
acid O 1 0.5762494206428528
changes O 0 0.01958126574754715
were O 0 0.005118044558912516
identified O 0 0.0095891198143363
in O 0 0.004263666458427906
four O 0 0.006456319242715836
patients O 1 0.7154838442802429
, O 0 0.0031997356563806534
three O 0 0.002716776682063937
of O 0 0.0024739005602896214
whom O 0 0.0055851140059530735
belonged O 0 0.006175394635647535
to O 0 0.0029028235003352165
the O 0 0.005084644537419081
non O 0 0.18071146309375763
- O 1 0.8004171848297119
FAP O 1 0.9853541851043701
group O 1 0.5022150278091431
of O 1 0.6315053701400757
colorectal B-Disease 1 0.9986905455589294
cancer I-Disease 1 0.9974339604377747
patients O 1 0.9860581755638123
. O 0 0.1340085119009018

Genotype O 1 0.9530490636825562
- O 1 0.8789990544319153
phenotype O 1 0.9817153215408325
correlations O 1 0.7127078771591187
identified O 0 0.04421986639499664
significant O 0 0.013869503512978554
differences O 0 0.011486752890050411
in O 0 0.004028839059174061
the O 0 0.0033497547265142202
nature O 0 0.008982066996395588
of O 0 0.00470996368676424
certain O 0 0.05949104204773903
extracolonic O 1 0.8422410488128662
manifestations O 1 0.8685611486434937
in O 0 0.20844031870365143
FAP B-Disease 1 0.9917035102844238
patients O 1 0.9777613878250122
belonging O 0 0.053384386003017426
to O 0 0.010435745120048523
three O 0 0.023317158222198486
mutation O 1 0.9769514203071594
subgroups O 1 0.6456807255744934
. O 0 0.047029945999383926

CONCLUSIONS O 0 0.11971759796142578
Extended O 0 0.2466357946395874
genotype O 1 0.9652028679847717
- O 1 0.7509366869926453
phenotype O 1 0.9740806221961975
correlations O 0 0.22101670503616333
made O 0 0.0050764186307787895
in O 0 0.003440601285547018
this O 0 0.002580399625003338
study O 0 0.007798790466040373
may O 0 0.0035028208512812853
have O 0 0.0016804696060717106
the O 0 0.0016620442038401961
potential O 0 0.0043564047664403915
to O 0 0.0017205339390784502
determine O 0 0.0034459512680768967
the O 0 0.0024244021624326706
most O 0 0.003778554731979966
appropriate O 0 0.02407773770391941
surveillance O 0 0.1383027583360672
and O 0 0.015834137797355652
prophylactic O 1 0.9682799577713013
treatment O 1 0.9643335342407227
regimens O 1 0.9682593941688538
for O 0 0.016871152445673943
those O 0 0.08924775570631027
patients O 1 0.9868882298469543
with O 0 0.19000086188316345
mutations O 1 0.9933848977088928
associated O 0 0.30276739597320557
with O 0 0.02114144340157509
life O 0 0.10667361319065094
threatening O 1 0.7526189684867859
conditions O 0 0.37239381670951843
. O 0 0.04176105186343193

This O 0 0.014638294465839863
study O 0 0.011570686474442482
also O 0 0.004662442021071911
provided O 0 0.0053048329427838326
evidence O 0 0.004491725005209446
for O 0 0.0029088929295539856
the O 0 0.003995005507022142
pathological O 0 0.39798080921173096
nature O 0 0.01650732383131981
of O 0 0.005768384784460068
amino O 1 0.5845389366149902
acid O 1 0.8125309944152832
changes O 0 0.06092894449830055
in O 0 0.012263965792953968
APC O 1 0.8216728568077087
associated O 0 0.11312413215637207
with O 0 0.011618906632065773
both O 0 0.027075709775090218
FAP B-Disease 1 0.9717356562614441
and O 0 0.04805178940296173
non O 1 0.8376612663269043
- O 1 0.9878957271575928
FAP O 1 0.997163712978363
colorectal B-Disease 1 0.9990624785423279
cancer I-Disease 1 0.9978001713752747
patients O 1 0.9863134622573853
. O 0 0.06970228999853134
. O 0 0.037267740815877914

Inherited B-Disease 1 0.9820559620857239
colorectal I-Disease 1 0.9944948554039001
polyposis I-Disease 1 0.991452693939209
and O 0 0.3414251506328583
cancer B-Disease 1 0.9908532500267029
risk O 1 0.6714685559272766
of O 0 0.014312617480754852
the O 0 0.018586011603474617
APC O 1 0.8841447234153748
I1307K O 1 0.8325924873352051
polymorphism O 1 0.841332197189331
. O 0 0.03948875889182091

Germ O 1 0.8460158705711365
- O 0 0.13379499316215515
line O 0 0.02514522708952427
and O 0 0.017236104235053062
somatic O 1 0.9262862205505371
truncating O 1 0.9302195310592651
mutations O 1 0.9548718333244324
of O 0 0.008380205370485783
the O 0 0.014437493868172169
APC B-Disease 1 0.9373276233673096
gene O 1 0.9349772334098816
are O 0 0.007803614251315594
thought O 0 0.030321797356009483
to O 0 0.03633330762386322
initiate O 1 0.9732846617698669
colorectal B-Disease 1 0.9982573390007019
tumor I-Disease 1 0.9967265129089355
formation O 1 0.9697755575180054
in O 1 0.8819469809532166
familial B-Disease 1 0.9972937703132629
adenomatous I-Disease 1 0.9979283809661865
polyposis I-Disease 1 0.9977203011512756
syndrome I-Disease 1 0.9970333576202393
and O 0 0.41065919399261475
sporadic O 1 0.9708483219146729
colorectal O 1 0.9954250454902649
carcinogenesis O 1 0.9706658720970154
, O 0 0.023777028545737267
respectively O 0 0.03273804485797882
. O 0 0.028067631646990776

Recently O 0 0.04160819202661514
, O 0 0.015057479962706566
an O 0 0.014894381165504456
isoleucine O 1 0.7407795786857605
- O 1 0.5349645614624023
- O 1 0.6214579343795776
> O 1 0.8453847765922546
lysine O 1 0.802618145942688
polymorphism O 1 0.724561870098114
at O 0 0.021252183243632317
codon O 1 0.771176278591156
1307 O 1 0.8387124538421631
( O 0 0.04716156795620918
I1307K O 0 0.22860299050807953
) O 0 0.007038802374154329
of O 0 0.003343623597174883
the O 0 0.005624375771731138
APC B-Disease 1 0.8634956479072571
gene O 1 0.8817183971405029
has O 0 0.004777452442795038
been O 0 0.003227673005312681
identified O 0 0.006601103115826845
in O 0 0.003152356017380953
6 O 0 0.0067730252631008625
% O 0 0.013833743520081043
- O 0 0.03226197883486748
7 O 0 0.006058122031390667
% O 0 0.006542360410094261
of O 0 0.003588445018976927
the O 0 0.005667830817401409
Ashkenazi O 0 0.3821728527545929
Jewish O 0 0.03487681224942207
population O 0 0.03999589383602142
. O 0 0.020520923659205437

To O 0 0.015608061105012894
assess O 0 0.026230281218886375
the O 0 0.008126499131321907
risk O 0 0.19806045293807983
of O 0 0.005699294153600931
this O 0 0.008179866708815098
common O 0 0.3504326641559601
APC B-Disease 1 0.963887095451355
allelic O 1 0.9838733077049255
variant O 1 0.9796568751335144
in O 0 0.29993736743927
colorectal O 1 0.9962827563285828
carcinogenesis O 1 0.9594491720199585
, O 0 0.006505733355879784
we O 0 0.003580530174076557
have O 0 0.0033610700629651546
analyzed O 0 0.009552222676575184
a O 0 0.005474256817251444
large O 0 0.007036216557025909
cohort O 0 0.17609059810638428
of O 0 0.008434940129518509
unselected O 1 0.6562501788139343
Ashkenazi O 1 0.7326032519340515
Jewish O 0 0.09445955604314804
subjects O 0 0.22643668949604034
with O 0 0.34771373867988586
adenomatous B-Disease 1 0.9968851208686829
polyps I-Disease 1 0.9942617416381836
and O 0 0.041658416390419006
. O 0 0.12485697120428085
or O 1 0.7616121768951416
colorectal B-Disease 1 0.9985675811767578
cancer I-Disease 1 0.9962896108627319
, I-Disease 0 0.013313103467226028
for O 0 0.008408579975366592
the O 0 0.013789708726108074
APC O 1 0.9081723093986511
I1307K O 1 0.8654958009719849
polymorphism O 1 0.8863405585289001
. O 0 0.04221413657069206

The O 0 0.03792059049010277
APC O 1 0.7803955674171448
I1307K O 1 0.6910518407821655
allele O 1 0.8206585049629211
was O 0 0.009649606421589851
identified O 0 0.01362383272498846
in O 0 0.005196156911551952
48 O 0 0.009099029004573822
( O 0 0.007253720890730619
10 O 0 0.004266890697181225
. O 0 0.0032357999589294195
1 O 0 0.005610350053757429
% O 0 0.010170185007154942
) O 0 0.010065924376249313
of O 0 0.009767296724021435
476 O 1 0.6336236596107483
patients O 1 0.958479106426239
. O 0 0.04644366726279259

Compared O 0 0.02932976372539997
with O 0 0.010136988013982773
the O 0 0.006246472243219614
frequency O 0 0.013378082774579525
in O 0 0.0036248944234102964
two O 0 0.0030731246806681156
separate O 0 0.007753962650895119
population O 0 0.008898960426449776
control O 0 0.013329788111150265
groups O 0 0.007557269185781479
, O 0 0.004043894354254007
the O 0 0.006345406174659729
APC O 1 0.8874084949493408
I1307K O 1 0.8910934925079346
allele O 1 0.9501931071281433
is O 0 0.011188502423465252
associated O 0 0.029699819162487984
with O 0 0.004587244242429733
an O 0 0.004191143903881311
estimated O 0 0.01614968292415142
relative O 0 0.038461338728666306
risk O 0 0.3092336058616638
of O 0 0.008074157871305943
1 O 0 0.017257900908589363
. O 0 0.017988303676247597

5 O 0 0.06904537975788116
- O 0 0.09263978898525238
1 O 0 0.04323353245854378
. O 0 0.03716474026441574

7 O 0 0.07764139026403427
for O 0 0.11393840610980988
colorectal B-Disease 1 0.9914603233337402
neoplasia I-Disease 1 0.9746730327606201
( O 0 0.07317649573087692
both O 0 0.01996655762195587
P O 0 0.4360101819038391
= O 0 0.2987178862094879
. O 0 0.015713686123490334
01 O 0 0.4200647473335266
) O 0 0.028554243966937065
. O 0 0.021854311227798462

Furthermore O 0 0.05076270550489426
, O 0 0.01578361913561821
compared O 0 0.020091529935598373
with O 0 0.013285858556628227
noncarriers O 0 0.37372082471847534
, O 0 0.014969870448112488
APC O 1 0.7068011164665222
I1307K O 0 0.45244526863098145
carriers O 0 0.14812661707401276
had O 0 0.007987190037965775
increased O 0 0.01731526106595993
numbers O 0 0.013436987064778805
of O 0 0.025722183287143707
adenomas B-Disease 1 0.9928038716316223
and O 0 0.47055163979530334
colorectal B-Disease 1 0.9987712502479553
cancers I-Disease 1 0.9970183372497559
per O 0 0.3718200623989105
patient O 1 0.9784634709358215
( O 0 0.28970685601234436
P O 1 0.695557713508606
= O 0 0.3213917016983032
. O 0 0.00803960021585226
03 O 0 0.18172523379325867
) O 0 0.005605512764304876
, O 0 0.0023193967062979937
as O 0 0.0022472834680229425
well O 0 0.0024626615922898054
as O 0 0.0026177719701081514
a O 0 0.0060998741537332535
younger O 0 0.10598498582839966
age O 0 0.11056164652109146
at O 0 0.05167807638645172
diagnosis O 1 0.981381893157959
. O 0 0.04768029972910881

We O 0 0.01576286368072033
conclude O 0 0.021777497604489326
that O 0 0.007623135577887297
the O 0 0.010047169402241707
APC O 1 0.8037498593330383
I1307K O 1 0.7804825901985168
variant O 1 0.8702486753463745
leads O 0 0.08698856085538864
to O 0 0.008247002959251404
increased O 0 0.2935483455657959
adenoma B-Disease 1 0.991058349609375
formation O 0 0.13332802057266235
and O 0 0.003782541723921895
directly O 0 0.0059101777151227
contributes O 0 0.031162353232502937
to O 0 0.003565770573914051
3 O 0 0.007581046782433987
% O 0 0.017545735463500023
- O 0 0.04465286061167717
4 O 0 0.006631248630583286
% O 0 0.007509913295507431
of O 0 0.004982775542885065
all O 0 0.009123852476477623
Ashkenazi O 1 0.878953754901886
Jewish O 1 0.8404725790023804
colorectal B-Disease 1 0.9969238638877869
cancer I-Disease 1 0.9930858612060547
. O 0 0.15120764076709747

The O 0 0.021726539358496666
estimated O 0 0.02658146061003208
relative O 0 0.07040312141180038
risk O 0 0.4798687994480133
for O 0 0.008359611965715885
carriers O 0 0.2727075219154358
may O 0 0.021601656451821327
justify O 0 0.047620680183172226
specific O 0 0.03737637400627136
clinical O 1 0.7006935477256775
screening O 0 0.05318322032690048
for O 0 0.0030434115324169397
the O 0 0.0031182619277387857
360 O 0 0.008967803791165352
, O 0 0.0031865143682807684
000 O 0 0.009445128031075
Americans O 0 0.0056815845891833305
expected O 0 0.0036107408814132214
to O 0 0.002841735491529107
harbor O 0 0.009566801600158215
this O 0 0.003656096290796995
allele O 1 0.7406477928161621
, O 0 0.0038682897575199604
and O 0 0.00365426205098629
genetic O 1 0.7622149586677551
testing O 0 0.023003745824098587
in O 0 0.00308044976554811
the O 0 0.002770046005025506
setting O 0 0.0063533540815114975
of O 0 0.004037580918520689
long O 0 0.061961278319358826
- O 0 0.25500449538230896
term O 0 0.15200470387935638
- O 0 0.34307101368904114
outcome O 0 0.1735759973526001
studies O 0 0.20742107927799225
may O 0 0.0970107913017273
impact O 0 0.3429805636405945
significantly O 1 0.8647602796554565
on O 0 0.4003913700580597
colorectal B-Disease 1 0.998936116695404
cancer I-Disease 1 0.9984334111213684
prevention O 1 0.9736627340316772
in O 0 0.015921125188469887
this O 0 0.011943100951611996
population O 0 0.04605467990040779
. O 0 0.02319657802581787

Localization O 0 0.12877677381038666
of O 0 0.017015589401125908
human O 0 0.1780952662229538
BRCA1 O 1 0.9715873003005981
and O 0 0.007272655144333839
its O 0 0.006931541487574577
loss O 0 0.0491228885948658
in O 0 0.007101596798747778
high O 0 0.025832099840044975
- O 0 0.27161696553230286
grade O 0 0.17374549806118011
, O 0 0.016371382400393486
non B-Disease 0 0.3762596845626831
- I-Disease 1 0.9362353682518005
inherited I-Disease 1 0.9911640882492065
breast I-Disease 1 0.9952722191810608
carcinomas I-Disease 1 0.9885591864585876
. O 0 0.14699727296829224

Although O 0 0.02363503910601139
the O 0 0.013737835921347141
link O 0 0.07850959897041321
between O 0 0.025548087432980537
the O 0 0.17394158244132996
BRCA1 O 1 0.9969748258590698
tumour B-Disease 1 0.9969929456710815
- O 1 0.9838829636573792
suppressor O 1 0.9946990013122559
gene O 1 0.9916839599609375
and O 0 0.41736429929733276
hereditary B-Disease 1 0.9958769083023071
breast I-Disease 1 0.9980409741401672
and I-Disease 1 0.8256092667579651
ovarian I-Disease 1 0.9990466237068176
cancer I-Disease 1 0.996898889541626
is O 0 0.016382604837417603
established O 0 0.008755273185670376
, O 0 0.003254187759011984
the O 0 0.0025984549429267645
role O 0 0.007190727163106203
, O 0 0.002641234314069152
if O 0 0.002380859572440386
any O 0 0.002503041410818696
, O 0 0.0027679521590471268
of O 0 0.005445241928100586
BRCA1 O 1 0.9906634092330933
in O 0 0.040653128176927567
non B-Disease 1 0.7366698980331421
- I-Disease 1 0.9635439515113831
familial I-Disease 1 0.9954202771186829
cancers I-Disease 1 0.994968593120575
is O 0 0.044658973813056946
unclear O 0 0.08462309837341309
. O 0 0.02798464335501194

BRCA1 O 1 0.9818488359451294
mutations O 1 0.9603204131126404
are O 0 0.02007744275033474
rare O 0 0.21940626204013824
in O 0 0.028254734352231026
sporadic B-Disease 1 0.832832932472229
cancers I-Disease 1 0.991999089717865
, O 0 0.00815563090145588
but O 0 0.005812184419482946
loss O 0 0.07716520130634308
of O 0 0.012337098829448223
BRCA1 O 1 0.9895780682563782
resulting O 0 0.26386213302612305
from O 0 0.009445109404623508
reduced O 0 0.08745957911014557
expression O 0 0.16566382348537445
or O 0 0.012507177889347076
incorrect O 0 0.10338485985994339
subcellular O 0 0.4317319393157959
localization O 0 0.23815716803073883
is O 0 0.004506775643676519
postulated O 0 0.025675524026155472
to O 0 0.0031059079337865114
be O 0 0.002460749354213476
important O 0 0.004164983984082937
in O 0 0.011437381617724895
non B-Disease 1 0.7182679176330566
- I-Disease 1 0.980993390083313
familial I-Disease 1 0.9975185394287109
breast I-Disease 1 0.9978681802749634
and I-Disease 1 0.8510039448738098
ovarian I-Disease 1 0.9982587695121765
cancers I-Disease 1 0.9957205653190613
. O 0 0.24968639016151428

Epigenetic O 1 0.8523358702659607
loss O 0 0.05631702393293381
, O 0 0.00968671590089798
however O 0 0.006346013862639666
, O 0 0.0038465354591608047
has O 0 0.003480432787910104
not O 0 0.0026339690666645765
received O 0 0.003954242914915085
general O 0 0.003563494188711047
acceptance O 0 0.022332843393087387
due O 0 0.006531982216984034
to O 0 0.0034051781985908747
controversy O 0 0.011069153435528278
regarding O 0 0.005756190046668053
the O 0 0.0043841092847287655
subcellular O 0 0.44963446259498596
localization O 0 0.3990853428840637
of O 0 0.019444679841399193
BRCA1 O 1 0.9939876794815063
proteins O 1 0.5822954177856445
, O 0 0.0034641737584024668
reports O 0 0.003473161719739437
of O 0 0.001980535453185439
which O 0 0.0018530222587287426
have O 0 0.0019012927077710629
ranged O 0 0.005985547322779894
from O 0 0.0031924571376293898
exclusively O 0 0.004723275545984507
nuclear O 0 0.005595064256340265
, O 0 0.002565910806879401
to O 0 0.00247178110294044
conditionally O 0 0.01552241574972868
nuclear O 0 0.0067309667356312275
, O 0 0.0031452015973627567
to O 0 0.003402597736567259
the O 0 0.006500046234577894
ER O 1 0.8684495687484741
/ O 1 0.6076581478118896
golgi O 1 0.6812845468521118
, O 0 0.007580507546663284
to O 0 0.006678126286715269
cytoplasmic O 1 0.5252686738967896
invaginations O 0 0.1662193089723587
into O 0 0.010590226389467716
the O 0 0.01122648548334837
nucleus O 0 0.2871517539024353
. O 0 0.028213661164045334

In O 0 0.014321655035018921
an O 0 0.00804266519844532
attempt O 0 0.010744523257017136
to O 0 0.004592071287333965
resolve O 0 0.01055943313986063
this O 0 0.0032512901816517115
issue O 0 0.004593092016875744
, O 0 0.00284745404496789
we O 0 0.0026595033705234528
have O 0 0.004207550548017025
comprehensively O 0 0.07710786908864975
characterized O 0 0.4409067928791046
19 O 0 0.06784570962190628
anti O 1 0.5816535353660583
- O 1 0.9265026450157166
BRCA1 O 1 0.9916321635246277
antibodies O 1 0.9715240597724915
. O 0 0.06931398808956146

These O 0 0.028942130506038666
reagents O 0 0.2931034564971924
detect O 0 0.1983032524585724
a O 0 0.01716085895895958
220 O 0 0.05275692418217659
- O 0 0.45228299498558044
kD O 1 0.8917688131332397
protein O 1 0.8517853617668152
localized O 1 0.7765466570854187
in O 0 0.010124982334673405
discrete O 0 0.16204872727394104
nuclear O 0 0.03755175322294235
foci O 1 0.516548216342926
in O 0 0.006582876667380333
all O 0 0.007058923132717609
epithelial O 1 0.9815927147865295
cell O 1 0.8006213903427124
lines O 0 0.039102327078580856
, O 0 0.004243297502398491
including O 0 0.005093986168503761
those O 0 0.006352746859192848
derived O 0 0.12613971531391144
from O 0 0.10125303268432617
breast B-Disease 1 0.9894564747810364
malignancies I-Disease 1 0.9768130779266357
. O 0 0.07934243977069855

Immunohistochemical O 1 0.9110426306724548
staining O 1 0.7809613943099976
of O 0 0.029391855001449585
human O 1 0.7279024124145508
breast O 1 0.9905523061752319
specimens O 0 0.4418359398841858
also O 0 0.031041018664836884
revealed O 1 0.5145202279090881
BRCA1 O 1 0.9896965026855469
nuclear O 0 0.43263673782348633
foci O 1 0.961145281791687
in O 0 0.36254677176475525
benign O 1 0.9932610392570496
breast O 1 0.9960246086120605
, O 1 0.6078194975852966
invasive B-Disease 1 0.9934712648391724
lobular I-Disease 1 0.994932234287262
cancers I-Disease 1 0.9947267174720764
and O 0 0.062071748077869415
low B-Disease 1 0.6153193712234497
- I-Disease 1 0.8256088495254517
grade I-Disease 1 0.8874097466468811
ductal I-Disease 1 0.9879255294799805
carcinomas I-Disease 1 0.9819174408912659
. O 0 0.11407571285963058

Conversely O 0 0.20382367074489594
, O 0 0.031113138422369957
BRCA1 O 1 0.9640515446662903
expression O 0 0.1097857877612114
was O 0 0.009327387437224388
reduced O 0 0.039739396423101425
or O 0 0.011600421741604805
undetectable O 0 0.4544370472431183
in O 0 0.0040605501271784306
the O 0 0.0034118208568543196
majority O 0 0.0063986326567828655
of O 0 0.004267626442015171
high O 0 0.022873688489198685
- O 0 0.32529497146606445
grade O 0 0.42535749077796936
, O 0 0.0760713592171669
ductal B-Disease 1 0.9937615990638733
carcinomas I-Disease 1 0.9887723326683044
, O 0 0.00927048735320568
suggesting O 0 0.034119561314582825
that O 0 0.004405361134558916
absence O 0 0.040081936866045
of O 0 0.009963907301425934
BRCA1 O 1 0.9901584982872009
may O 0 0.03373633697628975
contribute O 0 0.024652520194649696
to O 0 0.0036200322210788727
the O 0 0.004539972171187401
pathogenesis O 1 0.8326179385185242
of O 0 0.003607426304370165
a O 0 0.006054361816495657
significant O 0 0.014577632769942284
percentage O 0 0.047922514379024506
of O 0 0.027455512434244156
sporadic B-Disease 1 0.9693579077720642
breast I-Disease 1 0.9967533946037292
cancers I-Disease 1 0.9945525527000427
. O 0 0.052535030990839005
. O 0 0.031878113746643066

